PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bradley, J; Baltus, A; Skaletsky, H; Royce-Tolland, M; Dewar, K; Page, DC				Bradley, J; Baltus, A; Skaletsky, H; Royce-Tolland, M; Dewar, K; Page, DC			An X-to-autosome retrogene is required for spermatogenesis in mice	NATURE GENETICS			English	Article							SPERMATOGONIAL DEPLETION JSD; PROCESSED PSEUDOGENES; GENE; RETROPOSON; TESTIS; MOUSE; IDENTIFICATION; EXPRESSION; PROTEIN; PROLIFERATION	We identified the gene carrying the juvenile spermatogonial depletion mutation (jsd), a recessive spermatogenic defect mapped to mouse chromosome 1 (refs. 1,2). We localized jsd to a 272-kb region and resequenced this area to identify the underlying mutation: a frameshift that severely truncates the predicted protein product of a 2.3-kb genomic open reading frame. This gene, Utp14b, evidently arose through reverse transcription of an mRNA from an X-linked gene and integration of the resulting cDNA into an intron of an autosomal gene, whose promoter and 5' untranslated exons are shared with Utp14b. To our knowledge, Utp14b is the first protein-coding retrogene to be linked to a recessive mammalian phenotype. The X-linked progenitor of Utp14b is the mammalian ortholog of yeast Utp14, which encodes a protein required for processing of pre-rRNA(3) and hence for ribosome assembly. Our findings substantiate the hypothesis(4) that mammalian spermatogenesis is supported by autosomal retrogenes that evolved from X-linked housekeeping genes to compensate for silencing of the X chromosome during male meiosis(5-7). We find that Utp14b-like retrogenes arose independently and were conserved during evolution in at least four mammalian lineages. This recurrence implies a strong selective pressure, perhaps to enable ribosome assembly in male meiotic cells.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.							ASHWORTH A, 1990, EMBO J, V9, P1529, DOI 10.1002/j.1460-2075.1990.tb08271.x; Banks KG, 2003, GENOMICS, V82, P254, DOI 10.1016/S0888-7543(03)00155-1; BEAMER WG, 1988, BIOL REPROD, V38, P899, DOI 10.1095/biolreprod38.4.899; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; Boettger-Tong HL, 2000, BIOL REPROD, V63, P1185, DOI 10.1095/biolreprod63.4.1185; Boettger-Tong HL, 2001, BIOCHEM BIOPH RES CO, V288, P1129, DOI 10.1006/bbrc.2001.5899; Chen HH, 2002, GENOMICS, V80, P140, DOI 10.1006/geno.2002.6808; Cremers Frans P. M., 1992, Human Molecular Genetics, V1, P71, DOI 10.1093/hmg/1.2.71; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Dass B, 2001, J BIOL CHEM, V276, P8044, DOI 10.1074/jbc.M009091200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; HANDEL MA, 1994, CYTOGENET CELL GENET, V66, P83, DOI 10.1159/000133672; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Kojima Y, 1997, Int J Urol, V4, P500, DOI 10.1111/j.1442-2042.1997.tb00293.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARDON G, 1990, MOL CELL BIOL, V10, P681, DOI 10.1128/MCB.10.2.681; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Nagase T., 1996, DNA RES, V3; Ohta H, 2001, INT J ANDROL, V24, P15, DOI 10.1046/j.1365-2605.2001.00257.x; RICHLER C, 1994, MOL BIOL CELL, V5, P1341, DOI 10.1091/mbc.5.12.1341; SARGENT CA, 1994, HUM MOL GENET, V3, P1317, DOI 10.1093/hmg/3.8.1317; Scanlan M J, 2001, Cancer Immun, V1, P4; Sedlacek Z, 1999, GENOMICS, V61, P125, DOI 10.1006/geno.1999.5931; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Tohda A, 2001, BIOL REPROD, V65, P532, DOI 10.1095/biolreprod65.2.532; Uechi T, 2002, NUCLEIC ACIDS RES, V30, P5369, DOI 10.1093/nar/gkf696; VANIN EF, 1984, BIOCHIM BIOPHYS ACTA, V782, P231, DOI 10.1016/0167-4781(84)90057-5; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	31	86	90	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2004	36	8					872	876		10.1038/ng1390	http://dx.doi.org/10.1038/ng1390			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15258580				2022-12-27	WOS:000222974000021
J	Evgrafov, OV; Mersiyanova, I; Irobi, J; Van Den Bosch, L; Dierick, I; Leung, CL; Schagina, O; Verpoorten, N; Van Impe, K; Fedotov, V; Dadali, E; Auer-Grumbach, M; Windpassinger, C; Wagner, K; Mitrovic, Z; Hilton-Jones, D; Talbot, K; Martin, JJ; Vasserman, N; Tverskaya, S; Polyakov, A; Liem, RKH; Gettemans, J; Robberecht, W; De Jonghe, P; Timmerman, V				Evgrafov, OV; Mersiyanova, I; Irobi, J; Van Den Bosch, L; Dierick, I; Leung, CL; Schagina, O; Verpoorten, N; Van Impe, K; Fedotov, V; Dadali, E; Auer-Grumbach, M; Windpassinger, C; Wagner, K; Mitrovic, Z; Hilton-Jones, D; Talbot, K; Martin, JJ; Vasserman, N; Tverskaya, S; Polyakov, A; Liem, RKH; Gettemans, J; Robberecht, W; De Jonghe, P; Timmerman, V			Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy	NATURE GENETICS			English	Article							ALPHA-B-CRYSTALLIN; SPINAL MUSCULAR-ATROPHY; MISSENSE MUTATION; UP-REGULATION; HSP27; PROTEIN; TYPE-2; MAPS; GENE; MYOPATHY	Charcot-Marie-Tooth disease (CMT) is the most common inherited neuromuscular disease and is characterized by considerable clinical and genetic heterogeneity(1). We previously reported a Russian family with autosomal dominant axonal CMT and assigned the locus underlying the disease (CMT2F; OMIM 606595) to chromosome 7q11-q21 (ref. 2). Here we report a missense mutation in the gene encoding 27-kDa small heat-shock protein 131 (HSPB1, also called HSP27) that segregates in the family with CMT2F Screening for mutations in HSPB1 in 301 individuals with CMT and 115 individuals with distal hereditary motor neuropathies (distal HMNs) confirmed the previously observed mutation and identified four additional missense mutations. We observed the additional HSPB1 mutations in four families with distal HMN and in one individual with CMT neuropathy. Four mutations are located in the Hsp20-alpha-crystallin domain, and one mutation is in the C-terminal part of the HSP27 protein. Neuronal cells transfected with mutated HSPB1 were less viable than cells expressing the wild-type protein. Cotransfection of neurofilament light chain (NEFL) and mutant HSPB1 resulted in altered neurofilament assembly in cells devoid of cytoplasmic intermediate filaments.	New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, Dept Psychiat, Unit 28, New York, NY 10032 USA; Russian Acad Med Sci, Med Genet Res Ctr, DNA Diagnost Lab, Moscow, Russia; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Katholieke Univ Leuven, Dept Expt Neurol, Neurobiol Lab, Louvain, Belgium; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; State Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Ctr Diagnost, Genet Counseling Dept, Voronezh, Russia; Med Univ Graz, Inst Med Biol & Human Genet, Graz, Austria; Univ Zagreb, Sch Med, Clin Hosp Ctr, Dept Neurol,Ctr Neuromuscular Dis, Zagreb 41001, Croatia; Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 2JD, England; Univ Antwerp, Born Bunge Fdn, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium	New York State Psychiatry Institute; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Flanders Institute for Biotechnology (VIB); University of Antwerp; KU Leuven; Columbia University; Flanders Institute for Biotechnology (VIB); Ghent University; Medical University of Graz; University of Zagreb; Radcliffe Infirmary; University of Oxford; University of Antwerp; University of Antwerp	Evgrafov, OV (corresponding author), New York State Psychiat Inst & Hosp, Res Fdn Mental Hyg, Dept Psychiat, Unit 28, 1051 Riverside Dr, New York, NY 10032 USA.	Evgrafo@pi.cpmc.columbia.edu	Shchagina, Olga/W-4835-2018; Talbot, Kevin/F-7361-2011; Van Den Bosch, Ludo/B-7258-2012; Dadali, Elena/AFG-0883-2022; Timmerman, Vincent/O-7283-2019	Shchagina, Olga/0000-0003-4905-1303; Dadali, Elena/0000-0001-5602-2805; Timmerman, Vincent/0000-0002-2162-0933; Talbot, Kevin/0000-0001-5490-1697; Van Den Bosch, Ludo/0000-0003-0104-4067				Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Batulan Z, 2003, J NEUROSCI, V23, P5789; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; CARPER SW, 1990, NUCLEIC ACIDS RES, V18, P6457, DOI 10.1093/nar/18.21.6457; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; HARDING AE, 1980, J NEUROL SCI, V45, P337, DOI 10.1016/0022-510X(80)90177-X; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; IROBI J, 2004, NAT GENET; Ismailov SM, 2001, EUR J HUM GENET, V9, P646, DOI 10.1038/sj.ejhg.5200686; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Nelis E, 2004, J MED GENET, V41, P193, DOI 10.1136/jmg.2003.012633; Perez-Olle R, 2002, J CELL SCI, V115, P4937, DOI 10.1242/jcs.00148; Perng MD, 1999, J CELL SCI, V112, P2099; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tang BS, 2004, HUM GENET, V114, P527, DOI 10.1007/s00439-004-1102-1; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	30	459	490	1	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2004	36	6					602	606		10.1038/ng1354	http://dx.doi.org/10.1038/ng1354			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122254	Bronze			2022-12-27	WOS:000221763700017
J	Chae, TH; Kim, S; Marz, KE; Hanson, PI; Walsh, CA				Chae, TH; Kim, S; Marz, KE; Hanson, PI; Walsh, CA			The hyh mutation uncovers roles for alpha Snap in apical protein localization and control of neural cell fate	NATURE GENETICS			English	Article							DROSOPHILA NEUROBLAST; ASYMMETRIC DIVISIONS; COMPLEX; MOUSE; TRAFFICKING; FUSION; GENE; PROLIFERATION; HYDROCEPHALUS; CHROMOSOME-7	The hyh (hydrocephalus with hop gait) mouse shows a markedly small cerebral cortex at birth and dies postnatally from progressive enlargement of the ventricular system(1,2). Here we show that the small hyh cortex reflects altered cell fate. Neural progenitor cells withdraw prematurely from the cell cycle, producing more early-born, deep-layer cerebral cortical neurons but depleting the cortical progenitor pool, such that late-born, upper-layer cortical neurons are underproduced, creating a small cortex. hyh mice carry a hypomorphic missense mutation in the gene Napa encoding solubleN- ethylmaleimide-sensitive factor (NSF) attachment protein alpha (alphaSnap), involved in SNAP receptor (SNARE)- mediated vesicle fusion in many cellular contexts. A targeted null Napa mutation is embryonically lethal. Altered neural cell fate is accompanied by abnormal localization of many apical proteins implicated in regulation of neural cell fate, including E-cadherin, beta-catenin, atypical protein kinase C (aPKC) and INADL(inactivation-no-afterpotential D-like, also known as protein associated with Lin7, or Pals1). Apical localization of the SNARE Vamp7 is also disrupted. Thus, Snap is essential for apical protein localization and cell fate determination in neuroepithelial cells.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL)	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, HIM 816,4 Blackfan Circle, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	Hanson, Phyllis/E-9420-2012	Walsh, Christopher/0000-0002-0156-2238				Bogdanovic A, 2002, BIOCHEM J, V368, P29, DOI 10.1042/BJ20020845; BRONSON RT, 1990, DEV BRAIN RES, V54, P131, DOI 10.1016/0165-3806(90)90073-8; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CAVINESS VS, 1995, BRAIN DEV-JPN, V17, P159, DOI 10.1016/0387-7604(95)00029-B; Chae TH, 2002, MAMM GENOME, V13, P239, DOI 10.1007/s00335-001-2144-5; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Coco S, 1999, J NEUROSCI, V19, P9803; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jimenez AJ, 2001, J NEUROPATH EXP NEUR, V60, P1105, DOI 10.1093/jnen/60.11.1105; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pearlman A L, 1996, Prog Brain Res, V108, P117; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PUSCHEL AW, 1994, FEBS LETT, V347, P55, DOI 10.1016/0014-5793(94)00505-2; REH TA, 1989, J NEUROSCI, V9, P4179; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P375, DOI 10.1073/pnas.91.1.375; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	30	130	132	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					264	270		10.1038/ng1302	http://dx.doi.org/10.1038/ng1302			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14758363	Bronze			2022-12-27	WOS:000189250400015
J	Sumazaki, R; Shiojiri, N; Isoyama, S; Masu, M; Keino-Masu, K; Osawa, M; Nakauchi, H; Kageyama, R; Matsui, A				Sumazaki, R; Shiojiri, N; Isoyama, S; Masu, M; Keino-Masu, K; Osawa, M; Nakauchi, H; Kageyama, R; Matsui, A			Conversion of biliary system to pancreatic tissue in Hes1-deficient mice	NATURE GENETICS			English	Article							LOOP-HELIX FACTORS; ALAGILLE-SYNDROME; CELL LINEAGES; HUMAN JAGGED1; DIFFERENTIATION; NEUROGENIN3; HES-1; NOTCH; GENE; MORPHOGENESIS	The biliary system, pancreas and liver all develop from the nearby foregut at almost the same time in mammals. The molecular mechanisms that determine the identity of each organ in this complex area are unknown. Hes1 encodes the basic helix-loop-helix protein Hes1 (ref. 1), which represses positive basic helix-loop-helix genes(2) such as Neurog3 (ref. 3). Expression of Hes1 is controlled by the evolutionarily conserved Notch pathway(4). Hes1 operates as a general negative regulator of endodermal endocrine differentiation(5,6), and defects in Notch signaling lead to accelerated pancreatic endocrine differentiation(7,8). Mutations in JAG1, encoding a Notch ligand, cause the Alagille syndrome in humans(9,10), characterized by poor development of the biliary system(11), suggesting that the Notch pathway is also involved in normal biliary development. Here we show that Hes1 is expressed in the extrahepatic biliary epithelium throughout development and that Hes1-deficient mice 2 have gallbladder agenesis and severe hypoplasia of extrahepatic bile ducts. Biliary epithelium in Hes1(-/-) mice ectopically expresses the proendocrine gene Neurog3 (refs. 12,13), differentiates into endocrine and exocrine cells and forms acini and islet-like structures in the mutant bile ducts. Thus, biliary epithelium has the potential for pancreatic differentiation and Hes1 determines biliary organogenesis by preventing the pancreatic differentiation program, probably by directly repressing transcription of Neurog3	Univ Tsukuba, Inst Clin Med, Dept Child Hlth, Tsukuba, Ibaraki 305, Japan; Shizuoka Univ, Fac Sci, Inst Biol, Shizuoka, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab Stem Cell Therapy, Tokyo, Japan; Kyoto Univ, Inst Virus Res, Kyoto 606, Japan	University of Tsukuba; Shizuoka University; University of Tsukuba; University of Tokyo; Kyoto University	Sumazaki, R (corresponding author), Univ Tsukuba, Inst Clin Med, Dept Child Hlth, Tsukuba, Ibaraki 305, Japan.	rsuma@md.tsukuba.ac.jp						Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; ALAGILLE D, 1975, J PEDIATR-US, V86, P63, DOI 10.1016/S0022-3476(75)80706-2; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; ELLIOTT WM, 1993, ANAT REC, V237, P271, DOI 10.1002/ar.1092370214; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SHIOJIRI N, 1988, ANAT EMBRYOL, V178, P15, DOI 10.1007/BF00305009; Skipper M, 2000, NAT GENET, V24, P3, DOI 10.1038/71653; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3	28	173	181	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					83	87		10.1038/ng1273	http://dx.doi.org/10.1038/ng1273			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702043	Bronze			2022-12-27	WOS:000187666800018
J	Tokuhiro, S; Yamada, R; Chang, XT; Suzuki, A; Kochi, Y; Sawada, T; Suzuki, M; Nagasaki, M; Ohtsuki, M; Ono, M; Furukawa, H; Nagashima, M; Yoshino, S; Mabuchi, A; Sekine, A; Saito, S; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K				Tokuhiro, S; Yamada, R; Chang, XT; Suzuki, A; Kochi, Y; Sawada, T; Suzuki, M; Nagasaki, M; Ohtsuki, M; Ono, M; Furukawa, H; Nagashima, M; Yoshino, S; Mabuchi, A; Sekine, A; Saito, S; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K			An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis	NATURE GENETICS			English	Article							CYTOKINE GENE-CLUSTER; TRANSCRIPTIONAL REGULATION; LINKAGE DISEQUILIBRIUM; HUMAN GENOME; SUSCEPTIBILITY; IDENTIFICATION; EXPRESSION; PROMOTER; ASTHMA; DIFFERENTIATION	Rheumatoid arthritis is a common inflammatory disease with complex genetic components. We investigated the genetic contribution of the cytokine gene cluster in chromosome 5q31 to susceptibility to rheumatoid arthritis in the Japanese population by case-control linkage disequilibrium (LD) mapping using single nucleotide polymorphisms (SNPs). Here we report that there is significant association between rheumatoid arthritis and the organic cation transporter gene SLC22A4 (P=0.000034). We show that expression of SLC22A4 is specific to hematological and immunological tissues and that SLC22A4 is also highly expressed in the inflammatory joints of mice with collagen-induced arthritis. A SNP affects the transcriptional efficiency of SLC22A4 in vitro, owing to an allelic difference in affinity to Runt-related transcription factor 1 (RUNX1), a transcriptional regulator in the hematopoietic system. A SNP in RUNX1 is also strongly associated with rheumatoid arthritis (P=0.00035). Our data indicate that the regulation of SLC22A4 expression by RUNX1 is associated with susceptibility to rheumatoid arthritis, which may represent an example of an epistatic effect of two genes on this disorder.	RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Sankyo Co Ltd, Tokyo 140, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Nippon Med Coll, Dept Joint Dis & Rheumatism, Tokyo 113, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Kanagawa, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Kanagawa, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Res Grp Personalized Med, Tokyo, Japan	RIKEN; Daiichi Sankyo Company Limited; University of Tokyo; Nippon Medical School; RIKEN; RIKEN; RIKEN; University of Tokyo; RIKEN	Yamada, R (corresponding author), RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis,Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.		Tsunoda, Tatsuhiko/K-2061-2014; Yamamoto, Kazuhiko/N-5096-2015; Sawed, Tetsuji/GRX-6582-2022; Suzuki, Akari/N-5389-2015; Peng, Bo/A-6920-2009	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Peng, Bo/0000-0001-8225-2284; Yamada, Ryo/0000-0002-1587-630X				Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beohar N, 1998, J BIOL CHEM, V273, P9168, DOI 10.1074/jbc.273.15.9168; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; DEIGHTON CM, 1989, CLIN GENET, V36, P178; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; GALSON DL, 1988, MOL CELL BIOL, V8, P381, DOI 10.1128/MCB.8.1.381; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kauppi P, 2001, GENOMICS, V77, P35, DOI 10.1006/geno.2001.6613; Lee JK, 2002, BIOCHEM BIOPH RES CO, V295, P771, DOI 10.1016/S0006-291X(02)00679-4; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Mansur AH, 1998, CLIN EXP ALLERGY, V28, P141; Miyazawa K, 1998, J BIOL CHEM, V273, P7620, DOI 10.1074/jbc.273.13.7620; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Nepom GT, 1998, ADV IMMUNOL, V68, P315, DOI 10.1016/S0065-2776(08)60563-5; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Saito S, 2002, J HUM GENET, V47, P576, DOI 10.1007/s100380200088; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Uchida H, 1997, J IMMUNOL, V158, P2251; Wu X, 1998, J BIOL CHEM, V273, P32776, DOI 10.1074/jbc.273.49.32776; Yabuuchi H, 1999, J PHARMACOL EXP THER, V289, P768	42	464	492	2	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					341	348		10.1038/ng1267	http://dx.doi.org/10.1038/ng1267			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608356				2022-12-27	WOS:000186791000015
J	Assadi, AH; Zhang, GC; Beffert, U; McNeil, RS; Renfro, AL; Niu, S; Quattrocchi, CC; Antalffy, BA; Sheldon, M; Armstrong, DD; Wynshaw-Boris, A; Herz, J; D'Arcangelo, G; Clark, GD				Assadi, AH; Zhang, GC; Beffert, U; McNeil, RS; Renfro, AL; Niu, S; Quattrocchi, CC; Antalffy, BA; Sheldon, M; Armstrong, DD; Wynshaw-Boris, A; Herz, J; D'Arcangelo, G; Clark, GD			Interaction of reelin signaling and Lis1 in brain development	NATURE GENETICS			English	Article							NEURONAL MIGRATION; TYROSINE PHOSPHORYLATION; LISSENCEPHALY GENE; VLDL RECEPTOR; RADIAL GLIA; PROTEIN; COMPLEX; FAMILY; DAB1; LOCALIZATION	Loss-of-function mutations in RELN (encoding reelin) or PAFAH1B1 (encoding LIS1) cause lissencephaly, a human neuronal migration disorder(1). In the mouse, homozygous mutations in Reln result in the reeler phenotype, characterized by ataxia and disrupted cortical layers(2). Pafah1b1(+/-) mice have hippocampal layering defects, whereas homozygous mutants are embryonic lethal(3). Reln encodes an extracellular protein that regulates layer formation by interacting with VLDLR and ApoER2 (Lrp8) receptors(4-6), thereby phosphorylating the Dab1 signaling molecule(7-10). Lis1 associates with microtubules and modulates neuronal migration(11). We investigated interactions between the reelin signaling pathway and Lis1 in brain development. Compound mutant mice with disruptions in the Reln pathway and heterozygous Pafah1b1 mutations had a higher incidence of hydrocephalus and enhanced cortical and hippocampal layering defects. Dab1 and Lis1 bound in a reelin-induced phosphorylation-dependent manner. These data indicate genetic and biochemical interaction between the reelin signaling pathway and Lis1.	Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Texas, Sch Publ Hlth, Houston, TX USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Brescia, Program Neurosci, I-25121 Brescia, Italy; Baylor Coll Med, Div Hematol Oncol, Houston, TX 77030 USA; Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; Univ Calif San Diego, Dept Pediat & Med, San Diego, CA 92103 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Brescia; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; University of California System; University of California San Diego; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Clark, GD (corresponding author), Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA.	gclark@bcm.tmc.edu		Beffert, Uwe/0000-0001-5877-922X; D'Arcangelo, Gabriella/0000-0003-1575-1010; Quattrocchi, Carlo Cosimo/0000-0001-6823-7707	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Brich J, 2003, J NEUROSCI, V23, P187; Clark GD, 1997, J NEUROPATH EXP NEUR, V56, P1044, DOI 10.1097/00005072-199709000-00009; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Kitagawa M, 2000, FEBS LETT, V479, P57, DOI 10.1016/S0014-5793(00)01856-1; Luque JM, 2003, DEV BRAIN RES, V140, P195, DOI 10.1016/S0165-3806(02)00604-1; Miller MW, 2000, BRAIN RES, V852, P355, DOI 10.1016/S0006-8993(99)02176-9; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sweeney KJ, 2001, MECH DEVELOP, V101, P21, DOI 10.1016/S0925-4773(00)00543-8; Sweeney KJ, 2000, MECH DEVELOP, V92, P263, DOI 10.1016/S0925-4773(00)00242-2; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yan W, 2003, P NATL ACAD SCI USA, V100, P7189, DOI 10.1073/pnas.1236145100	30	167	178	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					270	276		10.1038/ng1257	http://dx.doi.org/10.1038/ng1257			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14578885				2022-12-27	WOS:000186273300024
J	Gretarsdottir, S; Thorleifsson, G; Reynisdottir, ST; Manolescu, A; Jonsdottir, S; Jonsdottir, T; Gudmundsdottir, T; Bjarnadottir, SM; Einarsson, OB; Gudjonsdottir, HM; Hawkins, M; Gudmundsson, G; Gudmundsdottir, H; Andrason, H; Gudmundsdottir, AS; Sigurdardottir, M; Chou, TT; Nahmias, J; Goss, S; Sveinbjornsdottir, S; Valdimarsson, EM; Jakobsson, F; Agnarsson, U; Gudnason, V; Thorgeirsson, G; Fingerle, J; Gurney, M; Gudbjartsson, D; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR				Gretarsdottir, S; Thorleifsson, G; Reynisdottir, ST; Manolescu, A; Jonsdottir, S; Jonsdottir, T; Gudmundsdottir, T; Bjarnadottir, SM; Einarsson, OB; Gudjonsdottir, HM; Hawkins, M; Gudmundsson, G; Gudmundsdottir, H; Andrason, H; Gudmundsdottir, AS; Sigurdardottir, M; Chou, TT; Nahmias, J; Goss, S; Sveinbjornsdottir, S; Valdimarsson, EM; Jakobsson, F; Agnarsson, U; Gudnason, V; Thorgeirsson, G; Fingerle, J; Gurney, M; Gudbjartsson, D; Frigge, ML; Kong, A; Stefansson, K; Gulcher, JR			The gene encoding phosphodiesterase 4D confers risk of ischemic stroke	NATURE GENETICS			English	Article							SMOOTH-MUSCLE CELLS; DEPENDENT PROTEIN-KINASE; COORDINATED REGULATION; PDE4D ACTIVITY; IN-VIVO; CAMP; ACTIVATION; PROLIFERATION; MUTATIONS; PHOSPHORYLATION	We previously mapped susceptibility to stroke to chromosome 5q12. Here we finely mapped this locus and tested it for association with stroke. We found the strongest association in the gene encoding phosphodiesterase 4D (PDE4D), especially for carotid and cardiogenic stroke, the forms of stroke related to atherosclerosis. Notably, we found that haplotypes can be classified into three distinct groups: wild-type, at-risk and protective. We also observed a substantial disregulation of multiple PDE4D isoforms in affected individuals. We propose that PDE4D is involved in the pathogenesis of stroke, possibly through atherosclerosis, which is the primary pathological process underlying ischemic stroke.	deCODE Genet, IS-101 Reykjavik, Iceland; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Iceland Heart Assoc Heart Prevent Clin, Reykjavik, Iceland; Hoffmann La Roche AG, Div Pharma, Preclin Res, Basel, Switzerland	Landspitali National University Hospital; Roche Holding	Gretarsdottir, S (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019; Manolescu, Andrei/G-4565-2014; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015	Manolescu, Andrei/0000-0002-0713-4664; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Gudbjartsson, Daniel/0000-0002-5222-9857				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; ALBERTS MJ, 1999, GENETICS CEREBROVASC; Baillie G, 2001, MOL PHARMACOL, V60, P1100, DOI 10.1124/mol.60.5.1100; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; BRASS LM, 1995, BAILLIERE CLIN NEUR, V4, P221; Caplan LR., 2000, CAPLANS STROKE CLIN, V3rd ed., P34; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; DEMPSTER AB, 1971, J MOL SPECTROSC, V39, P1, DOI 10.1016/0022-2852(71)90269-4; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FISHER CM, 1982, NEUROLOGY, V32, P871, DOI 10.1212/WNL.32.8.871; Fukumoto S, 1999, CIRC RES, V85, P985; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Indolfi C, 2000, J AM COLL CARDIOL, V36, P288, DOI 10.1016/S0735-1097(00)00679-3; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Landells LJ, 2001, BRIT J PHARMACOL, V133, P722, DOI 10.1038/sj.bjp.0704120; Le Jeune IR, 2002, J BIOL CHEM, V277, P35980, DOI 10.1074/jbc.M204832200; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEWONTIN RC, 1964, GENETICS, V49, P49; Leys D, 2002, J NEUROL, V249, P507, DOI 10.1007/s004150200057; Liu HG, 2000, J BIOL CHEM, V275, P26615, DOI 10.1074/jbc.M001634200; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; OGAWA S, 1992, AM J PHYSIOL, V262, pC546, DOI 10.1152/ajpcell.1992.262.3.C546; Palmer D, 1998, CIRC RES, V82, P852; PALSDOTTIR A, 1988, LANCET, V2, P603; PAN XL, 1994, BIOCHEM PHARMACOL, V48, P827, DOI 10.1016/0006-2952(94)90062-0; RICE JA, 1995, MATH STAT DATA ANAL, P308; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Vicini E, 1997, MOL ENDOCRINOL, V11, P839, DOI 10.1210/me.11.7.839	42	462	511	1	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					131	138		10.1038/ng1245	http://dx.doi.org/10.1038/ng1245			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	14517540				2022-12-27	WOS:000185625300009
J	Wuchty, S; Oltvai, ZN; Barabasi, AL				Wuchty, S; Oltvai, ZN; Barabasi, AL			Evolutionary conservation of motif constituents in the yeast protein interaction network	NATURE GENETICS			English	Article							GENE DISPENSABILITY; CELLULAR NETWORKS; ORGANIZATION; DATABASE	Understanding why some cellular components are conserved across species but others evolve rapidly is a key question of modern biology(1-3). Here we show that in Saccharomyces cerevisiae, proteins organized in cohesive patterns of interactions are conserved to a substantially higher degree than those that do not participate in such motifs. We find that the conservation of proteins in distinct topological motifs correlates with the interconnectedness and function of that motif and also depends on the structure of the overall interactome topology. These findings indicate that motifs may represent evolutionary conserved topological units of cellular networks molded in accordance with the specific biological function in which they participate.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA	University of Notre Dame; Northwestern University	Barabasi, AL (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	zno008@northwestern.edu; alb@nd.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522				Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hirsh AE, 2003, NATURE, V421, P497, DOI 10.1038/421497a; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	22	292	305	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					176	179		10.1038/ng1242	http://dx.doi.org/10.1038/ng1242			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973352				2022-12-27	WOS:000185625300015
J	Roubertoux, PL; Sluyter, F; Carlier, M; Marcet, B; Maarouf-Veray, F; Cherif, C; Marican, C; Arrechi, P; Godin, F; Jamon, M; Verrier, B; Cohen-Salmon, C				Roubertoux, PL; Sluyter, F; Carlier, M; Marcet, B; Maarouf-Veray, F; Cherif, C; Marican, C; Arrechi, P; Godin, F; Jamon, M; Verrier, B; Cohen-Salmon, C			Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice	NATURE GENETICS			English	Article							BRAIN; DYSFUNCTION; EFFICIENT; DISEASE; DECAY; MOUSE	Several lines of evidence indicate an association between mitochondrial DNA (mtDNA) and the functioning of the nervous system. As neuronal development(1,2) and structure(3-5) as well as axonal and synaptic activity(6,7) involve mitochondrial genes, it is not surprising that most mtDNA diseases are associated with brain disorders(8,9). Only one study has suggested an association between mtDNA and cognition(10), however. Here we provide direct evidence of mtDNA involvement in cognitive functioning. Total substitution of mtDNA was achieved by 20 repeated backcrosses in NZB/BINJ (N) and CBA/H (H) mice with different mtDNA origins. All 13 mitochondrial genes were expressed in the brains of the congenic quartet. In interaction with nuclear DNA (nDNA), mtDNA modified learning, exploration, sensory development and the anatomy of the brain. The effects of mtDNA substitution persisted with age, increasing in magnitude as the mice got older. We observed different effects with input of mtDNA from N versus H mice, varying according to the phenotypes. Exchanges of mtDNA may produce phenotypes outside the range of scores observed in the original mitochondrial and nuclear combinations. These findings show that mitochondrial polymorphisms are not as neutral as was previously believed.	CNRS, INPC, F-13402 Marseille, France; CNRS Genet Neurogenet Comportement, Orleans, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Roubertoux, PL (corresponding author), CNRS, INPC, 31 Chemin Joseph Aiguer, F-13402 Marseille, France.	rouber@lnf.cnrs-mrs.fr	Marcet, Brice/Q-1218-2016	Marcet, Brice/0000-0001-5015-2297				Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; CARLIER M, 1983, PHYSIOL BEHAV, V30, P837, DOI 10.1016/0031-9384(83)90245-7; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; DULIOUST E, 1995, P NATL ACAD SCI USA, V92, P589, DOI 10.1073/pnas.92.2.589; Freeman FM, 2000, PHARMACOL BIOCHEM BE, V67, P355, DOI 10.1016/S0091-3057(00)00373-7; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Le Roy I, 1998, BEHAV BRAIN RES, V95, P135, DOI 10.1016/S0166-4328(97)00218-0; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Martin-Romero FJ, 2002, J NEUROCHEM, V82, P705, DOI 10.1046/j.1471-4159.2002.01023.x; Nagao Y, 1998, GENES GENET SYST, V73, P21, DOI 10.1266/ggs.73.21; Roubertoux PL, 1996, BEHAV GENET, V26, P427, DOI 10.1007/BF02359487; *SAS I, 1989, SAS STAT US GUID VER; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; SIMIAND J, 1984, PSYCHOPHARMACOLOGY, V84, P48, DOI 10.1007/BF00432023; SKUDER P, 1995, INTELLIGENCE, V21, P1, DOI 10.1016/0160-2896(95)90035-7; Sluyter F, 1999, BRAIN RES, V835, P68, DOI 10.1016/S0006-8993(99)01385-2; Wahlsten D, 2003, J NEUROSCI METH, V123, P207, DOI 10.1016/S0165-0270(02)00359-X; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; YONEKAWA H, 1982, DIFFERENTIATION, V22, P222, DOI 10.1111/j.1432-0436.1982.tb01255.x; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; Zini R, 2002, LIFE SCI, V71, P3091, DOI 10.1016/S0024-3205(02)02161-6	29	169	172	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					65	69		10.1038/ng1230	http://dx.doi.org/10.1038/ng1230			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12923532				2022-12-27	WOS:000185018500012
J	Albertson, DG; Collins, C; McCormick, F; Gray, JW				Albertson, DG; Collins, C; McCormick, F; Gray, JW			Chromosome aberrations in solid tumors	NATURE GENETICS			English	Review							COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; HUMAN BREAST-CANCER; MOLECULAR CYTOGENETIC ANALYSIS; GENE-EXPRESSION PATTERNS; GROWTH-FACTOR RECEPTOR; TELOMERASE ACTIVITY; OVARIAN-CANCER; CELL-CYCLE; MICROSATELLITE ALTERATIONS	Chromosome aberrations in human solid tumors are hallmarks of gene deregulation and genome instability. This review summarizes current knowledge regarding aberrations, discusses their functional importance, suggests mechanisms by which aberrations may form during cancer progression and provides examples of clinical advances that have come from studies of chromosome aberrations.	Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Albertson, DG (corresponding author), Univ Calif San Francisco, Canc Res Inst, Box 0128, San Francisco, CA 94143 USA.		Pillay, Nischalan/F-9536-2012					Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Aebi S, 1996, CANCER RES, V56, P3087; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; Artandi SE, 2002, TRENDS MOL MED, V8, P44, DOI 10.1016/S1471-4914(01)02222-5; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; BAKER SJ, 1990, CANCER RES, V50, P7717; Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Banerjee D, 2002, BBA-MOL BASIS DIS, V1587, P164, DOI 10.1016/S0925-4439(02)00079-0; Barlund M, 2000, CANCER RES, V60, P5340; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Bartkova J, 1996, CANCER RES, V56, P5475; Baselga J, 2002, ONCOLOGY-BASEL, V63, P6, DOI 10.1159/000066198; Baselga J, 2002, ONCOLOGIST, V7, P2; Bastian BC, 2000, CANCER RES, V60, P1968; Bastian BC, 1999, J INVEST DERMATOL, V113, P1065, DOI 10.1046/j.1523-1747.1999.00787.x; Bednarek AK, 1997, CLIN CANCER RES, V3, P11; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; Bichsel VE, 2001, CANCER J, V7, P69; Bocker T, 1999, BBA-REV CANCER, V1423, pO1, DOI 10.1016/S0304-419X(99)00008-6; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen XQ, 1996, NAT MED, V2, P1033; Costello Joseph F, 2002, Methods Mol Biol, V200, P53; Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DAVIS RJ, 1994, CANCER RES, V54, P2869; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Eisenberger CF, 1999, JNCI-J NATL CANCER I, V91, P2028, DOI 10.1093/jnci/91.23.2028; Farag SS, 2002, INT J ONCOL, V21, P1041; Fauth C, 2001, CYTOGENET CELL GENET, V93, P1, DOI 10.1159/000056937; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fisk HA, 2002, CURR OPIN CELL BIOL, V14, P700, DOI 10.1016/S0955-0674(02)00385-X; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gong G, 2001, CLIN CANCER RES, V7, P2410; Gordon KE, 2003, CANCER RES, V63, P458; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Greaves M, 1996, TRENDS GENET, V12, P127, DOI 10.1016/0168-9525(96)30016-4; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Hampton GM, 1996, P NATL ACAD SCI USA, V93, P6704, DOI 10.1073/pnas.93.13.6704; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanna W, 2001, ONCOLOGY-BASEL, V61, P22, DOI 10.1159/000055398; Harrington L, 2002, ONCOGENE, V21, P592, DOI 10.1038/sj.onc.1205084; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HE J, 1995, CANCER RES, V55, P4833; HE J, 1994, CANCER RES, V54, P5804; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Hyman E, 2002, CANCER RES, V62, P6240; Ichikawa D, 1996, CANCER, V77, P2064; Imoto H, 1994, DNA Res, V1, P239, DOI 10.1093/dnares/1.5.239; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jing JP, 1998, P NATL ACAD SCI USA, V95, P8046, DOI 10.1073/pnas.95.14.8046; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6; Koivisto P, 1997, CANCER RES, V57, P314; Koshiji M, 2002, J SURG ONCOL, V80, P34, DOI 10.1002/jso.10096; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Kuukasjarvi T, 1997, AM J PATHOL, V150, P1465; Lahoz EG, 1999, MOL CELL BIOL, V19, P353; Lamprecht SA, 2002, CARCINOGENESIS, V23, P1777, DOI 10.1093/carcin/23.11.1777; Lassus H, 2001, LAB INVEST, V81, P517, DOI 10.1038/labinvest.3780260; Levitzki A, 2002, EUR J CANCER, V38, pS11, DOI 10.1016/S0959-8049(02)80598-6; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lichter P, 1997, TRENDS GENET, V13, P475, DOI 10.1016/S0168-9525(97)01307-3; Linardopoulos S, 2000, INT J CANCER, V88, P920, DOI 10.1002/1097-0215(20001215)88:6<920::AID-IJC13>3.0.CO;2-#; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LUKAS J, 1995, CANCER RES, V55, P4818; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Massion PP, 2002, CANCER RES, V62, P3636; Medina D, 2002, BBA-REV CANCER, V1603, P1, DOI 10.1016/S0304-419X(02)00053-7; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morini M, 2000, ONCOGENE, V19, P6007, DOI 10.1038/sj.onc.1204011; Morris DW, 1997, VIROLOGY, V238, P161, DOI 10.1006/viro.1997.8794; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; MULERIS M, 1990, CANCER GENET CYTOGEN, V46, P143, DOI 10.1016/0165-4608(90)90100-O; NAGAI MA, 1994, GENE CHROMOSOME CANC, V11, P58, DOI 10.1002/gcc.2870110109; Namazie A, 2002, LARYNGOSCOPE, V112, P472, DOI 10.1097/00005537-200203000-00013; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; ORLOW I, 1995, J NATL CANCER I, V87, P1524, DOI 10.1093/jnci/87.20.1524; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Poremba C, 1998, INT J ONCOL, V12, P641; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; REMVIKOS Y, 1995, GENE CHROMOSOME CANC, V12, P272, DOI 10.1002/gcc.2870120406; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Rubin R B, 2000, Am Clin Lab, V19, P28; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schenk T, 1997, CHEST, V111, P1691, DOI 10.1378/chest.111.6.1691; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; SCHLEGEL J, 1995, CANCER RES, V55, P6002; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P16910, DOI 10.1073/pnas.012679099; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Sokolova IA, 2000, J MOL DIAGN, V2, P116, DOI 10.1016/S1525-1578(10)60625-3; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soulie P, 1999, CANCER GENET CYTOGEN, V115, P118, DOI 10.1016/S0165-4608(99)00073-4; Speicher MR, 1996, NAT MED, V2, P1046, DOI 10.1038/nm0996-1046; Steinbeck RG, 1998, BRIT J CANCER, V77, P1027, DOI 10.1038/bjc.1998.171; Sugino T, 1996, INT J CANCER, V69, P301, DOI 10.1002/(SICI)1097-0215(19960822)69:4<301::AID-IJC11>3.0.CO;2-8; Suzuki S, 2000, CANCER RES, V60, P5382; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tirkkonen M, 1997, CANCER RES, V57, P1222; Utting M, 2002, CLIN CANCER RES, V8, P35; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; WAHL GM, 1979, J BIOL CHEM, V254, P8679; Waldman FM, 2000, JNCI-J NATL CANCER I, V92, P313, DOI 10.1093/jnci/92.4.313; Weaver Z, 2002, ONCOGENE, V21, P5097, DOI 10.1038/sj.onc.1205636; Wessels LFA, 2002, CANCER RES, V62, P7110; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Willenbucher RF, 1999, AM J PATHOL, V154, P1825, DOI 10.1016/S0002-9440(10)65438-7; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yoon DS, 2002, AM J PATHOL, V161, P391, DOI 10.1016/S0002-9440(10)64194-6; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zimonjic D, 2001, CANCER RES, V61, P8838	162	569	586	1	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					369	376		10.1038/ng1215	http://dx.doi.org/10.1038/ng1215			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12923544				2022-12-27	WOS:000184470500013
J	Kimura, T; Takeda, S; Sagiya, Y; Gotoh, M; Nakamura, Y; Arakawa, H				Kimura, T; Takeda, S; Sagiya, Y; Gotoh, M; Nakamura, Y; Arakawa, H			Impaired function of p53R2 in Rrm2b-null mice causes severe renal failure through attenuation of dNTP pools	NATURE GENETICS			English	Article							DNA-DAMAGE; RIBONUCLEOTIDE REDUCTASE; P53-DEPENDENT APOPTOSIS; POTENTIAL MEDIATOR; GENE; IDENTIFICATION; PROTEIN; PATHWAY; CELLS	p53R2, which is regulated by tumor suppressor p53, is a small subunit of ribonucleotide reductase(1). To determine whether it is involved in DNA repair by supplying deoxyribonucleotides (dNTPs) for resting cells in vivo(2 5), we generated a strain of mice lacking Rrm2b (encoding p53R2). These mice developed normally until they were weaned but from then on had growth retardation and early mortality. Pathological examination indicated that multiple organs had failed, and all Rrm2b-null mice died from severe renal failure by the age of 14 weeks. TUNEL staining showed a greater number of apoptotic cells in kidneys of 8-week-old Rrm2b(-/-) mice relative to wild-type mice. p53 was activated in kidney tissues of Rrm2b(-/-) mice, leading to transcriptional induction of p53 target genes. Rrm2b(-/-) mouse embryonic fibroblasts (MEFs) became immortal much earlier than Rrm2b(+/+) MEFs. dNTP pools were severely attenuated in Rrm2b(-/-) MEFs under oxidative stress. Rrm2b deficiency caused higher rates of spontaneous mutation in the kidneys of Rrm2b(-/-) mice. Our results suggest that p53R2 has a pivotal role in maintaining dNTP levels for repair of DNA in resting cells. Impairment of this pathway may enhance spontaneous mutation frequency and activate p53-dependent apoptotic pathway(s) in vivo, causing severe renal failure, growth retardation and early mortality.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan; Fukushima Med Univ, Sch Med, Dept Surg 1, Fukushima 9601295, Japan; Otsuka Pharmaceut Co Ltd, Otsuka GEN Res Inst, Tokushima 7710192, Japan	University of Tokyo; Fukushima Medical University; Otsuka Pharmaceutical	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yusuke@ims.u-tokyo.ac.jp	Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638				Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELLEDGE SJ, 1989, MOL CELL BIOL, V9, P4932, DOI 10.1128/MCB.9.11.4932; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; ELLEDGE SJ, 1989, MOL CELL BIOL, V9, P5373, DOI 10.1128/MCB.9.12.5373; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; HARPER JW, 1993, CELL, V75, P805; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Lozano G, 2000, NATURE, V404, P24, DOI 10.1038/35003670; Matsuda K, 2002, CANCER RES, V62, P2883; MIYASHITA T, 1995, CELL, V80, P293; Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yamaguchi T, 2001, CANCER RES, V61, P8256; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	21	114	122	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					440	445		10.1038/ng1212	http://dx.doi.org/10.1038/ng1212			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12858174				2022-12-27	WOS:000184470500023
J	Mburu, P; Mustapha, M; Varela, A; Weil, D; El-Amraoui, A; Holme, RH; Rump, A; Hardisty, RE; Blanchard, S; Coimbra, RS; Perfettini, I; Parkinson, N; Mallon, AM; Glenister, P; Rogers, MJ; Paige, AJ; Moir, L; Clay, J; Rosenthal, A; Liu, XZ; Blanco, G; Steel, KP; Petit, C; Brown, SDM				Mburu, P; Mustapha, M; Varela, A; Weil, D; El-Amraoui, A; Holme, RH; Rump, A; Hardisty, RE; Blanchard, S; Coimbra, RS; Perfettini, I; Parkinson, N; Mallon, AM; Glenister, P; Rogers, MJ; Paige, AJ; Moir, L; Clay, J; Rosenthal, A; Liu, XZ; Blanco, G; Steel, KP; Petit, C; Brown, SDM			Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31	NATURE GENETICS			English	Article							HAIR CELL STEREOCILIA; MYOSIN VIIA; UNCONVENTIONAL MYOSIN; RECESSIVE DEAFNESS; PROTEINS; MUTATIONS; GENE; HARMONIN; COMPLEX; IDENTIFICATION	The whirler mouse mutant (wi) does not respond to sound stimuli, and detailed ultrastructural analysis of sensory hair cells in the organ of Corti of the inner ear indicates that the whirler gene encodes a protein involved in the elongation and maintenance of stereocilia in both inner hair cells (IHCs) and outer hair cells (OHCs). BAC-mediated transgene correction of the mouse phenotype and mutation analysis identified the causative gene as encoding a novel PDZ protein called whirlin. The gene encoding whirlin also underlies the human autosomal recessive deafness locus DFNB31. In the mouse cochlea, whirlin is expressed in the sensory IHC and OHC stereocilia. Our findings suggest that this novel PDZ domain containing molecule acts as an organizer of submembranous molecular complexes that control the coordinated actin polymerization and membrane growth of stereocilia.	Inst Pasteur, INSERM, U587, Unite Genet Deficits Sensoriels, F-75724 Paris 15, France; MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England; MRC, UK Mouse Genome Ctr, Harwell OX11 0RD, Oxon, England; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; MetaGen Pharmaceut Gmbh, D-13347 Berlin, Germany; Inst Mol Biotechnol, Dept Genome Anal, D-07445 Jena, Germany; Univ Miami, Dept Otolaryngol, Miami, FL 33101 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Nottingham; University of Miami	Petit, C (corresponding author), Inst Pasteur, INSERM, U587, Unite Genet Deficits Sensoriels, 25 Rue Dr Roux, F-75724 Paris 15, France.	cpetit@pasteur.fr	Coimbra, Roney/B-3102-2013; Blanco, Gonzalo/D-8735-2014; Paige, Adam/CAF-2088-2022; Coimbra, Roney/ABA-0586-2022	Blanco, Gonzalo/0000-0003-3827-3111; Coimbra, Roney/0000-0002-9204-0573; EL-AMRAOUI, Aziz/0000-0003-2692-4984; Rump, Andreas/0000-0001-7116-6364; Petit, Christine/0000-0002-9069-002X; Moir, Lee/0000-0003-4829-3597	MRC [MC_U142684171] Funding Source: UKRI; Medical Research Council [MC_U142684171] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; BAUMANN H, 1985, MOL GEN GENET, V201, P505, DOI 10.1007/BF00331347; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gong TWL, 1996, HEARING RES, V96, P20, DOI 10.1016/0378-5955(96)00013-5; Harris BZ, 2001, J CELL SCI, V114, P3219; Holme RH, 2002, J COMP NEUROL, V450, P94, DOI 10.1002/cne.10301; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; KALTENBACH JA, 1994, J COMP NEUROL, V340, P87, DOI 10.1002/cne.903400107; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kollmar R, 1999, CURR OPIN NEUROBIOL, V9, P394, DOI 10.1016/S0959-4388(99)80059-2; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mallon AM, 2000, GENOME RES, V10, P758, DOI 10.1101/gr.10.6.758; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; Mustapha M, 2002, EUR J HUM GENET, V10, P210, DOI 10.1038/sj.ejhg.5200780; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Paige AJW, 2000, MAMM GENOME, V11, P51, DOI 10.1007/s003350010010; Parkinson N, 2002, GENOME BIOL, V3; PETIT C, 2001, METABOLIC MOL BASES, V4, P6281; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rogers MJC, 1999, MAMM GENOME, V10, P513, DOI 10.1007/s003359901032; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Self T, 1998, DEVELOPMENT, V125, P557; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Taudien S, 2000, TRENDS GENET, V16, P519, DOI 10.1016/S0168-9525(00)02127-2; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	45	236	251	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					421	428		10.1038/ng1208	http://dx.doi.org/10.1038/ng1208			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12833159				2022-12-27	WOS:000184470500020
J	Mootha, VK; Lindgren, CM; Eriksson, KF; Subramanian, A; Sihag, S; Lehar, J; Puigserver, P; Carlsson, E; Ridderstrale, M; Laurila, E; Houstis, N; Daly, MJ; Patterson, N; Mesirov, JP; Golub, TR; Tamayo, P; Spiegelman, B; Lander, ES; Hirschhorn, JN; Altshuler, D; Groop, LC				Mootha, VK; Lindgren, CM; Eriksson, KF; Subramanian, A; Sihag, S; Lehar, J; Puigserver, P; Carlsson, E; Ridderstrale, M; Laurila, E; Houstis, N; Daly, MJ; Patterson, N; Mesirov, JP; Golub, TR; Tamayo, P; Spiegelman, B; Lander, ES; Hirschhorn, JN; Altshuler, D; Groop, LC			PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes	NATURE GENETICS			English	Article							IMPAIRED GLUCOSE-TOLERANCE; GAMMA COACTIVATOR-1 PGC-1; SKELETAL-MUSCLE; MITOCHONDRIAL BIOGENESIS; EXPRESSION PROFILE; DETERMINANTS; RESPIRATION; MECHANISMS; DISCOVERY; DISEASE	DNA microarrays can be used to identify gene expression changes characteristic of human disease. This is challenging, however, when relevant differences are subtle at the level of individual genes. We introduce an analytical strategy, Gene Set Enrichment Analysis, designed to detect modest but coordinate changes in the expression of groups of functionally related genes. Using this approach, we identify a set of genes involved in oxidative phosphorylation whose expression is coordinately decreased in human diabetic muscle. Expression of these genes is high at sites of insulin-mediated glucose disposal, activated by PGC-1alpha and correlated with total-body aerobic capacity. Our results associate this gene set with clinically important variation in human metabolism and illustrate the value of pathway relationships in the analysis of genomic profiling experiments.	MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Harvard Med Sch, Dept Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Lund Univ, Dept Endocrinol, Wallenberg Lab, Univ Hosp MAS, S-20502 Malmo, Sweden; Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA; MIT, Dept Biol, Cambridge, MA USA; Harvard Med Sch, Dept Genet, Boston, MA USA; Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Lund University; Skane University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), MIT, Whitehead Inst, Ctr Genome Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	altshuler@molbio.mgh.harvard.edu; leif.groop@endo.mas.lu.se	Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Mesirov, Jill/AGF-7626-2022; Ridderstråle, Martin/F-7678-2012	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Lindgren, Cecilia/0000-0002-4903-9374	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BJOMTORP P, 1967, DIABETOLOGIA, V3, P346; BROWN GC, 1992, BIOCHEM J, V284, P1; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032; ERIKSSON KF, 1994, DIABETES, V43, P805, DOI 10.2337/diabetes.43.6.805; ERIKSSON KF, 1990, DIABETOLOGIA, V33, P526, DOI 10.1007/BF00404139; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; FLOREZ JC, IN PRESS ANN REV GEN; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kropf S, 2002, BIOMETRICAL J, V44, P789, DOI 10.1002/1521-4036(200210)44:7<789::AID-BIMJ789>3.0.CO;2-#; Lacquemant C, 2002, DIABETOLOGIA, V45, P602, DOI 10.1007/s00125-002-0783-z; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; SCHALINJANTTI C, 1995, EUR J CLIN INVEST, V25, P693, DOI 10.1111/j.1365-2362.1995.tb01988.x; SIMONEAU JA, 1995, FASEB J, V9, P273, DOI 10.1096/fasebj.9.2.7781930; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang X, 2002, DIABETOLOGIA, V45, P1584, DOI 10.1007/s00125-002-0905-7; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x	32	5756	5862	5	252	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					267	273		10.1038/ng1180	http://dx.doi.org/10.1038/ng1180			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808457				2022-12-27	WOS:000183815300013
J	Sansom, OJ; Berger, J; Bishop, SM; Hendrich, B; Bird, A; Clarke, AR				Sansom, OJ; Berger, J; Bishop, SM; Hendrich, B; Bird, A; Clarke, AR			Deficiency of Mbd2 suppresses intestinal tumorigenesis	NATURE GENETICS			English	Article							NEOPLASIA; MOUSE; GENE; DNA; HYPERMETHYLATION; PROTEIN; LOCUS; MICE	Gene silencing through de novo methylation of CpG island promoters contributes to cancer. We find that Mbd2, which recruits co-repressor complexes to methylated DNA, is essential for efficient tumorigenesis in the mouse intestine. As Mbd2-deficient mice are viable and fertile, their resistance to intestinal cancer may be of therapeutic relevance.	Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Cardiff University; University of Edinburgh	Bird, A (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.		clarke, alan r/P-2820-2014; Hendrich, Brian/AAG-5898-2020; Clarke, Alan R/A-6256-2008	Hendrich, Brian/0000-0002-0231-3073; Sansom, Owen J./0000-0001-9540-3010; Clarke, Alan/0000-0002-4281-426X				Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Eads CA, 2002, CANCER RES, V62, P1296; Esteller M, 2000, CANCER RES, V60, P4366; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lin XH, 2003, CANCER RES, V63, P498; LUONGO C, 1994, CANCER RES, V54, P5947; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Slack A, 2002, J GENE MED, V4, P381, DOI 10.1002/jgm.288; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108	15	140	151	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					145	147		10.1038/ng1155	http://dx.doi.org/10.1038/ng1155			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730693				2022-12-27	WOS:000183200500017
J	Patterson, SD; Aebersold, RH				Patterson, SD; Aebersold, RH			Proteomics: the first decade and beyond	NATURE GENETICS			English	Review							2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEIN INTERACTION MAP; GENE-EXPRESSION PATTERNS; CODED AFFINITY TAGS; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; ELECTROSPRAY-IONIZATION; POLYACRYLAMIDE-GELS	Proteomics is the systematic study of the many and diverse properties of proteins in a parallel manner with the aim of providing detailed descriptions of the structure, function and control of biological systems in health and disease. Advances in methods and technologies have catalyzed an expansion of the scope of biological studies from the reductionist biochemical analysis of single proteins to proteome-wide measurements. Proteomics and other complementary analysis methods are essential components of the emerging 'systems biology' approach that seeks to comprehensively describe biological systems through integration of diverse types of data and, in the future, to ultimately allow computational simulations of complex biological systems.	Celera Genom Corp, Rockville, MD 20850 USA; Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Patterson, SD (corresponding author), Farmal Biomed LLC, 129 N Hill Ave,Suite 107, Pasadena, CA 91106 USA.	scottp@farmalbiomed.com						Adam BL, 2002, CANCER RES, V62, P3609; Adam GC, 2002, NAT BIOTECHNOL, V20, P805, DOI 10.1038/nbt714; Adam GC, 2001, CHEM BIOL, V8, P81, DOI 10.1016/S1074-5521(00)90060-7; ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Aebersold R, 2000, NAT BIOTECHNOL, V18, P359, DOI 10.1038/74325; AEBERSOLD R, 1998, PROTEINS ANAL DESIGN, P3; AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; ANDERSON NG, 1982, CLIN CHEM, V28, P739; Anderson NL, 2000, CURR OPIN BIOTECH, V11, P408, DOI 10.1016/S0958-1669(00)00118-X; ANDERSON NL, 1984, CLIN CHEM, V30, P2031; Appella E, 1995, EXS, V73, P105; Bangur CS, 2002, ONCOGENE, V21, P3814, DOI 10.1038/sj.onc.1205480; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BELEW M, 1990, J CHROMATOGR, V516, P333, DOI 10.1016/S0021-9673(01)89275-X; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bogyo M, 1998, CHEM BIOL, V5, P307, DOI 10.1016/S1074-5521(98)90169-7; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Brody EN, 1999, MOL DIAGN, V4, P381, DOI 10.1016/S1084-8592(99)80014-9; Bures EJ, 2001, PROTEOMICS, V1, P79, DOI 10.1002/1615-9861(200101)1:1<79::AID-PROT79>3.0.CO;2-8; Cagney G, 2002, NAT BIOTECHNOL, V20, P163, DOI 10.1038/nbt0202-163; Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; CHOO Y, 1995, CURR OPIN BIOTECH, V6, P431, DOI 10.1016/0958-1669(95)80073-5; Collings BA, 2002, J AM SOC MASS SPECTR, V13, P577, DOI 10.1016/S1044-0305(02)00361-6; Conrads TP, 2001, ANAL CHEM, V73, P2132, DOI 10.1021/ac001487x; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.3.CO;2-3; Cravatt BF, 2000, CURR OPIN CHEM BIOL, V4, P663, DOI 10.1016/S1367-5931(00)00147-2; Davis MT, 2001, J CHROMATOGR B, V752, P281, DOI 10.1016/S0378-4347(00)00547-8; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; DELEENHEER AP, 1992, MASS SPECTROM REV, V11, P249, DOI 10.1002/mas.1280110402; Deshaies RJ, 2002, MOL CELL PROTEOMICS, V1, P3, DOI 10.1074/mcp.R100001-MCP200; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eklund M, 2002, PROTEINS, V48, P454, DOI 10.1002/prot.10169; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Futcher B, 1999, MOL CELL BIOL, V19, P7357; GARRELS JI, 1989, J BIOL CHEM, V264, P5283; GARRELS JI, 1989, J BIOL CHEM, V264, P5269; GARRELS JI, 1989, J BIOL CHEM, V264, P5299; Garrels JI, 1996, NUCLEIC ACIDS RES, V24, P46, DOI 10.1093/nar/24.1.46; Gauss C, 1999, ELECTROPHORESIS, V20, P575, DOI 10.1002/(SICI)1522-2683(19990301)20:3<575::AID-ELPS575>3.0.CO;2-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Goshe MB, 2001, ANAL CHEM, V73, P2578, DOI 10.1021/ac010081x; Gras R, 2001, CURR OPIN MOL THER, V3, P526; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greis KD, 1996, ANAL BIOCHEM, V234, P38, DOI 10.1006/abio.1996.0047; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; GUINA T, IN PRESS P NATL ACAD; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Gygi SP, 2002, J PROTEOME RES, V1, P47, DOI 10.1021/pr015509n; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HAAB BB, 2001, GENOME BIOL, V0002; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HAYES BK, 1995, ANAL BIOCHEM, V228, P115, DOI 10.1006/abio.1995.1322; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; Herbert B, 1999, ELECTROPHORESIS, V20, P660, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<660::AID-ELPS660>3.0.CO;2-Q; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holt LJ, 2000, CURR OPIN BIOTECH, V11, P445, DOI 10.1016/S0958-1669(00)00133-6; Houseman BT, 2002, TRENDS BIOTECHNOL, V20, P279, DOI 10.1016/S0167-7799(02)01984-4; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; JAMES P, 1993, BIOCHEM BIOPH RES CO, V195, P58, DOI 10.1006/bbrc.1993.2009; Jenkins RE, 2001, PROTEOMICS, V1, P13, DOI 10.1002/1615-9861(200101)1:1<13::AID-PROT13>3.3.CO;2-A; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; KLOSE J, 1975, HUMANGENETIK, V26, P231; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Krylov AS, 2001, NUCLEIC ACIDS RES, V29, P2654, DOI 10.1093/nar/29.12.2654; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; KUMAZAKI T, 1987, J BIOCHEM-TOKYO, V102, P1539, DOI 10.1093/oxfordjournals.jbchem.a122202; Lai R, 2002, CANCER, V95, P1071, DOI 10.1002/cncr.10772; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Link AJ, 1997, INT J MASS SPECTROM, V160, P303, DOI 10.1016/S0168-1176(96)04489-8; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; MacBeath G, 2000, SCIENCE, V289, P1760; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; MANN M, 1994, MICROCHARACTERIZATIO, P223; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Martin F, 1996, J MOL BIOL, V255, P86, DOI 10.1006/jmbi.1996.0008; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MCCONNELL SJ, 1995, J MOL BIOL, V250, P460, DOI 10.1006/jmbi.1995.0390; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; Medzihradszky KF, 2000, ANAL CHEM, V72, P552, DOI 10.1021/ac990809y; Mintz PJ, 1999, EMBO J, V18, P4308, DOI 10.1093/emboj/18.15.4308; Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V; Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225; Munchbach M, 2000, ANAL CHEM, V72, P4047, DOI 10.1021/ac000265w; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; NORD K, 1995, PROTEIN ENG, V8, P601, DOI 10.1093/protein/8.6.601; NUWAYSIR LM, 1993, J AM SOC MASS SPECTR, V4, P662, DOI 10.1016/1044-0305(93)85031-R; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Patterson SD, 2000, CELL DEATH DIFFER, V7, P137, DOI 10.1038/sj.cdd.4400640; PATTERSON SD, 1995, ELECTROPHORESIS, V16, P1791, DOI 10.1002/elps.11501601299; PATTERSON SD, 1998, PROTEOMICS INTEGRATI, P127; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RANISH JA, IN PRESS NAT GENET; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ritchie RF, 1999, J CLIN LAB ANAL, V13, P280, DOI 10.1002/(SICI)1098-2825(1999)13:6<280::AID-JCLA5>3.3.CO;2-L; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHEELE GA, 1975, J BIOL CHEM, V250, P5375; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Siebert R, 2001, CURR OPIN ONCOL, V13, P316, DOI 10.1097/00001622-200109000-00002; Simpson RJ, 2000, ELECTROPHORESIS, V21, P1707, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1707::AID-ELPS1707>3.0.CO;2-Q; Smith RD, 2001, ELECTROPHORESIS, V22, P1652, DOI 10.1002/1522-2683(200105)22:9<1652::AID-ELPS1652>3.0.CO;2-E; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Spahr CS, 2000, ELECTROPHORESIS, V21, P1635, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1635::AID-ELPS1635>3.0.CO;2-1; Spahr CS, 2001, PROTEOMICS, V1, P93, DOI 10.1002/1615-9861(200101)1:1<93::AID-PROT93>3.0.CO;2-3; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; Tanaka K., 1987, P 2 JAP CHIN JT S MA, P185; TARROUX P, 1987, ELECTROPHORESIS, V8, P187, DOI 10.1002/elps.1150080404; TEMPST P, 1990, ELECTROPHORESIS, V11, P537, DOI 10.1002/elps.1150110704; Thornton Janet, 2001, Trends in Biochemical Sciences, V26, P88, DOI 10.1016/S0968-0004(00)01765-5; Tramontano Anna, 1994, Journal of Molecular Recognition, V7, P9, DOI 10.1002/jmr.300070103; Tsien RY, 1998, SCIENCE, V280, P1954, DOI 10.1126/science.280.5371.1954; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tucker CL, 2001, NAT BIOTECHNOL, V19, P1042, DOI 10.1038/nbt1101-1042; Tucker CL, 2001, TRENDS CELL BIOL, V11, P102, DOI 10.1016/S0962-8924(00)01902-4; Turecek F, 2002, J MASS SPECTROM, V37, P1, DOI 10.1002/jms.275; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Uttenweiler-Joseph S, 2001, PROTEOMICS, V1, P668, DOI 10.1002/1615-9861(200104)1:5<668::AID-PROT668>3.3.CO;2-J; van Berkum NL, 2001, CURR OPIN BIOTECH, V12, P48, DOI 10.1016/S0958-1669(00)00173-7; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDEKERCKHOVE J, 1985, EUR J BIOCHEM, V152, P9, DOI 10.1111/j.1432-1033.1985.tb09157.x; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walter G, 2000, CURR OPIN MICROBIOL, V3, P298, DOI 10.1016/S1369-5274(00)00093-X; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wilkins MR, 1996, BIOTECHNOL GENET ENG, V13, P19, DOI 10.1080/02648725.1996.10647923; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; YATES JR, 1993, ANAL BIOCHEM, V214, P397, DOI 10.1006/abio.1993.1514; Yates JR, 1997, J PROTEIN CHEM, V16, P495; Zhang BL, 2000, METHOD ENZYMOL, V318, P399; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhang SH, 1999, J BIOL CHEM, V274, P17806, DOI 10.1074/jbc.274.25.17806; Zhou HH, 2001, TRENDS BIOTECHNOL, V19, pS34, DOI 10.1016/S0167-7799(01)01798-X; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	198	461	520	3	112	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			311	323		10.1038/ng1106	http://dx.doi.org/10.1038/ng1106			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610541				2022-12-27	WOS:000181390900012
J	Seidel-Rogol, BL; McCulloch, V; Shadel, GS				Seidel-Rogol, BL; McCulloch, V; Shadel, GS			Human mitochondrial transcription factor B1 methylates ribosomal RNA at a conserved stem-loop	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; DIMETHYLATION; YEAST; GENE	Human mitochondrial transcription factor B1 (h-mtTFB1) has an unprecedented relationship to RNA methyltransferases. Here, we show that this protein methylates a conserved stem-loop in bacterial 16S rRNA and that the homologous sequence in the human mitochondrial 12S molecule is similarly modified. Thus, h-mtTFB1 appears to be dual-function protein, acting both as a transcription factor and an rRNA-modification enzyme.	Emory Univ, Sch Med, Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Shadel, GS (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Biochem, Atlanta, GA 30322 USA.							DUBIN DT, 1974, J MOL BIOL, V84, P257, DOI 10.1016/0022-2836(74)90584-1; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; HELSER TL, 1971, NATURE-NEW BIOL, V233, P12, DOI 10.1038/newbio233012a0; Huntington KM, 2000, BIOCHEMISTRY-US, V39, P4543, DOI 10.1021/bi992452y; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; VANBUUL CPJJ, 1985, GENE, V38, P65, DOI 10.1016/0378-1119(85)90204-5; Vila-Sanjurjo A, 1999, J MOL BIOL, V293, P1, DOI 10.1006/jmbi.1999.3160	10	135	142	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					23	24		10.1038/ng1064	http://dx.doi.org/10.1038/ng1064			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12496758				2022-12-27	WOS:000180136100012
J	Suzuki, T; Shen, HF; Akagi, K; Morse, HC; Malley, JD; Naiman, DQ; Jenkins, NA; Copeland, NG				Suzuki, T; Shen, HF; Akagi, K; Morse, HC; Malley, JD; Naiman, DQ; Jenkins, NA; Copeland, NG			New genes involved in cancer identified by retroviral tagging	NATURE GENETICS			English	Article							TRANSPOSITION; LYMPHOMA; MAP; PROTOONCOGENE; ACTIVATION; EXPRESSION; INSERTION; DISTANCE; CLONING; REGION	Retroviral insertional mutagenesis in BXH2 and AKXD mice induces a high incidence of myeloid leukemia and B- and T-cell lymphoma, respectively. The retroviral integration sites (RISs) in these tumors thus provide powerful genetic tags for the discovery of genes involved in cancer(1,2). Here we report the first large-scale use of retroviral tagging for cancer gene discovery in the post-genome era. Using high throughput inverse PCR1, we cloned and analyzed the sequences of 884 RISs from a tumor panel composed primarily of B- cell lymphomas. We then compared these sequences, and another 415 RIS sequences previously cloned from BXH2 myeloid leukemias and from a few AKXD lymphomas, against the recently assembled mouse genome sequence. These studies identified 152 loci that are targets of retroviral integration in more than one tumor (common retroviral integration sites, CISs) and therefore likely to encode a cancer gene. Thirty-six CISs encode genes that are known or predicted to be genes involved in human cancer or their homologs, whereas others encode candidate genes that have not yet been examined for a role in human cancer. Our studies demonstrate the power of retroviral tagging for cancer gene discovery in the post-genome era and indicate a largely unrecognized complexity in mouse and presumably human cancer.	NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; NIAID, Immunopathol Lab, Bethesda, MD 20892 USA; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Johns Hopkins University	Copeland, NG (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA.	copeland@ncifcrf.gov	Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081; Morse, Herbert/0000-0002-9331-3705	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000268, ZIACT000268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000858, ZIAAI000858] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEN-DAVID Y, 1990, New Biologist, V2, P1015; Cao JN, 1997, J CANCER RES CLIN, V123, P447, DOI 10.1007/s004320050085; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; GILBERT DJ, 1993, J VIROL, V67, P2083, DOI 10.1128/JVI.67.4.2083-2090.1993; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Hartley JW, 2000, LAB INVEST, V80, P159, DOI 10.1038/labinvest.3780020; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; LARGAESPADA DA, 1995, J VIROL, V69, P5095, DOI 10.1128/JVI.69.8.5095-5102.1995; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; LUND AH, 2002, NAT GENET, V32, P80, DOI DOI 10.1038/NG956; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Mock BA, 1996, GENOMICS, V37, P24, DOI 10.1006/geno.1996.0516; Morse HC, 2001, LEUKEMIA RES, V25, P719, DOI 10.1016/S0145-2126(01)00022-4; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Neri A, 1996, LEUKEMIA LYMPHOMA, V23, P43, DOI 10.3109/10428199609054800; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; ZEIDLER R, 1994, GENE CHROMOSOME CANC, V9, P282, DOI 10.1002/gcc.2870090408; Zeng WR, 1997, ONCOGENE, V14, P2355, DOI 10.1038/sj.onc.1201076	27	341	354	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					166	174		10.1038/ng949	http://dx.doi.org/10.1038/ng949			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12185365				2022-12-27	WOS:000177714900017
J	Thorgeirsson, SS; Grisham, JW				Thorgeirsson, SS; Grisham, JW			Molecular pathogenesis of human hepatocellular carcinoma	NATURE GENETICS			English	Article							HEPATITIS-B-VIRUS; DIFFERENTIAL GENE-EXPRESSION; ABERRANT DNA METHYLATION; GENOME-WIDE ANALYSIS; HEPATOMA-CELL LINES; MICROSATELLITE INSTABILITY; DYSPLASTIC NODULES; CLONAL ANALYSIS; TELOMERASE ACTIVITY; CODON-249 MUTATION	Hepatocarcinogenesis is a slow process during which genomic changes progressively alter the hepatocellular phenotype to produce cellular intermediates that evolve into hepatocellular carcinoma. During the long pre-neoplastic stage, in which the liver is often the site of chronic hepatitis, cirrhosis, or both, hepatocyte cycling is accelerated by upregulation of mitogenic pathways, in part through epigenetic mechanisms. This leads to the production of monoclonal populations of aberrant and dysplastic hepatocytes that have telomere erosion and telomerase re-expression, sometimes microsatellite instability, and occasionally structural aberrations in genes and chromosomes. Development of dysplastic hepatocytes in foci and nodules and emergence of hepatocellular carcinoma are associated with the accumulation of irreversible structural alterations in genes and chromosomes, but the genomic basis of the malignant phenotype is heterogeneous. The malignant hepatocyte phenotype may be produced by the disruption of a number of genes that function in different regulatory pathways, producing several molecular variants of hepatocellular carcinoma. New strategies should enable these variants to be characterized.	NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov						Balsara BR, 2001, GENE CHROMOSOME CANC, V30, P245, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1083>3.0.CO;2-M; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Brechot C, 1998, HEPATO-GASTROENTEROL, V45, P1189; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Chen TC, 2000, ANTICANCER RES, V20, P1621; Chen YJ, 2000, GASTROENTEROLOGY, V119, P431, DOI 10.1053/gast.2000.9373; Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H; Chu CM, 2000, J GASTROEN HEPATOL, V15, pE25, DOI 10.1046/j.1440-1746.2000.02097.x; del Olmo JA, 1998, J CANCER RES CLIN, V124, P560, DOI 10.1007/s004320050215; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Ferlay J, 2001, GLOBOCAN 2000 CANC I; Grisham JW, 1997, CARCINOGENESIS, V18, P59, DOI 10.1093/carcin/18.1.59; Grisham JW, 2002, MOLECULAR BASIS OF HUMAN CANCER, P269; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Honda M, 2001, GASTROENTEROLOGY, V120, P955, DOI 10.1053/gast.2001.22468; Hsu HC, 1997, CANCER RES, V57, P5179; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Hussain SP, 2000, P NATL ACAD SCI USA, V97, P12770, DOI 10.1073/pnas.220416097; IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H; JINBAEK M, 2000, CANCER, V89, P60; Kanai Y, 1999, HEPATOLOGY, V29, P703, DOI 10.1002/hep.510290338; Kanai Y, 2000, CANCER LETT, V148, P73, DOI 10.1016/S0304-3835(99)00316-X; Kane JM, 1997, J SURG RES, V69, P321, DOI 10.1006/jsre.1997.5057; Kaneto H, 2001, GUT, V48, P372, DOI 10.1136/gut.48.3.372; Karachristos A, 1999, Mol Cell Biol Res Commun, V2, P155, DOI 10.1006/mcbr.1999.0170; KATO Y, 1994, CANCER, V74, P2234, DOI 10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6; Kawai H, 2000, HEPATOLOGY, V31, P1246, DOI 10.1053/jhep.2000.7298; KAWAKITA N, 1992, AM J PATHOL, V140, P513; Kemp CJ, 1999, AM J PATHOL, V154, P975, DOI 10.1016/S0002-9440(10)65347-3; Kitamoto M, 1999, CANCER, V85, P245, DOI 10.1002/(SICI)1097-0142(19990101)85:1<245::AID-CNCR37>3.0.CO;2-9; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Laes JF, 2000, CANCER GENET CYTOGEN, V117, P118, DOI 10.1016/S0165-4608(99)00157-0; Lau WY, 2000, ONCOL RES, V12, P59; Lin CH, 2001, CANCER RES, V61, P4238; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Liu T, 2001, TOXICOL SCI, V59, P185, DOI 10.1093/toxsci/59.1.185; LIU YW, 1993, CANCER LETT, V70, P189, DOI 10.1016/0304-3835(93)90230-7; Loeb LA, 2001, CANCER RES, V61, P3230; Maggioni M, 2000, HEPATOLOGY, V32, P942, DOI 10.1053/jhep.2000.18425; Mao TL, 2001, J PATHOL, V193, P95, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH720>3.0.CO;2-3; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; Nagai H, 1999, GENE, V237, P15, DOI 10.1016/S0378-1119(99)00322-4; Ng IOL, 2000, CANCER RES, V60, P6581; Nishikawa M, 2001, CANCER RES, V61, P1843; Ochiai T, 2000, HEPATOLOGY, V31, P615, DOI 10.1002/hep.510310311; OKA H, 1990, HEPATOLOGY, V12, P680, DOI 10.1002/hep.1840120411; Okabe H, 2000, HEPATOLOGY, V31, P1073, DOI 10.1053/he.2000.6409; Okabe H, 2001, CANCER RES, V61, P2129; Okuda T, 2001, CANCER LETT, V164, P91, DOI 10.1016/S0304-3835(00)00702-3; Paradis V, 1998, HEPATOLOGY, V28, P953, DOI 10.1002/hep.510280409; Paradis V, 2000, LAB INVEST, V80, P1553, DOI 10.1038/labinvest.3780165; Park YM, 2000, HEPATOL RES, V17, P102, DOI 10.1016/S1386-6346(99)00066-2; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Piao Z, 2000, INT J ONCOL, V17, P507; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rao UNM, 2001, MOL DIAGN, V6, P27, DOI 10.1054/modi.2001.22021; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roncalli M, 2000, HEPATOLOGY, V31, P846, DOI 10.1053/he.2000.5790; Saeki A, 2000, CANCER, V88, P1025, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1025::AID-CNCR11>3.0.CO;2-U; Saito Y, 2001, HEPATOLOGY, V33, P561, DOI 10.1053/jhep.2001.22507; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schwienbacher C, 2000, P NATL ACAD SCI USA, V97, P5445, DOI 10.1073/pnas.090087497; Seki S, 2000, CLIN CANCER RES, V6, P3469; Shen LL, 1998, HEPATO-GASTROENTEROL, V45, P1753; SHI CY, 1995, BRIT J CANCER, V72, P146, DOI 10.1038/bjc.1995.291; Shirota Y, 2001, HEPATOLOGY, V33, P832, DOI 10.1053/jhep.2001.23003; Smela ME, 2001, CARCINOGENESIS, V22, P535, DOI 10.1093/carcin/22.4.535; Soini Y, 1996, BRIT J CANCER, V73, P1025, DOI 10.1038/bjc.1996.199; Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P617; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Strauss BS, 1999, MUTAT RES-REV MUTAT, V437, P195, DOI 10.1016/S1383-5742(99)00066-6; Sun M, 2001, HEPATOLOGY, V33, P1415, DOI 10.1053/jhep.2001.24751; Takai D, 2000, JPN J CLIN ONCOL, V30, P306, DOI 10.1093/jjco/hyd079; Takaishi H, 2000, CANCER, V88, P312, DOI 10.1002/(SICI)1097-0142(20000115)88:2<312::AID-CNCR10>3.3.CO;2-I; TAKANO S, 1995, HEPATOLOGY, V21, P650; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; TAO LC, 1991, CANCER, V68, P341, DOI 10.1002/1097-0142(19910715)68:2<341::AID-CNCR2820680223>3.0.CO;2-Q; Tchou JC, 2000, INT J ONCOL, V16, P663; Terris B, 1999, ONCOGENE, V18, P6583, DOI 10.1038/sj.onc.1203051; Theise ND, 1996, LIVER, V16, P134; Thorgeirsson SS, 2000, TOXICOL LETT, V112, P553, DOI 10.1016/S0378-4274(99)00224-6; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; Tornillo L, 2000, J PATHOL, V192, P307, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH706&gt;3.0.CO;2-O; Toshikuni N, 2000, BRIT J CANCER, V82, P833, DOI 10.1054/bjoc.1999.1008; van Oijen MGCT, 2000, CANCER EPIDEM BIOMAR, V9, P249; Wilkens L, 2000, J PATHOL, V192, P43; Wilkens L, 2001, J PATHOL, V193, P476, DOI 10.1002/path.825; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349; Wong N, 2000, CLIN CANCER RES, V6, P4000; Xu L, 2001, CANCER RES, V61, P3176; Yamaguchi R, 2000, ONCOL REP, V7, P725; Yamashita T, 2001, BIOCHEM BIOPH RES CO, V282, P647, DOI 10.1006/bbrc.2001.4610; Zondervan PE, 2000, J PATHOL, V192, P207, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH690&gt;3.0.CO;2-#	96	1184	1243	0	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					339	346		10.1038/ng0802-339	http://dx.doi.org/10.1038/ng0802-339			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12149612	Green Published			2022-12-27	WOS:000177147100006
J	Guo, DH; Li, MY; Zhang, Y; Yang, P; Eckenrode, S; Hopkins, D; Zheng, WP; Purohit, S; Podolsky, RH; Muir, A; Wang, JZ; Dong, Z; Brusko, T; Atkinson, M; Pozzilli, P; Zeidler, A; Raffel, LJ; Jacob, CO; Park, Y; Serrano-Rios, M; Larrad, MTM; Zhang, ZX; Garchon, HJ; Bach, JF; Rotter, JI; She, JX; Wang, CY				Guo, DH; Li, MY; Zhang, Y; Yang, P; Eckenrode, S; Hopkins, D; Zheng, WP; Purohit, S; Podolsky, RH; Muir, A; Wang, JZ; Dong, Z; Brusko, T; Atkinson, M; Pozzilli, P; Zeidler, A; Raffel, LJ; Jacob, CO; Park, Y; Serrano-Rios, M; Larrad, MTM; Zhang, ZX; Garchon, HJ; Bach, JF; Rotter, JI; She, JX; Wang, CY			A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes	NATURE GENETICS			English	Article							CHROMOSOME 11Q13; LINKAGE-DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; SIGNAL-TRANSDUCTION; ACTIVATION; GENES; MELLITUS; IDDM4; TAB2; RECEPTOR	Previous studies have suggested more than 20 genetic intervals that are associated with susceptibility to type 1 diabetes (T1D)(1,2), but identification of specific genes has been challenging and largely limited to known candidate genes. Here, we report evidence for an association between T1D and multiple single-nucleotide polymorphisms in 197 kb of genomic DNA in the IDDM5 interval. We cloned a new gene (SUMO4), encoding small ubiquitin-like modifier 4 protein, in the interval. A substitution (M55V) at an evolutionarily conserved residue of the crucial CUE domain of SUMO4 was strongly associated with T1D (P = 1.9 x 10(-7)). SUMO4 conjugates to IkappaBalpha and negatively regulates NFkappaB transcriptional activity. The M55V substitution resulted in 5.5 times greater NFkappaB transcriptional activity and similar to2 times greater expression of IL12B, an NFkappaB-dependent gene. These findings suggest a new pathway that may be implicated in the pathogenesis of T1D.	Med Coll Georgia, Ctr Biotechnol & Gen Med, Augusta, GA 30912 USA; Med Coll Georgia, Off Biostat & Bioinformat, Augusta, GA 30912 USA; Med Coll Georgia, Childrens Med Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; Univ Roma La Sapienza, Ist Clin Med 2, Rome, Italy; Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA; Hanyang Univ Hosp, Seoul, South Korea; Univ Complutense, Fac Med, E-28040 Madrid, Spain; Beijing Red Cross Blood Ctr, HLA Lab, Beijing, Peoples R China; INSERM, Unite Rech, U580, Ctr Assoc Claude Bernard, Paris, France	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; State University System of Florida; University of Florida; Sapienza University Rome; University of Southern California; Hanyang University; Hanyang University Hospital; Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm)	She, JX (corresponding author), Med Coll Georgia, Ctr Biotechnol & Gen Med, 1120 15th St,CA4098, Augusta, GA 30912 USA.	jshe@mail.mcg.edu; cwang@mail.mcg.edu	Purohit, Sharad/ABA-8054-2021; Podolsky, Robert/GRY-0740-2022; Pozzilli, Paolo/A-5235-2010; zhang, yan/AAG-7349-2019	zhang, yan/0000-0003-0906-9410; Brusko, Todd/0000-0003-2878-9296; Wang, Cong-Yi/0000-0001-7914-168X; Purohit, Sharad/0000-0003-0385-3829				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; DENG GY, 1995, AM J HUM GENET, V56, P528; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Eckenrode S, 2000, HUM GENET, V106, P14, DOI 10.1007/s004399900186; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Onengut-Gumuscu S, 2002, IMMUNOL REV, V190, P182, DOI 10.1034/j.1600-065X.2002.19014.x; Owerbach D, 2000, DIABETES, V49, P508, DOI 10.2337/diabetes.49.3.508; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Twells RCJ, 2003, HUM GENET, V113, P99, DOI 10.1007/s00439-003-0940-6; Twells RCJ, 2001, GENOMICS, V72, P231, DOI 10.1006/geno.2000.6492; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6	30	315	352	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					837	841		10.1038/ng1391	http://dx.doi.org/10.1038/ng1391			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15247916				2022-12-27	WOS:000222974000015
J	Nakamura, Y; Itoh, T; Matsuda, H; Gojobori, T				Nakamura, Y; Itoh, T; Matsuda, H; Gojobori, T			Biased biological functions of horizontally transferred genes in prokaryotic genomes	NATURE GENETICS			English	Article							PATHOGENICITY ISLANDS; EVOLUTION; BACTERIA; NEISSERIA; SEQUENCE; EXCHANGE	Horizontal gene transfer is one of the main mechanisms contributing to microbial genome diversification(1-3). To clarify the overall picture of interspecific gene flow among prokaryotes, we developed a new method for detecting horizontally transferred genes and their possible donors by Bayesian inference with training models for nucleotide composition. Our method gives the average posterior probability ( horizontal transfer index) for each gene sequence, with a low horizontal transfer index indicating recent horizontal transfer. We found that 14% of open reading frames in 116 prokaryotic complete genomes were subjected to recent horizontal transfer. Based on this data set, we quantitatively determined that the biological functions of horizontally transferred genes, except mobile element genes, are biased to three categories: cell surface, DNA binding and pathogenicity-related functions. Thus, the transferability of genes seems to depend heavily on their functions.	Res Org Informat & Syst, Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; Res Org Informat & Syst, Natl Inst Genet, DNA Data Bank Japan, Shizuoka 4118540, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; Natl Inst Agrobiol Sci, Genome Res Dept, Tsukuba, Ibaraki 3058602, Japan; Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka 5608531, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Agrobiological Sciences - Japan; Osaka University	Gojobori, T (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Ctr Informat Biol, 1111 Yata, Shizuoka 4118540, Japan.	tgojobor@genes.nig.ac.jp	asif, huma/C-1441-2012	Matsuda, Hideo/0000-0002-4701-3779; Itoh, Takeshi/0000-0002-6291-4233				AMABILECUEVAS CF, 1992, CELL, V70, P189, DOI 10.1016/0092-8674(92)90095-T; BORODOVSKY M, 1995, NUCLEIC ACIDS RES, V23, P3554, DOI 10.1093/nar/23.17.3554; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Charlebois RL, 2003, NATURE, V421, P217, DOI 10.1038/421217a; Davis J, 2001, J BACTERIOL, V183, P4626, DOI 10.1128/JB.183.15.000-000.2001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Genereux DP, 2003, TRENDS GENET, V19, P191, DOI 10.1016/S0168-9525(03)00055-6; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang B, 2001, J MOL EVOL, V53, P244, DOI 10.1007/s002390010214; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	27	336	356	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					760	766		10.1038/ng1381	http://dx.doi.org/10.1038/ng1381			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208628	Bronze			2022-12-27	WOS:000222354100029
J	Vulliamy, T; Marrone, A; Szydlo, R; Walne, A; Mason, PJ; Dokal, I				Vulliamy, T; Marrone, A; Szydlo, R; Walne, A; Mason, PJ; Dokal, I			Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC	NATURE GENETICS			English	Article							SMALL NUCLEOLAR RNAS; APLASTIC-ANEMIA; CELLS; COMPONENT; LENGTH	Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.	Hammersmith Hosp, Imperial Coll London, Dept Haematol, Div Invest Sci, London W12 0NN, England	Imperial College London	Mason, PJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, Campus Box 8125,660 S Euclid Ave, St Louis, MO 63110 USA.	PMason@im.wustl.edu	Szydlo, Richard/C-6678-2012; Mason, Philip J/B-1087-2008	Szydlo, Richard/0000-0003-1102-8298; Dokal, Inderjeet/0000-0003-4462-4782				Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Lindblad K, 1999, SEMIN NEUROL, V19, P289, DOI 10.1055/s-2008-1040845; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6	15	336	348	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					447	449		10.1038/ng1346	http://dx.doi.org/10.1038/ng1346			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15098033	Bronze			2022-12-27	WOS:000221183000014
J	Knight, JC; Keating, BJ; Kwiatkowski, DP				Knight, JC; Keating, BJ; Kwiatkowski, DP			Allele-specific repression of lymphotoxin-alpha activated B cell factor-1	NATURE GENETICS			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; GENE POLYMORPHISM; FACTOR-BETA; SEVERE SEPSIS; AMINO-ACID; BINDING; PROTEINS; ENHANCER; ASTHMA	Genetic variation at the human LTA locus, encoding lymphotoxin-alpha, is associated with susceptibility to myocardial infarction, asthma and other diseases. By detailed haplotypic analysis of the locus, we identified a single-nucleotide polymorphism (SNP) at LTA + 80 as a main predictor of LTA protein production by human B cells. We found that activated B-cell factor-1 (ABF-1) binds to this site in vitro and suppresses reporter gene expression, but only in the presence of the LTA +80A allele. Using haplotype-specific chromatin immunoprecipitation, we confirmed that ABF-1 is preferentially recruited to the low-producer allele in vivo. These findings provide a molecular model of how LTA expression may be genetically regulated by allele-specific recruitment of the transcriptional repressor ABF-1.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Knight, JC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	julian@well.ox.ac.uk	Knight, Julian/C-7242-2009; Knight, Julian Charles/W-2399-2019	Knight, Julian/0000-0002-0377-5536; Knight, Julian Charles/0000-0002-0377-5536; Kwiatkowski, Dominic/0000-0002-5023-0176				Albuquerque RV, 1998, CLIN EXP ALLERGY, V28, P578; Aranburu A, 2001, BIOCHEM J, V354, P431, DOI 10.1042/0264-6021:3540431; BADENHOOP K, 1992, J CLIN ENDOCR METAB, V74, P287, DOI 10.1210/jc.74.2.287; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Demeter J, 1997, BRIT J HAEMATOL, V97, P107, DOI 10.1046/j.1365-2141.1997.9912636.x; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Lee SH, 1997, LUPUS, V6, P603, DOI 10.1177/096120339700600708; Majetschak M, 1999, ANN SURG, V230, P207, DOI 10.1097/00000658-199908000-00011; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OU SHI, 1994, J VIROL, V68, P7188, DOI 10.1128/JVI.68.11.7188-7199.1994; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PICOT F, 1993, EUR J IMMUNOL, V23, P224; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHIMURA T, 1994, CANCER, V73, P1184, DOI 10.1002/1097-0142(19940215)73:4<1184::AID-CNCR2820730410>3.0.CO;2-Y; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; Takahashi Y, 2000, GENE DEV, V14, P804; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Whichelow CE, 1996, EUR J IMMUNOGENET, V23, P425, DOI 10.1111/j.1744-313X.1996.tb00133.x; Wong J, 2001, DNA CELL BIOL, V20, P465, DOI 10.1089/104454901316976091; Yamaguchi E, 2001, CHEST, V119, P753, DOI 10.1378/chest.119.3.753	30	94	97	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					394	399		10.1038/ng1331	http://dx.doi.org/10.1038/ng1331			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15052269	Bronze			2022-12-27	WOS:000220647200024
J	Krakow, D; Robertson, SP; King, LM; Morgan, T; Sebald, ET; Bertolotto, C; Wachsmann-Hogiu, S; Acuna, D; Shapiro, SS; Takafuta, T; Aftimos, S; Kim, CA; Firth, H; Steiner, CE; Cormier-Daire, V; Superti-Furga, A; Bonafe, L; Graham, JM; Grix, A; Bacino, CA; Allanson, J; Bialer, MG; Lachman, RS; Rimoin, DL; Cohn, DH				Krakow, D; Robertson, SP; King, LM; Morgan, T; Sebald, ET; Bertolotto, C; Wachsmann-Hogiu, S; Acuna, D; Shapiro, SS; Takafuta, T; Aftimos, S; Kim, CA; Firth, H; Steiner, CE; Cormier-Daire, V; Superti-Furga, A; Bonafe, L; Graham, JM; Grix, A; Bacino, CA; Allanson, J; Bialer, MG; Lachman, RS; Rimoin, DL; Cohn, DH			Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis	NATURE GENETICS			English	Article							SPONDYLOCARPOTARSAL SYNOSTOSIS; PRENATAL-DIAGNOSIS; LARSENS-SYNDROME; PROTEIN; DISLOCATIONS; MIGRATION; DYSPLASIA; NEURONS	The filamins are cytoplasmic proteins that regulate the structure and activity of the cytoskeleton by cross-linking actin into three-dimensional networks, linking the cell membrane to the cytoskeleton and serving as scaffolds on which intracellular signaling and protein trafficking pathways are organized (reviewed in refs. 1,2). We identified mutations in the gene encoding filamin B in four human skeletal disorders. We found homozygosity or compound heterozygosity with respect to stop-codon mutations in autosomal recessive spondylocarpotarsal syndrome (SCT, OMIM 272460) and missense mutations in individuals with autosomal dominant Larsen syndrome (OMIM 150250) and the perinatal lethal atelosteogenesis I and III phenotypes (AOI, OMIM 108720; AOIII, OMIM 108721). We found that filamin B is expressed in human growth plate chondrocytes and in the developing vertebral bodies in the mouse. These data indicate an unexpected role in vertebral segmentation, joint formation and endochondral ossification for this ubiquitously expressed cytoskeletal protein.	Cedars Sinai Res Inst, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; Cedars Sinai Res Inst, Ahmanson Dept Pediat, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA USA; Univ Otago, Dept Paediat & Child Hlth, Dunedin, New Zealand; Cedars Sinai Res Inst, MIST, Los Angeles, CA USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Physiol, Philadelphia, PA 19107 USA; Yamanashi Med Univ, Dept Clin & Lab Med, Yamanashi, Japan; No Reg Genet Serv, Auckland, New Zealand; Univ Sao Paulo, Inst Crianca, Fac Med, BR-05508 Sao Paulo, Brazil; Addenbrookes Hosp, Dept Med Genet, Cambridge, England; Univ Estadual Campinas, Dept Med Genet, Sch Med Sci, Campinas, SP, Brazil; Hop Necker Enfants Malad, Dept Med Genet, Paris, France; CHU Vaudois, Div Mol Paediat, Lausanne, Switzerland; Baylor Coll Med, Dept Mol & Human Genet, Los Angeles, CA USA; Eastern Ontario Reg Genet Program, Ottawa, ON, Canada; N Shore NYU Med Ctr, Schneider Childrens Hosp, Dept Pediat, Manhasset, NY USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA; Permanente Med Grp Inc, Sacramento, CA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Otago; Cedars Sinai Medical Center; Jefferson University; University of Yamanashi; Universidade de Sao Paulo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade Estadual de Campinas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Permanente Medical Groups	Krakow, D (corresponding author), Cedars Sinai Res Inst, Dept Obstet & Gynecol, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	deborah.krakow@cshs.org; stephen.robertson@stonebow.otago.ac.nz	Graham, John M./J-1429-2019; Steiner, Carlos E/B-9319-2014; superti-furga, andrea/E-9162-2015; cormier-daire, valerie/H-6520-2017	Steiner, Carlos E/0000-0001-5148-3063; superti-furga, andrea/0000-0002-3543-7531; cormier-daire, valerie/0000-0002-2839-9856; Kim, Chong/0000-0002-1754-1300; Robertson, Stephen/0000-0002-5181-7809				Chakarova C, 2000, HUM GENET, V107, P597, DOI 10.1007/s004390000414; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Himmel M, 2003, BIOCHEMISTRY-US, V42, P430, DOI 10.1021/bi026501+; Honeywell C, 2002, AM J MED GENET, V109, P318, DOI 10.1002/ajmg.10383; LARSEN LJ, 1950, J PEDIATR-US, V37, P574, DOI 10.1016/S0022-3476(50)80268-8; LATTA RJ, 1971, J PEDIATR-US, V78, P291, DOI 10.1016/S0022-3476(71)80014-8; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; MARQUES MDT, 1980, J GENET HUM, V28, P83; NIEDERMAN R, 1983, J CELL BIOL, V96, P1400, DOI 10.1083/jcb.96.5.1400; Nishimura G, 1997, AM J MED GENET, V73, P132; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Schultz C, 1999, AM J MED GENET, V83, P28, DOI 10.1002/(SICI)1096-8628(19990305)83:1<28::AID-AJMG7>3.0.CO;2-G; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Sillence D, 1997, PEDIATR RADIOL, V27, P388, DOI 10.1007/s002470050154; Steiner CE, 2000, AM J MED GENET, V91, P131, DOI 10.1002/(SICI)1096-8628(20000313)91:2<131::AID-AJMG10>3.3.CO;2-7; STEINER CE, IN PRESS J MED GENET; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; VUJIC M, 1995, AM J HUM GENET, V57, P1104; Wessels MW, 2003, AM J MED GENET A, V122A, P148, DOI 10.1002/ajmg.a.20239	24	189	193	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					405	410		10.1038/ng1319	http://dx.doi.org/10.1038/ng1319			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	14991055	Bronze			2022-12-27	WOS:000220647200026
J	Lin, SP; Youngson, N; Takada, S; Seitz, H; Reik, W; Paulsen, M; Cavaille, J; Ferguson-Smith, ACF				Lin, SP; Youngson, N; Takada, S; Seitz, H; Reik, W; Paulsen, M; Cavaille, J; Ferguson-Smith, ACF			Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12	NATURE GENETICS			English	Article							UNIPARENTAL DISOMY; GENES; DOMAIN; GTL2; DELETION; H19; IDENTIFICATION; EXPRESSION; DNMT3L; LOCUS	Genomic imprinting causes parental origin specific gene expression(1). Cis-acting regulatory elements that control imprinting are not fully understood but involve regions that become differentially methylated on the two parental chromosomes during male and female gametogenesis(2-4). Understanding properties of maternally and paternally inherited imprints provides insight into the mechanisms and evolution of genomic imprinting. Previously we identified an intergenic germline-derived differentially methylated region (IG-DMR) that is a candidate control element for an imprinted domain on distal mouse chromosome 12 (ref. 5). The 1-Mb cluster contains the paternally expressed protein-coding genes Dlk1 (refs. 6,7) and Dio3 (ref. 8,9) and several maternally expressed non-coding RNAs, including Gtl2 (refs. 6,7,10) and C/D snoRNAs(11). A retrotransposon-like gene (Rtl1) is expressed from the paternal chromosome and has an antisense transcript expressed from the maternal chromosome containing two microRNAs with full complementarity to Rtl1 (ref. 12). Here we show that deletion of the IG-DMR from the maternally inherited chromosome causes bidirectional loss of imprinting of all genes in the cluster. When the deletion is transmitted from the father, imprinting is unaltered. These results prove that the IG-DMR is a control element for all imprinted genes on the maternal chromosome only and indicate that the two parental chromosomes control allele-specific gene expression differently.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Toulouse 3, CNRS, UMR 5099, LBME, F-31062 Toulouse, France; Babraham Inst, Lab Dev Genet & Imprinting, Dev Genet Programme, Cambridge CB2 4AT, England	University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Lin, SP (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.		Youngson, Neil/AAB-7389-2019; Ferguson-Smith, Anne C/G-7534-2011; Reik, Wolf/I-6794-2012; cavaille, jerome/AAM-8047-2020; Seitz, Hervé/AAE-6487-2019; Paulsen, Martina/G-2262-2010	Seitz, Hervé/0000-0001-8172-5393; Youngson, Neil/0000-0003-0690-4580; Lin, Shau-Ping/0000-0003-3423-991X; CAVAILLE, Jerome/0000-0003-2833-6836; Takada, Shuji/0000-0002-9406-4683; Reik, Wolf/0000-0003-0216-9881; Ferguson-Smith, Anne/0000-0002-7608-5894				Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Buiting K, 2003, AM J HUM GENET, V72, P571, DOI 10.1086/367926; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; Hata K, 2002, DEVELOPMENT, V129, P1983; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; WANG JCC, 1991, AM J HUM GENET, V48, P1069; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1	29	379	410	1	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					97	102		10.1038/ng1233	http://dx.doi.org/10.1038/ng1233			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12937418				2022-12-27	WOS:000185018500017
J	Ortega, S; Prieto, I; Odajima, J; Martin, A; Dubus, P; Sotillo, R; Barbero, JL; Malumbres, M; Barbacid, M				Ortega, S; Prieto, I; Odajima, J; Martin, A; Dubus, P; Sotillo, R; Barbero, JL; Malumbres, M; Barbacid, M			Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice	NATURE GENETICS			English	Article							CYCLIN-DEPENDENT KINASES; HISTONE GENE-TRANSCRIPTION; CHROMOSOME SYNAPSIS; MEIOTIC PROPHASE; CENTROSOME DUPLICATION; RETINOBLASTOMA PROTEIN; CDK2 KINASE; S-PHASE; MOUSE; PHOSPHORYLATION	We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells. Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture. Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation. Cdk2(-/-) mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types. But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.	Ctr Nacl Invest Oncol, Mol Oncol Program, E-28029 Madrid, Spain; CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28029 Madrid, Spain; Univ Bordeaux 2, EA 2406, F-33076 Bordeaux, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); UDICE-French Research Universities; Universite de Bordeaux	Ortega, S (corresponding author), Ctr Nacl Invest Oncol, Mol Oncol Program, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.		Malumbres, Marcos/E-8834-2011; Barbero, Jose Luis/J-9833-2014	Malumbres, Marcos/0000-0002-0829-6315; Dubus, Pierre/0000-0003-1803-4711; Sotillo, Rocio/0000-0002-0855-7917; Martin, Alberto/0000-0003-3427-7684; BARBERO, JOSE LUIS/0000-0002-1226-0323				Ashley T, 2001, J CELL SCI, V114, P685; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; ELLEDGE SJ, 1991, EMBO J, V10, P2653, DOI 10.1002/j.1460-2075.1991.tb07808.x; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; GENG Y, IN PRESS CELL; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Hanks MC, 1998, DEVELOPMENT, V125, P4521; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; HULTEN MA, 2001, HUMAN CYTOGENETICS C, P211; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Kneitz B, 2000, GENE DEV, V14, P1085; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lane ME, 2000, GENETICS, V155, P233; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PARISI T, IN PRESS EMBO J; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Scherthan H, 1996, J CELL BIOL, V134, P1109, DOI 10.1083/jcb.134.5.1109; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Sotillo R, 2001, EMBO J, V20, P6637, DOI 10.1093/emboj/20.23.6637; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; TSAI LH, 1993, ONCOGENE, V8, P1593; TSAI LH, 1991, NATURE, V353, P174, DOI 10.1038/353174a0; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	52	668	686	1	59	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					25	31		10.1038/ng1232	http://dx.doi.org/10.1038/ng1232			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12923533				2022-12-27	WOS:000185018500007
J	Abifadel, M; Varret, M; Rabes, JP; Allard, D; Ouguerram, K; Devillers, M; Cruaud, C; Benjannet, S; Wickham, L; Erlich, D; Derre, A; Villeger, L; Farnier, M; Beucler, I; Bruckert, E; Chambaz, J; Chanu, B; Lecerf, JM; Luc, G; Moulin, P; Weissenbach, J; Prat, A; Krempf, M; Junien, C; Seidah, NG; Boileau, C				Abifadel, M; Varret, M; Rabes, JP; Allard, D; Ouguerram, K; Devillers, M; Cruaud, C; Benjannet, S; Wickham, L; Erlich, D; Derre, A; Villeger, L; Farnier, M; Beucler, I; Bruckert, E; Chambaz, J; Chanu, B; Lecerf, JM; Luc, G; Moulin, P; Weissenbach, J; Prat, A; Krempf, M; Junien, C; Seidah, NG; Boileau, C			Mutations in PCSK9 cause autosomal dominant hypercholesterolemia	NATURE GENETICS			English	Article							LOCUS	Autosomal dominant hypercholesterolemia (ADH; OMIM144400), a risk factor for coronary heart disease, is characterized by an increase in low-density lipoprotein cholesterol levels that is associated with mutations in the genes LDLR (encoding low-density lipoprotein receptor) or APOB (encoding apolipoprotein B). We mapped a third locus associated with ADH, HCHOLA3 at 1p32, and now report two mutations in the gene PCSK9 (encoding proprotein convertase subtilisin/kexin type 9) that cause ADH. PCSK9 encodes NARC-1 (neural apoptosis regulated convertase), a newly identified human subtilase that is highly expressed in the liver and contributes to cholesterol homeostasis.	Univ Paris 05, INSERM, U383, Hop Necker Enfants Malad,APHP, F-75743 Paris 15, France; Univ St Joseph, Fac Pharm, Beirut 5076, Lebanon; Univ Versailles St Quentin Yvelines, Lab Biochim Hormonol & Genet Mol, CHU Ambroise Pare, APHP, F-92104 Boulogne, France; CHU Hotel Dieu, Serv Endocrinol, F-44093 Nantes, France; Genoscope, Ctr Natl Sequencage, Evry, France; Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; Rond Point Nat, Point Med, F-21000 Dijon, France; Hop La Pitie Salpetriere, Lab Lipides, Serv Endocrinol Metab, F-75013 Paris, France; Inst Biomed Cordeliers, INSERM, U505, F-75006 Paris, France; Hop Henri Mondor, Serv Med Interne, F-94010 Creteil, France; Hop Huriez, Serv Med Interne, F-59019 Lille, France; Hop Antiquaille, Serv Endocrinol & Maladies Nutr, F-69005 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint Joseph University Beirut; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; CHU de Nantes; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Lille - ISITE; CHU Lille; CHU Lyon	Boileau, C (corresponding author), Univ Paris 05, INSERM, U383, Hop Necker Enfants Malad,APHP, 149-161 Rue Sevres, F-75743 Paris 15, France.		boileau, catherine/M-4482-2017; Girelli, Domenico/B-1183-2008; VARRET, Mathilde/C-2279-2016; Seidah, Nabil/I-3596-2013; Abifadel, Marianne/ABH-5370-2020; Prat, Annik/S-6757-2018	boileau, catherine/0000-0002-0371-7539; Girelli, Domenico/0000-0001-9684-1899; VARRET, Mathilde/0000-0001-9261-1551; Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Cruaud, Corinne/0000-0002-4752-7278; ABIFADEL, Marianne/0000-0001-7645-8323; Rabes, Jean-Pierre/0000-0002-1215-1493; Krempf, Michel/0000-0002-4353-9511; ALLARD, Delphine/0000-0001-7534-8982				Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Varret M, 1999, AM J HUM GENET, V64, P1378, DOI 10.1086/302370	6	1991	2178	4	180	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					154	156		10.1038/ng1161	http://dx.doi.org/10.1038/ng1161			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730697				2022-12-27	WOS:000183200500020
J	Carlson, CS; Eberle, MA; Rieder, MJ; Smith, JD; Kruglyak, L; Nickerson, DA				Carlson, CS; Eberle, MA; Rieder, MJ; Smith, JD; Kruglyak, L; Nickerson, DA			Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON DISEASE GENES; SEQUENCE VARIATION; CANDIDATE GENES; IDENTIFICATION; DISCOVERY; MAP	More than 5 million single-nucleotide polymorphisms (SNPs) with minor-allele frequency greater than 10% are expected to exist in the human genome(1). Some of these SNPs may be associated with risk of developing common diseases(2-4). To assess the power of currently available SNPs to detect such associations, we resequenced 50 genes in two ethnic samples and measured patterns of linkage disequilibrium between the subset of SNPs reported in dbSNP and the complete set of common SNPs. Our results suggest that using all 2.7 million SNPs currently in the database would detect nearly 80% of all common SNPs in European populations but only 50% of those common in the African American population and that efficient selection of a minimal subset of SNPs for use in association studies requires measurement of allele frequency and linkage disequilibrium relationships for all SNPs in dbSNP.	Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Carlson, CS (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific, Seattle, WA 98195 USA.			Eberle, Michael/0000-0001-8965-1253				Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Devlin B, 1996, GENOMICS, V36, P1, DOI 10.1006/geno.1996.0419; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; REICH DE, 2003, NAT GENET, V33; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149	24	247	259	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					518	521		10.1038/ng1128	http://dx.doi.org/10.1038/ng1128			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652300	Bronze			2022-12-27	WOS:000181928600025
J	Anderson, KV; Ingham, PW				Anderson, KV; Ingham, PW			The transformation of the model organism: a decade of developmental genetics	NATURE GENETICS			English	Review							FUNCTIONAL GENOMIC ANALYSIS; LONG-RANGE ACTION; C-ELEGANS; CELL POLARITY; ASYMMETRIC LOCALIZATION; SIGNALING PATHWAYS; PROTEIN-KINASE; HEDGEHOG; WINGLESS; EXPRESSION	The past decade has seen the development of powerful techniques to dissect the molecular processes that regulate development. New tools have been used to reveal the basis of cell polarity, morphogen gradients and regulation of signaling in developing animals. Cell biology and developmental biology have become closely intertwined, and many genes that had been thought of as regulators of general cell biological (housekeeping) functions have been shown to act as specific developmental regulators. Vertebrate developmental genetics is now flourishing, with forward and reverse genetics in both zebrafish and the mouse providing new dimensions to our understanding of development.	Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; Univ Sheffield, Dept Biomed Sci, Ctr Dev Genet, Sheffield S10 2TN, S Yorkshire, England	Memorial Sloan Kettering Cancer Center; University of Sheffield	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	k-avderson@ski.mskcc.org	Ingham, Philip William/AAH-5884-2020; Ingham, Philip W/E-6710-2010; Ingham, Philip W/G-9903-2011	Ingham, Philip William/0000-0001-8224-9958; Ingham, Philip W/0000-0001-8224-9958; Anderson, Kathryn/0000-0003-1657-2161				Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Bilder D, 2001, CURR BIOL, V11, pR132, DOI 10.1016/S0960-9822(01)00060-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fuchs E, 2001, DEV CELL, V1, P13, DOI 10.1016/S1534-5807(01)00022-3; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Hughes CL, 2000, DEVELOPMENT, V127, P3683; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Karim FD, 1996, GENETICS, V143, P315; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mellitzer G, 2002, MECH DEVELOP, V118, P57, DOI 10.1016/S0925-4773(02)00191-0; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moustakas A, 2001, J CELL SCI, V114, P4359; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Sen J, 2000, DEVELOPMENT, V127, P5541; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wallis D, 2000, HUM MUTAT, V16, P99, DOI 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WILSON V, 1993, DEVELOPMENT, V117, P1321; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707; XU T, 1993, DEVELOPMENT, V117, P1223; Ye YH, 2000, SEMIN CELL DEV BIOL, V11, P211, DOI 10.1006/scdb.2000.0167; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	78	73	77	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			285	293		10.1038/ng1105	http://dx.doi.org/10.1038/ng1105			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610538				2022-12-27	WOS:000181390900009
J	Dumont, P; Leu, JIJ; Della Pietra, AC; George, DL; Murphy, M				Dumont, P; Leu, JIJ; Della Pietra, AC; George, DL; Murphy, M			The codon 72 polymorphic variants of p53 have markedly different apoptotic potential	NATURE GENETICS			English	Article							WILD-TYPE P53; RING-FINGER DOMAIN; LUNG-CANCER; PROTEIN; CELLS; MDM2; TRANSLOCATION; PRO-CASPASE-3; MITOCHONDRIA; SUPPRESSION	The gene TP53, encoding p53, has a common sequence polymorphism that results in either proline or arginine at amino-acid position 72. This polymorphism occurs in the proline-rich domain of p53, which is necessary for the protein to fully induce apoptosis. We found that in cell lines containing inducible versions of alleles encoding the Pro72 and Arg72 variants, and in cells with endogenous p53, the Arg72 variant induces apoptosis markedly better than does the Pro72 variant. Our data indicate that at least one source of this enhanced apoptotic potential is the greater ability of the Arg72 variant to localize to the mitochondria; this localization is accompanied by release of cytochrome c into the cytosol. These data indicate that the two polymorphic variants of p53 are functionally distinct, and these differences may influence cancer risk or treatment.	Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; University of Pennsylvania	Murphy, M (corresponding author), Fox Chase Canc Ctr, Dept Pharmacol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.			Murphy, Maureen/0000-0001-7644-7296				Attardi LD, 2000, GENE DEV, V14, P704; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Berger M, 2001, J BIOL CHEM, V276, P3785, DOI 10.1074/jbc.M008879200; BIRGANDER R, 1995, CARCINOGENESIS, V16, P2233, DOI 10.1093/carcin/16.9.2233; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Landers JE, 1997, CANCER RES, V57, P3562; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Pochampally R, 2000, BIOCHEM BIOPH RES CO, V279, P1001, DOI 10.1006/bbrc.2000.4056; Rosenthal AN, 1998, LANCET, V352, P871, DOI 10.1016/S0140-6736(98)07357-7; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Thomas M, 1999, MOL CELL BIOL, V19, P1092; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; WESTON A, 1994, CARCINOGENESIS, V15, P583, DOI 10.1093/carcin/15.4.583; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	36	1060	1104	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					357	365		10.1038/ng1093	http://dx.doi.org/10.1038/ng1093			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12567188				2022-12-27	WOS:000181312700012
J	Diez, E; Lee, SH; Gauthier, S; Yaraghi, Z; Tremblay, M; Vidal, S; Gros, P				Diez, E; Lee, SH; Gauthier, S; Yaraghi, Z; Tremblay, M; Vidal, S; Gros, P			Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; APOPTOSIS INHIBITORY PROTEIN; LEGIONNAIRES-DISEASE; NATURAL-RESISTANCE; SEQUENCE-ANALYSIS; MOUSE; NAIP; MACROPHAGES; INFECTION; IAP	In inbred mouse strains, permissiveness to intracellular replication of Legionella pneumophila is controlled by a single locus (Lgn1), which maps to a region within distal Chromosome 13 that contains multiple copies of the gene baculoviral IAP repeat-containing 1 (Birc1, also called Naip; refs. 1-3). Genomic BAC clones from the critical interval were transferred into transgenic mice to functionally complement the Lgn1-associated susceptibility of A/J mice to L. pneumophila. Here we report that two independent BAC clones that rescue susceptibility have an overlapping region of 56 kb in which the entire Lgn1 transcript must lie. The only known full-length transcript coded in this region is Birc1e (also called Naip5).	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ, Canada	McGill University; University of Ottawa; University of Ottawa; McGill University	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada.							BECKERS MC, 1995, MAMM GENOME, V6, P540, DOI 10.1007/BF00356173; Diez E, 1997, MAMM GENOME, V8, P682, DOI 10.1007/s003359900536; Diez E, 2000, J IMMUNOL, V164, P1470, DOI 10.4049/jimmunol.164.3.1470; Endrizzi M, 1999, GENOMICS, V60, P137, DOI 10.1006/geno.1999.5910; Endrizzi MG, 2000, GENOME RES, V10, P1095, DOI 10.1101/gr.10.8.1095; Gao LY, 1999, INFECT IMMUN, V67, P862, DOI 10.1128/IAI.67.2.862-870.1999; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; Growney JD, 2000, GENOMICS, V64, P62, DOI 10.1006/geno.1999.6111; Haider MZ, 2001, J BIOMED SCI, V8, P191, DOI 10.1007/BF02256412; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; Hozak RR, 2000, MOL CELL BIOL, V20, P1877, DOI 10.1128/MCB.20.5.1877-1885.2000; Koonin EV, 2000, TRENDS BIOCHEM SCI, V25, P223, DOI 10.1016/S0968-0004(00)01577-2; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Maier JKX, 2002, J NEUROSCI, V22, P2035, DOI 10.1523/JNEUROSCI.22-06-02035.2002; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Muller A, 1996, INFECT IMMUN, V64, P4900; Perrelet D, 2000, EUR J NEUROSCI, V12, P2059, DOI 10.1046/j.1460-9568.2000.00098.x; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Scharf JM, 1996, GENOMICS, V38, P405, DOI 10.1006/geno.1996.0644; Somerville MJ, 1997, AM J MED GENET, V69, P159, DOI 10.1002/(SICI)1096-8628(19970317)69:2<159::AID-AJMG8>3.3.CO;2-6; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; WRIGHT EK, 2003, IN PRESS CURR BIOL, V13; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; YAMAMOTO Y, 1988, INFECT IMMUN, V56, P370, DOI 10.1128/IAI.56.2.370-375.1988; Yamamoto Y, 1988, Adv Exp Med Biol, V239, P89; Yaraghi Z, 1998, GENOMICS, V51, P107, DOI 10.1006/geno.1998.5378; YOSHIDA SI, 1991, INFECT IMMUN, V59, P428, DOI 10.1128/IAI.59.1.428-432.1991	29	221	231	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					55	60		10.1038/ng1065	http://dx.doi.org/10.1038/ng1065			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12483212				2022-12-27	WOS:000180136100017
J	Chen, M; Kasahara, N; Keene, DR; Chan, L; Hoeffler, WK; Finlay, D; Barcova, M; Cannon, PM; Mazurek, C; Woodley, DT				Chen, M; Kasahara, N; Keene, DR; Chan, L; Hoeffler, WK; Finlay, D; Barcova, M; Cannon, PM; Mazurek, C; Woodley, DT			Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa	NATURE GENETICS			English	Article							MODIFIED RETROVIRAL VECTORS; HEMATOPOIETIC STEM-CELLS; ANCHORING FIBRILS; LENTIVIRUS VECTOR; GENE-TRANSFER; IN-VIVO; KERATINOCYTES; TRANSDUCTION; DELIVERY; THERAPY	Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders caused by mutations in the human type VII collagen gene (COL7A1). Individuals with DEB lack type VII collagen and anchoring fibrils, structures that attach epidermis and dermis. The current lack of treatment for DEB is an impetus to develop gene therapy strategies that efficiently transfer and stably express genes delivered to skin cells in vivo. In this study, we delivered and expressed full-length type VII collagen using a self-inactivating minimal lentivirus-based vector. Transduction of lentiviral vectors containing the COL7A1 transgene into recessive DEB (RDEB) keratinocytes and fibroblasts (in which type VII collagen was absent) resulted in persistent synthesis and secretion of type VII collagen. Unlike RDEB parent cells, the gene-corrected cells had normal morphology, proliferative potential, matrix attachment and motility. We used these gene-corrected cells to regenerate human skin on immune-deficient mice. Human skin regenerated by gene-corrected RDEB cells had restored expression of type VII collagen and formation of anchoring fibrils at the dermal-epidermal junction in vivo. These studies demonstrate that it is possible to restore type VII collagen gene expression in RDEB skin in vivo.	Univ So Calif, Dept Med, Div Dermatol, Los Angeles, CA 90033 USA; Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Dept Biochem, Los Angeles, CA 90033 USA; Shriners Hosp Children, Portland, OR 97201 USA; Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA; Xgene Corp, San Carlos, CA USA	University of Southern California; University of Southern California; University of Southern California; Northwestern University	Chen, M (corresponding author), Univ So Calif, Dept Med, Div Dermatol, CRL 204,1303 Mission Rd, Los Angeles, CA 90033 USA.			Kasahara, Noriyuki/0000-0002-6069-9082				ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Anderson WF, 1998, NATURE, V392, P25; BOYCE ST, 1983, J INVEST DERMATOL S1, V81, P335; BRIGGAMAN RA, 1975, J INVEST DERMATOL, V65, P71, DOI 10.1111/1523-1747.ep12598050; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; Chen M, 1999, EXP CELL RES, V249, P231, DOI 10.1006/excr.1999.4473; Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200; Chen M, 2000, J BIOL CHEM, V275, P24429, DOI 10.1074/jbc.M003440200; Choate KA, 1997, HUM GENE THER, V8, P895, DOI 10.1089/hum.1997.8.8-895; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CHRISTIANO AM, 1996, CURR OPIN DERMATOL, V3, P225; Cui Y, 1999, J VIROL, V73, P6171, DOI 10.1128/JVI.73.7.6171-6176.1999; Fenjves ES, 1996, J INVEST DERMATOL, V106, P576, DOI 10.1111/1523-1747.ep12344976; GAMMON WR, 1984, J INVEST DERMATOL, V82, P139, DOI 10.1111/1523-1747.ep12259692; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; Kuhn U, 2002, J VIROL, V76, P1496, DOI 10.1128/JVI.76.3.1496-1504.2002; MORGAN RA, 1993, ANNU REV BIOCHEM, V62, P191; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; OKEEFE EJ, 1988, J INVEST DERMATOL, V90, P2, DOI 10.1111/1523-1747.ep12462409; Robbins PB, 1997, J VIROL, V71, P9466, DOI 10.1128/JVI.71.12.9466-9474.1997; Robbins PB, 1998, P NATL ACAD SCI USA, V95, P10182, DOI 10.1073/pnas.95.17.10182; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sirven A, 2000, BLOOD, V96, P4103; UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713; Wang CK, 2000, J INVEST DERMATOL, V114, P674, DOI 10.1046/j.1523-1747.2000.00938.x; WOODLEY DT, 1988, J CELL PHYSIOL, V136, P140, DOI 10.1002/jcp.1041360118; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	30	131	145	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					670	675		10.1038/ng1041	http://dx.doi.org/10.1038/ng1041			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426566				2022-12-27	WOS:000179593000023
J	MacBeath, G				MacBeath, G			Protein microarrays and proteomics	NATURE GENETICS			English	Review							ROLLING-CIRCLE AMPLIFICATION; LINKED-IMMUNOSORBENT-ASSAY; HUMAN CYTOKINES; CDNA LIBRARY; CANCER-CELLS; IMMUNOASSAY; EXPRESSION; MULTIANALYTE; ELISA; CHIPS	The system-wide study of proteins presents an exciting challenge in this information-rich age of whole-genome biology. Although traditional investigations have yielded abundant information about individual proteins, they have been less successful at providing us with an integrated understanding of biological systems. The promise of proteomics is that, by studying many components simultaneously, we will learn how proteins interact with each other, as well as with non-proteinaceous molecules, to control complex processes in cells, tissues and even whole organisms. Here, I discuss the role of microarray technology in this burgeoning area.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University; Harvard University	MacBeath, G (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.			MacBeath, Gavin/0000-0003-2585-6772				Albala JS, 2000, J CELL BIOCHEM, V80, P187; Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Avseenko NV, 2002, ANAL CHEM, V74, P927, DOI 10.1021/ac010970k; Belov L, 2001, CANCER RES, V61, P4483; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Brizuela L, 2001, MOL BIOCHEM PARASIT, V118, P155, DOI 10.1016/S0166-6851(01)00366-8; Bussow K, 2000, GENOMICS, V65, P1, DOI 10.1006/geno.2000.6141; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Chen R, 1999, CLIN CHEM, V45, P1693; EKINS R, 1990, ANN BIOL CLIN-PARIS, V48, P655; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GE H, 2000, NUCL ACIDS RES, V28; HAAB BB, 2001, GENOME BIOL, V2; Heidelberger M, 1929, J EXP MED, V50, P809, DOI 10.1084/jem.50.6.809; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang RP, 2001, ANAL BIOCHEM, V294, P55, DOI 10.1006/abio.2001.5156; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jenison R, 2001, CLIN CHEM, V47, P1894; Joos TO, 2000, ELECTROPHORESIS, V21, P2641, DOI 10.1002/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.3.CO;2-X; Kim TE, 2002, EXP MOL MED, V34, P152, DOI 10.1038/emm.2002.22; Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6; Kodadek T, 2001, CHEM BIOL, V8, P105, DOI 10.1016/S1074-5521(00)90067-X; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; MacBeath G, 2000, SCIENCE, V289, P1760; Madoz-Gurpide J, 2001, PROTEOMICS, V1, P1279, DOI 10.1002/1615-9861(200110)1:10<1279::AID-PROT1279>3.3.CO;2-N; Mendoza LG, 1999, BIOTECHNIQUES, V27, P778, DOI 10.2144/99274rr01; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Moody MD, 2001, BIOTECHNIQUES, V31, P186, DOI 10.2144/01311dd03; Mullenix MC, 2001, CLIN CHEM, V47, P1926; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Silzel JW, 1998, CLIN CHEM, V44, P2036; Sreekumar A, 2001, CANCER RES, V61, P7585; Tam SW, 2002, J IMMUNOL METHODS, V261, P157, DOI 10.1016/S0022-1759(01)00572-5; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wiese R, 2001, CLIN CHEM, V47, P1451; Wiltshire S, 2000, CLIN CHEM, V46, P1990; YALOW RS, 1959, NATURE, V184, P1648, DOI 10.1038/1841648b0; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	50	650	705	3	173	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			526	532		10.1038/ng1037	http://dx.doi.org/10.1038/ng1037			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454649				2022-12-27	WOS:000179742900014
J	Yoshida, CA; Furuichi, T; Fujita, T; Fukuyama, R; Kanatani, N; Kobayashi, S; Satake, M; Takada, K; Komori, T				Yoshida, CA; Furuichi, T; Fujita, T; Fukuyama, R; Kanatani, N; Kobayashi, S; Satake, M; Takada, K; Komori, T			Core-binding factor beta interacts with Runx2 and is required for skeletal development	NATURE GENETICS			English	Article							FETAL LIVER HEMATOPOIESIS; TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; CBFA1-DEFICIENT MICE; CBF-BETA; CHONDROCYTE DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; BONE-FORMATION; GENE; EXPRESSION	Core-binding factor beta(CBFbeta, also called polyomavirus enhancer binding protein 2beta (PEBP2B)) is associated with an inversion of chromosome 16 and is associated with acute myeloid leukemia in humans(1). CBFbeta forms a heterodimer with RUNX1 (runt-related transcription factor 1), which has a DNA binding domain homologous to the pair-rule protein runt in Drosophila melanogaster. Both RUNX1 and CBFbeta are essential for hematopoiesis(2-6). Haploinsufficiency of another runt-related protein, RUNX2 (also called CBFA1), causes cleidocranial dysplasia in humans(7) and is essential in skeletal development by regulating osteoblast differentiation and chondrocyte maturation(8-15). Mice deficient in Cbfb (Cbfb(-/-)) die at midgestation(4-6), so the function of Cbfbeta in skeletal development has yet to be ascertained. To investigate this issue, we rescued hematopoiesis of Cbfb(-/-) mice by introducing Cbfb using the Gata1 promoter. The rescued Cbfb(-/-) mice recapitulated fetal liver hematopoiesis in erythroid and megakaryocytic lineages and survived until birth, but showed severely delayed bone formation. Although mesenchymal cells differentiated into immature osteoblasts, intramembranous bones were poorly formed. The maturation of chondrocytes into hypertrophic cells was markedly delayed, and no endochondral bones were formed. Electrophoretic mobility shift assays and reporter assays showed that Cbfbeta was necessary for the efficient DNA binding of Runx2 and for Runx2-dependent transcriptional activation. These findings indicate that Cbfbeta is required for the function of Runx2 in skeletal development.	Osaka Univ, Sch Med, Dept Mol Med, Suita, Osaka 5650871, Japan; Osaka Univ, Fac Dent, Dept Orthodont & Dentofacial Orthoped, Suita, Osaka 5650871, Japan; Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacol, Osaka, Japan; Teijin Inst Biomed Res, Tokyo, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 980, Japan; Japan Sci & Technol Corp, Tokyo, Japan	Osaka University; Osaka University; Setsunan University; Tohoku University; Japan Science & Technology Agency (JST)	Komori, T (corresponding author), Osaka Univ, Sch Med, Dept Mol Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Chiba N, 1997, ONCOGENE, V14, P2543, DOI 10.1038/sj.onc.1201109; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; LU J, 1995, MOL CELL BIOL, V15, P1651; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Niki M, 1997, P NATL ACAD SCI USA, V94, P5697, DOI 10.1073/pnas.94.11.5697; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Onishi M, 1996, EXP HEMATOL, V24, P324; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444	32	228	252	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					633	638		10.1038/ng1015	http://dx.doi.org/10.1038/ng1015			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12434152				2022-12-27	WOS:000179593000016
J	May, CA; Shone, AC; Kalaydjieva, L; Sajantila, A; Jeffreys, AJ				May, CA; Shone, AC; Kalaydjieva, L; Sajantila, A; Jeffreys, AJ			Crossover clustering and rapid decay of linkage disequilibrium in the Xp/Yp pseudoautosomal gene SHOX	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HIGH-RESOLUTION ANALYSIS; HUMAN SEX-CHROMOSOMES; RECOMBINATION HOTSPOT; TURNER-SYNDROME; SHORT STATURE; REGION; DIVERSITY; PATTERNS; POPULATIONS	Crossover between the human sex chromosomes during male meiosis is restricted to the terminal pseudoautosomal pairing regions. An obligatory exchange occurs in PAR1, an Xp/Yp pseudoautosomal region of 2.6 Mb, which creates a male-specific recombination 'hot domain' with a recombination rate that is about 20 times higher than the genome average(1-3). Low-resolution analysis of PART suggests that crossovers are distributed fairly randomly(4). By contrast, linkage disequilibrium (LD)(5) and sperm crossover analyses(6) indicate that crossovers in autosomal regions tend to duster into 'hot spots' of 1-2 kb that lie between islands of disequilibrium of tens to hundreds of kilobases(7). To determine whether at high resolution this autosomal pattern also applies to PAR1, we have examined linkage disequilibrium over an interval of 43 kb around the gene SHOX8. Here we show that in northern European populations, disequilibrium decays rapidly with physical distance, which is consistent with this interval of PAR1 being recombination ally active in male meiosis. Analysis of a subregion of 9.9 kb in sperm shows, however, that crossovers are not distributed randomly, but instead cluster into an intense recombination hot spot that is very similar in morphology to autosomal hot spots. Thus, PAR1 crossover activity may be influenced by male-specific hot spots that are highly suitable for characterization by sperm DNA analysis.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Edith Cowan Univ, Ctr Human Genet, Perth, WA, Australia; Western Australia Inst Med Res, Perth, WA, Australia; Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland	University of Leicester; Edith Cowan University; University of Helsinki	May, CA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cam5@lc.ac.uk	Sajantila, Antti/AAY-9084-2021	May, Celia/0000-0001-8541-2458; Sajantila, Antti/0000-0003-4117-5248				BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LEWONTIN RC, 1964, GENETICS, V49, P49; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Morton N. E., 1982, OUTLINE GENETIC EPID; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; Schiebel K, 2000, CYTOGENET CELL GENET, V91, P224, DOI 10.1159/000056849; SLATKIN M, 1994, GENETICS, V137, P331; SU A, 1996, NUCLEIC ACIDS RES, V24, P1574; SVED J A, 1971, Theoretical Population Biology, V2, P125; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	29	87	97	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2002	31	3					272	275		10.1038/ng918	http://dx.doi.org/10.1038/ng918			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089524				2022-12-27	WOS:000176494100014
J	Ranish, JA; Hahn, S; Lu, Y; Yi, EC; Li, XJ; Eng, J; Aebersold, R				Ranish, JA; Hahn, S; Lu, Y; Yi, EC; Li, XJ; Eng, J; Aebersold, R			Identification of TFB5, a new component of general transcription and DNA repair factor IIH	NATURE GENETICS			English	Article							FACTOR TFIIA; YEAST; SUBUNITS; COMPLEX; RECONSTITUTION; HOLOENZYME; KINASE; TAGS; CDK7	We previously described the use of quantitative proteomics to study macromolecular complexes(1). Applying the method to analyze a yeast RNA polymerase II preinitiation complex, we identified a new 8-kDa protein, encoded by the uncharacterized open reading frame YDR079c-a, as a potential new component of the preinitiation complex. Here we show that YDR079c-a is a bona fide component of polymerase II preinitiation complexes and investigate its role in transcription. YDR079c-a is recruited to promoters both in vivo and in vitro and is required for efficient transcription in vitro and for normal induction of GAL genes. In addition, YDR079c-a is a core component of general transcription and DNA repair factor IIH and is required for efficient recruitment of TFIIH to a promoter. Yeast lacking YDR079c-a grow slowly, and, like strains carrying mutations in core TFIIH subunits, are sensitive to ultraviolet radiation. YDR079c-a is conserved throughout evolution, and mutations in the human ortholog account for a DNA repair deficient form of the tricothiodystrophy disorder called TTD-A(2). The identification of a new, evolutionarily conserved, core TFIIH subunit is essential for our understanding of TFIIH function in transcription, DNA repair and human disease.	Inst Syst Biol, Seattle, WA 98103 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Ranish, JA (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jranish@systemsbiology.org	Eng, Jimmy K/I-4202-2012	Eng, Jimmy K/0000-0001-6352-6737				Adamczewski JP, 1996, EMBO J, V15, P1877, DOI 10.1002/j.1460-2075.1996.tb00538.x; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feaver WJ, 1997, J BIOL CHEM, V272, P19319, DOI 10.1074/jbc.272.31.19319; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; GIGLIAMARI G, 2004, NAT GENET       0627; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; LI XJ, 2003, NAT BIOTECHNOL, V75, P6648; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603	27	120	122	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					707	713		10.1038/ng1385	http://dx.doi.org/10.1038/ng1385			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220919	Bronze			2022-12-27	WOS:000222354100020
J	Ting, AH; Jair, KW; Suzuki, H; Yen, RWC; Baylin, SB; Schuebel, KE				Ting, AH; Jair, KW; Suzuki, H; Yen, RWC; Baylin, SB; Schuebel, KE			CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1	NATURE GENETICS			English	Article							METHYLATION; GENES; PROTEIN	The role of the primary mammalian DNA methyltransferase, DNMT1, in maintaining CpG island methylation in human colon cancer cells has recently been questioned. This controversy has arisen from discrepancies between genetic knockout and RNA interference-mediated knockdown studies. Here, we re-examined the RNA interference-based approach and found that hypermethylation of single-copy genes is maintained in cells transiently and stably depleted of DNMT1.	Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Baylin, SB (corresponding author), Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu; kornels@jhmi.edu						Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Myohanen SK, 1998, CANCER RES, V58, P591; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; SEDIVY JM, 1999, SCIENCE, V283, P9, DOI DOI 10.1126/SCIENCE.283.5398.9A); Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892	15	77	79	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					582	584		10.1038/ng1365	http://dx.doi.org/10.1038/ng1365			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15156141	Bronze			2022-12-27	WOS:000221763700014
J	Bottini, N; Musumeci, L; Alonso, A; Rahmouni, S; Nika, K; Rostamkhani, M; MacMurray, J; Meloni, GF; Lucarelli, P; Pellecchia, M; Eisenbarth, GS; Comings, D; Mustelin, T				Bottini, N; Musumeci, L; Alonso, A; Rahmouni, S; Nika, K; Rostamkhani, M; MacMurray, J; Meloni, GF; Lucarelli, P; Pellecchia, M; Eisenbarth, GS; Comings, D; Mustelin, T			A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENES; KINASE; P50(CSK); SEARCH; GENOME	We report that a single-nucleotide polymorphism ( SNP) in the gene (PTPN22) encoding the lymphoid protein tyrosine phosphatase (LYP), a suppressor of T-cell activation, is associated with type 1 diabetes mellitus (T1D). The variants encoded by the two alleles, 1858C and 1858T, differ in a crucial amino acid residue involved in association of LYP with the negative regulatory kinase Csk. Unlike the variant encoded by the more common allele 1858C, the variant associated with T1D does not bind Csk.	Burnham Inst, Canc Res Ctr, Program Signal Transduct, La Jolla, CA 92037 USA; City Hope Natl Med Ctr, Dept Med Genet, Duarte, CA 91010 USA; Univ Sassari, Dept Pediat, I-07100 Sassari, Italy; Italian Natl Res Council, Rome, Italy; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA	Sanford Burnham Prebys Medical Discovery Institute; City of Hope; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Mustelin, T (corresponding author), Burnham Inst, Canc Res Ctr, Program Signal Transduct, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tmustelin@burham-inst.org	Meloni, Gianfranco G.F./E-9426-2012; Alonso, Andrés/L-7523-2014; Pellecchia, Maurizio/Y-7072-2018; Ingegnoli, Francesca/B-6226-2017	Meloni, Gianfranco G.F./0000-0002-0604-8924; Alonso, Andrés/0000-0001-8674-9378; Mustelin, Tomas/0000-0001-5912-8840; Ingegnoli, Francesca/0000-0002-6727-1273; Nika, Konstantina/0000-0002-9620-0263				Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Bottini N, 2002, ARCH IMMUNOL THER EX, V50, P95; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Cohen S, 1999, BLOOD, V93, P2013, DOI 10.1182/blood.V93.6.2013.406k25_2013_2024; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; IIVANAINEN AV, 1990, EUR J IMMUNOL, V20, P2509, DOI 10.1002/eji.1830201123; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Mustelin GS, 2002, FRONT BIOSCI, V7, P85; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD918, DOI 10.2741/musteli1; Mustelin T, 2002, MOL PATHOLOGY AUTOIM, P127; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024	15	1067	1108	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					337	338		10.1038/ng1323	http://dx.doi.org/10.1038/ng1323			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15004560	Bronze			2022-12-27	WOS:000220647200015
J	Garcia-Cao, M; O'Sullivan, R; Peters, AHFM; Jenuwein, T; Blasco, MA				Garcia-Cao, M; O'Sullivan, R; Peters, AHFM; Jenuwein, T; Blasco, MA			Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases	NATURE GENETICS			English	Article							CHROMOSOMAL INSTABILITY; H3; HETEROCHROMATIN; METHYLATION; FUSIONS; REPEATS; MICE	Telomeres are capping structures at the ends of eukaryotic chromosomes composed of TTAGGG repeats bound to an array of specialized proteins(1-3). Telomeres are heterochromatic regions. Yeast and flies with defects in activities that modify the state of chromatin also have abnormal telomere function(4-6), but the putative role of chromatin-modifying activities in regulating telomeres in mammals is unknown. Here we report on telomere length and function in mice null with respect to both the histone methyltransferases (HMTases) Suv39h1 and Suv39h2 (called SUV39DN mice). Suv39h1 and Suv39h2 govern methylation of histone H3 Lys9 (H3-Lys9) in heterochromatic regions(7). We show that primary cells derived from SUV39DN mice have abnormally long telomeres relative to wild-type controls. Using chromatin immunoprecipitation (ChIP) analysis, we found that telomeres were enriched in di- and trimethylated H3-Lys9 but that telomeres of SUV39DN cells had less dimethylated and trimethylated H3-Lys9 but more monomethylated H3-Lys9. Concomitant with the decrease in H3-Lys9 methylation, telomeres in SUV39DN cells had reduced binding of the chromobox proteins Cbx1, Cbx3 and Cbx5, homologs of Drosophila melanogaster heterochromatin protein 1 (HP1). These findings indicate substantial changes in the state of telomeric heterochromatin in SUV39DN cells, which are associated with abnormal telomere elongation. Taken together, the results indicate epigenetic regulation of telomere length in mammals by Suv39h1 and Suv39h2.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Spanish Natl Canc Ctr CNIO, Mol Oncol Program, E-28029 Madrid, Spain	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, E-28029 Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Peters, Antoine/0000-0002-0311-1887				Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; McIlrath J, 2001, CANCER RES, V61, P912; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; PEREZBURGOS L, IN PRESS METHODS ENZ; PETERS AH, IN PRESS MOL CELL; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0	29	429	453	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					94	99		10.1038/ng1278	http://dx.doi.org/10.1038/ng1278			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702045	Bronze			2022-12-27	WOS:000187666800020
J	Helms, C; Cao, L; Krueger, JG; Wijsman, EM; Chamian, F; Gordon, D; Heffernan, M; Daw, JAW; Robarge, J; Ott, J; Kwok, PY; Menter, A; Bowcock, AM				Helms, C; Cao, L; Krueger, JG; Wijsman, EM; Chamian, F; Gordon, D; Heffernan, M; Daw, JAW; Robarge, J; Ott, J; Kwok, PY; Menter, A; Bowcock, AM			A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis	NATURE GENETICS			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; NEGATIVE REGULATION; GLYCOSYLATION; LINKAGE; HLA; IDENTIFICATION; POLYMORPHISM; GENETICS; COMPLEX; IMPACT	Psoriasis (OMIM 177900) is a chronic inflammatory skin disorder of unknown pathogenesis affecting similar to2% of the Western population(1). It occurs more frequently in individuals with human immunodeficiency virus(2), and 20-30% of individuals with psoriasis have psoriatic arthritis(3). Psoriasis is associated with HLA class I alleles(4-6), and previous linkage analysis by our group identified a second psoriasis locus at 17q24-q25 (PSORS2; ref. 7). Linkage to this locus was confirmed with independent family sets(8,9). Additional loci have also been proposed to be associated with psoriasis(10). Here we describe two peaks of strong association with psoriasis on chromosome 17q25 separated by 6 Mb. Associated single-nucleotide polymorphisms (SNPs) in the proximal peak lie in or near SLC9A3R1 (also called EBP50 and NHERF1) and NAT9, a new member of the N-acetyltransferase family. SLC9A3R1 is a PDZ domain containing phosphoprotein that associates with members of the ezrin-radixin-moesin family and is implicated in diverse aspects of epithelial membrane biology and immune synapse formation in T cells(11,12). The distal peak of association is in RAPTOR (p150 target of rapamycin (TOR)-scaffold protein containing WD-repeats)(13,14). Expression of SLC9A3R1 is highest in the uppermost stratum Malpighi of psoriatic and normal skin and in inactive versus active T cells. A disease-associated SNP lying between SLC9A3R1 and NAT9 leads to loss of RUNX1 binding. This is the second example of loss of a RUNX1 binding site associated with susceptibility to an autoimmune disease(15). It also suggests defective regulation of SLC9A3R1 or NAT9 by RUNX1 as a susceptibility factor for psoriasis.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Baylor Univ, Med Ctr, Dept Internal Med, Div Dermatol, Dallas, TX 75246 USA	Washington University (WUSTL); Rockefeller University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rockefeller University; Washington University (WUSTL); University of California System; University of California San Francisco; Baylor University; Baylor University Medical Center	Bowcock, AM (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	bowcock@genetics.wustl.edu	Gordon, Derek/AAU-2281-2020; Kwok, Pui-Yan/F-7725-2014; menter md, alan/A-8250-2009	Gordon, Derek/0000-0003-2945-1748; Kwok, Pui-Yan/0000-0002-5087-3059; Bowcock, Anne/0000-0001-8691-9090; Robarge, Jason/0000-0001-8941-1153; Wijsman, Ellen/0000-0002-2725-6669				Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Bowcock AM, 2003, J AM ACAD DERMATOL, V49, pS51, DOI 10.1016/S0190-9622(03)01135-6; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DUVIC M, 1990, J INVEST DERMATOL, V95, pS38, DOI 10.1111/1523-1747.ep12505743; Enlund F, 1999, HUM HERED, V49, P2, DOI 10.1159/000022832; ERICKSON P, 1992, BLOOD, V80, P1825; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; MENTER A, 1991, LANCET, V338, P231, DOI 10.1016/0140-6736(91)90358-V; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; *NAT PSOR FDN, 2002, NAT PSOR FDN B, V33, P6; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Voltz JW, 2001, ONCOGENE, V20, P6309, DOI 10.1038/sj.onc.1204774; WIJSMAN EM, 1987, AM J HUM GENET, V41, P356	30	226	236	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					349	356		10.1038/ng1268	http://dx.doi.org/10.1038/ng1268			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608357				2022-12-27	WOS:000186791000016
J	Rocha, EPC; Danchin, A				Rocha, EPC; Danchin, A			Essentiality, not expressiveness, drives gene-strand bias in bacteria	NATURE GENETICS			English	Article							ESCHERICHIA-COLI CHROMOSOME; BACILLUS-SUBTILIS; REPLICATION; TRANSCRIPTION; INVERSIONS; GENOMES	Preferential positioning of bacterial genes in the leading strand was thought to result from selection to avoid high head-on collision rates between DNA and RNA polymerases. Here we show, however, that in Bacillus subtilis and Escherichia coli, essentiality (the transcript product), not expressiveness (the collision rate), selectively drives the biased gene distribution.	Inst Pasteur, URA 2171, Unite GGB, F-75015 Paris, France; Univ Paris 06, Atelier Bioinformat, F-75005 Paris, France; HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; University of Hong Kong	Rocha, EPC (corresponding author), Inst Pasteur, URA 2171, Unite GGB, 28 Rue Dr Roux, F-75015 Paris, France.		Rocha, Eduardo/B-7009-2009; Shintani, Masaki/A-3219-2012; Rocha, Eduardo/A-4727-2008	Rocha, Eduardo/0000-0001-7704-822X; Shintani, Masaki/0000-0002-6505-9850; Danchin, Antoine/0000-0002-6350-5001				Bremer H, 1996, ESCHERICHIA COLI SAL; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LOUARN JM, 1985, MOL GEN GENET, V201, P467, DOI 10.1007/BF00331341; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Rocha EPC, 2002, TRENDS MICROBIOL, V10, P393, DOI 10.1016/S0966-842X(02)02420-4; SEGALL A, 1988, SCIENCE, V241, P1314, DOI 10.1126/science.3045970; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Wei Y, 2001, J BACTERIOL, V183, P545, DOI 10.1128/JB.183.2.545-556.2001	15	158	162	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					377	378		10.1038/ng1209	http://dx.doi.org/10.1038/ng1209			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12847524				2022-12-27	WOS:000184470500014
J	Parviz, F; Matullo, C; Garrison, WD; Savatski, L; Adamson, JW; Ning, G; Kaestner, KH; Rossi, JM; Zaret, KS; Duncan, SA				Parviz, F; Matullo, C; Garrison, WD; Savatski, L; Adamson, JW; Ning, G; Kaestner, KH; Rossi, JM; Zaret, KS; Duncan, SA			Hepatocyte nuclear factor 4 alpha controls the development of a hepatic epithelium and liver morphogenesis	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR HNF-4; RAT-LIVER; GENE-TRANSCRIPTION; VISCERAL ENDODERM; EXPRESSION; DIFFERENTIATION; CELLS; FETAL; EMBRYOGENESIS; GASTRULATION	Although advances have been made in understanding cell differentiation, only rudimentary knowledge exists concerning how differentiated cells form tissues and organs. We studied liver organogenesis because the cell and tissue architecture of this organ is well defined. Approximately 60% of the adult liver consists of hepatocytes that are arranged as single-cell anastomosing plates extending from the portal region of the liver lobule toward the central vein(1). The basal surface of the hepatocytes is separated from adjacent sinusoidal endothelial cells by the space of Disse, where the exchange of substances between serum and hepatocytes takes place. The hepatocytes apical surface forms bile canaliculi that transport bile to the hepatic ducts. Proper liver architecture is crucial for hepatic function(2) and is commonly disrupted in disease states, including cirrhosis and hepatitis(3). Here we report that hepatocyte nuclear factor 4alpha (Hnf4alpha) is essential for morphological and functional differentiation of hepatocytes(4), accumulation of hepatic glycogen stores and generation of a hepatic epithelium. We show that Hnf4alpha is a dominant regulator of the epithelial phenotype because its ectopic expression in fibroblasts induces a mesenchymal-to-epithelial transition. Most importantly, the morphogenetic parameters controlled by Hnf4alpha in hepatocytes are essential for normal liver architecture, including the organization of the sinusoidal endothelium.	Med Coll Wisconsin, Dept Anat Cell Biol & Neurobiol, Milwaukee, WI 53226 USA; Fox Chase Canc Ctr, Program Cell & Dev Biol, Philadelphia, PA 19111 USA; Blood Ctr SE, Blood Res Inst, Milwaukee, WI 53226 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	Medical College of Wisconsin; Fox Chase Cancer Center; Versiti Blood Center of Wisconsin; University of Pennsylvania	Duncan, SA (corresponding author), Med Coll Wisconsin, Dept Anat Cell Biol & Neurobiol, Milwaukee, WI 53226 USA.			Matullo, Christine/0000-0003-1598-7007; Duncan, Stephen/0000-0002-2507-7827				BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Boustead JN, 2003, BIOCHEM J, V369, P17, DOI 10.1042/BJ20021382; CASCIO S, 1991, DEVELOPMENT, V113, P217; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Daniels E, 1996, DEV DYNAM, V206, P272, DOI 10.1002/(SICI)1097-0177(199607)206:3<272::AID-AJA5>3.3.CO;2-U; DEWOLFPEETERS C, 1974, EXP MOL PATHOL, V21, P339, DOI 10.1016/0014-4800(74)90100-2; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Duncan SA, 1997, DEVELOPMENT, V124, P279; Enzan H, 1997, MICROSC RES TECHNIQ, V39, P336, DOI 10.1002/(SICI)1097-0029(19971115)39:4<336::AID-JEMT4>3.0.CO;2-F; FERACCI H, 1987, DEV BIOL, V123, P73, DOI 10.1016/0012-1606(87)90429-5; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Li JX, 2000, GENE DEV, V14, P464; MEDLOCK ES, 1983, ANAT REC, V207, P31, DOI 10.1002/ar.1092070105; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Parviz F, 2002, GENESIS, V32, P130, DOI 10.1002/gene.10058; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; SHERLOCK S, 1909, DIS LIVER BILIARY SY, P371; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; VASSY J, 1988, CELL DIFFER DEV, V24, P9, DOI 10.1016/0045-6039(88)90082-6; WOOD RL, 1965, ANAT RECORD, V151, P507, DOI 10.1002/ar.1091510403	26	433	458	0	24	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					292	296		10.1038/ng1175	http://dx.doi.org/10.1038/ng1175			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808453				2022-12-27	WOS:000183815300016
J	Menashe, I; Man, O; Lancet, D; Gilad, Y				Menashe, I; Man, O; Lancet, D; Gilad, Y			Different noses for different people	NATURE GENETICS			English	Article							MHC	Of more than 1,000 human olfactory receptor genes, more than half seem to be pseudogenes. We investigated whether the most recent of these disruptions might still segregate with the intact form by genotyping 51 candidate genes in 189 ethnically diverse humans. The results show an unprecedented prevalence of segregating pseudogenes, identifying one of the most pronounced cases of functional population diversity in the human genome.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Crown Human Genome Ctr, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Lancet, D (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.		Menashe, Idan/AAC-8670-2020; Menashe, Idan/W-6214-2019	Menashe, Idan/0000-0003-1961-1461; 				AMOORE JE, 1974, ANN NY ACAD SCI, V237, P137, DOI 10.1111/j.1749-6632.1974.tb49850.x; BARRON KS, 1994, HUM IMMUNOL, V40, P17, DOI 10.1016/0198-8859(94)90016-7; Ehlers A, 2000, GENOME RES, V10, P1968, DOI 10.1101/gr.10.12.1968; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Menashe I, 2002, HUM MOL GENET, V11, P1381, DOI 10.1093/hmg/11.12.1381; Schoneberg T, 2002, REV PHYSIOL BIOCH P, V144, P143; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; WYSOCKI CJ, 1984, P NATL ACAD SCI-BIOL, V81, P4899, DOI 10.1073/pnas.81.15.4899; Yeager M, 1999, IMMUNOL REV, V167, P45, DOI 10.1111/j.1600-065X.1999.tb01381.x; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	14	170	196	0	25	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					143	144		10.1038/ng1160	http://dx.doi.org/10.1038/ng1160			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730696				2022-12-27	WOS:000183200500016
J	Green, P; Ewing, B; Miller, W; Thomas, PJ; Green, ED				Green, P; Ewing, B; Miller, W; Thomas, PJ; Green, ED		NISC Comparative Sequencing Progr	Transcription-associated mutational asymmetry in mammalian evolution	NATURE GENETICS			English	Article							COUPLED REPAIR; SUBSTITUTION PATTERNS; BASE-COMPOSITION; STRAND SYMMETRY; DNA; RATES; GENES; REPLICATION; SEQUENCE; PSEUDOGENES	Although mutation is commonly thought of as a random process, evolutionary studies show that different types of nucleoticle substitution occur with widely varying rates that presumably reflect biases intrinsic to mutation and repair mechanisms(1-4). A strand asymmetry(5,6), the occurrence of particular substitution types at higher rates than their complementary types, that is associated with DNA replication has been found in bacteria(7) and mitochondria(8). A strand asymmetry that is associated with transcription and attributable to higher rates of cytosine deamination on the coding strand has been observed in enterobacteria(9-11). Here, we describe a qualitatively different transcription-associated strand asymmetry in mammals, which may be a byproduct of transcription-coupled repair(12) in germline cells. This mutational asymmetry has acted over long periods of time to produce a compositional asymmetry, an excess of G+T over A+C on the coding strand, in most genes. The mutational and compositional asymmetries can be used to detect the orientations and approximate extents of transcribed regions.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, P (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEBENEK K, 1990, J BIOL CHEM, V265, P13878; Beletskii A, 1998, BIOL CHEM, V379, P549; BULMER M, 1991, J MOL EVOL, V33, P305, DOI 10.1007/BF02102861; Collins JE, 2003, GENOME RES, V13, P27, DOI 10.1101/gr.695703; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Francino MP, 2001, MOL BIOL EVOL, V18, P1147, DOI 10.1093/oxfordjournals.molbev.a003888; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Francino MP, 2000, MOL BIOL EVOL, V17, P416; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; HESS ST, 1994, J MOL BIOL, V236, P1022, DOI 10.1016/0022-2836(94)90009-4; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Leadon SA, 1997, CANCER RES, V57, P3784; Li W. H, 1997, MOL EVOLUTION; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; WU CI, 1987, NATURE, V327, P169, DOI 10.1038/327169a0	30	211	220	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					514	517		10.1038/ng1103	http://dx.doi.org/10.1038/ng1103			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612582	Bronze			2022-12-27	WOS:000181928600024
J	Fujikawa, A; Shirasaka, D; Yamamoto, S; Ota, H; Yahiro, K; Fukada, M; Shintani, T; Wada, A; Aoyama, N; Hirayama, T; Fukamachi, H; Noda, M				Fujikawa, A; Shirasaka, D; Yamamoto, S; Ota, H; Yahiro, K; Fukada, M; Shintani, T; Wada, A; Aoyama, N; Hirayama, T; Fukamachi, H; Noda, M			Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori	NATURE GENETICS			English	Article							ZETA RPTP-BETA; VACUOLATING CYTOTOXIN; EPITHELIAL-CELLS; ZETA/RPTP-BETA; BINDING; MIGRATION; TOXIN; MOLECULE; COMPLEX; GENE	The vacuolating cytotoxin VacA produced by Helicobacter pylori causes massive cellular vacuolation in vitro(1-3) and gastric tissue damage in vivo, leading to gastric ulcers, when administered intragastrically(4). Here we report that mice deficient in protein tyrosine phosphatase receptor type Z (Ptprz, also called PTP-xi or RPTP-beta, encoded by Ptprz) do not show mucosal damage by VacA, although VacA is incorporated into the gastric epithelial cells to the same extent as in wild-type mice. Primary cultures of gastric epithelial cells from Ptprz(+/+) and Ptprz(-/-) mice also showed similar incorporation of VacA, cellular vacuolation and reduction in cellular proliferation, but only Ptprz(+/+) cells showed marked detachment from a reconstituted basement membrane 24 h after treatment with VacA. VacA bound to Ptprz, and the levels of tyrosine phosphorylation of the G protein-coupled receptor kinase-interactor 1 (Git1), a Ptprz substrate, were higher after treatment with VacA, indicating that VacA behaves as a ligand for Ptprz. Furthermore, pleiotrophin (PTN), an endogenous ligand of Ptprz, also induced gastritis specifically in Ptprz(+/+) mice when administered orally. Taken together, these data indicate that erroneous Ptprz signaling induces gastric ulcers.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448585, Japan; Kobe Univ, Dept Endoscopy, Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; Kobe Univ, Div Diabet Digest & Kidney Dis, Dept Clin Mol Med, Sch Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; Shionogi & Co Ltd, Discovery Res Labs, Fukushima Ku, Osaka 5530002, Japan; Shinshu Univ, Dept Biomed Lab Sci, Sch Hlth Sci, Sch Med, Matsumoto, Nagano 3908621, Japan; Nagasaki Univ, Dept Bacteriol, Inst Trop Med, Nagasaki 8528523, Japan; Univ Tokyo, Dept Sci Biol, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kobe University; Kobe University; Shionogi & Company Limited; Shinshu University; Nagasaki University; University of Tokyo	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 38 Nishigonaka,Myodaiji Cho, Okazaki, Aichi 4448585, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016; Fujikawa, Akihiro/K-9805-2015	Noda, Masaharu/0000-0002-3796-524X; Fujikawa, Akihiro/0000-0002-3950-0550; Shintani, Takafumi/0000-0002-6165-2307; Yahiro, Kinnosuke/0000-0002-9813-0780				Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; BLASER MJ, 1994, J CLIN INVEST, V94, P4, DOI 10.1172/JCI117336; COVER TL, 1992, J BIOL CHEM, V267, P10570; FUKAMACHI H, 1994, DIFFERENTIATION, V56, P83, DOI 10.1046/j.1432-0436.1994.56120083.x; Garner JA, 1996, INFECT IMMUN, V64, P4197, DOI 10.1128/IAI.64.10.4197-4203.1996; GHIRA P, 1995, INFECT IMMUN, V63, P4154, DOI 10.1128/IAI.63.10.4154-4160.1995; GLAVIN GB, 1992, FASEB J, V6, P825, DOI 10.1096/fasebj.6.3.1740232; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Manabe R, 2002, J CELL SCI, V115, P1497; Massari P, 1998, INFECT IMMUN, V66, P3981, DOI 10.1128/IAI.66.8.3981-3984.1998; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Padilla PI, 2000, J BIOL CHEM, V275, P15200, DOI 10.1074/jbc.275.20.15200; Pai R, 1999, BIOCHEM BIOPH RES CO, V262, P245, DOI 10.1006/bbrc.1999.1194; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Ricci V, 1996, INFECT IMMUN, V64, P2829, DOI 10.1128/IAI.64.7.2829-2833.1996; Ricci V, 1997, J PATHOL, V183, P453; Seto K, 1998, FEBS LETT, V431, P347, DOI 10.1016/S0014-5793(98)00788-1; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; TEE W, 1995, J CLIN MICROBIOL, V33, P1203, DOI 10.1128/JCM.33.5.1203-1205.1995; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Tominaga K, 1997, DIGESTION, V58, P120, DOI 10.1159/000201434; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; WARREN JR, 1983, LANCET, V1, P1273; Yahiro K, 1997, BIOCHEM BIOPH RES CO, V238, P629, DOI 10.1006/bbrc.1997.7345; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Zarrilli R, 1999, CELL MICROBIOL, V1, P93, DOI 10.1046/j.1462-5822.1999.00018.x; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	29	198	206	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					375	381		10.1038/ng1112	http://dx.doi.org/10.1038/ng1112			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12598897				2022-12-27	WOS:000181312700014
J	Rifkin, SA; Kim, J; White, KP				Rifkin, SA; Kim, J; White, KP			Evolution of gene expression in the Drosophila melanogaster subgroup	NATURE GENETICS			English	Article							SALIVARY-GLAND CHROMOSOMES; PHENOTYPIC EVOLUTION; PUFFING ACTIVITY; PATTERNS; CONSERVATION; SELECTION; VARIANCE; HOMOLOGY	Little is known about broad patterns of variation and evolution of gene expression during any developmental process. Here we investigate variation in genome-wide gene expression among Drosophila simulans, Drosophila yakuba and four strains of Drosophila melanogaster during a major developmental transition-the start of metamorphosis. Differences in gene activity between these lineages follow a phylogenetic pattern, and 27% of all of the genes in these genomes differ in their developmental gene expression between at least two strains or species. We identify, on a gene-by-gene basis, the evolutionary forces that shape this variation and show that, both within the transcriptional network that controls metamorphosis and across the whole genome, the expression changes of transcription factor genes are relatively stable, whereas those of their downstream targets are more likely to have evolved. Our results demonstrate extensive evolution of developmental gene expression among closely related species.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University; Yale University	White, KP (corresponding author), Yale Univ, Sch Med, Dept Genet, POB 208005, New Haven, CT 06520 USA.	kevin.white@yale.edu	TATSUTA, HARUKI/F-2997-2010	Rifkin, Scott/0000-0001-8476-3256				Alonso CR, 2001, CURR BIOL, V11, P1473, DOI 10.1016/S0960-9822(01)00425-0; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; ASHBURNER M, 1969, CHROMOSOMA, V27, P156, DOI 10.1007/BF00326142; ASHBURNER M, 1972, CHROMOSOMA, V38, P283, DOI 10.1007/BF00290926; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; DAMERVAL C, 1994, GENETICS, V137, P289; Davidson E. H., 2001, DEV EVOLUTION; DICKINSON WJ, 1988, BIOESSAYS, V8, P204, DOI 10.1002/bies.950080608; DICKINSON WJ, 1993, EVOLUTION, V47, P1396, DOI [10.2307/2410155, 10.1111/j.1558-5646.1993.tb02162.x]; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Hansen TF, 1996, EVOLUTION, V50, P1404, DOI 10.1111/j.1558-5646.1996.tb03914.x; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Johnson NA, 2001, GENETICA, V112, P45, DOI 10.1023/A:1013371201773; Kerr MK, 2002, STAT SINICA, V12, P203; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; LACHAISE D, 1988, EVOL BIOL, V22, P159; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lewontin R., 1983, SCIENTIA, V118, P63; Li YJ, 1999, GENES GENET SYST, V74, P117, DOI 10.1266/ggs.74.117; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; MARONI G, 1983, DROS INFORM SERV, V59, P142; MARTINS EP, 1994, AM NAT, V144, P193, DOI 10.1086/285670; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Palopoli MF, 1996, GENETICS, V144, P1321; Powell J. R., 1997, PROGR PROSPECTS EVOL; Reinke V, 2002, ANNU REV GENOM HUM G, V3, P153, DOI 10.1146/annurev.genom.3.031302.100922; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sokal RR, 1995, BIOMETRY; Stowers RS, 1999, DEV BIOL, V213, P116, DOI 10.1006/dbio.1999.9358; Swofford DL, 1996, PAUP PHYLOGENETIC AN; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Wagner GP, 1996, AM ZOOL, V36, P36; WAGNER GP, 1993, J EVOLUTION BIOL, V6, P449, DOI 10.1046/j.1420-9101.1993.6030449.x; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; WENSINK PC, 1974, CELL, V3, P315, DOI 10.1016/0092-8674(74)90045-2; White KP, 2001, NAT REV GENET, V2, P528, DOI 10.1038/35080565; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wilkins A.S, 2001, EVOLUTION DEV PATHWA; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640; Yang YH, 2001, PROC SPIE, V4266, P141, DOI 10.1117/12.427982	50	276	278	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					138	144		10.1038/ng1086	http://dx.doi.org/10.1038/ng1086			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12548287				2022-12-27	WOS:000180773700010
J	Brown, KD; Rathi, A; Kamath, R; Beardsley, DI; Zhan, QM; Mannino, JL; Baskaran, R				Brown, KD; Rathi, A; Kamath, R; Beardsley, DI; Zhan, QM; Mannino, JL; Baskaran, R			The mismatch repair system is required for S-phase checkpoint activation	NATURE GENETICS			English	Article							RADIORESISTANT DNA-SYNTHESIS; ATAXIA-TELANGIECTASIA GENE; NIJMEGEN BREAKAGE SYNDROME; IONIZING-RADIATION; TUMOR-CELLS; N-METHYL-N'-NITRO-N-NITROSOGUANIDINE; KINASE; HMLH1; PHOSPHORYLATION; DEFICIENT	Defective S-phase checkpoint activation results in an inability to downregulate DNA replication following genotoxic insult such as exposure to ionizing radiation. This 'radioresistant DNA synthesis' (RDS) is a phenotypic hallmark of ataxia-telangiectasia(1), a cancer-prone disorder caused by mutations in ATM(2). The mismatch repair system principally corrects nucleotide mismatches that arise during replication(3). Here we show that the mismatch repair system is required for activation of the S-phase checkpoint in response to ionizing radiation. Cells deficient in mismatch repair proteins showed RDS, and restoration of mismatch repair function restored normal S-phase checkpoint function. Catalytic activation of ATM and ATM-mediated phosphorylation of the protein NBS1 (also called nibrin) occurred independently of mismatch repair. However, ATM-dependent phosphorylation and activation of the checkpoint kinase CHK2 and subsequent degradation of its downstream target, CDC25A, was abrogated in cells lacking mismatch repair. In vitro and in vivo approaches both show that MSH2 binds to CHK2 and that MLH1 associates with ATM. These findings indicate that the mismatch repair complex formed at the sites of DNA damage facilitates the phosphorylation of CHK2 by ATM, and that defects in this mechanism form the molecular basis for the RDS observed in cells deficient in mismatch repair.	Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Baskaran, R (corresponding author), Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, E 1205 Biomed Sci Tower, Pittsburgh, PA 15261 USA.							Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Buermeyer AB, 1999, CANCER RES, V59, P538; Chen SK, 2001, RADIAT RES, V155, P832, DOI 10.1667/0033-7587(2001)155[0832:DOOIIC]2.0.CO;2; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fritzell JA, 1997, CANCER RES, V57, P5143; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KOI M, 1994, CANCER RES, V54, P4308; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nehme A, 1997, CANCER RES, V57, P3253; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; PAINTER RB, 1981, MUTAT RES, V84, P183, DOI 10.1016/0027-5107(81)90061-0; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Umar A, 1997, CANCER RES, V57, P3949; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Wang Y, 2000, GENE DEV, V14, P927; Yan T, 2001, CANCER RES, V61, P8290; Zhang H, 1999, CANCER RES, V59, P3021; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	30	166	170	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					80	84		10.1038/ng1052	http://dx.doi.org/10.1038/ng1052			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12447371				2022-12-27	WOS:000180136100022
J	Roetto, A; Papanikolaou, G; Politou, M; Alberti, F; Girelli, D; Christakis, J; Loukopoulos, D; Camaschella, C				Roetto, A; Papanikolaou, G; Politou, M; Alberti, F; Girelli, D; Christakis, J; Loukopoulos, D; Camaschella, C			Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; IRON OVERLOAD; GENE; MUTATION; SLC11A3; LIVER	Animal models indicate that the antimicrobial peptide hepcidin (HAMP; OMIM 606464) is probably a key regulator of iron absorption in mammals. Here we report the identification of two mutations (93delG and 166C-->T) in HAMP on 19q13 in two families with a new type of juvenile hemochromatosis.	Univ Turin, Dept Clin & Biol Sci, Azienda Osped San Luigi, I-10043 Orbassano, Italy; Univ Athens, Sch Med, Dept Med 1, Laikon Hosp, GR-11527 Athens, Greece; Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; Theagenio Canc Ctr, Dept Hematol, Thessaloniki, Greece	University of Turin; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; University of Verona	Camaschella, C (corresponding author), Univ Turin, Dept Clin & Biol Sci, Azienda Osped San Luigi, I-10043 Orbassano, Italy.		PAPANIKOLAOU, GEORGE/AAL-9017-2021; Roetto, Antonella/K-4731-2016; Camaschella, Clara/A-3289-2015; Girelli, Domenico/B-1183-2008	PAPANIKOLAOU, GEORGE/0000-0002-6755-3633; Girelli, Domenico/0000-0001-9684-1899; ROETTO, Antonella/0000-0003-1188-7375	Telethon [GP0255Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Camaschella C, 1997, EUR J HUM GENET, V5, P371, DOI 10.1159/000484794; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Papanikolaou G, 2002, BLOOD CELL MOL DIS, V29, P168, DOI 10.1006/bcmd.2002.0553; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379; Roetto A, 2001, BLOOD, V97, P2555, DOI 10.1182/blood.V97.9.2555; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260	15	663	711	1	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					21	22		10.1038/ng1053	http://dx.doi.org/10.1038/ng1053			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12469120				2022-12-27	WOS:000180136100011
J	Jamin, SP; Arango, NA; Mishina, Y; Hanks, MC; Behringer, RR				Jamin, SP; Arango, NA; Mishina, Y; Hanks, MC; Behringer, RR			Requirement of Bmpr1a for Mullerian duct regression during male sexual development	NATURE GENETICS			English	Article							IBMP RECEPTOR BMPRIB; MOUSE EMBRYOGENESIS; II RECEPTOR; EXPRESSION; HORMONE; GASTRULATION; PATHWAY; ALK2; FAMILY; LIMB	Elimination of the developing female reproductive tract in male fetuses is an essential step in mammalian sexual differentiation(1). In males, the fetal testis produces the transforming growth factor beta (TGF-beta) family member anti-Mullerian hormone (Amh, also known as Mullerian-inhibiting substance (Mis)), which causes regression of the Mullerian ducts, the primordia of the oviducts, uterus and upper vagina(2). Amh induces regression by binding to a specific type II receptor (Amhr2) expressed in the mesenchyme surrounding the ductal epithelium(3-7). Mutations in AMH or AMHR2 in humans and mice disrupt signaling, producing male pseudohermaphrodites that possess oviducts and uteri(8-10). The type I receptor and Smad proteins that are required in vivo for Mullerian duct regression have not yet been identified(11-14). Here we show that targeted disruption of the widely expressed type I bone morphogenetic protein (BMP) receptor Bmpr1a (also known as Alk3) in the mesenchymal cells of the Mullerian ducts leads to retention of oviducts and uteri in males. These results identify Bmpr1a as a type I receptor for Amh-induced regression of Mullerian ducts. Because Bmpr1a is evolutionarily conserved, these findings indicate that a component of the BMP signaling pathway has been co-opted during evolution for male sexual development in amniotes.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Procter & Gamble Co, Hlth Care Res Ctr, Mason, OH USA	University of Texas System; UTMD Anderson Cancer Center; Procter & Gamble	Behringer, RR (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.		Jamin, Soazik P./K-1507-2019; Jamin, Soazik/F-6796-2015	Jamin, Soazik P./0000-0002-1688-0167; 				Ahn K, 2001, DEVELOPMENT, V128, P4449; Albrecht U, 1996, DEV BIOL, V180, P579, DOI 10.1006/dbio.1996.0330; Allard S, 2000, DEVELOPMENT, V127, P3349; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Belville C, 1999, AM J MED GENET, V89, P218, DOI 10.1002/(SICI)1096-8628(19991229)89:4<218::AID-AJMG6>3.0.CO;2-E; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Gouedard L, 2000, J BIOL CHEM, V275, P27973; Gu ZY, 1998, GENE DEV, V12, P844, DOI 10.1101/gad.12.6.844; Gu ZY, 1999, DEVELOPMENT, V126, P2551; JOSSO N, 1993, RECENT PROG HORM RES, V48, P1; JOST A, 1953, RECENT PROG HORM RES, V8, P379; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Mishina Y, 2002, GENESIS, V32, P69, DOI 10.1002/gene.10038; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mishina Y, 1996, GENE DEV, V10, P2577, DOI 10.1101/gad.10.20.2577; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Newfeld SJ, 1999, GENETICS, V152, P783; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Roberts LM, 1999, DEV BIOL, V208, P110, DOI 10.1006/dbio.1998.9190; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Teixeira J, 1996, ENDOCRINOLOGY, V137, P160, DOI 10.1210/en.137.1.160; Visser JA, 2001, MOL ENDOCRINOL, V15, P936, DOI 10.1210/me.15.6.936; Yi SE, 2000, DEVELOPMENT, V127, P621; Yi SE, 2001, P NATL ACAD SCI USA, V98, P7994, DOI 10.1073/pnas.141002798	30	297	309	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					408	410		10.1038/ng1003	http://dx.doi.org/10.1038/ng1003			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12368913				2022-12-27	WOS:000179034800017
J	Bachtrog, D				Bachtrog, D			Evidence that positive selection drives Y-chromosome degeneration in Drosophila miranda	NATURE GENETICS			English	Article							NEO-Y; EVOLUTION; ACCUMULATION; HITCHHIKING; ADAPTATION; PATTERN; GENES	Why does the Y chromosome harbor so few functional loci? Evolutionary theory predicts that Y chromosomes degenerate because they lack genetic recombination(1). Both positive(2) and negative(1) selection models have been invoked to explain this degeneration, as both can result in the recurrent fixation of linked deleterious mutations on a nonrecombining Y chromosome. To distinguish between these models, I investigated patterns of nucleotide variability along 37 kb of the recently formed neo-Y chromosome in Drosophila miranda. Levels of nucleotide variability on this chromosome are 30 times lower than in highly recombining portions of the genome. Both positive and negative selection models can result in reduced variability levels, but their effects on the frequency spectrum of mutations differ. Using coalescent simulations, I show that the patterns of nucleotide variability on the neo-Y chromosome are unlikely under deleterious mutation models (including background selection and Muller's ratchet) but are expected under recent positive selection. These results implicate positive selection as an important force driving the degeneration of Y chromosomes; adaptation at a few loci, possibly increasing male fitness, occurs at the cost of most other genes on this chromosome.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Cornell Univ, Dept Genet & Mol Biol, Ithaca, NY 14853 USA	University of Edinburgh; Cornell University	Bachtrog, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	Doris.Bachtrog@cornell.edu						Andolfatto P, 2001, GENETICS, V158, P657; Bachtrog D, 2003, GENETICS, V165, P1221; Bachtrog D, 2003, NAT GENET, V34, P215, DOI 10.1038/ng1164; Bachtrog D, 2003, MOL BIOL EVOL, V20, P173, DOI 10.1093/molbev/msg035; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Drake JW, 1998, GENETICS, V148, P1667; Gordo I, 2002, GENETICS, V161, P835; HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson Richard R., 1994, P140; MUKAI T, 1972, GENETICS, V72, P335; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; RICE WR, 1987, GENETICS, V116, P161; SIMONSEN KL, 1995, GENETICS, V141, P413; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; Tachida H, 2000, GENE, V261, P3, DOI 10.1016/S0378-1119(00)00475-3; TAJIMA F, 1989, GENETICS, V123, P585; Yi SJ, 2003, GENETICS, V164, P1369	24	90	91	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					518	522		10.1038/ng1347	http://dx.doi.org/10.1038/ng1347			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107853	Bronze			2022-12-27	WOS:000221183000027
J	Perepelitsa-Belancio, V; Deininger, P				Perepelitsa-Belancio, V; Deininger, P			RNA truncation by premature polyadenylation attenuates human mobile element activity	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENT; LINE-1; EXPRESSION; MOUSE; RETROTRANSPOSONS; MECHANISM	Long interspersed elements (LINE-1s, also called L1s) are the only active members of the autonomous, non long terminal repeat (LTR) retrotransposon family, which reshapes mammalian genomes in many different ways(1-5). LINE-1 expression is low in most differentiated cells but high in some cancer cells, in testis and during embryonic development(6-12). To minimize the negative impact on their hosts genomes,, many mobile elements strategically limit their amplification potential, particularly in somatic cells(13-15). Here we show that the A-rich coding strand of the human LINE-1 contains multiple functional canonical and noncanonical polyadenylation (poly(A)) signals, resulting in truncation of full-length transcripts by premature polyadenylation. This attenuation lowers the rate of retrotransposition in assays using HeLa cells. It probably also increases the negative effects of LINE-1 insertions into genes(16).	Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, New Orleans, LA 70112 USA; Tulane Univ, Hlth Sci Ctr, Dept Environm Hlth Sci, New Orleans, LA 70112 USA	Tulane University; Tulane University	Deininger, P (corresponding author), Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, SL66,1430 Tulane Ave, New Orleans, LA 70112 USA.	pdeinin@tulane.edu		Deininger, Prescott/0000-0002-1067-3028				Asch HL, 1996, ONCOL RES, V8, P239; Benihoud K, 2002, ONCOGENE, V21, P5593, DOI 10.1038/sj.onc.1205730; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; BRATTHAUER GL, 1994, CANCER, V73, P2333, DOI 10.1002/1097-0142(19940501)73:9<2333::AID-CNCR2820730915>3.0.CO;2-4; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lerat E, 2002, J MOL EVOL, V54, P625, DOI 10.1007/s00239-001-0059-0; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MULHARDT C, 1994, NEURON, V13, P1003, DOI 10.1016/0896-6273(94)90265-8; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SIEBEL CW, 1990, SCIENCE, V248, P1200, DOI 10.1126/science.2161558; SKOWRONSKI J, 1985, P NATL ACAD SCI USA, V82, P6050, DOI 10.1073/pnas.82.18.6050; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	29	179	182	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					363	366		10.1038/ng1269	http://dx.doi.org/10.1038/ng1269			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14625551				2022-12-27	WOS:000186791000018
J	Ooi, SL; Shoemaker, DD; Boeke, JD				Ooi, SL; Shoemaker, DD; Boeke, JD			DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; REPLICATION FORK PROGRESSION; HOMOLOGOUS RECOMBINATION; YEAST SGS1; SRS2; REQUIREMENT; ABSENCE; MUTANTS; PURIFICATION; CHECKPOINT	We describe a new synthetic lethality analysis by microarray (SLAM) technique that uses 4,600 Saccharomyces cerevisiae haploid deletion mutants with molecular bar codes (TAGs). We used SGS1 and SRS2, two 3' --> 5' DNA helicase genes, as queries to identify their redundant and unique biological functions. We introduced these query mutations into a haploid deletion pool by integrative transformation to disrupt the query gene in every cell, generating a double mutant pool. Optimization of integrative transformation efficiency was essential to the success of SLAM. Synthetic interactions defined a DNA helicase genetic network and predicted a role for SRS2 in processing damaged replication forks but, unlike SGS1, not in rDNA replication, DNA topology or lagging strand synthesis. SGS1 and SRS2 have synthetic defects with MRC1 but not RAD9, suggesting that SGS1 and SRS2 function in a parallel pathway with MRC1 to transduce the DNA replication stress signal to the general DNA damage checkpoint pathway. Both helicase genes have rad51-reversible synthetic defects with 5 3 DNA helicase RRM3, suggesting that RRM3 helps prevent formation of toxic recombination intermediates. SLAM detects synthetic lethality efficiently and ranks candidate genetic interactions, making it an especially useful method.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Merck & Co Inc, San Diego, CA 92121 USA	Johns Hopkins University; Merck & Company	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 617 Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.			Boeke, Jef/0000-0001-5322-4946				ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bennett CB, 2001, NAT GENET, V29, P426, DOI 10.1038/ng778; Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; DOBZHANSKY T, 1946, GENETICS, V31, P269; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Frei C, 2000, GENE DEV, V14, P81; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Lee SK, 1999, SCIENCE, V286, P2339, DOI 10.1126/science.286.5448.2339; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Mankouri HW, 2002, NUCLEIC ACIDS RES, V30, P1103, DOI 10.1093/nar/30.5.1103; Morrow DM, 1997, GENETICS, V147, P371; Mullen JR, 2001, GENETICS, V157, P103; NOVICK P, 1989, GENETICS, V121, P659; OGAWA T, 1993, COLD SPRING HARB SYM, V58, P567, DOI 10.1101/SQB.1993.058.01.063; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; RONG L, 1993, J BIOL CHEM, V268, P1252; Schmidt KH, 2002, J BIOL CHEM, V277, P45331, DOI 10.1074/jbc.M207263200; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733	36	159	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					277	286		10.1038/ng1258	http://dx.doi.org/10.1038/ng1258			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14566339				2022-12-27	WOS:000186273300025
J	Wakabayashi, N; Itoh, K; Wakabayashi, J; Motohashi, H; Noda, S; Takahashi, S; Imakado, S; Kotsuji, T; Otsuka, F; Roop, DR; Harada, T; Engel, JD; Yamamoto, M				Wakabayashi, N; Itoh, K; Wakabayashi, J; Motohashi, H; Noda, S; Takahashi, S; Imakado, S; Kotsuji, T; Otsuka, F; Roop, DR; Harada, T; Engel, JD; Yamamoto, M			Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; LAMELLAR ICHTHYOSIS; OXIDATIVE STRESS; DROSOPHILA KELCH; DEFICIENT MICE; KNOCKOUT MICE; IN-VITRO; PROTEIN; GENES; EXPRESSION	Transcription factor Nrf2 (encoded by Nfe2l2) regulates a battery of detoxifying and antioxidant genes, and Keap1 represses Nrf2 function. When we ablated Keap1, Keap1-deficient mice died postnatally, probably from malnutrition resulting from hyperkeratosis in the esophagus and forestomach. Nrf2 activity affects the expression levels of several squamous epithelial genes. Biochemical data show that, without Keap1, Nrf2 constitutively accumulates in the nucleus to stimulate transcription of cytoprotective genes. Breeding to Nrf2-deficient mice reversed the phenotypic Keap1 deficiencies. These experiments show that Keap1 acts upstream of Nrf2 in the cellular response to oxidative and xenobiotic stress.	Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, ERATO, JST, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Clin Med Sci, Tsukuba, Ibaraki 3058577, Japan; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Inst Environm Toxicol, Mitsukaido, Ibaraki 3030043, Japan; Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba; University of Tsukuba; Baylor College of Medicine; Baylor College of Medicine; University of Michigan System; University of Michigan	Yamamoto, M (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	masi@tara.tsukuba.ac.jp	Itoh, Ken/B-9506-2013; Yamamoto, Masayuki/A-4873-2010; Motohashi, Hozumi/AAZ-2628-2020	Itoh, Ken/0000-0002-5518-0729; Yamamoto, Masayuki/0000-0002-9073-9436; 				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; DiSepio D, 1999, DIFFERENTIATION, V64, P225, DOI 10.1046/j.1432-0436.1999.6440225.x; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Li NX, 2000, METHOD ENZYMOL, V319, P273; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Parmentier L, 1996, HUM MOL GENET, V5, P555, DOI 10.1093/hmg/5.4.555; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; RUSSELL LJ, 1994, AM J HUM GENET, V55, P1146; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; Thiele JJ, 1999, J INVEST DERMATOL, V113, P335, DOI 10.1046/j.1523-1747.1999.00693.x; TIEMANN F, 1994, ONCOGENE, V9, P1907; Virolainen E, 2000, AM J HUM GENET, V66, P1132, DOI 10.1086/302813; WILLIAMS ML, 1985, ARCH DERMATOL, V121, P477, DOI 10.1001/archderm.121.4.477; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yoshida C, 1999, GENES CELLS, V4, P643, DOI 10.1046/j.1365-2443.1999.00291.x; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	36	649	675	6	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					238	245		10.1038/ng1248	http://dx.doi.org/10.1038/ng1248			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14517554				2022-12-27	WOS:000186273300019
J	Dewannieux, M; Esnault, C; Heidmann, T				Dewannieux, M; Esnault, C; Heidmann, T			LINE-mediated retrotransposition of marked Alu sequences	NATURE GENETICS			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; SIGNAL RECOGNITION PARTICLE; RIBONUCLEOPROTEIN-PARTICLES; INDICATOR GENE; L1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; MAMMALIAN-CELLS; ORF1 PROTEIN; HUMAN GENOME; RNA-BINDING	Alu elements are the most successful transposons in humans. They are 300-bp non-coding sequences transcribed by RNA polymerase III (Pol III) and are expected to retrotranspose with the aid of reverse transcriptases of cellular origin. We previously showed that human LINEs can generate cDNA copies of any mRNA transcript by means of a retroposition process involving reverse transcription and integration by the LINE-encoded endonuclease and reverse transcriptase. Here we show mobility of marked Alu sequences in human HeLa cells with the canonical features of a retrotransposition process, including splicing out of an autocatalytic intron introduced into the marked sequence, target site duplications of varying lengths and integrations into consensus A-rich sequences. We further show that the poly-A stretch at the Alu 3' end is essential for mobility, that LINEs are required for transposition and that the rate of retroposition is 100 1,000 times higher for Alu transcripts than for control mRNAs, thus accounting for the high mutational activity of these elements observed in humans.	Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Heidmann, T (corresponding author), Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	heidmann@igr.fr		Dewannieux, Marie/0000-0003-3918-2414				Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Boeke J. D., 1997, P343; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; Bovia F, 1996, J CELL SCI, V109, P2601; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Chaboissier MC, 2000, NUCLEIC ACIDS RES, V28, P2467, DOI 10.1093/nar/28.13.2467; CHANG DY, 1995, MOL CELL BIOL, V15, P2109; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Deininger PL, 1989, MOBILE DNA, P619; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e49; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; JENSEN S, 1991, EMBO J, V10, P1927, DOI 10.1002/j.1460-2075.1991.tb07719.x; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kolosha VO, 2003, J BIOL CHEM, V278, P8112, DOI 10.1074/jbc.M210487200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; QUENTIN Y, 1992, NUCLEIC ACIDS RES, V20, P487, DOI 10.1093/nar/20.3.487; Rowold DJ, 2000, GENETICA, V108, P57, DOI 10.1023/A:1004099605261; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Sarrowa J, 1997, MOL CELL BIOL, V17, P1144, DOI 10.1128/MCB.17.3.1144; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; SINNETT D, 1991, J BIOL CHEM, V266, P8675; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; TCHENIO T, 1995, J VIROL, V69, P1079; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Willoughby DA, 2000, J BIOL CHEM, V275, P759, DOI 10.1074/jbc.275.2.759	49	731	758	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					41	48		10.1038/ng1223	http://dx.doi.org/10.1038/ng1223			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12897783				2022-12-27	WOS:000185018500009
J	Roberts, SC; Gosling, LM				Roberts, SC; Gosling, LM			Genetic similarity and quality interact in mate choice decisions by female mice	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATING PREFERENCES; HOUSE MICE; SEXUAL SELECTION; ODOR PREFERENCES; MUS-DOMESTICUS; LEK PARADOX; MHC; EVOLUTION; RESOLUTION	Females express mate preferences for genetically dissimilar males(1), especially with respect to the major histocompatibility complex, MHC2,3, and for males whose sexually selected signals indicate high genetic quality(4,5). The balance of selection pressure on each trait will depend on how females weight these desirable qualities under different conditions(6), but this has not been tested empirically. Here we show in mice that although MHC dissimilarity and a 'good genes' indicator (investment in scent-marking) both have a role in determining female preference, their relative influence can vary depending on the degree of variability in each trait among available males. Such interactions between condition-dependent and disassortative mate choice criteria suggest a mechanism by which female choice can contribute to maintenance of additive genetic variance in both the MHC and condition-dependent traits, even under consistent directional selection.	Univ Newcastle Upon Tyne, Sch Biol, Evolut & Behav Res Grp, Newcastle Upon Tyne NE1 4HH, Tyne & Wear, England	Newcastle University - UK	Roberts, SC (corresponding author), Univ Newcastle Upon Tyne, Sch Biol, Evolut & Behav Res Grp, Framlington Pl, Newcastle Upon Tyne NE1 4HH, Tyne & Wear, England.		Roberts, S./A-2040-2009; Roberts, Craig/E-6919-2011	Roberts, Craig/0000-0002-9641-6101; Gosling, Leonard Morris/0000-0002-2028-3488				BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; Colegrave N, 2002, EVOL ECOL RES, V4, P911; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; DRICKAMER LC, 1992, ANIM BEHAV, V43, P868, DOI 10.1016/S0003-3472(05)80212-X; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Eggert Frank, 1996, Physiology and Behavior, V59, P57, DOI 10.1016/0031-9384(95)02029-2; Gosling LM, 2000, BEHAV ECOL SOCIOBIOL, V48, P328, DOI 10.1007/s002650000242; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; HAYASHI S, 1990, ZOOL SCI, V7, P889; Horne TJ, 1998, EVOLUTION, V52, P894, DOI [10.2307/2411284, 10.1111/j.1558-5646.1998.tb03714.x]; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Jordan WC, 1998, HEREDITY, V81, P239, DOI 10.1038/sj.hdy.6884280; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; Mossman CA, 1996, J COMP PSYCHOL, V110, P131, DOI 10.1037/0735-7036.110.2.131; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O; POTTS WK, 1995, IMMUNOL REV, V143, P181, DOI 10.1111/j.1600-065X.1995.tb00675.x; Rich TJ, 1998, ANIM BEHAV, V56, P727, DOI 10.1006/anbe.1998.0803; Von Schantz T, 1997, HEREDITAS, V127, P133, DOI 10.1111/j.1601-5223.1997.t01-1-00133.x; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	30	157	159	0	63	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					103	106		10.1038/ng1231	http://dx.doi.org/10.1038/ng1231			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12937417				2022-12-27	WOS:000185018500018
J	Carlton, VEH; Harris, BZ; Puffenberger, EG; Batta, AK; Knisely, AS; Robinson, DL; Strauss, KA; Schneider, BL; Lim, WA; Salen, G; Morton, DH; Bull, LN				Carlton, VEH; Harris, BZ; Puffenberger, EG; Batta, AK; Knisely, AS; Robinson, DL; Strauss, KA; Schneider, BL; Lim, WA; Salen, G; Morton, DH; Bull, LN			Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT	NATURE GENETICS			English	Article							TIGHT JUNCTIONS; EXTRAHEPATIC CHOLESTASIS; PDZ DOMAINS; HUMAN LIVER; EXPRESSION; TRANSPORT; PROTEINS; ZO-2	Familial hypercholanemia (FHC) is characterized by elevated serum bile acid concentrations, itching, and fat malabsorption(1,2). We show here that FHC in Amish individuals is associated with mutations in tight junction protein 2 (encoded by TJP2, also known as ZO-2) and bile acid Coenzyme A: amino acid N-acyltransferase (encoded by BAAT). The mutation of TJP2, which occurs in the first PDZ domain, reduces domain stability and ligand binding in vitro. We noted a morphological change in hepatic tight junctions. The mutation of BAAT, a bile acid-conjugating enzyme(3), abrogates enzyme activity; serum of individuals homozygous with respect to this mutation contains only unconjugated bile acids. Mutations in both TJP2 and BAAT may disrupt bile acid transport and circulation. Inheritance seems to be oligogenic, with genotype at BAAT modifying penetrance in individuals homozygous with respect to the mutation in TJP2.	Univ Calif San Francisco, San Francisco Gen Hosp, Liver Ctr Lab, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA; Clin Special Children, Strasburg, PA 17579 USA; Vet Affairs Med Ctr, E Orange, NJ 07018 USA; Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; Mt Sinai Sch Med, Dept Pediat, Div Pediat Hematol, New York, NY 10029 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bull, LN (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Liver Ctr Lab, San Francisco, CA 94110 USA.	lbull@medsfgh.ucsf.edu		Puffenberger, Erik/0000-0002-6388-9148				Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen JH, 1996, J FOOD DRUG ANAL, V4, P57; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; DAWSON PA, 2002, GASTROINTESTINAL LIV, P1051; FALANY CN, 1994, J BIOL CHEM, V269, P19375; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hostetler John, 1993, AMISH SOC, DOI 10.2307/539066; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; KOGA A, 1978, CELL TISSUE RES, V195, P267; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Mahapatra AK, 2002, PEDIATR NEUROSURG, V36, P113, DOI 10.1159/000048365; McCarthy KM, 2000, J CELL SCI, V113, P3387; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Morton DH, 2000, GASTROENTEROLOGY, V119, P188, DOI 10.1053/gast.2000.8547; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Rahner C, 1996, GASTROENTEROLOGY, V110, P1564, DOI 10.1053/gast.1996.v110.pm8613064; RONCHI G, 1973, BEITR PATHOL, V150, P316; Setchell KDR, 2001, LIVER DIS CHILDREN, P701; Shneider BL, 1997, HEPATOLOGY, V25, P1176, DOI 10.1002/hep.510250521; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088	25	208	219	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					91	96		10.1038/ng1147	http://dx.doi.org/10.1038/ng1147			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12704386				2022-12-27	WOS:000182667900023
J	Cooper, MK; Wassif, CA; Krakowiak, PA; Taipale, J; Gong, RY; Kelley, RI; Porter, FD; Beachy, PA				Cooper, MK; Wassif, CA; Krakowiak, PA; Taipale, J; Gong, RY; Kelley, RI; Porter, FD; Beachy, PA			A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis	NATURE GENETICS			English	Article							LEMLI-OPITZ-SYNDROME; A REDUCTASE-ACTIVITY; FLOOR PLATE; INHIBITION; FIBROBLASTS; CYCLOPAMINE; BINDING; CYCLODEXTRINS; INDUCTION; PROTEINS	Smith-Lemli-Opitz syndrome (SLOS), desmosterolosis and lathosterolosis are human syndromes caused by defects in the final stages of cholesterol biosynthesis. Many of the developmental malformations in these syndromes occur in tissues and structures whose embryonic patterning depends on signaling by the Hedgehog (Hh) family of secreted proteins. Here we report that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacologically depleted of sterols. We show that decreasing levels of cellular sterols correlate with diminishing responsiveness to the Hh signal. This diminished response occurs at sterol levels sufficient for normal autoprocessing of Hh protein, which requires cholesterol as cofactor and covalent adduct. We further find that sterol depletion affects the activity of Smoothened (Smo), an essential component of the Hh signal transduction apparatus.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Howard Hughes Med Inst, Baltimore, MD 21205 USA; NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Kennedy Krieger Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Kennedy Krieger Institute	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.			Wassif, Christopher/0000-0002-2524-1420	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000139] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000139] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; BITTMAN R, 1972, P NATL ACAD SCI USA, V69, P3795, DOI 10.1073/pnas.69.12.3795; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Clayton P, 1996, LANCET, V348, P404, DOI 10.1016/S0140-6736(05)65020-9; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; DONNAI D, 1987, AM J MED GENET, V28, P741, DOI 10.1002/ajmg.1320280323; GIBSON KM, 1990, J LIPID RES, V31, P515; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Guy RK, 2000, P NATL ACAD SCI USA, V97, P7307, DOI 10.1073/pnas.97.13.7307; Incardona JP, 2000, DEV BIOL, V224, P440, DOI 10.1006/dbio.2000.9775; Ingham PW, 2001, SCIENCE, V294, P1879, DOI 10.1126/science.1064115; Kelley R I, 2000, Adv Pediatr, V47, P1; KELLEY RI, 1995, CLIN CHIM ACTA, V236, P45, DOI 10.1016/0009-8981(95)06038-4; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; Nowaczyk MJM, 2001, AM J MED GENET, V102, P18, DOI 10.1002/1096-8628(20010722)102:1<18::AID-AJMG1376>3.0.CO;2-E; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; PARNES S, 1990, AM J MED GENET, V35, P397, DOI 10.1002/ajmg.1320350317; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wassink TH, 2001, PSYCHIAT GENET, V11, P57, DOI 10.1097/00041444-200106000-00001	30	298	307	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					508	513		10.1038/ng1134	http://dx.doi.org/10.1038/ng1134			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652302	Bronze			2022-12-27	WOS:000181928600023
J	Drenth, JPH; Morsche, RHMT; Smink, R; Bonifacino, JS; Jansen, JBMJ				Drenth, JPH; Morsche, RHMT; Smink, R; Bonifacino, JS; Jansen, JBMJ			Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease	NATURE GENETICS			English	Article							PROTEIN-KINASE-C; KIDNEY-DISEASE; GENE; ENCODES; IDENTIFICATION; RECEPTORS; CELLS	Polycystic liver disease (PCLD, OMIM 174050) is a dominantly inherited condition characterized by the presence of multiple liver cysts of biliary epithelial origin. Fine mapping established linkage to marker D19S581 (Z(max)=9.65; theta=0.01) in four large Dutch families with PCLD. We identified a splice-acceptor site mutation (1138-2A-->G) in PRKCSH in three families, and a splice-donor site mutation (292+1G-->C) in PRKCSH segregated completely with PCLD in another family. The protein encoded by PRKCSH, here named hepatocystin, is predicted to localize to the endoplasmic reticulum. These findings establish germline mutations in PRKCSH as the probable cause of PCLD.	Univ Med Ctr St Radboud, Dept Med, Div Gastroenterol & Hepatol, Nijmegen, Netherlands; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Drenth, JPH (corresponding author), Univ Med Ctr St Radboud, Dept Med, Div Gastroenterol & Hepatol, Nijmegen, Netherlands.		te Morsche, R/P-9143-2015; Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019	Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Curto M, 1998, BIOCHEM BIOPH RES CO, V243, P555, DOI 10.1006/bbrc.1997.7982; HIRAI M, 1990, BIOCHEM J, V270, P583, DOI 10.1042/bj2700583; Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; Reynolds DM, 2000, AM J HUM GENET, V67, P1598, DOI 10.1086/316904; SAKAI K, 1989, GENOMICS, V5, P309, DOI 10.1016/0888-7543(89)90063-3; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WARD CJ, 1994, CELL, V77, P881; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802	13	163	172	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					345	347		10.1038/ng1104	http://dx.doi.org/10.1038/ng1104			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577059				2022-12-27	WOS:000181312700010
J	Takeuchi, A; Mishina, Y; Miyaishi, O; Kojima, E; Hasegawa, T; Isobe, K				Takeuchi, A; Mishina, Y; Miyaishi, O; Kojima, E; Hasegawa, T; Isobe, K			Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; BINDING PROTEIN; P53 PROTEIN; MICE; DISRUPTION; ZBP-89; GENE; EXPRESSION; DEFICIENT	Zfp148 belongs to a large family of C2H2-type zinc-finger transcription factors. Zfp148 is expressed in fetal germ cells in 13.5-d-old (E13.5) mouse embryos. Germ-line transmission of mutations were not observed in chimeric Zfp148(+/-) mice, and some of these mice completely lacked spermatogonia. The number of primordial germ cells in Zfp148(+/-) tetraploid embryos was normal until E11.5, but declined from E11.5 to E13.5 and continued to decline until few germ cells were present at E18.5. This phenotype was not rescued by wild-type Sertoli or stromal cells, and is therefore a cell-autonomous phenotype. These results indicate that two functional alleles of Zfp148 are required for the normal development of fetal germ cells. Recent studies have shown that Zfp148 activates p53, which has an important role in cell-cycle regulation(1). Primordial germ cells stop proliferating at approximately E13.5, which correlates with induction of phosphorylation of p53 and its translocation to the nucleus. Phosphorylation of p53 is impaired in Zfp(148+/-) embryonic stem cells and in fetal germ cells from chimeric Zfp148(+/-) embryos. Thus, Zfp148 may be required for regulating p53 in the development of germ cells.	Natl Inst Longev Sci, Dept Basic Gerontol, Obu, Aichi 4748522, Japan; Natl Inst Environm Hlth Studies, Mol Dev Biol Grp, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Isobe, K (corresponding author), Natl Inst Longev Sci, Dept Basic Gerontol, 36-3 Gengo,Morioka Cho, Obu, Aichi 4748522, Japan.		Takeuchi, Akihide/AAT-4675-2020; isobe, ken-ichi/A-6685-2011	Takeuchi, Akihide/0000-0002-2781-0180; isobe, ken-ichi/0000-0002-8150-2496	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; BUEHR M, 1993, METHOD ENZYMOL, V225, P58; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Hasegawa T, 1999, BIOCHEM BIOPH RES CO, V256, P249, DOI 10.1006/bbrc.1999.0275; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; HOGAN B, 1994, MANIPULATING MOUSE E, P373; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NAGY A, 1990, DEVELOPMENT, V110, P815; ROSAI J, 1996, ACKERMANS SURG PATHO, P1260; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Taniuchi T, 1997, BIOCHEM BIOPH RES CO, V233, P154, DOI 10.1006/bbrc.1997.6310; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; WONG TW, 1973, ARCH PATHOL, V95, P151; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; YOSHINAGA K, 1991, DIFFERENTIATION, V48, P75, DOI 10.1111/j.1432-0436.1991.tb00245.x; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	25	79	96	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					172	176		10.1038/ng1072	http://dx.doi.org/10.1038/ng1072			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524542				2022-12-27	WOS:000180773700015
J	Carter, D; Chakalova, L; Osborne, CS; Dai, YF; Fraser, P				Carter, D; Chakalova, L; Osborne, CS; Dai, YF; Fraser, P			Long-range chromatin regulatory interactions in vivo	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; DNASEI HYPERSENSITIVE SITES; CONTROL REGION; GENE-EXPRESSION; DEVELOPMENTAL REGULATION; IN-VIVO; TRANSCRIPTION; ACTIVATION; UPSTREAM; ENHANCER	Communication between distal chromosomal elements is essential for control of many nuclear processes. For example, genes in higher eukaryotes often require distant enhancer sequences for high-level expression. The mechanisms proposed for long-range enhancer action fall into two basic categories. Non-contact models propose that enhancers act at a distance to create a favorable environment for gene transcription(1-3), or act as entry sites(4) or nucleation points(5) for factors that ultimately communicate with the gene. Contact models propose that communication occurs through direct interaction between the distant enhancer and the gene by various mechanisms that 'loop out' the intervening sequences(6-13). Although much attention has focused on contact models, the existence and nature of long-range interactions is still controversial and speculative, as there is no direct evidence that distant sequences physically interact in vivo(14). Here, we report the development of a widely applicable in situ technique to tag and recover chromatin in the immediate vicinity of an actively transcribed gene. We show that the classical enhancer element, HS2 of the prototypical locus control region (LCR) of the beta-globin gene cluster, is in close physical proximity to an actively transcribed HBB (beta-globin) gene located over 50 kb away in vivo, suggesting a direct regulatory interaction. The results give unprecedented insight into the in vivo structure of the LCR-gene interface and provide the first direct evidence of long-range enhancer communication.	Babraham Inst, Dev Genet Programme, Lab Chromat & Gene Express, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Fraser, P (corresponding author), Babraham Inst, Dev Genet Programme, Lab Chromat & Gene Express, Cambridge CB2 4AT, England.	peter.fraser@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Fraser, Peter/B-7549-2009; Chakalova, Lyubomira/C-6810-2012	Osborne, Cameron/0000-0003-4126-2499; dai, dai yan feng/0000-0001-7147-1748; Fraser, Peter/0000-0002-0041-1227				Bender MA, 2000, BLOOD, V95, P3600, DOI 10.1182/blood.V95.11.3600.011k42_3600_3604; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Bender MA, 2001, BLOOD, V98, P2022, DOI 10.1182/blood.V98.7.2022; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; COLLIS P, 1990, EMBO J, V9, P233, DOI 10.1002/j.1460-2075.1990.tb08100.x; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; Farrell CM, 2000, P NATL ACAD SCI USA, V97, P14554, DOI 10.1073/pnas.97.26.14554; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Iborra FJ, 1996, J CELL SCI, V109, P1427; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; MOREAU P, 1981, NUCLEIC ACIDS RES, V9, P6047, DOI 10.1093/nar/9.22.6047; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	24	474	497	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					623	626		10.1038/ng1051	http://dx.doi.org/10.1038/ng1051			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426570				2022-12-27	WOS:000179593000014
J	Kitamura, K; Yanazawa, M; Sugiyama, N; Miura, H; Iizuka-Kogo, A; Kusaka, M; Omichi, K; Suzuki, R; Kato-Fukui, Y; Kamiirisa, K; Matsuo, M; Kamijo, S; Kasahara, M; Yoshioka, H; Ogata, T; Fukuda, T; Kondo, I; Kato, M; Dobyns, WB; Yokoyama, M; Morohashi, K				Kitamura, K; Yanazawa, M; Sugiyama, N; Miura, H; Iizuka-Kogo, A; Kusaka, M; Omichi, K; Suzuki, R; Kato-Fukui, Y; Kamiirisa, K; Matsuo, M; Kamijo, S; Kasahara, M; Yoshioka, H; Ogata, T; Fukuda, T; Kondo, I; Kato, M; Dobyns, WB; Yokoyama, M; Morohashi, K			Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans	NATURE GENETICS			English	Article							ABSENT CORPUS-CALLOSUM; CORTICAL INTERNEURONS; AMBIGUOUS GENITALIA; NEURONAL MIGRATION; GENE; TELENCEPHALON; EXPRESSION; PROTEIN; LIS1; DIFFERENTIATION	Male embryonic mice with mutations in the X-linked aristaless-related homeobox gene (Arx) developed with small brains due to suppressed proliferation and regional deficiencies in the forebrain. These mice also showed aberrant migration and differentiation of interneurons containing gamma-aminobutyric acid (GABAergic interneurons) in the ganglionic eminence and neocortex as well as abnormal testicular differentiation. These characteristics recapitulate some of the clinical features of X-linked lissencephaly with abnormal genitalia (XLAG) in humans. We found multiple loss-of-function mutations in ARX in individuals affected with XLAG and in some female relatives, and conclude that mutation of ARX causes XLAG. The present report is, to our knowledge, the first to use phenotypic analysis of a knockout mouse to identify a gene associated with an X-linked human brain malformation.	Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 444, Japan; Japan Sci & Technol, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; Hyogo Univ Teachers Educ, Dept Nat Sci, Yashiro, Japan; Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo, Japan; Ehime Univ, Sch Med, Dept Hyg, Shigenobu, Ehime 79102, Japan; Ehime Univ, Fac Engn, Dept Appl Chem, Matsuyama, Ehime 790, Japan; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Hyogo University of Teacher Education; Keio University; Ehime University; Ehime University; University of Chicago	Kitamura, K (corresponding author), Mitsubishi Kagaku Inst Life Sci, 11 Minamiooya, Tokyo 1948511, Japan.	kunio@libra.ls.m-kagaku.co.jp	Katoh-Fukui, Yuko/Y-5383-2019; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; Katoh-Fukui, Yuko/0000-0001-6858-3693; Kato, Mitsuhiro/0000-0003-1485-8553; Ogata, Tsutomu/0000-0001-7178-9991				Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; BERRYKRAVIS E, 1994, ANN NEUROL, V25, P90; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bonneau D, 2002, ANN NEUROL, V51, P340, DOI 10.1002/ana.10119; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Capel B, 2000, MECH DEVELOP, V92, P89, DOI 10.1016/S0925-4773(99)00327-5; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Denaxa M, 2001, DEVELOPMENT, V128, P4635; des Portes V, 1998, CELL, V92, P51; Dobyns WB, 1999, AM J MED GENET, V86, P331, DOI 10.1002/(SICI)1096-8628(19991008)86:4<331::AID-AJMG7>3.0.CO;2-P; Dobyns WB, 1999, NEUROLOGY, V53, P270, DOI 10.1212/WNL.53.2.270; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; FLANCIS F, 1999, NEURON, V23, P247; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Kawabe K, 1999, MOL ENDOCRINOL, V13, P1267, DOI 10.1210/me.13.8.1267; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kitamura K, 1997, MECH DEVELOP, V67, P83, DOI 10.1016/S0925-4773(97)00110-X; LECTINIC K, 2002, NATURE, V417, P645; Leventer RJ, 2000, AM J MED GENET, V97, P213, DOI 10.1002/1096-8628(200023)97:3<213::AID-AJMG1039>3.0.CO;2-W; Marin O, 2000, J NEUROSCI, V20, P6063; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; Nomura M, 1998, J BIOCHEM, V124, P217, DOI 10.1093/oxfordjournals.jbchem.a022083; Ogata T, 2000, AM J MED GENET, V94, P174, DOI 10.1002/1096-8628(20000911)94:2<174::AID-AJMG11>3.0.CO;2-O; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; SIITERI PK, 1974, J CLIN ENDOCR METAB, V38, P113, DOI 10.1210/jcem-38-1-113; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Sussel L, 1999, DEVELOPMENT, V126, P3359; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	46	513	529	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					359	369		10.1038/ng1009	http://dx.doi.org/10.1038/ng1009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379852				2022-12-27	WOS:000179034800010
J	Carrasquillo, MM; McCallion, AS; Puffenberger, EG; Kashuk, CS; Nouri, N; Chakravarti, A				Carrasquillo, MM; McCallion, AS; Puffenberger, EG; Kashuk, CS; Nouri, N; Chakravarti, A			Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease	NATURE GENETICS			English	Article							ENDOTHELIN-B RECEPTOR; ENDOCRINE NEOPLASIA TYPE-2A; PROTEIN-COUPLED RECEPTORS; PHENOTYPIC-EXPRESSION; MISSENSE MUTATION; GROWTH-FACTOR; PROTOONCOGENE; LOCUS; CELLS; GENE	Genetic studies of Hirschsprung disease, a common congenital malformation, have identified eight genes with mutations that can be associated with this condition. Mutations at individual loci are, however, neither necessary nor sufficient to cause clinical disease. We conducted a genome-wide association study in 43 Mennonite family trios using 2,083 microsatellites and single-nucleotide polymorphisms and a new multipoint linkage disequilibrium method that searches for association arising from common ancestry. We identified susceptibility loci at 10q11, 13q22 and 16q23; the gene at 13q22 is EDNRB, encoding a G protein-coupled receptor (GPCR) and the gene at 10q11 is RET, encoding a receptor tyrosine kinase (RTK). Statistically significant joint transmission of RET and EDNRB alleles in affected individuals and non-complementation of aganglionosis in mouse intercrosses between Ret null and the Ednrb hypomorphic piebald allele are suggestive of epistasis between EDNRB and RET. Thus, genetic interaction between mutations in RET and EDNRB is an underlying mechanism for this complex disorder.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; Clin Special Children, Strasburg, PA USA; Affymetrix Inc, Santa Clara, CA USA	Case Western Reserve University; Johns Hopkins University; Affymetrix	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 600 N Wolfe St,Jefferson St Bldg 2-109, Baltimore, MD 21287 USA.			Puffenberger, Erik/0000-0002-6388-9148				Amiel J, 2001, AM J HUM GENET, V69, P1370, DOI 10.1086/324342; Andrew SD, 2000, GENE, V256, P283, DOI 10.1016/S0378-1119(00)00302-4; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bergey LL, 1992, PA MENNON HERIT, V15, P9; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Borrello MG, 1996, MOL CELL BIOL, V16, P2151; BOURNE HR, 1995, NATURE, V376, P727, DOI 10.1038/376727a0; CECCHERINI I, 1994, J ENDOCRINOL INVEST, V17, P201; Chakravarti A, 1996, HUM MOL GENET, V5, P303; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Fitze G, 1999, AM J HUM GENET, V65, P1469, DOI 10.1086/302618; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LAIRMORE TC, 1993, P NATL ACAD SCI USA, V90, P492, DOI 10.1073/pnas.90.2.492; LANE PW, 1966, J HERED, V57, P181; Leibl MA, 1999, GUT, V44, P246, DOI 10.1136/gut.44.2.246; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Nataf V, 1996, P NATL ACAD SCI USA, V93, P9645, DOI 10.1073/pnas.93.18.9645; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Rhim H, 2000, GENOME RES, V10, P17; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shin MK, 1997, P NATL ACAD SCI USA, V94, P13105, DOI 10.1073/pnas.94.24.13105; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; VAN BT, 1995, NATURE, V376, P781; WEBSTER W, 1974, ARCH PATHOL, V97, P111; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	37	209	217	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					237	244		10.1038/ng998	http://dx.doi.org/10.1038/ng998			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355085				2022-12-27	WOS:000178311100011
J	Park, JH; Cosgrove, MS; Youngman, E; Wolberger, C; Boeke, JD				Park, JH; Cosgrove, MS; Youngman, E; Wolberger, C; Boeke, JD			A core nucleosome surface crucial for transcriptional silencing	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; RIBOSOMAL DNA; YEAST; ACETYLATION; DOMAINS; SIR2; DEACETYLASE; REPRESSION; HISTONE-H4; PARTICLE	Transcriptional silencing in yeast provides a genetically tractable system for analyzing the formation and maintenance of heterochromatin, a transcriptionally repressive chromatin structure found in all organisms. The nucleosome constitutes the central structure of chromatin and comprises two chains each of histones H2A, H2B, H3 and H4. The structure of the nucleosome consists of a central globular core surrounded by outwardly protruding amino-terminal histone tails. We show that a specific surface of the assembled nucleosome core is required for silencing in yeast. This surface is located at a H3/H4 histone-fold motif and contains amino-acid side chains located on the nucleosome disk surface and on an adjacent surface that interacts with DNA. The side chains, identified from mutants in which all three forms of silencing (rDNA, telomere and silent mating locus silencing) are eliminated, are centered around Lys79 of histone H3, a residue methylated by the yeast Dot1 protein(1,2). Moreover, mutations in the genes encoding H3 (HHT1 and HHT2) and H4 (HHF1 and HHF2) mapping to spatially adjacent amino-acid residues affected the three forms of silencing distinctly, suggesting that specific interactions mediate each form of silencing. Several of the mutations that we identified resemble those in a cluster of previously identified mutations affecting a distinct histone-fold motif elsewhere in the nucleosome core. These two clusters relieve distinct forms of transcriptional repression (silencing versus repression resulting from lack of Swi/Snf chromatin remodeling activity).	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.		Youngman, Elaine/O-7449-2019	Wolberger, Cynthia/0000-0001-8578-2969; Boeke, Jef/0000-0001-5322-4946				BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Cockell MM, 2000, GENETICS, V154, P1069; DELANO WL, 2002, PYMOL MOL GRAPHICS; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, GENE DEV, V14, P1021; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Reynolds A., 1997, CURRENT PROTOCOLS MO; SIKORSKI RS, 1989, GENETICS, V122, P19; Singer MS, 1998, GENETICS, V150, P613; SINGH D, 1994, INDIAN J CHEM TECHN, V1, P266; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207	32	102	103	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					273	279		10.1038/ng982	http://dx.doi.org/10.1038/ng982			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244315				2022-12-27	WOS:000178311100016
J	Hoogenraad, CC; Koekkoek, B; Akhmanova, A; Krugers, H; Dortland, B; Miedema, M; van Alphen, A; Kistler, WM; Jaegle, M; Koutsourakis, M; Van Camp, N; Verhoye, M; van der Linden, A; Kaverina, I; Grosveld, F; De Zeeuw, CI; Galjart, N				Hoogenraad, CC; Koekkoek, B; Akhmanova, A; Krugers, H; Dortland, B; Miedema, M; van Alphen, A; Kistler, WM; Jaegle, M; Koutsourakis, M; Van Camp, N; Verhoye, M; van der Linden, A; Kaverina, I; Grosveld, F; De Zeeuw, CI; Galjart, N			Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice	NATURE GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; BEUREN-SYNDROME; IN-VIVO; MUTANT MICE; PROTEIN; 7Q11.23; GENE; DELETION; BRAIN; FEAR	Williams syndrome is a neurodevelopmental disorder caused by the hemizygous deletion of 1.6 Mb on human chromosome 7q11.23. This region comprises the gene CYLN2, encoding CLIP-115, a microtubule-binding protein of 115 kD. Using a gene-targeting approach, we provide evidence that mice with haploinsufficiency for Cyln2 have features reminiscent of Williams syndrome, including mild growth deficiency, brain abnormalities, hippocampal dysfunction and particular deficits in motor coordination. Absence of CLIP-115 also leads to increased levels of CLIP-170 (a closely related cytoplasmic linker protein) and dynactin at the tips of growing microtubules. This protein redistribution may affect dynein motor regulation and, together with the loss of CLIP-115-specific functions, underlie neurological alterations in Williams syndrome.	Erasmus Univ, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, MGC Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1012 WX Amsterdam, Netherlands; Univ Antwerp, RUCA, Bioimaging Lab, B-2020 Antwerp, Belgium; Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria	Erasmus University Rotterdam; Erasmus University Rotterdam; University of Amsterdam; University of Antwerp; Austrian Academy of Sciences	Galjart, N (corresponding author), Erasmus Univ, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	dezeeuw@anat.fgg.eur.nl; galjart@ch1.fgg.eur.nl	Galjart, Niels/D-1146-2010; Van Camp, Nadja/AAC-4357-2019; Akhmanova, Anna S/B-8896-2011; Hoogenraad, Casper/B-8866-2011; Van der Linden, Annemie/L-7855-2017; Van Camp, Nadja/H-5141-2017	Galjart, Niels/0000-0003-1964-3607; Van Camp, Nadja/0000-0002-2261-7314; Akhmanova, Anna S/0000-0002-9048-8614; Hoogenraad, Casper/0000-0002-2666-0758; Van der Linden, Annemie/0000-0003-2941-6520; Van Camp, Nadja/0000-0002-2261-7314; Verhoye, Marleen/0000-0002-6267-0611				Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; ARMSTRONG DM, 1986, PROG NEUROBIOL, V26, P273, DOI 10.1016/0301-0082(86)90021-3; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Bloedel JR, 1981, HDB PHYSL, VII, P735; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Coquelle FM, 2002, MOL CELL BIOL, V22, P3089, DOI 10.1128/MCB.22.9.3089-3102.2002; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Franceschi S., 1996, Journal of Epidemiology and Biostatistics, V1, P59; Francke U, 1999, HUM MOL GENET, V8, P1947, DOI 10.1093/hmg/8.10.1947; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Hoogenraad CC, 1998, GENOMICS, V53, P348, DOI 10.1006/geno.1998.5529; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kooy RF, 1999, EUR J HUM GENET, V7, P526, DOI 10.1038/sj.ejhg.5200348; Krugers HJ, 1997, NEUROREPORT, V8, P2505, DOI 10.1097/00001756-199707280-00018; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; OLSON TM, 1995, HUM MOL GENET, V4, P1677, DOI 10.1093/hmg/4.9.1677; Osborne LR, 1999, MOL GENET METAB, V67, P1, DOI 10.1006/mgme.1999.2844; Osborne LR, 1996, GENOMICS, V36, P328, DOI 10.1006/geno.1996.0469; PANKAU R, 1992, EUR J PEDIATR, V151, P751, DOI 10.1007/BF01959084; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmitt JE, 2001, DEV MED CHILD NEUROL, V43, P155, DOI 10.1017/S0012162201000305; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Sijbers J, 1997, MAGN RESON IMAGING, V15, P679, DOI 10.1016/S0730-725X(97)00033-7; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Tarantino LM, 2000, MAMM GENOME, V11, P555, DOI 10.1007/s003350010107; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vaughan KT, 1999, J CELL SCI, V112, P1437; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; YUAN C, 1993, JMRI-J MAGN RESON IM, V3, P894, DOI 10.1002/jmri.1880030617	49	126	129	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					116	127		10.1038/ng954	http://dx.doi.org/10.1038/ng954			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12195424				2022-12-27	WOS:000177714900010
J	Cheung, I; Schertzer, M; Rose, A; Lansdorp, PM				Cheung, I; Schertzer, M; Rose, A; Lansdorp, PM			Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA	NATURE GENETICS			English	Article							ORIENTATION-DEPENDENT INSTABILITY; C-ELEGANS; SECONDARY STRUCTURE; SYNDROME HELICASE; ESCHERICHIA-COLI; REPEATS EXHIBIT; LAGGING-STRAND; G4 DNA; REPLICATION; GERMLINE	Genetic integrity is crucial to normal cell function, and mutations in genes required for DNA replication and repair underlie various forms of genetic instability and disease, including cancer(1). One structural feature of intact genomes is runs of homopolymeric dC/dG. Here we describe an unusual mutator phenotype in Caenorhabditis elegans characterized by deletions that start around the 3' end of polyguanine tracts and terminate at variable positions 5' from such tracts. We observed deletions throughout genomic DNA in about half of polyguanine tracts examined, especially those containing 22 or more consecutive guanine nucleotides. The mutator phenotype results from disruption of the predicted gene F33H2.1, which encodes a protein with characteristics of a DEAH helicase and which we have named dog-1 (for deletions of guanine-rich DNA). Nematodes mutated in dog-1 showed germline as well as somatic deletions in genes containing polyguanine tracts, such as vab-1. We propose that DOG-1 is required to resolve the secondary structures of guanine-rich DNA that occasionally form during lagging-strand DNA synthesis.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Lansdorp, PM (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	plansdor@bccancer.bc.ca		Lansdorp, Peter/0000-0001-7435-1071				Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; BORK P, 1993, NUCLEIC ACIDS RES, V21, P751, DOI 10.1093/nar/21.3.751; BRENNER S, 1974, GENETICS, V77, P71; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Dalgaard JZ, 2001, GENE DEV, V15, P2060, DOI 10.1101/gad.200801; Degtyareva NP, 2002, P NATL ACAD SCI USA, V99, P2158, DOI 10.1073/pnas.032671599; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; FOLFSMEIER ML, 2001, GENETICS, V157, P1569; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hirst MC, 1998, NUCLEIC ACIDS RES, V26, P2353, DOI 10.1093/nar/26.10.2353; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Seydoux G, 2001, INT REV CYTOL, V203, P139; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Wicky C, 1996, P NATL ACAD SCI USA, V93, P8983, DOI 10.1073/pnas.93.17.8983; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; ZETKA MC, 1995, GENETICS, V141, P1339	28	215	220	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					405	409		10.1038/ng928	http://dx.doi.org/10.1038/ng928			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12101400				2022-12-27	WOS:000177147100017
J	Mukai, J; Liu, H; Burt, RA; Swor, DE; Lai, WS; Karayiorgou, M; Gogos, JA				Mukai, J; Liu, H; Burt, RA; Swor, DE; Lai, WS; Karayiorgou, M; Gogos, JA			Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia	NATURE GENETICS			English	Article							INTRON RETENTION; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; HAPLOTYPE; LOCUS	Using a relatively dense genetic map of 72 single-nucleotide polymorphisms (SNPs) distributed across the entire 1.5-Mb locus on chromosome 22q11 associated with susceptibilit to schizophrenia(1,2), we previously identified two subregions that were consistently associated with the disease(3,4). In the distal subregion, we detected an association signal with five neighboring SNPs distributed over a haplotypic block of 80 kb encompassing six known genes(4). One of these five SNPs, rs175174, had the strongest association of all 72 SNPs that we tested. Here we show that rs175174 regulates the level of the fully functional transcript by modulating the retention of intron 4 of the gene ZDHHC8, which encodes a putative transmembrane palmitoyltransferase. Zdhhc8-knockout mice had a sexually dimorphic deficit in prepulse inhibition, a gene dosage dependent decrease in exploratory activity in a new environment and a decreased sensitivity to the locomotor stimulatory effects of the psychomimetic drug dizocilpine (MK801). SNP rs175174 shows differences in transmission distortion between sexes in individuals with schizophrenia. Our results indicate that there is an unexpected connection between impaired palmitate modification of neuronal proteins and the psychiatric phenotypes associated with microdeletions of chromosome 22q11.	Rockefeller Univ, Human Neurogenet Lab, New York, NY 10021 USA; Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Rockefeller University; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Rockefeller Univ, Human Neurogenet Lab, 1230 York Ave, New York, NY 10021 USA.	karayim@rockefeller.edu; jag90@columbia.edu	Burt, Rachel/I-7874-2012	Burt, Rachel/0000-0001-8827-8266; Lai, Wen-Sung/0000-0001-6918-5531; Mukai, Jun/0000-0003-2065-4784				Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; D'Souza DN, 1999, NEUROSCIENCE, V93, P1539, DOI 10.1016/S0306-4522(99)00229-8; DIRKSEN WP, 1995, J BIOL CHEM, V270, P5346, DOI 10.1074/jbc.270.10.5346; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Huang YQ, 1996, MOL CELL BIOL, V16, P6046; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kienzle N, 1999, J VIROL, V73, P1195, DOI 10.1128/JVI.73.2.1195-1204.1999; Konnecke R, 2000, SCHIZOPHR RES, V44, P81, DOI 10.1016/S0920-9964(99)00139-5; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Li T, 2004, AM J MED GENET B, V129B, P13, DOI 10.1002/ajmg.b.30049; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; LOBO S, 2002, J BIOL CHEM, V277, P41628; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326	29	244	258	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					725	731		10.1038/ng1375	http://dx.doi.org/10.1038/ng1375			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15184899	Bronze			2022-12-27	WOS:000222354100023
J	Rosenbauer, F; Wagner, K; Kutok, JL; Iwasaki, H; Le Beau, MM; Okuno, Y; Akashi, K; Fiering, S; Tenen, DG				Rosenbauer, F; Wagner, K; Kutok, JL; Iwasaki, H; Le Beau, MM; Okuno, Y; Akashi, K; Fiering, S; Tenen, DG			Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1	NATURE GENETICS			English	Article							COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; C/EBP-ALPHA; TRANSGENIC MICE; DIFFERENTIATION; MUTATIONS; GENE; PROGENITORS; MYC; ABNORMALITIES	Transcription factors are believed to have a dominant role in acute myeloid leukemia (AML). This idea is supported by analysis of gene-knockout mice, which uncovered crucial roles of several transcription factors in normal hematopoiesis(1), and of individuals with leukemia, in whom transcription factors are frequently downregulated or mutated(2). However, analysis of knockout animals has not shown a direct link between abrogated transcription factors and the pathogenesis of AML. Sfpi1, encoding the lineage-specific transcription factor PU.1, is indispensable for normal myeloid and lymphoid development(3,4). We found that mice carrying hypomorphic Sfpi1 alleles that reduce PU.1 expression to 20% of normal levels, unlike mice carrying homo- or heterozygous deletions of Sfpi1, developed AML. Unlike complete or 50% loss, 80% loss of PU.1 induced a precancerous state characterized by accumulation of an abnormal precursor pool retaining responsiveness to G-CSF with disruption of M- and GM-CSF pathways. Malignant transformation was associated with a high frequency of clonal chromosomal changes. Retroviral restoration of PU.1 expression rescued myeloid differentiation of mutant progenitors and AML blasts. These results suggest that tightly graded reduction, rather than complete loss, of a lineage-indispensable transcription factor can induce AML.	Harvard Univ, Inst Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Canc Immunol & AIDS, Boston, MA 02115 USA; Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH 03756 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Chicago; Dartmouth College	Tenen, DG (corresponding author), Harvard Univ, Inst Med, Room 954,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu		Tenen, Daniel/0000-0002-6423-3888; Fiering, Steven/0000-0003-0624-974X; Rosenbauer, Frank/0000-0001-7977-9421	NCI NIH HHS [P30 CA023108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Duprez EA, 2002, BLOOD, V100, p61A; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Iwama A, 1998, NUCLEIC ACIDS RES, V26, P3034, DOI 10.1093/nar/26.12.3034; Iwasaki-Arai J, 2002, BLOOD, V100, p61A; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	30	405	412	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					624	630		10.1038/ng1361	http://dx.doi.org/10.1038/ng1361			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15146183	Bronze			2022-12-27	WOS:000221763700021
J	Tonkin, ET; Wang, TJ; Lisgo, S; Bamshad, MJ; Strachan, T				Tonkin, ET; Wang, TJ; Lisgo, S; Bamshad, MJ; Strachan, T			NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome	NATURE GENETICS			English	Article							BRACHMANN-DELANGE-SYNDROME; DUP(3Q) SYNDROME; EXPRESSION; DROSOPHILA; GENES; BRAIN; DELINEATION; ACTIVATION; PRIMORDIA; DISEASE	Cornelia de Lange syndrome (CdLS) is a multiple malformation disorder characterized by dysmorphic facial features, mental retardation, growth delay and limb reduction defects(1,2). We indentified and characterized a new gene, NIPBL, that is mutated in individuals with CdLS and determined its structure and the structures of mouse, rat and zebrafish homologs. We named its protein product delangin. Vertebrate delangins have substantial homology to orthologs in flies, worms, plants and fungi, including Scc2-type sister chromatid cohesion proteins, and D. melanogaster Nipped-B. We propose that perturbed delangin function may inappropriately activate DLX genes, thereby contributing to the proximodistal limb patterning defects in CdLS. Genome analyses typically identify individual delangin or Nipped-B-like orthologs in diploid animal and plant genomes. The evolution of an ancestral sister chromatid cohesion protein to acquire an additional role in developmental gene regulation suggests that there are parallels between CdLS and Roberts syndrome.	Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Newcastle University - UK; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Strachan, T (corresponding author), Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	tom.strachan@ncl.ac.uk	Tonkin, Emma T/L-8370-2016	Lisgo, Steven/0000-0001-5186-3971; Tonkin, Emma/0000-0001-5759-0927	MRC [G9826762, G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G9826762] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allanson JE, 1997, J MED GENET, V34, P645, DOI 10.1136/jmg.34.8.645; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; IRELAND M, 1991, J MED GENET, V28, P639, DOI 10.1136/jmg.28.9.639; IRELAND M, 1993, AM J MED GENET, V47, P959, DOI 10.1002/ajmg.1320470705; Iulianella A, 2003, GENE EXPR PATTERNS, V3, P571, DOI 10.1016/S1567-133X(03)00123-6; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; KRAJEWSKAWALASEK M, 1995, CLIN GENET, V47, P324; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Luzzani S, 2003, AM J MED GENET A, V119A, P283, DOI 10.1002/ajmg.a.20191; Mehta AV, 1997, AM J MED GENET, V71, P434, DOI 10.1002/(SICI)1096-8628(19970905)71:4<434::AID-AJMG12>3.0.CO;2-H; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Rollins RA, 1999, GENETICS, V152, P577; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rooney DE, 2001, HUMAN CYTOGENETICS C; Russell KL, 2001, AM J MED GENET, V104, P267, DOI 10.1002/ajmg.10066; SATALOFF RT, 1990, ARCH OTOLARYNGOL, V116, P1044; Seitz LC, 1996, GENETICS, V142, P1105; STEINBACH P, 1981, AM J MED GENET, V10, P159, DOI 10.1002/ajmg.1320100210; TONKIN ET, IN PRESS HUM GENET; VANALLEN MI, 1993, AM J MED GENET, V47, P947, DOI 10.1002/ajmg.1320470704; Vuilleumier N, 2002, ACTA NEUROPATHOL, V104, P327, DOI 10.1007/s00401-002-0562-4; WILSON GN, 1985, AM J MED GENET, V22, P117, DOI 10.1002/ajmg.1320220113; WILSON WG, 1983, J MED GENET, V20, P469, DOI 10.1136/jmg.20.6.469; Yamaguchi K, 1999, CLIN NEUROPATHOL, V18, P99	30	436	460	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					636	641		10.1038/ng1363	http://dx.doi.org/10.1038/ng1363			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15146185	Bronze			2022-12-27	WOS:000221763700023
J	Sen, G; Wehrman, TS; Myers, JW; Blau, HM				Sen, G; Wehrman, TS; Myers, JW; Blau, HM			Restriction enzyme-generated siRNA (REGS) vectors and libraries	NATURE GENETICS			English	Article							SHORT-INTERFERING RNAS; DOUBLE-STRANDED-RNA; GENE-EXPRESSION; STEM-CELLS; HAIRPIN RNAS; DIFFERENTIATION; MESSENGER; SYSTEM	Small interfering RNA (siRNA) technology facilitates the study of loss of gene function in mammalian cells and animal models, but generating multiple siRNA vectors using oligonucleotides is slow, inefficient and costly. Here we describe a new, enzyme-mediated method for generating numerous functional siRNA constructs from any gene of interest or pool of genes. To test our restriction enzyme generated siRNA (REGS) system, we silenced a transgene and two endogenous genes and obtained the predicted phenotypes. REGS generated on average 34 unique siRNAs per kilobase of sequence. REGS enabled us to create enzymatically a complex siRNA library (>4x10(5) clones) from double-stranded cDNA encompassing known and unknown genes with 96% of the clones containing inserts of the appropriate size.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 269 Campus Dr,CCSR 4225A, Stanford, CA 94305 USA.	hblau@stanford.edu						BOYD AC, 1986, NUCLEIC ACIDS RES, V14, P5255, DOI 10.1093/nar/14.13.5255; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P670, DOI 10.1093/nar/gkg141; Detter JC, 2002, GENOMICS, V80, P691, DOI 10.1006/geno.2002.7020; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shi Y, 2003, TRENDS GENET, V19, P9, DOI 10.1016/S0168-9525(02)00005-7; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	28	117	133	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					183	189		10.1038/ng1288	http://dx.doi.org/10.1038/ng1288			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14704668	Bronze			2022-12-27	WOS:000188542700022
J	Baxendale, S; Davison, C; Muxworthy, C; Wolff, C; Ingham, PW; Roy, S				Baxendale, S; Davison, C; Muxworthy, C; Wolff, C; Ingham, PW; Roy, S			The B-cell maturation factor Blimp-1 specifies vertebrate slow-twitch muscle fiber identity in response to Hedgehog signaling	NATURE GENETICS			English	Article							ZEBRAFISH EMBRYO; SOMITE FORMATION; SONIC HEDGEHOG; PLASMA-CELLS; EXPRESSION; REPRESSION; DIFFERENTIATION; PROTEIN; IDENTIFICATION; INDUCTION	Vertebrate skeletal muscles comprise distinct fiber types that differ in their morphology, contractile function, mitochondrial content and metabolic properties. Recent studies identified the transcriptional coactivator PGC-1 as a key mediator of the physiological stimuli that modulate fiber-type plasticity in postembryonic development(1). Although myoblasts become fated to differentiate into distinct kinds of fibers early in development, the identities of regulatory proteins that determine embryonic fiber-type specification are still obscure. Here we show that the gene u-boot (ubo), a mutation in which disrupts the induction of embryonic slow-twitch fibers(2), encodes the zebrafish homolog of Blimp-1, a SET domain containing transcription factor that promotes the terminal differentiation of B lymphocytes in mammals(3). Expression of ubo is induced by Hedgehog (Hh) signaling in prospective slow muscle precursors, and its activity alone is sufficient to direct slow-twitch fiber specific development by naive myoblasts. Our data provide the first molecular insight into the mechanism by which a specific group of muscle precursors is driven along a distinct pathway of fiber-type differentiation in response to positional cues in the vertebrate embryo.	Univ Sheffield, Sch Med & Biomed Sci, Ctr Dev Genet, MRC Intecellular Signaling Grp, Sheffield S10 2TN, S Yorkshire, England; Inst Mol & Cell Biol, Singapore 117609, Singapore	University of Sheffield; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ingham, PW (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Ctr Dev Genet, MRC Intecellular Signaling Grp, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.		Ingham, Philip W/G-9903-2011; Ingham, Philip William/AAH-5884-2020; Ingham, Philip W/E-6710-2010	Ingham, Philip W/0000-0001-8224-9958; Ingham, Philip William/0000-0001-8224-9958; Baxendale, Sarah/0000-0002-6760-9457	MRC [G0100151] Funding Source: UKRI; Medical Research Council [G0100151] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Borycki AG, 1998, DEVELOPMENT, V125, P777; Chang DH, 2002, MECH DEVELOP, V117, P305, DOI 10.1016/S0925-4773(02)00189-2; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; de Souza FSJ, 1999, EMBO J, V18, P6062, DOI 10.1093/emboj/18.21.6062; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Talbot WS, 1999, METHOD CELL BIOL, V60, P259; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	29	147	150	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					88	93		10.1038/ng1280	http://dx.doi.org/10.1038/ng1280			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702044	Bronze			2022-12-27	WOS:000187666800019
J	Katayama, H; Sasai, K; Kawai, H; Yuan, ZM; Bondaruk, J; Suzuki, F; Fujii, S; Arlinghaus, RB; Czerniak, BA; Sen, S				Katayama, H; Sasai, K; Kawai, H; Yuan, ZM; Bondaruk, J; Suzuki, F; Fujii, S; Arlinghaus, RB; Czerniak, BA; Sen, S			Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53	NATURE GENETICS			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; TUMOR AMPLIFIED KINASE; PROLYL ISOMERASE PIN1; CENTROSOME AMPLIFICATION; CELL-DIVISION; DNA-BINDING; PROTEIN; GENE; REGULATOR; REQUIRES	Aurora kinase A (also called STK15 and BTAK) is overexpressed in many human cancers. Ectopic overexpression of aurora kinase A in mammalian cells induces centrosome amplification, chromosome instability and oncogenic transformation, a phenotype characteristic of loss-of-function mutations of p53. Here we show that aurora kinase A phosphorylates p53 at Ser315, leading to its ubiquitination by Mdm2 and proteolysis. p53 is not degraded in the presence of inactive aurora kinase A or ubiquitination-defective Mdm2. Destabilization of p53 by aurora kinase A is abrogated in the presence of mutant Mdm2 that is unable to bind p53 and after repression of Mdm2 by RNA interference. Silencing of aurora kinase A results in less phosphorylation of p53 at Ser315, greater stability of p53 and cell-cycle arrest at G2-M. Cells depleted of aurora kinase A are more sensitive to cisplatin-induced apoptosis, and elevated expression of aurora kinase A abolishes this response. In a sample of bladder tumors with wildtype p53, elevated expression of aurora kinase A was correlated with low p53 concentration. We conclude that aurora kinase A is a key regulatory component of the p53 pathway and that overexpression of aurora kinase A leads to increased degradation of p53, causing downregulation of checkpoint-response pathways and facilitating oncogenic transformation of cells.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA; Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima 7348553, Japan; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Hiroshima University; University of Texas System; UTMD Anderson Cancer Center	Sen, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Div Pathol & Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	ssen@mail.mdanderson.org	高, 雨莉/HGU-8187-2022	Kawai, Hidehiko/0000-0003-2213-7166				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; CHAN CSM, 1993, GENETICS, V135, P677; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giet R, 1999, J CELL SCI, V112, P3591; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goepfert TM, 2000, CURR TOP DEV BIOL, V49, P331; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kiat LS, 2002, J BIOL CHEM, V277, P45558, DOI 10.1074/jbc.M206820200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu JX, 1996, MOL CELL BIOL, V16, P998; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Sen S, 1997, P NATL ACAD SCI USA, V94, P6164, DOI 10.1073/pnas.94.12.6164; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shaw P, 1996, ONCOGENE, V12, P921; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Shieh SY, 2000, GENE DEV, V14, P289; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Tanaka T, 1999, CANCER RES, V59, P2041; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	48	474	502	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					55	62		10.1038/ng1279	http://dx.doi.org/10.1038/ng1279			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702041	Bronze			2022-12-27	WOS:000187666800014
J	Otto, EA; Schermer, B; Obara, T; O'Toole, JF; Hiller, KS; Mueller, AM; Ruf, RG; Hoefele, J; Beekmann, F; Landau, D; Foreman, JW; Goodship, JA; Strachan, T; Kispert, A; Wolf, MT; Gagnadoux, MF; Nivet, H; Antignac, C; Walz, G; Drummond, IA; Benzing, T; Hildebrandt, F				Otto, EA; Schermer, B; Obara, T; O'Toole, JF; Hiller, KS; Mueller, AM; Ruf, RG; Hoefele, J; Beekmann, F; Landau, D; Foreman, JW; Goodship, JA; Strachan, T; Kispert, A; Wolf, MT; Gagnadoux, MF; Nivet, H; Antignac, C; Walz, G; Drummond, IA; Benzing, T; Hildebrandt, F			Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; ADOLESCENT NEPHRONOPHTHISIS; CANDIDATE GENE; SITUS-INVERSUS; PROTEIN; INTERACTS; NEPHROCYSTIN; IDENTIFICATION; PROGRESSION; PATHWAY	Nephronophthisis (NPHP), an autosomal recessive cystic kidney disease, leads to chronic renal failure in children. The genes mutated in NPHP1 and NPHP4 have been identified, and a gene locus associated with infantile nephronophthisis (NPHP2) was mapped. The kidney phenotype of NPHP2 combines clinical features of NPHP and polycystic kidney disease (PKD). Here, we identify inversin (INVS) as the gene mutated in NPHP2 with and without situs inversus. We show molecular interaction of inversin with nephrocystin, the product of the gene mutated in NPHP1 and interaction of nephrocystin with beta-tubulin, a main component of primary cilia. We show that nephrocystin, inversin and beta-tubulin colocalize to primary cilia of renal tubular cells. Furthermore, we produce a PKD-like renal cystic phenotype and randomization of heart looping by knockdown of invs expression in zebrafish. The interaction and colocalization in cilia of inversin, nephrocystin and beta-tubulin connect pathogenetic aspects of NPHP to PKD, to primary cilia function and to left-right axis determination.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Hosp Freiburg, Div Renal, Freiburg, Germany; Univ Hosp Freiburg, Clin Res Ctr, Freiburg, Germany; Massachusetts Gen Hosp, Renal Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA 02129 USA; Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Hannover Med Sch, Inst Mol Biol, Hannover, Germany; Univ Paris 05, Necker Hosp, Dept Pediat Nephrol, Paris, France; Univ Paris 05, Necker Hosp, INSERM, U574, Paris, France; CHU Tours, Chambray Les Tours, France; Inst Reg Sante, Chambray Les Tours, France; Univ Paris 05, Necker Hosp, Dept Genet, Paris, France; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Freiburg; University of Freiburg; Harvard University; Massachusetts General Hospital; Harvard University; Ben Gurion University; Soroka Medical Center; Duke University; Newcastle University - UK; Hannover Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, 8220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Hoefele, Julia/AAB-6448-2020; Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019; ANTIGNAC, Corinne/H-8945-2017	Hoefele, Julia/0000-0002-7917-7129; Schermer, Bernhard/0000-0002-5194-9000; Otto, Edgar/0000-0002-2387-9973; ANTIGNAC, Corinne/0000-0002-9934-4940	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069604, R01DK078209] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK069604, R01 DK078209] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Benzing T, 2000, J BIOL CHEM, V275, P28167; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Calvet JP, 2003, NAT GENET, V33, P113, DOI 10.1038/ng1078; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Drummond IA, 1998, DEVELOPMENT, V125, P4655; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; GAGNADOUX MF, 1989, PEDIATR NEPHROL, V3, P50, DOI 10.1007/BF00859626; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; HIDLEBRANDT F, 1999, PEDIAT NEPHROLOGY; Hildebrandt F, 2000, J AM SOC NEPHROL, V11, P1753, DOI 10.1681/ASN.V1191753; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kuida S, 2000, GENOME RES, V10, P49; McQuinn TC, 2001, ANAT RECORD, V263, P62, DOI 10.1002/ar.1077; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SMITH CH, 1945, AM J DIS CHILD, V69, P369; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; WOO DDL, 1994, NATURE, V368, P750, DOI 10.1038/368750a0; Woo DDL, 1997, KIDNEY INT, V51, P1613, DOI 10.1038/ki.1997.222; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Zeisberg M, 2001, CURR OPIN NEPHROL HY, V10, P315, DOI 10.1097/00041552-200105000-00004	49	460	479	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					413	420		10.1038/ng1217	http://dx.doi.org/10.1038/ng1217			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12872123	Green Accepted			2022-12-27	WOS:000184470500019
J	Conant, GC; Wagner, A				Conant, GC; Wagner, A			Convergent evolution of gene circuits	NATURE GENETICS			English	Article							EXPRESSION PATTERNS; ADAPTIVE EVOLUTION; DUPLICATE GENES; NETWORK MOTIFS; YEAST	Convergent evolution is a potent indicator of optimal design. We show here that convergent evolution occurs in genetic networks. Specifically, we show that multiple types of transcriptional regulation circuitry in Escherichia coli and the yeast Saccharomyces cerevisiae have evolved independently and not by duplication of one or a few ancestral circuits.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Wagner, A (corresponding author), Univ New Mexico, Dept Biol, 167 Castetter Hall, Albuquerque, NM 87131 USA.		Conant, Gavin/R-7022-2019; Yang, Chen/G-1379-2010	Conant, Gavin/0000-0002-8677-4933; 				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Gould S. J., 1989, WONDERFUL LIFE BURGE; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; Wagner A, 2000, P NATL ACAD SCI USA, V97, P6579, DOI 10.1073/pnas.110147097; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913	15	131	137	3	20	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					264	266		10.1038/ng1181	http://dx.doi.org/10.1038/ng1181			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12819781				2022-12-27	WOS:000183815300012
J	Jones, B; Jones, EL; Bonney, SA; Patel, HN; Mensenkamp, AR; Eichenbaum-Voline, S; Rudling, M; Myrdal, U; Annesi, G; Naik, S; Meadovvs, N; Quattrone, A; Islam, SA; Naoumova, RP; Angelin, B; Infante, R; Levy, E; Roy, CC; Freemont, PS; Scott, J; Shoulders, CC				Jones, B; Jones, EL; Bonney, SA; Patel, HN; Mensenkamp, AR; Eichenbaum-Voline, S; Rudling, M; Myrdal, U; Annesi, G; Naik, S; Meadovvs, N; Quattrone, A; Islam, SA; Naoumova, RP; Angelin, B; Infante, R; Levy, E; Roy, CC; Freemont, PS; Scott, J; Shoulders, CC			Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders	NATURE GENETICS			English	Article							CHYLOMICRON RETENTION DISEASE; ENDOPLASMIC-RETICULUM; ANDERSONS-DISEASE; APOPROTEIN-B; TRANSPORT; PROTEINS; COAT; BINDING; EXPORT	Dietary fat is an important source of nutrition. Here we identify eight mutations in SARA2 that are associated with three severe disorders of fat malabsorption. The Sar1 family of proteins initiates the intracellular transport of proteins in COPII (coat protein)-coated vesicles. Our data suggest that chylomicrons, which vastly exceed the size of typical COPII vesicles, are selectively recruited by the COPII machinery for transport through the secretory pathways of the cell.	Univ London Imperial Coll Sci Technol & Med, Genom & Mol Med Grp, MRC, Ctr Clin Sci, London, England; Huddinge Univ Hosp, Ctr Metab & Endocrinol, Karolinska Inst, Stockholm, Sweden; Huddinge Univ Hosp, Ctr Nutr & Toxicol, Karolinska Inst, Stockholm, Sweden; Cent Hosp Vasteras, Dept Paediat, Vasteras, Sweden; CNR, Inst Neurol Sci, Piano Lago Of Mangone, Consenza, Italy; Barts & London, Dept Adult & Paediat Gastroenterol, Queen Marys Sch Med & Dent, London, England; Univ London Imperial Coll Sci Technol & Med, Struct Bioinformat Grp, London, England; INSERM, Ctr Rech, Paris 12, France; Univ Montreal, Ctr Rech, Hop St Justine, Montreal, PQ H3C 3J7, Canada; Univ London Imperial Coll Sci Technol & Med, Ctr Struct Biol, Dept Sci Biol, London, England; Univ London Imperial Coll Sci Technol & Med, Genet & Genom Res Inst, London, England	Imperial College London; Karolinska Institutet; Karolinska Institutet; Vasteras Central Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); University of London; Queen Mary University London; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Imperial College London; University of London; Institute of Cancer Research - UK; Imperial College London	Scott, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Genom & Mol Med Grp, MRC, Ctr Clin Sci, London, England.		Mensenkamp, Arjen/L-4520-2015; Annesi, Grazia/AAX-5732-2020; QUATTRONE, Aldo/A-6734-2016	Mensenkamp, Arjen/0000-0003-3805-877X; Freemont, Paul/0000-0002-5658-8486; QUATTRONE, Aldo/0000-0003-2001-957X				Aguglia U, 2000, ANN NEUROL, V47, P260, DOI 10.1002/1531-8249(200002)47:2<260::AID-ANA21>3.0.CO;2-V; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BOUMA ME, 1986, J CLIN INVEST, V78, P398, DOI 10.1172/JCI112590; Dannoura AH, 1999, ARTERIOSCL THROM VAS, V19, P2494, DOI 10.1161/01.ATV.19.10.2494; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; NEMETH A, 1995, EUR J CLIN INVEST, V25, P271, DOI 10.1111/j.1365-2362.1995.tb01559.x; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; ROY CC, 1987, GASTROENTEROLOGY, V92, P390, DOI 10.1016/0016-5085(87)90133-8; Saito Y, 1998, J BIOCHEM-TOKYO, V124, P816, DOI 10.1093/oxfordjournals.jbchem.a022185; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153	15	260	266	2	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					29	31		10.1038/ng1145	http://dx.doi.org/10.1038/ng1145			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692552				2022-12-27	WOS:000182667900012
J	Saze, H; Scheid, OM; Paszkowski, J				Saze, H; Scheid, OM; Paszkowski, J			Maintenance of CpG methylation is essential for epigenetic inheritance during plant gametogenesis	NATURE GENETICS			English	Article							HISTONE H3 METHYLTRANSFERASE; DNA METHYLATION; ARABIDOPSIS-THALIANA; GENE; MUTANTS; CHROMOMETHYLASE3; IDENTIFICATION; FERTILIZATION; EXPRESSION; MUTATIONS	In mammals, the DNA methyltransferase 1 (Dnmt1) faithfully copies the pattern of cytosine methylation at CpG sites to the newly synthesized strand, and this is essential for epigenetic inheritance(1). In Arabidopsis thaliana, several DNA methyltransferases or chromatin modifiers coupled to methylation changes have been characterized, and mutations that cause loss of their function are recessive(2-7). This is surprising because plant gametogenesis includes postmeiotic DNA replication in haploid nuclei before fertilization. Therefore, the recessive character of the mutations excludes the affected components from a regulatory role in postmeiotic maintenance or modification of epigenetic states. Here we show, however, that depletion of A. thaliana MET1, a homolog of mammalian Dnmt1 (ref. 8), results in immense epigenetic diversification of gametes. This diversity seems to be a consequence of passive postmeiotic demethylation, leading to gametes with fully demethylated and hemidemethylated DNA, followed by remethylation of hemimethylated templates once. MET1 is again-supplied in a zygote.	Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Saze, H (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	saze@fmi.ch	Saze, Hidetoshi/B-5922-2015	Saze, Hidetoshi/0000-0002-8647-1430; Mittelsten Scheid, Ortrun/0000-0002-7757-4809				Adams S, 2000, DEVELOPMENT, V127, P2493; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Friedman WE, 1999, DEVELOPMENT, V126, P1065; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Genger RK, 1999, PLANT MOL BIOL, V41, P269, DOI 10.1023/A:1006347010369; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kakutani T, 1999, GENETICS, V151, P831; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; KANKEL MW, IN PRESS GENETICS; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Murfett J, 2001, PLANT CELL, V13, P1047, DOI 10.1105/tpc.13.5.1047; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	30	356	390	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					65	69		10.1038/ng1138	http://dx.doi.org/10.1038/ng1138			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12669067				2022-12-27	WOS:000182667900018
J	Mager, J; Montgomery, ND; de Villena, FPM; Magnuson, T				Mager, J; Montgomery, ND; de Villena, FPM; Magnuson, T			Genome imprinting regulated by the mouse Polycomb group protein Eed	NATURE GENETICS			English	Article							HISTONE H3 METHYLTRANSFERASE; BECKWITH-WIEDEMANN-SYNDROME; DNA METHYLATION; CHROMATIN; DROSOPHILA; MICE; GENE; ASSOCIATION; REPRESSION; COMPLEXES	Epigenetic regulation is essential for temporal, tissue-specific and parent-of-origin-dependent gene expression. It has recently been found that the mouse Polycomb group (PcG) gene Eed (embryonic ectoderm development) acts to maintain repression of the imprinted X chromosome. Here, we investigated whether Eed is also required for regulation of autosomal imprinted loci. Expression analyses showed that transcripts from the silent alleles of a subset of paternally repressed genes were present in Eed(-/-) embryos. Parent-of-origin methylation was preserved in these embryos, but we observed changes in the methylation status of specific CpGs in differentially methylated regions (DMRs) at affected but not at unaffected loci. These data identify Eed as a member of a new class of trans-acting factors that regulate parent-of-origin expression at imprinted loci.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, 103 Mason Farm Rd, Chapel Hill, NC 27599 USA.			Montgomery, Nathan/0000-0003-1765-6623				Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; FAUST C, 1995, DEVELOPMENT, V121, P273; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Goll MG, 2002, GENE DEV, V16, P1739, DOI 10.1101/gad.1013902; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; PIRROTTA V, 1995, CURR OPIN GENET DEV, V5, P466, DOI 10.1016/0959-437X(95)90050-Q; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Schofield PN, 2001, TOXICOL LETT, V120, P151, DOI 10.1016/S0378-4274(01)00294-6; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	30	205	211	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					502	507		10.1038/ng1125	http://dx.doi.org/10.1038/ng1125			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12627233	Bronze			2022-12-27	WOS:000181928600022
J	Nicolas, M; Wolfer, A; Raj, K; Kummer, JA; Mill, P; van Noort, M; Hui, CC; Clevers, H; Dotto, GP; Radtke, F				Nicolas, M; Wolfer, A; Raj, K; Kummer, JA; Mill, P; van Noort, M; Hui, CC; Clevers, H; Dotto, GP; Radtke, F			Notch1 functions as a tumor suppressor in mouse skin	NATURE GENETICS			English	Article							NEOPLASTIC TRANSFORMATION; KERATINOCYTE GROWTH; MICE; DIFFERENTIATION; GENE; DETERMINANT; EXPRESSION; HOMOLOG; MAMMARY; GLI	Notch proteins are important in binary cell-fate decisions and inhibiting differentiation in many developmental systems(1), and aberrant Notch signaling is associated with tumorigenesis(2-5). The role of Notch signaling in mammalian skin is less well characterized and is mainly based on in vitro studies, which suggest that Notch signaling induces differentiation in mammalian skin(6,7). Conventional gene targeting is not applicable to establishing the role of Notch receptors or ligands in the skin because Notch1(-/-) embryos die during gestation(8-12). Therefore, we used a tissue-specific inducible gene-targeting approach to study the physiological role of the Notch1 receptor in the mouse epidermis and the corneal epithelium of adult mice. Unexpectedly, ablation of Notch1 results in epidermal and corneal hyperplasia followed by the development of skin tumors and facilitated chemical-induced skin carcinogenesis. Notch1 deficiency in skin and in primary keratinocytes results in increased and sustained expression of Gli2, causing the development of basal-cell carcinoma-like tumors. Furthermore, Notch1 inactivation in the epidermis results in derepressed beta-catenin signaling in cells that should normally undergo differentiation. Enhanced beta-catenin signaling can be reversed by re-introduction of a dominant active form of the Notch1 receptor. This leads to a reduction in the signaling-competent pool of beta-catenin, indicating that Notch1 can inhibit beta-catenin-mediated signaling. Our results indicate that Notch1 functions as a tumor-suppressor gene in mammalian skin.	Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; Univ Toronto, Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; Univ Med Ctr Utrecht, Dept Immunol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; Harvard Med Sch, Charlestown, MA USA	Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute Experimental Cancer Research; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Erasmus University Rotterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts General Hospital	Radtke, F (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland.	Freddy.Radtke@isrec.unil.ch	Radtke, Freddy/Q-3198-2017; Wolfer, Anita/AAK-1720-2021; Mill, Pleasantine/AAE-4718-2019	Radtke, Freddy/0000-0003-4315-4045; Mill, Pleasantine/0000-0001-5218-134X				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Callahan CA, 2001, CURR OPIN GENET DEV, V11, P541, DOI 10.1016/S0959-437X(00)00230-6; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dahmane N, 2001, DEVELOPMENT, V128, P5201; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hamada Y, 1999, DEVELOPMENT, V126, P3415; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Philipp J, 1999, ONCOGENE, V18, P4689, DOI 10.1038/sj.onc.1202840; Polakis P, 2000, GENE DEV, V14, P1837; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Weinberg WC, 1999, CANCER RES, V59, P2050; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414	30	788	849	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					416	421		10.1038/ng1099	http://dx.doi.org/10.1038/ng1099			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590261				2022-12-27	WOS:000181312700022
J	Singh, N; Ebrahimi, FAW; Gimelbrant, AA; Ensminger, AW; Tackett, MR; Qi, PM; Gribnau, J; Chess, A				Singh, N; Ebrahimi, FAW; Gimelbrant, AA; Ensminger, AW; Tackett, MR; Qi, PM; Gribnau, J; Chess, A			Coordination of the random asynchronous replication of autosomal loci	NATURE GENETICS			English	Article							ALLELIC EXCLUSION; EXPRESSION; SYSTEM; GENES; INTERLEUKIN-2; PATTERNS; MOUSE	Random monoallelic expression and asynchronous replication define an unusual class of autosomal mammalian genes. We show that every cell has randomly chosen either the maternal or paternal copy of each given autosome pair, such that alleles of these genes scattered across the chosen chromosome replicate earlier than the alleles on the homologous chromosome. Thus, chromosome-pair non-equivalence, rather than being limited to X-chromosome inactivation, is a fundamental property of mouse chromosomes.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chess, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Ebrahimi, Farzad/Q-8829-2016	Ebrahimi, Farzad/0000-0001-9091-4647; Gimelbrant, Alexander/0000-0001-6986-0285; Ensminger, Alexander/0000-0003-0824-3704				CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Mostoslavsky R, 2001, NATURE, V414, P221, DOI 10.1038/35102606; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	15	85	86	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					339	341		10.1038/ng1102	http://dx.doi.org/10.1038/ng1102			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577058				2022-12-27	WOS:000181312700008
J	Stoeckert, CJ; Causton, HC; Ball, CA				Stoeckert, CJ; Causton, HC; Ball, CA			Microarray databases: standards and ontologies	NATURE GENETICS			English	Editorial Material							EXPRESSION; CANCER; GENES	A single microarray can provide information on the expression of tens of thousands of genes. The amount of information generated by a microarray-based experiment is sufficiently large that no single study can be expected to mine each nugget of scientific information. As a consequence, the scale and complexity of microarray experiments require that computer software programs do much of the data processing, storage, visualization, analysis and transfer. The adoption of common standards and ontologies for the management and sharing of microarray data is essential and will provide immediate benefit to the research community.	Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ London Imperial Coll Sci Technol & Med, Imperial Coll Microarray Ctr, Ctr Clin Sci, London W12 0NN, England; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of Pennsylvania; University of Pennsylvania; Imperial College London; Stanford University	Stoeckert, CJ (corresponding author), Univ Penn, Ctr Bioinformat, 423 Guardian Dr, Philadelphia, PA 19104 USA.	stoeckert@pcbi.upenn.edu		Causton, Helen/0000-0003-4630-6569				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRUBER TR, 1993, KNOWL ACQUIS, V5, P199, DOI 10.1006/knac.1993.1008; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Spellman PT, 2002, GENOME BIOL, V3; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Stoeckert C, 2001, BIOINFORMATICS, V17, P300, DOI 10.1093/bioinformatics/17.4.300; Waddell P J, 2000, Genome Inform Ser Workshop Genome Inform, V11, P129	13	89	97	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			469	473		10.1038/ng1028	http://dx.doi.org/10.1038/ng1028			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454640				2022-12-27	WOS:000179742900005
J	Hao, WS; Wenzel, A; Obin, MS; Chen, CK; Brill, E; Krasnoperova, NV; Eversole-Cire, P; Kleyner, Y; Taylor, A; Simon, MI; Grimm, C; Reme, C; Reme, CE; Lem, J				Hao, WS; Wenzel, A; Obin, MS; Chen, CK; Brill, E; Krasnoperova, NV; Eversole-Cire, P; Kleyner, Y; Taylor, A; Simon, MI; Grimm, C; Reme, C; Reme, CE; Lem, J			Evidence for two apoptotic pathways in light-induced retinal degeneration	NATURE GENETICS			English	Article							STATIONARY NIGHT BLINDNESS; RETINITIS-PIGMENTOSA; RHODOPSIN KINASE; PHOTORECEPTOR APOPTOSIS; MACULAR DEGENERATION; OCULAR PIGMENTATION; VISUAL CYCLE; OGUCHI FORM; CELL-DEATH; VITAMIN-A	Excessive phototransduction signaling is thought to be involved in light-induced and inherited retinal degeneration. Using knockout mice with defects in rhodopsin shut-off and transducin signaling, we show that two different pathways of photoreceptor-cell apoptosis are induced by light. Bright light induces apoptosis that is independent of transducin and accompanied by induction of the transcription factor AP-1. By contrast, low light induces an apoptotic pathway that requires transducin. We also provide evidence that additional genetic factors regulate sensitivity to light-induced damage. Our use of defined mouse mutants resolves some of the complexity underlying the mechanisms that regulate susceptibility to retinal degeneration.	Tufts Univ, New England Med Ctr, Dept Ophthalmol, Boston, MA 02111 USA; Tufts Univ, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Zurich Hosp, Lab Retinal Cell Biol, CH-8091 Zurich, Switzerland; Tufts Univ, Human Nutr Res Ctr Aging, JMUSDA, Nutr & Vis Res Lab, Boston, MA 02111 USA; Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; California Institute of Technology; University of Zurich; University Zurich Hospital; Tufts University; United States Department of Agriculture (USDA); Tufts University; Utah System of Higher Education; University of Utah	Lem, J (corresponding author), Tufts Univ, New England Med Ctr, Dept Ophthalmol, Boston, MA 02111 USA.			Grimm, Christian/0000-0001-9318-4352				Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Bentrop J, 1998, ACTA ANAT, V162, P85; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen J, 1999, INVEST OPHTH VIS SCI, V40, P2978; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514, DOI 10.1001/archopht.1993.01090040106042; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Dillon J, 1996, PHOTOCHEM PHOTOBIOL, V63, P680, DOI 10.1111/j.1751-1097.1996.tb05673.x; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hafezi F, 1999, VISION RES, V39, P2511, DOI 10.1016/S0042-6989(98)00313-7; Keller C, 2001, INVEST OPHTH VIS SCI, V42, P476; Khani SC, 1998, P NATL ACAD SCI USA, V95, P2824, DOI 10.1073/pnas.95.6.2824; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LAVAIL MM, 1987, EXP EYE RES, V44, P877, DOI 10.1016/S0014-4835(87)80050-7; LaVail MM, 1999, INVEST OPHTH VIS SCI, V40, P1020; LEIST M, 1994, J IMMUNOL, V153, P1778; LISMAN J, 1995, NAT MED, V1, P1254, DOI 10.1038/nm1295-1254; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Nakazawa M, 1998, ARCH OPHTHALMOL-CHIC, V116, P498, DOI 10.1001/archopht.116.4.498; NOELL WK, 1971, SCIENCE, V172, P76, DOI 10.1126/science.172.3978.76; Obin M, 2000, MECH AGEING DEV, V114, P133, DOI 10.1016/S0047-6374(00)00096-8; Organisciak DT, 1999, CURR EYE RES, V19, P188, DOI 10.1076/ceyr.19.2.188.5333; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; RAPP LM, 1980, EFFECTS CONSTANT LIG, P135; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; Wenzel A, 2000, J NEUROSCI, V20, P81, DOI 10.1523/JNEUROSCI.20-01-00081.2000; Wenzel A, 2001, INVEST OPHTH VIS SCI, V42, P1653; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yamada T, 1999, Ophthalmic Genet, V20, P117, DOI 10.1076/opge.20.2.117.2293; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175	41	200	206	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					254	260		10.1038/ng984	http://dx.doi.org/10.1038/ng984			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12219089				2022-12-27	WOS:000178311100013
J	Mata, J; Lyne, R; Burns, G; Bahler, J				Mata, J; Lyne, R; Burns, G; Bahler, J			The transcriptional program of meiosis and sporulation in fission yeast	NATURE GENETICS			English	Article							SCHIZOSACCHAROMYCES-POMBE; MEIOTIC RECOMBINATION; SPORE FORMATION; DNA-SYNTHESIS; GENES; EXPRESSION; PROTEIN; ENCODES; CONJUGATION; REGULATOR	Sexual reproduction requires meiosis to produce haploid gametes, which in turn can fuse to regenerate a diploid organism. We have studied the transcriptional program that drives this developmental process in Schizosaccharomyces pombe using DNA microarrays. Here we show that hundreds of genes are regulated in successive waves of transcription that correlate with major biological events of meiosis and sporulation. Each wave is associated with specific promoter motifs. Clusters of neighboring genes (mostly close to telomeres) are co-expressed early in the process, which reflects a more global control of these genes. We find that two Atf-like transcription factors are essential for the expression of late genes and formation of spores, and identify dozens of potential Atf target genes. Comparison with the meiotic program of the distantly related Saccharomyces cerevisiae reveals an unexpectedly small shared meiotic transcriptome, suggesting that the transcriptional regulation of meiosis evolved independently in both species.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Bahler, J (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	jurg@sanger.ac.uk	Bahler, Jurg/B-4572-2009; Lyne, Rachel/AAE-2189-2020	Bahler, Jurg/0000-0003-4036-1532; Lyne, Rachel/0000-0001-8050-402X; Mata, Juan/0000-0002-5514-3653	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Abe H, 2000, GENETICS, V154, P1497; Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Blanco MA, 2001, J CELL SCI, V114, P2135; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cooper KF, 2000, P NATL ACAD SCI USA, V97, P14548, DOI 10.1073/pnas.250351297; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Ding R, 1998, MOL GEN GENET, V258, P663, DOI 10.1007/s004380050780; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fares H, 1996, J CELL BIOL, V132, P399, DOI 10.1083/jcb.132.3.399; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; IINO Y, 1985, MOL GEN GENET, V198, P416, DOI 10.1007/BF00332932; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; NURSE P, 1985, MOL GEN GENET, V198, P497, DOI 10.1007/BF00332946; Ohmiya R, 1999, MOL GEN GENET, V261, P297, DOI 10.1007/s004380050970; PETERSEN J, 1995, MOL CELL BIOL, V15, P3697; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; SUGIYAMA A, 1994, EMBO J, V13, P1881, DOI 10.1002/j.1460-2075.1994.tb06457.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamamoto A, 2001, BIOESSAYS, V23, P526, DOI 10.1002/bies.1072; YAMAMOTO M, 1997, MOL CELLULAR BIOL YE, P1035; ZHU Y, 1994, GENE DEV, V8, P885, DOI 10.1101/gad.8.8.885	30	380	395	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					143	147		10.1038/ng951	http://dx.doi.org/10.1038/ng951			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12161753				2022-12-27	WOS:000177714900013
J	Gu, ZL; Rifkin, SA; White, KP; Li, WH				Gu, ZL; Rifkin, SA; White, KP; Li, WH			Duplicate genes increase gene expression diversity within and between species	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REGULATION; EVOLUTION; EUKARYOTES; MUTATIONS	Using microarray gene expression data from several Drosophila species and strains, we show that duplicated genes, compared with single-copy genes, significantly increase gene expression diversity during development. We show further that duplicate genes tend to cause expression divergences between Drosophila species (or strains) to evolve faster than do single-copy genes. This conclusion is also supported by data from different yeast strains.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University of Chicago; Yale University; Yale University	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	whli@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456; Rifkin, Scott/0000-0001-8476-3256				Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Davidson E. H., 2001, DEV EVOLUTION; Force A, 1999, GENETICS, V151, P1531; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Jozefowicz Chris, 2003, Journal of Structural and Functional Genomics, V3, P185, DOI 10.1023/A:1022690723661; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Ohno S., 1970, EVOLUTION GENE DUPLI; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	15	145	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					577	579		10.1038/ng1355	http://dx.doi.org/10.1038/ng1355			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122255	Bronze			2022-12-27	WOS:000221763700012
J	Rizzoti, K; Brunelli, S; Carmignac, D; Thomas, PQ; Robinson, IC; Lovell-Badge, R				Rizzoti, K; Brunelli, S; Carmignac, D; Thomas, PQ; Robinson, IC; Lovell-Badge, R			SOX3 is required during the formation of the hypothalamo-pituitary axis	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME; MOUSE; HORMONE; GENES; EXPRESSION; GROWTH; ORGANOGENESIS; PROTEIN; SRY	The pituitary develops from the interaction of the infundibulum, a region of the ventral diencephalon, and Rathke's pouch, a derivative of oral ectoderm. Postnatally, its secretory functions are controlled by hypothalamic neurons, which also derive from the ventral diencephalon. In humans, mutations affecting the X-linked transcription factor SOX3 are associated with hypopituitarism and mental retardation, but nothing is known of their etiology. We find that deletion of Sox3 in mice leads to defects of pituitary function and of specific central nervous system (CNS) midline structures. Cells in the ventral diencephalon, where Sox3 is usually highly expressed, have altered properties in mutant embryos, leading to abnormal development of Rathke's pouch, which does not express the gene. Pituitary and hypothalamic defects persist postnatally, and SOX3 may also function in a subset of hypothalamic neurons. This study shows how sensitive the pituitary is to subtle developmental defects and how one gene can act at several levels in the hypothalamic-pituitary axis.	Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; Natl Inst Med Res, MRC, Div Mol Endocrinol, London NW7 1AA, England; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Lovell-Badge, R (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, Mill Hill, London NW7 1AA, England.	rlovell@nimr.mrc.ac.uk	Thomas, Paul Q/K-4497-2012; Brunelli, Silvia/J-3248-2014; Brunelli, Silvia/P-3853-2019; Rizzoti, Karine/AAW-1090-2021	Brunelli, Silvia/0000-0003-1753-5346; Brunelli, Silvia/0000-0003-1753-5346; Rizzoti, Karine/0000-0003-0711-5452; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2000, GENESIS, V27, P76, DOI 10.1002/1526-968X(200006)27:2<76::AID-GENE40>3.0.CO;2-A; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Cochran W.G., 1967, STAT METHODS; Collignon J, 1996, DEVELOPMENT, V122, P509; COLLIGNON J, 1992, STUDY NEW FAMILY GEN; Dasen JS, 2001, ANNU REV NEUROSCI, V24, P327, DOI 10.1146/annurev.neuro.24.1.327; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Ericson J, 1998, DEVELOPMENT, V125, P1005; Flavell DM, 1996, EMBO J, V15, P3871, DOI 10.1002/j.1460-2075.1996.tb00761.x; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; Graves JAM, 1998, BIOESSAYS, V20, P264, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;264::AID-BIES10&gt;3.0.CO;2-1; JONES CM, 1991, ANN NY ACAD SCI, V642, P339; Kaufman MH, 1994, ATLAS MOUSE DEV; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; LINDSAY R, 1994, J PEDIATR-US, V125, P29, DOI 10.1016/S0022-3476(94)70117-2; Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789; Mayo KE, 2000, RECENT PROG HORM RES, V55, P237; McGuinness L, 2003, ENDOCRINOLOGY, V144, P720, DOI 10.1210/en.2002-220847; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Overton PM, 2002, DEVELOPMENT, V129, P4219; PARSONS M, 1997, FUNCTIONAL ANAL SOX3; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shibusawa N, 2000, MOL ENDOCRINOL, V14, P137, DOI 10.1210/me.14.1.137; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; STEVANOVIC M, 1993, HUM MOL GENET, V2, P2013, DOI 10.1093/hmg/2.12.2013; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Weiss J, 2003, MOL CELL BIOL, V23, P8084, DOI 10.1128/MCB.23.22.8084-8091.2003; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Zernicka-Goetz M, 2001, METHODS, V24, P55, DOI 10.1006/meth.2001.1157; Zucchi I, 1999, GENOMICS, V57, P209, DOI 10.1006/geno.1999.5768	40	211	217	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					247	255		10.1038/ng1309	http://dx.doi.org/10.1038/ng1309			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981518	Bronze			2022-12-27	WOS:000189250400013
J	Rizzuto, R; Pozzan, T				Rizzuto, R; Pozzan, T			When calcium goes wrong: genetic alterations of a ubiquitous signaling route	NATURE GENETICS			English	Review							CENTRAL CORE DISEASE; HYPOKALEMIC PERIODIC PARALYSIS; STATIONARY NIGHT BLINDNESS; RYANODINE RECEPTOR GENE; SPINOCEREBELLAR ATAXIA TYPE-6; CA2+ RELEASE CHANNELS; HAILEY-HAILEY-DISEASE; MALIGNANT-HYPERTHERMIA; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE	In all eukaryotic cells, the cytosolic concentration of calcium ions ([Ca2+](c)) is tightly controlled by complex interactions among transporters, pumps, channels and binding proteins. Finely tuned changes in [Ca2+](c) modulate a variety of intracellular functions, and disruption of Ca2+ handling leads to cell death. Here we review the human genetic diseases associated with perturbations in the Ca2+ signaling machinery. Despite the importance of Ca2+ in physiology and pathology, the number of known genetic diseases that can be attributed to defects in proteins directly involved in Ca2+ homeostasis is limited to few examples, which will be discussed. This paucity in contrast with the wide molecular repertoire may depend on the extreme severity of the phenotype (leading to death in utero) or, conversely, on functional compensation due to redundancy. In the latter case, it stands to reason that other genetic defects in calcium signaling have yet to be identified owing to their subtle phenotype.	Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Ferrara, Interdisciplinary Ctr Study Inflammat, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Padua, Dept Biomed Sci, I-35100 Padua, Italy	University of Ferrara; University of Ferrara; University of Padua	Rizzuto, R (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Via Borsari 46, I-44100 Ferrara, Italy.		Rizzuto, Rosario/B-6312-2008	Rizzuto, Rosario/0000-0001-7044-5097				Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198; Balschun D, 1999, EMBO J, V18, P5264, DOI 10.1093/emboj/18.19.5264; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; BRODY IA, 1969, NEW ENGL J MED, V281, P187, DOI 10.1056/NEJM196907242810403; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Clapham DE, 2002, J GEN PHYSIOL, V120, P217, DOI 10.1085/jgp.20028618; Da Silva MRD, 2002, J CLIN ENDOCR METAB, V87, P4881, DOI 10.1210/jc.2002-020698; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Futatsugi A, 1999, NEURON, V24, P701, DOI 10.1016/S0896-6273(00)81123-X; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guida S, 2001, AM J HUM GENET, V68, P759, DOI 10.1086/318804; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; KARPATI G, 1986, ANN NEUROL, V20, P38, DOI 10.1002/ana.410200108; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Margolis Russell L, 2002, Curr Neurol Neurosci Rep, V2, P447, DOI 10.1007/s11910-002-0072-8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 2000, HUM GENET, V106, P482, DOI 10.1007/s004390000297; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Periz G, 1999, EMBO J, V18, P5983, DOI 10.1093/emboj/18.21.5983; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Priori SG, 2001, CIRCULATION, V103, P196; Quane KA, 1997, BRIT J ANAESTH, V79, P332, DOI 10.1093/bja/79.3.332; Rajabally YA, 2002, MUSCLE NERVE, V25, P453, DOI 10.1002/mus.10069; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Sternberg D, 2001, BRAIN, V124, P1091, DOI 10.1093/brain/124.6.1091; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Tiso N, 2002, BIOCHEM BIOPH RES CO, V299, P594, DOI 10.1016/S0006-291X(02)02689-X; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	67	81	83	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					135	141		10.1038/ng0603-135	http://dx.doi.org/10.1038/ng0603-135			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12776115				2022-12-27	WOS:000183200500015
J	Haug, K; Warnstedt, M; Alekov, AK; Sander, T; Ramirez, A; Poser, B; Maljevic, S; Hebeisen, S; Kubisch, C; Rebstock, J; Horvath, S; Hallmann, K; Dullinger, JS; Rau, B; Haverkamp, F; Beyenburg, S; Schulz, H; Janz, D; Giese, B; Muller-Newen, G; Propping, P; Elger, CE; Fahlke, C; Lerche, H; Heils, A				Haug, K; Warnstedt, M; Alekov, AK; Sander, T; Ramirez, A; Poser, B; Maljevic, S; Hebeisen, S; Kubisch, C; Rebstock, J; Horvath, S; Hallmann, K; Dullinger, JS; Rau, B; Haverkamp, F; Beyenburg, S; Schulz, H; Janz, D; Giese, B; Muller-Newen, G; Propping, P; Elger, CE; Fahlke, C; Lerche, H; Heils, A			RETRACTED: Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies (Retracted article. See vol 41, pg. 1043, 2009)	NATURE GENETICS			English	Article; Retracted Publication							POSTSYNAPTIC INHIBITION; ION CHANNELS; NEURONS; GABA; GAMMA-2-SUBUNIT; CONDUCTANCE; HIPPOCAMPUS; POTASSIUM; MOUSE; CELLS	Idiopathic generalized epilepsy (IGE) is an inherited neurological disorder affecting about 0.4% of the world's population. Mutations in ten genes causing distinct forms of idiopathic epilepsy have been identified so far(1-7), but the genetic basis of many IGE subtypes is still unknown. Here we report a gene associated with the four most common IGE subtypes: childhood and juvenile absence epilepsy (CAE and JAE), juvenile myoclonic epilepsy (JME), and epilepsy with grand mal seizures on awakening (EGMA; ref. 8). We identified three different heterozygous mutations in the chloride-channel gene CLCN2 in three unrelated families with IGE. These mutations result in (i) a premature stop codon (M200fsX231), (ii) an atypical splicing (del74-117) and (iii) a single amino-acid substitution (G715E). All mutations produce functional alterations that provide distinct explanations for their pathogenic phenotypes. M200fsX231 and del74-117 cause a loss of function of ClC-2 channels and are expected to lower the transmembrane chloride gradient essential for GABAergic inhibition. G715E alters voltage-dependent gating, which may cause membrane depolarization and hyperexcitability.	Univ Klinikum Bonn, Inst Humangenet, D-53111 Bonn, Germany; Ctr Estudios Cient, Valdivia, Chile; Rhein Westfal TH Aachen, Inst Biochem, D-52057 Aachen, Germany; Univ Klinikum Bonn, Klinikum Padiatrie, D-59113 Bonn, Germany; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA; Univ Klinikum Bonn, Klin Epileptol, D-53105 Bonn, Germany; Humboldt Univ, Virchow Klinikum, Klinikum Charite, Arbeitsgrp Epilepsie Genet,Neurol Klin, D-13353 Berlin, Germany; Univ Ulm, Abt Angew Physiol & Neurol, D-89069 Ulm, Germany; Rhein Westfal TH Aachen, Lehr & Forschungsgebeit Physiol, D-52057 Aachen, Germany	University of Bonn; RWTH Aachen University; University of Bonn; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ulm University; RWTH Aachen University	Heils, A (corresponding author), Univ Klinikum Bonn, Inst Humangenet, Wilhelmstr 31, D-53111 Bonn, Germany.	holger.lerche@medizin.uni-ulm.de; armin.heils@ukb.uni-bonn.de	Ramirez, Alfredo/S-5126-2019; Alekov, Alexi/ABE-4170-2020; Fahlke, Christoph/G-3635-2013; Kubisch, Christian/F-1893-2011	Ramirez, Alfredo/0000-0003-4991-763X; Fahlke, Christoph/0000-0001-8602-9952; Kubisch, Christian/0000-0003-4220-0978; Alekov, Alexi/0000-0001-6362-7247; Maljevic, Snezana/0000-0003-1876-5872				[Anonymous], 1989, EPILEPSIA, V30, P389; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Berkovic SF, 2001, EPILEPSIA, V42, P16, DOI 10.1046/j.1528-1157.2001.0420s5016.x; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; CID LP, 1995, HUM MOL GENET, V4, P407, DOI 10.1093/hmg/4.3.407; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Kaila K, 1997, J NEUROSCI, V17, P7662; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; MISGELD U, 1986, SCIENCE, V232, P1413, DOI 10.1126/science.2424084; Mladinic M, 1999, P ROY SOC B-BIOL SCI, V266, P1207, DOI 10.1098/rspb.1999.0764; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; Sander T, 2000, HUM MOL GENET, V9, P1465, DOI 10.1093/hmg/9.10.1465; Serratosa JM, 1999, EPILEPSIA, V40, P12, DOI 10.1111/j.1528-1157.1999.tb00893.x; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Steinlein OK, 2000, CURR OPIN GENET DEV, V10, P286, DOI 10.1016/S0959-437X(00)00079-4; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49	30	255	275	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					527	532		10.1038/ng1121	http://dx.doi.org/10.1038/ng1121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612585	Bronze			2022-12-27	WOS:000181928600027
J	Cheung, VG; Conlin, LK; Weber, TM; Arcaro, M; Jen, KY; Morley, M; Spielman, RS				Cheung, VG; Conlin, LK; Weber, TM; Arcaro, M; Jen, KY; Morley, M; Spielman, RS			Natural variation in human gene expression assessed in lymphoblastoid cells	NATURE GENETICS			English	Article							LOCUS; MAP	The sequencing of the human genome has resulted in greater attention to genetic variation among individuals, and variation at the DNA sequence level is now being extensively studied. At the same time, it has become possible to study variation at the level of gene expression by various methods. At present, it is largely unknown how widespread this variation in transcript levels is over the entire genome and to what extent individual differences in expression level are genetically determined. In the present study, we used lymphoblastoid cells to examine variation in gene expression and identified genes whose transcript levels differed greatly among unrelated individuals. We also found evidence for familial aggregation of expression phenotype by comparing variation among unrelated individuals, among siblings within families and between monozygotic twins. These observations suggest that there is a genetic contribution to polymorphic variation in the level of gene expression.	Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020; Jen, Kuang-Yu/AAM-5429-2020; Jen, Kuang-Yu/AAM-5722-2020	Jen, Kuang-Yu/0000-0003-2815-5912; Morley, Michael/0000-0002-0958-7376	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM081930, R01 GM081930-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Watts JA, 2002, AM J HUM GENET, V71, P791, DOI 10.1086/342974; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	13	436	578	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					422	425		10.1038/ng1094	http://dx.doi.org/10.1038/ng1094			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12567189				2022-12-27	WOS:000181312700023
J	Dupuis, S; Jouanguy, E; Al-Hajjar, S; Fieschi, C; Al-Mohsen, IZ; Al-Jumaah, S; Yang, K; Chapgier, A; Eidenschenk, C; Eid, P; Al Ghonaium, A; Tufenkeji, H; Frayha, H; Al-Gazlan, S; Al-Rayes, HA; Schreiber, RD; Gresser, I; Casanova, JL				Dupuis, S; Jouanguy, E; Al-Hajjar, S; Fieschi, C; Al-Mohsen, IZ; Al-Jumaah, S; Yang, K; Chapgier, A; Eidenschenk, C; Eid, P; Al Ghonaium, A; Tufenkeji, H; Frayha, H; Al-Gazlan, S; Al-Rayes, HA; Schreiber, RD; Gresser, I; Casanova, JL			Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency	NATURE GENETICS			English	Article							GAMMA-RECEPTOR DEFICIENCY; I INTERFERON; MYCOBACTERIAL INFECTION; TARGETED DISRUPTION; ANTIVIRAL DEFENSE; VIRUS-INFECTION; MICE LACKING; MUTATION; SUSCEPTIBILITY; IMMUNITY	The receptors for interferon-alpha/beta IFN-alpha/beta and IFN-gamma activate components of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, leading to the formation of at least two transcription factor complexes(1). STAT1 interacts with STAT2 and p48/IRF-9 to form the transcription factor IFN-stimulated gene factor 3 (ISGF3). STAT1 dimers form gamma-activated factor (GAF). ISGF3 is induced mainly by IFN-alpha/beta and GAF by IFN-gamma, although both factors can be activated by both types of IFN. Individuals with mutations in either chain of the IFN-gamma receptor (IFN-gammaR) are susceptible to infection with mycobacteria(2-5). A heterozygous STAT1 mutation that impairs GAF but not ISGF3 activation has been found in other individuals with mycobacterial disease(6). No individuals with deleterious mutations in the IFN-alpha/beta signaling pathway have been described. We report here two unrelated infants homozygous with respect to mutated STAT1 alleles. Neither IFN-alpha/beta nor IFN-gamma activated STAT1-containing transcription factors. Like individuals with IFN-gammaR deficiency, both infants suffered from mycobacterial disease, but unlike individuals with IFN-gammaR deficiency, both died of viral disease. Viral multiplication was not inhibited by recombinant IFN-alpha/beta in cell lines from the two individuals. Inherited impairment of the STAT1-dependent response to human IFN-alpha/beta thus results in susceptibility to viral disease.	Univ Paris 05, Lab Genet Humaine Malad Infect, INSERM UMR550, Fac Med Necker Enfants Malades, F-75015 Paris, France; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; CNRS, Lab Oncol Virale, UPR 9045, Villejuif, France; Washington Univ, Dept Pathol, St Louis, MO 63110 USA; Ctr Rech Biomed Cordeliers, Lab Immunol Cellulaire & Clin, INSERM, U255, F-75005 Paris, France; Hop Necker Enfants Malad, Unite Hematol Immunol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; King Faisal Specialist Hospital & Research Center; Centre National de la Recherche Scientifique (CNRS); Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Univ Paris 05, Lab Genet Humaine Malad Infect, INSERM UMR550, Fac Med Necker Enfants Malades, F-75015 Paris, France.		Schreiber, Robert D/A-1276-2013; Boisson-Dupuis, Stéphanie/I-2040-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Schreiber, Robert/Q-7550-2019; Jouanguy, Emmanuelle/H-7901-2017; Casanova, Jean-Laurent/I-3418-2017	Schreiber, Robert D/0000-0001-6311-0432; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Jouanguy, Emmanuelle/0000-0002-7358-9157; Schreiber, Robert/0000-0003-1590-2341; Casanova, Jean-Laurent/0000-0002-7782-4169; Chapgier, Ariane/0000-0002-1734-0744				Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Dorman SE, 1999, J PEDIATR-US, V135, P640, DOI 10.1016/S0022-3476(99)70064-8; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; Garcia-Sastre A, 1998, J VIROL, V72, P8550; GRESSER I, 1984, INTERFERONS IMMUNE S, P221; Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999; Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Improta T, 1997, CYTOKINE, V9, P383, DOI 10.1006/cyto.1996.0180; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Shen Y, 2001, J VIROL, V75, P2627, DOI 10.1128/JVI.75.6.2627-2633.2001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Yang CH, 1996, J BIOL CHEM, V271, P8057, DOI 10.1074/jbc.271.14.8057	30	580	598	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					388	391		10.1038/ng1097	http://dx.doi.org/10.1038/ng1097			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590259				2022-12-27	WOS:000181312700016
J	Carpten, JD; Robbins, CM; Villablanca, A; Forsberg, L; Presciuttini, S; Bailey-Wilson, J; Simonds, WF; Gillanders, EM; Kennedy, AM; Chen, JD; Agarwal, SK; Sood, R; Jones, MP; Moses, TY; Haven, C; Petillo, D; Leotlela, PD; Harding, B; Cameron, D; Pannett, AA; Hoog, A; Heath, H; James-Newton, LA; Robinson, B; Zarbo, RJ; Cavaco, BM; Wassif, W; Perrier, ND; Rosen, IB; Kristoffersson, U; Turnpenny, PD; Farnebo, LO; Besser, GM; Jackson, CE; Morreau, H; Trent, JM; Thakker, RV; Marx, SJ; Teh, BT; Larsson, C; Hobbs, MR				Carpten, JD; Robbins, CM; Villablanca, A; Forsberg, L; Presciuttini, S; Bailey-Wilson, J; Simonds, WF; Gillanders, EM; Kennedy, AM; Chen, JD; Agarwal, SK; Sood, R; Jones, MP; Moses, TY; Haven, C; Petillo, D; Leotlela, PD; Harding, B; Cameron, D; Pannett, AA; Hoog, A; Heath, H; James-Newton, LA; Robinson, B; Zarbo, RJ; Cavaco, BM; Wassif, W; Perrier, ND; Rosen, IB; Kristoffersson, U; Turnpenny, PD; Farnebo, LO; Besser, GM; Jackson, CE; Morreau, H; Trent, JM; Thakker, RV; Marx, SJ; Teh, BT; Larsson, C; Hobbs, MR			HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome	NATURE GENETICS			English	Article							HEREDITARY HYPERPARATHYROIDISM; FAMILIAL HYPERPARATHYROIDISM; PARATHYROID TUMORS; GENE; REGION; LOCUS; CHROMOSOME-11; DISTINCT; 1Q21-Q32; LINKAGE	We report here the identification of a gene associated with the hyperparathyroidism-jaw tumor (HPT-JT) syndrome. A single locus associated with HPT-JT (HRPT2) was previously mapped to chromosomal region 1q25-q32. We refined this region to a critical interval of 12 cM by genotyping in 26 affected kindreds. Using a positional candidate approach, we identified thirteen different heterozygous, germline, inactivating mutations in a single gene in fourteen families with HPT-JT. The proposed role of HRPT2 as a tumor suppressor was supported by mutation screening in 48 parathyroid adenomas with cystic features, which identified three somatic inactivating mutations, all located in exon 1. None of these mutations were detected in normal controls, and all were predicted to cause deficient or impaired protein function. HRPT2 is a ubiquitously expressed, evolutionarily conserved gene encoding a predicted protein of 531 amino acids, for which we propose the name parafibromin. Our findings suggest that HRPT2 is a tumor-suppressor gene, the inactivation of which is directly involved in predisposition to HPT-JT and in development of some sporadic parathyroid tumors.	Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden; Karolinska Hosp, Dept Pathol & Oncol, S-10401 Stockholm, Sweden; Karolinska Hosp, Dept Surg Sci, S-10401 Stockholm, Sweden; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Inherited Dis Res Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Metab Dis Branch, Bethesda, MD 20892 USA; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Mol Endocrinol Grp, Oxford OX3 9DU, England; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI USA; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RA Leiden, Netherlands; Princess Alexandra Hosp, Dept Endocrinol & Diabet, Brisbane, Qld 4102, Australia; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW 2006, Australia; Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; Inst Portugues Oncol Francisco Gentil, Ctr Invest Patobiol Mol, Lisbon, Portugal; Kings Coll London, Sch Med & Dent, Dept Clin Biochem, London, England; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; Royal Devon & Exeter Hosp Wonford, Dept Clin Genet, Exeter, Devon, England; St Bartholomews Hosp, Dept Endocrinol, London, England; Henry Ford Hosp, Dept Med Genet, Detroit, MI 48202 USA; Univ Utah, Div Endocrinol, Salt Lake City, UT USA; Univ Utah, Dept Infect Dis, Salt Lake City, UT USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oxford; Van Andel Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eli Lilly; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Henry Ford Health System; Henry Ford Hospital; Portuguese Institute of Oncology; University of London; King's College London; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lund University; Skane University Hospital; University of Exeter; University of London; Queen Mary University London; Henry Ford Health System; Henry Ford Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Carpten, JD (corresponding author), Karolinska Hosp, Dept Mol Med, S-10401 Stockholm, Sweden.	jdc@nhgri.nih.gov; Catharina.Larsson@cmm.ki.se	Caligo, Adelaide Maria/K-4289-2018; Agarwal, Sunita K/D-1428-2016; Perrier, Nancy/T-7474-2019	Caligo, Adelaide Maria/0000-0003-0589-1829; Agarwal, Sunita K/0000-0002-7557-3191; Perrier, Nancy/0000-0001-5933-1005; Bailey-Wilson, Joan/0000-0002-9153-2920; Thakker, Rajesh/0000-0002-1438-3220; Cavaco, Branca/0000-0001-8946-8635; Kennedy, Ann/0000-0003-0290-396X; Teh, Bin Tean/0000-0003-1514-1124	NATIONAL CANCER INSTITUTE [R01CA075177] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK043009, Z01DK043012, Z01DK043006] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; Cavaco BM, 2001, QJM-INT J MED, V94, P213, DOI 10.1093/qjmed/94.4.213; DINNEN JS, 1977, J CLIN PATHOL, V30, P966, DOI 10.1136/jcp.30.10.966; EVERSOLE LR, 1985, ORAL SURG ORAL MED O, V60, P505, DOI 10.1016/0030-4220(85)90239-7; FRIEDMAN E, 1992, CANCER RES, V52, P6804; Haven CJ, 2000, J CLIN ENDOCR METAB, V85, P1449, DOI 10.1210/jc.85.4.1449; Hobbs MR, 1999, AM J HUM GENET, V64, P518, DOI 10.1086/302259; Hobbs MR, 2002, AM J HUM GENET, V70, P1376, DOI 10.1086/340093; JACKSON CE, 1967, AM J MED, V43, P727, DOI 10.1016/0002-9343(67)90114-3; JACKSON CE, 1990, SURGERY, V108, P1006; KENNETT S, 1971, ORAL SURG ORAL MED O, V31, P502, DOI 10.1016/0030-4220(71)90347-1; Kerkmann K, 2001, CURR GENET, V39, P284, DOI 10.1007/s002940100229; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Simonds WF, 2002, MEDICINE, V81, P1, DOI 10.1097/00005792-200201000-00001; Sood R, 2001, GENOMICS, V73, P211, DOI 10.1006/geno.2001.6500; SZABO J, 1995, AM J HUM GENET, V56, P944; Teh BT, 1998, J CLIN ENDOCR METAB, V83, P2114, DOI 10.1210/jc.83.6.2114; Teh BT, 1996, J CLIN ENDOCR METAB, V81, P4204, DOI 10.1210/jc.81.12.4204; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; Villablanca A, 2002, CLIN ENDOCRINOL, V56, P259; Wassif WS, 1999, CLIN ENDOCRINOL, V50, P191, DOI 10.1046/j.1365-2265.1999.00633.x; Williamson C, 1999, J BONE MINER RES, V14, P230, DOI 10.1359/jbmr.1999.14.2.230	25	503	524	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					676	680		10.1038/ng1048	http://dx.doi.org/10.1038/ng1048			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12434154				2022-12-27	WOS:000179593000024
J	Cheung, VG; Spielman, RS				Cheung, VG; Spielman, RS			The genetics of variation in gene expression	NATURE GENETICS			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; BLOCKS; ATM	The genetic basis of variation in gene expression lends itself to investigation by microarrays. For genetic analysis, we view the expression level of a gene as a quantitative or 'complex' trait, analogous to an individual's height or cholesterol level, and, therefore, as an inherited phenotype. Several genetic analyses of 'gene expression phenotypes' have been carried out in experimental organisms, and initial steps have been taken toward similar studies in humans-although these present challenging technical and statistical problems. Further advances in the genetic analysis of variation in gene expression will contribute to our understanding of transcriptional regulation and will provide models for studying other quantitative and complex traits.	Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020					Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Chen XN, 1999, GENOME RES, V9, P492; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P347, DOI 10.1093/nar/25.2.347; Concannon P, 2002, NAT GENET, V32, P89, DOI 10.1038/ng0902-89; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ewens WJ, 2001, THEOR POPUL BIOL, V60, P135, DOI 10.1006/tpbi.2001.1547; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Griffin TJ, 1999, P NATL ACAD SCI USA, V96, P6301, DOI 10.1073/pnas.96.11.6301; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Oliphant A, 2002, BIOTECHNIQUES, P56; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spring K, 2002, NAT GENET, V32, P185, DOI 10.1038/ng958; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; THOMSON G, 1995, AM J HUM GENET, V57, P487; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Watts JA, 2002, AM J HUM GENET, V71, P791, DOI 10.1086/342974	32	148	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			522	525		10.1038/ng1036	http://dx.doi.org/10.1038/ng1036			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454648				2022-12-27	WOS:000179742900013
J	Bu, L; Jin, YP; Shi, YF; Chu, RY; Ban, AR; Eiberg, H; Andres, L; Jiang, HS; Zheng, GY; Qian, MQ; Cui, B; Xia, Y; Liu, J; Hu, LD; Zhao, GP; Hayden, MR; Kong, XY				Bu, L; Jin, YP; Shi, YF; Chu, RY; Ban, AR; Eiberg, H; Andres, L; Jiang, HS; Zheng, GY; Qian, MQ; Cui, B; Xia, Y; Liu, J; Hu, LD; Zhao, GP; Hayden, MR; Kong, XY			Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; SHOCK; ACTIVATOR; HUMANS	Congenital cataracts cause 10-30% of all blindness in children, with one-third of cases estimated to have a genetic cause(1). Lamellar cataract is the most common type of infantile cataract(2). We carried out whole-genome linkage analysis of Chinese individuals with lamellar cataract, and found that the disorder is associated with inheritance of a 5.11-cM locus on chromosome 16. This locus coincides with one previously described for Marner cataract(3). We screened individuals of three Chinese families for mutations in HSF4 (a gene at this locus that encodes heat-shock transcription factor 4) and discovered that in each family, a distinct missense mutation, predicted to affect the DNA-binding domain of the protein, segregates with the disorder. We also discovered an association between a missense mutation and Marner cataract in an extensive Danish family. We suggest that HSF4 is critical to lens development.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China; Univ Sci & Technol China, Hefei 230026, Peoples R China; Fudan Univ, Coll Med, EENT Hosp, Dept Ophthalmol, Shanghai, Peoples R China; Peoples Hosp Yichuan, Dept Ophthalmol, Luoyang, Peoples R China; Univ Copenhagen, Panum Inst, DK-2200 Copenhagen, Denmark; Xenon Genet, Burnaby, BC, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; Chinese Acad Sci, Shanghai Inst Biol Sci, Hlth Sci Ctr, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University; University of Copenhagen; University of British Columbia; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Kong, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Res Ctr Biotechnol, Shanghai 200233, Peoples R China.		Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; BU, LEI/0000-0003-4476-2157				Bagchi M, 2002, J CELL BIOCHEM, V84, P278, DOI 10.1002/jcb.10023; Bagchi M, 2001, J CELL BIOCHEM, V82, P409, DOI 10.1002/jcb.1168; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; EIBERG H, 1988, CLIN GENET, V34, P272; Falls HF, 1943, ARCH OPHTHALMOL-CHIC, V29, P210, DOI 10.1001/archopht.1943.00880140056002; FAWCETT TW, 1994, J BIOL CHEM, V269, P32272; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUND AM, 1992, CLIN GENET, V41, P65; MARNER E, 1949, ACTA OPHTHALMOL, V27, P537; Monaghan KG, 1997, AM J MED GENET, V73, P180, DOI 10.1002/(SICI)1096-8628(1997)73:2<180::AID-AJMG13>3.0.CO;2-Q; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; STRAATSMA BR, 1985, ANN INTERN MED, V102, P82, DOI 10.7326/0003-4819-102-1-82; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; TORRES FAG, 1995, MOL CELL BIOL, V15, P5063; Xiao SX, 2000, GENOMICS, V68, P247, DOI 10.1006/geno.2000.6285	19	208	252	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					276	278		10.1038/ng921	http://dx.doi.org/10.1038/ng921			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089525				2022-12-27	WOS:000176494100015
J	Cao, L; Jiao, XY; Zuzga, DS; Liu, YH; Fong, DM; Young, D; During, MJ				Cao, L; Jiao, XY; Zuzga, DS; Liu, YH; Fong, DM; Young, D; During, MJ			VEGF links hippocampal activity with neurogenesis, learning and memory	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ENVIRONMENTAL ENRICHMENT; CELL-PROLIFERATION; RESPONSE ELEMENT; RAT-BRAIN; EXPRESSION; ANGIOGENESIS; VIVO; DIFFERENTIATION	An enriched environment is associated with hippocampal plasticity, including improved cognitive performance and increased neurogenesis. Here, we show that hippocampal expression of vascular endothelial growth factor ( VEGF) is increased by both an enriched environment and performance in a spatial maze. Hippocampal gene transfer of VEGF in adult rats resulted in similar to2 times more neurogenesis associated with improved cognition. In contrast, overexpression of placental growth factor, which signals through Flt1 but not kinase insert domain protein receptors (KDRs), had negative effects on neurogenesis and inhibited learning, although it similarly increased endothelial cell proliferation. Expression of a dominant-negative mutant KDR inhibited basal neurogenesis and impaired learning. Coexpression of mutant KDR antagonized VEGF-enhanced neurogenesis and learning without inhibiting endothelial cell proliferation. Furthermore, inhibition of VEGF expression by RNA interference completely blocked the environmental induction of neurogenesis. These data support a model in which VEGF, acting through KDR, mediates the effect of the environment on neurogenesis and cognition.	Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; Univ Auckland, Dept Mol Med & Pathol, Lab Funct Genom & Translat Neurosci, Auckland, New Zealand	Cornell University; Jefferson University; University of Auckland	During, MJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA.	mjd2002@med.cornell.edu	Cao, Lei/H-3185-2019; Cao, Lei/E-2841-2011; During, Matthew/AAC-1388-2020	Young, Deborah/0000-0003-1085-2824; Cao, Lei/0000-0003-0322-4985				Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Cao L, 2000, J VIROL, V74, P11456, DOI 10.1128/JVI.74.24.11456-11463.2000; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gustafsson T, 1999, AM J PHYSIOL-HEART C, V276, pH679, DOI 10.1152/ajpheart.1999.276.2.H679; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee MY, 1999, NEUROSCI LETT, V265, P107, DOI 10.1016/S0304-3940(99)00219-0; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PARK JE, 1994, J BIOL CHEM, V269, P25646; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEATHERLY LS, 1996, BRAIN RES, V716, P29; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Yourey PA, 2000, J NEUROSCI, V20, P6781, DOI 10.1523/JNEUROSCI.20-18-06781.2000; Zeng HY, 2001, J BIOL CHEM, V276, P26969, DOI 10.1074/jbc.M103213200; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	43	625	670	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					827	835		10.1038/ng1395	http://dx.doi.org/10.1038/ng1395			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15258583				2022-12-27	WOS:000222974000014
J	Buaas, FW; Kirsh, AL; Sharma, M; McLean, DJ; Morris, JL; Griswold, MD; de Rooij, DG; Braun, RE				Buaas, FW; Kirsh, AL; Sharma, M; McLean, DJ; Morris, JL; Griswold, MD; de Rooij, DG; Braun, RE			Plzf is required in adult male germ cells for stem cell self-renewal	NATURE GENETICS			English	Article							ZINC-FINGER PROTEIN; PROMYELOCYTIC LEUKEMIA; GENE-EXPRESSION; MOUSE; DIFFERENTIATION; PROLIFERATION; EMBRYO; BMI-1; MAP	Adult germline stem cells are capable of self-renewal, tissue regeneration and production of large numbers of differentiated progeny. We show here that the classical mouse mutant luxoid affects adult germline stem cell self-renewal. Young homozygous luxoid mutant mice produce limited numbers of normal spermatozoa and then progressively lose their germ line after birth. Transplantation studies showed that germ cells from mutant mice did not colonize recipient testes, suggesting that the defect is intrinsic to the stem cells. We determined that the luxoid mutant contains a nonsense mutation in the gene encoding Plzf, a transcriptional repressor that regulates the epigenetic state of undifferentiated cells, and showed that Plzf is coexpressed with Oct4 in undifferentiated spermatogonia. This is the first gene shown to be required in germ cells for stem cell self-renewal in mammals.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Fac Biol, Dept Endocrinol, NL-3584 CH Utrecht, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; Utrecht University; Utrecht University	Braun, RE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Box 357730,1705 NE Pacific St, Seattle, WA 98195 USA.	braun@u.washington.edu	de Rooij, D.G./AAW-1195-2021	de Rooij, Dirk/0000-0003-3932-4419; McLean, Derek/0000-0001-6151-2796				BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; FORSTHOEFEL PAULINUS FREDERICK, 1958, J MORPH, V102, P247, DOI 10.1002/jmor.1051020203; GREEN MARGARET C., 1955, JOUR HEREDITY, V46, P91; Hawe N, 1996, BLOOD, V88, P1151; JOHNSON DR, 1971, J EMBRYOL EXP MORPH, V25, P223; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li JY, 1997, J BIOL CHEM, V272, P22447, DOI 10.1074/jbc.272.36.22447; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OBRIEN DA, 1980, DEV BIOL, V75, P405, DOI 10.1016/0012-1606(80)90172-4; Ohmura M, 2003, BIOL REPROD, V68, P2304, DOI 10.1095/biolreprod.102.013276; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; REID A, 1995, BLOOD, V86, P4544, DOI 10.1182/blood.V86.12.4544.bloodjournal86124544; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	29	651	689	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					647	652		10.1038/ng1366	http://dx.doi.org/10.1038/ng1366			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15156142	Green Submitted, Bronze			2022-12-27	WOS:000221763700025
J	Ye, JZS; de Lange, T				Ye, JZS; de Lange, T			TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex	NATURE GENETICS			English	Article							POLY(ADP-RIBOSE) POLYMERASE; REGULATOR	Telomere length in humans is partly controlled by a feedback mechanism in which telomere elongation by telomerase is limited by the accumulation of the TRF1 complex at chromosome ends(1-5). TRF1 itself can be inhibited by the poly(ADP-ribose) polymerase (PARP) activity of its interacting partner tankyrase 1, which abolishes its DNA binding activity in vitro and removes the TRF1 complex from telomeres in vivo. Here we report that the inhibition of TRF1 by tankyrase is in turn controlled by a second TRF1-interacting factor, TIN2 (ref. 6). Partial knockdown of TIN2 by small hairpin RNA in a telomerase-positive cell line resulted in telomere elongation, which is typical of reduced TRF1 function. Transient inhibition of TIN2 with small interfering RNA led to diminished telomeric TRF1 signals. This effect could be reversed with the PARP inhibitor 3-aminobenzamide and did not occur in cells overexpressing a PARP-dead mutant of tankyrase 1. TIN2 formed a ternary complex with TRF1 and tankyrase 1 and stabilized their interaction, an effect also observed with the PARP-dead mutant of tankyrase 1. In vitro, TIN2 protected TRF1 from poly(ADP-ribosyl)ation by tankyrase 1 without affecting tankyrase 1 automodification. These data identify TIN2 as a PARP modulator in the TRF1 complex and can explain how TIN2 contributes to the regulation of telomere length.	Rockefeller Univ, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	de Lange, T (corresponding author), NYU, Sch Med, Div Hematol, Dept Med, 550 1St Ave, New York, NY 10016 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X				Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; De Rycker M, 2003, BIOCHEM J, V372, P87, DOI 10.1042/BJ20021450; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Seimiya H, 2002, J BIOL CHEM, V277, P14116, DOI 10.1074/jbc.M112266200; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	20	146	155	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					618	623		10.1038/ng1360	http://dx.doi.org/10.1038/ng1360			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15133513	Bronze			2022-12-27	WOS:000221763700020
J	Inoue, K; Khajavi, M; Ohyama, T; Hirabayashi, S; Wilson, J; Reggin, JD; Mancias, P; Butler, IJ; Wilkinson, MF; Wegner, M; Lupski, JR				Inoue, K; Khajavi, M; Ohyama, T; Hirabayashi, S; Wilson, J; Reggin, JD; Mancias, P; Butler, IJ; Wilkinson, MF; Wegner, M; Lupski, JR			Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR SOX10; WAARDENBURG-HIRSCHSPRUNG-DISEASE; MESSENGER-RNA DECAY; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; NONSENSE-MEDIATED DECAY; MARIE-TOOTH-DISEASE; REGULATORY MECHANISM; CLINICAL PHENOTYPES; FUNCTIONAL-ANALYSIS; P-0 MUTATIONS	The molecular mechanisms by which different mutations in the same gene can result in distinct disease phenotypes remain largely unknown. Truncating mutations of SOX10 cause either a complex neurocristopathy designated PCWH or a more restricted phenotype known as Waardenburg-Shah syndrome (WS4; OMIM 277580). Here we report that although all nonsense and frameshift mutations that cause premature termination of translation generate truncated SOX10 proteins with potent dominant-negative activity, the more severe disease phenotype, PCWH, is realized only when the mutant mRNAs escape the nonsense-mediated decay (NMD) pathway. We observe similar results for truncating mutations of MPZ that convey distinct myelinopathies. Our experiments show that triggering NMD and escaping NMD may cause distinct neurological phenotypes.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Nagano Childrens Hosp, Div Pediat Neurol, Nagano, Japan; Great Ormond St Hosp Children, Dept Neurol, London WC1N 3JH, England; Meritcare Neurosci Clin, Fargo, ND USA; Univ Texas, Sch Med, Dept Neurol, Houston, TX USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Texas System; University of Texas System; UTMD Anderson Cancer Center; University of Erlangen Nuremberg; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu		Ohyama, Tomoko/0000-0003-1697-1138; Wegner, Michael/0000-0002-4586-3294				BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Bondurand N, 1999, HUM MOL GENET, V8, P1785, DOI 10.1093/hmg/8.9.1785; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FORGET BG, 1974, NATURE, V247, P379, DOI 10.1038/247379a0; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Inoue K, 2002, ANN NEUROL, V52, P836, DOI 10.1002/ana.10404; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; JACOBS JM, 1992, ACTA NEUROPATHOL, V83, P670, DOI 10.1007/BF00299420; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Pingault V, 2000, ANN NEUROL, V48, P671, DOI 10.1002/1531-8249(200010)48:4<671::AID-ANA17>3.0.CO;2-8; Pingault V, 2002, HUM GENET, V111, P198, DOI 10.1007/s00439-002-0765-8; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Sham MH, 2001, J MED GENET, V38, DOI 10.1136/jmg.38.9.e30; Shames I, 2003, J NEUROPATH EXP NEUR, V62, P751, DOI 10.1093/jnen/62.7.751; Snead MP, 1999, J MED GENET, V36, P353; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Toki F, 2003, PEDIATR SURG INT, V19, P725, DOI 10.1007/s00383-003-1057-7; Touraine RL, 2000, AM J HUM GENET, V66, P1496, DOI 10.1086/302895; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Wong MH, 1996, J CELL BIOL, V134, P1531, DOI 10.1083/jcb.134.6.1531; Yoshida M, 2001, NEUROCHEM RES, V26, P703, DOI 10.1023/A:1010999622760	44	320	334	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					361	369		10.1038/ng1322	http://dx.doi.org/10.1038/ng1322			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15004559	Bronze			2022-12-27	WOS:000220647200019
J	Lindgren, G; Backstrom, N; Swinburne, J; Hellborg, L; Einarsson, A; Sandberg, K; Cothran, G; Vila, C; Binns, M; Ellegren, H				Lindgren, G; Backstrom, N; Swinburne, J; Hellborg, L; Einarsson, A; Sandberg, K; Cothran, G; Vila, C; Binns, M; Ellegren, H			Limited number of patrilines in horse domestication	NATURE GENETICS			English	Article							HUMAN Y-CHROMOSOME; SEQUENCE VARIATION; ORIGINS; DIVERSITY; LINEAGES	Genetic studies using mitochondrial DNA ( mtDNA) have identified extensive matrilinear diversity among domestic horses. Here, we show that this high degree of polymorphism is not matched by a corresponding patrilinear diversity of the male-specific Y chromosome. In fact, a screening for single-nucleotide polymorphisms (SNPs) in 14.3 kb of noncoding Y chromosome sequence among 52 male horses of 15 different breeds did not identify a single segregation site. These observations are consistent with a strong sex-bias in the domestication process, with few stallions contributing genetically to the domestic horse.	Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; Anim Hlth Trust, Newmarket CB8 7UU, Suffolk, England; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75007 Uppsala, Sweden; Univ Kentucky, Dept Vet Sci, Lexington, KY 40546 USA	Uppsala University; Animal Health Trust; Swedish University of Agricultural Sciences; University of Kentucky	Ellegren, H (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	Hans.Ellegren@ebc.uu.se	Vila, Carles/H-4893-2013; Backström, Niclas/C-8425-2012	Vila, Carles/0000-0002-4206-5246; Lindgren, Gabriella/0000-0001-6046-9669				Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Cunningham EP, 2001, ANIM GENET, V32, P360, DOI 10.1046/j.1365-2052.2001.00785.x; Hammer MF, 2003, GENETICS, V164, P1495; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Levine MA, 1999, J ANTHROPOL ARCHAEOL, V18, P29, DOI 10.1006/jaar.1998.0332; Lister A.M., 1998, ANCIENT BIOMOLECULES, V2, P267; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Olsen S. L., 1996, HORSES TIME; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Shen PD, 2000, P NATL ACAD SCI USA, V97, P7354, DOI 10.1073/pnas.97.13.7354; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Wallner B, 2003, ANIM GENET, V34, P453, DOI 10.1046/j.0268-9146.2003.01044.x; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254	15	115	122	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					335	336		10.1038/ng1326	http://dx.doi.org/10.1038/ng1326			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15034578	Bronze, Green Published			2022-12-27	WOS:000220647200014
J	Ota, T; Suzuki, Y; Nishikawa, T; Otsuki, T; Sugiyama, T; Irie, R; Wakamatsu, A; Hayashi, K; Sato, H; Nagai, K; Kimura, K; Makita, H; Sekine, M; Obayashi, M; Nishi, T; Shibahara, T; Tanaka, T; Ishii, S; Yamamoto, J; Saito, K; Kawai, Y; Isono, Y; Nakamura, Y; Nagahari, K; Murakami, K; Yasuda, T; Iwayanagi, T; Wagatsuma, M; Shiratori, A; Sudo, H; Hosoiri, T; Kaku, Y; Kodaira, H; Kondo, H; Sugawara, M; Takahashi, M; Kanda, K; Yokoi, T; Furuya, T; Kikkawa, E; Omura, Y; Abe, K; Kamihara, K; Katsuta, N; Sato, K; Tanikawa, M; Yamazaki, M; Ninomiya, K; Ishibashi, T; Yamashita, H; Murakawa, K; Fujimori, K; Tanai, H; Kimata, M; Watanabe, M; Hiraoka, S; Chiba, Y; Ishida, S; Ono, Y; Takiguchi, S; Watanabe, S; Yosida, M; Hotuta, T; Kusano, J; Kanehori, K; Takahashi-Fujii, A; Hara, H; Tanase, T; Nomura, Y; Togiya, S; Komai, F; Hara, R; Takeuchi, K; Arita, M; Imose, N; Musashino, K; Yuuki, H; Oshima, A; Sasaki, N; Aotsuka, S; Yoshikawa, Y; Matsunawa, H; Ichihara, T; Shiohata, N; Sano, S; Moriya, S; Momiyama, H; Satoh, N; Takami, S; Terashima, Y; Suzuki, O; Nakagawa, S; Senoh, A; Mizoguchi, H; Goto, Y; Shimizu, F; Wakebe, H; Hishigaki, H; Watanabe, T; Sugiyama, A; Takemoto, M; Kawakami, B; Yamazaki, M; Watanabe, K; Kumagai, A; Itakura, S; Fukuzumi, Y; Fujimori, Y; Komiyama, M; Tashiro, H; Tanigami, A; Fujiwara, T; Ono, T; Yamada, K; Fujii, Y; Ozaki, K; Hirao, M; Ohmori, Y; Kawabata, A; Hikiji, T; Kobatake, N; Inagaki, H; Ikema, Y; Okamoto, S; Okitani, R; Kawakami, T; Noguchi, S; Itoh, T; Shigeta, K; Senba, T; Matsumura, K; Nakajima, Y; Mizuno, T; Morinaga, M; Sasaki, M; Togashi, T; Oyama, M; Hata, H; Watanabe, M; Komatsu, T; Mizushima-Sugano, J; Satoh, T; Shirai, Y; Takahashi, Y; Nakagawa, K; Okumura, K; Nagase, T; Nomura, N; Kikuchi, H; Masuho, Y; Yamashita, R; Nakai, K; Yada, T; Nakamura, Y; Ohara, O; Isogai, T; Sugano, S				Ota, T; Suzuki, Y; Nishikawa, T; Otsuki, T; Sugiyama, T; Irie, R; Wakamatsu, A; Hayashi, K; Sato, H; Nagai, K; Kimura, K; Makita, H; Sekine, M; Obayashi, M; Nishi, T; Shibahara, T; Tanaka, T; Ishii, S; Yamamoto, J; Saito, K; Kawai, Y; Isono, Y; Nakamura, Y; Nagahari, K; Murakami, K; Yasuda, T; Iwayanagi, T; Wagatsuma, M; Shiratori, A; Sudo, H; Hosoiri, T; Kaku, Y; Kodaira, H; Kondo, H; Sugawara, M; Takahashi, M; Kanda, K; Yokoi, T; Furuya, T; Kikkawa, E; Omura, Y; Abe, K; Kamihara, K; Katsuta, N; Sato, K; Tanikawa, M; Yamazaki, M; Ninomiya, K; Ishibashi, T; Yamashita, H; Murakawa, K; Fujimori, K; Tanai, H; Kimata, M; Watanabe, M; Hiraoka, S; Chiba, Y; Ishida, S; Ono, Y; Takiguchi, S; Watanabe, S; Yosida, M; Hotuta, T; Kusano, J; Kanehori, K; Takahashi-Fujii, A; Hara, H; Tanase, T; Nomura, Y; Togiya, S; Komai, F; Hara, R; Takeuchi, K; Arita, M; Imose, N; Musashino, K; Yuuki, H; Oshima, A; Sasaki, N; Aotsuka, S; Yoshikawa, Y; Matsunawa, H; Ichihara, T; Shiohata, N; Sano, S; Moriya, S; Momiyama, H; Satoh, N; Takami, S; Terashima, Y; Suzuki, O; Nakagawa, S; Senoh, A; Mizoguchi, H; Goto, Y; Shimizu, F; Wakebe, H; Hishigaki, H; Watanabe, T; Sugiyama, A; Takemoto, M; Kawakami, B; Yamazaki, M; Watanabe, K; Kumagai, A; Itakura, S; Fukuzumi, Y; Fujimori, Y; Komiyama, M; Tashiro, H; Tanigami, A; Fujiwara, T; Ono, T; Yamada, K; Fujii, Y; Ozaki, K; Hirao, M; Ohmori, Y; Kawabata, A; Hikiji, T; Kobatake, N; Inagaki, H; Ikema, Y; Okamoto, S; Okitani, R; Kawakami, T; Noguchi, S; Itoh, T; Shigeta, K; Senba, T; Matsumura, K; Nakajima, Y; Mizuno, T; Morinaga, M; Sasaki, M; Togashi, T; Oyama, M; Hata, H; Watanabe, M; Komatsu, T; Mizushima-Sugano, J; Satoh, T; Shirai, Y; Takahashi, Y; Nakagawa, K; Okumura, K; Nagase, T; Nomura, N; Kikuchi, H; Masuho, Y; Yamashita, R; Nakai, K; Yada, T; Nakamura, Y; Ohara, O; Isogai, T; Sugano, S			Complete sequencing and characterization of 21,243 full-length human cDNAs	NATURE GENETICS			English	Article							DNA-SEQUENCE; MESSENGER-RNAS; GENE; DATABASE; ORGANIZATION; GENOME	As a base for human transcriptome and functional genomics, we created the "full-length long Japan" (FLJ) collection of sequenced human cDNAs. We determined the entire sequence of 21,243 selected clones and found that 14,490 cDNAs (10,897 clusters) were unique to the FLJ collection. About half of them (5,416) seemed to be protein-coding. Of those, 1,999 clusters had not been predicted by computational methods. The distribution of GC content of nonpredicted cDNAs had a peak at similar to58% compared with a peak at similar to42% for predicted cDNAs. Thus, there seems to be a slight bias against GC-rich transcripts in current gene prediction procedures. The rest of the cDNAs unique to the FLJ collection (5,481) contained no obvious open reading frames (ORFs) and thus are candidate noncoding RNAs. About one-fourth of them (1,378) showed a clear pattern of splicing. The distribution of GC content of noncoding cDNAs was narrow and had a peak at similar to42%, relatively low compared with that of protein-coding cDNAs.	Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Helix Res Inst, Chiba 2920812, Japan; Kyowa Hakko Kogyo Co Ltd, Tokyo Res Lab, Tokyo 1948533, Japan; Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan; Natl Inst Technol & Evaluat, Shibuya Ku, Tokyo 1510066, Japan; Otsuka Pharmaceut Co Ltd, Tokushima 7710192, Japan; Hitachi, Life Sci Grp, Kawagoe, Saitama 3501165, Japan; Hitachi Sci Syst, Tokyo 1858601, Japan; Takara Shuzo Co Ltd, Shiga 5250055, Japan; Nisshinbo Ind, Midori Ku, Chiba 2670056, Japan; Toyobo, Fukui 9140047, Japan; Fujiya, Kanagawa 2570031, Japan; Aisin Cosmos Res & Dev Co Ltd, Chiba 2920812, Japan; Kazusa DNA Res Inst, Chiba 2920812, Japan; AIST, BIRC, Koto Ku, Tokyo 1350064, Japan	University of Tokyo; Kyowa Kirin Ltd; Hitachi Limited; Otsuka Pharmaceutical; Hitachi Limited; Hitachi Limited; Takara Holdings Inc.; Nisshinbo Holdings Inc.; Aisin Seiki; Kazusa DNA Research Institute; National Institute of Advanced Industrial Science & Technology (AIST)	Sugano, S (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ssugano@ims.u-tokyo.ac.jp	Ohara, Osamu/A-9119-2012; Tanaka, Toshihiro/J-9310-2014; murakami, katsuhiko/C-2083-2009; Ohara, Osamu/G-5448-2015; Nakai, Kenta/B-7293-2009; Komatsu, Toru/AAH-8504-2019	Tanaka, Toshihiro/0000-0001-6201-9784; murakami, katsuhiko/0000-0002-1923-4259; Ohara, Osamu/0000-0002-3328-9571; Nakai, Kenta/0000-0002-8721-8883; Ozaki, Kouichi/0000-0003-0028-1570; Oyama, Masaaki/0000-0001-6478-3735				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERNARDI G, 1993, GENE, V135, P57, DOI 10.1016/0378-1119(93)90049-9; BOGUSKI MS, 1995, TRENDS BIOCHEM SCI, V20, P295, DOI 10.1016/S0968-0004(00)89051-9; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Chance MR, 2002, PROTEIN SCI, V11, P723, DOI 10.1110/ps.4570102; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fickett JW, 1998, METHOD BIOCHEM ANAL, V39, P231; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIESECKE H, 1992, J VIROL METHODS, V38, P47, DOI 10.1016/0166-0934(92)90168-D; HATTORI A, 2001, DNA RES, V7, P1; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARUYAMA K, 1994, GENE, V138, P171; Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Yudate HT, 2001, NUCLEIC ACIDS RES, V29, P185, DOI 10.1093/nar/29.1.185	29	689	11143	0	198	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					40	45		10.1038/ng1285	http://dx.doi.org/10.1038/ng1285			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702039	Bronze			2022-12-27	WOS:000187666800012
J	Beja-Pereira, A; Luikart, G; England, PR; Bradley, DG; Jann, OC; Bertorelle, G; Chamberlain, AT; Nunes, TP; Metodiev, S; Ferrand, N; Erhardt, G				Beja-Pereira, A; Luikart, G; England, PR; Bradley, DG; Jann, OC; Bertorelle, G; Chamberlain, AT; Nunes, TP; Metodiev, S; Ferrand, N; Erhardt, G			Gene-culture coevolution between cattle milk protein genes and human lactase genes	NATURE GENETICS			English	Article							EUROPEAN CATTLE; HAPLOTYPE DIVERSITY; BREEDS; ORIGIN	Milk from domestic cows has been a valuable food source for over 8,000 years, especially in lactose-tolerant human societies that exploit dairy breeds. We studied geographic patterns of variation in genes encoding the six most important milk proteins in 70 native European cattle breeds. We found substantial geographic coincidence between high diversity in cattle milk genes, locations of the European Neolithic cattle farming sites (>5,000 years ago) and present-day lactose tolerance in Europeans. This suggests a gene-culture coevolution between cattle and humans.	Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine Genom Populat & Biodivers, F-38041 Grenoble 9, France; Univ Porto, Ctr Invest Biodiversidade & Recursos Genet CIBIO, P-4485661 Vairao, Portugal; Univ Porto, Fac Ciencias, Seccao Autonoma Ciencias Agrarias, P-4485661 Vairao, Portugal; Univ Dublin Trinity Coll, Dept Genet, Smurfit Inst, Dublin 2, Ireland; Univ Giessen, Inst Tierzucht & Haustiergenet, D-35390 Giessen, Germany; Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy; Univ Sheffield, Dept Archaeol & Prehist, Sheffield S1 4ET, S Yorkshire, England; Polo Univ Ajuda, Fac Med Vet, DETSA, UISEE,CIISA, P-1300477 Lisbon, Portugal; Thracian Univ, Fac Agr, Dept Anim Breeding & Genet, Stara Zagora 6000, Bulgaria; Fac Ciencias Praca Gomes Teixeira, Dept Zool Antropol, P-4099002 Oporto, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Universidade do Porto; Universidade do Porto; Trinity College Dublin; Justus Liebig University Giessen; University of Ferrara; University of Sheffield; Universidade de Lisboa; Trakia University	Beja-Pereira, A (corresponding author), Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine Genom Populat & Biodivers, BP 53, F-38041 Grenoble 9, France.		Beja-Pereira, Albano/B-3681-2008; Ferrand, Nuno/E-6085-2014; Bertorelle, Giorgio/AAE-9078-2022	Beja-Pereira, Albano/0000-0002-1607-7382; Ferrand, Nuno/0000-0002-2408-4195; Luikart, Gordon/0000-0001-8697-0582; Nunes, Telmo/0000-0003-4388-5366; Bertorelle, Giorgio/0000-0002-2498-2702; Bradley, Daniel G/0000-0001-7335-7092				Balasse M, 2002, J ARCHAEOL SCI, V29, P853, DOI 10.1006/jasc.2001.0725; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Dunner S, 2003, GENET SEL EVOL, V35, P103, DOI 10.1051/gse:2002038; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Feldman M. W., 1989, MATH EVOLUTIONARY TH, P145; Hill AVS, 1997, PHILOS T R SOC B, V352, P1317, DOI 10.1098/rstb.1997.0116; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MEDJUGORAC I, 1994, ANIM GENET, V25, P19, DOI 10.1111/j.1365-2052.1994.tb00399.x; Midgley M, 1992, TRB CULTURE 1 FARMER; SCHRIMSHAW NS, 1988, AM J CLIN NUTR, V48, P1059; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Ward TJ, 1997, GENETICS, V147, P1863; Zvelebil M., 2000, ARCHAEOGENETICS DNA, P57	15	187	204	1	96	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					311	313		10.1038/ng1263	http://dx.doi.org/10.1038/ng1263			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14634648				2022-12-27	WOS:000186791000009
J	Irwin, WA; Bergamin, N; Sabatelli, P; Reggiani, C; Megighian, A; Merlini, L; Braghetta, P; Columbaro, M; Volpin, D; Bressan, GM; Bernardi, P; Bonaldo, P				Irwin, WA; Bergamin, N; Sabatelli, P; Reggiani, C; Megighian, A; Merlini, L; Braghetta, P; Columbaro, M; Volpin, D; Bressan, GM; Bernardi, P; Bonaldo, P			Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency	NATURE GENETICS			English	Article							PERMEABILITY TRANSITION; MECHANISM; CHANNELS; RELEASE; FIBERS; ONSET; CA2+	Collagen VI is an extracellular matrix protein that forms a microfilamentous network in skeletal muscles and other organs(1-3). Inherited mutations in genes encoding collagen VI in humans cause two muscle diseases, Bethlem myopathy and Ullrich congenital muscular dystrophy(4,5). We previously generated collagen VI deficient (Col6a1(-/-)) mice and showed that they have a muscle phenotype that strongly resembles Bethlem myopathy(6). The pathophysiological defects and mechanisms leading to the myopathic disorder were not known. Here we show that Col6a1(-/-) muscles have a loss of contractile strength associated with ultrastructural alterations of sarcoplasmic reticulum (SR) and mitochondria and spontaneous apoptosis. We found a latent mitochondrial dysfunction in myofibers of Col6a1(-/-) mice on incubation with the selective F1FO-ATPase inhibitor oligomycin, which caused mitochondrial depolarization, Ca2+ deregulation and increased apoptosis. These defects were reversible, as they could be normalized by plating Col6a1(-/-) myofibers on collagen VI or by addition of cyclosporin A (CsA), the inhibitor of mitochondrial permeability transition pore (PTP). Treatment of Col6a1(-/-) mice with CsA rescued the muscle ultrastructural defects and markedly decreased the number of apoptotic nuclei in vivo. These findings indicate that collagen VI myopathies have an unexpected mitochondrial pathogenesis that could be exploited for therapeutic intervention.	Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; ITOI CNR IOR, I-40136 Bologna, Italy; Univ Padua, Dept Human Anat, I-35121 Padua, Italy; Univ Padua, Dept Physiol, I-35121 Padua, Italy; Orthoped Inst Rizzoli, I-40136 Bologna, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.	bernardi@bio.unipd.it; bonaldo@bio.unipd.it	Megighian, Aram/G-6478-2014; Bergamin, Natascha/A-9315-2010; Braghetta, Paola/K-5478-2016; MEGIGHIAN, ARAM/I-8146-2019; Sabatelli, Patrizia/C-7479-2019; Bernardi, Paolo/C-3656-2008; Columbaro, Marta/C-6960-2019; Merlini, Luciano/N-6478-2019	Megighian, Aram/0000-0002-7971-5310; Braghetta, Paola/0000-0003-2547-8679; MEGIGHIAN, ARAM/0000-0002-7971-5310; Sabatelli, Patrizia/0000-0003-2345-5094; Bernardi, Paolo/0000-0001-9187-3736; Merlini, Luciano/0000-0002-1108-1198; Columbaro, Marta/0000-0002-4439-8976; Bonaldo, Paolo/0000-0002-9571-8140	Telethon [GGP02123, GP0229Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; Bowser DN, 2002, FASEB J, V16, P1105, DOI 10.1096/fj.01-0828fje; Bowser DN, 1998, BIOPHYS J, V75, P2004, DOI 10.1016/S0006-3495(98)77642-8; Camacho V.O., 2001, P NATL ACAD SCI USA, V98, P7516, DOI DOI 10.1073/PNAS.121027598; D'hahan N, 1999, P NATL ACAD SCI USA, V96, P12162, DOI 10.1073/pnas.96.21.12162; Germinario E, 2002, J APPL PHYSIOL, V92, P2045, DOI 10.1152/japplphysiol.00673.2001; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gugliucci A, 2002, J BIOL CHEM, V277, P31789, DOI 10.1074/jbc.M204450200; Howell SJ, 1998, EXP CELL RES, V241, P230, DOI 10.1006/excr.1998.4051; Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P10014, DOI 10.1073/pnas.1633614100; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Plant DR, 2002, J PHYSIOL-LONDON, V543, P169, DOI 10.1113/jphysiol.2002.022418; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rossi R, 2001, AM J PHYSIOL-CELL PH, V281, pC585, DOI 10.1152/ajpcell.2001.281.2.C585; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; TIMPL R, 1994, EXTRACELLULAR MATRIX, P208; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	26	383	392	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					367	371		10.1038/ng1270	http://dx.doi.org/10.1038/ng1270			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14625552				2022-12-27	WOS:000186791000019
J	Min-Oo, G; Fortin, A; Tam, MF; Nantel, A; Stevenson, MM; Gros, P				Min-Oo, G; Fortin, A; Tam, MF; Nantel, A; Stevenson, MM; Gros, P			Pyruvate kinase deficiency in mice protects against malaria	NATURE GENETICS			English	Article							PLASMODIUM-FALCIPARUM MALARIA; RECOMBINANT CONGENIC STRAINS; GENETIC-CONTROL; MOUSE MALARIA; SUSCEPTIBILITY; RESISTANCE; CELL; INFECTION; LOCUS; HOST	The global health impact of malaria is enormous, with an estimated 300-500 million clinical cases and 1 million annual deaths(1). In humans, initial susceptibility to infection with Plasmodium species, disease severity and ultimate outcome of malaria (self-healing or lethal) are under complex genetic control. Alleles associated with sickle cell anemia, beta-thalassemia and deficiency in glucose-6-phosphate dehydrogenase have a protective effect against malaria and may have been retained by positive selection in areas of endemic malaria(2). Likewise, genetic variations in erythrocyte antigens and levels of host cytokines affect type and severity of disease(3,4). A mouse model of infection with Plasmodium chabaudi was used to study the genetic component of malaria susceptibility. Segregation analyses in informative F-2 crosses derived from resistant C57BL/6J and susceptible A/J, C3H and SJL strains using extent of blood stage replication of the parasite and survival as traits mapped three P. chabaudi resistance ( Char) loci on chromosomes 9 (Char1), 8 (Char2) and 17 (Char3, MHC-linked)(5-7). Recombinant congenic strains AcB55 and AcB61 are unusually resistant to malaria despite carrying susceptibility alleles at Char1 and Char2. Malaria resistance in AcB55 and AcB61 is associated with splenomegaly and constitutive reticulocytosis, is inherited in an autosomal recessive fashion and is controlled by a locus on chromosome 3 (Char4)(8). Sequencing of candidate genes from the Char4 region identified a loss-of-function mutation (269T-->A, resulting in the amino acid substitution I90N) in the pyruvate kinase gene (Pklr) that underlies the malaria resistance in AcB55 and AcB61. These results suggest that pyruvate kinase deficiency may similarly protect humans against malaria.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; National Research Council Canada	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2002, GENES IMMUN, V3, P177, DOI 10.1038/sj.gene.6363841; Fortin A, 2002, HUM MOL GENET, V11, P2469, DOI 10.1093/hmg/11.20.2469; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Jacobasch G, 1996, MOL ASPECTS MED, V17, P143, DOI 10.1016/0098-2997(96)88345-2; Kemp SJ, 1997, NAT GENET, V16, P194, DOI 10.1038/ng0697-194; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; OELSHLEGEL FJ, 1975, NATURE, V255, P345, DOI 10.1038/255345a0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROTH E, 1990, BLOOD CELLS, V16, P453; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SAMBROOK J, 2001, MOL CLONING LAB MANU, V1; STEVENSON MM, 1982, INFECT IMMUN, V38, P80, DOI 10.1128/IAI.38.1.80-88.1982; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vanSolinge WW, 1997, BLOOD, V90, P1197; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vladimirov V, 2003, INFECT IMMUN, V71, P2041, DOI 10.1128/IAI.71.4.2041-2046.2003; Weatherall D, 2002, GENES IMMUN, V3, P331, DOI 10.1038/sj.gene.6363878; WILLCOX M, 1983, ANN TROP MED PARASIT, V77, P239, DOI 10.1080/00034983.1983.11811704; Zanella A, 2000, BEST PRACT RES CL HA, V13, P57, DOI 10.1053/beha.1999.0057	29	96	99	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					357	362		10.1038/ng1260	http://dx.doi.org/10.1038/ng1260			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14595440				2022-12-27	WOS:000186791000017
J	Repping, S; Skaletsky, H; Brown, L; van Daalen, SKM; Korver, CM; Pyntikova, T; Kuroda-Kawaguchi, T; de Vries, JWA; Oates, RD; Silber, S; van der Veen, F; Page, DC; Rozen, S				Repping, S; Skaletsky, H; Brown, L; van Daalen, SKM; Korver, CM; Pyntikova, T; Kuroda-Kawaguchi, T; de Vries, JWA; Oates, RD; Silber, S; van der Veen, F; Page, DC; Rozen, S			Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection	NATURE GENETICS			English	Article							INTRACHROMOSOMAL RECOMBINATION; HUMAN-POPULATIONS; INFERTILE MEN; COPY NUMBER; AZFC REGION; DAZ GENES; MICRODELETIONS; MARKER; MALES; YQ11	Many human Y-chromosomal deletions are thought to severely impair reproductive fitness, which precludes their transmission to the next generation and thus ensures their rarity in the population. Here we report a 1.6-Mb deletion that persists over generations and is sufficiently common to be considered a polymorphism. We hypothesized that this deletion might affect spermatogenesis because it removes almost half of the Y chromosome's AZFc region, a gene-rich segment that is critical for sperm production(1,2). An association study established that this deletion, called gr/gr, is a significant risk factor for spermatogenic failure. The gr/gr deletion has far lower penetrance with respect to spermatogenic failure than previously characterized Y-chromosomal deletions; it is often transmitted from father to son. By studying the distribution of gr/gr-deleted chromosomes across the branches of the Y chromosome's genealogical tree, we determined that this deletion arose independently at least 14 times in human history. We suggest that the existence of this deletion as a polymorphism reflects a balance between haploid selection, which culls gr/gr-deleted Y chromosomes from the population, and homologous recombination, which continues to generate new gr/gr deletions.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; Ichikawa Gen Hosp, Tokyo Dent Coll, Reprod Ctr, Chiba, Japan; Boston Univ, Med Ctr, Dept Urol, Boston, MA 02118 USA; St Lukes Hosp, Infertil Ctr, St Louis, MO 63017 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; Tokyo Dental College; Boston University; Saint Luke's Hospital - Missouri	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	; Rozen, Steven G./J-5939-2013	Oates, Robert/0000-0003-2330-6697; Rozen, Steven G./0000-0002-4288-0056; Repping, Sjoerd/0000-0002-6959-149X				Bienvenu T, 2001, ANN GENET-PARIS, V44, P125, DOI 10.1016/S0003-3995(01)01078-4; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Vries JWA, 2002, FERTIL STERIL, V77, P68, DOI 10.1016/S0015-0282(01)02935-1; Ellis N, 2002, GENOME RES, V12, P339; Ewis AA, 2002, J HUM GENET, V47, P257, DOI 10.1007/s100380200035; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kuroki Y, 1999, J HUM GENET, V44, P289, DOI 10.1007/s100380050162; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soucie JM, 1998, AM J HEMATOL, V59, P288, DOI 10.1002/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; World Health Organization, 1992, WHO LAB MAN EX HUM S; Yen P, 2001, NAT GENET, V29, P243, DOI 10.1038/ng1101-243	28	308	333	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					247	251		10.1038/ng1250	http://dx.doi.org/10.1038/ng1250			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14528305				2022-12-27	WOS:000186273300020
J	Woodruff, ML; Wang, ZY; Chung, HY; Redmond, TM; Fain, GL; Lem, J				Woodruff, ML; Wang, ZY; Chung, HY; Redmond, TM; Fain, GL; Lem, J			Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis	NATURE GENETICS			English	Article							PIGMENT ACTIVATES TRANSDUCTION; EQUIVALENT-LIGHT HYPOTHESIS; VITAMIN-A; VISUAL PIGMENT; MOUSE MODEL; RETINITIS-PIGMENTOSA; SALAMANDER RODS; BINDING PROTEIN; NIGHT BLINDNESS; RPE65 GENE	Mutations in Rpe65 disrupt synthesis of the opsin chromophore ligand 11-cis- retinal and cause Leber congenital amaurosis (LCA), a severe, early-onset retinal dystrophy. To test whether light-independent signaling by unliganded opsin causes the degeneration, we used Rpe65 - null mice, a model of LCA. Dark-adapted Rpe65(-/-) mice behaved as if light adapted, exhibiting reduced circulating current, accelerated response turn-off, and diminished intracellular calcium. A genetic block of transducin signaling completely rescued degeneration irrespective of an elevated level of retinyl ester. These studies clearly show that activation of sensory transduction by unliganded opsin, and not the accumulation of retinyl esters, causes light-independent retinal degeneration in LCA. A similar mechanism may also be responsible for degeneration induced by vitamin A deprivation.	Tufts Univ, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; NEI, Retinal Cell & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Genet Program, Boston, MA 02111 USA; Tufts Univ, Sch Med, Tufts Ctr Vis Res, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of California System; University of California Los Angeles; Tufts University; Tufts University	Lem, J (corresponding author), Tufts Univ, New England Med Ctr, Mol Cardiol Res Inst, 750 Washington St,Box 5045, Boston, MA 02111 USA.			Redmond, T. Michael/0000-0002-1813-5291; Fain, Gordon/0000-0002-9813-0342	NATIONAL EYE INSTITUTE [ZIAEY000260, Z01EY000260] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ablonczy Z, 2002, J BIOL CHEM, V277, P40491, DOI 10.1074/jbc.M205507200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; CERVETTO L, 1986, J PHYSIOL-LONDON, V370, P91, DOI 10.1113/jphysiol.1986.sp015924; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; CORNWALL MC, 1995, J GEN PHYSIOL, V106, P543, DOI 10.1085/jgp.106.3.543; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; Dartnall H. J. A., 1972, HDB SENSORY PHYSIOLO, V7, P122; DOWLING JE, 1960, P NATL ACAD SCI USA, V46, P587, DOI 10.1073/pnas.46.5.587; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; Fain GL, 1999, INVEST OPHTH VIS SCI, V40, P2770; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Felius J, 2002, ARCH OPHTHALMOL-CHIC, V120, P55; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; JONES GJ, 1993, J GEN PHYSIOL, V102, P483, DOI 10.1085/jgp.102.3.483; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Matthews HR, 2002, J PHYSIOL-LONDON, V542, P829, DOI 10.1113/jphysiol.2001.013218; MATTHEWS HR, IN PRESS J PHYSL; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Mendez A, 2003, J NEUROSCI, V23, P3124; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2003, INVEST OPHTH VIS SCI, V44, P310, DOI 10.1167/iovs.02-0567; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Surya A, 1997, J BIOL CHEM, V272, P21745, DOI 10.1074/jbc.272.35.21745; TANG G, 1993, J NUTR BIOCHEM, V4, P58, DOI 10.1016/0955-2863(93)90021-N; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987	42	149	154	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					158	164		10.1038/ng1246	http://dx.doi.org/10.1038/ng1246			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	14517541				2022-12-27	WOS:000185625300012
J	Benson, KF; Li, FQ; Person, RE; Albani, D; Duan, ZJ; Wechsler, J; Meade-White, K; Williams, K; Acland, GM; Niemeyer, G; Lothrop, CD; Horwitz, M				Benson, KF; Li, FQ; Person, RE; Albani, D; Duan, ZJ; Wechsler, J; Meade-White, K; Williams, K; Acland, GM; Niemeyer, G; Lothrop, CD; Horwitz, M			Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase	NATURE GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; CATHEPSIN-G; BETA-3A SUBUNIT; SORTING SIGNALS; PROTEIN COMPLEX; AP-3 ADAPTER; DISTINCT; IDENTIFICATION; TRAFFICKING; MEMBRANES	Cyclic hematopoiesis is a stem cell disease in which the number of neutrophils and other blood cells oscillates in weekly phases. Autosomal dominant mutations of ELA2, encoding the protease neutrophil elastase(1), found in lysosome-like granules, cause cyclic hematopoiesis(2) and most cases of the pre-leukemic disorder severe congenital neutropenia (SCN; ref. 3) in humans. Over 20 different mutations of neutrophil elastase have been identified, but their consequences are elusive, because they confer no consistent effects on enzymatic activity(4). The similar autosomal recessive disease of dogs, canine cyclic hematopoiesis(5), is not caused by mutations in ELA2 ( data not shown). Here we show that homozygous mutation of the gene encoding the dog adaptor protein complex 3 (AP3) beta-subunit, directing trans-Golgi export of transmembrane cargo proteins to lysosomes, causes canine cyclic hematopoiesis. C-terminal processing of neutrophil elastase exposes an AP3 interaction signal responsible for redirecting neutrophil elastase trafficking from membranes to granules. Disruption of either neutrophil elastase or AP3 perturbs the intracellular trafficking of neutrophil elastase. Most mutations in ELA2 that cause human cyclic hematopoiesis prevent membrane localization of neutrophil elastase, whereas most mutations in ELA2 that cause SCN lead to exclusive membrane localization.	Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cornell University; Auburn University System; Auburn University	Horwitz, M (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Box 357720,1705 NE Pacific St,HSB-K236B, Seattle, WA 98195 USA.	horwitz@u.washington.edu		Horwitz, Marshall/0000-0002-1683-1680				Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; ALLEN DH, 1995, J BIOL CHEM, V270, P1408, DOI 10.1074/jbc.270.3.1408; Bainton DF, 1999, J IMMUNOL METHODS, V232, P153, DOI 10.1016/S0022-1759(99)00173-8; BIETH JG, 1998, HDB PROTEOLYTIC ENZY, P54; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; CLARK JM, 1980, J CELL BIOL, V84, P102, DOI 10.1083/jcb.84.1.102; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; FUKS A, 1983, BIOCHIM BIOPHYS ACTA, V755, P195, DOI 10.1016/0304-4165(83)90203-9; GULLBERG U, 1995, J BIOL CHEM, V270, P12912, DOI 10.1074/jbc.270.21.12912; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Kaup M, 2002, BIOL CHEM, V383, P1011, DOI 10.1515/BC.2002.108; KJELDSEN L, 1993, BLOOD, V82, P3183; Kolkenbrock H, 2000, BIOL CHEM, V381, P49, DOI 10.1515/BC.2000.007; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; LOTHROP CD, 1987, ENDOCRINOLOGY, V120, P1027, DOI 10.1210/endo-120-3-1027; Mardones G, 2003, J IMMUNOL METHODS, V275, P169, DOI 10.1016/S0022-1759(03)00015-2; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; PAIGEN K, 1989, PROG NUCLEIC ACID RE, V37, P155; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Vita F, 1996, EXP CELL RES, V227, P367, DOI 10.1006/excr.1996.0286; Yang W, 2000, J CELL SCI, V113, P4077	29	129	133	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					90	96		10.1038/ng1224	http://dx.doi.org/10.1038/ng1224			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12897784				2022-12-27	WOS:000185018500016
J	Ewart-Toland, A; Briassouli, P; de Koning, JP; Mao, JH; Yuan, JW; Chan, F; MacCarthy-Morrogh, L; Ponder, BAJ; Nagase, H; Burn, J; Ball, S; Almeida, M; Linardopoulos, S; Balmain, A				Ewart-Toland, A; Briassouli, P; de Koning, JP; Mao, JH; Yuan, JW; Chan, F; MacCarthy-Morrogh, L; Ponder, BAJ; Nagase, H; Burn, J; Ball, S; Almeida, M; Linardopoulos, S; Balmain, A			Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER; CENTROSOME AMPLIFICATION; COLORECTAL CANCERS; BREAST-CANCER; SKIN TUMORS; KINASE; LOCUS; ASSOCIATION; MICE	Linkage analysis and haplotype mapping in interspecific mouse crosses (Mus musculus x Mus spretus) identified the gene encoding Aurora2 (Stk6 in mouse and STK15 in human) as a candidate skin tumor susceptibility gene. The Stk6 allele inherited from the susceptible M. musculus parent was overexpressed in normal cells and preferentially amplified in tumor cells from F 1 hybrid mice. We identified a common genetic variant in STK15 ( resulting in the amino acid substitution F31I) that is preferentially amplified and associated with the degree of aneuploidy in human colon tumors. The Ile31 variant transforms rat1 cells more potently than the more common Phe31 variant. The E2 ubiquitin-conjugating enzyme UBE2N was a preferential binding partner of the weak STK15 Phe31 variant form in yeast two-hybrid screens and in human cells. This interaction results in colocalization of UBE2N with STK15 at the centrosomes during mitosis. These results are consistent with an important role for the Ile31 variant of STK15 in human cancer susceptibility.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Inst Canc Res, Haddows Labs, Ctr Canc Therapeut, Canc Res UK, Sutton SM2 5NG, Surrey, England; Strangeways Res Labs, Univ Dept Oncol, Human Canc Genet Grp, Canc Res UK, Cambridge CB1 8RN, England; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Inst Human Genet, Newcastle Upon Tyne NE1 3B2, Tyne & Wear, England; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Roswell Park Cancer Institute; University of California System; University of California San Francisco	Linardopoulos, S (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA.	spiros@icr.ac.uk; abalmain@cc.ucsf.edu	Toland, Amanda Ewart/E-4202-2011; Mao, Jian-Hua/EIZ-8595-2022; Almeida, Maria Rosário/C-4385-2018	Mao, Jian-Hua/0000-0001-9320-6021; Almeida, Maria Rosário/0000-0002-1889-5469; Linardopoulos, Spiros/0000-0002-6600-400X; Toland, Amanda/0000-0002-0271-1792; Burn, John/0000-0002-9823-2322				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; ALDAZ CM, 1989, MOL CARCINOGEN, V2, P22, DOI 10.1002/mc.2940020104; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Giet R, 1999, J CELL SCI, V112, P3591; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; IWABUCHI H, 1995, CANCER RES, V55, P6172; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KEMP CJ, 1993, CANCER RES, V53, P6022; Korn WM, 1999, GENE CHROMOSOME CANC, V25, P82, DOI 10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; SEGRAVES R, 2002, DNA ARRAYS LAB MANUA, P380; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	39	280	295	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					403	412		10.1038/ng1220	http://dx.doi.org/10.1038/ng1220			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12881723				2022-12-27	WOS:000184470500018
J	Gibbons, RJ; Pellagatti, A; Garrick, D; Wood, WG; Malik, N; Ayyub, H; Langford, C; Boultwood, J; Wainscoat, JS; Higgs, DR				Gibbons, RJ; Pellagatti, A; Garrick, D; Wood, WG; Malik, N; Ayyub, H; Langford, C; Boultwood, J; Wainscoat, JS; Higgs, DR			Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS)	NATURE GENETICS			English	Article							PIG-A GENE; MENTAL-RETARDATION; MOLECULAR ANALYSIS; CLINICAL-FEATURES; GLOBIN; SPECTRUM	Inherited mutations of specific genes have elucidated the normal roles of the proteins they encode by relating specific mutations to particular phenotypes. But many potentially informative mutations in such genes are lethal early in development. Consequently, inherited mutations may not reflect all the functional roles of such proteins. Acquired, somatic defects should reflect a wider spectrum of mutations because they are not prone to negative selection in development. It has been difficult to identify such mutations so far, but microarray analysis provides a new opportunity to do so. Using this approach, we have shown that in individuals with myelodysplasia associated with alpha-thalassemia (ATMDS), somatic mutations of the gene encoding the chromatin remodeling factor ATRX cause an unexpectedly severe hematological phenotype compared with the wide spectrum of inherited mutations affecting this gene. These findings cast new light on this pleiotropic cofactor, which appears to be an essential component rather than a mere facilitator of globin gene expression.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, LRF Mol Haematol Unit, Oxford OX3 9DS, England; Sanger Ctr, Cambridge, England	University of Oxford; University of Oxford; Wellcome Trust Sanger Institute	Higgs, DR (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	drhiggs@molbiol.ox.ac.uk	Garrick, David/F-1728-2017; GARRICK, David/O-5734-2019; Gibbons, Richard/E-6937-2011	Garrick, David/0000-0001-7422-7986; GARRICK, David/0000-0001-7422-7986; Boultwood, Jacqueline/0000-0002-4330-2928; Gibbons, Richard/0000-0002-7680-9311; Pellagatti, Andrea/0000-0002-6122-0221				Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; CRADDOCK CF, 1995, EMBO J, V14, P1718, DOI 10.1002/j.1460-2075.1995.tb07161.x; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; HAPPLE R, 1986, CLIN GENET, V29, P321; Higgs D., 2001, DISORDERS HEMOGLOBIN, P431; HIGGS DR, 1983, AM J MED, V75, P181, DOI 10.1016/0002-9343(83)91189-0; HIGGS DR, 1989, BLOOD, V73, P1081; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Nafa K, 1998, BLOOD CELL MOL DIS, V24, P370, DOI 10.1006/bcmd.1998.0203; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Wada T, 2003, CONTEMPORARY CLIN NE, P309; WEATHERALL DJ, 1978, BRIT J HAEMATOL, V38, P305, DOI 10.1111/j.1365-2141.1978.tb01049.x; WILKIE AOM, 1990, AM J HUM GENET, V46, P1127	16	105	108	3	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					446	449		10.1038/ng1213	http://dx.doi.org/10.1038/ng1213			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12858175				2022-12-27	WOS:000184470500024
J	Slager, RE; Lynn, T; Newton, TL; Vlangos, CN; Finucane, B; Elsea, SH				Slager, RE; Lynn, T; Newton, TL; Vlangos, CN; Finucane, B; Elsea, SH			Mutations in RAI1 associated with Smith-Magenis syndrome	NATURE GENETICS			English	Article							CRITICAL INTERVAL; GENE; 17P11.2; DELETION; MOUSE	Smith-Magenis syndrome (SMS) is a mental retardation syndrome associated with deletions involving chromosome 17p11.2. Persons with SMS have characteristic behavioral abnormalities, including self-injurious behaviors and sleep disturbance, and distinct craniofacial and skeletal anomalies. We identified dominant frameshift mutations leading to protein truncation in RAI1 in three individuals who have phenotypic features consistent with SMS but do not have 17p11.2 deletions detectable by standard fluorescence in situ hybridization techniques.	Michigan State Univ, Grad Program Genet, E Lansing, MI 48823 USA; Michigan State Univ, Dept Zool, E Lansing, MI 48823 USA; Michigan State Univ, Dept Pediat Human Dev, E Lansing, MI 48823 USA; Elwyn Training & Res Inst, Elwyn, PA 19063 USA	Michigan State University; Michigan State University; Michigan State University	Elsea, SH (corresponding author), Michigan State Univ, Grad Program Genet, S-320 Plant Biol Bldg, E Lansing, MI 48823 USA.			Elsea, Sarah/0000-0002-1400-8519; Finucane, Brenda/0000-0003-4841-669X				Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Elsea SH, 1997, CYTOGENET CELL GENET, V79, P276, DOI 10.1159/000134742; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; Juyal RC, 1996, AM J HUM GENET, V58, P998; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lucas RE, 2001, EUR J HUM GENET, V9, P892, DOI 10.1038/sj.ejhg.5200734; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Rekdal C, 2000, J BIOL CHEM, V275, P40288, DOI 10.1074/jbc.M006978200; Seranski P, 2001, GENE, V270, P69, DOI 10.1016/S0378-1119(01)00415-2; Smith ACM, 1998, AM J MED GENET, V81, P179, DOI 10.1002/(SICI)1096-8628(19980328)81:2<179::AID-AJMG10>3.0.CO;2-E; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; VLANGOS CN, IN PRESS MOL GENET M	15	230	240	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					466	468		10.1038/ng1126	http://dx.doi.org/10.1038/ng1126			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652298	Bronze			2022-12-27	WOS:000181928600016
J	Woolhouse, MEJ; Webster, JP; Domingo, E; Charlesworth, B; Levin, BR				Woolhouse, MEJ; Webster, JP; Domingo, E; Charlesworth, B; Levin, BR			Biological and biomedical implications of the co-evolution of pathogens and their hosts	NATURE GENETICS			English	Review							T-LYMPHOCYTE RESPONSES; PARASITE COEVOLUTION; IMMUNE-RESPONSES; SCHISTOSOMA-MANSONI; NATURAL-SELECTION; EVOLUTION; RESISTANCE; ADAPTATION; VIRULENCE; VIRUS	Co-evolution between host and pathogen is, in principle, a powerful determinant of the biology and genetics of infection and disease. Yet co-evolution has proven difficult to demonstrate rigorously in practice, and co-evolutionary thinking is only just beginning to inform medical or veterinary research in any meaningful way, even though it can have a major influence on how genetic variation in biomedically important traits is interpreted. Improving our understanding of the biomedical significance of co-evolution will require changing the way in which we look for it, complementing the phenomenological approach traditionally favored by evolutionary biologists with the exploitation of the extensive data becoming available on the molecular biology and molecular genetics of host-pathogen interactions.	Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland; Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; Univ Oxford, Oxford, England; Dept Zool, Oxford OX1 3PS, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh, Midlothian, Scotland; Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of Edinburgh; Autonomous University of Madrid; University of Oxford; University of Edinburgh; Emory University	Woolhouse, MEJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Easter Bush, Roslin EH25 9RG, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	Domingo, Esteban/K-3937-2014	Domingo, Esteban/0000-0002-0573-1676; Webster, Joanne P./0000-0001-8616-4919	NIGMS NIH HHS [R01 GM091875] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM091875] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Agrawal A, 2002, EVOL ECOL RES, V4, P79; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allen JE, 1997, IMMUNOL TODAY, V18, P387, DOI 10.1016/S0167-5699(97)01102-X; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altschuler EL, 2000, MED HYPOTHESES, V54, P1003, DOI 10.1054/mehy.1999.1017; ANDERSON R M, 1991; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Barbujani G., 1999, EVOLUTION HLTH DIS; BASANEZ MG, 1995, PARASITOLOGY, V110, P409, DOI 10.1017/S0031182000064751; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bohannan BJM, 1999, EVOLUTION, V53, P292, DOI 10.1111/j.1558-5646.1999.tb05355.x; BRAUNBRETON C, 1981, J BACTERIOL, V148, P845, DOI 10.1128/JB.148.3.845-852.1981; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Charlesworth D, 2001, TRENDS ECOL EVOL, V16, P235, DOI 10.1016/S0169-5347(01)02126-7; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DAVIES NB, 1989, J ANIM ECOL, V58, P225, DOI 10.2307/4996; Day CL, 2001, J VIROL, V75, P6279, DOI 10.1128/JVI.75.14.6279-6291.2001; DELATORRE JC, 1988, J VIROL, V62, P2050, DOI 10.1128/JVI.62.6.2050-2058.1988; Domingo E, 2001, QUASISPECIES RNA VIR; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI [10.1111/j.1558-5646.1998.tb01833.x, 10.2307/2411236]; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Falconer D. S., 1996, INTRO QUANTITATIVE G; Faure S, 2000, SCIENCE, V287, P2274, DOI 10.1126/science.287.5461.2274; Fenner F., 1999, BIOL CONTROL VERTEBR; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Fraser CM, 2000, NATURE, V406, P799, DOI 10.1038/35021244; Gandon S, 2002, ECOL LETT, V5, P246, DOI 10.1046/j.1461-0248.2002.00305.x; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Helmby H, 1998, INFECT IMMUN, V66, P5167, DOI 10.1128/IAI.66.11.5167-5174.1998; Hill AVS, 1997, PHILOS T R SOC B, V352, P1317, DOI 10.1098/rstb.1997.0116; HOFNUNG M, 1976, MOL GEN GENET, V145, P207, DOI 10.1007/BF00269595; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; Kniskern J, 2001, POPUL ECOL, V43, P3, DOI 10.1007/PL00012012; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Levin BR, 1996, MATH BIOSCI, V132, P69, DOI 10.1016/0025-5564(95)00053-4; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Little TJ, 2002, J EVOLUTION BIOL, V15, P1, DOI 10.1046/j.1420-9101.2002.00366.x; Lively C. M., 1995, P421, DOI 10.1017/CBO9780511629396.017; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; MCFADDEN G, 1995, NAT MED, V1, P408, DOI 10.1038/nm0595-408; MODE CJ, 1958, EVOLUTION, V12, P158, DOI 10.2307/2406026; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Morand S, 1996, P ROY SOC B-BIOL SCI, V263, P119, DOI 10.1098/rspb.1996.0019; NUISMER SL, 1998, P ROY SOC LOND B BIO, V266, P605; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Oppliger A, 1999, J EVOLUTION BIOL, V12, P951, DOI 10.1046/j.1420-9101.1999.00101.x; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455, DOI 10.1098/rspb.1999.0659; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Searle S, 1999, J MED GENET, V36, P295; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Sorci G, 1997, TRENDS ECOL EVOL, V12, P196, DOI 10.1016/S0169-5347(97)01056-2; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stosor V, 2001, NEW ENGL J MED, V345, P761, DOI 10.1056/NEJM200109063451010; SULLIVAN JT, 1981, INT J PARASITOL, V11, P481, DOI 10.1016/0020-7519(81)90067-9; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Thompson JD., 1994, COEVOLUTIONARY PROCE; THOMPSON JN, 1992, NATURE, V360, P121, DOI 10.1038/360121a0; THOMPSON JN, 1999, AM NAT, V153, P51; Vartanian JP, 2001, P NATL ACAD SCI USA, V98, P13172, DOI 10.1073/pnas.221334898; Vogel TU, 1999, IMMUNOL REV, V167, P327, DOI 10.1111/j.1600-065X.1999.tb01402.x; Wakelin D., 1988, GENETICS RESISTANCE; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Webster JP, 1998, EVOLUTION, V52, P1627, DOI [10.2307/2411336, 10.1111/j.1558-5646.1998.tb02243.x]; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804; Webster JP, 2001, PARASITOLOGY, V122, P423, DOI 10.1017/S0031182001007442; Webster JP, 1999, P ROY SOC B-BIOL SCI, V266, P391, DOI 10.1098/rspb.1999.0650; Webster R.G., 1999, ORIGIN EVOLUTION VIR; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Woolhouse MEJ, 2001, PHILOS T ROY SOC B, V356, P981, DOI 10.1098/rstb.2001.0899; Woolhouse MEJ, 2001, TRENDS MICROBIOL, V9, P67, DOI 10.1016/S0966-842X(00)01912-0; Woolhouse MEJ, 2000, PARASITOL TODAY, V16, P506, DOI 10.1016/S0169-4758(00)01820-2; Yan G, 1997, EVOLUTION, V51, P441, DOI [10.2307/2411116, 10.1111/j.1558-5646.1997.tb02431.x]; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	105	557	575	2	243	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					569	577		10.1038/ng1202-569	http://dx.doi.org/10.1038/ng1202-569			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12457190	Green Published			2022-12-27	WOS:000179593000007
J	Bufe, B; Hofmann, T; Krautwurst, D; Raguse, JD; Meyerhof, W				Bufe, B; Hofmann, T; Krautwurst, D; Raguse, JD; Meyerhof, W			The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides	NATURE GENETICS			English	Article							ADAPTATION; IDENTIFICATION; TRANSDUCTION; EXPRESSION; FAMILY; CELLS	Bitter taste generally causes aversion, which protects humans from ingesting toxic substances. But bitter flavors also contribute to the palatability of food and beverages, thereby influencing nutritional habits in humans(1). Although many studies have examined bitter taste(2-6), the underlying receptor mechanisms remain poorly understood. Anatomical, functional and genetic data from rodents suggest the existence of a family of receptors that are responsive to bitter compounds(7-9). Here we report that a human member of this family, TAS2R16, is present in taste receptor cells on the tongue and is activated by bitter beta-glucopyranosides. Responses to these phytonutrients show a similar concentration dependence and desensitization in transfected cells and in experiments assessing taste perception in humans. Bitter compounds consisting of a hydrophobic residue attached to glucose by a beta-glycosidic bond activate TAS2R16. Thus, TAS2R16 links the recognition of a specific chemical structure to the perception of bitter taste. If the ability of TAS2R16 to detect substances with common molecular properties is typical of the bitter receptor family, it may explain how a few receptors permit the perception of numerous bitter substances.	German Inst Human Nutr, Dept Mol Genet, D-14558 Potsdam, Germany; German Res Ctr Food Chem, Garching, Germany; Clin & Policlin Oral & Maxillofacial Surg & Plast, Charite, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meyerhof, W (corresponding author), German Inst Human Nutr, Dept Mol Genet, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	meyerhof@mail.dife.de	Krautwurst, Dietmar/AAD-5579-2019; Bufe, Bernd/N-6685-2018	Krautwurst, Dietmar/0000-0002-3350-8682; Bufe, Bernd/0000-0003-1610-0658				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ammon C, 2001, ARCH PHYSIOL BIOCHEM, V110, P137; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Drewnowski A, 2001, NUTR REV, V59, P163, DOI 10.1111/j.1753-4887.2001.tb07007.x; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dulac C, 2000, CELL, V100, P607, DOI 10.1016/S0092-8674(00)80697-2; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Frank O, 2001, J AGR FOOD CHEM, V49, P231, DOI 10.1021/jf0010073; Keast RSJ, 2002, CHEM SENSES, V27, P123, DOI 10.1093/chemse/27.2.123; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KUBO I, 1994, PHYSIOL BEHAV, V56, P1203, DOI 10.1016/0031-9384(94)90367-0; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; MAILGAARD M, 1999, SENSORY EVALUATION T, P122; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MEYERHOF W, 1992, P NATL ACAD SCI USA, V89, P10267, DOI 10.1073/pnas.89.21.10267; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Roosterman D, 1997, J NEUROENDOCRINOL, V9, P741, DOI 10.1046/j.1365-2826.1997.00632.x; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Torre V, 1995, J NEUROSCI, V15, P7757; Vane JR, 2000, J PHYSIOL PHARMACOL, V51, P573; VONLEIBIG J, 1844, CHEM BRIEFE; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	26	323	363	9	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					397	401		10.1038/ng1014	http://dx.doi.org/10.1038/ng1014			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379855				2022-12-27	WOS:000179034800015
J	Hess, P; Pihan, G; Sawyers, CL; Flavell, RA; Davis, RJ				Hess, P; Pihan, G; Sawyers, CL; Flavell, RA; Davis, RJ			Survival signaling mediated by c-Jun NH2-terminal kinase in transformed B lymphoblasts	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL ONCOGENE; HEMATOPOIETIC-CELLS; MYELOPROLIFERATIVE DISEASE; PHILADELPHIA-CHROMOSOME; BCL-2 EXPRESSION; BONE-MARROW; PATHWAY; ACTIVATION; APOPTOSIS	The c-Jun NH2-terminal kinase (JNK) is implicated in the apoptotic response of cells exposed to stress(1), but the JNK signal transduction pathway may not act exclusively in apoptosis(1). In some studies of tumor cells, JNK has been implicated in signaling cell survival(1). The possibility that JNK might mediate a survival signal in tumor cells is consistent with the observation that it is activated in response to some oncogenes, such as the leukemogenic oncogene BCR-ABL, which is created by a reciprocal translocation between human chromosomes 9 and 22 (ref. 2). The BCR-ABL protein activates the JNK signaling pathway in hematopoietic cells and increases transcriptional activity mediated by the transcription factor AP1 (ref. 3). Also, inhibition of c-Jun or JNK prevents BCR-ABL-induced cell transformation in vitro(3,4). Although this implicates the JNK signaling pathway in transformation by BCR-ABL, the possible role of JNK in this process is unclear. We find that disruption of the JNK ortholog Mapk8 (also known as Jnk1) in mice causes defective transformation of pre-B cells by BCR-ABL in vitro and in vivo. The Jnk1 protein is required for the survival of the transformed cells in the absence of stromal support. Failure to survive is associated with decreased expression of Bcl2, and the effect of Jnk1 deficiency can be rescued by transgenic expression of Bcl2. Our results show that Jnk1 signals cell survival in transformed B lymphoblasts and suggest that it may contribute to the pathogenesis of some proliferative diseases.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; Yale University; Yale University	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, 373 Plantat St, Worcester, MA 01605 USA.		Sawyers, Charles/G-5327-2016					Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cortez D, 1997, ONCOGENE, V15, P2333, DOI 10.1038/sj.onc.1201400; DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Packham G, 1998, GENE DEV, V12, P2475, DOI 10.1101/gad.12.16.2475; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; SANCHEZGARCIA I, 1995, P NATL ACAD SCI USA, V92, P5287, DOI 10.1073/pnas.92.12.5287; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Shuai K, 1996, ONCOGENE, V13, P247; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; WHITLOCK CA, 1984, J IMMUNOL METHODS, V67, P353, DOI 10.1016/0022-1759(84)90475-7; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	29	140	145	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					201	205		10.1038/ng946	http://dx.doi.org/10.1038/ng946			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12161751				2022-12-27	WOS:000177714900023
J	Zuchner, S; Mersiyanova, IV; Muglia, M; Bissar-Tadmouri, N; Rochelle, J; Dadali, EL; Zappia, M; Nelis, E; Patitucci, A; Senderek, J; Parman, Y; Evgrafov, O; De Jonghe, P; Takahashi, Y; Tsuji, S; Pericak-Vance, MA; Quattrone, A; Battologlu, E; Polyakov, AV; Timmerman, V; Schroder, JM; Vance, JM				Zuchner, S; Mersiyanova, IV; Muglia, M; Bissar-Tadmouri, N; Rochelle, J; Dadali, EL; Zappia, M; Nelis, E; Patitucci, A; Senderek, J; Parman, Y; Evgrafov, O; De Jonghe, P; Takahashi, Y; Tsuji, S; Pericak-Vance, MA; Quattrone, A; Battologlu, E; Polyakov, AV; Timmerman, V; Schroder, JM; Vance, JM			Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A	NATURE GENETICS			English	Article							GENETIC-HETEROGENEITY; DISEASE TYPE-2; FUSION; FISSION; CMT2A; MFN2; DNA	We report missense mutations in the mitochondrial fusion protein mitofusin 2 (MFN2) in seven large pedigrees affected with Charcot-Marie-Tooth neuropathy type 2A (CMT2A). Although a mutation in kinesin family member 1B-beta (KIF1B) was associated with CMT2A in a single Japanese family, we found no mutations in KIF1B in these seven families. Because these families include all published pedigrees with CMT2A and are ethnically diverse, we conclude that the primary gene mutated in CMT2A is MFN2.	Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Rhein Westfal TH Aachen, Univ Hosp, Dept Neuropathol, D-52074 Aachen, Germany; Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; CNR, Inst Neurol Sci, Cosenza, Italy; Bogazici Univ, Dept Mol Biol & Genet, TR-34342 Istanbul, Turkey; Fatih Univ, Dept Biol, TR-34500 Istanbul, Turkey; Univ Magna Graecia, Inst Neurol, Catanzaro, Italy; Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; Rhein Westfal TH Aachen, Univ Hosp, Inst Human Genet, D-52074 Aachen, Germany; Univ Istanbul, Istanbul Med Sch, Dept Neurol, TR-34342 Istanbul, Turkey; Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan	Duke University; RWTH Aachen University; RWTH Aachen University Hospital; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); Bogazici University; Fatih University; Magna Graecia University of Catanzaro; Flanders Institute for Biotechnology (VIB); University of Antwerp; RWTH Aachen University; RWTH Aachen University Hospital; Istanbul University; University of Tokyo	Vance, JM (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, 595 LaSalle St, Durham, NC 27710 USA.	jeff@chg.duhs.duke.edu	Zappia, Mario/AAB-7800-2019; Senderek, Jan/F-8405-2015; QUATTRONE, Aldo/A-6734-2016; Dadali, Elena/AFG-0883-2022; Battaloğlu, Esra/AAF-1559-2020; Timmerman, Vincent/O-7283-2019	Senderek, Jan/0000-0002-8263-1783; QUATTRONE, Aldo/0000-0003-2001-957X; Dadali, Elena/0000-0001-5602-2805; Timmerman, Vincent/0000-0002-2162-0933; Vance, Jeffery/0000-0003-3815-8199; PATITUCCI, ALESSANDRA/0000-0002-4122-2019; MUGLIA, MARIA/0000-0001-6413-3935				Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BENOTHMANE K, 1993, GENOMICS, V17, P370; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Muglia M, 2001, NEUROLOGY, V56, P100, DOI 10.1212/WNL.56.1.100; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Pericak-Vance MA, 1997, NEUROGENETICS, V1, P89, DOI 10.1007/s100480050013; Rojo M, 2002, J CELL SCI, V115, P1663; Saito M, 1997, NEUROLOGY, V49, P1630, DOI 10.1212/WNL.49.6.1630; Santel A, 2001, J CELL SCI, V114, P867; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	1127	1169	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					449	451		10.1038/ng1341	http://dx.doi.org/10.1038/ng1341			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15064763	Bronze			2022-12-27	WOS:000221183000015
J	Nagaki, K; Cheng, ZK; Ouyang, S; Talbert, PB; Kim, M; Jones, KM; Henikoff, S; Buell, CR; Jiang, JM				Nagaki, K; Cheng, ZK; Ouyang, S; Talbert, PB; Kim, M; Jones, KM; Henikoff, S; Buell, CR; Jiang, JM			Sequencing of a rice centromere uncovers active genes	NATURE GENETICS			English	Article							CENP-A; CHROMATIN IMMUNOPRECIPITATION; TRANSPOSABLE ELEMENT; SATELLITE REPEAT; DNA ELEMENT; ORGANIZATION; NEOCENTROMERE; KINETOCHORE; REGIONS; COMPLEX	Centromeres are the last frontiers of complex eukaryotic genomes, consisting of highly repetitive sequences that resist mapping, cloning and sequencing. The centromere of rice Chromosome 8 (Cen8) has an unusually low abundance of highly repetitive satellite DNA, which allowed us to determine its sequence. A region of similar to750 kb in Cen8 binds rice CENH3, the centromere-specific H3 histone. CENH3 binding is contained within a larger region that has abundant dimethylation of histone H3 at Lys9 (H3-Lys9), consistent with Cen8 being embedded in heterochromatin. Fourteen predicted and at least four active genes are interspersed in Cen8, along with CENH3 binding sites. The retrotransposons located in and outside of the CENH3 binding domain have similar ages and structural dynamics. These results suggest that Cen8 may represent an intermediate stage in the evolution of centromeres from genic regions, as in human neocentromeres, to fully mature centromeres that accumulate megabases of homogeneous satellite arrays.	Inst Genom Res, Rockville, MD 20850 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	J. Craig Venter Institute; University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Buell, CR (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	rbuell@tigr.org; jjiang1@wisc.edu	Nagaki, Kiyotaka/B-2519-2011; Jiang, Jiming/V-6060-2019; Jiang, Jiming/A-9614-2009	Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Buell, C Robin/0000-0002-6727-4677; Henikoff, Steven/0000-0002-7621-8685				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Cheng ZK, 2001, CHROMOSOMA, V110, P24, DOI 10.1007/s004120000126; CHLEBOWICZSLEDZIEWSKA E, 1985, GENE, V39, P25, DOI 10.1016/0378-1119(85)90103-9; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; DEVLIN RH, 1990, GENETICS, V125, P129; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Hosouchi T, 2002, DNA RES, V9, P117, DOI 10.1093/dnares/9.4.117; Hudakova S, 2001, NUCLEIC ACIDS RES, V29, P5029, DOI 10.1093/nar/29.24.5029; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Kaszas E, 1998, GENETICS, V150, P1683; Kniola B, 2001, MOL BIOL CELL, V12, P2767, DOI 10.1091/mbc.12.9.2767; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; LOHE AR, 1995, CURR OPIN GENET DEV, V5, P746, DOI 10.1016/0959-437X(95)80007-R; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Motohashi R, 1996, MOL GEN GENET, V250, P148, DOI 10.1007/BF02174173; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2003, GENETICS, V163, P759; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Satinover DL, 2001, CHROMOSOMA, V110, P275, DOI 10.1007/s004120100143; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; TALBERT PB, 2000, ANN DROS RES C, V41, pC247; Tolchkov EV, 2000, GENETICS, V154, P1611; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Vafa O, 1999, CHROMOSOMA, V108, P367, DOI 10.1007/s004120050388; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Wong LH, 2001, GENOME RES, V11, P513, DOI 10.1101/gr.183901; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yu HG, 1997, J CELL BIOL, V139, P831, DOI 10.1083/jcb.139.4.831; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	50	411	455	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					138	145		10.1038/ng1289	http://dx.doi.org/10.1038/ng1289			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14716315	Bronze			2022-12-27	WOS:000188542700014
J	Bernstein, E; Kim, SY; Carmell, MA; Murchison, EP; Alcorn, H; Li, MZ; Mills, AA; Elledge, SJ; Anderson, KV; Hannon, GJ				Bernstein, E; Kim, SY; Carmell, MA; Murchison, EP; Alcorn, H; Li, MZ; Mills, AA; Elledge, SJ; Anderson, KV; Hannon, GJ			Dicer is essential for mouse development	NATURE GENETICS			English	Article							RNA-INTERFERENCE	To address the biological function of RNA interference (RNAi) related pathways in mammals, we disrupted the gene Dicer1 in mice. Loss of Dicer1 lead to lethality early in development, with Dicer1 - null embryos depleted of stem cells. Coupled with our inability to generate viable Dicer1 - null embryonic stem (ES) cells, this suggests a role for Dicer, and, by implication, the RNAi machinery, in maintaining the stem cell population during early mouse development.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.org	Hannon, Gregory/AAB-3568-2019	Kim, Sang Yong/0000-0001-7326-7505; Murchison, Elizabeth Proby/0000-0001-7462-8907; Anderson, Kathryn/0000-0003-1657-2161				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; HUTVAGNER G, 2002, SCIENCE, V1, P1; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	15	1444	1549	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					215	217		10.1038/ng1253	http://dx.doi.org/10.1038/ng1253			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14528307				2022-12-27	WOS:000186273300014
J	Draper, N; Walker, EA; Bujalska, IJ; Tomlinson, JW; Chalder, SM; Arlt, W; Lavery, GG; Bedendo, O; Ray, DW; Laing, I; Malunowicz, E; White, PC; Hewison, M; Mason, PJ; Connell, JM; Shackleton, CHL; Stewart, PM				Draper, N; Walker, EA; Bujalska, IJ; Tomlinson, JW; Chalder, SM; Arlt, W; Lavery, GG; Bedendo, O; Ray, DW; Laing, I; Malunowicz, E; White, PC; Hewison, M; Mason, PJ; Connell, JM; Shackleton, CHL; Stewart, PM			Mutations in the genes encoding 11 beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency	NATURE GENETICS			English	Article							APPARENT MINERALOCORTICOID EXCESS; MICROSOMAL ELECTRON-TRANSPORT; POLYCYSTIC-OVARY-SYNDROME; EXPRESSION; OBESITY; HYPERCORTISOLISM; INHERITANCE; DISEASE; STRESS; MICE	In cortisone reductase deficiency (CRD), activation of cortisone to cortisol does not occur, resulting in adrenocorticotropin-mediated androgen excess and a phenotype resembling polycystic ovary syndrome (PCOS; refs. 1,2). This suggests a defect in the gene HSD11B1 encoding 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), a primary regulator of tissue-specific glucocorticoid bioavailability(3). We identified intronic mutations in HSD11B1 that resulted in reduced gene transcription in three individuals with CRD. In vivo, 11beta-HSD1 catalyzes the reduction of cortisone to cortisol(4) whereas purified enzyme acts as a dehydrogenase converting cortisol to cortisone(5). Oxo-reductase activity can be regained using a NADPH-regeneration system and the cytosolic enzyme glucose-6-phosphate dehydrogenase(4,5). But the catalytic domain of 11beta-HSD1 faces into the lumen of the endoplasmic reticulum ( ER; ref. 6). We hypothesized that endolumenal hexose-6-phosphate dehydrogenase ( H6PDH) regenerates NADPH in the ER7, thereby influencing directionality of 11beta-HSD1 activity. Mutations in exon 5 of H6PD in individuals with CRD attenuated or abolished H6PDH activity. These individuals have mutations in both HSD11B1 and H6PD in a triallelic digenic model of inheritance, resulting in low 11beta-HSD1 expression and ER NADPH generation with loss of 11beta-HSD1 oxoreductase activity. CRD defines a new ER-specific redox potential and establishes H6PDH as a potential factor in the pathogenesis of PCOS.	Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England; Univ Manchester, Endocrine Sci Res Grp, Manchester, Lancs, England; Manchester Royal Infirm, Dept Clin Biochem, Manchester M13 9WL, Lancs, England; Childrens Mem Hlth Inst, Dept Lab Diagnost, Warsaw, Poland; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London, England; Univ Glasgow, MRC, Blood Pressure Unit, Glasgow, Lanark, Scotland; Childrens Hosp Med Ctr, Steroid Lab, Oakland, CA USA	University of Birmingham; University of Manchester; University of Manchester; Children's Memorial Health Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Imperial College London; University of Glasgow	Stewart, PM (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.		Lavery, Gareth/F-9346-2010; Mason, Philip J/B-1087-2008; Arlt, Wiebke/B-6310-2009	Arlt, Wiebke/0000-0001-5106-9719; Tomlinson, Jeremy/0000-0002-3170-8533; Ray, David/0000-0002-4739-6773				AGARWAL AK, 1990, MOL ENDOCRINOL, V4, P1827, DOI 10.1210/mend-4-12-1827; Agarwal AK, 2001, ENDOCR RES, V27, P1, DOI 10.1081/ERC-100107163; Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Biason-Lauber A, 2000, HORM RES, V53, P260, DOI 10.1159/000023577; Bujalska IJ, 2002, J CLIN ENDOCR METAB, V87, P1205, DOI 10.1210/jc.87.3.1205; Bujalska IJ, 1997, LANCET, V349, P1210, DOI 10.1016/S0140-6736(96)11222-8; CARL S, 1996, P DYNAMIC SYSTEMS AP, V2, P91; Cooper MS, 2002, J BONE MINER RES, V17, P979, DOI 10.1359/jbmr.2002.17.6.979; Filling C, 2001, MOL CELL ENDOCRINOL, V171, P99, DOI 10.1016/S0303-7207(00)00419-6; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fraser R, 1999, HYPERTENSION, V33, P1364, DOI 10.1161/01.HYP.33.6.1364; Jamieson A, 1999, J CLIN ENDOCR METAB, V84, P3570, DOI 10.1210/jc.84.10.3570; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; KIMURA K, 1979, J BIOCHEM-TOKYO, V85, P319, DOI 10.1093/oxfordjournals.jbchem.a132336; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Mason PJ, 1999, BLOOD CELL MOL DIS, V25, P30, DOI 10.1006/bcmd.1999.0224; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; NIKKILA H, 1993, J CLIN ENDOCR METAB, V77, P687, DOI 10.1210/jc.77.3.687; OZOLS J, 1995, J BIOL CHEM, V270, P2305, DOI 10.1074/jbc.270.5.2305; Phillipov G, 1996, J CLIN ENDOCR METAB, V81, P3855, DOI 10.1210/jc.81.11.3855; RODIN A, 1994, NEW ENGL J MED, V330, P460, DOI 10.1056/NEJM199402173300703; Savage DB, 2002, NAT GENET, V31, P379, DOI 10.1038/ng926; STEGEMAN JJ, 1979, BIOCHEM BIOPH RES CO, V87, P410, DOI 10.1016/0006-291X(79)91811-4; Stewart PM, 1999, VITAM HORM, V57, P249; Stewart PM, 1996, LANCET, V347, P88, DOI 10.1016/S0140-6736(96)90211-1; Walker EA, 2001, J BIOL CHEM, V276, P21343, DOI 10.1074/jbc.M011142200; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245	30	239	257	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					434	439		10.1038/ng1214	http://dx.doi.org/10.1038/ng1214			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12858176				2022-12-27	WOS:000184470500022
J	Crow, JF				Crow, JF			Was there life before 1953?	NATURE GENETICS			English	Editorial Material									Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Crow, JF (corresponding author), Univ Wisconsin, Genet Lab, 445 Henry Mall, Madison, WI 53706 USA.							COOK RC, 1932, J HERED, V23, P355; Crick F., 1988, WHAT MAD PURSUIT; Crow EW, 2002, GENETICS, V160, P1; DAVENPORT CB, 1932, P 6 INT C GEN, V1, P135; Dobzhansky T., 1937; HAMILTON WD, 1996, NARROW ROADS GENE LA, V1; HOLT J, 2002, NEW YORKER      1028, P102; Kimura M., 1983, NEUTRAL THEORY MOL E; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; MULLER H. J., 1929, PROC INTERNAL CONGRESS PLANT SCIENCES ITHACA NEW YORK 1926, V1, P897; MULLER HJ, 1947, PROC R SOC SER B-BIO, V134, P1, DOI 10.1098/rspb.1947.0001; Sturtevant A. H., 1948, American Scientist, V36, P225; Sutton WS, 1903, BIOL BULL-US, V4, P231, DOI 10.2307/1535741	13	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					449	450		10.1038/ng0403-449	http://dx.doi.org/10.1038/ng0403-449			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12665867	Bronze			2022-12-27	WOS:000181928600008
J	Mawer, S				Mawer, S			DNA and the meaning of life	NATURE GENETICS			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					453	454		10.1038/ng0403-453	http://dx.doi.org/10.1038/ng0403-453			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12665869				2022-12-27	WOS:000181928600010
J	Ramaswamy, S; Ross, KN; Lander, ES; Golub, TR				Ramaswamy, S; Ross, KN; Lander, ES; Golub, TR			A molecular signature of metastasis in primary solid tumors	NATURE GENETICS			English	Article							EXPRESSION; CANCER; BREAST; CELLS; GENE; CLASSIFICATION; CARCINOMA; REVEALS	Metastasis is the principal event leading to death in individuals with cancer, yet its molecular basis is poorly understood(1). To explore the molecular differences between human primary tumors and metastases, we compared the gene-expression profiles of adenocarcinoma metastases of multiple tumor types to unmatched primary adenocarcinomas. We found a gene-expression signature that distinguished primary from metastatic adenocarcinomas. More notably, we found that a subset of primary tumors resembled metastatic tumors with respect to this gene-expression signature. We confirmed this finding by applying the expression signature to data on 279 primary solid tumors of diverse types. We found that solid tumors carrying the gene-expression signature were most likely to be associated with metastasis and poor clinical outcome (P < 0.03). These results suggest that the metastatic potential of human tumors is encoded in the bulk of a primary tumor, thus challenging the notion that metastases arise from rare cells within a primary tumor that have the ability to metastasize(2).	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Ramaswamy, S (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Brown LF, 1999, CLIN CANCER RES, V5, P1041; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HAINSWORTH JD, 1993, NEW ENGL J MED, V329, P257; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hellman S., 2001, CANC PRINCIPLES PRAC; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Jensen BV, 2002, INT J CANCER, V98, P582, DOI 10.1002/ijc.10187; Olumi AF, 1999, CANCER RES, V59, P5002; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	29	1828	1944	2	123	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					49	54		10.1038/ng1060	http://dx.doi.org/10.1038/ng1060			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12469122				2022-12-27	WOS:000180136100016
J	Santoro, R; Li, JW; Grummt, I				Santoro, R; Li, JW; Grummt, I			The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription	NATURE GENETICS			English	Article							POLYMERASE I TRANSCRIPTION; HISTONE METHYLATION; DNA METHYLATION; CHROMATIN; ISWI; TEMPLATES; SUBUNIT; HDAC1; FORM	Epigenetic control mechanisms silence about half of the ribosomal RNA (rRNA) genes in metabolically active cells. In exploring the mechanism by which the active or silent state of rRNA genes is inherited, we found that NoRC, a nucleolar remodeling complex containing Snf2h (also called Smarca5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin, subfamily a, member 5), represses rDNA transcription. NoRC mediates rDNA silencing by recruiting DNA methyltransferase and histone deacetylase activity to the rDNA promoter, thus establishing structural characteristics of heterochromatin such as DNA methylation, histone hypoacetylation and methylation of the Lys9 residue of histone H3. These results indicate that active and inactive rRNA genes can be demarcated by their associated proteins, and link chromatin remodeling to DNA methylation and specific histone modifications.	German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Grummt, I (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany.	I.Grummt@DKFZ-Heidelberg.de	Santoro, Raffaella/L-2637-2013					Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; GOODMARK JP, 2000, CELL, V103, P423; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	26	323	332	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					393	396		10.1038/ng1010	http://dx.doi.org/10.1038/ng1010			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12368916				2022-12-27	WOS:000179034800014
J	Xu, JF; Zheng, SL; Komiya, A; Mychaleckyj, JC; Isaacs, SD; Hu, JJ; Sterling, D; Lange, EM; Hawkins, GA; Turner, A; Ewing, CM; Faith, DA; Johnson, JR; Suzuki, H; Bujnovszky, P; Wiley, KE; DeMarzo, AM; Bova, GS; Chang, BL; Hall, MC; McCullough, DL; Partin, AW; Kassabian, VS; Carpten, JD; Bailey-Wilson, JE; Trent, JM; Ohar, J; Bleecker, ER; Walsh, PC; Isaacs, WB; Meyers, DA				Xu, JF; Zheng, SL; Komiya, A; Mychaleckyj, JC; Isaacs, SD; Hu, JJ; Sterling, D; Lange, EM; Hawkins, GA; Turner, A; Ewing, CM; Faith, DA; Johnson, JR; Suzuki, H; Bujnovszky, P; Wiley, KE; DeMarzo, AM; Bova, GS; Chang, BL; Hall, MC; McCullough, DL; Partin, AW; Kassabian, VS; Carpten, JD; Bailey-Wilson, JE; Trent, JM; Ohar, J; Bleecker, ER; Walsh, PC; Isaacs, WB; Meyers, DA			Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk	NATURE GENETICS			English	Article							TUMOR-ASSOCIATED MACROPHAGES; LINKAGE ANALYSIS; SUSCEPTIBILITY; CHROMOSOME-1; EXPRESSION; INFECTION; TOPOLOGY; BINDING; MODEL	Deletions on human chromosome 8p22-23 in prostate cancer cells 1 and linkage studies in families affected with hereditary prostate cancer (HPC)(2-4) have implicated this region in the development of prostate cancer. The macrophage scavenger receptor 1 gene (MSR1, also known as SR-A) is located at 8p22 and functions in several processes proposed to be relevant to prostate carcinogenesis (5-10). Here we report the results of genetic analyses that indicate that mutations in MSR1 may be associated with risk of prostate cancer. Among families affected with HPC, we identified six rare missense mutations and one nonsense mutation in MSR1. A family-based linkage and association test indicated that these mutations co-segregate with prostate cancer (P = 0.0007). In addition, among men of European descent, MSR1 mutations were detected in 4.4% of individuals affected with non-HPC as compared with 0.8% of unaffected men (P = 0.009). Among African American men, these values were 12.5% and 1.8%, respectively (P = 0.01). These results show that MSR1 may be important in susceptibility to prostate cancer in men of both African American and European descent.	Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genet, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; St Louis Univ, Dept Med, St Louis, MO 63103 USA; Georgia Urol, Atlanta, GA USA; NHGRI, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Saint Louis University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Isaacs, WB (corresponding author), Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, 600 N Wolfe St, Baltimore, MD 21287 USA.		Sterling, David/H-6738-2019	Bailey-Wilson, Joan/0000-0002-9153-2920; Bova, George/0000-0003-1639-3104	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000107] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACTON S, 1993, J BIOL CHEM, V268, P3530; BOVA GS, 1993, CANCER RES, V53, P3869; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; DEJAGER S, 1993, J CLIN INVEST, V92, P894, DOI 10.1172/JCI116664; EMI M, 1993, J BIOL CHEM, V268, P2120; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Latil A, 1998, VIRCHOWS ARCH, V432, P389, DOI 10.1007/s004280050183; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; Nelson WG, 2001, UROLOGY, V57, P39, DOI 10.1016/S0090-4295(00)00939-0; OTT J, 1998, ANAL HUMAN GENETIC L; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Shimura S, 2000, CANCER RES, V60, P5857; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Strickler HD, 2001, EPIDEMIOL REV, V23, P144, DOI 10.1093/oxfordjournals.epirev.a000781; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; WADA Y, 1995, ANN NY ACAD SCI, V748, P226; Weir BS., 1996, GENETIC DATA ANAL; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; Xu JF, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 2002, CANCER EPIDEM BIOMAR, V11, P664	30	247	263	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					321	325		10.1038/ng994	http://dx.doi.org/10.1038/ng994			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244320				2022-12-27	WOS:000178311100025
J	Pickering, MC; Cook, HT; Warren, J; Bygrave, AE; Moss, J; Walport, MJ; Botto, M				Pickering, MC; Cook, HT; Warren, J; Bygrave, AE; Moss, J; Walport, MJ; Botto, M			Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H	NATURE GENETICS			English	Article							HEMOLYTIC-UREMIC SYNDROME; HOMOZYGOUS FACTOR-H; ALTERNATIVE PATHWAY; GLOMERULAR DEPOSITS; PROTEIN BETA-1H; CONVERTASE; DISEASE; HYPOCOMPLEMENTEMIA; HEREDITARY; FAMILY	The alternative pathway of complement is activated continuously in vivo through the C3 'tick-over' pathway(1). This pathway is triggered by the hydrolysis of C3, resulting in the formation of C3 convertase. This, in turn, generates C3b, which mediates many of the biological functions of complement. Factor H, the main regulator of this activation, prevents formation and promotes dissociation of the C3 convertase enzyme(2,3), and, together with factor I, mediates the proteolytic inactivation of C3b(4). Factor H deficiency, described in 29 individuals from 12 families(5-14) and in pigs(15), allows unhindered activation of fluid-phase C3 and severe depletion of plasma C3 (ref. 11). Membranoproliferative glomerulonephritis (MPGN) occurs in factor H-deficient humans(6,12,13) and pigs(15). Although MPGN has been reported in other conditions in which uncontrolled activation of C3 occurs, the role of C3 dysregulation in the pathogenesis of MPGN is not understood. Here we show that mice deficient in factor H (Cfh(-/-) mice) develop MPGN spontaneously and are hypersensitive to developing renal injury caused by immune complexes. Introducing a second mutation in the gene encoding complement factor B, which prevents C3 turnover in vivo, obviates the phenotype of Cfh(-/-) mice. Thus, uncontrolled C3 activation in vivo is essential for the development of MPGN associated with deficiency of factor H.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Histopathol, London W12 0NN, England; Charing Cross Hosp, Dept Histopathol, Electron Microscopy Unit, London W6 8RF, England	Imperial College London; Imperial College London; Imperial College London	Botto, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.		Mohammed, Imran/J-8271-2012	Mohammed, Imran/0000-0002-8412-0768; Walport, Mark/0000-0001-7220-5273; Pickering, Matthew/0000-0002-1153-0192				Alexander JJ, 2001, J BIOL CHEM, V276, P32129, DOI 10.1074/jbc.M101299200; BERGER J, 1962, J Urol Nephrol (Paris), V68, P116; BRAI M, 1988, J CLIN IMMUNOL, V8, P50, DOI 10.1007/BF00915156; DAHA MR, 1976, J IMMUNOL, V116, P1; DROZ D, 1979, KIDNEY INT, V15, P386, DOI 10.1038/ki.1979.50; Fijen CAP, 1996, CLIN EXP IMMUNOL, V105, P511, DOI 10.1046/j.1365-2249.1996.d01-777.x; GALLE P, 1975, AM J MED, V58, P749, DOI 10.1016/0002-9343(75)90631-2; HOGASEN K, 1995, J CLIN INVEST, V95, P1054, DOI 10.1172/JCI117751; LEVY M, 1986, KIDNEY INT, V30, P949, DOI 10.1038/ki.1986.278; LOPEZLARREA C, 1987, BIOCHEM SOC T, V15, P648, DOI 10.1042/bst0150648; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; NIELSEN HE, 1989, SCAND J IMMUNOL, V30, P711, DOI 10.1111/j.1365-3083.1989.tb02480.x; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; PEPYS MB, 1977, IMMUNOLOGY, V33, P491; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; Robson MG, 2001, J IMMUNOL, V166, P6820, DOI 10.4049/jimmunol.166.11.6820; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; SIMPSON IJ, 1978, KIDNEY INT, V13, P467, DOI 10.1038/ki.1978.69; SPITZER RE, 1969, SCIENCE, V164, P436, DOI 10.1126/science.164.3878.436; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; VERROUST PJ, 1974, KIDNEY INT, V6, P157, DOI 10.1038/ki.1974.94; VIK DP, 1988, J BIOL CHEM, V263, P16720; VOGT BA, 1995, PEDIATR NEPHROL, V9, P11, DOI 10.1007/BF00858956; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; West CD, 2001, AM J KIDNEY DIS, V37, P1120, DOI 10.1053/ajkd.2001.24511; WEST CD, 1995, AM J KIDNEY DIS, V25, P853, DOI 10.1016/0272-6386(95)90567-7; WOODROW DF, 1989, J PATHOL, V157, P47, DOI 10.1002/path.1711570107	30	376	400	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					424	428		10.1038/ng912	http://dx.doi.org/10.1038/ng912			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12091909				2022-12-27	WOS:000177147100021
J	Lee, CK; Shibata, Y; Rao, B; Strahl, BD; Lieb, JD				Lee, CK; Shibata, Y; Rao, B; Strahl, BD; Lieb, JD			Evidence for nucleosome depletion at active regulatory regions genome-wide	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; ENVIRONMENTAL-CHANGES; CHROMATIN STRUCTURE; CROSS-LINKING; YEAST; GENES; TRANSCRIPTION; PROMOTER; ACTIVATION	The identification of nuclease-hypersensitive sites in an active globin gene(1) and in the 5' regions of fruit fly heat shock genes(2) first suggested that chromatin changes accompany gene regulation in vivo. Here we present evidence that the basic repeating units of eukaryotic chromatin, nucleosomes, are depleted from active regulatory elements throughout the Saccharomyces cerevisiae genome in vivo. We found that during rapid mitotic growth, the level of nucleosome occupancy is inversely proportional to the transcriptional initiation rate at the promoter. We also observed a partial loss of histone H3 and H4 tetramers from the coding regions of the most heavily transcribed genes. Alterations in the global transcriptional program caused by heat shock or a change in carbon source resulted in an increased nucleosome occupancy at repressed promoters, and a decreased nucleosome occupancy at promoters that became active. Nuclease-hypersensitive sites occur in species from yeast to humans and result from chromatin perturbation(3-5). Given the conservation of sequence and function among components of both chromatin and the transcriptional machinery, nucleosome depletion at promoters may be a fundamental feature of eukaryotic transcriptional regulation.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, CB 3280,202 Fordham Hall, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu	Lee, Cheol-Koo/F-2103-2013; Strahl, Brian/C-7601-2012	Lee, Cheol-Koo/0000-0003-3927-9195; Strahl, Brian/0000-0002-4947-6259; Lieb, Jason/0000-0001-7601-8061				Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CAVALLI G, 1993, EMBO J, V12, P4603, DOI 10.1002/j.1460-2075.1993.tb06149.x; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; ELGIN SCR, 1981, CELL, V27, P413, DOI 10.1016/0092-8674(81)90381-0; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jackson V, 1999, METHODS, V17, P125, DOI 10.1006/meth.1998.0724; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Lohr D, 1997, J BIOL CHEM, V272, P26795, DOI 10.1074/jbc.272.43.26795; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yu LN, 1999, MOL CELL BIOL, V19, P5279	29	553	567	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					900	905		10.1038/ng1400	http://dx.doi.org/10.1038/ng1400			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15247917				2022-12-27	WOS:000222974000026
J	Baker, DJ; Jeganathan, KB; Cameron, JD; Thompson, M; Juneja, S; Kopecka, A; Kumar, R; Jenkins, RB; de Groen, PC; Roche, P; van Deursen, JM				Baker, DJ; Jeganathan, KB; Cameron, JD; Thompson, M; Juneja, S; Kopecka, A; Kumar, R; Jenkins, RB; de Groen, PC; Roche, P; van Deursen, JM			BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice	NATURE GENETICS			English	Article							MITOTIC CHECKPOINT GENES; CANCER; DEFICIENT; AGE	Faithful segregation of replicated chromosomes is essential for maintenance of genetic stability and seems to be monitored by several mitotic checkpoints. Various components of these checkpoints have been identified in mammals, but their physiological relevance is largely unknown. Here we show that mutant mice with low levels of the spindle assembly checkpoint protein BubR1 develop progressive aneuploidy along with a variety of progeroid features, including short lifespan, cachectic dwarfism, lordokyphosis, cataracts, loss of subcutaneous fat and impaired wound healing. Graded reduction of BubR1 expression in mouse embryonic fibroblasts causes increased aneuploidy and senescence. Male and female mutant mice have defects in meiotic chromosome segregation and are infertile. Natural aging of wild-type mice is marked by decreased expression of BubR1 in multiple tissues, including testis and ovary. These results suggest a role for BubR1 in regulating aging and infertility.	Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; Mayo Clin, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Dept Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, 200 1st St SW, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Baker, Darren/0000-0001-9006-1939; Jeganathan, KARTHIK/0000-0001-5587-1266; Kumar, Rajiv/0000-0003-3497-3057; Juneja, Subhash/0000-0002-8536-5724	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058546, R01DK065830, R01DK025409] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK065830, R01 DK058546, R01 DK025409] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; Feldmann KA, 2001, HISTOCHEM CELL BIOL, V115, P489; Ford WCL, 2000, HUM REPROD, V15, P1703, DOI 10.1093/humrep/15.8.1703; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li RH, 2000, P NATL ACAD SCI USA, V97, P3236, DOI 10.1073/pnas.040529797; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Shichiri M, 2002, CANCER RES, V62, P13; Thomas NS, 2001, HUM MOL GENET, V10, P243, DOI 10.1093/hmg/10.3.243; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	28	559	575	2	27	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					744	749		10.1038/ng1382	http://dx.doi.org/10.1038/ng1382			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208629	Bronze			2022-12-27	WOS:000222354100026
J	Dos Santos, C; Essioux, L; Teinturier, C; Tauber, M; Goffin, V; Bougneres, P				Dos Santos, C; Essioux, L; Teinturier, C; Tauber, M; Goffin, V; Bougneres, P			A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; EXPRESSION; COMPLEX; DIVERSITY; MUTATION; CHILDREN; ISOFORM; HEIGHT; GH	Growth hormone is used to increase height in short children who are not deficient in growth hormone, but its efficacy varies largely across individuals. The genetic factors responsible for this variation are entirely unknown. In two cohorts of short children treated with growth hormone, we found that an isoform of the growth hormone receptor gene that lacks exon 3 (d3-GHR) was associated with 1.7 to 2 times more growth acceleration induced by growth hormone than the full-length isoform (P < 0.0001). In transfection experiments, the transduction of growth hormone signaling through d3-GHR homo- or heterodimers was similar to 30% higher than through full-length GHR homodimers (P < 0.0001). One-half of Europeans are hetero- or homozygous with respect to the allele encoding the d3-GHR isoform, which is dominant over the full-length isoform. These observations suggest that the polymorphism in exon 3 of GHR is important in growth hormone pharmacogenetics.	Univ Paris 05, St Vincent de Paul Hosp, INSERM, U561, F-75014 Paris, France; Univ Paris 05, St Vincent de Paul Hosp, Dept Pediat Endocrinol, F-75014 Paris, France; Childrens Hosp, Unite Endocrinol, Toulouse, France; Univ Paris 05, INSERM, U584, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bougneres, P (corresponding author), Univ Paris 05, St Vincent de Paul Hosp, INSERM, U561, 82 Ave Denfert Rochereau, F-75014 Paris, France.	bougneres@paris5.inserm.fr	GOFFIN, Vincent/G-3322-2013	GOFFIN, Vincent/0000-0002-8021-3086; DOS SANTOS MENGUY, Christine/0000-0002-6748-5183				BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; Bryant J, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004440, 10.1002/14651858.CD004440]; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Frank SJ, 2002, ENDOCRINOLOGY, V143, P2, DOI 10.1210/en.143.1.2; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; ITHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; KELLY PA, 1993, RECENT PROG HORM RES, V48, P123; LESAGE C, 1991, J PEDIATR-US, V119, P29, DOI 10.1016/S0022-3476(05)81034-0; Ochoa R, 2003, HORM RES, V60, P68, DOI 10.1159/000071873; Pantel J, 2000, J BIOL CHEM, V275, P18664, DOI 10.1074/jbc.M001615200; Pantel J, 2003, J CLIN ENDOCR METAB, V88, P1705, DOI 10.1210/jc.2002-021667; SOBRIER ML, 1993, FEBS LETT, V319, P16, DOI 10.1016/0014-5793(93)80028-S; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; URBANEK M, 1993, J BIOL CHEM, V268, P19025	18	258	271	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					720	724		10.1038/ng1379	http://dx.doi.org/10.1038/ng1379			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208626	Bronze			2022-12-27	WOS:000222354100022
J	Peltekova, VD; Wintle, RF; Rubin, LA; Amos, CI; Huang, QQ; Gu, XJ; Newman, B; Van Oene, M; Cescon, D; Greenberg, G; Griffiths, AM; St George-Hyslop, PH; Siminovitch, KA				Peltekova, VD; Wintle, RF; Rubin, LA; Amos, CI; Huang, QQ; Gu, XJ; Newman, B; Van Oene, M; Cescon, D; Greenberg, G; Griffiths, AM; St George-Hyslop, PH; Siminovitch, KA			Functional variants of OCTN cation transporter genes are associated with Crohn disease	NATURE GENETICS			English	Article							ORGANIC CATION/CARNITINE TRANSPORTER; TISSUE DISTRIBUTION PATTERN; INFLAMMATORY-BOWEL-DISEASE; CARNITINE TRANSPORT; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; TRANSCRIPTION; LOCALIZATION; EXPRESSION; ALLELES	Crohn disease is a chronic, inflammatory disease of the gastrointestinal tract. A locus of similar to250 kb at 5q31 (IBD5)(1,2) was previously associated with susceptibility to Crohn disease, as indicated by increased prevalence of a risk haplotype of 11 single-nucleotide polymorphisms(3) among individuals with Crohn disease, but the pathogenic lesion in the region has not yet been identified. We report here that two variants in the organic cation transporter cluster at 5q31 ( a missense substitution in SLC22A4 and a G-->C transversion in the SLC22A5 promoter) form a haplotype associated with susceptibility to Crohn disease. These variants alter transcription and transporter functions of the organic cation transporters and interact with variants in another gene associated with Crohn disease, CARD15, to increase risk of Crohn disease. These results suggest that SLC22A4, SLC22A5 and CARD15 act in a common pathogenic pathway to cause Crohn disease.	Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Immunol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Toronto Gen Res Inst, Toronto, ON, Canada; Ellipsis Biotherapeut Corp, Toronto, ON M5G 1Z6, Canada; St Michaels Hosp, Div Rheumatol, Toronto, ON M5B 1W8, Canada; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Siminovitch, KA (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada.	ksimin@ellipsisbiotherapeutics.com	Siminovitch, Katherine/K-1475-2013; Greenberg, Gordon/C-4620-2015	Wintle, Richard/0000-0003-1987-1095; Newman, William/0000-0002-6382-4678; St George-Hyslop, Peter/0000-0003-0796-7209				BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Burckhardt G, 2000, AM J PHYSIOL-RENAL, V278, pF853, DOI 10.1152/ajprenal.2000.278.6.F853; CONLON RA, 1992, DEVELOPMENT, V116, P357; Duran JM, 2002, J MEMBRANE BIOL, V185, P65, DOI 10.1007/s00232-001-0110-5; Elimrani I, 2003, AM J PHYSIOL-GASTR L, V284, pG863, DOI 10.1152/ajpgi.00220.2002; Giallourakis C, 2003, AM J HUM GENET, V73, P205, DOI 10.1086/376417; JURIVICH DA, 1994, P NATL ACAD SCI USA, V91, P2280, DOI 10.1073/pnas.91.6.2280; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamhonwah AM, 2003, BIOCHEM BIOPH RES CO, V301, P98, DOI 10.1016/S0006-291X(02)02946-7; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mirza MM, 2003, AM J HUM GENET, V72, P1018, DOI 10.1086/373880; Newman B, 2004, AM J GASTROENTEROL, V99, P306, DOI 10.1111/j.1572-0241.2004.04038.x; Newman B, 2003, J RHEUMATOL, V30, P305; Ng PC, 2000, BIOINFORMATICS, V16, P760, DOI 10.1093/bioinformatics/16.9.760; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROEDIGER WEW, 1986, BRIT J EXP PATHOL, V67, P773; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Seth P, 1999, J BIOL CHEM, V274, P33388, DOI 10.1074/jbc.274.47.33388; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu X, 2000, BBA-BIOMEMBRANES, V1466, P315, DOI 10.1016/S0005-2736(00)00189-9; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482	27	596	624	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					471	475		10.1038/ng1339	http://dx.doi.org/10.1038/ng1339			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107849	Bronze			2022-12-27	WOS:000221183000018
J	Anholt, RRH; Dilda, CL; Chang, S; Fanara, JJ; Kulkarni, NH; Ganguly, I; Rollmann, SM; Kamdar, KP; Mackay, TFC				Anholt, RRH; Dilda, CL; Chang, S; Fanara, JJ; Kulkarni, NH; Ganguly, I; Rollmann, SM; Kamdar, KP; Mackay, TFC			The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptome	NATURE GENETICS			English	Article							OLFACTORY BEHAVIOR; BINDING PROTEINS; CHANNEL; FAMILY; IMMUNITY; GROWTH; SEX	We combined transcriptional profiling and quantitative genetic analysis to elucidate the genetic architecture of olfactory behavior in Drosophila melanogaster. We applied whole-genome expression analysis to five coisogenic smell-impaired (smi) mutant lines and their control. We used analysis of variance to partition variation in transcript abundance between males and females and between smi genotypes and to determine the genotype-by-sex interaction. A total of 666 genes showed sexual dimorphism in transcript abundance, and 530 genes were coregulated in response to one or more smi mutations, showing considerable epistasis at the level of the transcriptome in response to single mutations. Quantitative complementation tests of mutations at these coregulated genes with the smi mutations showed that in most cases (67%) epistatic interactions for olfactory behavior mirrored epistasis at the level of transcription, thus identifying new candidate genes regulating olfactory behavior.	N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; Torrey Mesa Res Inst, La Jolla, CA USA; Univ Buenos Aires, Dept Ecol Genet & Evolut, Buenos Aires, DF, Argentina	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Buenos Aires	Anholt, RRH (corresponding author), N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA.	anholt@ncsu.edu	Anholt, Robert/S-5977-2019					Anholt RRH, 1996, GENETICS, V143, P293; BALAKRISHNAN R, 1991, J EXP BIOL, V157, P161; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Fedorowicz GM, 1998, GENETICS, V148, P1885; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Gaines P, 2000, GENETICS, V154, P1627; Galindo K, 2001, GENETICS, V159, P1059; Ganguly I, 2003, GENETICS, V164, P1447; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kim MS, 1998, GENETICS, V150, P711; Kulkarni NH, 2002, GENETICS, V161, P1507; Kuniyoshi H, 2002, GENETICS, V162, P1775; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Raghavan S, 2000, CURR BIOL, V10, P269, DOI 10.1016/S0960-9822(00)00364-X; Roche JP, 2002, J NEUROSCI, V22, P6471, DOI 10.1523/jneurosci.22-15-06471.2002; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wang JW, 2002, J NEUROGENET, V16, P45, DOI 10.1080/01677060213106; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Wu LP, 2001, GENETICS, V159, P189	30	112	118	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					180	184		10.1038/ng1240	http://dx.doi.org/10.1038/ng1240			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12958599				2022-12-27	WOS:000185625300016
J	Palstra, RJ; Tolhuis, B; Splinter, E; Nijmeijer, R; Grosveld, F; de Laat, W				Palstra, RJ; Tolhuis, B; Splinter, E; Nijmeijer, R; Grosveld, F; de Laat, W			The beta-globin nuclear compartment in development and erythroid differentiation	NATURE GENETICS			English	Article							LOCUS-CONTROL REGION; HYPERSENSITIVE SITE; TARGETED DELETION; GENE CLUSTERS; IN-VIVO; TRANSCRIPTION; VISUALIZATION; ORGANIZATION; EXPRESSION; DYNAMICS	Efficient transcription of genes requires a high local concentration of the relevant trans - acting factors. Nuclear compartmentalization can provide an effective means to locally increase the concentration of rapidly moving trans - acting factors; this may be achieved by spatial clustering of chromatin-associated binding sites for such factors(1-5). Here we analyze the structure of an erythroid-specific spatial cluster of cis regulatory elements and active beta-globin genes, the active chromatin hub (ACH; ref. 6), at different stages of development and in erythroid progenitors. We show, in mice and humans, that a core ACH is developmentally conserved and consists of the hypersensitive sites (HS1-HS6) of the locus control region (LCR), the upstream 5' HS 60/-62 and downstream 3' HS1. Globin genes switch their interaction with this cluster during development, correlating with the switch in their transcriptional activity(7). In mouse erythroid progenitors that are committed to but do not yet express beta-globin, only the interactions between 5' HS 60/-62, 3' HS1 and hypersensitive sites at the 5 side of the LCR are stably present. After induction of differentiation, these sites cluster with the rest of the LCR and the gene that is activated. We conclude that during erythroid differentiation, cis - regulatory DNA elements create a developmentally conserved nuclear compartment dedicated to RNA polymerase II transcription of beta-globin genes.	ErasmusMC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Laat, W (corresponding author), ErasmusMC, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.			Palstra, Robert-Jan/0000-0003-4600-2303; de Laat, Wouter/0000-0002-6393-595X				Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Droge P, 2001, BIOESSAYS, V23, P179, DOI 10.1002/1521-1878(200102)23:2<179::AID-BIES1025>3.0.CO;2-6; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; Farrell CM, 2000, P NATL ACAD SCI USA, V97, P14554, DOI 10.1073/pnas.97.26.14554; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; HARDISON R, 1993, MOL BIOL EVOL, V10, P73; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Imam AMA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e65; Isogai Y, 2003, CURR OPIN CELL BIOL, V15, P296, DOI 10.1016/S0955-0674(03)00052-8; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Stamatoyannopoulos G., 2001, MOL BASIS BLOOD DIS, Vthird, P135; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wai AWK, 2003, EMBO J, V22, P4489, DOI 10.1093/emboj/cdg437; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0	28	419	443	0	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					190	194		10.1038/ng1244	http://dx.doi.org/10.1038/ng1244			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	14517543				2022-12-27	WOS:000185625300018
J	Parkhill, J; Sebaihia, M; Preston, A; Murphy, LD; Thomson, N; Harris, DE; Holden, MTG; Churcher, CM; Bentley, SD; Mungall, KL; Cerdeno-Tarraga, AM; Temple, L; James, K; Harris, B; Quail, MA; Achtman, M; Atkin, R; Baker, S; Basham, D; Bason, N; Cherevach, I; Chillingworth, T; Collins, M; Cronin, A; Davis, P; Doggett, J; Feltwell, T; Goble, A; Hamlin, N; Hauser, H; Holroyd, S; Jagels, K; Leather, S; Moule, S; Norberczak, H; O'Neil, S; Ormond, D; Price, C; Rabbinowitsch, E; Rutter, S; Sanders, M; Saunders, D; Seeger, K; Sharp, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Unwin, L; Whitehead, S; Barrell, BG; Maskell, DJ				Parkhill, J; Sebaihia, M; Preston, A; Murphy, LD; Thomson, N; Harris, DE; Holden, MTG; Churcher, CM; Bentley, SD; Mungall, KL; Cerdeno-Tarraga, AM; Temple, L; James, K; Harris, B; Quail, MA; Achtman, M; Atkin, R; Baker, S; Basham, D; Bason, N; Cherevach, I; Chillingworth, T; Collins, M; Cronin, A; Davis, P; Doggett, J; Feltwell, T; Goble, A; Hamlin, N; Hauser, H; Holroyd, S; Jagels, K; Leather, S; Moule, S; Norberczak, H; O'Neil, S; Ormond, D; Price, C; Rabbinowitsch, E; Rutter, S; Sanders, M; Saunders, D; Seeger, K; Sharp, S; Simmonds, M; Skelton, J; Squares, R; Squares, S; Stevens, K; Unwin, L; Whitehead, S; Barrell, BG; Maskell, DJ			Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica	NATURE GENETICS			English	Article							III SECRETION; FILAMENTOUS HEMAGGLUTININ; GENE; VIRULENCE; TOXIN; PATHOGENICITY; ADHERENCE; PROMOTER; BACTERIA; CLONING	Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica are closely related Gram-negative beta-proteobacteria that colonize the respiratory tracts of mammals. B. pertussis is a strict human pathogen of recent evolutionary origin and is the primary etiologic agent of whooping cough. B. parapertussis can also cause whooping cough, and B. bronchiseptica causes chronic respiratory infections in a wide range of animals. We sequenced the genomes of B. bronchiseptica RB50 (5,338,400 bp; 5,007 predicted genes), B. parapertussis 12822 (4,773,551 bp; 4,404 genes) and B. pertussis Tohama I (4,086,186 bp; 3,816 genes). Our analysis indicates that B. parapertussis and B. pertussis are independent derivatives of B. bronchiseptica-like ancestors. During the evolution of these two host-restricted species there was large-scale gene loss and inactivation; host adaptation seems to be a consequence of loss, not gain, of function, and differences in virulence may be related to loss of regulatory or control functions.	Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Clin Vet Med, Cambridge CB3 0ES, England; Drew Univ, Madison, NJ 07940 USA; Max Planck Inst Infekt Biol, Dept Biol Mol, D-10117 Berlin, Germany	Wellcome Trust Sanger Institute; University of Cambridge; Drew University; Max Planck Society	Parkhill, J (corresponding author), Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk; djm47@cam.ac.uk	Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014; Sebaihia, Mohammed/AAF-6589-2019; Parkhill, Julian/G-4703-2011; Thomson, Nicholas/P-5988-2014	Holden, Matthew TG/0000-0002-4958-2166; Sebaihia, Mohammed/0000-0002-3324-3346; Parkhill, Julian/0000-0002-7069-5958; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Murphy, Lee/0000-0001-6467-7449; Baker, Stephen/0000-0003-1308-5755; Achtman, Mark/0000-0001-6815-0070; Davis, Paul/0000-0001-5545-0824; Thomson, Nicholas/0000-0002-4432-8505; Preston, Andrew/0000-0002-1489-280X				ARICO B, 1987, J BACTERIOL, V169, P2847, DOI 10.1128/jb.169.6.2847-2853.1987; BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; Brockmeier SL, 2002, INFECT IMMUN, V70, P481, DOI 10.1128/IAI.70.2.481-490.2002; Cherry JD, 1996, J INFECT DIS, V174, pS259, DOI 10.1093/infdis/174.Supplement_3.S259; Cotter PA, 2001, PRINCIPLES BACTERIAL, P619; Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153; Coutte L, 2001, EMBO J, V20, P5040, DOI 10.1093/emboj/20.18.5040; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; Foreman-Wykert AK, 2003, TRENDS MICROBIOL, V11, P105, DOI 10.1016/S0966-842X(03)00007-6; FROSCH M, 1991, MOL MICROBIOL, V5, P1251, DOI 10.1111/j.1365-2958.1991.tb01899.x; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Jacob-Dubuisson F, 2000, MICROBIOL-SGM, V146, P1211, DOI 10.1099/00221287-146-5-1211; Kania SA, 2000, GENE, V256, P149, DOI 10.1016/S0378-1119(00)00360-7; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; KUWANO A, 1992, J VET MED SCI, V54, P1057, DOI 10.1292/jvms.54.1057; LIVEY I, 1987, MOL MICROBIOL, V1, P203, DOI 10.1111/j.1365-2958.1987.tb00513.x; Mackiewicz P, 2001, GENOME BIOL, V2; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; MOOI FR, 1990, FEMS MICROBIOL LETT, V66, P327, DOI 10.1016/0378-1097(90)90307-C; MOORE CH, 1995, J BACTERIOL, V177, P1116, DOI 10.1128/jb.177.4.1116-1118.1995; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; NEI M, 1986, MOL BIOL EVOL, V3, P418; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PEDRONI P, 1988, MOL MICROBIOL, V2, P539, DOI 10.1111/j.1365-2958.1988.tb00061.x; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 2001, MOL CLONING LAB MANU, V3; STIBITZ S, 1992, J BACTERIOL, V174, P7770, DOI 10.1128/JB.174.23.7770-7777.1992; Stibitz S, 1999, J BACTERIOL, V181, P5512, DOI 10.1128/JB.181.17.5512-5515.1999; Stockbauer KE, 2003, CELL MICROBIOL, V5, P123, DOI 10.1046/j.1462-5822.2003.00260.x; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; TUOMANEN E, 1988, J EXP MED, V168, P267, DOI 10.1084/jem.168.1.267; TUOMANEN EI, 1983, INFECT IMMUN, V42, P692, DOI 10.1128/IAI.42.2.692-695.1983; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; Vinogradov E, 2000, EUR J BIOCHEM, V267, P7230, DOI 10.1046/j.1432-1327.2000.01835.x; WEISS AA, 1989, INFECT IMMUN, V57, P2674, DOI 10.1128/IAI.57.9.2674-2682.1989; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; WHO, 2002, RED RISKS PROM HLTH; WILLEMS RJL, 1992, MOL MICROBIOL, V6, P2661, DOI 10.1111/j.1365-2958.1992.tb01443.x; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x	49	732	2330	3	84	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					32	40		10.1038/ng1227	http://dx.doi.org/10.1038/ng1227			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12910271	Bronze			2022-12-27	WOS:000185018500008
J	Lambrechts, D; Storkebaum, E; Morimoto, M; Del-Favero, J; Desmet, F; Marklund, SL; Wyns, S; Thijs, V; Andersson, J; van Marion, I; Al-Chalabi, A; Bornes, S; Musson, R; Hansen, V; Beckman, L; Adolfsson, R; Pall, HS; Prats, H; Vermeire, S; Rutgeerts, P; Katayama, S; Awata, T; Leigh, N; Lang-Lazdunski, L; Dewerchin, M; Shaw, C; Moons, L; Vlietinck, R; Morrison, KE; Robberecht, W; Van Broeckhoven, C; Collen, D; Andersen, PM; Carmeliet, P				Lambrechts, D; Storkebaum, E; Morimoto, M; Del-Favero, J; Desmet, F; Marklund, SL; Wyns, S; Thijs, V; Andersson, J; van Marion, I; Al-Chalabi, A; Bornes, S; Musson, R; Hansen, V; Beckman, L; Adolfsson, R; Pall, HS; Prats, H; Vermeire, S; Rutgeerts, P; Katayama, S; Awata, T; Leigh, N; Lang-Lazdunski, L; Dewerchin, M; Shaw, C; Moons, L; Vlietinck, R; Morrison, KE; Robberecht, W; Van Broeckhoven, C; Collen, D; Andersen, PM; Carmeliet, P			VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEAVY NEUROFILAMENT SUBUNIT; HIPPOCAMPAL-NEURONS; GENETIC ASSOCIATION; MESSENGER-RNA; SPORADIC ALS; POLYMORPHISM; DISEASE; TRANSFORMATION; PATHOGENESIS	Amyotrophic lateral sclerosis (ALS) is an incurable degenerative disorder of motoneurons. We recently reported that reduced expression of Vegfa causes ALS-like motoneuron degeneration in Vegfa(partial derivative/partial derivative) mice. In a meta-analysis of over 900 individuals from Sweden and over 1,000 individuals from Belgium and England, we now report that subjects homozygous with respect to the haplotypes -2,578A/-1,154A/-634G or -2,578A/-1,154G/-634G in the VEGF promoter/leader sequence had a 1.8 times greater risk of ALS (P = 0.00004). These at-risk haplotypes lowered circulating VEGF levels in vivo and reduced VEGF gene transcription, IRES-mediated VEGF expression and translation of a novel large-VEGF isoform (L-VEGF) in vivo. Moreover, SOD1(G93A) mice crossbred with Vegfa(partial derivative/partial derivative) mice died earlier due to more severe motoneuron degeneration. Vegfa(partial derivative/partial derivative) mice were unusually susceptible to persistent paralysis after spinal cord ischemia, and treatment with Vegfa protected mice against ischemic motoneuron death. These findings indicate that VEGF is a modifier of motoneuron degeneration in human ALS and unveil a therapeutic potential of Vegfa for stressed motoneurons in mice.	Katholieke Univ Leuven VIB, Univ Hosp Gasthuisberg, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurol, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Internal Med, B-3000 Louvain, Belgium; Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; Umea Univ Hosp, Dept Neurol, S-90185 Umea, Sweden; Umea Univ, Inst Clin Neurosci & Med Genet, S-90185 Umea, Sweden; Univ Birmingham, Sch Med, Dept Neurol, Birmingham B15 2TT, W Midlands, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Neurol, London SE5 8AF, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London SE5 8AF, England; Kings Coll London, Inst Psychiat, London SE5 8AF, England; CHU Rangueil, Inst Federat Rech Louis Bugnard, INSERM 397, F-31403 Toulouse 4, France; Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden; Saitama Med Sch, Dept Med 4, Moroyama, Saitama 3500495, Japan; Hop Europeen Georges Pompidou, Serv Chirurg Thorac, F-75015 Paris, France; Univ Maastricht, Dept Populat Genet Genom & Bioinformat, NL-6200 MD Maastricht, Netherlands	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); University of Antwerp; Umea University; Umea University; University of Birmingham; University of London; King's College London; University of London; King's College London; University of London; King's College London; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Umea University; Saitama Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Maastricht University	Carmeliet, P (corresponding author), Katholieke Univ Leuven VIB, Univ Hosp Gasthuisberg, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.ac.be	Carmeliet, Peter/AAQ-5140-2020; Bornes, Stephanie/C-2142-2015; De Smet, Frederik/Q-7808-2016; Van Broeckhoven, Christine/M-7853-2019; Thijs, Vincent/C-3647-2009; Verdrengh, Evelien/H-4571-2012; Al-Chalabi, Ammar/E-5361-2010; Van Broeckhoven, Christine/G-8362-2017; lang-lazdunski, loic/AFN-8047-2022; Storkebaum, Erik/B-5389-2017; Lambrechts, Diether/AAJ-3167-2020	Carmeliet, Peter/0000-0001-7961-1821; De Smet, Frederik/0000-0002-6669-3335; Van Broeckhoven, Christine/0000-0003-0183-7665; Thijs, Vincent/0000-0002-6614-8417; Al-Chalabi, Ammar/0000-0002-4924-7712; Van Broeckhoven, Christine/0000-0003-0183-7665; Storkebaum, Erik/0000-0002-9519-5642; Lambrechts, Diether/0000-0002-3429-302X; Adolfsson, Rolf/0000-0001-9785-8473; Prats, Herve/0000-0002-4861-2167; Awata, Takuya/0000-0003-2622-8129; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Vermeire, Severine/0000-0001-9942-3019; Bornes, Stephanie/0000-0003-3944-6192; Del Favero, jurgen/0000-0002-7427-7489; Morrison, Karen Elaine/0000-0003-0216-5717				Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Andersen PM, 2001, AMYOTROPH LATERAL SC, V2, pS37; Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Brown RH, 2001, SEMIN NEUROL, V21, P131; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Giess R, 2000, NEUROLOGY, V54, P1003, DOI 10.1212/WNL.54.4.1003; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Hand CK, 2002, MUSCLE NERVE, V25, P135; Hudder A, 2000, J BIOL CHEM, V275, P34586, DOI 10.1074/jbc.M005199200; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Lang-Lazdunski L, 2000, STROKE, V31, P208, DOI 10.1161/01.STR.31.1.208; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li BL, 2003, MOL BRAIN RES, V111, P155, DOI 10.1016/S0169-328X(03)00025-1; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McCarron SL, 2002, CANCER RES, V62, P3369; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Panas M, 2000, J NEUROL, V247, P940, DOI 10.1007/s004150070050; Prats AC, 2002, PROG NUCLEIC ACID RE, V72, P367, DOI 10.1016/S0079-6603(02)72075-8; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Siddique T, 1998, NEUROGENETICS, V1, P213, DOI 10.1007/s100480050031; Siddique Teepu, 2002, Adv Neurol, V88, P21; Skene JHP, 2001, NAT GENET, V28, P107, DOI 10.1038/88805; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Thijs V, 2000, ACTA NEUROL BELG, V100, P84; Turner MR, 2001, SEMIN NEUROL, V21, P167, DOI 10.1055/s-2001-15262; Van Landeghem GF, 1999, EUR J NEUROL, V6, P639; Veldink JH, 2001, NEUROLOGY, V56, P749, DOI 10.1212/WNL.56.6.749; West MJ, 1995, ONCOGENE, V11, P2515; Wick A, 2002, J NEUROSCI, V22, P6401; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yang ZJ, 2002, J NEUROSCI RES, V70, P140, DOI 10.1002/jnr.10380	50	693	736	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					383	394		10.1038/ng1211	http://dx.doi.org/10.1038/ng1211			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12847526	Green Published			2022-12-27	WOS:000184470500016
J	Rutsch, F; Ruf, N; Vaingankar, S; Toliat, MR; Suk, A; Hohne, W; Schauer, G; Lehmann, M; Roscioli, T; Schnabel, D; Epplen, JT; Knisely, A; Superti-Furga, A; McGill, J; Filippone, M; Sinaiko, AR; Vallance, H; Hinrichs, B; Smith, W; Ferre, M; Terkeltaub, R; Nurnberg, P				Rutsch, F; Ruf, N; Vaingankar, S; Toliat, MR; Suk, A; Hohne, W; Schauer, G; Lehmann, M; Roscioli, T; Schnabel, D; Epplen, JT; Knisely, A; Superti-Furga, A; McGill, J; Filippone, M; Sinaiko, AR; Vallance, H; Hinrichs, B; Smith, W; Ferre, M; Terkeltaub, R; Nurnberg, P			Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification	NATURE GENETICS			English	Article							NONSENSE; PC-1	Idiopathic infantile arterial calcification (IIAC; OMIM 208000) is characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. We analyzed affected individuals from 11 unrelated kindreds and found that IIAC was associated with mutations that inactivated ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). This cell surface enzyme generates inorganic pyrophosphate (PPi), a solute that regulates cell differentiation and serves as an essential physiologic inhibitor of calcification.	Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, La Jolla, CA 92161 USA; Humboldt Univ, Charite Univ Hosp, Inst Med Genet, Berlin, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany; Humboldt Univ, Charite Univ Hosp, Inst Biochem, Berlin, Germany; Childrens Hosp & Clin, Dept Pathol, Minneapolis, MN USA; Royal Prince Alfred Hosp, Dept Clin & Mol Genet, Sydney, NSW, Australia; Humboldt Univ, Charite Univ Hosp, Dept Pediat, Berlin, Germany; Ruhr Univ Bochum, Dept Human Genet, D-4630 Bochum, Germany; Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England; Univ Childrens Hosp, Div Metab & Mol Dis, Zurich, Switzerland; Royal Childrens Hosp, Dept Metab Med, Brisbane, Qld, Australia; Univ Padua, Sch Med, Dept Pediat, Padua, Italy; Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Childrens & Womens Hlth Ctr British Columbia, Dept Pathol & Lab Med, Biochem Dis Lab, Vancouver, BC, Canada; Eppendorf Univ Hosp, Dept Neonatol, Hamburg, Germany; Barbara Bush Childrens Hosp, Maine Med Ctr, Div Genet, Portland, OR USA; Prenatal Diagnost Ctr, Roanoke, VA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Children's Hospitals & Clinics of Minnesota; University of Sydney; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University Children's Hospital Zurich; Royal Children's Hospital Brisbane; University of Padua; University of Minnesota System; University of Minnesota Twin Cities; BC Women's Hospital & Health Centre; University of Hamburg; University Medical Center Hamburg-Eppendorf	Terkeltaub, R (corresponding author), Univ Calif San Diego, Vet Affairs Med Ctr, Dept Med, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.	rterkeltaub@ucsd.edu	superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Schnabel, Dirk/0000-0002-7944-7790; Epplen, Joerg T./0000-0002-6087-3327; Vallance, Hilary/0000-0003-1734-1445				Bollen M, 2000, CRIT REV BIOCHEM MOL, V35, P393, DOI 10.1080/10409230091169249; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; MAQUAT LE, 2000, TRANSLATIONAL CONTRO; MENTEN ML, 1948, AM J CLIN PATHOL, V18, P805; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Rutsch F, 2003, CURR OPIN RHEUMATOL, V15, P302, DOI 10.1097/00002281-200305000-00019; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Saxena A, 2003, PEDIATR CARDIOL, V24, P80, DOI 10.1007/s00246-001-0067-2; VERA J, 1990, PEDIATR RADIOL, V20, P585, DOI 10.1007/BF02129060; Wax JR, 2001, AM J OBSTET GYNECOL, V185, P1267, DOI 10.1067/mob.2001.117186	15	425	446	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					379	381		10.1038/ng1221	http://dx.doi.org/10.1038/ng1221			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12881724				2022-12-27	WOS:000184470500015
J	Suzuki, A; Yamada, R; Chang, XT; Tokuhiro, S; Sawada, T; Suzuki, M; Nagasaki, M; Nakayama-Hamada, M; Kawaida, R; Ono, M; Ohtsuki, M; Furukawa, H; Yoshino, S; Yukioka, M; Tohma, S; Matsubara, T; Wakitani, S; Teshima, R; Nishioka, Y; Sekine, A; Iida, A; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K				Suzuki, A; Yamada, R; Chang, XT; Tokuhiro, S; Sawada, T; Suzuki, M; Nagasaki, M; Nakayama-Hamada, M; Kawaida, R; Ono, M; Ohtsuki, M; Furukawa, H; Yoshino, S; Yukioka, M; Tohma, S; Matsubara, T; Wakitani, S; Teshima, R; Nishioka, Y; Sekine, A; Iida, A; Takahashi, A; Tsunoda, T; Nakamura, Y; Yamamoto, K			Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis	NATURE GENETICS			English	Article							SHARED EPITOPE HYPOTHESIS; ANTIFILAGGRIN AUTOANTIBODIES; IMMUNOBLOTTING DETECTION; ANTIKERATIN ANTIBODIES; MESSENGER-RNA; SUSCEPTIBILITY; LINKAGE; POLYMORPHISMS; DIAGNOSIS; FILAGGRIN	Individuals with rheumatoid arthritis frequently have autoantibodies to citrullinated peptides, suggesting the involvement of the peptidylarginine deiminases citrullinating enzymes (encoded by PADI genes) in rheumatoid arthritis. Previous linkage studies have shown that a susceptibility locus for rheumatoid arthritis includes four PADI genes but did not establish which PADI gene confers susceptibility to rheumatoid arthritis. We used a case-control linkage disequilibrium study to show that PADI type 4 is a susceptibility locus for rheumatoid arthritis (P = 0.000008). PADI4 was expressed in hematological and rheumatoid arthritis synovial tissues. We also identified a haplotype of PADI4 associated with susceptibility to rheumatoid arthritis that affected stability of transcripts and was associated with levels of antibody to citrullinated peptide in sera from individuals with rheumatoid arthritis. Our results imply that the PADI4 haplotype associated with susceptibility to rheumatoid arthritis increases production of citrullinated peptides acting as autoantigens, resulting in heightened risk of developing the disease.	Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Sankyo Co Ltd, Tokyo 140, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; Nippon Med Coll, Dept Joint Dis & Rheumatism, Tokyo 113, Japan; Yukioka Hosp, Osaka, Japan; Natl Sagamihara Hosp, Kanagawa, Japan; Matsubara Mayflower Hosp, Hyogo, Japan; Osaka Minami Natl Hosp, Osaka, Japan; Tottori Univ, Dept Orthoped Surg, Tottori 680, Japan; Yamanashi Prefectural Cent Hosp, Yamanashi, Japan; Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Kanagawa, Japan; Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Kanagawa, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; Daiichi Sankyo Company Limited; University of Tokyo; Nippon Medical School; Tottori University; RIKEN; RIKEN; University of Tokyo	Yamada, R (corresponding author), Inst Phys & Chem Res, SNP Res Ctr, Lab Rheumat Dis, Tsurumi Ku, 1-7-22 Suehirocho, Yokohama, Kanagawa 2300045, Japan.		Iida, Aritoshi/CAA-1373-2022; Tsunoda, Tatsuhiko/K-2061-2014; Yamamoto, Kazuhiko/N-5096-2015; Sawed, Tetsuji/GRX-6582-2022; Suzuki, Akari/N-5389-2015; Peng, Bo/A-6920-2009	Iida, Aritoshi/0000-0001-7538-1651; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Peng, Bo/0000-0001-8225-2284; Yamada, Ryo/0000-0002-1587-630X				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; Baeten D, 2001, ARTHRITIS RHEUM, V44, P2255, DOI 10.1002/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Cuadrado A, 2002, NUCLEIC ACIDS RES, V30, P2202, DOI 10.1093/nar/30.10.2202; de Vries N, 2002, ARTHRITIS RHEUM-US, V46, P921, DOI 10.1002/art.10210; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; GOMESDAUDRIX V, 1994, ANN RHEUM DIS, V53, P735, DOI 10.1136/ard.53.11.735; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hirano T, 2002, NAT IMMUNOL, V3, P342, DOI 10.1038/ni0402-342; Jansen ALMA, 2002, J RHEUMATOL, V29, P2074; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Menard HA, 2000, ARTHRITIS RES, V2, P429, DOI 10.1186/ar122; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nepom GT, 1998, ADV IMMUNOL, V68, P315, DOI 10.1016/S0065-2776(08)60563-5; Nogueira L, 2001, ANN RHEUM DIS, V60, P882; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Schildkraut Joellen M., 1998, P379; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; van Venrooij WJ, 2000, ARTHRITIS RES, V2, P249, DOI 10.1186/ar95; VINCENT C, 1989, ANN RHEUM DIS, V48, P712, DOI 10.1136/ard.48.9.712; Vincent C, 1998, J RHEUMATOL, V25, P838; Vincent C, 2002, ARTHRITIS RHEUM, V46, P2051, DOI 10.1002/art.10436; Weyand CM, 2000, ARTHRITIS RES, V2, P212, DOI 10.1186/ar90; Yang TY, 2003, J BIOL CHEM, V278, P15291, DOI 10.1074/jbc.M300954200; Zhou XD, 2002, ARTHRITIS RHEUM-US, V46, P2990, DOI 10.1002/art.10601; Zhou ZJ, 2002, CURR OPIN RHEUMATOL, V14, P250, DOI 10.1097/00002281-200205000-00010	40	816	894	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					395	402		10.1038/ng1206	http://dx.doi.org/10.1038/ng1206			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12833157				2022-12-27	WOS:000184470500017
J	Marculescu, R; Vanura, K; Le, T; Simon, P; Jager, U; Nadel, B				Marculescu, R; Vanura, K; Le, T; Simon, P; Jager, U; Nadel, B			Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL	NATURE GENETICS			English	Article							CELL ACUTE-LEUKEMIA; TCR-BETA LOCUS; CHROMOSOMAL TRANSLOCATIONS; TAL2; RECOMBINATION; LCK; DNA	After V(D) J-mediated translocations, signal joints are retained on one of the derivative chromosomes. We report here that such signal joints are highly reactive and constitute unstable genomic elements with potential oncogenic properties.	Univ Vienna, Dept Internal Med 1, Div Hematol, A-1090 Vienna, Austria; Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; Univ Vienna, Dept Surg, Vienna, Austria; Parc Sci Luminy, Ctr Immunol, CNRS INSERM Marseille Luminy, F-13288 Marseille, France	University of Vienna; Austrian Academy of Sciences; University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Nadel, B (corresponding author), Univ Vienna, Dept Lab Med, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.		Nadel, Bertrand/J-2197-2014; Vanura, Katrina/AAG-1236-2021	Vanura, Katrina/0000-0002-2217-4998; Simon, Paul/0000-0002-2932-5074				BAER R, 1993, SEMIN CANCER BIOL, V4, P341; BURNETT RC, 1994, BLOOD, V84, P1232; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; HWANG LY, 1995, CURR OPIN IMMUNOL, V7, P659, DOI 10.1016/0952-7915(95)80074-3; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Mathieu N, 2000, J EXP MED, V192, P625, DOI 10.1084/jem.192.5.625; Neiditch MB, 2002, MOL CELL, V9, P871, DOI 10.1016/S1097-2765(02)00494-X; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; TYCKO B, 1989, J EXP MED, V169, P369, DOI 10.1084/jem.169.2.369; TYCKO B, 1991, J EXP MED, V174, P867, DOI 10.1084/jem.174.4.867; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; XIA Y, 1994, ONCOGENE, V9, P1437; XIA Y, 1991, P NATL ACAD SCI USA, V88, P11416, DOI 10.1073/pnas.88.24.11416	15	24	24	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					342	344		10.1038/ng1092	http://dx.doi.org/10.1038/ng1092			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12567187				2022-12-27	WOS:000181312700009
J	Le, WD; Xu, PY; Jankovic, J; Jiang, H; Appel, SH; Smith, RG; Vassilatis, DK				Le, WD; Xu, PY; Jankovic, J; Jiang, H; Appel, SH; Smith, RG; Vassilatis, DK			Mutations in NR4A2 associated with familial Parkinson disease	NATURE GENETICS			English	Article							RECEPTOR NURR1 GENE; NURR1-DEFICIENT MICE; NEURONS; IDENTIFICATION; TRANSCRIPTION; ORGANIZATION; LOCALIZATION; EXPRESSION; PROMOTER; AGENESIS	NR4A2, encoding a member of nuclear receptor superfamily 1, is essential for the differentiation of the nigral dopaminergic neurons(2-4). To determine whether NR4A2 is a susceptibility gene for Parkinson disease, we carried out genetic analyses in 201 individuals affected with Parkinson disease and 221 age-matched unaffected controls. We identified two mutations in NR4A2 associated with Parkinson disease (-291Tdel and -245T-->G), which map to the first exon of NR4A2 and affect one allele in 10 of 107 individuals with familial Parkinson disease but not in any individuals with sporadic Parkinson disease (n = 94) or in unaffected controls (n = 221). The age at onset of disease and clinical features of these ten individuals were not different from those of individuals with typical Parkinson disease. The mutations resulted in a marked decrease in NR4A2 mRNA levels in transfected cell lines and in lymphocytes of affected individuals. Additionally, mutations in NR4A2 affect transcription of the gene encoding tyrosine hydroxylase. These data suggest that mutations in NR4A2 can cause dopaminergic dysfunction, associated with Parkinson disease.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Le, WD (corresponding author), Baylor Coll Med, Dept Neurol, 1 Baylor Plaza, Houston, TX 77030 USA.	Weidongl@bcm.tmc.edu						Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Castillo SO, 1997, GENOMICS, V41, P250, DOI 10.1006/geno.1997.4677; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen YH, 2001, AM J MED GENET, V105, P753, DOI 10.1002/ajmg.10036; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Healy DG, 2002, MOVEMENT DISORD, V17, pS34; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Iwawaki T, 2000, BIOCHEM BIOPH RES CO, V274, P590, DOI 10.1006/bbrc.2000.3204; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Langston JW, 1998, ANN NEUROL, V44, pS45, DOI 10.1002/ana.410440707; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 1999, EXP NEUROL, V159, P451, DOI 10.1006/exnr.1999.7191; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; MAGES HW, 1994, MOL ENDOCRINOL, V8, P1583, DOI 10.1210/me.8.11.1583; MARTIN ED, 2001, JAMA-J AM MED ASSOC, V286, P2239; Nataraj AJ, 1999, ELECTROPHORESIS, V20, P1177, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1177::AID-ELPS1177>3.0.CO;2-2; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SaucedoCardenas O, 1996, J MOL NEUROSCI, V7, P51, DOI 10.1007/BF02736848; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Torii T, 1999, GENE, V230, P225, DOI 10.1016/S0378-1119(99)00064-5; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	30	353	381	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2003	33	1					85	89		10.1038/ng1066	http://dx.doi.org/10.1038/ng1066			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12496759				2022-12-27	WOS:000180136100023
J	Zardo, G; Tiirikainen, MI; Hong, CB; Misra, A; Feuerstein, BG; Volik, S; Collins, CC; Lamborn, KR; Bollen, A; Pinkel, D; Albertson, DG; Costello, JF				Zardo, G; Tiirikainen, MI; Hong, CB; Misra, A; Feuerstein, BG; Volik, S; Collins, CC; Lamborn, KR; Bollen, A; Pinkel, D; Albertson, DG; Costello, JF			Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors	NATURE GENETICS			English	Article							DNA COPY NUMBER; GLIOBLASTOMA-MULTIFORME; METHYLATION; CANCER; LOCI; HYPERMETHYLATION; CHROMOSOME-10; CARCINOMA; PATTERNS; LUNG	Aberrant methylation of CpG islands and genomic deletion are two predominant mechanisms of gene inactivation in tumorigenesis, but the extent to which they interact is largely unknown. The lack of an integrated approach to study these mechanisms has limited the understanding of tumor genomes and cancer genes. Restriction landmark genomic scanning (RLGS; ref. 1) is useful for global analysis of aberrant methylation of CpG islands, but has not been amenable to alignment with deletion maps because the identity of most RLGS fragments is unknown. Here, we determined the nucleotide sequence and exact chromosomal position of RLGS fragments throughout the genome using the whole chromosome of origin of the fragments 2 and in silico restriction digestion of the human genome sequence. To study the interaction of these gene-inactivation mechanisms in primary brain tumors, we integrated RLGS-based methylation analysis with high-resolution deletion maps from microarray-based comparative genomic hybridization (array CGH; ref. 3). Certain subsets of gene-associated CpG islands were preferentially affected by convergent methylation and deletion, including genes that exhibit tumor-suppressor activity, such as CISH1 (encoding SOCS1; ref. 4), as well as genes such as COE3 that have been missed by traditional non-integrated approaches. Our results show that most aberrant methylation events are focal and independent of deletions, and the rare convergence of these mechanisms can pinpoint biallelic gene inactivation without the use of positional cloning.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94115 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Costello, JF (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA.		Tirikainen, M/B-6954-2012; Feuerstein, Burt G/A-5186-2015	Tirikainen, M/0000-0002-8124-3818; Feuerstein, Burt G/0000-0001-7276-8842				Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fruhwald MC, 2001, ONCOGENE, V20, P5033, DOI 10.1038/sj.onc.1204613; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; Ginzinger DG, 2000, CANCER RES, V60, P5405; HATADA I, 1991, P NATL ACAD SCI USA, V88, P9523, DOI 10.1073/pnas.88.21.9523; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; KARLBOM AE, 1993, HUM GENET, V92, P169; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Mohapatra G, 1998, GENE CHROMOSOME CANC, V21, P195, DOI 10.1002/(SICI)1098-2264(199803)21:3<195::AID-GCC3>3.3.CO;2-A; Rouillard JM, 2001, GENOME RES, V11, P1453, DOI 10.1101/gr.181601; Rush LJ, 2001, BLOOD, V97, P3226, DOI 10.1182/blood.V97.10.3226; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; von Deimling A, 2000, J NEUROPATH EXP NEUR, V59, P544, DOI 10.1093/jnen/59.6.544; Yoshikawa H, 2001, NAT GENET, V28, P29, DOI 10.1038/88225; Yoshikawa H, 1996, GENOMICS, V31, P28, DOI 10.1006/geno.1996.0005	21	127	140	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					453	458		10.1038/ng1007	http://dx.doi.org/10.1038/ng1007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12355068				2022-12-27	WOS:000179034800026
J	Bernal, JA; Luna, R; Espina, A; Lazaro, I; Ramos-Morales, F; Romero, F; Arias, C; Silva, A; Tortolero, M; Pintor-Toro, JA				Bernal, JA; Luna, R; Espina, A; Lazaro, I; Ramos-Morales, F; Romero, F; Arias, C; Silva, A; Tortolero, M; Pintor-Toro, JA			Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis	NATURE GENETICS			English	Article							TUMOR-TRANSFORMING GENE; EXPRESSION; HPTTG; PROGRESSION; INHIBITOR; DIVISION; PROTEIN; CANCER; GROWTH; CELLS	The gene PTTG1 (encoding the pituitary tumor-transforming 1 protein) is overexpressed in several different tumor types, is tumorigenic in vivo and shows transcriptional activity(1-4). The PTTG1 protein is cell-cycle regulated and was identified as the human securin (a category of proteins involved in the regulation of sister-chromatid separation) on the basis of biochemical similarities with the Pds1p protein of budding yeast and the Cut2p protein of fission yeast(5,6). To unravel the function of human securin in oncogenesis, we carried out a phage-display screening to identify proteins that interact with securin. Notably, we isolated the p53 tumor suppressor. Pull-down and coimmunoprecipitation assays demonstrated that p53 interacts specifically with securin both in vitro and in vivo. This interaction blocks the specific binding of p53 to DNA and inhibits its transcriptional activity. Securin also inhibits the ability of p53 to induce cell death. Moreover, we observed that transfection of H1299 cells with securin induced an accumulation of G2 cells that compensated for the loss of G2 cells caused by transfection with p53. We demonstrated the physiological relevance of this interaction in PTTG1-deficient human tumor cells (PTTG1(-/-)): both apoptotic and transactivating functions of p53 were potentiated in these cells compared to parental cells. We propose that the oncogenic effect of increased expression of securin may result from modulation of p53 functions.	CSIC, Inst Recursos Nat & Agrobiol, E-41080 Seville, Spain; CSIC, Ctr Invest Biol, Madrid, Spain; Univ Sevilla, Dept Genet, Seville, Spain; Univ Sevilla, Fac Biol, Dept Microbiol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Sevilla; University of Sevilla	Pintor-Toro, JA (corresponding author), CSIC, Inst Recursos Nat & Agrobiol, Apdo 1052, E-41080 Seville, Spain.		Espina Zambrano, Águeda Gema/AAB-2657-2021; Ramos-Morales, Francisco/C-5734-2008; LUNA, ROSA/F-3974-2016; Romero, Francisco/K-2101-2014; Tortolero, Maria/K-5744-2014; Bernal, Juan A/N-4544-2014; Pintor-Toro, Jose/L-4737-2014	Espina Zambrano, Águeda Gema/0000-0003-1962-0990; Ramos-Morales, Francisco/0000-0002-1151-4547; LUNA, ROSA/0000-0002-6131-6610; Romero, Francisco/0000-0002-9588-6881; Tortolero, Maria/0000-0003-1797-9940; Bernal, Juan A/0000-0002-9933-5550; Pintor-Toro, Jose/0000-0002-9060-5243				BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LOEB LA, 1991, CANCER RES, V51, P3075; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; OConnor DJ, 1995, EMBO J, V14, P6184, DOI 10.1002/j.1460-2075.1995.tb00309.x; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Schmitt CA, 1999, J PATHOL, V187, P127; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	30	162	173	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					306	311		10.1038/ng997	http://dx.doi.org/10.1038/ng997			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355087				2022-12-27	WOS:000178311100022
J	Mikkers, H; Allen, J; Knipscheer, P; Romeyn, L; Hart, A; Vink, E; Berns, A				Mikkers, H; Allen, J; Knipscheer, P; Romeyn, L; Hart, A; Vink, E; Berns, A			High-throughput retroviral tagging to identify components of specific signaling pathways in cancer (vol 32, pg 153, 2002)	NATURE GENETICS			English	Correction																		Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b	1	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					331	331		10.1038/ng1002-331d	http://dx.doi.org/10.1038/ng1002-331d			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12185366	Bronze			2022-12-27	WOS:000178311100030
J	O'Sullivan, JN; Bronner, MP; Brentnall, TA; Finley, JC; Shen, WT; Emerson, S; Emond, MJ; Gollahon, KA; Moskovitz, AH; Crispin, DA; Potter, JD; Rabinovitch, PS				O'Sullivan, JN; Bronner, MP; Brentnall, TA; Finley, JC; Shen, WT; Emerson, S; Emond, MJ; Gollahon, KA; Moskovitz, AH; Crispin, DA; Potter, JD; Rabinovitch, PS			Chromosomal instability in ulcerative colitis is related to telomere shortening	NATURE GENETICS			English	Article							LENGTH DYNAMICS; DYSFUNCTION; CANCER; MICE; EVOLUTION; DYSPLASIA; SEQUENCE; TUMORS; CELLS; P53	Ulcerative colitis, a chronic inflammatory disease of the colon, is associated with a high risk of colorectal carcinoma(1) that is thought to develop through genomic instability(2). We considered that the rapid cell turnover and oxidative injury observed in ulcerative colitis might accelerate telomere shortening(3), thereby increasing the potential of chromosomal ends to fuse(4), resulting in cycles of chromatin bridge breakage and fusion(5,6) and chromosomal instability associated with tumor cell progression(7,8). Here we have used quantitative fluorescence in situ hybridization to compare chromosomal aberrations and telomere shortening in non-dysplastic mucosa taken from individuals affected by ulcerative colitis, either with (UC progressors) or without (UC non-progressors) dysplasia or cancer. Losses, but not gains, of chromosomal arms and centromeres are highly correlated with telomere shortening. Chromosomal losses are greater and telomeres are shorter in biopsy samples from UC progressors than in those from UC non-progressors or control individuals without ulcerative colitis. A mechanistic link between telomere shortening and chromosomal instability is supported by a higher frequency of anaphase bridges-an intermediate in the breakage and fusion of chromatin bridges(9)-in UC progressors than in UC non-progressors or control individuals. Our study shows that telomere length is correlated with chromosomal instability in a precursor of human cancer.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Surg, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Rabinovitch, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	petersr@u.washington.edu		Potter, John/0000-0001-5439-1500; O'Sullivan, Jacintha/0000-0001-8622-9858				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Day JP, 1998, CARCINOGENESIS, V19, P259, DOI 10.1093/carcin/19.2.259; DELANGE T, 1995, TELOMERES, P265; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Kilburn AE, 2001, MOL CELL BIOL, V21, P126, DOI 10.1128/MCB.21.1.126-135.2001; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Loeb KR, 1999, AM J PATHOL, V154, P1621, DOI 10.1016/S0002-9440(10)65415-6; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; McClintock B, 1941, GENETICS, V26, P234; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; Oexle K, 1998, J THEOR BIOL, V190, P369, DOI 10.1006/jtbi.1997.0559; Rabinovitch PS, 1999, CANCER RES, V59, P5148; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; RUBIN CE, 1992, GASTROENTEROLOGY, V103, P1611, DOI 10.1016/0016-5085(92)91185-7; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tlsty TD, 1997, CURR TOP MICROBIOL, V221, P37; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Whitehead CM, 1999, J CELL BIOCHEM, P192; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592	29	269	279	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					280	284		10.1038/ng989	http://dx.doi.org/10.1038/ng989			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355086				2022-12-27	WOS:000178311100017
J	Bennett, D; Alphey, L				Bennett, D; Alphey, L			PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster	NATURE GENETICS			English	Article							TGF-BETA RECEPTOR; PROTEIN PHOSPHATASE-1; STRUCTURAL BASIS; KINASE; RECOGNITION; EXPRESSION; ACTIVATION; POSITION; GRADIENT; MITOSIS	In signaling involving the transforming growth factor-beta (TGF-beta) superfamily of proteins, ligand binding brings the constitutively active type II receptor kinase into close proximity to its substrate, the type I receptor kinase, which it then activates by phosphorylation(1). The type I receptor kinase in turn phosphorylates one of the Smad family of transcription factors, which translocates to the nucleus and regulates gene expression(2-5). Smads are recruited to the receptor complex by an anchor protein, SARA (Smad anchor for receptor activation)(6). Although several protein kinases in this pathway were known, including the receptors themselves, the relevant phosphatases had not previously been identified. Here we report the isolation of a Drosophila melanogaster homolog of SARA (Sara) in a screen for proteins that bind the catalytic subunit of type I serine/threonine protein phosphatase (PP1c). We identified a PP1c-binding motif in Sara, disruption of which reduced the ability of Sara to bind PP1c. Expression of this non-PP1c- binding mutant resulted in hyperphosphorylation of the type I receptor and stimulated expression of a target of TGF-beta signaling. Reducing PP1c activity enhanced the increase in the basal level of expression of genes responsive to Dpp (Decapentaplegic) caused by ectopic expression of the type II receptor Punt. Together these data suggest that PP1c is targeted to Dpp receptor complexes by Sara, where it acts as a negative regulator of Dpp signaling by affecting the phosphorylation state of the type I receptor.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Alphey, L (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Bennett, Daimark/E-2701-2014	Bennett, Daimark/0000-0002-0014-2290; Alphey, Luke/0000-0002-2916-3802				Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Alphey L, 1997, J CELL BIOL, V138, P395, DOI 10.1083/jcb.138.2.395; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; BAKSA K, 1993, GENETICS, V135, P117; Bennett D, 1999, BIOCHEMISTRY-US, V38, P16276, DOI 10.1021/bi9917028; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; Cohen PTW, 2002, J CELL SCI, V115, P241; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Haerry TE, 1998, DEVELOPMENT, V125, P3977; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Moustakas A, 2001, J CELL SCI, V114, P4359; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Parker L, 2001, BIOTECHNIQUES, V31, P1280, DOI 10.2144/01316st01; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Raghavan S, 2000, CURR BIOL, V10, P269, DOI 10.1016/S0960-9822(00)00364-X; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VENTURA F, 1994, EMBO J, V13, P5581, DOI 10.1002/j.1460-2075.1994.tb06895.x; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92	29	76	87	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					419	423		10.1038/ng938	http://dx.doi.org/10.1038/ng938			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134149				2022-12-27	WOS:000177147100020
J	Savage, DB; Agostini, M; Barroso, I; Gurnell, M; Luan, J; Meirhaeghe, A; Harding, AH; Ihrke, G; Rajanayagam, O; Soos, MA; George, S; Berger, D; Thomas, EL; Bell, JD; Meeran, K; Ross, RJ; Vidal-Puig, A; Wareham, NJ; O'Rahilly, S; Chatterjee, VKK; Schafer, AJ				Savage, DB; Agostini, M; Barroso, I; Gurnell, M; Luan, J; Meirhaeghe, A; Harding, AH; Ihrke, G; Rajanayagam, O; Soos, MA; George, S; Berger, D; Thomas, EL; Bell, JD; Meeran, K; Ross, RJ; Vidal-Puig, A; Wareham, NJ; O'Rahilly, S; Chatterjee, VKK; Schafer, AJ			Digenic inheritance of severe insulin resistance in a human pedigree	NATURE GENETICS			English	Article							PPAR-GAMMA; PROTEIN PHOSPHATASE-1; SKELETAL-MUSCLE; MICE; CELL; FAT; EXPRESSION; METABOLISM; RECEPTORS; AGONISTS	Impaired insulin action is a key feature of type 2 diabetes and is also found, to a more extreme degree, in familial syndromes of insulin resistance. Although inherited susceptibility to insulin resistance may involve the interplay of several genetic loci, no clear examples of interactions among genes have yet been reported. Here we describe a family in which five individuals with severe insulin resistance, but no unaffected family members, were compound heterozygous with respect to frameshift/premature stop mutations in two unlinked genes, PPARG and PPP1R3A these encode peroxisome proliferator activated receptor, which is highly expressed in adipocytes, and protein phosphatase 1, regulatory subunit 3, the muscle-specific regulatory subunit of protein phosphatase 1, which are centrally involved in the regulation of carbohydrate and lipid metabolism, respectively. That mutant molecules primarily involved in either carbohydrate or lipid metabolism can combine to produce a phenotype of extreme insulin resistance provides a model of interactions among genes that may underlie common human metabolic disorders such as type 2 diabetes.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Incyte Genom, Palo Alto, CA USA; Univ Cambridge, Addenbrookes Hosp, Dept Publ Hlth, Cambridge CB2 2QQ, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med,Robert Steiner MRI Unit, MRC,Clin Sci Ctr, London, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Charing Cross Hosp, Dept Endocrinol, London, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Hammersmith Hosp, Dept Endocrinol, London, England; Univ Sheffield, Div Clin Sci, Sheffield, S Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Incyte; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; Imperial College London; Imperial College London; University of Sheffield	O'Rahilly, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Hills Rd, Cambridge CB2 2QQ, England.		Thomas, Elizabeth Louise/AIF-0055-2022; Ross, Richard/B-2672-2012; Meirhaeghe, Aline/E-4663-2015; O'Rahilly, Stephen/ABF-6509-2020	Ross, Richard/0000-0001-9222-9678; Meirhaeghe, Aline/0000-0001-6983-2364; O'Rahilly, Stephen/0000-0003-2199-4449; Vidal-Puig, Antonio/0000-0003-4220-9577; Ihrke, Gudrun/0000-0003-4604-735X; Thomas, Elizabeth/0000-0003-4235-4694; Barroso, Ines/0000-0001-5800-4520; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Savage, David Bousfield/0000-0002-7857-7032	MRC [MC_U120061305] Funding Source: UKRI; Medical Research Council [MC_U120061305] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Birnbaum MJ, 2001, NATURE, V409, P672, DOI 10.1038/35055643; BJORNTORP P, 1978, METABOLISM, V27, P1853, DOI 10.1016/S0026-0495(78)80004-3; BLACK D, 1983, J R COLL PHYSICIANS, V17, P5; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Burghes AHM, 2001, SCIENCE, V293, P2213, DOI 10.1126/science.1065930; COLLINGWOOD TN, 1994, MOL ENDOCRINOL, V8, P1262, DOI 10.1210/me.8.9.1262; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Kelley DE, 2001, DIABETES CARE, V24, P933, DOI 10.2337/diacare.24.5.933; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Newgard CB, 2000, DIABETES, V49, P1967, DOI 10.2337/diabetes.49.12.1967; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Rasmussen SK, 2000, DIABETOLOGIA, V43, P718, DOI 10.1007/s001250051369; Rico-Sanz J, 1999, J APPL PHYSIOL, V87, P2068, DOI 10.1152/jappl.1999.87.6.2068; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; TANG PM, 1991, J BIOL CHEM, V266, P15782; Thomas EL, 1998, J APPL PHYSIOL, V85, P1778, DOI 10.1152/jappl.1998.85.5.1778; Thorpe KL, 1999, IMMUNOGENETICS, V49, P256, DOI 10.1007/s002510050491; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	29	113	117	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					379	384		10.1038/ng926	http://dx.doi.org/10.1038/ng926			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12118251				2022-12-27	WOS:000177147100012
J	Ng, D; Thakker, N; Corcoran, CM; Donnai, D; Perveen, R; Schneider, A; Hadley, DW; Tifft, C; Zhang, LQ; Wilkie, AOM; van der Smagt, JJ; Gorlin, RJ; Burgess, SM; Bardwell, VJ; Black, GCM; Biesecker, LG				Ng, D; Thakker, N; Corcoran, CM; Donnai, D; Perveen, R; Schneider, A; Hadley, DW; Tifft, C; Zhang, LQ; Wilkie, AOM; van der Smagt, JJ; Gorlin, RJ; Burgess, SM; Bardwell, VJ; Black, GCM; Biesecker, LG			Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; GERMINAL-CENTER FORMATION; DENTAL OFCD SYNDROME; B-CELL LYMPHOMAS; GENE; BCL-6; TRANSLOCATIONS; LOCALIZATION; INFLAMMATION; COREPRESSOR	Lenz microphthalmia is inherited in an X-linked recessive pattern and comprises microphthalmia, mental retardation, and skeletal and other anomalies. Two loci associated with this syndrome, MAA ( microphthalmia with associated anomalies) and MAA2, are situated respectively at Xq27-q28 (refs. 1,2) and Xp11.4-p21.2 (ref. 3). We identified a substitution, nt 254C --> T; P85L, in BCOR (encoding BCL-6-interacting corepressor, BCOR 4) in affected males from the family with Lenz syndrome previously used to identify the MAA2 locus 3. Oculofaciocardiodental syndrome (OFCD; OMIM 300166) is inherited in an X-linked dominant pattern with presumed male lethality and comprises microphthalmia, congenital cataracts, radiculomegaly, and cardiac and digital abnormalities. Given their phenotypic overlap, we proposed that OFCD and MAA2 - associated Lenz microphthalmia were allelic, and we found different frameshift, deletion and nonsense mutations in BCOR in seven families affected with OFCD. Like wild-type BCOR, BCOR P85L and an OFCD-mutant form of BCOR can interact with BCL-6 and efficiently repress transcription. This indicates that these syndromes are likely to result from defects in alternative functions of BCOR, such as interactions with transcriptional partners other than BCL-6. We cloned the zebrafish (Danio rerio) ortholog of BCOR and found that knock-down of this ortholog caused developmental perturbations of the eye, skeleton and central nervous system consistent with the human syndromes, confirming that BCOR is a key transcriptional regulator during early embryogenesis.	St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; Univ Minnesota, Ctr Canc, Minneapolis, MN USA; Albert Einstein Med Ctr, Dept Genet, Philadelphia, PA 19141 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet Dev & Dis Res Branch, NIH, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Div Genet, Washington, DC 20010 USA; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Utrecht, Med Ctr, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; Univ Minnesota, Dept Oral Pathol & Genet, Sch Dent, Minneapolis, MN USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Ctr Mol Med, Manchester, Lancs, England; Cent Manchester & Manchester Childrens Univ Hosp, Manchester Royal Eye Hosp, Manchester, Lancs, England	University of Manchester; University of Manchester; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System; University of Oxford; Utrecht University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Manchester; Manchester Royal Eye Hospital	Black, GCM (corresponding author), St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England.	gblack@man.ac.uk	Wilkie, Andrew/AAC-3820-2020; wei, wei/HHR-8613-2022; Black, Graeme/K-7374-2015	Wilkie, Andrew/0000-0002-2972-5481; Burgess, Shawn/0000-0003-1147-0596; Thakker, Nalin/0000-0002-8664-1508; Black, Graeme/0000-0001-8727-6592	NATIONAL CANCER INSTITUTE [R01CA071540] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200328, Z01HG000181, Z01HG000183] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA071540] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aalfs CM, 1996, CLIN DYSMORPHOL, V5, P93, DOI 10.1097/00019605-199604000-00001; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Brown J, 1996, GENOMICS, V37, P200, DOI 10.1006/geno.1996.0543; Chen Q, 2002, J BIOL CHEM, V277, P24081, DOI 10.1074/jbc.M201821200; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Epstein JA, 2003, NATURE, V426, P238, DOI 10.1038/426238a; Forrester S, 2001, AM J MED GENET, V98, P92; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Gorlin RJ, 1996, AM J MED GENET, V63, P290; GRAHAM CA, 1991, OPHTHALMIC PAED GEN, V12, P43, DOI 10.3109/13816819109023084; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Hedera P, 2003, AM J MED GENET A, V123A, P261, DOI 10.1002/ajmg.a.20444; Huynh KD, 2000, GENE DEV, V14, P1810; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; MIKI T, 1994, BLOOD, V83, P217; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ng D, 2002, AM J MED GENET, V110, P308, DOI 10.1002/ajmg.10484; Schulze BRB, 1999, AM J MED GENET, V82, P429, DOI 10.1002/(SICI)1096-8628(19990219)82:5<429::AID-AJMG13>3.0.CO;2-S; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; van Genderen MM, 2000, BRIT J OPHTHALMOL, V84, P1177, DOI 10.1136/bjo.84.10.1177; Wilkie A O, 1993, Clin Dysmorphol, V2, P114; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BHH, 1993, CANCER RES, V53, P2732	26	228	233	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					411	416		10.1038/ng1321	http://dx.doi.org/10.1038/ng1321			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15004558	Bronze			2022-12-27	WOS:000220647200027
J	Chen, WSV; Delrow, J; Corrin, PD; Frazier, JP; Soriano, P				Chen, WSV; Delrow, J; Corrin, PD; Frazier, JP; Soriano, P			Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNA; DEVELOPMENTAL GENES; EXPRESSION PATTERNS; FUNCTIONAL-ANALYSIS; GROWTH-FACTORS; MOUSE GENOME; MUTANT MICE; IN-VITRO; SCREEN	We developed a versatile, high-throughput genetic screening strategy by coupling gene mutagenesis and expression profiling technologies. Using a retroviral gene-trap vector optimized for efficient mutagenesis and cloning, we randomly disrupted genes in mouse embryonic stem (ES) cells and amplified them to construct a cDNA microarray. With this gene-trap array, we show that transcriptional target genes of platelet-derived growth factor (PDGF) can be efficiently and reliably identified in physiologically relevant cells and are immediately accessible to genetic studies to determine their in vivo roles and relative contributions to PDGF-regulated developmental processes. The same platform can be used to search for genes of specific biological relevance in a broad array of experimental settings, providing a fast track from gene identification to functional validation.	Fred Hutchinson Canc Res Ctr, Program Dev Biol, Div Basic Sci, Seattle, WA 98109 USA; Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Fred Hutchinson Cancer Center; University of Michigan System; University of Michigan	Soriano, P (corresponding author), Fred Hutchinson Canc Res Ctr, Program Dev Biol, Div Basic Sci, Seattle, WA 98109 USA.	psoriano@fhcrc.org	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X				Abuin A, 2002, TRENDS BIOTECHNOL, V20, P36, DOI 10.1016/S0167-7799(01)01843-1; Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bonaldo P, 1998, EXP CELL RES, V244, P125, DOI 10.1006/excr.1998.4208; Chen WSV, 2003, METHOD ENZYMOL, V365, P367; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Komada M, 2000, GENE DEV, V14, P1332; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SORIANO P, 1991, J VIROL, V65, P2314, DOI 10.1128/JVI.65.5.2314-2319.1991; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; VONMELCHNER H, 1992, GENE DEV, V6, P919, DOI 10.1101/gad.6.6.919; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	42	89	96	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					304	312		10.1038/ng1306	http://dx.doi.org/10.1038/ng1306			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981515	Bronze			2022-12-27	WOS:000189250400022
J	Parks, AL; Cook, KR; Belvin, M; Dompe, NA; Fawcett, R; Huppert, K; Tan, LR; Winter, CG; Bogart, KP; Deal, JE; Deal-Herr, ME; Grant, D; Marcinko, M; Miyazaki, WY; Robertson, S; Shaw, KJ; Tabios, M; Vysotskaia, V; Zhao, L; Andrade, RS; Edgar, KA; Howie, E; Killpack, K; Milash, B; Norton, A; Thao, D; Whittaker, K; Winner, MA; Friedman, L; Margolis, J; Singer, MA; Kopczynski, C; Curtis, D; Kaufman, TC; Plowman, GD; Duyk, G; Francis-Lang, HL				Parks, AL; Cook, KR; Belvin, M; Dompe, NA; Fawcett, R; Huppert, K; Tan, LR; Winter, CG; Bogart, KP; Deal, JE; Deal-Herr, ME; Grant, D; Marcinko, M; Miyazaki, WY; Robertson, S; Shaw, KJ; Tabios, M; Vysotskaia, V; Zhao, L; Andrade, RS; Edgar, KA; Howie, E; Killpack, K; Milash, B; Norton, A; Thao, D; Whittaker, K; Winner, MA; Friedman, L; Margolis, J; Singer, MA; Kopczynski, C; Curtis, D; Kaufman, TC; Plowman, GD; Duyk, G; Francis-Lang, HL			Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome	NATURE GENETICS			English	Article							CHROMOSOME REARRANGEMENTS; RECOMBINATION	In fruit fly research, chromosomal deletions are indispensable tools for mapping mutations, characterizing alleles and identifying interacting loci. Most widely used deletions were generated by irradiation or chemical mutagenesis. These methods are labor-intensive, generate random breakpoints and result in unwanted secondary mutations that can confound phenotypic analyses. Most of the existing deletions are large, have molecularly undefined endpoints and are maintained in genetically complex stocks. Furthermore, the existence of haplolethal or haplosterile loci makes the recovery of deletions of certain regions exceedingly difficult by traditional methods, resulting in gaps in coverage. Here we describe two methods that address these problems by providing for the systematic isolation of targeted deletions in the D. melanogaster genome. The first strategy used a P element based technique to generate deletions that closely flank haploinsufficient genes and minimize undeleted regions. This deletion set has increased overall genomic coverage by 5-7%. The second strategy used FLP recombinase and the large array of FRT-bearing insertions described in the accompanying paper(1) to generate 519 isogenic deletions with molecularly defined endpoints. This second deletion collection provides 56% genome coverage so far. The latter methodology enables the generation of small custom deletions with predictable endpoints throughout the genome and should make their isolation a simple and routine task.	Indiana Univ, Dept Biol, Bloomington Drosophila Stock Ctr, Bloomington, IN 47405 USA; Exelixis, San Francisco, CA 94083 USA	Indiana University System; Indiana University Bloomington; Exelixis, Inc.	Cook, KR (corresponding author), Indiana Univ, Dept Biol, Bloomington Drosophila Stock Ctr, 1001 E 3rd St, Bloomington, IN 47405 USA.	kcook@bio.indiana.edu	PLOWMAN, Greg D/E-2012-2011	Parks, Annette/0000-0002-4619-2277; Cook, Kevin/0000-0001-9260-364X; Huppert, Kari A./0000-0003-0842-1937; Plowman, Gregory D/0000-0002-6465-309X	NCRR NIH HHS [R24 RR014106] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR014106] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ashburner M., 1989, DROSOPHILA LAB HDB; BERG R, 1980, SCIENCE, V210, P427, DOI 10.1126/science.6776625; COOLEY L, 1990, P NATL ACAD SCI USA, V87, P3170, DOI 10.1073/pnas.87.8.3170; Golic KG, 1996, GENETICS, V144, P1693; Gray YHM, 1996, GENETICS, V144, P1601; Preston CR, 1996, GENETICS, V144, P1623; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; THIBAULT ST, 2004, NAT GENET       0222; TOWER J, 1993, GENETICS, V133, P347	9	586	599	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					288	292		10.1038/ng1312	http://dx.doi.org/10.1038/ng1312			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981519	Bronze			2022-12-27	WOS:000189250400019
J	Corn, PG; McDonald, ER; Herman, JG; El-Deiry, WS				Corn, PG; McDonald, ER; Herman, JG; El-Deiry, WS			Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; RENAL-CARCINOMA; REGULATE HIF; COMPLEX; MUTATIONS; DISEASE; IDENTIFICATION; PROTEOLYSIS; FAMILY; PVHL	von Hippel Lindau (VHL) gene inactivation occurs in von Hippel Lindau (VHL) disease. The protein pVHL functions in a multi-subunit E3 ubiquitin ligase that targets the hypoxia-inducible transcription factor Hif1alpha for proteasomal degradation during normoxia. We establish that pVHL binds to Tat-binding protein-1 (TBP-1), a component of the 19S regulatory complex of the proteasome. TBP-1 associates with the beta-domain of pVHL and complexes with pVHL and Hif1 in vivo. Overexpression of TBP-1 promotes degradation of Hif1 in a pVHL-dependent manner that requires the ATPase domain of TBP-1. Blockade of TBP-1 expression by small interfering RNA ( siRNA) causes prolonged degradation kinetics of Hif1alpha. Several distinct mutations in exon 2 of VHL disrupt binding of pVHL to TBP-1. A pVHL mutant containing a P154L substitution coimmunoprecipitates with Hif1alpha, but not TBP-1, and does not promote degradation of Hif1alpha. Thus, the ability of pVHL to degrade Hif1alpha depends in part on its interaction with TBP-1 and suggests a new mechanism for Hif1alpha stabilization in some pVHL-deficient tumors.	Univ Penn, Howard Hughes Med Inst, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine	El-Deiry, WS (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Med, Philadelphia, PA 19104 USA.	wafik@mail.med.upenn.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266				Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; CROSSEY PA, 1994, HUM MOL GENET, V3, P1303; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gnarra JR, 1996, BBA-REV CANCER, V1242, P201, DOI 10.1016/0304-419X(95)00012-5; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hoyle J, 1997, HUM GENET, V99, P285, DOI 10.1007/s004390050356; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nakamura T, 1998, BBA-GENE STRUCT EXPR, V1399, P93, DOI 10.1016/S0167-4781(98)00105-5; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2000, GENE DEV, V14, P1983; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; WHALEY JM, 1994, AM J HUM GENET, V55, P1092; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	38	61	63	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					229	237		10.1038/ng1254	http://dx.doi.org/10.1038/ng1254			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14556007				2022-12-27	WOS:000186273300018
J	Vrontou, S; Petrou, P; Meyer, BI; Galanopoulos, VK; Imai, K; Yanagi, M; Chowdhury, K; Scambler, PJ; Chalepakis, G				Vrontou, S; Petrou, P; Meyer, BI; Galanopoulos, VK; Imai, K; Yanagi, M; Chowdhury, K; Scambler, PJ; Chalepakis, G			Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice	NATURE GENETICS			English	Article							MEMBRANE-SPANNING PROTEOGLYCAN; DROSOPHILA-MELANOGASTER; EXTRACELLULAR-MATRIX; KIDNEY MORPHOGENESIS; EXPRESSION; DISEASE; MUTANTS; MODEL; NG2	Loss of tight association between epidermis and dermis underlies several blistering disorders and is frequently caused by impaired function of extracellular matrix (ECM) proteins(1,2). Here we describe a new protein in mouse, Fras1, that is specifically detected in a linear fashion underlying the epidermis and the basal surface of other epithelia in embryos. Loss of Fras1 function results in the formation of subepidermal hemorrhagic blisters as well as unilateral or bilateral renal agenesis during mouse embryogenesis. Postnatally, homozygous Fras1 mutants have fusion of the eyelids and digits and unilateral renal agenesis or dysplasia. The defects observed in Fras1(-/-) mice phenocopy those of the existing bl (blebbed) mouse mutants(3,4), which have been considered a model for the human genetic disorder Fraser syndrome(5,6). We show that bl/bl homozygous embryos are devoid of Fras1 protein, consistent with the finding that Fras1 is mutated in these mice(6). In sum, our data suggest that perturbations in the composition of the extracellular space underlying epithelia could account for the onset of the blebbed phenotype in mouse and Fraser syndrome manifestation in human.	FORTH, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Dev Genet, Neuherberg, Germany; Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England	Foundation for Research & Technology - Hellas (FORTH); University of Crete; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; University College London	Chalepakis, G (corresponding author), FORTH, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.		Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628				Arin MJ, 2001, TRENDS MOL MED, V7, P422, DOI 10.1016/S1471-4914(01)02095-0; Bruckner-Tuderman L, 1998, J MOL MED-JMM, V76, P226, DOI 10.1007/s001090050213; Darling S, 1994, Clin Dysmorphol, V3, P91; Gustafsson E, 2000, EXP CELL RES, V261, P52, DOI 10.1006/excr.2000.5042; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; LYON MF, 1996, GENETIC VARIANTS STR; McGowan KA, 2000, MICROSC RES TECHNIQ, V51, P262, DOI 10.1002/1097-0029(20001101)51:3<262::AID-JEMT6>3.0.CO;2-V; MCGREGOR L, 2003, NAT GENET, V34; MOUELLIC H, 1990, P NATL ACAD SCI USA, V87, P4712; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; ROEBROEK AJM, 1992, J BIOL CHEM, V267, P17208; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; SNYDER PB, 1986, P NATL ACAD SCI USA, V83, P3341, DOI 10.1073/pnas.83.10.3341; Spirito F, 2001, J BIOL CHEM, V276, P18828, DOI 10.1074/jbc.M100381200; Tillet E, 1997, J BIOL CHEM, V272, P10769; Willem M, 2002, DEVELOPMENT, V129, P2711; WINTER RM, 1990, CLIN GENET, V37, P494	21	93	95	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					209	214		10.1038/ng1168	http://dx.doi.org/10.1038/ng1168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12766770	Green Published			2022-12-27	WOS:000183200500029
J	Muckenthaler, M; Roy, CN; Custodio, AO; Minana, B; deGraaf, J; Montross, LK; Andrews, NC; Hentze, MW				Muckenthaler, M; Roy, CN; Custodio, AO; Minana, B; deGraaf, J; Montross, LK; Andrews, NC; Hentze, MW			Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis	NATURE GENETICS			English	Article							IRON TRANSPORTER; HEREDITARY HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE; DUODENAL EXPRESSION; MESSENGER-RNAS; C/EBP-ALPHA; GENE; DEFICIENCY; ABSORPTION; OVERLOAD	Individuals with hereditary hemochromatosis suffer from systemic iron overload due to duodenal hyperabsorption(1,2). Most cases arise from a founder mutation in HFE (845G-->)A; ref. 2) that results in the amino-acid substitution C282Y and prevents the association of FIFE with beta2-microglobulin. Mice homozygous with respect to a null allele of We (Hfe(-/-)) or homozygous with respect to the orthologous 882G-->A mutation (Hfe(845A/845A)) develop iron overload that recapitulates hereditary hemochromatosis in humans, confirming that hereditary hemochromatosis arises from loss of FIFE function(3). Much work has focused on an exclusive role for the intestine in hereditary hemochromatosis. HFE deficiency in intestinal crypt cells is thought to cause intestinal iron deficiency and greater expression of iron transporters such as SLC11A2 (also called DMT1, DCT1 and NRAMP2) and SLC11A3 (also called IREG1, ferroportin and MTP1; ref. 3). Published data on the expression of these transporters in the duodenum of HFE-deficient mice and humans are contradictory(4-8). in this report, we used a custom microarray to assay changes in duodenal and hepatic gene expression in Hfe-deficient mice. We found unexpected alterations in the expression of Slc39a1 (mouse ortholog of SLC11A3) and Cybrd1, which encode key iron transport proteins, and Hamp (hepcidin antimicrobial peptide), a hepatic regulator of iron transport. We propose that inappropriate regulatory cues from the liver underlie greater duodenal iron absorption, possibly involving the ferric reductase Cybrd1.	Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), Harvard Univ, Sch Med, Div Med Sci, Boston, MA 02115 USA.	hentze@embl.de	Hentze, Matthias W/V-3980-2017; minana, belen/K-5530-2015	Hentze, Matthias W/0000-0002-4023-7876; minana, belen/0000-0001-7676-5788; Andrews, Nancy/0000-0003-0243-4462; Custodio, Angel Omar/0000-0003-0916-2826; Muckenthaler, Martina/0000-0002-3778-510X				Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Canonne-Hergaux F, 2001, BLOOD, V97, P1138, DOI 10.1182/blood.V97.4.1138; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Fleming RE, 2002, ANNU REV PHYSIOL, V64, P663, DOI 10.1146/annurev.physiol.64.081501.155838; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Richter A, 2002, BIOTECHNIQUES, V33, P620, DOI 10.2144/02333rr05_11834a; Rolfs A, 2002, AM J PHYSIOL-GASTR L, V282, pG598, DOI 10.1152/ajpgi.00371.2001; Simpson RJ, 2003, GUT, V52, P510, DOI 10.1136/gut.52.4.510; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Trinder D, 2002, P NATL ACAD SCI USA, V99, P5622, DOI 10.1073/pnas.082112299; Trinder D, 2000, GUT, V46, P270, DOI 10.1136/gut.46.2.270; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; Zoller H, 2001, GASTROENTEROLOGY, V120, P1412, DOI 10.1053/gast.2001.24033	30	247	251	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					102	107		10.1038/ng1152	http://dx.doi.org/10.1038/ng1152			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12704390				2022-12-27	WOS:000182667900025
J	Dode, C; Levilliers, J; Dupont, JM; De Paepe, A; Le Du, N; Soussi-Yanicostas, N; Coimbra, RS; Delmaghani, S; Compain-Nouaille, S; Baverel, F; Pecheux, C; Le Tessier, D; Cruaud, C; Delpech, M; Speleman, F; Vermeulen, S; Amalfitano, A; Bachelot, Y; Bouchard, P; Cabrol, S; Carel, JC; Delemarre-van de Waal, H; Goulet-Salmon, B; Kottler, ML; Richard, O; Sanchez-Franco, F; Saura, R; Young, J; Petit, C; Hardelin, JP				Dode, C; Levilliers, J; Dupont, JM; De Paepe, A; Le Du, N; Soussi-Yanicostas, N; Coimbra, RS; Delmaghani, S; Compain-Nouaille, S; Baverel, F; Pecheux, C; Le Tessier, D; Cruaud, C; Delpech, M; Speleman, F; Vermeulen, S; Amalfitano, A; Bachelot, Y; Bouchard, P; Cabrol, S; Carel, JC; Delemarre-van de Waal, H; Goulet-Salmon, B; Kottler, ML; Richard, O; Sanchez-Franco, F; Saura, R; Young, J; Petit, C; Hardelin, JP			Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome	NATURE GENETICS			English	Article							HEPARAN-SULFATE; ANOSMIN-1; GENE	We took advantage of overlapping interstitial deletions at chromosome 8p11-p12 in two individuals with contiguous gene syndromes and defined an interval of roughly 540 kb associated with a dominant form of Kallmann syndrome, KAL2. We establish here that loss-of-function mutations in FGFR1 underlie KAL2 whereas a gain-of-function mutation in FGFR1 has been shown to cause a form of craniosynostosis. Moreover, we suggest that the KAL1 gene product, the extracellular matrix protein anosmin-1, is involved in FGF signaling and propose that the gender difference in anosmin-1 dosage (because KAL1 partially escapes X inactivation) explains the higher prevalence of the disease in males.	Inst Pasteur, Unite Genet Deficits Sensoriels, F-75724 Paris 15, France; Hop Cochin, Lab Biochim & Genet Mol, F-75014 Paris, France; Inst Cochin Genet Mol, F-75014 Paris, France; Hop Cochin, Lab Cytogenet, F-75674 Paris, France; Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Genoscope, Evry, France; Duke Univ, Med Ctr, Durham, NC 27706 USA; Hop A Michallon, Grenoble, France; Hop St Antoine, Serv Endocrinol, F-75571 Paris, France; Hop Armand Trousseau, Serv Physiol, Paris, France; Hop St Vincent de Paul, Serv Physiol, F-75674 Paris, France; Hop St Vincent de Paul, Serv Physiol, F-75674 Paris, France; Hop St Vincent de Paul, Serv Endocrinol Pediat, F-75674 Paris, France; Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands; Ctr Hosp Alencon, Alencon, France; Hop Clemenceau, Dept Genet & Reprod, Caen, France; Hop Nord St Etienne, Serv Pediat & Genet, St Etienne, France; Inst Salud Carlos III, Madrid, Spain; Hop Pellegrin, Serv Genet Med, F-33076 Bordeaux, France; Hop Bicetre, Serv Endocrinol, Le Kremlin Bicetre, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Ghent University; Ghent University Hospital; Duke University; CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; CHU de Caen NORMANDIE; CHU de St Etienne; Instituto de Salud Carlos III; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Hardelin, JP (corresponding author), Inst Pasteur, Unite Genet Deficits Sensoriels, F-75724 Paris 15, France.	hardelin@pasteur.fr	Carel, Jean-Claude/AAZ-7691-2020; Young, Jacques/N-5251-2019; Coimbra, Roney/ABA-0586-2022; Young, Jacques/T-2976-2018; Soussi-Yanicostas, Nadia/GPF-8264-2022; speleman, frank/AAR-5184-2020; Soussi-Yanicostas, Nadia/U-6339-2018	Carel, Jean-Claude/0000-0002-0424-6767; Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; Soussi-Yanicostas, Nadia/0000-0001-7734-9401; speleman, frank/0000-0002-6628-8559; Coimbra, Roney/0000-0002-9204-0573; DUPONT, Jean-Michel/0000-0002-9680-3662; Vermeulen, Stefan/0000-0003-3710-800X; Cruaud, Corinne/0000-0002-4752-7278; Delmaghani, Sedigheh/0000-0003-2092-5097; Petit, Christine/0000-0002-9069-002X				Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Hardelin JP, 2001, MOL CELL ENDOCRINOL, V179, P75, DOI 10.1016/S0303-7207(01)00462-2; Hardelin JP, 1999, DEV DYNAM, V215, P26, DOI 10.1002/(SICI)1097-0177(199905)215:1<26::AID-DVDY4>3.3.CO;2-4; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; SANTEN RJ, 1973, J CLIN ENDOCR METAB, V36, P47, DOI 10.1210/jcem-36-1-47; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; SoussiYanicostas N, 1996, J CELL SCI, V109, P1749; Vermeulen S, 2002, AM J MED GENET, V108, P315, DOI 10.1002/ajmg.10295; WHITE BJ, 1983, AM J MED GENET, V15, P417, DOI 10.1002/ajmg.1320150307	15	547	566	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					463	465		10.1038/ng1122	http://dx.doi.org/10.1038/ng1122			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12627230	Bronze			2022-12-27	WOS:000181928600015
J	Puls, I; Jonnakuty, C; LaMonte, BH; Holzbaur, ELF; Tokito, M; Mann, E; Floeter, MK; Bidus, K; Drayna, D; Oh, SJ; Brown, RH; Ludlow, CL; Fischbeck, KH				Puls, I; Jonnakuty, C; LaMonte, BH; Holzbaur, ELF; Tokito, M; Mann, E; Floeter, MK; Bidus, K; Drayna, D; Oh, SJ; Brown, RH; Ludlow, CL; Fischbeck, KH			Mutant dynactin in motor neuron disease	NATURE GENETICS			English	Article							FAST AXONAL-TRANSPORT; DROSOPHILA-MELANOGASTER; P150(GLUED) COMPONENT; CYTOPLASMIC DYNEIN; SWISS-MODEL; COMPLEX	Impaired axonal transport in motor neurons has been proposed as a mechanism for neuronal degeneration in motor neuron disease. Here we show linkage of a lower m neuron disease to a region of 4 Mb at chromosome 2p13. Mutation analysis of a gene this interval that encodes the largest subunit of the axonal transport protein dynactin showed a single base-pair change resulting in an amino-acid substitution that is p dicted to distort the folding of dynactin's microtubule-binding domain. Binding assays show decreased binding of the mutant protein to microtubules. Our results show the dysfunction of dynactin-mediated transport can lead to human motor neuron disease.	NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; NINDS, Laryngeal & Speech Sect, NIH, Bethesda, MD 20892 USA; NINDS, Electromyography Sect, NIH, Bethesda, MD 20892 USA; NIDCD, Sect Syst Biol Commun Disorders, NIH, Bethesda, MD 20892 USA; Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; Massachusetts Gen Hosp, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital	Puls, I (corresponding author), NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA.			Ludlow, Christy/0000-0002-2015-6171	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002974, ZIANS002976, Z01NS002976, ZIANS002980, Z01NS002980, ZIANS002974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Dupuis L, 2000, NEUROBIOL DIS, V7, P274, DOI 10.1006/nbdi.2000.0292; Gepner J, 1996, GENETICS, V142, P865; GRIFFIN JW, 1988, ANN NEUROL, V23, P3, DOI 10.1002/ana.410230103; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARTE PJ, 1983, DEV BIOL, V99, P88, DOI 10.1016/0012-1606(83)90256-7; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; WatermanStorer CM, 1996, J BIOL CHEM, V271, P1153, DOI 10.1074/jbc.271.2.1153; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	715	738	1	27	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					455	456		10.1038/ng1123	http://dx.doi.org/10.1038/ng1123			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12627231	Bronze			2022-12-27	WOS:000181928600011
J	Ray, A; Hector, RE; Roy, N; Song, JH; Berkner, KL; Runge, KW				Ray, A; Hector, RE; Roy, N; Song, JH; Berkner, KL; Runge, KW			Sir3p phosphorylation by the Slt2p pathway effects redistribution of silencing function and shortened lifespan	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIC RESTRICTION; RIBOSOMAL DNA; YEAST; SPAN; GENE; MECHANISMS; LONGEVITY; STRENGTH; SYSTEM	An organism's lifespan is modulated by environmental conditions. When nutrients are abundant, the metabolism of many organisms shifts to growth or reproduction at the expense of longer lifespan, whereas a scarcity of nutrients reverses this shift(1-3). These correlations suggest that organisms respond to environmental changes by altering their metabolism to promote either reproduction and growth or long life. The only previously reported signaling mechanism involved in this response is the nutrient-responsive insulin/insulin-like growth factor-1 receptor pathway(1). Here we report another pathway that controls the length of yeast lifespan. Commitment to cell growth activates the Slt2p MAP kinase pathway, which phosphorylates the transcriptional silencing protein Sir3p, resulting in a shorter lifespan. Elimination of the Sir3p phosphorylation site at Ser275 extended lifespan by 38%. Lifespan extension occurs by a mechanism that is independent of suppressing rDNA recombination. Thus, Slt2p is an enzymatic regulator of silencing function that couples commitment to cell growth and shorter lifespan.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Runge, KW (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, 9500 Euclid Ave,NC20, Cleveland, OH 44195 USA.		Runge, Kurt/AAW-9308-2021; Roy, Nilanjan/I-5113-2014	Runge, Kurt/0000-0001-8492-0530; Roy, Nilanjan/0000-0002-4888-2079; Berkner, Kathleen/0000-0001-8054-8081; Roy, Nilanjan/0000-0001-8788-7350	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081093, R01HL055666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019960] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019960] Funding Source: Medline; NIGMS NIH HHS [R01 GM050752] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; de Nobel H, 2000, TRENDS MICROBIOL, V8, P344, DOI 10.1016/S0966-842X(00)01805-9; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Park PU, 2002, METHOD ENZYMOL, V351, P468; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Roy N, 2000, CURR BIOL, V10, P111, DOI 10.1016/S0960-9822(00)00298-0; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638	29	44	44	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					522	526		10.1038/ng1132	http://dx.doi.org/10.1038/ng1132			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12640455	Bronze			2022-12-27	WOS:000181928600026
J	Winrow, CJ; Hemming, ML; Allen, DM; Quistad, GB; Casida, JE; Barlow, C				Winrow, CJ; Hemming, ML; Allen, DM; Quistad, GB; Casida, JE; Barlow, C			Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity	NATURE GENETICS			English	Article							GULF-WAR; CATALYTIC DOMAIN; INHIBITION; NERVE; BRAIN; NEURODEGENERATION; FAMILY; AGENTS; ATAXIA; HENS	Neuropathy target esterase (NTE) is involved in neural development and is the target for neurodegeneration induced by selected organophosphorus pesticides and chemical warfare agents. We generated mice with disruptions in Nte, the gene encoding NTE. Nte(-/-) mice die after embryonic day 8, and Nte(+/-) mice have lower activity of Nte in the brain and higher mortality when exposed to the Nte-inhibiting compound ethyl octylphosphonofluoridate (EOPF) than do wild-type mice. Nte(+/-) and wild-type mice treated with 1 mg per kg of body weight of EOPF have elevated motor activity, showing that even minor reduction of Nte activity leads to hyperactivity. These studies show that genetic or chemical reduction of Nte activity results in a neurological phenotype of hyperactivity in mammals and indicate that EOPF toxicity occurs directly through inhibition of Nte without the requirement for Nte gain of function or aging.	Univ Calif Berkeley, Dept Environm Sci Policy & Management, Environm Chem & Toxicol Lab, Berkeley, CA 94720 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Salk Institute	Barlow, C (corresponding author), Merck Res Labs, 3535 Gen Atom Court, San Diego, CA 92121 USA.	carrolee_barlow@merck.com	Winrow, Christopher/K-1864-2014	Winrow, Christopher/0000-0001-8248-4157; Hemming, Mathew/0000-0003-4674-7778				Akbarsha M. A., 1998, Indian Journal of Experimental Biology, V36, P34; Atkins J, 2000, J BIOL CHEM, V275, P24477, DOI 10.1074/jbc.M002921200; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Burgess JR, 2000, AM J CLIN NUTR, V71, p327S, DOI 10.1093/ajcn/71.1.327S; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Cavanagh J B, 1973, CRC Crit Rev Toxicol, V2, P365, DOI 10.3109/10408447309082021; DEBLEECKER JL, 1992, CLIN NEUROL NEUROSUR, V94, P93, DOI 10.1016/0303-8467(92)90065-B; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; EHRICH M, 1993, CHEM-BIOL INTERACT, V87, P431, DOI 10.1016/0009-2797(93)90071-6; EHRICH M, 2001, HDB PESTICIDE TOXICO, V2, P987; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Enserink M, 2001, SCIENCE, V291, P812, DOI 10.1126/science.291.5505.812; Escudero MA, 1997, J NEUROCHEM, V68, P2170; Forshaw PJ, 2001, J NEUROCHEM, V79, P400, DOI 10.1046/j.1471-4159.2001.00562.x; Glynn P, 1999, BIOCHEM J, V344, P625, DOI 10.1042/0264-6021:3440625; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P231, DOI 10.1001/jama.277.3.231; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P223, DOI 10.1001/jama.277.3.223; Hamm JT, 1998, NEUROTOXICOLOGY, V19, P853; Hardell L, 2002, ENVIRON RES, V88, P141, DOI 10.1006/enrs.2002.4337; Hitt E, 2002, NAT MED, V8, P198, DOI 10.1038/nm0302-198a; HUSAIN K, 1993, J APPL TOXICOL, V13, P143, DOI 10.1002/jat.2550130212; Ishimatsu M, 2002, J NEUROPHYSIOL, V87, P1206, DOI 10.1152/jn.00463.2001; Jamal GA, 1998, ADVERSE DRUG REACT T, V17, P1; Jamal GA, 1997, ADVERSE DRUG REACT T, V16, P133; JOHNSON MK, 1977, ARCH TOXICOL, V37, P113, DOI 10.1007/BF00293860; JOHNSON MK, 1974, J NEUROCHEM, V23, P785, DOI 10.1111/j.1471-4159.1974.tb04404.x; Johnson MK., 2001, HDB PESTICIDE TOXICO, P953, DOI 10.1016/B978-012426260-7.50050-1; KARCZMAR AG, 1984, FUND APPL TOXICOL, V4, pS1, DOI 10.1016/0272-0590(84)90133-7; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lotti M, 2002, MUSCLE NERVE, V25, P492, DOI 10.1002/mus.10086; Lush MJ, 1998, BIOCHEM J, V332, P1; MEREDITH C, 1988, J NEUROCHEM, V51, P1097, DOI 10.1111/j.1471-4159.1988.tb03073.x; MIGNERY GA, 1988, GENE, V62, P27, DOI 10.1016/0378-1119(88)90577-X; Moretto A, 2002, ARCH TOXICOL, V76, P367, DOI 10.1007/s00204-002-0352-8; Moser M, 2000, MECH DEVELOP, V90, P279, DOI 10.1016/S0925-4773(99)00239-7; Randall JC, 1997, J TOXICOL ENV HEALTH, V51, P571, DOI 10.1080/009841097159845; Ray DE, 2001, TOXICOL LETT, V120, P343, DOI 10.1016/S0378-4274(01)00266-1; Ried Thomas, 1992, Human Molecular Genetics, V1, P307, DOI 10.1093/hmg/1.5.307; Ross CA, 1999, PHILOS T ROY SOC B, V354, P1005, DOI 10.1098/rstb.1999.0452; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Solberg Y, 1997, TRENDS PHARMACOL SCI, V18, P183, DOI 10.1016/S0165-6147(97)89540-5; TORMO N, 1993, J NEUROCHEM, V61, P2164, DOI 10.1111/j.1471-4159.1993.tb07455.x; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Veronesi B, 1997, NEUROTOXICOLOGY, V18, P283; VILANOVA E, 1993, CHEM-BIOL INTERACT, V87, P369, DOI 10.1016/0009-2797(93)90065-7; Wilson BW, 2002, DRUG CHEM TOXICOL, V25, P131, DOI 10.1081/DCT-120003255; WU SY, 1995, CHEM RES TOXICOL, V8, P1070, DOI 10.1021/tx00050a011; Wu SY, 1996, TOXICOL APPL PHARM, V139, P195, DOI 10.1006/taap.1996.0158; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481	50	132	140	2	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					477	485		10.1038/ng1131	http://dx.doi.org/10.1038/ng1131			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12640454	Bronze			2022-12-27	WOS:000181928600018
J	Mira, MT; Alcais, A; Van Thuc, N; Thai, VH; Huong, NT; Ba, NN; Verner, A; Hudson, TJ; Abel, L; Schurr, E				Mira, MT; Alcais, A; Van Thuc, N; Thai, VH; Huong, NT; Ba, NN; Verner, A; Hudson, TJ; Abel, L; Schurr, E			Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population	NATURE GENETICS			English	Article							GENETIC EPIDEMIOLOGY; TUBERCULOID LEPROSY; LINKAGE ANALYSIS; ASSOCIATION; POLYMORPHISM; SEGREGATION; GENOTYPE	Leprosy, a chronic infectious disease caused by Mycobacterium leprae, affects an estimated 700,000 persons each year(1). Clinically, leprosy can be categorized as paucibacillary or multibacillary disease(2). These clinical forms develop in persons that are intrinsically susceptible to leprosy per se, that is, leprosy independent of its specific clinical manifestation(3). We report here on a genome-wide search for loci controlling susceptibility to leprosy per se in a panel of 86 families including 205 siblings affected with leprosy from Southern Vietnam. Using model-free linkage analysis, we found significant evidence for a susceptibility gene on chromosome region 6q25 (maximum likelihood binomial (MLB) lod score 4.31; P=5x10(-6)). We confirmed this by family-based association analysis in an independent panel of 208 Vietnamese leprosy simplex families. Of seven microsatellite markers underlying the linkage peak, alleles of two markers (D6S1035 and D6S305) showed strong evidence for association with leprosy (P=6.7x10(-4) and P=5.9x10(-5), respectively).	McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; Univ Paris 05, Inst Natl Sante & Rech Med, U550, Unite Human Genet Infect Dis,Necker Med Sch, Paris, France; Hosp Dermato Venereol, Ho Chi Minh City, Vietnam; McGill Univ, Montreal Genome Ctr, Ctr Hlth, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University	Schurr, E (corresponding author), McGill Univ, McGill Ctr Study Host Resistance, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	erwin@igloo.epi.mcgill.ca	Mira, Marcelo T/B-5046-2010; Alcais, Alexandre/J-5882-2017; Abel, Laurent/H-8888-2017	Mira, Marcelo T/0000-0002-8087-9400; Alcais, Alexandre/0000-0002-1012-2226; Abel, Laurent/0000-0001-7016-6493				Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Abel L, 1998, J INFECT DIS, V177, P133, DOI 10.1086/513830; ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Chakravartti MR, 1973, TOPICS HUMAN GENETIC, P1; FEITOSA MF, 1995, AM J HUM GENET, V56, P1179; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jacobson RR, 1999, LANCET, V353, P655, DOI 10.1016/S0140-6736(98)06322-3; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Meisner SJ, 2001, AM J TROP MED HYG, V65, P733, DOI 10.4269/ajtmh.2001.65.733; Rajalingam R, 1997, TISSUE ANTIGENS, V49, P168, DOI 10.1111/j.1399-0039.1997.tb02731.x; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; RISCH N, 1987, AM J HUM GENET, V40, P1; Roy S, 1997, J INFECT DIS, V176, P530, DOI 10.1086/517282; Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536; Shaw MA, 2001, GENES IMMUN, V2, P196, DOI 10.1038/sj.gene.6363754; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; VANEDEN W, 1980, J INFECT DIS, V141, P693, DOI 10.1093/infdis/141.6.693; VANEDEN W, 1985, J INFECT DIS, V151, P9, DOI 10.1093/infdis/151.1.9; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P1	24	138	147	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					412	415		10.1038/ng1096	http://dx.doi.org/10.1038/ng1096			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577057				2022-12-27	WOS:000181312700021
J	Tanner, SM; Aminoff, M; Wright, FA; Liyanarachchi, S; Kuronen, M; Saarinen, A; Massika, O; Mandel, H; Broch, H; de la Chapelle, A				Tanner, SM; Aminoff, M; Wright, FA; Liyanarachchi, S; Kuronen, M; Saarinen, A; Massika, O; Mandel, H; Broch, H; de la Chapelle, A			Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia	NATURE GENETICS			English	Article							HUMAN GENOME; GENE; CUBILIN; PROTEIN; IDENTIFICATION; EXPRESSION; MUTATIONS; PROMOTERS; RECEPTOR; MEGALIN	The amnionless gene, Amn, on mouse chromosome 12 encodes a type I transmembrane protein that is expressed in the extraembryonic visceral layer during gastrulation(1). Mice homozygous with respect to the amn mutation generated by a transgene insertion have no amnion(2,3). The embryos are severely compromised, surviving to the tenth day of gestation but seem to lack the mesodermal layers that normally produce the trunk(4). The Amn protein has one transmembrane domain separating a larger, N-terminal extracellular region and a smaller, C-terminal cytoplasmic region. The extracellular region harbors a cysteine-rich domain resembling those occurring in Chordin, found in Xenopus laevis embryos, and Sog, found in Drosophila melanogaster. As these cysteine-rich domains bind bone morphogenetic proteins (Bmps), it has been speculated that the cysteine-rich domain in Amn also binds Bmps(4). We show that homozygous mutations affecting exons 1-4 of human AMN lead to selective malabsorption of vitamin B-12 (a phenotype associated with megaloblastic anemia 1, MGA1; OMIM 261100; refs. 5,6) in otherwise normal individuals, suggesting that the 5' end of AMN is dispensable for embryonic development but necessary for absorption of vitamin B-12. When the 5 end of AMN is truncated by mutations, translation is initiated from alternative downstream start codons.	Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, Helsinki, Finland; Rambam Med Ctr, Dept Pediat, Metab Unit, Haifa, Israel; Vestfold Cent Hosp, Dept Pediat, Tonsberg, Norway	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Helsinki; Rambam Health Care Campus; Technion Israel Institute of Technology	de la Chapelle, A (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA.			Seitsonen, Anne/0000-0001-5488-0291				Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; BROCH H, 1984, ACTA PAEDIATR SCAND, V73, P248, DOI 10.1111/j.1651-2227.1984.tb09937.x; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Dunn NR, 2001, NAT GENET, V27, P351, DOI 10.1038/86829; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; GRASBECK R, 1960, ACTA MED SCAND, V167, P289; IMERSLUND O, 1960, ACTA PAEDIATR SCAND, P1; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Kalantry S, 2001, NAT GENET, V27, P412, DOI 10.1038/86912; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Moestrup SK, 1998, J BIOL CHEM, V273, P5235, DOI 10.1074/jbc.273.9.5235; SAMBROOK J, 1989, MOL CLONING LAB MANU, V3; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Tomihara-Newberger C, 1998, DEV BIOL, V204, P34, DOI 10.1006/dbio.1998.9034; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; Wang X, 1996, DEV BIOL, V177, P274, DOI 10.1006/dbio.1996.0162; WRIGHT FA, 2001, GENOME BIOL, V2; Xu DB, 1999, BLOOD, V94, P3604, DOI 10.1182/blood.V94.10.3604.422k22_3604_3606; Yamashita T, 1996, BLOOD, V87, P4424, DOI 10.1182/blood.V87.10.4424.bloodjournal87104424; Zhang MQ, 1998, GENOME RES, V8, P319, DOI 10.1101/gr.8.3.319	23	103	105	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					426	429		10.1038/ng1098	http://dx.doi.org/10.1038/ng1098			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590260				2022-12-27	WOS:000181312700024
J	Robert, MF; Morin, S; Beaulieu, N; Gauthier, F; Chute, IC; Barsalou, A; MacLeod, AR				Robert, MF; Morin, S; Beaulieu, N; Gauthier, F; Chute, IC; Barsalou, A; MacLeod, AR			DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells	NATURE GENETICS			English	Article							DNA METHYLATION; METHYLTRANSFERASES; EXPRESSION; 5-AZADEOXYCYTIDINE; P16(INK4A); NEOPLASIA; TISSUES; ISLANDS; TUMORS; HMLH1	Transcriptional silencing by CpG island methylation is a prevalent mechanism of tumor-suppressor gene suppression in cancers(1-4). Genetic experiments have defined the importance of the DNA methyltransferase Dnmt1 for the maintenance of methylation in mouse cells(5) and its role in neoplasia(6). In human bladder cancer cells, selective depletion of DNMT1 with antisense inhibitors has been shown to induce demethylation and reactivation of the silenced tumor-suppressor gene CDKN2A(7). In contrast, targeted disruption of DNMT1 alleles in HCT116 human colon cancer cells produced clones that retained CpG island methylation and associated tumor-suppressor gene silencing 8, whereas HCT116 clones with inactivation of both DNMT1 and DNMT3B showed much lower levels of DNA methylation, suggesting that the two enzymes are highly cooperative(9). We used a combination of genetic (antisense and siRNA) and pharmacologic (5-aza-2'-deoxycytidine) inhibitors of DNA methyl transferases to study the contribution of the DNMT isotypes to cancer-cell methylation. Selective depletion of DNMT1 using either antisense or siRNA resulted in lower cellular maintenance methyltransferase activity, global and gene-specific demethylation and re-expression of tumor-suppressor genes in human cancer cells. Specific depletion of DNMT1 but not DNMT3A or DNMT3B markedly potentiated the ability of 5-aza-2'-deoxycytidine to reactivate silenced tumor-suppressor genes, indicating that inhibition of DNMT1 function is the principal means by which 5-aza-2'-deoxycytidine reactivates genes. These results indicate that DNMT1 is necessary and sufficient to maintain global methylation and aberrant CpG island methylation in human cancer cells.	MethylGene, Dept Mol Biol, Montreal, PQ H4S 2A1, Canada		MacLeod, AR (corresponding author), MethylGene, Dept Mol Biol, 7220 Frederick Banting, Montreal, PQ H4S 2A1, Canada.							Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; CHRISTMAN JK, 1985, J BIOL CHEM, V260, P4059; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fournel M, 1999, J BIOL CHEM, V274, P24250, DOI 10.1074/jbc.274.34.24250; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; HAAF T, 1989, CHROMOSOMA, V98, P93, DOI 10.1007/BF00291043; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; JUTTERMAN R, 1994, P NATL ACAD SCI USA, V981, P11797; Kane MF, 1997, CANCER RES, V57, P808; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Leung SY, 1999, CANCER RES, V59, P159; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Margot JB, 2001, J CELL BIOCHEM, V83, P373, DOI 10.1002/jcb.1236; MERLO A, 1995, NAT MED, V1, P633; Myohanen SK, 1998, CANCER RES, V58, P591; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pogribny I, 1999, BIOCHEM BIOPH RES CO, V262, P624, DOI 10.1006/bbrc.1999.1187; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Rountree MR, 2001, ONCOGENE, V20, P3156, DOI 10.1038/sj.onc.1204339; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	30	486	525	1	63	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					61	65		10.1038/ng1068	http://dx.doi.org/10.1038/ng1068			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12496760				2022-12-27	WOS:000180136100018
J	Holloway, AJ; van Laar, RK; Tothill, RW; Bowtell, DDL				Holloway, AJ; van Laar, RK; Tothill, RW; Bowtell, DDL			Options available - from start to finish - for obtaining data from DNA microarrays	NATURE GENETICS			English	Review							GENE-EXPRESSION DATA; CELL LUNG CARCINOMAS; MOLECULAR CLASSIFICATION; QUALITY-CONTROL; ARRAY; PREDICTION; NORMALIZATION; PATTERNS; CANCER; SINGLE	Microarray technology has undergone a rapid evolution. With widespread interest in large-scale genomic research, an abundance of equipment and reagents have now become available and affordable to a large cross section of the scientific community. As protocols become more refined, careful investigators are able to obtain good quality microarray data quickly. In most recent times, however, perhaps one of the biggest obstacles researchers face is not the manufacture and use of microarrays at the bench, but storage and analysis of the array data. This review discusses the most recent equipment, reagents and protocols available to the researcher, as well as describing data analysis and storage options available from the evolving field of microarray informatics.	Peter MacCallum Canc Inst, Ian Potter Fdn Ctr Canc Genom & Predict Med, Melbourne, Vic 8006, Australia; Peter MacCallum Canc Inst, Trescowthick Res Labs, Melbourne, Vic 8006, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Bowtell, DDL (corresponding author), Peter MacCallum Canc Inst, Ian Potter Fdn Ctr Canc Genom & Predict Med, Locked Bag 1,ABeckett St, Melbourne, Vic 8006, Australia.	d.bowtell@pmci.unimelb.edu.au	Bowtell, David/H-1007-2016	Bowtell, David/0000-0001-9089-7525; Tothill, Richard William/0000-0003-4522-1184; van Laar, Ryan/0000-0003-2828-4175				Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2002, NATURE, V419, P323, DOI 10.1038/419323a; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertucci F, 1999, HUM MOL GENET, V8, P1715, DOI 10.1093/hmg/8.9.1715; Bilban Martin, 2002, Current Issues in Molecular Biology, V4, P57; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BOWTELL D, 2002, DNA MICROARRAYS MOL; Bowtell DDL, 1999, NAT GENET, V21, P25, DOI 10.1038/4455; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Colantuoni C, 2002, BIOTECHNIQUES, V32, P1316, DOI 10.2144/02326mt02; Delozier Eric P., 1992, Medical Reference Services Quarterly, V11, P29, DOI 10.1300/J115V11N03_03; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Sayed NM, 2000, INT J PARASITOL, V30, P329, DOI 10.1016/S0020-7519(00)00015-1; Fielden MR, 2002, BIOINFORMATICS, V18, P771, DOI 10.1093/bioinformatics/18.5.771; Gardiner-Garden M, 2001, Brief Bioinform, V2, P143, DOI 10.1093/bib/2.2.143; Geschwind DH, 2001, NAT REV NEUROSCI, V2, P435, DOI 10.1038/35077576; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Halgren RG, 2001, NUCLEIC ACIDS RES, V29, P582, DOI 10.1093/nar/29.2.582; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hill AA, 2001, GENOME BIOL, V2; Holmes G, 2002, INT J FOOD MICROBIOL, V73, P351, DOI 10.1016/S0168-1605(01)00671-7; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Karsten SL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e4; KELLAM P, 2001, GENOME BIOL, V2; Kerr MK, 2001, GENET RES, V77, P123; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Knight J, 2001, NATURE, V410, P860, DOI 10.1038/35073680; Lee JM, 2002, FUNCT INTEGR GENOMIC, V2, P13, DOI 10.1007/s10142-002-0046-6; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Relogio A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e51; RIPLEY B., 2001, MSOR CONNECTIONS NEW, V1, P23, DOI [10.11120/msor.2001.01010023, DOI 10.11120/MSOR.2001.01010023, DOI 10.11120/MS0R.2001.01010023]; Rouillard JM, 2002, BIOINFORMATICS, V18, P486, DOI 10.1093/bioinformatics/18.3.486; Saal LH, 2002, GENOME BIOL, V3; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shannon MF, 2002, SCIENCE, V296, P666, DOI 10.1126/science.1062936; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Volm M, 2002, CLIN CANCER RES, V8, P1843; Wang X, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.15.e75; Wei Y, 2001, J BACTERIOL, V183, P545, DOI 10.1128/JB.183.2.545-556.2001; Xu Y, 2002, CANCER RES, V62, P3493; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114; 2002, NATURE GENET, V32, P333	73	182	196	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			481	489		10.1038/ng1030	http://dx.doi.org/10.1038/ng1030			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454642				2022-12-27	WOS:000179742900007
J	Lemmers, RJLF; de Kievit, P; Sandkuijl, L; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM				Lemmers, RJLF; de Kievit, P; Sandkuijl, L; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM			Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere	NATURE GENETICS			English	Article							GENE; REARRANGEMENTS; IDENTIFICATION; FAMILY; REGION	Contractions in the polymorphic D4Z4 repeat array of subtelomere 4qter cause autosomal dominant facioscapulohumeral muscular dystrophy in humans. A polymorphic segment of 10 kb directly distal to D4Z4 exists in two allelic forms, 4qA and 4qB. Although both alleles are equally common in the general population, we now report that FSHD is associated solely with the 4qA allele.	Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands; Univ Med Ctr Nijmegen, Dept Neurol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.		van der Maarel, Silvere/X-3631-2018; Padberg, G.W.A.M./H-8079-2014	van der Maarel, Silvere/0000-0001-8103-711X; 				AGRESTI A, 1989, J MOL BIOL, V205, P625, DOI 10.1016/0022-2836(89)90308-2; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Geel M, 2000, CYTOGENET CELL GENET, V88, P316, DOI 10.1159/000015518; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26	12	191	204	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					235	236		10.1038/ng999	http://dx.doi.org/10.1038/ng999			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355084				2022-12-27	WOS:000178311100010
J	Crawford, DC; Bhangale, T; Li, N; Hellenthal, G; Rieder, MJ; Nickerson, DA; Stephens, M				Crawford, DC; Bhangale, T; Li, N; Hellenthal, G; Rieder, MJ; Nickerson, DA; Stephens, M			Evidence for substantial fine-scale variation in recombination rates across the human genome	NATURE GENETICS			English	Article							MEIOTIC RECOMBINATION; LINKAGE-DISEQUILIBRIUM; HAPLOTYPE BLOCKS; HOT; POLYMORPHISM; RECONSTRUCTION; DIVERSITY; HOTSPOTS; ORIGIN; SPOTS	Characterizing fine-scale variation in human recombination rates is important, both to deepen understanding of the recombination process(1) and to aid the design of disease association studies(2,3). Current genetic maps show that rates vary on a megabase scale, but studying finer-scale variation using pedigrees is difficult. Sperm-typing experiments(4-6) have characterized regions where crossovers cluster into 1-2-kb hot spots, but technical difficulties limit the number of studies(7). An alternative is to use population variation to infer fine-scale characteristics of the recombination process. Several surveys(8-10) reported block-like patterns of diversity, which may reflect fine-scale recombination rate variation(11-13), but limitations of available methods made this impossible to assess. Here, we applied a new statistical method, which overcomes these limitations, to infer patterns of fine-scale recombination rate variation in 74 genes. We found extensive rate variation both within and among genes. In particular, recombination hot spots are a common feature of the human genome: 47% (35 of 74) of genes showed substantive evidence for a hot spot, and many more showed evidence for some rate variation. No primary sequence characteristics are consistently associated with precise hot-spot location, although G+C content and nucleotide diversity are correlated with local recombination rate.	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stephens, M (corresponding author), Univ Washington, Dept Stat, Box 354322, Seattle, WA 98195 USA.	stephens@stat.washington.edu	Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012	Crawford, Dana/0000-0002-6437-6248; 				Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fullerton SM, 2000, MOL BIOL EVOL, V17, P179, DOI 10.1093/oxfordjournals.molbev.a026230; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li N, 2003, GENETICS, V165, P2213; LI N, 2003, THESIS U WASHINGTON; Nachman MW, 1998, GENETICS, V150, P1133; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; PTAK SE, IN PRESS GENETICS; PTAK SE, IN PRESS PLOS BIOL; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398	30	219	239	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					700	706		10.1038/ng1376	http://dx.doi.org/10.1038/ng1376			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15184900	Bronze			2022-12-27	WOS:000222354100019
J	Giglia-Mari, G; Coin, F; Ranish, JA; Hoogstraten, D; Theil, A; Wijgers, N; Jaspers, NGJ; Raams, A; Argentini, M; van der Spek, PJ; Botta, E; Stefanini, M; Egly, JM; Aebersold, R; Hoeijmakers, JHJ; Vermeulen, W				Giglia-Mari, G; Coin, F; Ranish, JA; Hoogstraten, D; Theil, A; Wijgers, N; Jaspers, NGJ; Raams, A; Argentini, M; van der Spek, PJ; Botta, E; Stefanini, M; Egly, JM; Aebersold, R; Hoeijmakers, JHJ; Vermeulen, W			A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A	NATURE GENETICS			English	Article							XERODERMA-PIGMENTOSUM; TRANSCRIPTION FACTOR; XPD GENE; IN-VIVO; MUTATIONS; DISORDER; SUBUNITS; COMPLEX	DNA repair-deficient trichothiodystrophy (TTD) results from mutations in the XPD and XPB subunits of the DNA repair and transcription factor TFIIH. In a third form of DNA repair deficient TTD, called group A, none of the nine subunits encoding TFIIH carried mutations; instead, the steady-state level of the entire complex was severely reduced(1). A new, tenth TFIIH subunit (TFB5) was recently identified in yeast(2). Here, we describe the identification of the human TFB5 ortholog and its association with human TFIIH. Microinjection of cDNA encoding TFB5 (GTF2H5, also called TTDA) corrected the DNA-repair defect of TTD-A cells, and we identified three functional inactivating mutations in this gene in three unrelated families with TTD-A. The GTF2H5 gene product has a role in regulating the level of TFIIH. The identification of a new evolutionarily conserved subunit of TFIIH implicated in TTD-A provides insight into TFIIH function in transcription, DNA repair and human disease.	Erasmus MC, Med Genet Cluster, Dept Genet, NL-3000 DR Rotterdam, Netherlands; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Inst Syst Biol, Seattle, WA USA; Erasmus MC, Dept Bioinformat, NL-3000 DR Rotterdam, Netherlands; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy	Erasmus University Rotterdam; Erasmus MC; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institute for Systems Biology (ISB); Erasmus University Rotterdam; Erasmus MC; Consiglio Nazionale delle Ricerche (CNR)	Vermeulen, W (corresponding author), Erasmus MC, Med Genet Cluster, Dept Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	w.vermeulen@erasmusmc.nl	Coin, Frédéric/F-5925-2013; Botta, Elena/B-9065-2015; Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021; Giglia-Mari, Giuseppina/F-5114-2010; BOTTA, ELENA/O-3892-2019	Coin, Frédéric/0000-0002-5620-8519; Vermeulen, Wim/0000-0003-3616-734X; Giglia-Mari, Giuseppina/0000-0003-2001-1965; BOTTA, ELENA/0000-0003-2060-0110				Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Broughton BC, 2001, HUM MOL GENET, V10, P2539, DOI 10.1093/hmg/10.22.2539; Cavusoglu N, 2003, PROTEOMICS, V3, P217, DOI 10.1002/pmic.200390030; Cenkci B, 2003, J BIOL CHEM, V278, P22574, DOI 10.1074/jbc.M303249200; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; GERARD M, 1991, J BIOL CHEM, V266, P20940; Graham JM, 2001, AM J HUM GENET, V69, P291, DOI 10.1086/321295; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Petrini JHJ, 2000, NAT GENET, V26, P257, DOI 10.1038/81529; Rabilloud T, 1999, METH MOL B, V112, P297; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Ranish JA, 2004, NAT GENET, V36, P707, DOI 10.1038/ng1385; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Sijbers AM, 1996, NUCLEIC ACIDS RES, V24, P3370, DOI 10.1093/nar/24.17.3370; STEFANINI M, 1993, AM J HUM GENET, V53, P817; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Weeda G, 1997, AM J HUM GENET, V60, P320	30	251	255	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					714	719		10.1038/ng1387	http://dx.doi.org/10.1038/ng1387			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220921	Bronze			2022-12-27	WOS:000222354100021
J	Hong, YK; Foreman, K; Shin, JW; Hirakawa, S; Curry, CL; Sage, DR; Libermann, T; Dezube, BJ; Fingeroth, JD; Detmar, M				Hong, YK; Foreman, K; Shin, JW; Hirakawa, S; Curry, CL; Sage, DR; Libermann, T; Dezube, BJ; Fingeroth, JD; Detmar, M			Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; GENE-EXPRESSION; CELLS; IDENTIFICATION; ORIGIN; PROX1; KSHV	Kaposi sarcoma is considered a neoplasm of lymphatic endothelium infected with Kaposi sarcoma-associated herpesvirus. It is characterized by the expression of lymphatic lineage-specific genes by Kaposi sarcoma tumor cells. Here we show that infection of differentiated blood vascular endothelial cells with Kaposi sarcoma-associated herpesvirus leads to their lymphatic reprogramming; induction of similar to70% of the main lymphatic lineage-specific genes, including PROX1, a master regulator of lymphatic development; and downregulation of blood vascular genes.	Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Beth Israel Deaconess Med Ctr, Dept Med, BIDMC Genom Ctr, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Loyola University Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Detmar, M (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	michael.detmar@cbrc2.mgh.harvard.edu		Libermann, Towia/0000-0002-4006-8179; Curry, Christine L/0000-0003-4783-9623				Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; BECKSTEAD JH, 1985, AM J PATHOL, V119, P294; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Jussila L, 1998, CANCER RES, V58, P1599; Moses AV, 2002, J VIROL, V76, P8383, DOI 10.1128/JVI.76.16.8383-8399.2002; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; SCHALLING M, 1995, NAT MED, V1, P707, DOI 10.1038/nm0795-707; Skobe M, 1999, J INVEST DERMATOL, V113, P1047, DOI 10.1046/j.1523-1747.1999.00798.x; Tang J, 2003, J VIROL, V77, P5975, DOI 10.1128/JVI.77.10.5975-5984.2003; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Weninger W, 1999, LAB INVEST, V79, P243; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	15	279	287	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					683	685		10.1038/ng1383	http://dx.doi.org/10.1038/ng1383			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220917	Bronze			2022-12-27	WOS:000222354100016
J	Lipkin, SM; Rozek, LS; Rennert, G; Yang, W; Chen, PC; Hacia, J; Hunt, N; Shin, B; Fodor, S; Kokoris, M; Greenson, JK; Fearon, E; Lynch, H; Collins, F; Gruber, SB				Lipkin, SM; Rozek, LS; Rennert, G; Yang, W; Chen, PC; Hacia, J; Hunt, N; Shin, B; Fodor, S; Kokoris, M; Greenson, JK; Fearon, E; Lynch, H; Collins, F; Gruber, SB			The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer	NATURE GENETICS			English	Article							MISMATCH-REPAIR; MICROSATELLITE INSTABILITY; MSH6 MUTATIONS; COLON-CANCER; MUTL; EXPRESSION; GENE; IDENTIFICATION; ASHKENAZI; FAMILIES	Most susceptibility to colorectal cancer (CRC) is not accounted for by known risk factors. Because MLH1, MSH2 and MSH6 mutations underlie high-penetrance CRC susceptibility in hereditary nonpolyposis colon cancer (HNPCC), we hypothesized that attenuated alleles might also underlie susceptibility to sporadic CRC. We looked for gene variants associated with HNPCC in Israeli probands with familial CRC unstratified with respect to the microsatellite instability (MSI) phenotype. Association studies identified a new MLH1 variant (415G-->C, resulting in the amino acid substitution D132H) in similar to1.3% of Israeli individuals with CRC self-described as Jewish, Christian and Muslim. MLH1 415C confers clinically significant susceptibility to CRC. In contrast to classic HNPCC, CRCs associated with MLH1 415C usually do not have the MSI defect, which is important for clinical mutation screening. Structural and functional analyses showed that the normal ATPase function of MLH1 is attenuated, but not eliminated, by the MLH1 415G-->C mutation. The new MLH1 variant confers a high risk of CRC and identifies a previously unrecognized mechanism in microsatellite-stable tumors. These studies suggest that variants of mismatch repair proteins with attenuated function may account for a higher proportion of susceptibility to sporadic microsatellite-stable CRC than previously assumed.	Univ Calif Irvine, Dept Med, Div Oncol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Div Oncol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Div Epidemiol, Irvine, CA 92697 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel; NIDDKD, Mol Struct Sect, Bethesda, MD 20892 USA; Univ So Calif, Inst Med Genet, Los Angeles, CA 90089 USA; Affymetrix Corp, Santa Clara, CA 95051 USA; BioCaptus, Bothell, WA 99164 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Creighton Univ, Hereditary Canc Inst, Omaha, NE USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California; Affymetrix; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Creighton University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Lipkin, SM (corresponding author), Univ Calif Irvine, Dept Med, Div Oncol, Irvine, CA 92697 USA.	slipkin@uci.edu; sgruber@med.umich.edu	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Rennert, Gad/0000-0002-8512-068X; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Boland CR, 1998, CANCER RES, V58, P5248; Charames GS, 2000, HUM GENET, V107, P623, DOI 10.1007/s004390000417; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Foulkes WD, 2002, AM J HUM GENET, V71, P1395, DOI 10.1086/345075; Gazzoli I, 2003, MOL CELL BIOL, V23, P7992, DOI 10.1128/MCB.23.22.7992-8007.2003; Greenson JK, 2003, AM J SURG PATHOL, V27, P563, DOI 10.1097/00000478-200305000-00001; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Hacia JG, 1998, NUCLEIC ACIDS RES, V26, P3865, DOI 10.1093/nar/26.16.3865; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kokoris M, 2000, MOL DIAGN, V5, P329; Kolodner RD, 1999, CANCER RES, V59, P5068; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; Liu ZJ, 1999, MAR BIOTECHNOL, V1, P437, DOI 10.1007/PL00011800; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Peterlongo P, 2003, INT J CANCER, V107, P571, DOI 10.1002/ijc.11415; Quaresima B, 2003, BIOCHEM J, V371, P183, DOI 10.1042/BJ20021205; Samowitz WS, 2002, J CLIN ONCOL, V20, P3178, DOI 10.1200/JCO.2002.20.14.3178; Scartozzi M, 2002, J CLIN ONCOL, V20, P1203, DOI 10.1200/JCO.20.5.1203; Scholz B, 2003, NUCLEIC ACIDS RES, V31, P1426, DOI 10.1093/nar/gkg229; Shiri-Sverdlov R, 2000, HUM MUTAT, V16, P491, DOI 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.3.CO;2-A; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Szabo CI, 2004, CANCER RES, V64, P840, DOI 10.1158/0008-5472.CAN-03-2678; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773	30	83	89	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					694	699		10.1038/ng1374	http://dx.doi.org/10.1038/ng1374			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15184898	Bronze			2022-12-27	WOS:000222354100018
J	Zhu, L; Lee, HO; Jordan, CRS; Cantrell, VA; Southard-Smith, EM; Shin, MK				Zhu, L; Lee, HO; Jordan, CRS; Cantrell, VA; Southard-Smith, EM; Shin, MK			Spatiotemporal regulation of endothelin receptor-B by SOX10 in neural crest-derived enteric neuron precursors	NATURE GENETICS			English	Article							MOUSE MODEL; DOMINANT-MEGACOLON; AGANGLIONIC BOWEL; PROGENITOR CELLS; MIGRATION; GENE; RET; MUTATION; EDNRB; HAPLOINSUFFICIENCY	Hirschsprung disease (HSCR) is a multigenic, congenital disorder that affects 1 in 5,000 newborns and is characterized by the absence of neural crest derived enteric ganglia in the colon(1). One of the primary genes affected in HSCR encodes the G protein coupled endothelin receptor-B (EDNRB)(2,3). The expression of Ednrb is required at a defined time period during the migration of the precursors of the enteric nervous system (ENS) into the colon(4). In this study, we describe a conserved spatiotemporal ENS enhancer of Ednrb. This 1-kb enhancer is activated as the ENS precursors approach the colon, and partial deletion of this enhancer at the endogenous Ednrb locus results in pigmented mice that die postnatally from megacolon. We identified binding sites for SOX10, an SRY-related transcription factor associated with HSCR5, in the Ednrb ENS enhancer, and mutational analyses of these sites suggested that SOX10 may have multiple roles in regulating Ednrb in the ENS.	Fox Chase Canc Ctr, Cellular & Dev Biol Program, Philadelphia, PA 19111 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Vanderbilt Univ, Sch Med, Dept Med, Div Med Genet, Nashville, TN 37232 USA	Fox Chase Cancer Center; Princeton University; Vanderbilt University	Shin, MK (corresponding author), Fox Chase Canc Ctr, Cellular & Dev Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Myung.Shin@fccc.edu	Southard-Smith, Michelle/C-3488-2012	Southard-Smith, E Michelle/0000-0003-4718-5869	NIDDK NIH HHS [R01 DK060047-03, R01 DK060047-01A1, R01 DK060047, R01 DK060047-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060047] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; KAPUR RP, 1995, DEVELOPMENT, V121, P3787; Kapur RP, 1996, DEV BIOL, V174, P360, DOI 10.1006/dbio.1996.0080; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leibl MA, 1999, GUT, V44, P246, DOI 10.1136/gut.44.2.246; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Newgreen DF, 1995, ACTA ANAT, V154, P243; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROTHMAN TP, 1993, DEV BIOL, V159, P559, DOI 10.1006/dbio.1993.1264; Rothman TP, 1996, DEV BIOL, V178, P498, DOI 10.1006/dbio.1996.0234; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shin MK, 1997, P NATL ACAD SCI USA, V94, P13105, DOI 10.1073/pnas.94.24.13105; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Wu JJ, 1999, DEVELOPMENT, V126, P1161	30	95	99	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					732	737		10.1038/ng1371	http://dx.doi.org/10.1038/ng1371			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15170213	Bronze			2022-12-27	WOS:000222354100024
J	Remold, SK; Lenski, RE				Remold, SK; Lenski, RE			Pervasive joint influence of epistasis and plasticity on mutational effects in Escherichia coli	NATURE GENETICS			English	Article							TERM EXPERIMENTAL EVOLUTION; ENVIRONMENT INTERACTIONS; DELETERIOUS MUTATIONS; ADAPTATION; GENERATIONS; POPULATIONS; DIVERGENCE; GENOTYPE; BACTERIA; FITNESS	The effects of mutations on phenotype and fitness may depend on the environment (phenotypic plasticity), other mutations ( genetic epistasis) or both. Here we examine the fitness effects of 18 random insertion mutations in E. coli in two resource environments and five genetic backgrounds. We tested each mutation for plasticity and epistasis by comparing its fitness effects across these ecological and genetic contexts. Some mutations had no measurable effect in any of these contexts. None of the mutations had effects on phenotypic plasticity that were independent of genetic background. However, half the mutations had epistatic interactions such that their effects differed among genetic backgrounds, usually in an environment-dependent manner. Also, the pattern of mutational effects across backgrounds indicated that epistasis had been shaped primarily by unique events in the evolutionary history of a population rather than by repeatable events associated with shared environmental history.	Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University	Remold, SK (corresponding author), Yale Univ, Dept Ecol & Evolut Biol, Osborn Mem Labs, 165 Prospect St, New Haven, CT 06520 USA.	susanna.remold@yale.edu		Lenski, Richard/0000-0002-1064-8375				DEAN AM, 1995, GENETICS, V139, P19; DEVISSER JAG, 1996, EVOLUTION, V51, P1499; DYKHUIZEN DE, 1983, GENETICS, V105, P1; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 2001, EVOLUTION, V55, P1746; Elena SF, 1998, GENETICA, V102-3, P349, DOI 10.1023/A:1017031008316; Fedorowicz GM, 1998, GENETICS, V148, P1885; Hansen TF, 2001, GENETICS, V158, P477; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Lenski R. E., 2004, PLANT BREED REV, V24, P225, DOI DOI 10.1002/9780470650288.CH8; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; PODLICH DW, 1998, SIMULATED EVOLUTION, P171; Remold SK, 2001, P NATL ACAD SCI USA, V98, P11388, DOI 10.1073/pnas.201140198; Schmalhausen II, 1949, FACTORS EVOLUTION TH; Sokal RR, 1995, BIOMETRY; Travisano M, 1997, GENETICS, V146, P471; Travisano M, 1996, GENETICS, V143, P15; Wade Michael J., 2000, P213; Wade MJ, 1998, EVOLUTION, V52, P1537, DOI 10.1111/j.1558-5646.1998.tb02235.x; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125	29	100	100	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					423	426		10.1038/ng1324	http://dx.doi.org/10.1038/ng1324			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15072075	Bronze			2022-12-27	WOS:000220647200029
J	Khokha, MK; Hsu, D; Brunet, LJ; Dionne, MS; Harland, RM				Khokha, MK; Hsu, D; Brunet, LJ; Dionne, MS; Harland, RM			Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; SONIC-HEDGEHOG; VERTEBRATE LIMB; FEEDBACK LOOP; DEFORMITY GENE; GROWTH; OUTGROWTH; INDUCTION; PROTEINS; FAMILY	During limb outgrowth, signaling by bone morphogenetic proteins (BMPs) must be moderated to maintain the signaling loop between the zone of polarizing activity (ZPA) and the apical ectodermal ridge (AER). Gremlin, an extracellular BMP antagonist, has been proposed to fulfill this function and therefore be important in limb patterning. We tested this model directly by mutating the mouse gene encoding gremlin (Cktsf1b1, herein called gremlin). In the mutant limb, the feedback loop between the ZPA and the AER is interrupted, resulting in abnormal skeletal pattern. We also show that the gremlin mutation is allelic to the limb deformity mutation (ld). Although BMPs and their antagonists have multiple roles in limb development, these experiments show that gremlin is the principal BMP antagonist required for early limb outgrowth and patterning.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Harland, RM (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, 401 Barker Hall, Berkeley, CA 94720 USA.	harland@socrates.berkeley.edu	Dionne, Marc/J-2572-2013	Dionne, Marc/0000-0002-8283-1750				Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; CHAN DC, 1995, DEVELOPMENT, V121, P3151; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Kuhlman J, 1997, DEVELOPMENT, V124, P133; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; MAAS RL, 1990, NATURE, V346, P853, DOI 10.1038/346853a0; Marigo V, 1996, DEVELOPMENT, V122, P1225; Merino R, 1999, DEVELOPMENT, V126, P2161; Merino R, 1999, DEVELOPMENT, V126, P5515; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Pizette S, 1999, DEVELOPMENT, V126, P883; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; VOGT TF, 1992, MAMM GENOME, V3, P431, DOI 10.1007/BF00356152; Wang CC, 1997, GENOMICS, V39, P303, DOI 10.1006/geno.1996.4519; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; ZELLER R, 1989, GENE DEV, V3, P1481, DOI 10.1101/gad.3.10.1481; Zhang DH, 2002, J BONE MINER RES, V17, P293, DOI 10.1359/jbmr.2002.17.2.293; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	284	298	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					303	307		10.1038/ng1178	http://dx.doi.org/10.1038/ng1178			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808456				2022-12-27	WOS:000183815300018
J	Zhang, B; Cunningham, MA; Nichols, WC; Bernat, JA; Seligsohn, U; Pipe, SW; McVey, JH; Schulte-Overberg, U; de Bosch, NB; Ruiz-Saez, A; White, GC; Tuddenham, EGD; Kaufman, RJ; Ginsburg, D				Zhang, B; Cunningham, MA; Nichols, WC; Bernat, JA; Seligsohn, U; Pipe, SW; McVey, JH; Schulte-Overberg, U; de Bosch, NB; Ruiz-Saez, A; White, GC; Tuddenham, EGD; Kaufman, RJ; Ginsburg, D			Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex	NATURE GENETICS			English	Article							COAGULATION-FACTOR-VIII; COMBINED FACTOR-V; SOLUBLE SECRETORY PROTEINS; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; RECESSIVE TRAITS; ERGIC-53 GENE; DEFICIENCY; VESICLES; FAMILIES	Mutations in LMAN1 (also called ERGIC-53) result in combined deficiency of factor V and factor VIII ( F5F8D), an autosomal recessive bleeding disorder characterized by coordinate reduction of both clotting proteins(1). LMAN1 is a mannose-binding type 1 transmembrane protein localized to the endoplasmic reticulum Golgi intermediate compartment (ERGIC; refs. 2,3), suggesting that F5F8D could result from a defect in secretion of factor V and factor VIII (ref. 4). Correctly folded proteins destined for secretion are packaged in the ER into COPII-coated vesicles(5), which subsequently fuse to form the ERGIC. Secretion of certain abundant proteins suggests a default pathway requiring no export signals (bulk flow; refs. 6,7). An alternative mechanism involves selective packaging of secreted proteins with the help of specific cargo receptors(8-13). The latter model would be consistent with mutations in LMAN1 causing a selective block to export of factor V and factor VIII. But similar to30% of individuals with F5F8D have normal levels of LMAN1, suggesting that mutations in another gene may also be associated with F5F8D(14,15). Here we show that inactivating mutations in MCFD2 cause F5F8D with a phenotype indistinguishable from that caused by mutations in LMAN1. MCFD2 is localized to the ERGIC through a direct, calcium-dependent interaction with LMAN1. These findings suggest that the MCFD2-LMAN1 complex forms a specific cargo receptor for the ER-to-Golgi transport of selected proteins.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; Humboldt Univ, Charite Med Ctr, Berlin, Germany; Ctr Nacl Hemofilia, Banco Municipal Sangre, Caracas, Venezuela; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Michigan System; University of Michigan; Imperial College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu	Tuddenham, Edward/AAS-6196-2020; Pipe, Steven W./ABC-3843-2020; Zhang, Bin/B-8102-2012	Tuddenham, Edward/0000-0001-8955-2909; Pipe, Steven W./0000-0003-2558-2089; Bernat, John/0000-0003-2033-6129; Ruiz-Saez, Arlette/0000-0002-4341-1294; McVey, John/0000-0002-7416-533X	MRC [MC_U120074259] Funding Source: UKRI; Medical Research Council [MC_U120074259] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARAR C, 1995, J BIOL CHEM, V270, P3551, DOI 10.1074/jbc.270.8.3551; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; DEKA N, 1988, GENE, V71, P123, DOI 10.1016/0378-1119(88)90084-4; Fiedler K, 1996, J CELL SCI, V109, P271; GINSBURG D, 2002, EMERY RIMOINS PRINCI, V2, P1926; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Itin C, 1996, MOL BIOL CELL, V7, P483, DOI 10.1091/mbc.7.3.483; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Neerman-Arbez M, 1999, BLOOD, V93, P2253; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nichols WC, 1997, J CLIN INVEST, V99, P596, DOI 10.1172/JCI119201; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nichols WC, 1999, BLOOD, V93, P2261; OERI J, 1954, MED PROBL PAEDIAT, V1, P575; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Springer S, 2000, P NATL ACAD SCI USA, V97, P4034, DOI 10.1073/pnas.070044097; SUSSMAN DJ, 1984, MOL CELL BIOL, V4, P1641, DOI 10.1128/MCB.4.8.1641; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	30	200	208	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					220	225		10.1038/ng1153	http://dx.doi.org/10.1038/ng1153			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12717434				2022-12-27	WOS:000183200500031
J	Dyer, MA; Livesey, FJ; Cepko, CL; Oliver, G				Dyer, MA; Livesey, FJ; Cepko, CL; Oliver, G			Prox1 function controls progenitor cell proliferation and horizontal, cell genesis in the mammalian retina	NATURE GENETICS			English	Article							RAT RETINA; AMACRINE CELLS; GANGLION-CELL; HOMEOBOX; MATH5; DIFFERENTIATION; ANTIBODIES	Retinal progenitor cells regulate their proliferation during development so that the correct number of each cell type is made at the appropriate time. We found that the homeodomain protein Prox1 regulates the exit of progenitor cells from the cell cycle in the embryonic mouse retina. Cells lacking Prox1 are less likely to stop dividing, and ectopic expression of Prox1 forces progenitor cells to exit the cell cycle. During retinogenesis, Prox1 can be detected in differentiating horizontal, bipolar and All amacrine cells. Horizontal cells are absent in retinae of. Prox1(-/-) mice and misexpression of Prox1 in postnatal progenitor cells promotes horizontal-cell formation. Thus, Prox1 activity is both necessary and sufficient for progenitor-cell proliferation and cell-fate determination in the vertebrate retina.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Cambridge	Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.	cepko@rascal.med.harvard.edu; guillermo.oliver@stjude.org	Dyer, Michael/N-8134-2018	Livesey, Rick/0000-0001-6128-3372				Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2001, J COMP NEUROL, V429, P601; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Morrow EM, 1998, J NEUROSCI, V18, P3738; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WASSLE H, 1993, J COMP NEUROL, V332, P407; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844	22	306	316	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					53	58		10.1038/ng1144	http://dx.doi.org/10.1038/ng1144			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692551				2022-12-27	WOS:000182667900016
J	Boocock, GRB; Morrison, JA; Popovic, M; Richards, N; Ellis, L; Durie, PR; Rommens, JM				Boocock, GRB; Morrison, JA; Popovic, M; Richards, N; Ellis, L; Durie, PR; Rommens, JM			Mutations in SBDS are associated with Shwachman-Diamond syndrome	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; GENE; PSEUDOGENE; DELETION; DNA	Shwachman-Diamond syndrome (SDS; OMIM 260400) is an autosomal recessive disorder with clinical features that include pancreatic exocrine insufficiency, hematological dysfunction and skeletal abnormalities(1-4). Here, we report identification of disease-associated mutations in an uncharacterized gene, SBDS, in the interval of 1.9 cM at 7q11 previously shown to be associated with the disease(5,6). We report that SBDS has a 1.6-kb transcript and encodes a predicted protein of 250 amino acids. A pseudogene copy (SBDSP) with 97% nucleotide sequence identity resides in a locally duplicated genomic segment of 305 kb. We found recurring mutations resulting from gene conversion in 89% of unrelated individuals with SDS (141 of 158), with 60% (95 of 158) carrying two converted alleles. Converted segments consistently included at least one of two pseudogene-like sequence changes that result in protein truncation. SDBS is a member of a highly conserved protein family of unknown function with putative orthologs in diverse species including archaea and eukaryotes. Archaeal orthologs are located within highly conserved operons that include homologs of RNA-processing genes(7), suggesting that SDS may be caused by a deficiency in an aspect of RNA metabolism that is essential for development of the exocrine pancreas, hematopoiesis and chrondrogenesis.	Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Div Gastroenterol & Nutr, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Program Integrat Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Rommens, JM (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 555 Univ Ave,Room 11-109A,Elm Wing Annex, Toronto, ON M5G 1X8, Canada.	johanna@genet.sickkids.on.ca	Rommens, Johanna/AAT-7465-2021					Antonarakis S. E., 2001, METABOLIC MOL BASES, P343; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; BODIAN M, 1964, ACTA PAEDIATR, V53, P282, DOI 10.1111/j.1651-2227.1964.tb07237.x; Bunge S, 1998, EUR J HUM GENET, V6, P492, DOI 10.1038/sj.ejhg.5200213; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; Cai L, 2001, J MOL MED, V79, P536, DOI 10.1007/s001090100275; Chen JM, 2000, J MED GENET, V37, P67, DOI 10.1136/jmg.37.1.67; Chen JM, 2000, EUR J HUM GENET, V8, P473, DOI 10.1038/sj.ejhg.5200492; Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X; Ginzberg H, 2000, AM J HUM GENET, V66, P1413, DOI 10.1086/302856; Goobie S, 2001, AM J HUM GENET, V68, P1048, DOI 10.1086/319505; Hahnen E, 1996, AM J HUM GENET, V59, P1057; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ip WF, 2002, J PEDIATR-US, V141, P259, DOI 10.1067/mpd.2002.125849; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Popovic M, 2002, EUR J HUM GENET, V10, P250, DOI 10.1038/sj.ejhg.5200798; Roesler J, 2000, BLOOD, V95, P2150, DOI 10.1182/blood.V95.6.2150; Rozen S, 2000, BIOINFORMATICS METHO; Sambrook J., 2001, MOL CLONING; SCHWACHMAN H, 1964, J PEDIATR-US, V65, P645; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; STRACHAN T, 1994, J INHERIT METAB DIS, V17, P430, DOI 10.1007/BF00711358; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	29	487	514	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2003	33	1					97	101		10.1038/ng1062	http://dx.doi.org/10.1038/ng1062			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12496757				2022-12-27	WOS:000180136100025
J	Gitler, AD; Zhu, Y; Ismat, FA; Lu, MM; Yamauchi, Y; Parada, LF; Epstein, JA				Gitler, AD; Zhu, Y; Ismat, FA; Lu, MM; Yamauchi, Y; Parada, LF; Epstein, JA			Nf1 has an essential role in endothelial cells	NATURE GENETICS			English	Article							NEURAL CREST; NEUROFIBROMATOSIS TYPE-1; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; CARDIAC DEVELOPMENT; TRANSGENIC MICE; MODEL; TRANSFORMATION; ABNORMALITIES; MORPHOGENESIS	Neurofibromatosis type 1 (NF1) or von Recklinghausen neurofibromatosis is a genetic disorder that occurs in 1 of 4000 births and is characterized by benign and malignant tumors. Cardiovascular defects also contribute to NF1, though the pathogenesis is still unclear. Deficiency in neurofibromin (encoded by Nf1) in mice results in mid-embryonic lethality owing to cardiac abnormalities previously thought to be secondary to cardiac neural-crest defects. Using tissue-specific gene inactivation, we show that endothelial-specific inactivation of Nf1 recapitulates key aspects of the complete null phenotype, including multiple cardiovascular abnormalities involving the endocardial cushions and myocardium. This phenotype is associated with an elevated level of ras signaling in Nf1(-/-) endothelial cells and greater nuclear localization of the transcription factor Nfatc1. Inactivation of Nf1 in the neural crest does not cause cardiac defects but results in tumors of neural-crest origin resembling those seen in humans with NF1. These results establish a new and essential role for Nf1 in endothelial cells and confirm the requirement for neurofibromin in the neural crest.	Univ Penn Hlth Syst, Dept Med, Div Cardiol, Philadelphia, PA 19104 USA; Univ Penn Hlth Syst, Dept Dev & Cell Biol, Philadelphia, PA 19104 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA; Kumamoto Univ, Sch Med, Dept Dev Genet, Kumamoto 860, Japan	University of Pennsylvania; University of Pennsylvania; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Kumamoto University	Epstein, JA (corresponding author), Univ Penn Hlth Syst, Dept Med, Div Cardiol, 954 BRB II-III,421 Curie Blvd, Philadelphia, PA 19104 USA.		Zhu, Yuan/ABF-8405-2020; Ismat, Fraz Ahmed/AAG-7470-2019; Parada, luis F/B-9400-2014	Gitler, Aaron/0000-0001-8603-1526; Ismat, Fraz/0000-0002-2172-146X; Epstein, Jonathan/0000-0001-8637-4465	NINDS NIH HHS [R01 NS034296, R01 NS034296-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034296] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Epstein JA, 1996, TRENDS CARDIOVAS MED, V6, P255, DOI 10.1016/S1050-1738(96)00110-7; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Feiner L, 2001, DEVELOPMENT, V128, P3061; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jiang XB, 2000, DEVELOPMENT, V127, P1607; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; Li J, 2000, GENESIS, V26, P162, DOI 10.1002/(SICI)1526-968X(200002)26:2<162::AID-GENE21>3.0.CO;2-R; Lin AE, 2000, AM J MED GENET, V95, P108, DOI 10.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; RICCI A, 1984, AM J SURG PATHOL, V8, P19, DOI 10.1097/00000478-198401000-00002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; WOODROW MA, 1993, J IMMUNOL, V150, P3853; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; YANG JT, 1995, DEVELOPMENT, V121, P549; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	30	126	128	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					75	79		10.1038/ng1059	http://dx.doi.org/10.1038/ng1059			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12469121	Green Accepted			2022-12-27	WOS:000180136100021
J	Kundu, M; Javed, A; Jeon, JP; Horner, A; Shum, L; Eckhaus, M; Muenke, M; Lian, JB; Yang, YZ; Nuckolls, GH; Stein, GS; Liu, PP				Kundu, M; Javed, A; Jeon, JP; Horner, A; Shum, L; Eckhaus, M; Muenke, M; Lian, JB; Yang, YZ; Nuckolls, GH; Stein, GS; Liu, PP			Cbf beta interacts with Runx2 and has a critical role in bone development	NATURE GENETICS			English	Article							BINDING-FACTOR-BETA; MYOSIN HEAVY-CHAIN; CLEIDOCRANIAL DYSPLASIA; OSTEOBLAST DIFFERENTIATION; ACUTE-LEUKEMIA; TRANSCRIPTION; PROTEINS; TRANSACTIVATION; HEMATOPOIESIS; CBF-ALPHA-2	Runx2 (runt-related transcription factor 2, also known as Cbfa1, Osf2 and AML3) is essential for bone development in mice, and mutations in RUNX2 are found in 65-80% of individuals with cleidocranial dysplasia(1,2). Although all Runx family members can interact with Cbfbeta (core-binding factor b, encoded by Cbfb), a role for Cbfbeta in bone development has not been demonstrated owing to lethality in Cbfb(-/-) mouse embryos at 12.5 days post coitum (d.p.c.)from hemorrhages and lack of definitive hematopoiesis(3,4). Using a 'knock-in' strategy, we generated mouse embryonic stem (ES) cells that express Cbfb fused in-frame to a cDNA encoding green fluorescent protein (GFP)(5). Cbfb(+/GFP) mice had normal life spans and appeared normal, but Cbfb(GFP/GFP) pups died within the first day after birth. The Cbfb(GFP/GFP) mice exhibited a delay in endochondral and intramembranous ossification as well as in chondrocyte differentiation, similar to but less severe than delays observed in Runx2(-/-) mice(6,7). We demonstrate that Cbfbeta is expressed in developing bone and forms a functional interaction with Runx2, and that Cbfb(GFP) is a hypomorphic allele. The fusion allele maintains sufficient function in hematopoietic cells to bypass the early embryonic lethality, and identifies a new role for Cbfb in bone development. Our findings raise the possibility that mutations in CBFB may be responsible for some cases of cleidocranial dysplasia that are not linked to mutations in RUNX2.	NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; Univ Massachusetts, Dept Cell Biol, Worcester, MA 01605 USA; NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Vet Resources Program, NIH, Bethesda, MD 20892 USA; NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Liu, PP (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, 49 Convent Dr,Bldg 49,Room 3A26, Bethesda, MD 20892 USA.		Liu, Paul/A-7976-2012; Kundu, Mondira/N-8139-2018	Liu, Paul/0000-0002-6779-025X; Kundu, Mondira/0000-0001-9946-2472; Muenke, Maximilian/0000-0002-7719-6545; Javed, Amjad/0000-0002-0847-8266	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000030, Z01HG000030] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adya N, 1998, MOL CELL BIOL, V18, P7432, DOI 10.1128/MCB.18.12.7432; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Javed A, 2000, J CELL SCI, V113, P2221; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, BLOOD, V100, P2449, DOI 10.1182/blood-2002-04-1064; Meyers S, 1996, ONCOGENE, V13, P303; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Miller JD, 2001, BLOOD, V97, P2248, DOI 10.1182/blood.V97.8.2248; Mundlos S, 1999, J MED GENET, V36, P177; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	32	184	192	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					639	644		10.1038/ng1050	http://dx.doi.org/10.1038/ng1050			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12434156				2022-12-27	WOS:000179593000017
J	Kurose, K; Gilley, K; Matsumoto, S; Watson, PH; Zhou, XP; Eng, C				Kurose, K; Gilley, K; Matsumoto, S; Watson, PH; Zhou, XP; Eng, C			Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas	NATURE GENETICS			English	Article							EXPRESSION; CANCERS	We have recently shown that loss of heterozygosity of specific markers, including those at 10q23, 17p13-p15 and 16q24, can occur in the stromal and epithelial compartments of primary invasive breast carcinomas. Here, we demonstrate high frequencies of somatic mutations in TP53 (encoding tumor protein p53) and PTEN (encoding phosphate and tensin homolog) in breast neoplastic epithelium and stroma. Mutations in TP53 and PTEN are mutually exclusive in either compartment. In contrast, mutations in WFDC1 (16q24, encoding WAP four-disulfide core domain 1) occur with low frequency in the stroma.	Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada; Univ Cambridge, Human Canc Genet Res Grp, Canc Res UK, Cambridge CB2 2XZ, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Manitoba; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eng, C (corresponding author), Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA.			Eng, Charis/0000-0002-3693-5145; Watson, Peter/0000-0002-1642-0638				ENG C, 2001, METABOLIC MOL BASES, V1, P979; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Larsen M, 2000, MAMM GENOME, V11, P767, DOI 10.1007/s003350010135; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tomlinson IPM, 2002, GENE CHROMOSOME CANC, V34, P349, DOI 10.1002/gcc.10085; Wernert N, 2001, ANTICANCER RES, V21, P2259	8	339	358	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					355	357		10.1038/ng1013	http://dx.doi.org/10.1038/ng1013			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379854				2022-12-27	WOS:000179034800009
J	Suka, N; Luo, KH; Grunstein, M				Suka, N; Luo, KH; Grunstein, M			Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin	NATURE GENETICS			English	Article							SILENT MATING LOCI; TELOMERIC HETEROCHROMATIN; SACCHAROMYCES-CEREVISIAE; DOSAGE COMPENSATION; MOLECULAR-MODEL; MSL COMPLEX; H3; METHYLATION; DROSOPHILA; PROTEINS	The Sir3 protein helps form telomeric heterochromatin by interacting with hypoacetylated histone H4 lysine 16 (H4-Lys16). The molecular nature of the heterochromatin boundary is still unknown. Here we show that the MYST-like acetyltransferase Sas2p is required for the acetylation (Ac) of H4-Lys16 in euchromatin. In a sas2Delta strain or a phenocopy Lys16Arg mutant, Sir3p spreads from roughly 3 kb to roughly 15 kb, causing hypoacetylation and repression of adjacent chromatin. We also found that disruption of Sir3p binding in a deacetylase-deficient sir2Delta strain can be suppressed by sas2Delta. These data indicate that opposing effects of Sir2p and Sas2p on acetylation of H4-Lys16 maintain the boundary at telomeric heterochromatin.	Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Grunstein, M (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Boyer Hall, Los Angeles, CA 90095 USA.							Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown AJP, 1998, METHOD MICROBIOL, V26, P119; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KIMURA A, 2002, NAT GENET, V32; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wach A, 1998, METHOD MICROBIOL, V26, P67	33	335	345	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					378	383		10.1038/ng1017	http://dx.doi.org/10.1038/ng1017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379856				2022-12-27	WOS:000179034800012
J	Fernandez-Valle, C; Tang, Y; Ricard, J; Rodenas-Ruano, A; Taylor, A; Hackler, E; Biggerstaff, J; Iacovelli, J				Fernandez-Valle, C; Tang, Y; Ricard, J; Rodenas-Ruano, A; Taylor, A; Hackler, E; Biggerstaff, J; Iacovelli, J			Paxillin binds schwannomin and regulates its density-dependent localization and effect on cell morphology	NATURE GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-2 GENE; NF2 TUMOR-SUPPRESSOR; LIM DOMAINS; FERM DOMAIN; LD4 MOTIF; PROTEIN; MERLIN; KINASE; EXPRESSION; MUTATIONS	Neurofibromatosis type 2 is an autosomal dominant disorder characterized by tumors, predominantly schwannomas, in the nervous system. It is caused by mutations in the gene NF2, encoding the growth regulator schwannomin (also known as merlin). Mutations occur throughout the 17-exon gene, with most resulting in protein truncation and undetectable amounts of schwannomin protein. Pathogenic mutations that result in production of defective schwannomin include in-frame deletions of exon 2 and three independent missense mutations within this same exon. Mice with conditional deletion of exon 2 in Schwann cells develop schwannomas, which confirms the crucial nature of exon 2 for growth control. Here we report that the molecular adaptor paxillin binds directly to schwannomin at residues 50-70, which are encoded by exon 2. This interaction mediates the membrane localization of schwannomin to the plasma membrane, where it associates with beta1 integrin and erbB2. It defines a pathogenic mechanism for the development of NF2 in humans with mutations in exon 2 of NF2.	Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida	Fernandez-Valle, C (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA.	cfernand@mail.ucf.edu	Iacovelli, Jared/G-3668-2011	Ricard, Jerome/0000-0002-9019-4165; Taylor, Anna/0000-0002-6501-3393				BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; BOURN D, 1994, HUM MOL GENET, V3, P813, DOI 10.1093/hmg/3.5.813; Brown MC, 1998, MOL BIOL CELL, V9, P1803, DOI 10.1091/mbc.9.7.1803; Bunge Richard P., 1995, P44; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Deguen B, 1998, HUM MOL GENET, V7, P217, DOI 10.1093/hmg/7.2.217; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; FernandezValle C, 1997, J NEUROSCI, V17, P241, DOI 10.1523/JNEUROSCI.17-01-00241.1997; FERNANDEZVALLE C, 1994, J NEUROBIOL, V25, P1207, DOI 10.1002/neu.480251004; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; Fields RD, 1998, J NEUROBIOL, V37, P158, DOI 10.1002/(SICI)1097-4695(199810)37:1<158::AID-NEU12>3.0.CO;2-A; Giovannini M, 2000, GENE DEV, V14, P1617; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Gronholm M, 1999, J CELL SCI, V112, P895; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Jacoby LB, 1996, GENE CHROMOSOME CANC, V17, P45, DOI 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Obremski VJ, 1998, J NEUROBIOL, V37, P487, DOI 10.1002/(SICI)1097-4695(199812)37:4<487::AID-NEU1>3.3.CO;2-2; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; PYKETT MJ, 1994, HUM MOL GENET, V3, P559, DOI 10.1093/hmg/3.4.559; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sainio M, 1997, J CELL SCI, V110, P2249; Scherer SS, 1996, J NEUROSCI RES, V46, P595, DOI 10.1002/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.3.CO;2-2; Schmucker B, 1997, EUR J CELL BIOL, V72, P46; Scoles DR, 2000, HUM MOL GENET, V9, P1567, DOI 10.1093/hmg/9.11.1567; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Scoles DR, 1996, NEUROLOGY, V47, P544, DOI 10.1212/WNL.47.2.544; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Stokowski RP, 2000, AM J HUM GENET, V66, P873, DOI 10.1086/302812; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Turner CE, 2000, J CELL SCI, V113, P4139; TURNER CE, 1994, J CELL SCI, V107, P1583; Turunen O, 1998, BBA-PROTEIN STRUCT M, V1387, P1, DOI 10.1016/S0167-4838(98)00103-4; Vadlamudi R, 1999, ONCOGENE, V18, P7253, DOI 10.1038/sj.onc.1203163; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Welling DB, 1996, HUM GENET, V98, P189, DOI 10.1007/s004390050188; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200	50	100	102	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					354	362		10.1038/ng930	http://dx.doi.org/10.1038/ng930			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12118253				2022-12-27	WOS:000177147100009
J	Martin, MP; Gao, XJ; Lee, JH; Nelson, GW; Detels, R; Goedert, JJ; Buchbinder, S; Hoots, K; Vlahov, D; Trowsdale, J; Wilson, M; O'Brien, SJ; Carrington, M				Martin, MP; Gao, XJ; Lee, JH; Nelson, GW; Detels, R; Goedert, JJ; Buchbinder, S; Hoots, K; Vlahov, D; Trowsdale, J; Wilson, M; O'Brien, SJ; Carrington, M			Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS	NATURE GENETICS			English	Article							CELL-INHIBITORY RECEPTOR; NATURAL-KILLER-CELLS; IMMUNE-RESPONSES; T-LYMPHOCYTES; GENE FAMILIES; HIV-1; RECOGNITION; MOLECULES; BW4; POLYMORPHISM	Natural killer (NK) cells provide defense in the early stages of the innate immune response against viral infections by producing cytokines and causing cytotoxicity(1). The killer immunoglobulin-like receptors (KIRs) on NK cells regulate the inhibition and activation of NK-cell responses through recognition of human leukocyte antigen (HLA) class I molecules on target cells(2). KIR and HLA loci are both highly polymorphic, and some HLA class I products bind and trigger cell-surface receptors specified by KIR genes. Here we report that the activating KIR allele KIR3DS1, in combination with HLA-B alleles that encode molecules with isoleucine at position 80 (HLA-B Bw4-80Ile), is associated with delayed progression to AIDS in individuals infected with human immunodeficiency virus type 1 (HIV-1). In the absence of KIR3DS1, the HLA-B Bw4-80Ile allele was not associated with any of the AIDS outcomes measured. By contrast, in the absence of HLA-B Bw4-80Ile alleles, KIR3DS1 was significantly associated with more rapid progression to AIDS. These observations are strongly suggestive of a model involving an epistatic interaction between the two loci. The strongest synergistic effect of these loci was on progression to depletion of CD4(+) T cells, which suggests that a protective response of NK cells involving KIR3DS1 and its HLA class I ligands begins soon after HIV-1 infection.	NCI, Basic Res Program, SAIC Frederick, Frederick, MD 21702 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; San Francisco City Clin Cohort, San Francisco, CA 94102 USA; Univ Texas, Hlth Sci Ctr, Gulf States Hemophilia Ctr, Houston, TX 77030 USA; Johns Hopkins Med Inst, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA; Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Johns Hopkins Medicine; University of Cambridge	Carrington, M (corresponding author), NCI, Basic Res Program, SAIC Frederick, Frederick, MD 21702 USA.		OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				BLASSONI R, 1996, J EXP MED, V183, P645; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Carrington M, 2001, IMMUNOL LETT, V79, P131, DOI 10.1016/S0165-2478(01)00275-9; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; DeMaria A, 1997, P NATL ACAD SCI USA, V94, P10285, DOI 10.1073/pnas.94.19.10285; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Hughes AL, 1996, IMMUNOL CELL BIOL, V74, P444, DOI 10.1038/icb.1996.74; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Long EO, 2000, SEMIN IMMUNOL, V12, P101, DOI 10.1006/smim.2000.0212; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lorenzo ME, 2001, SEMIN IMMUNOL, V13, P1, DOI 10.1006/smim.2000.0290; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; MULLER CA, 1989, IMMUNOGENETICS, V30, P200, DOI 10.1007/BF02421207; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Peruzzi M, 1996, J EXP MED, V184, P1585, DOI 10.1084/jem.184.4.1585; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Rojo S, 1997, EUR J IMMUNOL, V27, P568, DOI 10.1002/eji.1830270231; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597	30	904	948	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					429	434		10.1038/ng934	http://dx.doi.org/10.1038/ng934			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134147	Bronze			2022-12-27	WOS:000177147100022
J	Krantz, ID; McCallum, J; DeScipio, C; Kaur, M; Gillis, LA; Yaeger, D; Jukofsky, L; Wasserman, N; Bottani, A; Morris, CA; Nowaczyk, MJM; Toriello, H; Bamshad, MJ; Carey, JC; Rappaport, E; Kawauchi, S; Lander, AD; Calof, AL; Li, HH; Devoto, M; Jackson, LG				Krantz, ID; McCallum, J; DeScipio, C; Kaur, M; Gillis, LA; Yaeger, D; Jukofsky, L; Wasserman, N; Bottani, A; Morris, CA; Nowaczyk, MJM; Toriello, H; Bamshad, MJ; Carey, JC; Rappaport, E; Kawauchi, S; Lander, AD; Calof, AL; Li, HH; Devoto, M; Jackson, LG			Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B	NATURE GENETICS			English	Article							BRACHMANN-DELANGE SYNDROME; ALAGILLE-SYNDROME; COHESINS	Cornelia de Lange syndrome (CdLS; OMIM 122470) is a dominantly inherited multisystem developmental disorder characterized by growth and cognitive retardation; abnormalities of the upper limbs; gastroesophageal dysfunction; cardiac, ophthalmologic and genitourinary anomalies; hirsutism; and characteristic facial features(1-3). Genital anomalies, pyloric stenosis, congenital diaphragmatic hernias, cardiac septal defects, hearing loss and autistic and self-injurious tendencies also frequently occur(2). Prevalence is estimated to be as high as 1 in 10,000 (ref. 4). We carried out genome-wide linkage exclusion analysis in 12 families with CdLS and identified four candidate regions, of which chromosome 5p13.1 gave the highest multipoint lod score of 2.7. This information, together with the previous identification of a child with CdLS with a de novo t(5;13)(p13.1;q12.1) translocation, allowed delineation of a 1.1-Mb critical region on chromosome 5 for the gene mutated in CdLS. We identified mutations in one gene in this region, which we named NIPBL, in four sporadic and two familial cases of CdLS. We characterized the genomic structure of NIPBL and found that it is widely expressed in fetal and adult tissues. The fly homolog of NIPBL, Nipped-B, facilitates enhancer-promoter communication and regulates Notch signaling and other developmental pathways in Drosophila melanogasters.	Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Hosp Geneva, Div Med Genet, Geneva, Switzerland; Univ Nevada, Sch Med, Las Vegas, NV 89154 USA; Univ Med Ctr, Hamilton, ON, Canada; Michigan State Univ, E Lansing, MI 48824 USA; Univ Utah, Ctr Hlth Sci, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Ctr Hlth Sci, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; Nemours Childrens Clin, Wilmington, DE USA; Univ Genoa, Dept Oncol Biol & Genet, I-16126 Genoa, Italy; Drexel Univ, Sch Med, Div Obstet & Gynecol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Geneva; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Michigan State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Genoa; Drexel University	Krantz, ID (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA.	ian2@mail.med.upenn.edu	Rappaport, Eric/GRO-4051-2022; Lander, Arthur/L-2827-2019; Lander, Arthur D/C-9008-2011; Devoto, Marcella/AAP-7595-2021; Calof, Anne/A-8644-2013	Lander, Arthur/0000-0002-4380-5525; Lander, Arthur D/0000-0002-4380-5525; Calof, Anne/0000-0003-3676-2499; DEVOTO, MARCELLA/0000-0002-4431-5114	NICHD NIH HHS [R01 HD039323] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039323] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; De Lange C., 1933, ARCH MED ENFANTS, V36, P713; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Hulinsky R, 2003, AM J HUM GENET, V73, P602; IRELAND M, 1993, AM J MED GENET, V47, P959, DOI 10.1002/ajmg.1320470705; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Krantz ID, 1997, AM J MED GENET, V70, P80, DOI 10.1002/(SICI)1096-8628(19970502)70:1<80::AID-AJMG15>3.3.CO;2-H; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; OPITZ JM, 1985, AM J MED GENET, V22, P89, DOI 10.1002/ajmg.1320220110; Rollins RA, 1999, GENETICS, V152, P577	14	498	521	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					631	635		10.1038/ng1364	http://dx.doi.org/10.1038/ng1364			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15146186	Green Accepted, Bronze, Green Submitted			2022-12-27	WOS:000221763700022
J	Wang, XD; Chamberlin, HM				Wang, XD; Chamberlin, HM			Evolutionary innovation of the excretory system in Caenorhabditis elegans	NATURE GENETICS			English	Article							REGULATORY EVOLUTION; DROSOPHILA; GENE	The evolution of complexity relies on changes that result in new gene functions. Here we show that the unique morphological and functional features of the excretory duct cell in C. elegans result from the gain of expression of a single gene. Our results show that innovation can be achieved by altered expression of a transcription factor without coevolution of all target genes.	Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Chamberlin, HM (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	chamberlin.27@osu.edu	Chamberlin, Helen/L-4206-2019	Chamberlin, Helen/0000-0001-7203-2691				Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LYNCH AS, 1995, NAT GENET, V11, P309, DOI 10.1038/ng1195-309; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2	12	48	50	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2004	36	3					231	232		10.1038/ng1301	http://dx.doi.org/10.1038/ng1301			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14758362	Bronze			2022-12-27	WOS:000189250400010
J	Asano, Y; Takashima, S; Asakura, M; Shintani, Y; Liao, YL; Minamino, T; Asanuma, H; Sanada, S; Kim, J; Ogai, A; Fukushima, T; Oikawa, Y; Okazaki, Y; Kaneda, Y; Sato, M; Miyazaki, J; Kitamura, S; Tomoike, H; Kitakaze, M; Hori, M				Asano, Y; Takashima, S; Asakura, M; Shintani, Y; Liao, YL; Minamino, T; Asanuma, H; Sanada, S; Kim, J; Ogai, A; Fukushima, T; Oikawa, Y; Okazaki, Y; Kaneda, Y; Sato, M; Miyazaki, J; Kitamura, S; Tomoike, H; Kitakaze, M; Hori, M			Lamr1 functional retroposon causes right ventricular dysplasia in mice	NATURE GENETICS			English	Article							II HISTONE DEACETYLASES; HETEROCHROMATIN PROTEIN-1; LONG ARM; CARDIOMYOPATHY; GENE; EXPRESSION; LOCUS; DNA; LOCALIZATION; METHYLATION	Arrhythmogenic right ventricular dysplasia (ARVD) is a hereditary cardiomyopathy that causes sudden death in the young. We found a line of mice with inherited right ventricular dysplasia (RVD) caused by a mutation of the gene laminin receptor 1 (Lamr1). This locus contained an intron-processed retroposon that was transcribed in the mice with RVD. Introduction of a mutated Lamr1 gene into normal mice by breeding or by direct injection caused susceptibility to RVD, which was similar to that seen in the RVD mice. An in vitro study of cardiomyocytes expressing the product of mutated Lamr1 showed early cell death accompanied by alteration of the chromatin architecture. We found that heterochromatin protein 1 ( HP1) bound specifically to mutant LAMR1. HP1 is a dynamic regulator of heterochromatin sites, suggesting that mutant LAMR1 impairs a crucial process of transcriptional regulation. Indeed, mutant LAMR1 caused specific changes to gene expression in cardiomyocytes, as detected by gene chip analysis. Thus, we concluded that products of the Lamr1 retroposon interact with HP1 to cause degeneration of cardiomyocytes. This mechanism may also contribute to the etiology of human ARVD.	Natl Cardiovasc Ctr, Cardiovasc Div Internal Med, Osaka 5658565, Japan; Osaka Univ, Dept Internal Med & Therapeut, Grad Sch Med, Osaka 5650871, Japan; RIKEN, Lab Genome, Explorat Res Grp, Yokohama Inst,Genom Sci Ctr, Kanagawa 2300045, Japan; Osaka Univ, Dept Gene Therapy Sci, Grad Sch Med, Osaka 5650871, Japan; Osaka Univ, Dept Nutr & Physiol Chem, Grad Sch Med, Osaka 5650871, Japan	National Cerebral & Cardiovascular Center - Japan; Osaka University; RIKEN; Osaka University; Osaka University	Kitakaze, M (corresponding author), Natl Cardiovasc Ctr, Cardiovasc Div Internal Med, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	takasima@medone.med.osaka-u.ac.jp; kitakaze@zf6.so-net.ne.jp	Miyazaki, Jun-ichi/N-1976-2015; Liao, Yulin/AAP-6315-2021	Miyazaki, Jun-ichi/0000-0003-2475-589X; Shintani, Yasunori/0000-0001-9579-0727; Okazaki, Yasushi/0000-0003-3241-5502				Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; BRIGHT JM, 1995, J AM VET MED ASSOC, V207, P64; Burke AP, 1998, CIRCULATION, V97, P1571, DOI 10.1161/01.CIR.97.16.1571; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cranefield PF, 1975, CONDUCTION CARDIAC I; DAHL HHM, 1990, GENOMICS, V8, P225, DOI 10.1016/0888-7543(90)90275-Y; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Fox PR, 2000, CIRCULATION, V102, P1863; GEBARA MM, 1992, MOL CELL BIOL, V12, P1422, DOI 10.1128/MCB.12.4.1422; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; ISHIKAWA S, 1977, ARCH PATHOL LAB MED, V101, P388; Kaneda Y, 1998, CELL DEATH DIFFER, V5, P20, DOI 10.1038/sj.cdd.4400315; Kondo K., 1957, B EXP ANIM, V6, P107; Li DX, 2000, AM J HUM GENET, V66, P148, DOI 10.1086/302713; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nasir K, 2003, PACE, V26, P1955, DOI 10.1046/j.1460-9592.2003.00302.x; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Peters S, 2003, ANN NONINVAS ELECTRO, V8, P238, DOI 10.1046/j.1542-474X.2003.08312.x; Protonotarios N, 2001, J AM COLL CARDIOL, V38, P1477, DOI 10.1016/S0735-1097(01)01568-6; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; Richardson MP, 1998, GENE, V206, P145, DOI 10.1016/S0378-1119(97)00586-6; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Severini GM, 1996, GENOMICS, V31, P193, DOI 10.1006/geno.1996.0031; SIMPSON KW, 1994, J VET INTERN MED, V8, P306, DOI 10.1111/j.1939-1676.1994.tb03240.x; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; Steenman M, 2003, PHYSIOL GENOMICS, V12, P97, DOI 10.1152/physiolgenomics.00148.2002; Thiene G, 1997, TRENDS CARDIOVAS MED, V7, P84, DOI 10.1016/S1050-1738(97)00011-X; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	36	41	42	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					123	130		10.1038/ng1294	http://dx.doi.org/10.1038/ng1294			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14730304	Bronze			2022-12-27	WOS:000188542700012
J	Liu, G; Parant, JM; Lang, G; Chau, P; Chavez-Reyes, A; El-Naggar, AK; Multani, A; Chang, S; Lozano, G				Liu, G; Parant, JM; Lang, G; Chau, P; Chavez-Reyes, A; El-Naggar, AK; Multani, A; Chang, S; Lozano, G			Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice	NATURE GENETICS			English	Article							P53-DEPENDENT APOPTOSIS; GENETIC INSTABILITY; GENOMIC INSTABILITY; V(D)J RECOMBINATION; P53-DEFICIENT MICE; IN-VIVO; P53; ACTIVATION; GROWTH; RADIATION	The p53 protein integrates multiple upstream signals and functions as a tumor suppressor by activating distinct downstream genes(1-3). At the cellular level, p53 induces apoptosis, cell cycle arrest and senescence. A rare mutant form of p53 with the amino acid substitution R175P, found in human tumors, is completely defective in initiating apoptosis but still induces cell cycle arrest(4,5). To decipher the functional importance of these pathways in spontaneous tumorigenesis, we used homologous recombination to generate mice with mutant p53-R172P ( the mouse equivalent of R175P in humans). Mice inheriting two copies of this mutation (Trp53(515C/515C)) escape the early onset of thymic lymphomas that characterize Trp53-null mice. At 7 months of age, 90% of Trp53-null mice had died, but 85% of Trp53(515C/515C) mice were alive and tumor-free, indicating that p53-dependent apoptosis was not required for suppression of early onset of spontaneous tumors. The lymphomas and sarcomas that eventually developed in Trp53(515C/515C) mice retained a diploid chromosome number, in sharp contrast to aneuploidy observed in tumors and cells from Trp53 null mice. The ability of mutant p53-R172P to induce a partial cell cycle arrest and retain chromosome stability are crucial for suppression of early onset tumorigenesis.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, G (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.		Chavez-Reyes, Arturo/ABG-1231-2020	Chavez-Reyes, Arturo/0000-0002-6655-815X; Chau, Gilda/0000-0002-7907-3290				CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donehower LA, 1997, CANCER SURV, V29, P329; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; HARVEY M, 1993, ONCOGENE, V8, P2457; Hundley JE, 1997, MOL CELL BIOL, V17, P723, DOI 10.1128/MCB.17.2.723; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tlsty TD, 1996, CANCER SURV, V28, P217; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	30	263	266	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					63	68		10.1038/ng1282	http://dx.doi.org/10.1038/ng1282			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702042	Bronze			2022-12-27	WOS:000187666800015
J	Hu, W; Yan, Q; Shen, DK; Liu, F; Zhu, ZD; Song, HD; Xu, XR; Wang, ZJ; Rong, YP; Zeng, LC; Wu, J; Zhang, X; Wang, JJ; Xu, XN; Wang, SY; Fu, G; Zhang, XL; Wang, ZQ; Brindley, PJ; McManus, DP; Xue, CL; Feng, Z; Chen, Z; Han, ZG				Hu, W; Yan, Q; Shen, DK; Liu, F; Zhu, ZD; Song, HD; Xu, XR; Wang, ZJ; Rong, YP; Zeng, LC; Wu, J; Zhang, X; Wang, JJ; Xu, XN; Wang, SY; Fu, G; Zhang, XL; Wang, ZQ; Brindley, PJ; McManus, DP; Xue, CL; Feng, Z; Chen, Z; Han, ZG			Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource	NATURE GENETICS			English	Article							COMPARATIVE GENOMICS; SEX DETERMINATION; SEQUENCE; EXPRESSION; MANSONI; PROTEIN; CLONING; HOST	Schistosoma japonicum causes schistosomiasis in humans and livestock in the Asia-Pacific region. Knowledge of the genome of this parasite should improve understanding of schistosome-host interactions, biomedical aspects of schistosomiasis and invertebrate evolution. We assigned 43,707 expressed sequence tags ( ESTs) derived from adult S. japonicum and their eggs to 13,131 gene clusters. Of these, 35% shared no similarity with known genes and 75% had not been reported previously in schistosomes. Notably, S. japonicum encoded mammalian-like receptors for insulin, progesterone, cytokines and neuropeptides, suggesting that host hormones, or endogenous parasite homologs, could orchestrate schistosome development and maturation and that schistosomes modulate anti-parasite immune responses through inhibitors, molecular mimicry and other evasion strategies.	Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Dept Parasitol, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200025, Peoples R China; Tulane Univ, Hlth Sci Ctr, Dept Trop Med, New Orleans, LA 70112 USA; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Australian Ctr Int Hlth & Nutr, Brisbane, Qld 4029, Australia	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Tulane University; QIMR Berghofer Medical Research Institute	Han, ZG (corresponding author), Chinese Natl Human Genome Ctr Shanghai, 351 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	hanzg@chgc.sh.cn	HU, Wei/F-1004-2012; Wang, Zhaojun/GKS-9141-2022; McManus, Donald P./G-2678-2013; McManus, Don/AAC-5394-2020; Song, Huai-Dong/G-8961-2011	Wang, Zhaojun/0000-0003-2853-1850; McManus, Don/0000-0001-6443-1449; Brindley, Paul J./0000-0003-1765-0002; Han, Ze-Guang/0000-0002-1018-1752				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7; Boag PR, 2001, ADV PARASIT, V50, P153, DOI 10.1016/S0065-308X(01)50031-7; Bostic JR, 1996, MOL BIOCHEM PARASIT, V79, P79, DOI 10.1016/0166-6851(96)02640-0; Brindley PJ, 1997, MOL BIOCHEM PARASIT, V89, P1, DOI 10.1016/S0166-6851(97)00098-4; BUEDING E, 1982, J PARASITOL, V68, P208, DOI 10.2307/3281177; CAMACHO M, 1995, J PARASITOL, V81, P637, DOI 10.2307/3283866; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; de Mendonca RL, 2000, PARASITOL TODAY, V16, P233, DOI 10.1016/S0169-4758(00)01641-0; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GORMAN M, 1993, CELL, V72, P39, DOI 10.1016/0092-8674(93)90048-U; Halton DW, 1997, INT J PARASITOL, V27, P693, DOI 10.1016/S0020-7519(97)00011-8; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; Holland PWH, 1999, NATURE, V402, pC41, DOI 10.1038/35011536; Imase A, 2001, PARASITOLOGY, V123, P163, DOI 10.1017/S0031182001008198; Johnston DA, 1999, BIOESSAYS, V21, P131, DOI 10.1002/(SICI)1521-1878(199902)21:2<131::AID-BIES7>3.0.CO;2-I; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kuwabara PE, 1998, DEV BIOL, V204, P251, DOI 10.1006/dbio.1998.9062; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le TH, 2002, TRENDS PARASITOL, V18, P206, DOI 10.1016/S1471-4922(02)02252-3; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Lum DH, 2000, GENE DEV, V14, P3153; Mei HP, 1997, EXP PARASITOL, V86, P69, DOI 10.1006/expr.1997.4150; Morand S, 2000, PARASITOLOGY, V120, P45, DOI 10.1017/S0031182099005235; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; PULTZ MA, 1995, DEVELOPMENT, V121, P99; Ravindran B, 2001, TRENDS PARASITOL, V17, P70, DOI 10.1016/S1471-4922(00)01835-3; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Salzet M, 2000, PARASITOL TODAY, V16, P536, DOI 10.1016/S0169-4758(00)01787-7; Santos TM, 1999, MOL BIOCHEM PARASIT, V103, P79, DOI 10.1016/S0166-6851(99)00100-0; Skelly PJ, 1996, P NATL ACAD SCI USA, V93, P3642, DOI 10.1073/pnas.93.8.3642; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Sokol SB, 2000, GENE DEV, V14, P901; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xu XR, 2001, P NATL ACAD SCI USA, V98, P15089, DOI 10.1073/pnas.241522398	46	261	298	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					139	147		10.1038/ng1236	http://dx.doi.org/10.1038/ng1236			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973349				2022-12-27	WOS:000185625300010
J	Verjovski-Almeida, S; DeMarco, R; Martins, EAL; Guimaraes, PEM; Ojopi, EPB; Paquola, ACM; Piazza, JP; Nishiyama, MY; Kitajima, JP; Adamson, RE; Ashton, PD; Bonaldo, MF; Coulson, PS; Dillon, GP; Farias, LP; Gregorio, SP; Ho, PL; Leite, RA; Malaquias, LCC; Marques, RCP; Miyasato, PA; Nascimento, ALTO; Ohlweiler, FP; Reis, EM; Ribeiro, MA; Sa, RG; Stukart, GC; Soares, MB; Gargioni, C; Kawano, T; Rodrigues, V; Madeira, AMBN; Wilson, RA; Menck, CFM; Setubal, JC; Leite, LCC; Dias-Neto, E				Verjovski-Almeida, S; DeMarco, R; Martins, EAL; Guimaraes, PEM; Ojopi, EPB; Paquola, ACM; Piazza, JP; Nishiyama, MY; Kitajima, JP; Adamson, RE; Ashton, PD; Bonaldo, MF; Coulson, PS; Dillon, GP; Farias, LP; Gregorio, SP; Ho, PL; Leite, RA; Malaquias, LCC; Marques, RCP; Miyasato, PA; Nascimento, ALTO; Ohlweiler, FP; Reis, EM; Ribeiro, MA; Sa, RG; Stukart, GC; Soares, MB; Gargioni, C; Kawano, T; Rodrigues, V; Madeira, AMBN; Wilson, RA; Menck, CFM; Setubal, JC; Leite, LCC; Dias-Neto, E			Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni	NATURE GENETICS			English	Article							GENE-EXPRESSION; RNA INTERFERENCE; CDNA LIBRARIES; LIFE-SPAN; GENOME; SEQUENCE; PROTEINS; MEMBRANE; INVERTEBRATES; CONSTRUCTION	Schistosoma mansoni is the primary causative agent of schistosomiasis, which affects 200 million individuals in 74 countries. We generated 163,000 expressed-sequence tags ( ESTs) from normalized cDNA libraries from six selected developmental stages of the parasite, resulting in 31,000 assembled sequences and 92% sampling of an estimated 14,000 gene complement. By analyzing automated Gene Ontology assignments, we provide a detailed view of important S. mansoni biological systems, including characterization of metazoa-specific and eukarya-conserved genes. Phylogenetic analysis suggests an early divergence from other metazoa. The data set provides insights into the molecular mechanisms of tissue organization, development, signaling, sexual dimorphism, host interactions and immune evasion and identifies novel proteins to be investigated as vaccine candidates and potential drug targets.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil; Univ Sao Paulo, HCFM, Inst Psiquiatria, Lab Neurosci LIM27, BR-05403010 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, Lab Bioinformat, BR-05508900 Sao Paulo, Brazil; Univ Estadual Campinas, Inst Computacao, BR-13084971 Campinas, SP, Brazil; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; Univ Vale Rio Doce, BR-35030390 Governador Valadares, MG, Brazil; Inst Butantan, Parasitol Lab, BR-05503900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Vet & Zootecnia, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Univ Iowa, Dept Orthopaed, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol, Iowa City, IA 52242 USA; Univ Iowa, Dept Biophys, Iowa City, IA 52242 USA; Inst Adolfo Lutz Registro, Dept Parasitol, BR-01246902 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of York - UK; University of Iowa; Universidade de Sao Paulo; University Vale Rio Doce; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Instituto Adolfo Lutz	Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.	verjo@iq.usp.br	Setubal, Joao Carlos/C-7305-2012; Rodrigues, Vanderlei/I-4528-2012; Wilson, Alan/AAD-5050-2020; Nascimento, Ana L. T. O./E-8488-2012; Ojopi, Elida Benquique/A-6773-2012; Nishiyama, Milton/AAE-5736-2021; Ho, Paulo/P-8267-2015; Leite, Luciana/D-1353-2012; Farias, Leonardo P/C-4072-2012; Reis, Eduardo Moraes Rego/AAF-3553-2020; Reis, Eduardo M/H-2008-2011; Menck, Carlos FM/G-6321-2011; DeMarco, Ricardo/A-7773-2008; Dias-Neto, Emmanuel/A-5869-2008; Farias, Leonardo Paiva/GLV-4591-2022; Nishiyama, Milton Y/H-4002-2013; Madeira, AMBN/E-7971-2012; Malaquias, Luiz Cosme/K-7210-2013; Verjovski-Almeida, Sergio/E-4082-2012; Miyasato, Patricia A/P-8045-2018; Dias-Neto, Emmanuel/AAA-6701-2019; Martins, Elizabeth AL/B-7135-2015; Guimaraes, Pedro/A-9715-2008; GARGIONI, CYBELE/B-5213-2016	Setubal, Joao Carlos/0000-0001-9174-2816; Nascimento, Ana L. T. O./0000-0003-4851-0870; Ojopi, Elida Benquique/0000-0001-5824-5199; Nishiyama, Milton/0000-0002-2410-0562; Ho, Paulo/0000-0003-3652-241X; Leite, Luciana/0000-0003-0156-1312; Farias, Leonardo P/0000-0002-4909-5333; Reis, Eduardo M/0000-0002-9556-3070; Menck, Carlos FM/0000-0003-1941-0694; DeMarco, Ricardo/0000-0001-8944-1301; Dias-Neto, Emmanuel/0000-0001-5670-8559; Farias, Leonardo Paiva/0000-0002-4909-5333; Nishiyama, Milton Y/0000-0002-2410-0562; Madeira, AMBN/0000-0002-3917-1849; Malaquias, Luiz Cosme/0000-0002-4920-072X; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Miyasato, Patricia A/0000-0003-4871-5972; Martins, Elizabeth AL/0000-0002-2333-9379; Guimaraes, Pedro/0000-0002-7530-600X; GARGIONI, CYBELE/0000-0002-9154-6839; Dillon, Gary/0000-0002-7743-5040; Wilson, Alan/0000-0002-7210-0321; Ashton, Peter/0000-0002-7446-5009				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BASCH PF, 1988, COMP BIOCHEM PHYS B, V90, P389, DOI 10.1016/0305-0491(88)90093-4; Boyle JP, 2003, MOL BIOCHEM PARASIT, V128, P205, DOI 10.1016/S0166-6851(03)00078-1; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Coulson PS, 1997, ADV PARASIT, V39, P271, DOI 10.1016/S0065-308X(08)60048-2; Cutts L, 1997, PARASITE IMMUNOL, V19, P91, DOI 10.1046/j.1365-3024.1997.d01-184.x; DAMONNEVILLE M, 1984, INT ARCH ALLER A IMM, V73, P248, DOI 10.1159/000233477; de Mendonca RL, 2000, PARASITOL TODAY, V16, P233, DOI 10.1016/S0169-4758(00)01641-0; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DeMarco R, 2003, BIOCHEM BIOPH RES CO, V307, P831, DOI 10.1016/S0006-291X(03)01268-3; DISSOUS C, 1995, PARASITOL TODAY, V11, P45, DOI 10.1016/0169-4758(95)80111-1; Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0; Dorsey CH, 2002, MICRON, V33, P279, DOI 10.1016/S0968-4328(01)00019-1; Dunne D., 2001, BOOKSGOOGLECOM, P133, DOI [10.1142/9781848161511_0005, DOI 10.1142/9781848161511_0005]; Fietto JLR, 2002, BIOTECHNIQUES, V32, P1404, DOI 10.2144/02326rr01; FULFORD AJC, 1995, PARASITOLOGY, V110, P307, DOI 10.1017/S0031182000080896; Halton DW, 1996, PARASITOLOGY, V113, pS47, DOI 10.1017/S0031182000077891; Hausdorf B, 2000, SYST BIOL, V49, P130, DOI 10.1080/10635150050207438; Hoffmann KF, 2001, MOL BIOCHEM PARASIT, V112, P113, DOI 10.1016/S0166-6851(00)00352-2; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; King CL, 2001, SCHISTOSOMIASIS, P218; Mair GR, 2000, PARASITOLOGY, V121, P163, DOI 10.1017/S0031182099006174; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mansour TE., 2002, CHEMOTHERAPEUTIC TAR, DOI 10.1017/CBO9780511546440; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Neto ED, 1997, GENE, V186, P135, DOI 10.1016/S0378-1119(96)00699-3; Osman A, 2001, J BIOL CHEM, V276, P10072, DOI 10.1074/jbc.M005933200; PAPPAS PW, 1975, EXP PARASITOL, V37, P469, DOI 10.1016/0014-4894(75)90016-8; Paquola ACM, 2003, BIOINFORMATICS, V19, P1587, DOI 10.1093/bioinformatics/btg196; PAX RA, 1991, PARASITOLOGY, V102, pS31, DOI 10.1017/S0031182000073273; Pryon SC, 2000, ACTA BIOL HUNG, V51, P331; Racoosin EL, 1999, MOL BIOCHEM PARASIT, V104, P285, DOI 10.1016/S0166-6851(99)00156-5; Ramos CRR, 2003, J BIOL CHEM, V278, P12745, DOI 10.1074/jbc.M211268200; Salter JP, 2002, J BIOL CHEM, V277, P24618, DOI 10.1074/jbc.M202364200; Santos TM, 1999, MOL BIOCHEM PARASIT, V103, P79, DOI 10.1016/S0166-6851(99)00100-0; Saule P, 2002, J PARASITOL, V88, P849, DOI 10.1645/0022-3395(2002)088[0849:EVOHTA]2.0.CO;2; SIMPSON AJG, 1982, MOL BIOCHEM PARASIT, V6, P125, DOI 10.1016/0166-6851(82)90070-6; SKELLY PJ, 1994, J BIOL CHEM, V269, P4247; Skelly PJ, 2003, INT J PARASITOL, V33, P363, DOI 10.1016/S0020-7519(03)00030-4; SMART D, 1994, J COMP NEUROL, V347, P426, DOI 10.1002/cne.903470308; SNYDER SD, 2000, INTERRELATIONSHIPS P, P194; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Williams SA, 1999, PARASITOLOGY, V118, pS19, DOI 10.1017/S0031182099004473; WILSON RA, 1977, PARASITOLOGY, V74, P61, DOI 10.1017/S0031182000047533; World Health Organization (WHO), 2002, TDR STRAT DIR RES SC; XU XF, 1992, EUR J CELL BIOL, V57, P229	50	392	414	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					148	157		10.1038/ng1237	http://dx.doi.org/10.1038/ng1237			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973350				2022-12-27	WOS:000185625300011
J	Awatramani, R; Soriano, P; Rodriguez, C; Mai, JJ; Dymecki, SM				Awatramani, R; Soriano, P; Rodriguez, C; Mai, JJ; Dymecki, SM			Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASES; MOUSE EMBRYOS; NEURAL CREST; DEVELOPING HINDBRAIN; NERVOUS-SYSTEM; EPH FAMILY; EXPRESSION; RHOMBOMERES; FATE; RECOMBINATION	The hindbrain roof plate and choroid plexus are essential organizing centers for inducing dorsal neuron fates and sustaining neuron function. To map the formation of these structures, we developed a broadly applicable, high resolution, recombinase-based method for mapping the fate of cells originating from coordinates defined by intersecting combinations of expressed genes. Using this method, we show that distinct regions of hindbrain roof plate originate from discrete subdomains of rhombencephalic neuroectoderm expressing Wnt1; that choroid plexus, a secretory epithelium important for patterning later-formed hindbrain structures and maintaining neuron function(1), derives from the same embryonic primordium as the hindbrain roof plate; and that, unlike the floor plate(2,3), these dorsal organizing centers develop in a patterned, segmental manner, built from lineage-restricted compartments. Our data suggest that the roof plate and choroid plexus may be formed of functional units that are capable of differentially organizing the generation of distinct neuronal cell types at different axial levels.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.		Rodriguez, Carolyn I/K-8479-2014; Soriano, Philippe M/E-5797-2015	Rodriguez, Carolyn I/0000-0001-6697-1692; Soriano, Philippe M/0000-0002-0427-926X	NHGRI NIH HHS [F31 HG000180] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG000180] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altman J, 1997, DEV CEREBELLAR SYSTE; BALLYCUIF L, 1992, DEVELOPMENT, V115, P999; BECKER N, 1994, MECH DEVELOP, V47, P3, DOI 10.1016/0925-4773(94)90091-4; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Chai Y, 2000, DEVELOPMENT, V127, P1671; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; FRASCH M, 1995, DEVELOPMENT, V121, P957; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Gale NW, 1996, ONCOGENE, V13, P1343; Inoue T, 1997, DEV BIOL, V183, P183, DOI 10.1006/dbio.1996.8501; Jiang W, 1998, BIOTECHNIQUES, V24, P349; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Manzanares M, 2000, MECH DEVELOP, V94, P147, DOI 10.1016/S0925-4773(00)00288-4; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; PRINCE V, 1994, DEVELOPMENT, V120, P911; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Yamamoto M, 1996, DEV BRAIN RES, V93, P182, DOI 10.1016/0165-3806(96)00038-7; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	30	153	156	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					70	75		10.1038/ng1228	http://dx.doi.org/10.1038/ng1228			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12923530				2022-12-27	WOS:000185018500013
J	Cheok, MH; Yang, WL; Pui, CH; Downing, JR; Cheng, C; Naeve, CW; Relling, MV; Evans, WE				Cheok, MH; Yang, WL; Pui, CH; Downing, JR; Cheng, C; Naeve, CW; Relling, MV; Evans, WE			Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA STRAND BREAKS; NONPOLYPOSIS COLORECTAL-CANCER; TYROSINE KINASE; METHOTREXATE; ACCUMULATION; DAMAGE; PHARMACOGENOMICS; CLASSIFICATION; CHEMOTHERAPY	To elucidate the genomics of cellular responses to cancer treatment, we analyzed the expression of over 9,600 human genes in acute lymphoblastic leukemia cells before and after in vivo treatment with methotrexate and mercaptopurine given alone or in combination. Based on changes in gene expression, we identified 124 genes that accurately discriminated among the four treatments. Discriminating genes included those involved in apoptosis, mismatch repair, cell cycle control and stress response. Only 14% of genes that changed when these medications were given as single agents also changed when they were given together. These data indicate that lymphoid leukemia cells of different molecular subtypes share common pathways of genomic response to the same treatment, that changes in gene expression are treatment-specific and that gene expression can illuminate differences in cellular response to drug combinations versus single agents.	St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Hematol Malignancies Program, Memphis, TN 38105 USA; Univ Bonn, D-5300 Bonn, Germany; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Univ Tennessee, Memphis, TN USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Bonn; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Hematol Malignancies Program, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Downing, James R./N-8102-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Cheok, Meyling h/C-3822-2014; Evans, William E./C-2069-2012; Cheng, Cheng/N-8075-2018; Cheok, Meyling/AFS-4025-2022	Pui, Ching-Hon/0000-0003-0303-5658; Cheok, Meyling h/0000-0002-7820-8026; Evans, William E./0000-0002-9333-5322; Cheok, Meyling/0000-0002-7820-8026				Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BOKKERINK JPM, 1993, BIOCHEM PHARMACOL, V45, P1455, DOI 10.1016/0006-2952(93)90045-X; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gong JG, 1999, NATURE, V399, P806; Gorlick R, 1996, NEW ENGL J MED, V335, P1041, DOI 10.1056/NEJM199610033351408; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; LI JC, 1984, P NATL ACAD SCI-BIOL, V81, P5694, DOI 10.1073/pnas.81.18.5694; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LORICO A, 1988, CANCER RES, V48, P2036; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Palmirotta R, 1998, EUR J CANCER, V34, P927, DOI 10.1016/S0959-8049(98)00031-8; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Tsurusawa M, 1997, INT J HEMATOL, V66, P79; Wijnen J, 1996, AM J HUM GENET, V58, P300; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	29	196	215	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					85	90		10.1038/ng1151	http://dx.doi.org/10.1038/ng1151			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12704389				2022-12-27	WOS:000182667900022
J	Tamaru, H; Zhang, X; McMillen, D; Singh, PB; Nakayama, J; Grewal, SI; Allis, CD; Cheng, XD; Selker, EU				Tamaru, H; Zhang, X; McMillen, D; Singh, PB; Nakayama, J; Grewal, SI; Allis, CD; Cheng, XD; Selker, EU			Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa	NATURE GENETICS			English	Article							INDUCED POINT MUTATION; METHYLTRANSFERASE ACTIVITY; PROTEIN; DOMAIN; PATTERNS; HP1; HETEROCHROMATIN; CHROMOSOME; ENHANCER; GENES	Besides serving to package nuclear DNA, histones carry information in the form of a diverse array of post-translational modifications. Methylation of histones H3 and H4 has been implicated in long-term epigenetic 'memory'(1). Dimethylation or trimethylation of Lys4 of histone H3 (H3 Lys4) has been found in expressible euchromatin of yeasts and mammals(2-4). In contrast, methylation of Lys9 of histone H3 (H3 Lys9) has been implicated in establishing and maintaining the largely quiescent heterochromatin of mammals, yeasts, Drosophila melanogaster and plants". we have previously shown that a DNA methylation mutant of Neurospora crassa, dim-5 (defective in methylation), has a nonsense mutation in the SET domain of an H3-specific histone methyltransferase and that substitutions of H3 Lys9 cause gross hypomethylation of DNA(10). Similarly, the KRYPTONITE histone methyltransferase is required for full DNA methylation in Arabidopsis thaliana(11). We used biochemical, genetic and immunological methods to investigate the specific mark for DNA methylation in N. crassa. Here we show that trimethylated H3 Lys9, but not dimethylated H3 Lys9, marks chromatin regions for cytosine methylation and that DIM-5 specifically creates this mark.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Roslin Inst, Div Gene Express & Dev, Nuc Reprogramming Lab, Roslin EH25 9PS, Midlothian, Scotland; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Oregon; Emory University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; Cold Spring Harbor Laboratory; University of Virginia	Selker, EU (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		Nakayama, Jun-ichi/C-6003-2011; Singh, Prim/G-1088-2014	Nakayama, Jun-ichi/0000-0002-5597-8239; Singh, Prim/0000-0002-9571-0974				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; FOSS HM, 1993, SCIENCE, V262, P1737, DOI 10.1126/science.7505062; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Hays SM, 2002, GENETICS, V160, P961; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kouzminova E, 2001, EMBO J, V20, P4309, DOI 10.1093/emboj/20.15.4309; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Margolin BS, 1998, GENETICS, V149, P1787; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; SELKER EU, IN PRESS NATURE; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	30	299	314	1	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					75	79		10.1038/ng1143	http://dx.doi.org/10.1038/ng1143			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12679815				2022-12-27	WOS:000182667900020
J	Bergamaschi, D; Samuels, Y; O'Neil, NJ; Trigiante, G; Crook, T; Hsieh, JK; O'Connor, DJ; Zhong, S; Campargue, I; Tomlinson, ML; Kuwabara, PE; Lu, X				Bergamaschi, D; Samuels, Y; O'Neil, NJ; Trigiante, G; Crook, T; Hsieh, JK; O'Connor, DJ; Zhong, S; Campargue, I; Tomlinson, ML; Kuwabara, PE; Lu, X			iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; CAENORHABDITIS-ELEGANS; DROSOPHILA P53; APOPTOSIS; HOMOLOG	We have previously shown that ASPP1 and ASPP2 are specific activators of p53; one mechanism by which wild-type p53 is tolerated in human breast carcinomas is through loss of ASPP activity. We have further shown that 53BP2, which corresponds to a C-terminal fragment of ASPP2, acts as a dominant negative inhibitor of p53 (ref. 1). Hence, an inhibitory form of ASPP resembling 53BP2 could allow cells to bypass the tumor-suppressor functions of p53 and the ASPP proteins. Here, we characterize such a protein, iASPP (inhibitory member of the ASPP family), encoded by PPP1R13L in humans and ape-1 in Caenorhabditis elegans. iASPP is an evolutionarily conserved inhibitor of p53; inhibition of iASPP by RNA-mediated interference or antisense RNA in C elegans or human cells, respectively, induces p53-dependent apoptosis. Moreover, iASPP is an oncoprotein that cooperates with Ras, E1A and E7, but not mutant p53, to transform cells in vitro. Increased expression of iASPP also confers resistance to ultraviolet radiation and to cisplatin-induced apoptosis. iASPP expression is upregulated in human breast carcinomas expressing wild-type p53 and normal levels of ASPP. Inhibition of iASPP could provide an important new strategy for treating tumors expressing wild-type p53.	Univ London Imperial Coll Sci & Technol, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England; Wellcome Trust Sanger Inst, Cambridge, England	Imperial College London; Ludwig Institute for Cancer Research; Wellcome Trust Sanger Institute	Lu, X (corresponding author), Univ London Imperial Coll Sci & Technol, Sch Med, Ludwig Inst Canc Res, St Marys Campus,Norfolk Pl, London W2 1PG, England.		O'Neil, Nigel/J-4012-2014	O'Neil, Nigel/0000-0002-1992-6976; Lu, Xin/0000-0002-6587-1152; Samuels, Yardena/0000-0002-3349-7266; Bergamaschi, Daniele/0000-0002-3955-1091; Kuwabara, Patricia/0000-0002-1108-7776				Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Harlow E., 1988, ANTIBODIES LAB MANUA; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662	12	297	354	1	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					162	167		10.1038/ng1070	http://dx.doi.org/10.1038/ng1070			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524540				2022-12-27	WOS:000180773700013
J	Cowles, CR; Hirschhorn, JN; Altshuler, D; Lander, ES				Cowles, CR; Hirschhorn, JN; Altshuler, D; Lander, ES			Detection of regulatory variation in mouse genes	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GILBERTS-SYNDROME; CANDIDATE GENES; EXPRESSION; DNA; DIVERSITY; REGIONS; ASSAY	Functional polymorphism in genes can be classified as coding variation, altering the amino-acid sequence of the encoded protein, or regulatory variation, affecting the level or pattern of expression of the gene. Coding variation can be recognized directly from DNA sequence, and consequently its frequency and characteristics have been extensively described. By contrast, virtually nothing is known about the extent to which gene regulation varies in populations. Yet it is likely that regulatory variants are important in modulating gene function: alterations in gene regulation have been proposed to influence disease susceptibility and to have been the primary substrate for the evolution of species(1). Here, we report a systematic study to assess the extent of cis-acting regulatory variation in 69 genes across four inbred mouse strains. We find that at least four of these genes show allelic differences in expression level of 1.5-fold or greater, and that some of these differences are tissue specific. The results show that the impact of regulatory variants can be detected at a significant frequency in a genomic survey and suggest that such variation may have important consequences for organismal phenotype and evolution. The results indicate that larger-scale surveys in both mouse and human could identify a substantial number of genes with common regulatory variation.	Whitehead Inst, Cambridge, MA 02142 USA; MIT, Ctr Genome Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lander@wi.mit.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Hirschhorn, Joel/0000-0002-1650-7901				BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Grabe Niels, 2002, In Silico Biology, V2, pS1; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOBAYASHI M, 1995, MOL CELL PROBE, V9, P175, DOI 10.1006/mcpr.1995.0027; Landegren U, 1998, GENOME RES, V8, P769, DOI 10.1101/gr.8.8.769; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; LI WH, 1991, GENETICS, V129, P513; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Monaghan G, 1996, LANCET, V347, P578, DOI 10.1016/S0140-6736(96)91273-8; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RaveHarel N, 1997, AM J HUM GENET, V60, P87; SINGERSAM J, 1994, PCR METH APPL, V3, pS48; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097	23	295	307	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					432	437		10.1038/ng992	http://dx.doi.org/10.1038/ng992			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410233				2022-12-27	WOS:000179034800022
J	Spring, K; Ahangari, F; Scott, SP; Waring, P; Purdie, DM; Chen, PC; Hourigan, K; Ramsay, J; McKinnon, PJ; Swift, M; Lavin, MF				Spring, K; Ahangari, F; Scott, SP; Waring, P; Purdie, DM; Chen, PC; Hourigan, K; Ramsay, J; McKinnon, PJ; Swift, M; Lavin, MF			Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer	NATURE GENETICS			English	Article							BREAST-CANCER; IONIZING-RADIATION; EARLY-ONSET; MISSENSE MUTATIONS; ALLELIC VARIANTS; DEFICIENT MICE; PHENOTYPE; FAMILIES; IDENTIFICATION; KINASE	Ataxia-telangiectasia is characterized by radiosensitivity, genome instability and predisposition to cancer(1,2). Heterozygous carriers of ATM, the gene defective in ataxia-telangiectasia, have a higher than normal risk of developing breast and other cancers(3-6). We demonstrate here that Atm 'knock-in' (Atm-DeltaSRI) heterozygous mice harboring an in-frame deletion corresponding to the human 7636del9 mutation show an increased susceptibility to developing tumors. In contrast, no tumors are observed in Atm knockout (Atm(+/-)) heterozygous mice. In parallel, we report the appearance of tumors in 6 humans from 12 families who are heterozygous for the 7636del9 mutation. Expression of ATM cDNA containing the 7636del9 mutation had a dominant-negative effect in control cells, inhibiting radiation-induced ATM kinase activity in vivo and in vitro. This reduces the survival of these cells after radiation exposure and enhances the level of radiation-induced chromosomal aberrations. These results show for the first time that mouse carriers of a mutated Atm that are capable of expressing Atm have a higher risk of cancer. This finding provides further support for cancer predisposition in human ataxia-telangiectasia carriers.	Queensland Inst Med Res, Herston, Qld 4029, Australia; Peter MacCallum Canc Inst, Melbourne, Vic, Australia; Alexandra House, Brisbane, Qld, Australia; St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; Pace Univ, Dept Biol Sci, Pleasantville, NY USA; Royal Brisbane Hosp, Dept Surg, Herston, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; St Jude Children's Research Hospital; Pace University; Royal Brisbane & Women's Hospital	Lavin, MF (corresponding author), Queensland Inst Med Res, PO Royal Brisbane Hosp, Herston, Qld 4029, Australia.	martinL@qimr.edu.au	Lavin, Martin F/F-5961-2014; Ramsay, Jonathan/F-7009-2013	Lavin, Martin F/0000-0002-5940-4769; Spring, Kevin/0000-0003-0601-924X				Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barlow C, 1999, NAT GENET, V21, P359, DOI 10.1038/7684; Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Dork T, 2001, CANCER RES, V61, P7608; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gilad S, 1996, HUM MOL GENET, V5, P433, DOI 10.1093/hmg/5.4.433; Gueven N, 2001, J BIOL CHEM, V276, P8884, DOI 10.1074/jbc.M006190200; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Inskip HM, 1999, BRIT J CANCER, V79, P1304, DOI 10.1038/sj.bjc.6690209; Izatt L, 1999, GENE CHROMOSOME CANC, V26, P286, DOI 10.1002/(SICI)1098-2264(199912)26:4<286::AID-GCC2>3.0.CO;2-X; Larson GP, 1997, GENET TEST, V1, P165, DOI 10.1089/gte.1997.1.165; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Li AR, 2000, AM J MED GENET, V92, P170, DOI 10.1002/(SICI)1096-8628(20000529)92:3<170::AID-AJMG3>3.0.CO;2-#; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Olsen JH, 2001, JNCI-J NATL CANCER I, V93, P121, DOI 10.1093/jnci/93.2.121; PATERSON MC, 1985, ATAXIA TELANGIECTASI, P73; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scott SP, 2002, P NATL ACAD SCI USA, V99, P925, DOI 10.1073/pnas.012329699; Spring K, 2001, CANCER RES, V61, P4561; Stewart GS, 2001, J BIOL CHEM, V276, P30133, DOI 10.1074/jbc.M103160200; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Teraoka SN, 2001, CANCER-AM CANCER SOC, V92, P479, DOI 10.1002/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G; Vorechovsky I, 1996, CANCER RES, V56, P4130; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021	30	117	120	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					185	190		10.1038/ng958	http://dx.doi.org/10.1038/ng958			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12195425				2022-12-27	WOS:000177714900020
J	Lipkin, SM; Moens, PB; Wang, V; Lenzi, M; Shanmugarajah, D; Gilgeous, A; Thomas, J; Cheng, J; Touchman, JW; Green, ED; Schwartzberg, P; Collins, FS; Cohen, PE				Lipkin, SM; Moens, PB; Wang, V; Lenzi, M; Shanmugarajah, D; Gilgeous, A; Thomas, J; Cheng, J; Touchman, JW; Green, ED; Schwartzberg, P; Collins, FS; Cohen, PE			Meiotic arrest and aneuploidy in MLH3-deficient mice	NATURE GENETICS			English	Article							DNA MISMATCH REPAIR; CROSSING-OVER; MUTS HOMOLOG; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SYNAPSIS; MEIOSIS; GENE; RECOMBINATION; MLH1; MSH5	MutL homolog 3 (Mlh3) is a member of a family of proteins conserved during evolution and having dual roles in DNA mismatch repair and meiosis(1,2). The pathway in eukaryotes consists of the DNA-binding components, which are the homologs of the bacterial MutS protein (MSH 2-6), and the MutL homologs, which bind to the MutS homologs and are essential for the repair process. Three of the six homologs of MutS that function in these processes, Msh2, Msh3 and Msh6, are involved in the mismatch repair of mutations, frameshifts and replication errors(2,3), and two others, Msh4 and Msh5, have specific roles in meiosis(4-10). Of the four MutL homologs, Mlh1, Mlh3, Pms1 and Pms2, three are involved in mismatch repair and at least two, Pms2 and Mlh1, are essential for meiotic progression in both yeast and mice(2,3,11-14). To assess the role of Mlh3 in mammalian meiosis, we have generated and characterized Mlh3(-/-) mice 15. Here we show that Mlh3(-/-) mice are viable but sterile. Mlh3 is required for Mlh1 binding to meiotic chromosomes and localizes to meiotic chromosomes from the mid pachynema stage of prophase I. Mlh3(-/-) spermatocytes reach metaphase before succumbing to apoptosis, but oocytes fail to complete meiosis I after fertilization. Our results show that Mlh3 has an essential and distinct role in mammalian meiosis.	Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92697 USA; NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; York Univ, Dept Biol, N York, ON M3J 1P3, Canada; Albert Einstein Coll Med, Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; NHGRI, Transgen & Knockout Core Facil, Bethesda, MD 20892 USA	University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); York University - Canada; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Cohen, PE (corresponding author), Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92697 USA.		wang, vicky/AAO-6474-2020		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000123, ZIAHG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 2000, CANCER RES, V60, P803; Ellsworth RE, 2000, P NATL ACAD SCI USA, V97, P1172, DOI 10.1073/pnas.97.3.1172; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Green ED, 2001, NAT REV GENET, V2, P573, DOI 10.1038/35084503; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Her CT, 1999, MAMM GENOME, V10, P1054, DOI 10.1007/s003359901161; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Kneitz B, 2000, GENE DEV, V14, P1085; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Moens PB, 2002, J CELL SCI, V115, P1611; Osoegawa K, 2000, GENOME RES, V10, P116; PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Touchman JW, 2000, GENOME RES, V10, P165, DOI 10.1101/gr.10.2.165; Wang DH, 1996, CANCER LETT, V100, P31, DOI 10.1016/0304-3835(95)04068-4; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395	29	274	288	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					385	390		10.1038/ng931	http://dx.doi.org/10.1038/ng931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12091911				2022-12-27	WOS:000177147100013
J	Deng, XZ; Hofmann, ER; Villanueva, A; Hobert, O; Capodieci, P; Veach, DR; Yin, XL; Campodonico, L; Glekas, A; Cordon-Cardo, C; Clarkson, B; Bornmann, WG; Fuks, Z; Hengartner, MO; Kolesnick, R				Deng, XZ; Hofmann, ER; Villanueva, A; Hobert, O; Capodieci, P; Veach, DR; Yin, XL; Campodonico, L; Glekas, A; Cordon-Cardo, C; Clarkson, B; Bornmann, WG; Fuks, Z; Hengartner, MO; Kolesnick, R			Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation	NATURE GENETICS			English	Article							PROGRAMMED CELL-DEATH; C-ABL; TUMOR-SUPPRESSOR; BCR-ABL; GENE; P53; EXPRESSION; RADIATION; MEIOSIS; HOMOLOG	c-Abl, a conserved nonreceptor tyrosine kinase, integrates genotoxic stress responses, acting as a transducer of both pro- and antiapoptotic effector pathways(1). Nuclear c-Abl seems to interact with the p53 homolog p73 to elicit apoptosis(2,3). Although several observations suggest that cytoplasmic localization of c-Abl is required for antiapoptotic function(4,5), the signals that mediate its antiapoptotic effect are largely unknown. Here we show that worms carrying an abl-1 deletion allele, abl-1(ok171), are specifically hypersensitive to radiation-induced apoptosis in the Caenorhabditis elegans germ line. Our findings delineate an apoptotic pathway antagonized by ABL-1, which requires sequentially the cell cycle checkpoint genes clk-2, hus-1 and mrt-2; the C. elegans p53 homolog, cep-1; and the genes encoding the components of the conserved apoptotic machinery, ced-3, ced-9 and egl-1. ABL-1 does not antagonize germline apoptosis induced by the DNA-alkylating agent ethylnitrosourea. Furthermore, worms treated with the c-Abl inhibitor STI-571 ( Gleevec; used in human cancer therapy), two newly synthesized STI-571 variants or PD166326 had a phenotype similar to that generated by abl-1( ok171). These studies indicate that ABL-1 distinguishes proapoptotic signals triggered by two different DNA-damaging agents and suggest that C. elegans might provide tissue models for development of anticancer drugs.	Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; Univ Zurich, Dept Mol Biol, CH-8057 Zurich, Switzerland; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Organ Synth Core Facil, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Zurich; Columbia University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kolesnick, R (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008	Hobert, Oliver/0000-0002-7634-2854; Veach, Darren/0000-0002-8201-622X; Hengartner, Michael/0000-0002-7584-596X	NCI NIH HHS [P30 CA008748, P01 CA064593] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA064593, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 1999, NATURE, V399, P809; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Berman E, 2000, LEUKEMIA RES, V24, P289, DOI 10.1016/S0145-2126(99)00179-4; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Buchdunger E, 1996, CANCER RES, V56, P100; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Druker BJ, 2002, TRENDS MOL MED, V8, pS14, DOI 10.1016/S1471-4914(02)02305-5; ELLIS RE, 1991, GENETICS, V129, P79; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gong JG, 1999, NATURE, V399, P806; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hamby JM, 1997, J MED CHEM, V40, P2296, DOI 10.1021/jm970367n; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; KRAUSE M, 1994, DEV BIOL, V166, P133, DOI 10.1006/dbio.1994.1302; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Rinaldo C, 2002, GENETICS, V160, P471; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shah A, 1999, AGING MENT HEALTH, V3, P153, DOI 10.1080/13607869956316; Takanami T, 2000, NUCLEIC ACIDS RES, V28, P4232, DOI 10.1093/nar/28.21.4232; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Wisniewski D, 2002, CANCER RES, V62, P4244; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	29	63	91	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					906	912		10.1038/ng1396	http://dx.doi.org/10.1038/ng1396			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273685				2022-12-27	WOS:000222974000027
J	Fredman, D; White, SJ; Potter, S; Eichler, EE; Den Dunnen, JT; Brookes, AJ				Fredman, D; White, SJ; Potter, S; Eichler, EE; Den Dunnen, JT; Brookes, AJ			Complex SNP-related sequence variation in segmental genome duplications	NATURE GENETICS			English	Article							DEPENDENT PROBE AMPLIFICATION; NUCLEOTIDE POLYMORPHISMS SNPS; MICROARRAY ANALYSIS; GENE CONVERSION; REARRANGEMENTS; DESIGN; IMPACT; MAP	There is uncertainty about the true nature of predicted single-nucleotide polymorphisms ( SNPs) in segmental duplications (duplicons) and whether these markers genuinely exist at increased density as indicated in public databases. We explored these issues by genotyping 157 predicted SNPs in duplicons and control regions in normal diploid genomes and fully homozygous complete hydatidiform moles. Our data identified many true SNPs in duplicon regions and few paralogous sequence variants. Twenty-eight percent of the polymorphic duplicon sequences we tested involved multisite variation, a new type of polymorphism representing the sum of the signals from many individual duplicon copies that vary in sequence content due to duplication, deletion or gene conversion. Multisite variations can masquerade as normal SNPs when genotyped. Given that duplicons comprise at least 5% of the genome and many are yet to be annotated in the genome draft, effective strategies to identify multisite variation must be established and deployed.	Karolinska Inst, Ctr Gen & Bioinformat, S-17177 Stockholm, Sweden; Leiden Univ, Med Ctr, NL-2333 AL Leiden, Netherlands; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Karolinska Institutet; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Case Western Reserve University	Brookes, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	anthony.brookes@cgb.ki.se	dunnen, johan den/ABH-4228-2020; Fredman, David J/H-3566-2013	dunnen, johan den/0000-0002-6304-1710; Fredman, David J/0000-0003-3507-0554				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Fredman D, 2004, HUM MUTAT, V24, P1, DOI 10.1002/humu.20066; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Hurles M, 2002, SCIENCE, V298; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Prince JA, 2001, GENOME RES, V11, P152, DOI 10.1101/gr.150201; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sebire NJ, 2003, PEDIATR DEVEL PATHOL, V6, P69, DOI 10.1007/s10024-002-0079-9; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Tsui C, 2003, NUCLEIC ACIDS RES, V31, P4910, DOI 10.1093/nar/gkg664; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054	29	179	190	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					861	866		10.1038/ng1401	http://dx.doi.org/10.1038/ng1401			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15247918				2022-12-27	WOS:000222974000019
J	Topaz, O; Shurman, DI; Bergman, R; Indelman, M; Ratajczak, P; Mizrachi, M; Khamaysi, Z; Behar, D; Petronius, D; Friedman, V; Zelikovic, I; Raimer, S; Metzker, A; Richard, G; Sprecher, E				Topaz, O; Shurman, DI; Bergman, R; Indelman, M; Ratajczak, P; Mizrachi, M; Khamaysi, Z; Behar, D; Petronius, D; Friedman, V; Zelikovic, I; Raimer, S; Metzker, A; Richard, G; Sprecher, E			Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; PHOSPHATE; CLONING; FGF23	Familial tumoral calcinosis (FTC; OMIM 211900) is a severe autosomal recessive metabolic disorder that manifests with hyperphosphatemia and massive calcium deposits in the skin and subcutaneous tissues. Using linkage analysis, we mapped the gene underlying FTC to 2q24-q31. This region includes the gene GALNT3, which encodes a glycosyltransferase responsible for initiating mucin-type O-glycosylation. Sequence analysis of GALNT3 identified biallelic deleterious mutations in all individuals with FTC, suggesting that defective post-translational modification underlies the disease.	Technion Israel Inst Technol, Rambam Med Ctr, Dept Dermatol, Haifa, Israel; Technion Israel Inst Technol, Rambam Med Ctr, Lab Mol Dermatol, Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel; Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Rambam Med Ctr, Pediat Nephrol Unit, Haifa, Israel; Rambam Med Ctr, Lab Dev Nephrol, Haifa, Israel; Univ Texas, Med Branch, Dept Dermatol, Galveston, TX USA	Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Jefferson University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; University of Texas System; University of Texas Medical Branch Galveston	Sprecher, E (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Dept Dermatol, Haifa, Israel.	e-sprecher@rambam.health.gov.il						Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Berndt T, 2003, J CLIN INVEST, V112, P785, DOI 10.1172/JC1200318563; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; de Beur SMJ, 2002, J CLIN ENDOCR METAB, V87, P2467, DOI 10.1210/jc.87.6.2467; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; PRINCE MJ, 1982, ANN INTERN MED, V96, P586, DOI 10.7326/0003-4819-96-5-586; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Schiavi SC, 2004, KIDNEY INT, V65, P1, DOI 10.1111/j.1523-1755.2004.00355.x; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; SLAVIN RE, 1993, AM J SURG PATHOL, V17, P788, DOI 10.1097/00000478-199308000-00004; STEINHERZ R, 1985, AM J DIS CHILD, V139, P816, DOI 10.1001/archpedi.1985.02140100078036; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007	15	389	404	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					579	581		10.1038/ng1358	http://dx.doi.org/10.1038/ng1358			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15133511	Bronze			2022-12-27	WOS:000221763700013
J	Marchini, J; Cardon, LR; Phillips, MS; Donnelly, P				Marchini, J; Cardon, LR; Phillips, MS; Donnelly, P			The effects of human population structure on large genetic association studies	NATURE GENETICS			English	Article							STRATIFICATION; DIFFERENTIATION; INFERENCE	Large-scale association studies hold substantial promise for unraveling the genetic basis of common human diseases. A well-known problem with such studies is the presence of undetected population structure, which can lead to both false positive results and failures to detect genuine associations. Here we examine similar to15,000 genome-wide single-nucleotide polymorphisms typed in three population groups to assess the consequences of population structure on the coming generation of association studies. The consequences of population structure on association outcomes increase markedly with sample size. For the size of study needed to detect typical genetic effects in common diseases, even the modest levels of population structure within population groups cannot safely be ignored. We also examine one method for correcting for population structure ( Genomic Control). Although it often performs well, it may not correct for structure if too few loci are used and may overcorrect in other settings, leading to substantial loss of power. The results of our analysis can guide the design of large-scale association studies.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; McGill Univ, Genome Ctr, Montreal, PQ H3A 1A4, Canada; Genome Quebec, Montreal, PQ H3A 1A4, Canada	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; McGill University	Donnelly, P (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	donnelly@stats.ox.ac.uk	Peng, Bo/A-6920-2009; Marchini, Jonathan/ABE-9024-2020	Peng, Bo/0000-0001-8225-2284; Marchini, Jonathan/0000-0003-0610-8322; Donnelly, Peter/0000-0001-9495-3408				Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; CLAYTON D, 2001, HDB STAT GENETICS, P519; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Excoffier L, 2001, HDB STAT GENETICS, P271; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Moller T, 2003, ANN ONCOL, V14, P946, DOI 10.1093/annonc/mdg255; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Ripatti S, 2001, GENET EPIDEMIOL, V21, pS409, DOI 10.1002/gepi.2001.21.s1.s409; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Spence MA, 2003, AM J HUM GENET, V72, P1084, DOI 10.1086/374826; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758; [No title captured]	28	630	658	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					512	517		10.1038/ng1337	http://dx.doi.org/10.1038/ng1337			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15052271	Bronze			2022-12-27	WOS:000221183000026
J	Mitelman, F; Johansson, B; Mertens, F				Mitelman, F; Johansson, B; Mertens, F			Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SOLID TUMORS; TRANSLOCATIONS; FIBROSARCOMA; INSTABILITY	Cytogenetic aberrations have been reported in 45,000 human neoplasms. Structural balanced rearrangements are associated with distinct tumor subtypes with remarkable specificity and have been essential for identifying genes involved in tumorigenesis(1,2). All balanced rearrangements that have been characterized molecularly act by deregulating a gene in one of the breakpoints or by creating a fusion gene(3-6). Because most recurrent aberrations and rearranged genes have been found in hematological disorders, whereas numerous genomic imbalances have been identified in solid tumors(7,8), it has become generally accepted that there are pathogenetic differences between these neoplasms. We here show that in every tumor type, the numbers of recurrent balanced chromosome abnormalities, fusion genes and genes rearranged as a consequence of balanced aberrations are simply a function of the number of cases with an abnormal karyotype. Hence, there may not be any fundamental tissue-specific differences in the genetic mechanisms by which neoplasia is initiated.	Univ Hosp, Dept Clin Genet, SE-22185 Lund, Sweden	Lund University; Skane University Hospital	Mitelman, F (corresponding author), Univ Hosp, Dept Clin Genet, SE-22185 Lund, Sweden.	felix.mitelman@klingen.lu.se		Mitelman, Felix/0000-0002-3757-7212; Mertens, Fredrik/0000-0002-6278-5232				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Druker BJ, 2002, ONCOGENE, V21, P8541, DOI 10.1038/sj.onc.1206081; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Gorunova L, 1998, GENE CHROMOSOME CANC, V23, P81, DOI 10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEIM S, 1988, CANCER RES, V48, P5911; Heim S, 1995, CANC CYTOGENETICS; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lengauer C, 2001, P NATL ACAD SCI USA, V98, P12331, DOI 10.1073/pnas.231485898; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Mertens F, 1997, CANCER RES, V57, P2765; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Rabbitts TH, 2003, NAT MED, V9, P383, DOI 10.1038/nm0403-383; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROMANA SP, 1995, BLOOD, V85, P3662, DOI 10.1182/blood.V85.12.3662.bloodjournal85123662; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin BP, 1998, AM J PATHOL, V153, P1451, DOI 10.1016/S0002-9440(10)65732-X; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0	26	237	256	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2004	36	4					331	334		10.1038/ng1335	http://dx.doi.org/10.1038/ng1335			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15054488	Green Published, Bronze			2022-12-27	WOS:000220647200013
J	Kim, MJ; Park, BJ; Kang, YS; Kim, HJ; Park, JH; Kang, JW; Lee, SW; Han, JM; Lee, HW; Kim, S				Kim, MJ; Park, BJ; Kang, YS; Kim, HJ; Park, JH; Kang, JW; Lee, SW; Han, JM; Lee, HW; Kim, S			Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation	NATURE GENETICS			English	Article							FAR UPSTREAM ELEMENT; SURFACTANT; MICE; GENE; IDENTIFICATION; TRANSCRIPTION; PROLIFERATION; DEFECTS; COMPLEX; GROWTH	p38 is associated with a macromolecular tRNA synthetase complex(1). It has an essential role as a scaffold for the complex, and genetic disruption of p38 in mice causes neonatal lethality(2). Here we investigated the molecular mechanisms underlying lethality of p38-mutant mice. p38-deficient mice showed defects in lung differentiation and respiratory distress syndrome. p38 was found to interact with FUSE-binding protein (FBP), a transcriptional activator of c-myc(3). Binding of p38 stimulated ubiquitination and degradation of FBP, leading to downregulation of c-myc, which is required for differentiation of functional alveolar type II cells. Transforming growth factor-beta (TGF-beta) induced p38 expression and promoted its translocation to nuclei for the regulation of FBP and c-myc. Thus, this work identified a new activity of p38 as a mediator of TGF-beta signaling and its functional importance in the control of c-myc during lung differentiation.	Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea; Seoul Natl Univ, Biotechnol Incubat Ctr, Seoul 151742, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU)	Kim, S (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr ARS Network, Coll Pharm, Seoul 151742, South Korea.	sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Han, Jung Min/0000-0003-3372-7575				Ben-Izhak O, 2002, HISTOPATHOLOGY, V41, P519, DOI 10.1046/j.1365-2559.2002.01444.x; Chinoy MR, 2001, PEDIATR PULM, V32, P129, DOI 10.1002/ppul.1099.abs; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Duncan R, 1996, MOL CELL BIOL, V16, P2274; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Ehrhardt A, 2001, BRIT J CANCER, V84, P813, DOI 10.1054/bjoc.2000.1676; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1034/j.1399-3003.1999.13f36.x; Guo QM, 2000, CANCER RES, V60, P5922; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KALINA M, 1992, AM J RESP CELL MOL, V6, P594, DOI 10.1165/ajrcmb/6.6.594; Kang J, 2000, J BIOL CHEM, V275, P31682, DOI 10.1074/jbc.M909965199; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Lawson PR, 2000, IMMUNOL REV, V173, P66, DOI 10.1034/j.1600-065X.2000.917308.x; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; NICOLAIDES NC, 1995, GENOMICS, V29, P329, DOI 10.1006/geno.1995.9997; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; SUGAHARA K, 1994, AM J RESP CELL MOL, V11, P397, DOI 10.1165/ajrcmb.11.4.7917308; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wang XJ, 1998, NEUROSCI LETT, V252, P191, DOI 10.1016/S0304-3940(98)00598-9; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Zhou MY, 1996, J BIOL CHEM, V271, P24769, DOI 10.1074/jbc.271.40.24769	29	141	160	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					330	336		10.1038/ng1182	http://dx.doi.org/10.1038/ng1182			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12819782				2022-12-27	WOS:000183815300023
J	Reboul, J; Vaglio, P; Rual, JF; Lamesch, P; Martinez, M; Armstrong, CM; Li, SM; Jacotot, L; Bertin, N; Janky, R; Moore, T; Hudson, JR; Hartley, JL; Brasch, MA; Vandenhaute, J; Boulton, S; Endress, GA; Jenna, S; Chevet, E; Papasotiropoulos, V; Tolias, PP; Ptacek, J; Snyder, M; Huang, R; Chance, MR; Lee, HM; Doucette-Stamm, L; Hill, DE; Vidal, M				Reboul, J; Vaglio, P; Rual, JF; Lamesch, P; Martinez, M; Armstrong, CM; Li, SM; Jacotot, L; Bertin, N; Janky, R; Moore, T; Hudson, JR; Hartley, JL; Brasch, MA; Vandenhaute, J; Boulton, S; Endress, GA; Jenna, S; Chevet, E; Papasotiropoulos, V; Tolias, PP; Ptacek, J; Snyder, M; Huang, R; Chance, MR; Lee, HM; Doucette-Stamm, L; Hill, DE; Vidal, M			C-elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression	NATURE GENETICS			English	Article							GENES; IDENTIFICATION; MICROARRAYS; CLONING	To verify the genome annotation and to create a resource to functionally characterize the proteome, we attempted to Gateway-clone all predicted protein-encoding open reading frames (ORFs), or the 'ORFeome,' of Caenorhabditis elegans. We successfully cloned approximately 12,000 ORFs (ORFeome 1.1), of which roughly 4,000 correspond to genes that are untouched by any cDNA or expressed-sequence tag (EST). More than 50% of predicted genes needed corrections in their intron-exon structures. Notably, approximately 11,000 C. elegans proteins can now be expressed under many conditions and characterized using various high-throughput strategies, including large-scale interactome mapping. We suggest that similar ORFeome projects will be valuable for other organisms, including humans.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Fac Univ Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Belgium; Res Genet Invitrogen, Huntsville, AL USA; Life Technol Invitrogen, Rockville, MD USA; Protedyne Crop, Windsor, CT 06095 USA; McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; Publ Hlth Res Inst, Ctr Appl Genom, Newark, NJ 07103 USA; Yale Univ, New Haven, CT 06520 USA; Albert Einstein Coll Med, Ctr Synchrotron Biosci, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Genome Therapeut, Waltham, MA 02453 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Namur; Thermo Fisher Scientific; McGill University; Yale University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vidal, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	marc_vidal@dfci.harvard.edu	Bertin, Nicolas/O-9602-2019; Hill, David E/B-6617-2011; chevet, eric/E-4992-2016; Reboul, Jerome/P-9103-2016; Bertin, Nicolas/C-3025-2008	chevet, eric/0000-0001-5855-4522; Reboul, Jerome/0000-0002-5513-4546; Huang, Raymond/0000-0001-7661-797X; Vaglio, Philippe/0000-0003-2900-5596; Papasotiropoulos, Vasileios/0000-0002-0292-6793; Rual, Jean-Francois/0000-0003-4465-8819; Bertin, Nicolas/0000-0002-9835-9606; Janky, Rekin's/0000-0001-5135-2469				Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Gera JF, 2002, METHOD ENZYMOL, V350, P499, DOI 10.1016/S0076-6879(02)50981-2; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Harrison PM, 2001, NUCLEIC ACIDS RES, V29, P818, DOI 10.1093/nar/29.3.818; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hazbun TR, 2001, P NATL ACAD SCI USA, V98, P4277, DOI 10.1073/pnas.091096398; Hillier L, 1991, PCR Methods Appl, V1, P124; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; KINOSHITA N, 1995, CELL, V83, P621, DOI 10.1016/0092-8674(95)90102-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MacBeath G, 2000, SCIENCE, V289, P1760; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Vaglio P, 2003, NUCLEIC ACIDS RES, V31, P237, DOI 10.1093/nar/gkg092; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	30	284	314	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					35	41		10.1038/ng1140	http://dx.doi.org/10.1038/ng1140			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12679813				2022-12-27	WOS:000182667900014
J	Stewart, SA; Ben-Porath, I; Carey, VJ; O'Connor, BF; Hahn, WC; Weinberg, RA				Stewart, SA; Ben-Porath, I; Carey, VJ; O'Connor, BF; Hahn, WC; Weinberg, RA			Erosion of the telomeric single-strand overhang at replicative senescence	NATURE GENETICS			English	Article							NORMAL HUMAN-CELLS; HUMAN FIBROBLASTS; LIFE-SPAN; IN-VITRO; HUMAN-CHROMOSOMES; VIVO; END; LOOP	Cultured primary human cells inevitably enter a state of replicative senescence for which the specific molecular trigger is unknown. We show that the single-strand telomeric overhang, a key component of telomere structure, is eroded at senescence. Expression of telomerase prevents overhang loss, suggesting that this enzyme prevents senescence by maintaining proper telomere structure. In contrast, progressive overhang loss occurs in cells that avoid senescence through the inactivation of p53 and Rb, indicating that overhang erosion is the result of continuous cell division and not a consequence of senescence. We thus provide evidence for a specific molecular alteration in telomere structure at senescence and suggest that this change, rather than overall telomere length, serves to trigger this state.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Channing Lab, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Stewart, Sheila A/C-5213-2012					ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1973, AM J MED SCI, V265, P432, DOI 10.1097/00000441-197306000-00001; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; KARSEDER J, 2002, SCIENCE, V295, P2446; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Stansel RM, 2001, EMBO J, V20, P5532; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	28	256	268	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					492	496		10.1038/ng1127	http://dx.doi.org/10.1038/ng1127			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652299	Bronze			2022-12-27	WOS:000181928600020
J	Lower, KM; Turner, G; Kerr, BA; Mathews, KD; Shaw, MA; Gedeon, AK; Schelley, S; Hoyme, HE; White, SM; Delatycki, MB; Lampe, AK; Clayton-Smith, J; Stewart, H; van Ravenswaay, CMA; de Vries, BBA; Cox, B; Grompe, M; Ross, S; Thomas, P; Mulley, JC; Gecz, J				Lower, KM; Turner, G; Kerr, BA; Mathews, KD; Shaw, MA; Gedeon, AK; Schelley, S; Hoyme, HE; White, SM; Delatycki, MB; Lampe, AK; Clayton-Smith, J; Stewart, H; van Ravenswaay, CMA; de Vries, BBA; Cox, B; Grompe, M; Ross, S; Thomas, P; Mulley, JC; Gecz, J			Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome	NATURE GENETICS			English	Article							LINKED MENTAL-RETARDATION; GENE LOCALIZATION; PROTEINS; FINGER; XLMR; REV	Borjeson-Forssman-Lehmann syndrome (BFLS; OMIM 301900) is characterized by moderate to severe mental retardation, epilepsy, hypogonadism, hypometabolism, obesity with marked gynecomastia, swelling of subcutaneous tissue of the face, narrow palpebral fissure and large but not deformed ears(1). Previously, the gene associated with BFLS was localized to 17 Mb in Xq26-q27 (refs 2-4). We have reduced this interval to roughly 9 Mb containing more than 62 genes. Among these, a novel, widely expressed zinc-finger (plant homeodomain (PHD)-like finger) gene (PHF6) had eight different missense and truncation mutations in seven familial and two sporadic cases of BFLS. Transient transfection studies with PHF6 tagged with green fluorescent protein (GFP) showed diffuse nuclear staining with prominent nucleolar accumulation. Such localization, and the presence of two PHD-like zinc fingers, is suggestive of a role for PHF6 in transcription.	Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA 5001, Australia; Univ Newcastle, Waratah, NSW, Australia; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Iowa Hosp & Clin, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; Stanford Univ, Sch Med, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; Royal Childrens Hosp, Genet Hlth Serv, Melbourne, Vic, Australia; Int Ctr Life, Inst Human Genet, Dept Clin Genet, Newcastle Upon Tyne, Tyne & Wear, England; Churchill Hosp, Dept Med Genet, Oxford OX3 7LJ, England; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Adelaide, Dept Mol Biosci, Adelaide, SA, Australia	Womens & Childrens Hospital Australia; University of Adelaide; University of Newcastle; University of Manchester; University of Iowa; University of Iowa; Stanford University; Royal Children's Hospital Melbourne; Newcastle University - UK; University of Oxford; Radboud University Nijmegen; Oregon Health & Science University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Adelaide	Gecz, J (corresponding author), Womens & Childrens Hosp, Ctr Med Genet, Dept Cytogenet & Mol Genet, 72 King William Rd, Adelaide, SA 5006, Australia.		Gedeon, Agi/G-7890-2011; Delatycki, Martin B/A-5409-2013; Gecz, Jozef/X-3469-2019; Thomas, Paul Q/K-4497-2012	Gecz, Jozef/0000-0002-7884-6861; mathews, katherine/0000-0003-4160-0435; Lower, Karen/0000-0003-2196-5234; Grompe, Markus/0000-0002-6616-4345; Hoyme, Harold/0000-0002-1979-693X				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; BORJESON M, 1962, ACTA MED SCAND, V171, P13; Cabezas DA, 2000, J MED GENET, V37, P663, DOI 10.1136/jmg.37.9.663; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326; Gedeon AK, 1996, AM J MED GENET, V64, P121, DOI 10.1002/(SICI)1096-8628(19960712)64:1<121::AID-AJMG20>3.0.CO;2-O; Gedeon AK, 1996, AM J MED GENET, V64, P63, DOI 10.1002/(SICI)1096-8628(19960712)64:1<63::AID-AJMG9>3.0.CO;2-S; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GUSTAVSON KH, 1993, AM J MED GENET, V45, P654, DOI 10.1002/ajmg.1320450527; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; MATHEWS KD, 1989, AM J MED GENET, V34, P470, DOI 10.1002/ajmg.1320340403; Meetei AR, 2000, J BIOL CHEM, V275, P38500, DOI 10.1074/jbc.M002734200; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Prives C, 1999, J PATHOL, V187, P112; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; SKARE J, 1993, GENOMICS, V16, P254, DOI 10.1006/geno.1993.1169; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; TURNER G, 1989, AM J MED GENET, V34, P463, DOI 10.1002/ajmg.1320340402; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999	26	154	158	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					661	665		10.1038/ng1040	http://dx.doi.org/10.1038/ng1040			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12415272				2022-12-27	WOS:000179593000021
J	Miller, J; Horner, A; Stacy, T; Lowrey, C; Lian, JB; Stein, G; Nuckolls, GH; Speck, NA				Miller, J; Horner, A; Stacy, T; Lowrey, C; Lian, JB; Stein, G; Nuckolls, GH; Speck, NA			The core-binding factor beta subunit is required for bone formation and hematopoietic maturation	NATURE GENETICS			English	Article							FETAL LIVER HEMATOPOIESIS; RECEPTOR TYROSINE KINASES; CLEIDOCRANIAL DYSPLASIA; CBFA1-DEFICIENT MICE; ENDOTHELIAL-CELLS; DNA RECOGNITION; RUNT DOMAIN; CBF-BETA; GENE; AML1	Core-binding factor beta (Cbfbeta) is the common non-DNA-binding subunit of the Cbf family of heterodimeric transcription factors. Mice deficient in Cbfbeta have a severe block in fetal liver hematopoiesis at the stage of hematopoietic stem cell (HSC) emergence(1,2). Here we show that by providing Cbfbeta function in endothelial cells and hematopoietic progenitors we can rescue fetal liver hematopoiesis in Cbfbeta-deficient embryos. The rescued mice die at birth, however, with severe defects in skeletal development, though intramembranous ossification occurs to some extent. Fetal liver hematopoiesis is restored at embryonic day (E) 12.5, but by E17.5 significant impairments in lymphopoiesis and myelopoiesis are observed. Thus, we conclude that the Cbfbeta subunit is required for HSC emergence, bone formation and normal differentiation of lymphoid and myeloid lineage cells.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; NIAMSD, Cartilage Biol & Orthoped Branch, NIH, Bethesda, MD 20892 USA; Dartmouth Coll Sch Med, Dept Med, Hanover, NH USA; Dartmouth Coll Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA USA	Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Dartmouth College; Dartmouth College; University of Massachusetts System; University of Massachusetts Worcester	Speck, NA (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA.			Nuckolls, Glen/0000-0002-7466-6433				Castilla LH, 1999, NAT GENET, V23, P144, DOI 10.1038/13776; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LI QL, 2002, CELL, V109; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagata T, 2001, J MOL BIOL, V308, P191, DOI 10.1006/jmbi.2001.4596; North T, 1999, DEVELOPMENT, V126, P2563; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rucklidge GJ, 1996, BIOCHEM BIOPH RES CO, V224, P297, DOI 10.1006/bbrc.1996.1024; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	29	133	135	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					645	649		10.1038/ng1049	http://dx.doi.org/10.1038/ng1049			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12434155				2022-12-27	WOS:000179593000018
J	Hoffmann, K; Dreger, CK; Olins, AL; Olins, DE; Shultz, LD; Lucke, B; Karl, H; Kaps, R; Muller, D; Vaya, A; Aznar, J; Ware, RE; Cruz, NS; Lindner, TH; Herrmann, H; Reis, A; Sperling, K				Hoffmann, K; Dreger, CK; Olins, AL; Olins, DE; Shultz, LD; Lucke, B; Karl, H; Kaps, R; Muller, D; Vaya, A; Aznar, J; Ware, RE; Cruz, NS; Lindner, TH; Herrmann, H; Reis, A; Sperling, K			Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly)	NATURE GENETICS			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; ENVELOPE INNER MEMBRANE; INTEGRAL PROTEIN; PORE COMPLEXES; ROD DOMAIN; A/C; LBR; ORGANIZATION; SYSTEM; CELLS	Pelger-Huet anomaly (PHA; OMIM *169400) is an autosomal dominant disorder characterized by abnormal nuclear shape and chromatin organization in blood granulocytes. Affected individuals show hypolobulated neutrophil nuclei with coarse chromatin. Presumed homozygous individuals have ovoid neutrophil nuclei, as well as varying degrees of developmental delay, epilepsy and skeletal abnormalities(1-3). Homozygous off-spring in an extinct rabbit lineage showed severe chondrodystrophy, developmental anomalies and increased pre- and postnatal mortality(4,5). Here we show, by carrying out a genome-wide linkage scan, that PHA is linked to chromosome 1q41-43. We identified four splice-site, two frameshift and two nonsense mutations in LBR, encoding the lamin B receptor. The lamin B receptor (LBR), a member of the sterol reductase family(6), is evolutionarily conserved and integral to the inner nuclear membrane; it targets heterochromatin and lamins to the nuclear membrane(7,8). Lymphoblastoid cells from heterozygous individuals affected with PHA show reduced expression of the lamin B receptor, and cells homozygous with respect to PHA contain only trace amounts of it. We found that expression of the lamin B receptor affects neutrophil nuclear shape and chromatin distribution in a dose-dependent manner. Our findings have implications for understanding nuclear envelope-heterochromatin interactions, the pathogenesis of Pelger-like conditions in leukemia(9), infection(10) and toxic drug reactions(11), and the evolution of neutrophil nuclear shape(12).	Max Delbruck Ctr Mol Med, Gene Mapping Ctr, D-13125 Berlin, Germany; Humboldt Univ, Charite, HELIOS Klinikum, Franz Volhard Clin, Berlin, Germany; German Canc Res Ctr, D-6900 Heidelberg, Germany; Fdn Blood Res, Scarborough, ME 04074 USA; Bowdoin Coll, Brunswick, ME 04011 USA; Jackson Lab, Bar Harbor, ME 04609 USA; DRK, Inst Transfus Med, Chemnitz, Germany; Klinikum Chemnitz, Inst Med Genet, Chemnitz, Germany; La Fe Univ Hosp, Dept Clin Pathol, Valencia, Spain; Duke Univ, Dept Pediat, Med Ctr, Durham, NC 27706 USA; Hosp Infantil Estado Sonora, Hermosillo, Sonora, Mexico; Univ Wurzburg, Med Clin, Dept Nephrol, Wurzburg, Germany; Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; Humboldt Univ, Charite, Inst Human Genet, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Helmholtz Association; German Cancer Research Center (DKFZ); Foundation for Blood Research (FBR); Bowdoin College; Jackson Laboratory; Chemnitz Clinic; Duke University; University of Wurzburg; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sperling, K (corresponding author), Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Robert Rossle Str 10, D-13125 Berlin, Germany.		Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363				AZNAR J, 1981, ACTA HAEMATOL-BASEL, V66, P59, DOI 10.1159/000207095; BEGEMANN NH, 1952, ACTA HAEMATOL-BASEL, V7, P295, DOI 10.1159/000204063; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; GREEN MC, 1975, TRANSPLANTATION, V20, P172, DOI 10.1097/00007890-197508000-00014; HOGER TH, 1990, CHROMOSOMA, V99, P379, DOI 10.1007/BF01726689; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; JOHANSSON EO, 1963, THESIS UPPSALA U; Juneja SK, 1996, BRIT J HAEMATOL, V93, P139, DOI 10.1046/j.1365-2141.1996.4701020.x; KARL H, 1967, THESIS HUMBOLDT U BE; LATIMER KS, 1988, VET PATHOL, V25, P325, DOI 10.1177/030098588802500416; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; NACHTSHEIM H, 1950, J HERED, V41, P131, DOI 10.1093/oxfordjournals.jhered.a106108; Ognibene A, 1999, MUSCLE NERVE, V22, P864, DOI 10.1002/(SICI)1097-4598(199907)22:7<864::AID-MUS8>3.3.CO;2-7; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Sainty D, 2000, BLOOD, V96, P1287; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; SCHULER E, 1994, J BIOL CHEM, V269, P11312; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; SHENKENBERG TD, 1982, ARCH INTERN MED, V142, P153, DOI 10.1001/archinte.142.1.153; Siegert E, 1983, Kinderarztl Prax, V51, P164; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; SKENDZEL LP, 1962, AM J CLIN PATHOL, V37, P294; UNDRITZ E, 1939, SCHWEIZ MED WSCHR, V69, P1177; UNDRITZ E, 1943, FOLIA HAEMATOL, V67, P249; Vigouroux C, 2001, J CELL SCI, V114, P4459; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	30	249	262	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					410	414		10.1038/ng925	http://dx.doi.org/10.1038/ng925			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12118250				2022-12-27	WOS:000177147100018
J	Leveillard, T; Mohand-Said, S; Lorentz, O; Hicks, D; Fintz, AC; Clerin, E; Simonutti, M; Forster, V; Cavusoglu, N; Chalmel, F; Dolle, P; Poch, O; Lambrou, G; Sahel, JA				Leveillard, T; Mohand-Said, S; Lorentz, O; Hicks, D; Fintz, AC; Clerin, E; Simonutti, M; Forster, V; Cavusoglu, N; Chalmel, F; Dolle, P; Poch, O; Lambrou, G; Sahel, JA			Identification and characterization of rod-derived cone viability factor	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; SURVIVAL; DEGENERATION; THIOREDOXIN; MOUSE; CELLS; PHOTORECEPTORS; MUTATIONS; PROTEINS	Retinitis pigmentosa is an untreatable, inherited retinal disease that leads to blindness. The disease initiates with the loss of night vision due to rod photoreceptor degeneration, followed by irreversible, progressive loss of cone photoreceptor(1-3). Cone loss is responsible for the main visual handicap, as cones are essential for day and high-acuity vision(4). Their loss is indirect, as most genes associated with retinitis pigmentosa are not expressed by these cells. We previously showed that factors secreted from rods are essential for cone viability(5-8). Here we identified one such trophic factor by expression cloning and named it rod-derived cone viability factor (RdCVF). RdCVF is a truncated thioredoxin-like protein specifically expressed by photoreceptors. The identification of this protein offers new treatment possibilities for retinitis pigmentosa.	Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol & Retine, F-75571 Paris 12, France; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Novartis Pharma AG Ophthalmol Res WKL127 1 04, CH-4002 Basel, Switzerland; UCL, Inst Ophthalmol, London WC1E 6BT, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis; University of London; University College London	Leveillard, T (corresponding author), Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol & Retine, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	leveilla@st-antoine.inserm.fr	Léveillard, Thierry/AAR-1804-2020; Dolle, Pascal/A-8037-2010; Sahel, Jose-Alain/F-3172-2017; Chalmel, Frédéric/AAM-1079-2021; Chalmel, Frederic/M-1297-2016; Chalmel, Frédéric/L-5360-2018	Léveillard, Thierry/0000-0001-5692-8770; Dolle, Pascal/0000-0002-9294-9090; Sahel, Jose-Alain/0000-0002-4831-1153; Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Clerin, Emmanuelle/0000-0003-1451-6051; Cavusoglu, Nukhet/0000-0001-9350-5312				ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Cau E, 1997, DEVELOPMENT, V124, P1611; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dixon W. J., 1969, INTRO STAT ANAL; DOWLING JE, 1987, RETINAL CELLS PROCES; Fintz AC, 2003, INVEST OPHTH VIS SCI, V44, P818, DOI 10.1167/iovs.01-1144; Fontaine V, 1998, J NEUROSCI, V18, P9662; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	21	320	342	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					755	759		10.1038/ng1386	http://dx.doi.org/10.1038/ng1386			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220920	Green Submitted, Bronze			2022-12-27	WOS:000222354100028
J	Fraser, AG; Marcotte, EM				Fraser, AG; Marcotte, EM			A probabilistic view of gene function	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; ORIGIN RECOGNITION COMPLEX; SACCHAROMYCES-CEREVISIAE; INTERACTION NETWORKS; SMALL-WORLD; CAENORHABDITIS-ELEGANS; DNA-REPLICATION; MODULES; DATABASE; YEAST	Cells are controlled by the complex and dynamic actions of thousands of genes. With the sequencing of many genomes, the key problem has shifted from identifying genes to knowing what the genes do; we need a framework for expressing that knowledge. Even the most rigorous attempts to construct ontological frameworks describing gene function (e.g., the Gene Ontology project) ultimately rely on manual curation and are thus labor-intensive and subjective. But an alternative exists: the field of functional genomics is piecing together networks of gene interactions, and although these data are currently incomplete and error-prone, they provide a glimpse of a new, probabilistic view of gene function. We outline such a framework, which revolves around a statistical description of gene interactions derived from large, systematically compiled data sets. In this probabilistic view, pleiotropy is implicit, all data have errors and the definition of gene function is an iterative process that ultimately converges on the correct functions. The relationships between the genes are defined by the data, not by hand. Even this comprehensive view fails to capture key aspects of gene function, not least their dynamics in time and space, showing that there are limitations to the model that must ultimately be addressed.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Texas, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	Wellcome Trust Sanger Institute; University of Texas System; University of Texas Austin	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	agf@sanger.ac.uk; marcotte@icmb.utexas.edu		Marcotte, Edward/0000-0001-8808-180X; Fraser, Andrew/0000-0001-9939-6014				Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Clare A, 2002, BIOINFORMATICS, V18, P160, DOI 10.1093/bioinformatics/18.1.160; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jansen Ronald, 2002, Journal of Structural and Functional Genomics, V2, P71, DOI 10.1023/A:1020495201615; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Krause R, 2003, BIOINFORMATICS, V19, P1901, DOI 10.1093/bioinformatics/btg344; Manke T, 2003, J MOL BIOL, V333, P75, DOI 10.1016/j.jmb.2003.08.004; Marcotte E, 2001, Brief Bioinform, V2, P363, DOI 10.1093/bib/2.4.363; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Saito R, 2002, NUCLEIC ACIDS RES, V30, P1163, DOI 10.1093/nar/30.5.1163; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Snel B, 2002, P NATL ACAD SCI USA, V99, P5890, DOI 10.1073/pnas.092632599; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tjian R, 1996, PHILOS T R SOC B, V351, P491, DOI 10.1098/rstb.1996.0047; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906	58	88	91	1	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2004	36	6					559	564		10.1038/ng1370	http://dx.doi.org/10.1038/ng1370			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15167932	Bronze			2022-12-27	WOS:000221763700009
J	Hu, YG; Liu, YH; Pelletier, S; Buchdunger, E; Warmuth, M; Fabbro, D; Hallek, M; Van Etten, RA; Li, SG				Hu, YG; Liu, YH; Pelletier, S; Buchdunger, E; Warmuth, M; Fabbro, D; Hallek, M; Van Etten, RA; Li, SG			Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL ONCOGENE; TYROSINE KINASE; IMATINIB MESYLATE; BLAST CRISIS; MYELOPROLIFERATIVE DISEASE; PHILADELPHIA-CHROMOSOME; SIGNAL-TRANSDUCTION; CLINICAL RESISTANCE; STI571 RESISTANCE	The Abl kinase inhibitor imatinib mesylate is the preferred treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in chronic phase but is much less effective in CML blast crisis or Ph+ B-cell acute lymphoblastic leukemia (B-ALL). Here, we show that Bcr-Abl activated the Src kinases Lyn, Hck and Fgr in B-lymphoid cells. BCR-ABL1 retrovirus-transduced marrow from mice lacking all three Src kinases efficiently induced CML but not B-ALL in recipients. The kinase inhibitor CGP76030 impaired the proliferation of B-lymphoid cells expressing Bcr-Abl in vitro and prolonged survival of mice with B-ALL but not CML. The combination of CGP76030 and imatinib was superior to imatinib alone in this regard. The biochemical target of CGP76030 in leukemia cells was Src kinases, not Bcr-Abl. These results implicate Src family kinases as therapeutic targets in Ph+ B-ALL and suggest that simultaneous inhibition of Src and Bcr-Abl kinases may benefit individuals with Ph+ acute leukemia.	Jackson Lab, Bar Harbor, ME 04609 USA; Novartis Pharma AG, CH-4002 Basel, Switzerland; Univ Munich, Med Klin 3, Munich, Germany; Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Jackson Laboratory; Novartis; University of Munich; Tufts Medical Center; Tufts University	Li, SG (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	sli@jax.org	Hallek, Michael/Y-3191-2019	Hallek, Michael/0000-0002-7425-4455; Hu, Yiguo/0000-0002-3973-2140				Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cuenco GM, 2001, ONCOGENE, V20, P8236, DOI 10.1038/sj.onc.1205095; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; FINER MH, 1994, BLOOD, V83, P43; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; La Rosee P, 2002, CANCER RES, V62, P7149; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Million RP, 2000, BLOOD, V96, P664; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Stanglmaier M, 2003, LEUKEMIA, V17, P283, DOI 10.1038/sj.leu.2402778; TAUCHI T, 1994, J BIOL CHEM, V269, P15381; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wolff NC, 2001, BLOOD, V98, P2808, DOI 10.1182/blood.V98.9.2808; Yang WT, 1998, EXP HEMATOL, V26, P1126	40	324	340	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					453	461		10.1038/ng1343	http://dx.doi.org/10.1038/ng1343			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15098032	Green Published, Bronze			2022-12-27	WOS:000221183000016
J	Biesecker, LG				Biesecker, LG			Phenotype matters	NATURE GENETICS			English	Editorial Material								The association of diseases with genes is complex, even among mendelian disorders. A new study shows that mutations in the gene encoding filamin B (FLNB) cause four distinct disorders of human skeletal development.	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Biesecker, LG (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200328] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Jones K. L., 1997, SMITHS RECOGNIZABLE; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robin NH, 2001, GENET MED, V3, P290, DOI 10.1097/00125817-200107000-00004; Spranger J, 2002, BONE DYSPLASIAS ATLA, V2nd; Taybi H, 1996, RADIOLOGY SYNDROMES	6	16	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					323	324		10.1038/ng0404-323	http://dx.doi.org/10.1038/ng0404-323			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15054484	Bronze			2022-12-27	WOS:000220647200006
J	Moreira, MC; Klur, S; Watanabe, M; Nemeth, AH; Le Ber, I; Moniz, JC; Tranchant, C; Aubourg, P; Tazir, M; Schols, L; Pandolfo, M; Schulz, JB; Pouget, J; Calvas, P; Shizuka-Ikeda, M; Shoji, M; Tanaka, M; Izatt, L; Shaw, CE; M'Zahem, A; Dunne, E; Bomont, P; Benhassine, T; Bouslam, N; Stevanin, G; Brice, A; Guimaraes, J; Mendonca, P; Barbot, C; Coutinho, P; Sequeiros, J; Durr, A; Warter, JM; Koenig, M				Moreira, MC; Klur, S; Watanabe, M; Nemeth, AH; Le Ber, I; Moniz, JC; Tranchant, C; Aubourg, P; Tazir, M; Schols, L; Pandolfo, M; Schulz, JB; Pouget, J; Calvas, P; Shizuka-Ikeda, M; Shoji, M; Tanaka, M; Izatt, L; Shaw, CE; M'Zahem, A; Dunne, E; Bomont, P; Benhassine, T; Bouslam, N; Stevanin, G; Brice, A; Guimaraes, J; Mendonca, P; Barbot, C; Coutinho, P; Sequeiros, J; Durr, A; Warter, JM; Koenig, M			Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; PERIPHERAL NEUROPATHY; CEREBELLAR ATROPHY; GENE; DNA; ENCODES; SEN1	Ataxia-ocular apraxia 2 (AOA2) was recently identified as a new autosomal recessive ataxia. We have now identified causative mutations in 15 families, which allows us to clinically define this entity by onset between 10 and 22 years, cerebellar atrophy, axonal sensorimotor neuropathy, oculomotor apraxia and elevated alpha-fetoprotein (AFP). Ten of the fifteen mutations cause premature termination of a large DEAxQ-box helicase, the human ortholog of yeast Sen1p, involved in RNA maturation and termination.	ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; Gunma Univ, Sch Med, Maebashi, Gumma 3718511, Japan; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Hop La Pitie Salpetriere, APHP, INSERM, U289, F-75651 Paris, France; Hop La Pitie Salpetriere, APHP, Dept Genet Cytogenet & Embryol, F-75651 Paris, France; Hosp Sto Antonio dos Capuchos, Lisbon, Portugal; Hop Univ Strasbourg, F-67091 Strasbourg, France; Hop St Vincent de Paul, INSERM, U342, F-75675 Paris, France; Ctr Hosp Univ Algier, Algiers, Algeria; Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium; Univ Tubingen, Ctr Neurol, Dept Gen Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; Hop Timone Adults, F-13385 Marseille, France; Hop Purpan, F-31059 Toulouse, France; Guys Hosp, Dept Clin Genet, London SE1 9RT, England; Univ London Kings Coll, Inst Psychiat, London SE5 8AF, England; Guys Kings & St Thomas Sch Med, London SE5 8AF, England; Ctr Hosp Univ Ben Badis, Constantine, Algeria; Inst Pasteur Alger, Algiers, Algeria; Hosp Egas Moniz, Lisbon, Portugal; Hosp Divino Espirito Santo, Dept Hematol, Azores, Portugal; Univ Porto, UnIGENe, IBMC, ICBAS, P-4150180 Oporto, Portugal; Hosp Maria Pia, Dept Neuropediat, P-4050 Oporto, Portugal; Hosp Sao Sebastiao, Dept Neurol, P-4520 Sta Maria Da Feira, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Gunma University; University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruhr University Bochum; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Toulouse; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Egas Moniz Hospital; Universidade do Porto	Koenig, M (corresponding author), ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	mkoenig@igbmc.u-strasbg.fr	brice, alexis/AAE-8275-2019; Barbot, Clara/K-6378-2013; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; Bomont, Pascale/GLS-8721-2022; Bomont, Pascale L/Y-5517-2018; Coutinho, Paula/K-6053-2013; Dunne, Eimear/C-6785-2012; Dunne, Eimear/AGX-1949-2022; Schöls, Ludger/ABB-2482-2021; Lima, Marta T/C-7042-2009; Pandolfo, Massimo/B-2853-2010; Schulz, Jörg B/D-9786-2012	brice, alexis/0000-0002-0941-3990; Barbot, Clara/0000-0002-5597-107X; Stevanin, Giovanni/0000-0001-9368-8657; Bomont, Pascale/0000-0001-7216-3261; Bomont, Pascale L/0000-0001-7216-3261; Dunne, Eimear/0000-0001-9862-1398; Dunne, Eimear/0000-0001-9862-1398; Schöls, Ludger/0000-0001-7774-5025; Schulz, Jörg B/0000-0002-8903-0593; Franco Mendonca, Pedro/0000-0002-3850-2909; Shoji, Mikio/0000-0003-1027-1712; Nemeth, Andrea/0000-0002-2941-7657; tranchant, christine/0000-0002-2895-1292; Sequeiros, Jorge/0000-0002-9846-1037; Coutinho, Paula/0000-0002-3461-230X				Bomont P, 2000, EUR J HUM GENET, V8, P986, DOI 10.1038/sj.ejhg.5200586; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Nemeth AH, 2000, AM J HUM GENET, V67, P1320, DOI 10.1016/S0002-9297(07)62962-0; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Watanabe M, 1998, ANN NEUROL, V44, P265, DOI 10.1002/ana.410440220	15	343	355	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					225	227		10.1038/ng1303	http://dx.doi.org/10.1038/ng1303			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14770181	Green Published, Bronze			2022-12-27	WOS:000189250400008
J	Liu, XQ; Zhao, Y; Gao, JG; Pawlyk, B; Starcher, B; Spencer, JA; Yanagisawa, H; Zuo, J; Li, TS				Liu, XQ; Zhao, Y; Gao, JG; Pawlyk, B; Starcher, B; Spencer, JA; Yanagisawa, H; Zuo, J; Li, TS			Elastic fiber homeostasis requires lysyl oxidase-like 1 protein	NATURE GENETICS			English	Article							BINDING PROTEIN; AORTIC-ANEURYSMS; PELVIC FLOOR; MICE; EMPHYSEMA; TROPOELASTIN; CELL	Elastic fibers are components of the extracellular matrix and confer resilience(1). Once laid down, they are thought to remain stable(2), except in the uterine tract where cycles of active remodeling occur(3). Loss of elastic fibers underlies connective tissue aging and important diseases including emphysema(4-7). Failure to maintain elastic fibers is explained by a theory of antielastase-elastase imbalance(8), but little is known about the role of renewal. Here we show that mice lacking the protein lysyl oxidase like 1 (LOXL1) do not deposit normal elastic fibers in the uterine tract post partum and develop pelvic organ prolapse, enlarged airspaces of the lung, loose skin and vascular abnormalities with concomitant tropoelastin accumulation. Distinct from the prototypic lysyl oxidase (LOX), LOXL1 localizes specifically to sites of elastogenesis and interacts with fibulin-5. Thus elastin polymer deposition is a crucial aspect of elastic fiber maintenance and is dependent on LOXL1, which serves both as a cross-linking enzyme and an element of the scaffold to ensure spatially defined deposition of elastin.	Harvard Univ, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Texas Hlth Ctr, Dept Biochem, Tyler, TX 75708 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; St Jude Children's Research Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Li, TS (corresponding author), Harvard Univ, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA.	tli@meei.harvard.edu	Yanagisawa, Hiromi/Y-2843-2019	Yanagisawa, Hiromi/0000-0002-7576-9186				BLUMENKRANZ MS, 1986, OPHTHALMOLOGY, V93, P552; Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200; Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835; DAVIS EC, 1993, HISTOCHEMISTRY, V100, P17, DOI 10.1007/BF00268874; Hasham SN, 2002, CURR OPIN CARDIOL, V17, P677, DOI 10.1097/00001573-200211000-00015; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1986, J CELL BIOL, V103, P1121, DOI 10.1083/jcb.103.3.1121; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kielty CM, 2002, J CELL SCI, V115, P2817; Koduri S, 2000, CURR OPIN OBSTET GYN, V12, P399, DOI 10.1097/00001703-200010000-00009; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Nakamoto T, 2002, PLANT PROD SCI, V5, P175, DOI 10.1626/pps.5.175; PasqualiRonchetti I, 1997, MICROSC RES TECHNIQ, V38, P428, DOI 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; SNOOKS SJ, 1990, BRIT J SURG, V77, P1358, DOI 10.1002/bjs.1800771213; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; STARCHER B, 1985, CONNECT TISSUE RES, V13, P207, DOI 10.3109/03008208509152400; Sultan AH, 1996, BRIT J HOSP MED, V55, P575; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Yamamoto M, 2002, CELL BIOL INT, V26, P441, DOI 10.1006/cbir.2002.0877; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a	30	501	539	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					178	182		10.1038/ng1297	http://dx.doi.org/10.1038/ng1297			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14745449	Bronze			2022-12-27	WOS:000188542700021
J	Aoki, K; Tamai, Y; Horiike, S; Oshima, M; Taketo, MM				Aoki, K; Tamai, Y; Horiike, S; Oshima, M; Taketo, MM			Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc(+/Delta 716) Cdx(2+/-) compound mutant mice	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; GENOMIC INSTABILITY; COLORECTAL ADENOMA; CDX2 EXPRESSION; KNOCKOUT MICE; MOUSE EMBRYO; CELL-LINES; CYCLIN D1; APC; PROTEIN	The mammalian homeobox transcription factor CDX2 has key roles in intestinal development and differentiation. Heterozygous Cdx2 mice develop one or two benign hamartomas in the proximal colon, whereas heterozygous Apc(Delta716) mice develop numerous adenomatous polyps, mostly in the small intestine. Here we show that the colonic polyp number is about six times higher in Apc(+/Delta716) Cdx2(+/-) compound mutant mice. Levels of both APC and CDX2 were significantly lower in the distal colon, which caused high anaphase bridge index (ABI) associated with a higher frequency of loss of heterozygosity (LOH) at Apc. In cultured rat intestinal epithelial and human colon cancer cell lines, suppression of CDX2 by antisense RNA caused marked increases in ABI and chromosomal aberrations. This was mediated by stimulation of the mTOR pathway, causing translational deregulation and G(1)-S acceleration, associated with low levels of p27 and activation of cyclin E-Cdk2. We obtained similar results in the colonic mucosa of Apc(+/Delta716) Cdx2(+/-) compound mutant mice. Forced activation of mTOR through upstream regulator Akt also increased ABI in colon cancer cells. High ABI in all cell lines was suppressed by mTOR inhibitors LY294002 and rapamycin. These results suggest that reduced expression of CDX2 is important in colon tumorigenesis through mTOR-mediated chromosomal instability.	Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; Banyu Tsukuba Res Inst Merck, Ibaraki 3002611, Japan; Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 6028566, Japan	Kyoto University; Merck & Company; Kyoto Prefectural University of Medicine	Taketo, MM (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.		Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004				BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; CHEN TR, 1995, CANCER GENET CYTOGEN, V81, P103, DOI 10.1016/0165-4608(94)00225-Z; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; EE HC, 1995, AM J PATHOL, V147, P586; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Goel A, 2003, CANCER RES, V63, P1608; GRODEN J, 1995, CANCER RES, V55, P1531; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Homfray TFR, 1998, HUM MUTAT, V11, P114, DOI 10.1002/(SICI)1098-1004(1998)11:2<114::AID-HUMU3>3.0.CO;2-J; Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Lorentz O, 1997, J CELL BIOL, V139, P1553, DOI 10.1083/jcb.139.6.1553; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mallo GV, 1997, INT J CANCER, V74, P35, DOI 10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1; McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Seno H, 2002, INT J ONCOL, V21, P769; Shih IM, 2001, CANCER RES, V61, P818; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P16910, DOI 10.1073/pnas.012679099; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tamai Y, 1999, CANCER RES, V59, P2965; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tischfield JA, 2003, NAT GENET, V33, P5, DOI 10.1038/ng0103-5; Traber PG, 1996, ANNU REV PHYSIOL, V58, P275, DOI 10.1146/annurev.physiol.58.1.275; Willenbucher RF, 1999, AM J PATHOL, V154, P1825, DOI 10.1016/S0002-9440(10)65438-7; Zhou P, 1996, CANCER RES, V56, P36	48	191	197	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					323	330		10.1038/ng1265	http://dx.doi.org/10.1038/ng1265			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14625550	Green Submitted			2022-12-27	WOS:000186791000013
J	Scortegagna, M; Ding, K; Oktay, Y; Gaur, A; Thurmond, F; Yan, LJ; Marck, BT; Matsumoto, AM; Shelton, JM; Richardson, JA; Bennett, MJ; Garcia, JA				Scortegagna, M; Ding, K; Oktay, Y; Gaur, A; Thurmond, F; Yan, LJ; Marck, BT; Matsumoto, AM; Shelton, JM; Richardson, JA; Bennett, MJ; Garcia, JA			Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1(-/-) mice	NATURE GENETICS			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; HYPOXIA-INDUCIBLE FACTOR-1; SYSTEMIC CARNITINE DEFICIENCY; LUNG EPITHELIAL-CELLS; GENE-EXPRESSION; OXIDATIVE STRESS; MITOCHONDRIAL ABNORMALITIES; DILATED CARDIOMYOPATHY; ENDOTHELIAL-CELLS; KNOCKOUT MICE	Hypoxia-inducible factor (HIF) transcription factors respond to multiple environmental stressors, including hypoxia and hypoglycemia. We report that mice lacking the HIF family member HIF-2alpha (encoded by Epas1) have a syndrome of multiple-organ pathology, biochemical abnormalities and altered gene expression patterns. Histological and ultrastructural analyses showed retinopathy, hepatic steatosis, cardiac hypertrophy, skeletal myopathy, hypocellular bone marrow, azoospermia and mitochondrial abnormalities in these mice. Serum and urine metabolite studies showed hypoglycemia, lactic acidosis, altered Krebs cycle function and dysregulated fatty acid oxidation. Biochemical assays showed enhanced generation of reactive oxygen species (ROS), whereas molecular analyses indicated reduced expression of genes encoding the primary antioxidant enzymes (AOEs). Transfection analyses showed that HIF-2alpha could efficiently transactivate the promoters of the primary AOEs. Prenatal or postnatal treatment of Epas1(-/-) mice with a superoxide dismutase (SOD) mimetic reversed several aspects of the null phenotype. We propose a rheostat role for HIF-2alpha that allows for the maintenance of ROS as well as mitochondrial homeostasis.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Washington, Sch Med, Dept Med,VA Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA 98108 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Childrens Med Ctr, Dept Pathol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garcia, JA (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Oktay, Yavuz/G-4794-2015; Matsumoto, Alvin/AAH-6096-2020	Oktay, Yavuz/0000-0002-0158-2693; Garcia, Joseph/0000-0002-5621-7538; Yan, Liang-Jun/0000-0002-5815-5430; , Kan/0000-0003-3485-8200	NHLBI NIH HHS [K08 HL067154] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067154] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boveris A, 2002, METHOD ENZYMOL, V349, P280, DOI 10.1016/S0076-6879(02)49342-1; Brodsky SV, 2002, AM J PHYSIOL-HEART C, V283, pH2130, DOI 10.1152/ajpheart.00196.2002; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Chang SH, 2003, BIOCHEM J, V371, P877, DOI 10.1042/BJ20021731; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Ghoshal K, 1999, BIOCHEM BIOPH RES CO, V264, P735, DOI 10.1006/bbrc.1999.1563; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Guyton KZ, 1996, FREE RADICAL BIO MED, V20, P735, DOI 10.1016/0891-5849(95)02151-5; HORIUCHI M, 1994, BBA-MOL BASIS DIS, V1226, P25, DOI 10.1016/0925-4439(94)90054-X; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; ISCHIROPOULOS H, 1995, J NEUROCHEM, V65, P2366; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jackson RM, 1998, FREE RADICAL BIO MED, V25, P463, DOI 10.1016/S0891-5849(98)00101-4; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kaido M, 1997, EUR NEUROL, V38, P302, DOI 10.1159/000113399; Kamiya H, 2001, BASIC RES CARDIOL, V96, P431, DOI 10.1007/s003950170024; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kuhn DM, 1999, J NEUROSCI, V19, P10289; Lai CT, 1997, BIOCHEM PHARMACOL, V53, P363, DOI 10.1016/S0006-2952(96)00731-9; Lando D, 2000, J BIOL CHEM, V275, P4618, DOI 10.1074/jbc.275.7.4618; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; MIYAGAWA J, 1995, VIRCHOWS ARCH, V426, P271; MohazzabH KM, 1997, CIRCULATION, V96, P614; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Phelan SA, 1998, GENOMICS, V54, P132, DOI 10.1006/geno.1998.5568; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; Rogers RJ, 2001, J BIOL CHEM, V276, P20419, DOI 10.1074/jbc.M008915200; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SCHISLER NJ, 1985, BIOCHEM GENET, V23, P291, DOI 10.1007/BF00504326; SCHISLER NJ, 1991, BIOCHEM GENET, V29, P65, DOI 10.1007/BF00578241; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; St Clair DK, 2002, METHOD ENZYMOL, V349, P306, DOI 10.1016/S0076-6879(02)49345-7; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WARNER BB, 1996, AM J PHYSIOL, V271, P150; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360	50	372	378	0	33	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					331	340		10.1038/ng1266	http://dx.doi.org/10.1038/ng1266			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608355				2022-12-27	WOS:000186791000014
J	Floyd, JA; Gold, DA; Concepcion, D; Poon, TH; Wang, XB; Keithley, E; Chen, D; Ward, EJ; Chinn, SB; Friedman, RA; Yu, HT; Moriwaki, K; Shiroishi, T; Hamilton, BA				Floyd, JA; Gold, DA; Concepcion, D; Poon, TH; Wang, XB; Keithley, E; Chen, D; Ward, EJ; Chinn, SB; Friedman, RA; Yu, HT; Moriwaki, K; Shiroishi, T; Hamilton, BA			A natural allele of Nxf1 suppresses retrovirus insertional mutations	NATURE GENETICS			English	Article							MESSENGER-RNA EXPORT; NUCLEAR EXPORT; BINDING DOMAIN; HAIRLESS GENE; MOUSE MODEL; MICE; EXPRESSION; COMPLEX; GENOME; AXIN	Endogenous retroviruses have shaped the evolution of mammalian genomes. Host genes that control the effects of retrovirus insertions are therefore of great interest. The modifier-of-vibrator-1 locus (Mvb1) controls levels of correctly processed mRNA from genes mutated by endogenous retrovirus insertions into introns, including the Pitpn(vb) tremor mutation and the Eya1(BOR) model of human branchiootorenal syndrome. Positional complementation cloning identifies Mvb1 as the nuclear export factor Nxf1, providing an unexpected link between the mRNA export receptor and pre-mRNA processing. Population structure of the suppressive allele in wild Mus musculus castaneus suggests selective advantage. A congenic Mvb1(CAST) allele is a useful tool for modifying gene expression from existing mutations and could be used to manipulate engineered mutations containing retroviral elements.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Otolaryngol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Mol Pathol Grad Program, La Jolla, CA 92093 USA; House Ear Res Inst, Los Angeles, CA 90057 USA; Natl Taiwan Univ, Dept Zool, Taipei 107, Taiwan; RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan; Natl Inst Genet, Mammalian Genet Lab, Mishima, Shizuoka 4118540, Japan; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Rebecca & John Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; House Research Institute; National Taiwan University; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of California System; University of California San Diego; University of California System; University of California San Diego	Hamilton, BA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Chinn, Steven/0000-0003-4282-0640; Hamilton, Bruce/0000-0001-5599-9139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004796] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004796-05, R01 DC004796] Funding Source: Medline; NIGMS NIH HHS [T32 GM008666, R01 GM086912] Funding Source: Medline; NIMH NIH HHS [R01 MH059207-04, R01 MH059207-06, R01 MH059207-01, R01 MH059207-02, R01 MH059207-05, R01 MH059207, R01 MH059207-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Boeke J. D., 1997, P343; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2; Grant RP, 2002, NAT STRUCT BIOL, V9, P247, DOI 10.1038/nsb773; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hamilton BA, 2001, CELL, V107, P13, DOI 10.1016/S0092-8674(01)00514-1; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Johnson KR, 1999, HUM MOL GENET, V8, P645, DOI 10.1093/hmg/8.4.645; Lindtner S, 2002, RNA, V8, P345, DOI 10.1017/S1355838202027759; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tabernero C, 1997, J VIROL, V71, P95, DOI 10.1128/JVI.71.1.95-101.1997; Vasicek TJ, 1997, GENETICS, V147, P777; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEIMAR WR, 1982, BRAIN RES, V251, P357, DOI 10.1016/0006-8993(82)90754-5; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	33	30	31	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					221	228		10.1038/ng1247	http://dx.doi.org/10.1038/ng1247			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14517553	Green Accepted, Green Published			2022-12-27	WOS:000186273300017
J	Martienssen, RA				Martienssen, RA			Maintenance of heterochromatin by RNA interference of tandem repeats	NATURE GENETICS			English	Article							FISSION YEAST; CENTROMERE; DOMAIN	Tandem repeats are prone to epigenetic silencing regulated by RNA interference. This may be because siRNAs from tandem array transcripts are regenerated by RNA-dependent RNA polymerase (RdRP) and Dicer, but siRNAs from single-copy sequences are exhausted by sequential use of downstream primers by RdRP. This could account for the formation of heterochromatin from tandem repeats.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.							Ayoub N, 2000, GENETICS, V156, P983; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pontecorvo G, 1944, NATURE, V153, P365, DOI 10.1038/153365a0; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Selker EU, 2002, ADV GENET, V46, P439; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0	18	151	168	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					213	214		10.1038/ng1252	http://dx.doi.org/10.1038/ng1252			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14593407				2022-12-27	WOS:000186273300013
J	O'Driscoll, M; Ruiz-Perez, VL; Woods, CG; Jeggo, PA; Goodship, JA				O'Driscoll, M; Ruiz-Perez, VL; Woods, CG; Jeggo, PA; Goodship, JA			A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome	NATURE GENETICS			English	Article							DNA-DAMAGE; CELLULAR RADIOSENSITIVITY; HISTONE H2AX; CHECKPOINT; GENE; FIBROBLASTS; SEQUENCE	Seckel syndrome (OMIM 210600) is an autosomal recessive disorder characterized by intrauterine growth retardation, dwarfism, microcephaly and mental retardation. Clinically, Seckel syndrome shares features in common with disorders involving impaired DNA-damage responses, such as Nijmegen breakage syndrome (OMIM 251260) and LIG4 syndrome (OMIM 606593). We previously mapped a locus associated with Seckel syndrome to chromosome 3q22.1-q24 in two consanguineous Pakistani families(1). Further marker analysis in the families, including a recently born unaffected child with a recombination in the critical region, narrowed the region to an interval of 5 Mbp between markers D3S1316 and D3S1S57 (145.29 Mbp and 150.37 Mbp). The gene encoding ataxia-telangiectasia and Rad3-related protein (ATR) maps to this region(2,3). A fibroblast cell line derived from an affected individual displays a defective DNA damage response caused by impaired ATR function. We identified a synonymous mutation in affected individuals that alters ATR splicing. The mutation confers a phenotype including marked microcephaly (head circumference 12 s.d. below the mean) and dwarfism (5 s.d. below the mean). Our analysis shows that UV-induced ATR activation can occur in non-replicating cells following processing by nucleotide excision repair.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Sussex; Saint James's University Hospital; University of Leeds; Newcastle University - UK	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk	Ruiz-Perez, Victor L/K-6066-2014; woods, christopher g/A-1361-2010	Ruiz-Perez, Victor L/0000-0003-0635-3619; O'Driscoll, Mark/0000-0003-2765-316X				ARLETT CF, 1988, INT J RADIAT BIOL, V54, P911, DOI 10.1080/09553008814552321; ARLETT CF, 1992, MUTAT RES, V273, P127, DOI 10.1016/0921-8777(92)90074-D; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brown EJ, 2000, GENE DEV, V14, P397; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Goodship J, 2000, AM J HUM GENET, V67, P498, DOI 10.1086/303023; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Marcou Y, 2001, RADIOTHER ONCOL, V60, P75, DOI 10.1016/S0167-8140(01)00370-X; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	20	590	601	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					497	501		10.1038/ng1129	http://dx.doi.org/10.1038/ng1129			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12640452	Bronze			2022-12-27	WOS:000181928600021
J	Haigis, KM; Dove, WF				Haigis, KM; Dove, WF			A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity	NATURE GENETICS			English	Article							WILD HOUSE MICE; MITOTIC RECOMBINATION; INTESTINAL NEOPLASIA; HOMOLOGOUS RECOMBINATION; MOUSE; ADENOMAS; CHROMOSOMES; CANCER; PREDISPOSITION; MULTIPLICITY	In mammals, loss of APC/Apc gatekeeper function initiates intestinal tumorigenesis. Several different mechanisms have been shown or proposed to mediate functional loss of APC/Apc: mutation in APC/Apc, non-disjunction, homologous somatic recombination and epigenetic silencing. The demonstration that, in the C57BL/6 (B6) Apc(Min/+) mouse model of inherited intestinal cancer, loss of Apc function can occur by loss of heterozygosity (LOH) through somatic recombination between homologs presents an opportunity to search for polymorphisms in the homologous somatic recombination pathway. We report that the Robertsonian translocation Rb(7.18)9Lub (Rb9) suppresses the multiplicity of intestinal adenomas in this mouse model. As the copy number of Rb9 increases, the association with the interphase nucleolus of the rDNA repeats centromeric to the Apc locus on Chromosome 18 is increasingly disrupted. Our analysis shows that homologous somatic recombination is the principal pathway for LOH in adenomas in B6 Apc(Min/+) mice. These studies provide additional evidence that neoplastic growth can initiate in the complete absence of canonical genomic instability.	Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Dove, WF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.							BRASCH JM, 1979, CYTOGENET CELL GENET, V24, P122, DOI 10.1159/000131365; Bridger JM, 1998, J CELL SCI, V111, P1241; Cormier RT, 2000, CANCER RES, V60, P3965; DAVISSON MT, 1987, CYTOGENET CELL GENET, V45, P70, DOI 10.1159/000132432; DAVISSON MT, 1993, GENETICS, V133, P649; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; EPPIG JT, 1988, J HERED, V79, P425, DOI 10.1093/oxfordjournals.jhered.a110545; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Frydman N, 2001, HUM REPROD, V16, P2274, DOI 10.1093/humrep/16.11.2274; GARCIABELLIDO A, 1978, MOL GEN GENET, V161, P317, DOI 10.1007/BF00331007; Gould KA, 1996, GENETICS, V144, P1769; GROPP A, 1982, CYTOGENET CELL GENET, V34, P67, DOI 10.1159/000131794; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; Harbour JW, 2001, ARCH OPHTHALMOL-CHIC, V119, P1699; Jacoby RF, 1997, GASTROENTEROLOGY, V112, P1398, DOI 10.1016/S0016-5085(97)70156-2; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LANE PW, 1985, J HERED, V76, P476, DOI 10.1093/oxfordjournals.jhered.a110152; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; LUONGO C, 1994, CANCER RES, V54, P5947; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; MERRIAM JR, 1972, MOL GEN GENET, V115, P294, DOI 10.1007/BF00333168; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Morrison C, 1997, NAT GENET, V17, P479, DOI 10.1038/ng1297-479; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Robertson WRB, 1916, J MORPHOL, V27, P179, DOI 10.1002/jmor.1050270202; Rothstein R, 2000, GENE DEV, V14, P1; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shao CS, 2000, P NATL ACAD SCI USA, V97, P7405, DOI 10.1073/pnas.97.13.7405; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Shoemaker AR, 1998, P NATL ACAD SCI USA, V95, P10826, DOI 10.1073/pnas.95.18.10826; Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8; SILVER LM, 1981, NATURE, V290, P68, DOI 10.1038/290068a0; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tucker M, 2000, J NATL CANCER I, V92, P530, DOI 10.1093/jnci/92.7.530; Turker MS, 1999, CANCER RES, V59, P4781; WALLACE BMN, 1992, CYTOGENET CELL GENET, V61, P211, DOI 10.1159/000133410	43	73	75	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					33	39		10.1038/ng1055	http://dx.doi.org/10.1038/ng1055			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12447373				2022-12-27	WOS:000180136100014
J	Kashkush, K; Feldman, M; Levy, AA				Kashkush, K; Feldman, M; Levy, AA			Transcriptional activation of retrotransposons alters the expression of adjacent genes in wheat	NATURE GENETICS			English	Article							LONG-TERMINAL REPEATS; TRANSPOSABLE ELEMENTS; ANTISENSE PROMOTER; L1 RETROTRANSPOSON; GENOME EVOLUTION; MAIZE GENOME; WIS 2-1A; ALLOPOLYPLOIDY; METHYLATION; SEQUENCE	Retrotransposons are a principal component of most eukaryotic genomes, representing roughly 40% of the human genome 1 and 50-80% of some grass genomes(2). They are usually transcriptionally silent but can be activated under certain stresses. Despite their considerable contribution to genome structure, their impact on the expression of adjacent genes is not well understood. The steady-state transcript levels originating from Wis 2-1A retrotransposons are much higher in newly synthesized wheat amphiploids (two or more diverged genomes in the same nucleus). On activation, both Wis 2-1A long terminal repeats drive the readout synthesis of new transcripts from adjacent sequences including the antisense or sense strands of known genes. Here we report that activation of these antisense or sense transcripts is associated with silencing or activation of the corresponding genes, respectively. These data, together with the abundance of retrotransposons in genomes and their ability to be activated by various signals, support the view of transposons as potential controlling elements.	Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Levy, AA (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	avi.levy@weizmann.ac.il	KASHKUSH, KHALIL/ABT-5599-2022	KASHKUSH, KHALIL/0000-0001-7861-4959				De Keukeleire P, 2001, MOL GENET GENOMICS, V265, P72, DOI 10.1007/s004380000390; FEDOROFF NV, 1989, CELL, V56, P181, DOI 10.1016/0092-8674(89)90891-X; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fu HH, 2001, P NATL ACAD SCI USA, V98, P8903, DOI 10.1073/pnas.141221898; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Kashkush K, 2002, GENETICS, V160, P1651; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUCAS H, 1992, MOL BIOL EVOL, V9, P716; MARTIENSSEN R, 1990, GENE DEV, V4, P331, DOI 10.1101/gad.4.3.331; MASSON P, 1987, GENETICS, V117, P117; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Muniz LM, 2001, GENOME, V44, P979, DOI 10.1139/gen-44-6-979; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; POUTEAU S, 1991, EMBO J, V10, P1911, DOI 10.1002/j.1460-2075.1991.tb07717.x; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; SanMiguel PJ, 2002, FUNCT INTEGR GENOMIC, V2, P70, DOI 10.1007/s10142-002-0056-4; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Vicient CM, 2001, PLANT PHYSIOL, V125, P1283, DOI 10.1104/pp.125.3.1283; Vinogradova T, 2002, MOL GENET GENOMICS, V266, P796, DOI 10.1007/s00438-001-0596-7; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wicker T, 2001, PLANT J, V26, P307, DOI 10.1046/j.1365-313X.2001.01028.x	26	522	574	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					102	106		10.1038/ng1063	http://dx.doi.org/10.1038/ng1063			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12483211				2022-12-27	WOS:000180136100026
J	Bereshchenko, OR; Gu, W; Dalla-Favera, R				Bereshchenko, OR; Gu, W; Dalla-Favera, R			Acetylation inactivates the transcriptional repressor BCL6	NATURE GENETICS			English	Article							CENTER B-CELLS; GERMINAL-CENTER FORMATION; FINGER ENCODING GENE; SOMATIC HYPERMUTATION; HISTONE DEACETYLASES; POZ DOMAIN; P53; LYMPHOMA; PROTEIN; DIFFERENTIATION	The proto-oncogene BCL6 encodes a BTB/POZ-zinc finger transcriptional repressor that is necessary for germinal-center formation and has been implicated in the pathogenesis of B-cell lymphomas. Here we show that the coactivator p300 binds and acetylates BCL6 in vivo and inhibits its function. Acetylation disrupts the ability of BCL6 to recruit histone deacetylases (HDACs), thereby hindering its capacity to repress transcription and to induce cell transformation. BCL6 is acetylated under physiologic conditions in normal germinal-center B cells and in germinal center-derived B-cell tumors. Treatment with specific inhibitors shows that levels of acetylation of BCL6 are controlled by both HDAC-dependent and SIR2-dependent pathways. Pharmacological inhibition of these pathways leads to the accumulation of the inactive acetylated BCL6 and to cell-cycle arrest and apoptosis in B-cell lymphoma cells. These results identify a new mechanism of regulation of the proto-oncogene BCL6 with potential for therapeutic exploitation. Furthermore, these findings provide a new mechanism by which acetylation can promote transcription not only by modifying histones and activating transcriptional activators, but also by inhibiting transcriptional repressors.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.			Bereshchenko, Oxana/0000-0002-2772-6042				Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Artiga MJ, 2002, AM J PATHOL, V160, P1371, DOI 10.1016/S0002-9440(10)62564-3; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chan HM, 2001, J CELL SCI, V114, P2363; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Moller MB, 1999, CLIN CANCER RES, V5, P1085; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	50	328	342	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					606	613		10.1038/ng1018	http://dx.doi.org/10.1038/ng1018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12402037				2022-12-27	WOS:000179593000012
J	Churchill, GA				Churchill, GA			Fundamentals of experimental design for cDNA microarrays	NATURE GENETICS			English	Review							GENE-EXPRESSION; VARIANCE; SEX	Microarray technology is now widely available and is being applied to address increasingly complex scientific questions. Consequently, there is a greater demand for statistical assessment of the conclusions drawn from microarray experiments. This review discusses fundamental issues of how to design an experiment to ensure that the resulting data are amenable to statistical analysis. The discussion focuses on two-color spotted cDNA microarrays, but many of the same issues apply to single-color gene-expression assays as well.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Churchill, GA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284				Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Callow MJ, 2000, GENOME RES, V10, P2022, DOI 10.1101/gr.10.12.2022; Churchill GA, 2001, NAT GENET, V29, P355, DOI 10.1038/ng1201-355; COX DR, 1958, DESIGN EXPT; Fisher R.A., 1951, DESIGN EXPT, V6; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Kerr MK, 2002, STAT SINICA, V12, P203; Kerr MK, 2001, GENET RES, V77, P123; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rosenbaum PR, 2001, AM STAT, V55, P223, DOI 10.1198/000313001317098220; Simon R, 2002, GENET EPIDEMIOL, V23, P21, DOI 10.1002/gepi.202; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; TANNER JM, 1949, J APPL PHYSIOL, V2, P1; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	22	741	792	2	53	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			490	495		10.1038/ng1031	http://dx.doi.org/10.1038/ng1031			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454643				2022-12-27	WOS:000179742900008
J	Kielman, MF; Rindapaa, M; Gaspar, C; van Poppel, N; Breukel, C; van Leeuwen, S; Taketo, MM; Roberts, S; Smits, R; Fodde, R				Kielman, MF; Rindapaa, M; Gaspar, C; van Poppel, N; Breukel, C; van Leeuwen, S; Taketo, MM; Roberts, S; Smits, R; Fodde, R			Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling	NATURE GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; COLON-CANCER; MOUSE MODEL; GENES; MUTATION; TUMORS; MICE; EXPRESSION; REGULATORS; ACTIVATION	The Wnt signal-transduction pathway induces the nuclear translocation of membrane-bound beta-catenin (Catnb) and has a key role in cell-fate determination. Tight somatic regulation of this signal is essential, as uncontrolled nuclear accumulation of beta-catenin can cause developmental defects and tumorigenesis in the adult organism. The adenomatous polyposis coli gene (APC) is a major controller of the Wnt pathway and is essential to prevent tumorigenesis in a variety of tissues and organs. Here, we have investigated the effect of different mutations in Apc on the differentiation potential of mouse embryonic stem (ES) cells. We provide genetic and molecular evidence that the ability and sensitivity of ES cells to differentiate into the three germ layers is inhibited by increased doses of beta-catenin by specific Apc mutations. These range from a severe differentiation blockade in Apc alleles completely deficient in beta-catenin regulation to more specific neuroectodermal, dorsal mesodermal and endodermal defects in more hypomorphic alleles. Accordingly, a targeted oncogenic mutation in Catnb also affects the differentiation potential of ES cells. Expression profiling of wildtype and Apc-mutated teratomas supports the differentiation defects at the molecular level and pinpoints a large number of downstream structural and regulating genes. Chimeric experiments showed that this effect is cell-autonomous. Our results imply that constitutive activation of the Apc/beta-catenin signaling pathway results in differentiation defects in tissue homeostasis, and possibly underlies tumorigenesis in the colon and other self-renewing tissues.	Leiden Univ, Med Ctr, Sylvius Lab, Ctr Human & Clin Genet, NL-2333 RA Leiden, Netherlands; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; Rosetta Inpharmat, Kirkland, WA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kyoto University; Merck & Company	Fodde, R (corresponding author), Leiden Univ, Med Ctr, Sylvius Lab, Ctr Human & Clin Genet, Wassenaarseweg 72, NL-2333 RA Leiden, Netherlands.		Gaspar, Claudia/I-6402-2013; Fodde, Riccardo/AAW-9394-2021	Gaspar, Claudia/0000-0003-1051-0998; Fodde, Riccardo/0000-0001-9839-4324				Boman BM, 2001, CANCER RES, V61, P8408; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen JR, 2001, MOL CELL ENDOCRINOL, V177, P43, DOI 10.1016/S0303-7207(01)00456-7; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Fodde Riccardo, 1995, Critical Reviews in Oncogenesis, V6, P291; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; LAMIUM H, 1999, NAT MED, V5, P1071; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Polakis P, 2000, GENE DEV, V14, P1837; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Stevens L C, 1967, Adv Morphog, V6, P1; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927	36	297	312	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					594	605		10.1038/ng1045	http://dx.doi.org/10.1038/ng1045			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426568				2022-12-27	WOS:000179593000011
J	Reinke, V				Reinke, V			Functional exploration of the C-elegans genome using DNA microarrays	NATURE GENETICS			English	Review							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; POLYCOMB GROUP; GERMLINE; PROTEIN; ORGANIZATION; TOUCH; RNAI; TRANSCRIPTION; HOMOLOG	Global changes in gene expression underlie developmental processes such as organogenesis, embryogenesis and aging in Caenorhabditis elegans. Recently developed methods allow gene expression profiles to be determined selectively for individual tissues and cell types. Results from both whole-animal and tissue-specific expression profiling have provided an unprecedented view into genome organization and gene function. Integration of these results with other types of functional genomics data gathered from RNA-mediated interference and yeast two-hybrid analyses will allow rapid identification and exploration of the complex functional gene networks that govern C. elegans development.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University	Reinke, V (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	valerie.reinke@yale.edu						Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Colaiacovo MP, 2002, GENETICS, V162, P113; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Hunter CP, 1999, CURR BIOL, V9, pR440, DOI 10.1016/S0960-9822(99)80276-0; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Korf I, 1998, DEVELOPMENT, V125, P2469; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; LYNCH AS, 1995, NAT GENET, V11, P309, DOI 10.1038/ng1195-309; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PIANO F, IN PRESS CURRENT BIO; Qian J, 2001, J MOL BIOL, V314, P1053, DOI 10.1006/jmbi.2000.5219; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; von Mering C, 2002, NATURE, V417, P797, DOI 10.1038/417797a; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	41	28	34	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			541	546		10.1038/ng1039	http://dx.doi.org/10.1038/ng1039			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454651				2022-12-27	WOS:000179742900016
J	Kimura, A; Umehara, T; Horikoshi, M				Kimura, A; Umehara, T; Horikoshi, M			Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERES; YEAST HETEROCHROMATIN; LYSINE RESIDUES; CORE HISTONES; STRAND BREAKS; ACETYLTRANSFERASE; REPRESSION; H3; COMPLEX; PROTEIN	Genes located in chromosomal regions near telomeres are transcriptionally silent, whereas those located in regions away from telomeres are not. Here we show that there is a gradient of acetylation of histone H4 at lysine 16 (H4-Lys16) along a yeast chromosome; this gradient ranges from a hypoacetylated state in regions near the telomere to a hyperacetylated state in more distant regions. The hyperacetylation is regulated by Sas2p, a member of the MYST-type family of histone acetylases, whereas hypoacetylation is under the control of Sir2p, a histone deacetylase. Loss of hyperacetylation is accompanied by an increase in localization of the telomere protein Sir3p and the inactivation of gene expression in telomere-distal regions. Thus, the Sas2p and Sir2p function in concert to regulate transcription in yeast, by acetylating and deacetylating H4-Lys16 in a mechanism that may be common to all eukaryotes.	Japan Sci & Technol Corp, Horikoshi Gene Selector Project, Exploratoey Res Adv Technol, Tsukuba, Ibaraki 3002635, Japan; Univ Tokyo, Dev Biol Lab, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Horikoshi, M (corresponding author), Japan Sci & Technol Corp, Horikoshi Gene Selector Project, Exploratoey Res Adv Technol, 5-9-6 Tokodai, Tsukuba, Ibaraki 3002635, Japan.		Umehara, Takashi/N-5683-2015; Umehara, Takashi/AHB-1730-2022	Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kimura A, 1998, FEBS LETT, V431, P131, DOI 10.1016/S0014-5793(98)00752-2; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; SUKA N, 2002, NATURE GENET, V32; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; VegaPalas MA, 1997, NAT GENET, V15, P232, DOI 10.1038/ng0397-232; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	51	290	296	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					370	377		10.1038/ng993	http://dx.doi.org/10.1038/ng993			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410229				2022-12-27	WOS:000179034800011
J	Hartman, AR; Ford, JM				Hartman, AR; Ford, JM			BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair	NATURE GENETICS			English	Article							GLOBAL GENOMIC REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; TRANSCRIPTION-COUPLED REPAIR; HUMAN FIBROBLASTS; P53 MUTATIONS; HUMAN-CELLS; GENE; EXPRESSION; CANCER; BREAST	Inheritance of a mutation in the gene BRCA1 confers on women a 50-85% lifetime risk of developing breast cancer(1,2). Mutations in the TP53 tumor-suppressor gene are found in 70-80% of BRCA1-mutated breast cancer but only 30% of those with wildtype BRCA1 (ref. 3). The p53 protein regulates nucleotide excision repair (NER) through transcriptional regulation of genes involved in the recognition of adducts in genomic DNA. Loss of p53 function results in deficient global genomic repair (GGR), a subset of NER that targets and removes lesions from the whole genome(4-6). Here we show that BRCA1 specifically enhances the GGR pathway, independent of p53, and can induce p53-independent expression of the NER genes XPC, DDB2, and GADD45. Defects in the NER pathway in BRCA1-associated breast cancers may be causal in tumor development, suggesting a multistep model of carcinogenesis.	Stanford Univ, Med Ctr, Dept Internal Med Oncol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Ford, JM (corresponding author), Stanford Univ, Med Ctr, Dept Internal Med Oncol, Stanford, CA 94305 USA.			Ford, James/0000-0002-2513-7025				Adimoolam S, 2001, J BIOL CHEM, V276, P25813, DOI 10.1074/jbc.M102240200; Bowman KK, 2000, MOL CARCINOGEN, V29, P17, DOI 10.1002/1098-2744(200009)29:1<17::AID-MC3>3.3.CO;2-5; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Cressman VL, 1999, MOL CELL BIOL, V19, P7061; EASTON DF, 1995, AM J HUM GENET, V56, P65; Emmert S, 2000, P NATL ACAD SCI USA, V97, P2151, DOI 10.1073/pnas.040559697; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Ford JM, 1998, CANCER RES, V58, P599; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Gorlewska-Roberts K, 2002, ENVIRON MOL MUTAGEN, V39, P184, DOI 10.1002/em.10060; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Greenblatt MS, 2001, CANCER RES, V61, P4092; Hanawalt PC, 2001, ENVIRON MOL MUTAGEN, V38, P89, DOI 10.1002/em.1057; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Husain A, 1998, CANCER RES, V58, P1120; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jin SQ, 2000, ONCOGENE, V19, P4050, DOI 10.1038/sj.onc.1203759; Lloyd DR, 2000, CANCER RES, V60, P517; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Motykiewicz G, 2001, CANCER DETECT PREV, V25, P328; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; Schuyer M, 1999, MOL CELL ENDOCRINOL, V155, P143, DOI 10.1016/S0303-7207(99)00117-3; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Tang JY, 2000, MOL CELL, V5, P737, DOI 10.1016/S1097-2765(00)80252-X; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	30	180	191	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					180	184		10.1038/ng953	http://dx.doi.org/10.1038/ng953			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12195423				2022-12-27	WOS:000177714900019
J	Lund, AH; Turner, G; Trubetskoy, A; Verhoeven, E; Wientjens, E; Hulsman, D; Russell, R; DePinho, RA; Lenz, J; van Lohuizen, M				Lund, AH; Turner, G; Trubetskoy, A; Verhoeven, E; Wientjens, E; Hulsman, D; Russell, R; DePinho, RA; Lenz, J; van Lohuizen, M			Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice	NATURE GENETICS			English	Article							P53-DEPENDENT APOPTOSIS; CELL-PROLIFERATION; SENESCENCE; EXPRESSION; RAS; ACTIVATION; P19(ARF); ARREST; MYC; P53	We have used large-scale insertional mutagenesis to identify functional landmarks relevant to cancer in the recently completed mouse genome sequence. We infected Cdkn2a(-/-) mice with Moloney murine leukemia virus (MoMuLV) to screen for loci that can participate in tumorigenesis in collaboration with loss of the Cdkn2a-encoded tumor suppressors p16INK4a and p19ARF. Insertional mutagenesis by the latent retrovirus was synergistic with loss of Cdkn2a expression, as indicated by a marked acceleration in the development of both myeloid and lymphoid tumors. We isolated 747 unique sequences flanking retroviral integration sites and mapped them against the mouse genome sequence databases from Celera and Ensembl. In addition to 17 insertions targeting gene loci known to be cancer-related, we identified a total of 37 new common insertion sites (CISs), of which 8 encode components of signaling pathways that are involved in cancer. The effectiveness of large-scale insertional mutagenesis in a sensitized genetic background is demonstrated by the preference for activation of MAP kinase signaling, collaborating with Cdkn2a loss in generating the lymphoid and myeloid tumors. Collectively, our results show that large-scale retroviral insertional mutagenesis in genetically predisposed mice is useful both as a system for identifying genes underlying cancer and as a genetic framework for the assignment of such genes to specific oncogenic pathways.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol Genet & Med, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Netherlands Cancer Institute; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Lenz, J (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA.	lenz@aecom.yu.edu; m.v.lohuizen@nki.nl	Lund, Anders H./F-4786-2014	Lund, Anders H./0000-0002-7407-3398; DePinho, Ronald/0000-0002-5625-577X				Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Roth P, 1998, BLOOD, V91, P3773, DOI 10.1182/blood.V91.10.3773.3773_3773_3783; Ruas M, 1998, BIOCHIM BIOPHYS ACTA, V1378, P115, DOI 10.1016/s0304-419x(98)00017-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; SUZUKI T, 2002, NAT GENET, V32, P86; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	29	188	197	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					160	165		10.1038/ng956	http://dx.doi.org/10.1038/ng956			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12185367				2022-12-27	WOS:000177714900016
J	Engel, N; West, AG; Felsenfeld, G; Bartolomei, MS				Engel, N; West, AG; Felsenfeld, G; Bartolomei, MS			Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations	NATURE GENETICS			English	Article							IMPRINTED EXPRESSION; SEQUENCE UPSTREAM; PROTEIN CTCF; METHYLATION; GENE; IGF2; INSULATOR; ELEMENT; REGION; DELETION	Imprinted expression at the H19-Igf2 locus depends on a differentially methylated domain (DMD) that acts both as a maternal-specific, methylation-sensitive insulator and as a paternal-specific site of hypermethylation. Four repeats in the DMD bind CCCTC-binding factor ( CTCF) on the maternal allele and have been proposed to attract methylation on the paternal allele. We introduced point mutations into the DMD to deplete the repeats of CpGs while retaining CTCF-binding and enhancer-blocking activity. Maternal inheritance of the mutations left H19 expression and Igf2 imprinting intact, consistent with the idea that the DMD acts as an insulator. Conversely, paternal inheritance of these mutations disrupted maintenance of DMD methylation, resulting in biallelic H19 expression. Furthermore, an insulator was established on the paternally inherited mutated allele in vivo, reducing Igf2 expression and resulting in a 40% reduction in size of newborn offspring. Thus, the nine CpG mutations in the DMD showed that the two parental-specific roles of the H19 DMD, methylation maintenance and insulator assembly, are antagonistic.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bartolomei, MS (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	bartolom@mail.med.upenn.edu		Engel, Nora/0000-0002-0618-3624; West, Adam/0000-0003-3502-7804	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK034001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ainscough JFX, 2000, MECH DEVELOP, V91, P365, DOI 10.1016/S0925-4773(99)00289-0; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Srivastava M, 2000, GENE DEV, V14, P1186; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	30	95	100	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					883	888		10.1038/ng1399	http://dx.doi.org/10.1038/ng1399			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273688				2022-12-27	WOS:000222974000023
J	Davila, S; Furu, L; Gharavi, AG; Tian, X; Onoe, T; Qian, Q; Li, AR; Cai, YQ; Kamath, PS; King, BF; Azurmendi, PJ; Tahvanainen, P; Kaariainen, H; Hockerstedt, K; Devuyst, O; Pirson, Y; Martin, RS; Lifton, RP; Tahvanainen, E; Torres, VE; Somlo, S				Davila, S; Furu, L; Gharavi, AG; Tian, X; Onoe, T; Qian, Q; Li, AR; Cai, YQ; Kamath, PS; King, BF; Azurmendi, PJ; Tahvanainen, P; Kaariainen, H; Hockerstedt, K; Devuyst, O; Pirson, Y; Martin, RS; Lifton, RP; Tahvanainen, E; Torres, VE; Somlo, S			Mutations in SEC63 cause autosomal dominant polycystic liver disease	NATURE GENETICS			English	Article							N-LINKED GLYCANS; KIDNEY-DISEASE; TRANSLOCATION; PATHWAY; PRKCSH	Mutations in PRKCSH, encoding the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum (ER), cause autosomal dominant polycystic liver disease. We found that mutations in SEC63, encoding a component of the protein translocation machinery in the ER, also cause this disease. These findings are suggestive of a role for cotranslational protein-processing pathways in maintaining epithelial luminal structure and implicate noncilial ER proteins in human polycystic disease.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Mayo Clin, Dept Med, Rochester, MN USA; Mayo Clin, Dept Radiol, Rochester, MN USA; Univ Buenos Aires, Buenos Aires, DF, Argentina; Natl Inst Publ Hlth, Dept Human Mol Genet, Helsinki, Finland; Turku Univ, Dept Med Genet, Turku, Finland; Univ Helsinki Hosp, Transplantat & Liver Surg Unit, Helsinki, Finland; Clin Univ St, Brussels, Belgium; Univ Helsinki, Dept Med Genet, Helsinki, Finland	Yale University; Yale University; Mayo Clinic; Mayo Clinic; University of Buenos Aires; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Somlo, S (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208029,333 Cedar St, New Haven, CT 06520 USA.	stefan.somlo@yale.edu		Azurmendi, Pablo Javier/0000-0001-7787-5882; Devuyst, Olivier/0000-0003-3744-4767				Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Furu L, 2003, J AM SOC NEPHROL, V14, P2004, DOI 10.1097/01.ASN.0000078805.87038.05; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Iglesias DM, 1999, DIGEST DIS SCI, V44, P385, DOI 10.1023/A:1026623005401; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Pirson Y, 1996, HEPATOLOGY, V23, P249, DOI 10.1002/hep.510230208; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; Reynolds DM, 2000, AM J HUM GENET, V67, P1598, DOI 10.1086/316904; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Tahvanainen P, 2003, J HEPATOL, V38, P39, DOI 10.1016/S0168-8278(02)00348-3; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262	15	182	190	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					575	577		10.1038/ng1357	http://dx.doi.org/10.1038/ng1357			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15133510	Bronze			2022-12-27	WOS:000221763700011
J	Joeng, KS; Song, EJ; Lee, KJ; Lee, J				Joeng, KS; Song, EJ; Lee, KJ; Lee, J			Long lifespan in worms with long telomeric DNA	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; IN-VITRO; HNRNP A1; GENE; LONGEVITY; PROTEIN; STRESS; DAF-16; THERMOTOLERANCE	Telomere length is a crucial factor in senescence(1-3), but it has not been determined whether animals with long telomeres live longer than those with normal-length telomeres in the isogenic background of a given species. Here we show the effect of long telomeres on lifespan in the nematode Caenorhabditis elegans. We examined the effect of telomere length on lifespan by overexpressing HRP-1, a telomere-binding protein, which gradually increased telomere length in worms. Worms with longer telomeres lived longer. We confirmed that the extension of lifespan was due to the increased telomere length, and not to the overexpression of HRP-1 per se, by examining the lifespans of nontransgenic progeny of the transgenic worms, who retained the longer telomeres. The lifespan-extending effect of long telomeres was dependent on daf-16. The number of germ stem cells was not affected in worms with long telomeres, indicating that the telomere effect on lifespan is independent of germ stem cell cycling. Worms with long telomeres were more resistant to heat stress. Taken together, our results suggest that signaling may be initiated in postmitotic somatic cells by telomere length to regulate organismal lifespan.	Yonsei Univ, Dept Biol, Natl Res Lab & Mol Aging Res Ctr, Seoul 120749, South Korea; Ewha Womans Univ, Div Mol Life Sci, Ctr Cell Signaling Res, Seoul 120750, South Korea; Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Yonsei University; Ewha Womans University; Ewha Womans University	Lee, J (corresponding author), Yonsei Univ, Dept Biol, Natl Res Lab & Mol Aging Res Ctr, 134 Shinchon, Seoul 120749, South Korea.	leej@yonsei.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Song, Eun Joo/0000-0002-2420-6666	NICHD NIH HHS [P01 HD070394] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Benard C, 2002, MECH AGEING DEV, V123, P869, DOI 10.1016/S0047-6374(02)00024-6; Benard C, 2001, DEVELOPMENT, V128, P4045; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Fiset S, 2001, NUCLEIC ACIDS RES, V29, P2268, DOI 10.1093/nar/29.11.2268; Garigan D, 2002, GENETICS, V161, P1101; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Krupp G, 2000, CELL MOL LIFE SCI, V57, P464, DOI 10.1007/PL00000708; Kwon JY, 1999, P NATL ACAD SCI USA, V96, P14990, DOI 10.1073/pnas.96.26.14990; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lim CS, 2001, CURR BIOL, V11, P1706, DOI 10.1016/S0960-9822(01)00526-7; LIN JJ, 1994, NUCLEIC ACIDS RES, V22, P4906, DOI 10.1093/nar/22.23.4906; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morin GB, 1997, EXP GERONTOL, V32, P375, DOI 10.1016/S0531-5565(96)00164-7; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Wicky C, 1996, P NATL ACAD SCI USA, V93, P8983, DOI 10.1073/pnas.93.17.8983	27	97	107	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					607	611		10.1038/ng1356	http://dx.doi.org/10.1038/ng1356			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122256	Bronze			2022-12-27	WOS:000221763700018
J	Neves, G; Zucker, J; Daly, M; Chess, A				Neves, G; Zucker, J; Daly, M; Chess, A			Stochastic yet biased expression of multiple Dscam splice variants by individual cells	NATURE GENETICS			English	Article							DROSOPHILA DSCAM; RECEPTOR; GUIDANCE; GENOME; GENES	The Drosophila melanogaster gene Dscam is essential for axon guidance and has 38,016 possible alternative splice forms. This diversity can potentially be used to distinguish cells. We analyzed the Dscam mRNA isoforms expressed by different cell types and individual cells. The choice of splice variants expressed is regulated both spatially and temporally. Different subtypes of photoreceptors express broad yet distinctive spectra of Dscam isoforms. Single-cell RT-PCR documented that individual cells express several different Dscam isoforms and allowed an estimation of the diversity that is present. For example, we estimate that each R3/R4 photoreceptor cell expresses 14-50 distinct mRNAs chosen from the spectrum of thousands of splice variants distinctive of its cell type. Thus, the Dscam repertoire of each cell is different from those of its neighbors, providing a potential mechanism for generating unique cell identity in the nervous system and elsewhere.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chess, A (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	chess@wi.mit.edu	Neves, Guilherme/G-8957-2011	Neves, Guilherme/0000-0001-6463-6997				ASBURNER M, 1989, DROSOPHILA LAB MANUA; Barlow GM, 2002, BIOCHEM BIOPH RES CO, V293, P881, DOI 10.1016/S0006-291X(02)00307-8; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Celotto AM, 2001, GENETICS, V159, P599; Cooper MTD, 2000, CURR BIOL, V10, P1507, DOI 10.1016/S0960-9822(00)00826-5; Echalier G., 1997, DROSOPHILA CELLS CUL; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; KLICKSTEIN LB, 1995, CURRENT PROTOCOLS MO, V1; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	25	191	193	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					240	246		10.1038/ng1299	http://dx.doi.org/10.1038/ng1299			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14758360	Bronze			2022-12-27	WOS:000189250400012
J	Stegmaier, K; Ross, KN; Colavito, SA; O'Malley, S; Stockwell, BR; Golub, TR				Stegmaier, K; Ross, KN; Colavito, SA; O'Malley, S; Stockwell, BR; Golub, TR			Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; SMALL-MOLECULE INHIBITORS; TRANS-RETINOIC ACID; GROWTH-INHIBITION; CELLS; HL-60; MECHANISM; IDENTIFICATION; METHOTREXATE; DISCOVERY	Chemical genomics involves generating large collections of small molecules and using them to modulate cellular states. Despite recent progress in the systematic synthesis of structurally diverse compounds, their use in screens of cellular circuitry is still an ad hoc process(1-4). Here, we outline a general, efficient approach called gene expression based high-throughput screening (GE-HTS) in which a gene expression signature is used as a surrogate for cellular states, and we describe its application in a particular setting: the identification of compounds that induce the differentiation of acute myeloid leukemia cells. In screening 1,739 compounds, we identified 8 that reliably induced the differentiation signature and, furthermore, yielded functional evidence of bona fide differentiation. The results indicate that GE-HTS may be a powerful, general approach for chemical screening.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute	Golub, TR (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	golub@broad.mit.edu	Colavito, Sierra A/AAE-3957-2019; Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868; Colavito, Sierra/0000-0002-2814-4853				Baker K, 2002, P NATL ACAD SCI USA, V99, P16537, DOI 10.1073/pnas.262420099; Barrie SE, 2003, ANAL BIOCHEM, V320, P66, DOI 10.1016/S0003-2697(03)00349-X; BENBARUCH N, 1994, MOL PHARMACOL, V46, P73; BODNER AJ, 1981, J NATL CANCER I, V67, P1025; Clemons PA, 2001, CHEM BIOL, V8, P1183, DOI 10.1016/S1074-5521(01)00086-2; Dubey RK, 2000, HYPERTENSION, V35, P262, DOI 10.1161/01.HYP.35.1.262; DUNCAN GS, 1982, J IMMUNOPHARMACOL, V4, P79, DOI 10.3109/08923978209031077; Fici GJ, 1997, LIFE SCI, V60, P1597, DOI 10.1016/S0024-3205(97)00126-4; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Guillemin MC, 2002, J EXP MED, V196, P1373, DOI 10.1084/jem.20021129; Harvath L, 1999, Methods Mol Biol, V115, P281; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Johnson PH, 2002, MOL CANCER THER, V1, P1293; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KALINYAK KA, 1985, LIFE SCI, V36, P1909, DOI 10.1016/0024-3205(85)90439-4; MANTEL N, 1967, CANCER RES, V27, P209; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCBURNEY MW, 1975, CANCER RES, V35, P586; Mountford JC, 1999, EXP HEMATOL, V27, P451, DOI 10.1016/S0301-472X(98)00078-2; Perachon S, 1999, EUR J PHARMACOL, V366, P293, DOI 10.1016/S0014-2999(98)00896-6; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; REYES P, 1965, MOL PHARMACOL, V1, P14; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Seiter K, 2000, BRIT J HAEMATOL, V108, P40, DOI 10.1046/j.1365-2141.2000.01804.x; Shim GJ, 2003, P NATL ACAD SCI USA, V100, P6694, DOI 10.1073/pnas.0731830100; SOKOLOSKI JA, 1986, CANCER RES, V46, P2314; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; Yang L, 2001, GENOME RES, V11, P1888, DOI 10.1101/gr.190901; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	30	205	229	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					257	263		10.1038/ng1305	http://dx.doi.org/10.1038/ng1305			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14770183	Bronze			2022-12-27	WOS:000189250400014
J	Kakiuchi, C; Iwamoto, K; Ishiwata, M; Bundo, M; Kasahara, T; Kusumi, I; Tsujita, T; Okazaki, Y; Nanko, S; Kunugi, H; Sasaki, T; Kato, T				Kakiuchi, C; Iwamoto, K; Ishiwata, M; Bundo, M; Kasahara, T; Kusumi, I; Tsujita, T; Okazaki, Y; Nanko, S; Kunugi, H; Sasaki, T; Kato, T			Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM; ER STRESS; SUSCEPTIBILITY LOCUS; CHROMOSOME-22; ATF6; EXPRESSION; PROTEINS; CORTEX; BINDS; SCAN	The pathophysiology of bipolar disorder is still unclear, although family, twin and linkage studies implicate genetic factors(1). Here we identified XBP1, a pivotal gene in the endoplasmic reticulum ( ER) stress response, as contributing to the genetic risk factor for bipolar disorder. Using DNA microarray analysis of lymphoblastoid cells derived from two pairs of twins discordant with respect to the illness, we found downregulated expression of genes related to ER stress response in both affected twins. A polymorphism (-116C-->G) in the promoter region of XBP1, affecting the putative binding site of XBP1, was significantly more common in Japanese patients ( odds ratio = 4.6) and overtransmitted to affected offspring in trio samples of the NIMH Bipolar Disorder Genetics Initiative. XBP1-dependent transcription activity of the -116G allele was lower than that of the -116C allele, and in the cells with the G allele, induction of XBP1 expression after ER stress was markedly reduced. Valproate, one of three mood stabilizers, rescued the impaired response by inducing ATF6, the gene upstream of XBP1. These results indicate that the -116C--> G polymorphism in XBP1 causes an impairment of its positive feedback system and increases the risk of bipolar disorder.	RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan; Hokkaido Univ, Dept Psychiat, Sapporo, Hokkaido 0608648, Japan; Nagasaki Univ, Dept Psychiat, Nagasaki 8528523, Japan; Mie Univ, Dept Psychiat, Tsu, Mie 5148507, Japan; Teikyo Univ, Sch Med, Dept Psychiat, Itabashi Ku, Tokyo 1738605, Japan; Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1878502, Japan; Univ Tokyo, Hlth Serv Ctr, Dept Psychiat, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; Hokkaido University; Nagasaki University; Mie University; Teikyo University; National Center for Neurology & Psychiatry - Japan; University of Tokyo	Kato, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan.		Kasahara, Takaoki/AAJ-5367-2020; Kato, Tadafumi/J-3583-2014; Kusumi, Ichiro/A-4067-2012; Kakiuchi, Chihiro/AAO-1103-2020; Kunugi, Hiroshi/ABC-5260-2021	Kasahara, Takaoki/0000-0002-0953-5146; Kato, Tadafumi/0000-0001-7856-3952; Kunugi, Hiroshi/0000-0002-7209-3790				BANKS RE, 1990, J AFFECT DISORDERS, V19, P1, DOI 10.1016/0165-0327(90)90002-P; Bown C, 2000, NEUROPSYCHOPHARMACOL, V22, P327, DOI 10.1016/S0893-133X(99)00091-3; Chen B, 2000, BIOL PSYCHIAT, V48, P658, DOI 10.1016/S0006-3223(00)00878-7; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Edenberg HJ, 1997, AM J MED GENET, V74, P238, DOI 10.1002/(SICI)1096-8628(19970531)74:3<238::AID-AJMG2>3.0.CO;2-M; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Gray NA, 2003, J CLIN PSYCHIAT, V64, P3; Ikeda A, 2003, PSYCHIAT CLIN NEUROS, V57, P243, DOI 10.1046/j.1440-1819.2003.01112.x; Kato T, 2002, LIFE SCI, V71, P581, DOI 10.1016/S0024-3205(02)01725-3; Kato T, 2001, NEUROSCI RES, V40, P105, DOI 10.1016/S0168-0102(01)00221-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kelsoe JR, 2001, P NATL ACAD SCI USA, V98, P585, DOI 10.1073/pnas.011358498; KUSUMI I, 1995, BIOL PSYCHIAT, V37, P553, DOI 10.1016/0006-3223(94)00364-9; Lachman HM, 1997, AM J MED GENET, V74, P121, DOI 10.1002/(SICI)1096-8628(19970418)74:2<121::AID-AJMG2>3.0.CO;2-X; PEREZ J, 1995, AM J PSYCHIAT, V152, P1204; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; Pritchard JK, 2000, GENETICS, V155, P945; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Wang JF, 2001, INT J NEUROPSYCHOPH, V4, P65, DOI 10.1017/S1461145701002231; Yoon IS, 2001, MOL PSYCHIATR, V6, P678, DOI 10.1038/sj.mp.4000901; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	25	223	234	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					171	175		10.1038/ng1235	http://dx.doi.org/10.1038/ng1235			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12949534				2022-12-27	WOS:000185625300014
J	Kashima, T; Manley, JL				Kashima, T; Manley, JL			A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy	NATURE GENETICS			English	Article							HNRNP A/B PROTEINS; MOTOR-NEURON SMN; IN-VIVO; SILENCER ELEMENT/; SINGLE NUCLEOTIDE; DETERMINING GENE; BINDING-SITES; SR PROTEINS; A1; ASF/SF2	Spinal muscular atrophy (SMA) is a relatively common neurodegenerative disease caused by homozygous loss of the survival motor neuron 1 (SMN1) gene(1). Humans possess a linked, nearly identical gene, SMN2, which produces a functional SMN protein but at levels insufficient to compensate for loss of SMN1 (refs. 1,2). A C/T transition at position +6 in exon 7 is all that differentiates the two genes, but this is sufficient to prevent efficient exon 7 splicing in SMN2 ( refs. 2,3). Here we show that the C/T transition functions not to disrupt an exonic splicing enhancer (ESE) in SMN1 (ref. 4), as previously suggested, but rather to create an exonic splicing silencer (ESS) in SMN2. We show that this ESS functions as a binding site for a known repressor protein, hnRNP A1, which binds to SMN2 but not SMN1 exon 7 RNA. We establish the physiological importance of these results by using small interfering RNAs to reduce hnRNP A protein levels in living cells and show that this results in efficient SMN2 exon 7 splicing. Our findings not only define a new mechanism underlying the inefficient splicing of SMN2 exon 7 but also illustrate more generally the remarkable sensitivity and precision that characterizes control of mRNA splicing.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.			Manley, James/0000-0002-8341-1459				Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Hutchison S, 2002, J BIOL CHEM, V277, P29745, DOI 10.1074/jbc.M203633200; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Tange TO, 2001, EMBO J, V20, P5748; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; WANG J, 1995, RNA, V1, P335; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Wilkinson MF, 2002, NAT CELL BIOL, V4, pE144, DOI 10.1038/ncb0602-e144; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	30	417	432	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2003	34	4					460	463		10.1038/ng1207	http://dx.doi.org/10.1038/ng1207			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12833158				2022-12-27	WOS:000184470500027
J	Nakai, H; Montini, E; Fuess, S; Storm, TA; Grompe, M; Kay, MA				Nakai, H; Montini, E; Fuess, S; Storm, TA; Grompe, M; Kay, MA			AAV serotype 2 vectors preferentially integrate into active genes in mice	NATURE GENETICS			English	Article							IN-VIVO; RETROVIRAL INTEGRATION; HUMAN GENOME; LEUKEMIA; EXPRESSION; THERAPY; SITES; LIVER; NUCLEOSOMES; JUNCTIONS	Recombinant adeno-associated virus serotype 2 (rAAV2) is a promising vector for gene therapy because it can achieve long-term stable transgene expression in animals and human subjects after direct administration of vectors into various target tissues(1). In the liver, although stable transgene expression primarily results from extrachromosomal vector genomes(2), a series of experiments has shown that vector genomes integrate into host chromosomes in hepatocytes(3-5) at a low frequency(2). Despite the low integration efficiency, recent reports of retroviral insertional mutagenesis in mice(6) and two human subjects(7,8) have raised concerns about the potential for rAAV2-mediated insertional mutagenesis. Here we characterize rAAV2-targeted chromosomal integration sites isolated from selected or non-selected hepatocytes in vector-injected mouse livers. We document frequent chromosomal deletions of up to 2 kb at integration sites (14 of 14 integrations, 100%; most of the deletions were <0.3 kb) and preferred integration into genes (21 of 29 integrations, 72%). In addition, all of the targeted genes analyzed (20 of 20 targeted genes, 100%) were expressed in the liver. This is the first report to our knowledge on host chromosomal effects of rAAV2 integration in animals, and it provides insights into the nature of rAAV2 vector integration into chromosomes in quiescent somatic cells in animals and human subjects.	Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Stanford University; Stanford University; Oregon Health & Science University; Oregon Health & Science University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Sch Med, 300 Pasteur Dr,Rm G305A, Stanford, CA 94305 USA.	markay@stanford.edu	Montini, Eugenio/L-1152-2016	Montini, Eugenio/0000-0003-1771-6067; Kay, Mark/0000-0002-2799-2615; Grompe, Markus/0000-0002-6616-4345				CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Chen SJ, 2000, MOL THER, V1, P414, DOI 10.1006/mthe.2000.0065; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leclercq I, 2000, J VIROL, V74, P2305, DOI 10.1128/JVI.74.5.2305-2312.2000; Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893; Marshall E, 2003, SCIENCE, V299, P320, DOI 10.1126/science.299.5605.320; Marshall E, 2002, SCIENCE, V298, P34, DOI 10.1126/science.298.5591.34; Miao CH, 1998, NAT GENET, V19, P13, DOI 10.1038/ng0598-13; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Miller DG, 2002, NAT GENET, V30, P147, DOI 10.1038/ng824; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Nakai H, 2003, MOL THER, V7, P101, DOI 10.1016/S1525-0016(02)00023-0; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; SCHERDIN U, 1990, J VIROL, V64, P907, DOI 10.1128/JVI.64.2.907-912.1990; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VIJAYA S, 1986, J VIROL, V60, P683, DOI 10.1128/JVI.60.2.683-692.1986; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997	29	278	297	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					297	302		10.1038/ng1179	http://dx.doi.org/10.1038/ng1179			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12778174				2022-12-27	WOS:000183815300017
J	Hashimshony, T; Zhang, JM; Keshet, I; Bustin, M; Cedar, H				Hashimshony, T; Zhang, JM; Keshet, I; Bustin, M; Cedar, H			The role of DNA methylation in setting up chromatin structure during development	NATURE GENETICS			English	Article							H3 LYSINE-4 METHYLATION; MOUSE EMBRYO; HISTONE H1; BINDING; TRANSCRIPTION; COMPLEX	DNA methylation inhibits gene expression in animal cells, probably by affecting chromatin structure. Biochemical studies suggest that this process may be mediated by methyl-specific binding proteins that recruit enzymatic machinery capable of locally altering histone modification(1). To test whether DNA methylation actually has a role in the assembly of chromatin during normal development, we used cell transfection and a transgene construct genetically programmed to be either methylated or unmethylated in all cell types of the mouse(2). Chromatin immunoprecipitation (ChIP) analysis shows that the presence of DNA methylation brings about the deacetylation of histone H4 and methylation of Lys9 of histone H3 (H3 Lys9) and prevents methylation of Lys4 of histone H3 (H3 Lys4), thus generating a structure identical to that of methylated sequences in the genome. These results indicate that the methylation pattern established in early embryogenesis is profoundly important in setting up the structural profile of the genome.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Expt Med & Canc Res, IL-91120 Jerusalem, Israel; NCI, Prot Sect, Mol Carcinogenesis Lab, Div Basic Sci,NIH, Bethesda, MD 20892 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, POB 12272, IL-91120 Jerusalem, Israel.	cedar@md2.huji.ac.il	Bustin, Michael/G-6155-2015	Bustin, Michael/0000-0002-5147-7242	NATIONAL CANCER INSTITUTE [ZIABC004496, Z01BC004496] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BUSTIN M, 1989, METHOD ENZYMOL, V170, P214; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; FUKS F, 2002, J BIOL CHEM; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; MONK M, 1987, DEVELOPMENT, V99, P371; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; RENZ M, 1975, P NATL ACAD SCI USA, V72, P733, DOI 10.1073/pnas.72.2.733; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200	24	266	276	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					187	192		10.1038/ng1158	http://dx.doi.org/10.1038/ng1158			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12740577				2022-12-27	WOS:000183200500025
J	Tufarelli, C; Stanley, JAS; Garrick, D; Sharpe, JA; Ayyub, H; Wood, WG; Higgs, DR				Tufarelli, C; Stanley, JAS; Garrick, D; Sharpe, JA; Ayyub, H; Wood, WG; Higgs, DR			Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; HUMAN TELOMERIC REGION; ALPHA-GLOBIN; MOUSE EMBRYOS; CPG ISLAND; EXPRESSION; LOCUS; CELLS; MICE; DIFFERENTIATION	Nearly all human genetic disorders result from a limited repertoire of mutations in an associated gene or its regulatory elements. We recently described an individual with an inherited form of anemia (alpha-thalassemia) who has a deletion that results in a truncated, widely expressed gene (LUC7L) becoming juxtaposed to a structurally normal alpha-globin gene (HBA2). Although it retains all of its local and remote cis-regulatory elements, expression of HBA2 is silenced and its CpG island becomes completely methylated early during development. Here we show that in the affected individual, in a transgenic model and in differentiating embryonic stem cells, transcription of antisense RNA mediates silencing and methylation of the associated CpG island. These findings identify a new mechanism underlying human genetic disease.	Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med,John Radcliffe Hosp, Oxford OX3 9DS, England	University of Oxford	Higgs, DR (corresponding author), Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med,John Radcliffe Hosp, Oxford OX3 9DS, England.		GARRICK, David/O-5734-2019; Tufarelli, Cristina/AAD-3265-2019; Garrick, David/F-1728-2017	GARRICK, David/0000-0001-7422-7986; Tufarelli, Cristina/0000-0002-1053-4618; Garrick, David/0000-0001-7422-7986				Barbour VM, 2000, BLOOD, V96, P800, DOI 10.1182/blood.V96.3.800.015k11a_800_807; Baylin Stephen B., 2000, P293; Bedell MA, 1996, NAT GENET, V12, P229, DOI 10.1038/ng0396-229; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cooper D. N., 1993, HUMAN GENE MUTATION; Daniels R, 1997, HUM REPROD, V12, P2251, DOI 10.1093/humrep/12.10.2251; Ehrlich Melanie, 2000, P273; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; FEI YJ, 1988, BRIT J HAEMATOL, V68, P249, DOI 10.1111/j.1365-2141.1988.tb06197.x; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; KULOZIK AE, 1988, BLOOD, V71, P467; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; MARTIN GR, 1978, NATURE, V271, P829; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; ROMBEL I, 1995, P NATL ACAD SCI USA, V92, P6454, DOI 10.1073/pnas.92.14.6454; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; SHARPE JA, 1993, P NATL ACAD SCI USA, V90, P11262, DOI 10.1073/pnas.90.23.11262; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; SPIVAK JL, 1973, BLOOD, V42, P257, DOI 10.1182/blood.V42.2.257.257; Tufarelli C, 2001, GENOMICS, V71, P307, DOI 10.1006/geno.2000.6394; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	43	428	455	2	29	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					157	165		10.1038/ng1157	http://dx.doi.org/10.1038/ng1157			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730694				2022-12-27	WOS:000183200500021
J	Mikkers, H; Allen, J; Knipscheer, P; Romeyn, L; Hart, A; Vink, E; Berns, A				Mikkers, H; Allen, J; Knipscheer, P; Romeyn, L; Hart, A; Vink, E; Berns, A			High-throughput retroviral tagging to identify components of specific signaling pathways in cancer	NATURE GENETICS			English	Article							E-MU-MYC; C-MYC; TRANSGENIC MICE; PIM-1 KINASE; COOPERATING ONCOGENES; STEEL FACTOR; ACTIVATION; PHOSPHORYLATION; LYMPHOMAGENESIS; IDENTIFICATION	Genetic screens carried out in lower organisms such as yeast(1), Drosophila melanogaster(2) and Caenorhabditis elegans 3 have revealed many signaling pathways. For example, components of the RAS signaling cascade were identified using a mutant eye phenotype in D. melanogaster as a readout(2). Screening is usually based on enhancing or suppressing a phenotype by way of a known mutation in a particular signaling pathway. Such in vivo screens have been difficult to carry out in mammals, however, owing to their relatively long generation times and the limited number of animals that can be screened. Here we describe an in vivo mammalian genetic screen used to identify components of pathways contributing to oncogenic transformation. We applied retroviral insertional mutagenesis in Myc transgenic (EmuMyc) mice lacking expression of Pim1 and Pim2 to search for genes that can substitute for Pim1 and Pim2 in lymphomagenesis. We determined the chromosomal positions of 477 retroviral insertion sites (RISs) derived from 38 tumors from EmuMyc Pim1(-/-) Pim2(-/-) mice and 27 tumors from EmuMyc control mice using the Ensembl and Celera annotated mouse genome databases. There were 52 sites occupied by proviruses in more than one tumor. These common insertion sites (CISs) are likely to contain genes contributing to tumorigenesis. Comparison of the RISs in tumors of Pim-null mice with the RISs in tumors of EmuMyc control mice indicated that 10 of the 52 CISs belong to the Pim complementation group. In addition, we found that Pim3 is selectively activated in Pim-null tumor cells, which supports the validity of our approach.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Radiotherapy, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl						Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Craig NL, 1997, ANNU REV BIOCHEM, V66, P437, DOI 10.1146/annurev.biochem.66.1.437; CUYPERS HT, 1984, CELL, V37, P141; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Ishibashi Y, 2001, FEBS LETT, V506, P33, DOI 10.1016/S0014-5793(01)02881-2; Jacobs H, 1999, J EXP MED, V190, P1059, DOI 10.1084/jem.190.8.1059; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; LAIRD PW, 1993, NUCLEIC ACIDS RES, V21, P4750, DOI 10.1093/nar/21.20.4750; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Losman J, 1999, COLD SPRING HARB SYM, V64, P405, DOI 10.1101/sqb.1999.64.405; LUND AH, 2002, NAT GENET, V32, P80, DOI DOI 10.1038/NG956; MIYAZAWA K, 1992, BLOOD, V80, P1685; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; SELTEN G, 1984, EMBO J, V3, P3215, DOI 10.1002/j.1460-2075.1984.tb02281.x; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; SUZUKI T, 2002, NAT GENET, V32, P86; TSUJI K, 1992, BLOOD, V79, P2855; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7	30	7	7	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					153	159		10.1038/ng950	http://dx.doi.org/10.1038/ng950			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12185366				2022-12-27	WOS:000177714900015
J	Chang, S; Multani, AS; Cabrera, NG; Naylor, ML; Laud, P; Lombard, D; Pathak, S; Guarente, L; DePinho, RA				Chang, S; Multani, AS; Cabrera, NG; Naylor, ML; Laud, P; Lombard, D; Pathak, S; Guarente, L; DePinho, RA			Essential role of limiting telomeres in the pathogenesis of Werner syndrome	NATURE GENETICS			English	Article							SYNDROME GENE-PRODUCT; IONIZING-RADIATION; WRN; TOPOISOMERASE; DYSFUNCTION; SENSITIVITY; FIBROBLASTS; HELICASES; HOMOLOG; GENOME	Mutational inactivation of the gene WRN causes Werner syndrome, an autosomal recessive disease characterized by premature aging, elevated genomic instability and increased cancer incidence(1,2). The capacity of enforced telomerase expression to rescue premature senescence of cultured cells from individuals with Werner syndrome(3) and the lack of a disease phenotype in Wrn-deficient mice with long telomeres(4) implicate telomere attrition in the pathogenesis of Werner syndrome. Here, we show that the varied and complex cellular phenotypes of Werner syndrome are precipitated by exhaustion of telomere reserves in mice. In late-generation mice null with respect to both Wrn and Terc ( encoding the telomerase RNA component), telomere dysfunction elicits a classical Werner-like premature aging syndrome typified by premature death, hair graying, alopecia, osteoporosis, type II diabetes and cataracts. This mouse model also showed accelerated replicative senescence and accumulation of DNA-damage foci in cultured cells, as well as increased chromosomal instability and cancer, particularly nonepithelial malignancies typical of Werner syndrome. These genetic data indicate that the delayed manifestation of the complex pleiotropic of Wrn deficiency relates to telomere shortening.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Chang, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Box 11,1515 Holcombe Blvd, Houston, TX 77030 USA.	schang@mdanderson.org; ron_depinho@dfci.harvard.edu		Lombard, David/0000-0002-4292-0185; DePinho, Ronald/0000-0002-5625-577X	NATIONAL INSTITUTE ON AGING [K08AG024873, K08AG001019] Funding Source: NIH RePORTER; NIA NIH HHS [K08 AG001019, K08 AG024873] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; EPSTEIN CJ, 1966, MEDICINE, V45, P5893; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Kaneko H, 1999, CLIN EXP IMMUNOL, V118, P285; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Melcher R, 2000, CYTOGENET CELL GENET, V91, P180, DOI 10.1159/000056841; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Schulz VP, 1996, HUM GENET, V97, P750; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	24	350	365	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					877	882		10.1038/ng1389	http://dx.doi.org/10.1038/ng1389			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15235603				2022-12-27	WOS:000222974000022
J	Suzuki, T; Delgado-Escueta, AV; Aguan, K; Alonso, ME; Shi, J; Hara, Y; Nishida, M; Numata, T; Medina, MT; Takeuchi, T; Morita, R; Bai, DS; Ganesh, S; Sugimoto, Y; Inazawa, J; Bailey, JN; Ochoa, A; Jara-Prado, A; Rasmussen, A; Ramos-Peek, J; Cordova, S; Rubio-Donnadieu, F; Inoue, Y; Osawa, M; Kaneko, S; Oguni, H; Mori, Y; Yamakawa, K				Suzuki, T; Delgado-Escueta, AV; Aguan, K; Alonso, ME; Shi, J; Hara, Y; Nishida, M; Numata, T; Medina, MT; Takeuchi, T; Morita, R; Bai, DS; Ganesh, S; Sugimoto, Y; Inazawa, J; Bailey, JN; Ochoa, A; Jara-Prado, A; Rasmussen, A; Ramos-Peek, J; Cordova, S; Rubio-Donnadieu, F; Inoue, Y; Osawa, M; Kaneko, S; Oguni, H; Mori, Y; Yamakawa, K			Mutations in EFHC1 cause juvenile myoclonic epilepsy	NATURE GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSY; CHILDHOOD ABSENCE EPILEPSY; E CALCIUM-CHANNEL; GENE; LINKAGE; CANDIDATE; LOCUS; HETEROGENEITY; SUBUNIT; MICE	Juvenile myoclonic epilepsy (JME) is the most frequent cause of hereditary grand mal seizures(1,2). We previously mapped and narrowed a region associated with JME on chromosome 6p12-p11 (EJM1)(3-5). Here, we describe a new gene in this region, EFHC1, which encodes a protein with an EF-hand motif. Mutation analyses identified five missense mutations in EFHC1 that cosegregated with epilepsy or EEG polyspike wave in affected members of six unrelated families with JME and did not occur in 382 control individuals. Overexpression of EFHC1 in mouse hippocampal primary culture neurons induced apoptosis that was significantly lowered by the mutations. Apoptosis was specifically suppressed by SNX-482, an antagonist of R-type voltage-dependent Ca2+ channel (Ca(v)2.3). EFHC1 and Ca(v)2.3 immunomaterials overlapped in mouse brain, and EFHC1 coimmunoprecipitated with the Cav2.3 C terminus. In patch-clamp analysis, EFHC1 specifically increased R-type Ca2+ currents that were reversed by the mutations associated with JME.	RIKEN, Brain Sci Inst, Neurogenet Lab, Wako, Saitama 3510198, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; Univ Calif Los Angeles, David Geffen Sch Med, Comprehens Epilepsy Program, Epilepsy Genet Gen Labs, Los Angeles, CA 90024 USA; VA GLAHS W Los Angeles, W Los Angeles DVA Med Ctr, Los Angeles, CA 90073 USA; Natl Inst Neurol & Neurosurg, Mexico City, DF, Mexico; Grad Univ Adv Studies, Ctr Integrat Biosci, Okazaki, Aichi, Japan; Kyoto Univ, Grad Sch Engn, Kyoto, Japan; Natl Autonomous Univ, Tegucigalpa, Honduras; Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Los Angeles, CA USA; Shizuoka Med Inst Neurol Disorders, Natl Epilepsy Ctr, Shizuoka, Japan; Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan; Hirosaki Univ, Sch Med, Dept Neuropsychiat, Aomori, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Kyoto University; Universidad Nacional Autonoma de Honduras; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tokyo Women's Medical University; Hirosaki University	Delgado-Escueta, AV (corresponding author), RIKEN, Brain Sci Inst, Neurogenet Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	escueta@ucla.edu; yamakawa@brain.riken.go.jp	Numata, Tomohiro/AAW-2453-2020; shi, jun/C-2389-2011; Ochoa, Adriana/AAU-2918-2020; Jara-Prado, Aurelio/AAU-3017-2020; Numata, Tomohiro/AAC-2330-2021; Ganesh, Subramniam/B-4131-2009; Yamakawa, Kazuhiro/N-5050-2015; Rasmussen, Astrid/A-4878-2013	Numata, Tomohiro/0000-0002-5719-4884; Ochoa, Adriana/0000-0003-1084-2984; Numata, Tomohiro/0000-0002-5719-4884; Yamakawa, Kazuhiro/0000-0002-1478-4390; Rasmussen, Astrid/0000-0001-7744-2948; Medina, Marco Tulio/0000-0003-0469-054X; Delgado-Escueta, Antonio V./0000-0002-1581-6999; Suzuki, Toshimitsu/0000-0003-0585-5692; Jara-Prado, Aurelio/0000-0001-8985-3744; Nishida, Motohiro/0000-0002-2587-5458				Bai DS, 2002, AM J MED GENET, V113, P268, DOI 10.1002/ajmg.10724; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Delgado-Escueta A V, 1999, Adv Neurol, V79, P351; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; JANZ D, 1957, J NEUROL, V176, P344; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LIU AW, 1995, AM J HUM GENET, V57, P368; Liu AW, 1996, AM J MED GENET, V63, P438; Meencke H J, 1999, Adv Neurol, V79, P123; Morita R, 1999, EPILEPSY RES, V37, P151, DOI 10.1016/S0920-1211(99)00061-3; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; NIIDOME T, 1992, FEBS LETT, V308, P7, DOI 10.1016/0014-5793(92)81038-N; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Pinto D, 2004, EPILEPSIA, V45, P211, DOI 10.1111/j.0013-9580.2004.36003.x; Saegusa H, 2000, P NATL ACAD SCI USA, V97, P6132, DOI 10.1073/pnas.100124197; Sander T, 1997, NEUROLOGY, V49, P842, DOI 10.1212/WNL.49.3.842; Sugimoto Y, 2000, GENOMICS, V68, P264, DOI 10.1006/geno.2000.6296; Suzuki T, 2002, EPILEPSY RES, V50, P265, DOI 10.1016/S0920-1211(02)00052-9; Virtaneva K, 1997, NAT GENET, V15, P393, DOI 10.1038/ng0497-393; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Woermann FG, 1998, BRAIN, V121, P1661, DOI 10.1093/brain/121.9.1661; YOKOYAMA CT, 1995, J NEUROSCI, V15, P6419	29	244	259	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					842	849		10.1038/ng1393	http://dx.doi.org/10.1038/ng1393			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15258581				2022-12-27	WOS:000222974000016
J	Roy, CN; Custodio, AO; de Graaf, J; Schneider, S; Akpan, I; Montross, LK; Sanchez, M; Gaudino, A; Hentze, MW; Andrews, NC; Muckenthaler, MU				Roy, CN; Custodio, AO; de Graaf, J; Schneider, S; Akpan, I; Montross, LK; Sanchez, M; Gaudino, A; Hentze, MW; Andrews, NC; Muckenthaler, MU			An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-4; ACUTE-PHASE PROTEINS; PEPTIDE HEPCIDIN; IRON-DEFICIENCY; MOUSE MODEL; ANEMIA; EXPRESSION; GENE; LIVER	Inflammation influences iron balance in the whole organism. A common clinical manifestation of these changes is anemia of chronic disease (ACD; also called anemia of inflammation). Inflammation reduces duodenal iron absorption and increases macrophage iron retention, resulting in low serum iron concentrations (hyposideremia). Despite the protection hyposideremia provides against proliferating microorganisms, this iron withholding reduces the iron available to maturing red blood cells and eventually contributes to the development of anemia(1). Hepcidin antimicrobial peptide (Hamp) is a hepatic defensin-like peptide hormone(2,3) that inhibits duodenal iron absorption and macrophage iron release(4-7). Hamp is part of the type II acute phase response 8 and is thought to have a crucial regulatory role in sequestering iron in the context of ACD(7,9). Mice with deficiencies in the hemochromatosis gene product, Hfe, mounted a general inflammatory response after injection of lipopolysaccharide but lacked appropriate Hamp expression and did not develop hyposideremia. These data suggest a previously unidentified role for Hfe in innate immunity and ACD.	Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Howard Hughes Medical Institute	Andrews, NC (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	hentze@embl.de; nandrews@enders.tch.harvard.edu	Sanchez, Mayka/F-5140-2010; Hentze, Matthias W/V-3980-2017	Sanchez, Mayka/0000-0002-6499-5989; Hentze, Matthias W/0000-0002-4023-7876; Muckenthaler, Martina/0000-0002-3778-510X; Andrews, Nancy/0000-0003-0243-4462; Akpan, Imo/0000-0002-6793-599X; Custodio, Angel Omar/0000-0003-0916-2826				ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319; Bopst M, 1998, EUR J IMMUNOL, V28, P4130, DOI 10.1002/(SICI)1521-4141(199812)28:12<4130::AID-IMMU4130>3.0.CO;2-W; Davis D, 1997, BRIT J RHEUMATOL, V36, P950; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GORDEUK VR, 1988, J CLIN INVEST, V82, P1934, DOI 10.1172/JCI113812; Kaplan J, 2002, CELL, V111, P603, DOI 10.1016/S0092-8674(02)01164-9; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; LEE GR, 1983, SEMIN HEMATOL, V20, P61; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; MUENCH KH, 1989, AM J MED, V87, pN40; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Richter A, 2002, BIOTECHNIQUES, V33, P620, DOI 10.2144/02333rr05_11834a; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; Torrance J.D., 1980, METHODS HEMATOLOGY, P104; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	30	98	104	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					481	485		10.1038/ng1350	http://dx.doi.org/10.1038/ng1350			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15098034	Bronze			2022-12-27	WOS:000221183000020
J	Su, RC; Brown, KE; Saaber, S; Fisher, AG; Merkenschlager, M; Smale, ST				Su, RC; Brown, KE; Saaber, S; Fisher, AG; Merkenschlager, M; Smale, ST			Dynamic assembly of silent chromatin during thymocyte maturation	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; NUCLEAR-ORGANIZATION; GENE-EXPRESSION; METHYLATION; HISTONE; HETEROCHROMATIN; PROTEINS; TRANSCRIPTION; ESTABLISHMENT; COMPETITION	Considerable knowledge has been gained from temporal analyses of molecular events culminating in gene activation(1), but technical hurdles have hindered comparable studies of gene silencing. Here we describe the temporal assembly of silent chromatin at the mouse terminal transferase gene (Dntt), which is silenced and repositioned to pericentromeric heterochromatin during thymocyte maturation(2). Silencing was nucleated at the Dntt promoter by the ordered deacetylation of histone H3 at Lys9 (H3-Lys9), loss of methylation at H3-Lys4 and acquisition of methylation at H3-Lys9, followed by bidirectional spreading of each event. Deacetylation at H3-Lys9 coincided with pericentromeric repositioning, and neither of these early events required de novo protein synthesis. CpG methylation increased primarily in mature T cells that had left the thymus. A transformed thymocyte line supported reversible inactivation of Dntt without repositioning. In these cells, histone modification changes were nucleated at the promoter but did not spread. These results provide a foundation for elucidating the mechanisms of silent chromatin assembly during development.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Imperial College London	Smale, ST (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu		Merkenschlager, Matthias/0000-0003-2889-3288	Medical Research Council [MC_U120081295] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brockdorff N, 2002, TRENDS GENET, V18, P352, DOI 10.1016/S0168-9525(02)02717-8; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fisher AG, 2002, CURR OPIN GENET DEV, V12, P193, DOI 10.1016/S0959-437X(02)00286-1; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; GROVES T, 1995, J IMMUNOL, V154, P5011; GROVES T, 1997, J IMMUNOL, V158, P67; Guidos CJ, 1996, CURR OPIN IMMUNOL, V8, P225, DOI 10.1016/S0952-7915(96)80061-6; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	24	117	120	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					502	506		10.1038/ng1351	http://dx.doi.org/10.1038/ng1351			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15098035	Bronze			2022-12-27	WOS:000221183000024
J	Helgadottir, A; Manolescu, A; Thorleifsson, G; Gretarsdottir, S; Jonsdottir, H; Thorsteinsdottir, U; Samani, NJ; Gudmundsson, G; Grant, SFA; Thorgeirsson, G; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Johannsson, H; Gudmundsdottir, O; Gurney, ME; Sainz, J; Thorhallsdottir, M; Andresdottir, M; Frigge, ML; Topol, EJ; Kong, A; Gudnason, V; Hakonarson, H; Gulcher, JR; Stefansson, K				Helgadottir, A; Manolescu, A; Thorleifsson, G; Gretarsdottir, S; Jonsdottir, H; Thorsteinsdottir, U; Samani, NJ; Gudmundsson, G; Grant, SFA; Thorgeirsson, G; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Johannsson, H; Gudmundsdottir, O; Gurney, ME; Sainz, J; Thorhallsdottir, M; Andresdottir, M; Frigge, ML; Topol, EJ; Kong, A; Gudnason, V; Hakonarson, H; Gulcher, JR; Stefansson, K			The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; CORONARY; SUSCEPTIBILITY; LEUKOTRIENES; DISEASE; POLYMORPHISMS; LOCALIZATION; SUGGESTS; LOCUS; CELLS	We mapped a gene predisposing to myocardial infarction to a locus on chromosome 13q12-13. A four-marker single-nucleotide polymorphism (SNP) haplotype in this locus spanning the gene ALOX5AP encoding 5-lipoxygenase activating protein (FLAP) is associated with a two times greater risk of myocardial infarction in Iceland. This haplotype also confers almost two times greater risk of stroke. Another ALOX5AP haplotype is associated with myocardial infarction in individuals from the UK. Stimulated neutrophils from individuals with myocardial infarction produce more leukotriene B4, a key product in the 5-lipoxygenase pathway, than do neutrophils from controls, and this difference is largely attributed to cells from males who carry the at-risk haplotype. We conclude that variants of ALOX5AP are involved in the pathogenesis of both myocardial infarction and stroke by increasing leukotriene production and inflammation in the arterial wall.	deCODE Genet, Reykjavik, Iceland; Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Iceland Heart Assoc, Reykjavik, Iceland	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Landspitali National University Hospital; Cleveland Clinic Foundation; Icelandic Heart Association	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, Reykjavik, Iceland.	kstefans@decode.is	Gudnason, Vilmundur/K-6885-2015; Stefansson, Kari/AAE-7187-2019; Manolescu, Andrei/G-4565-2014; Gudnason, Vilmundur/AAE-7126-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Manolescu, Andrei/0000-0002-0713-4664; Gudnason, Vilmundur/0000-0001-5696-0084; Topol, Eric/0000-0002-1478-4729; Grant, Struan/0000-0003-2025-5302				Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; *AM HEART ASS, 2002, HEART DIS STROK STAT; [Anonymous], 1979, Circulation, V59, P607; Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; BURKE JA, 1982, J PHARMACOL EXP THER, V221, P235; Chen XN, 1997, P NATL ACAD SCI USA, V94, P10756, DOI 10.1073/pnas.94.20.10756; DAHINDEN CA, 1985, P NATL ACAD SCI USA, V82, P6632, DOI 10.1073/pnas.82.19.6632; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gudmundsson G, 2002, AM J HUM GENET, V70, P586, DOI 10.1086/339251; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; HILL WG, 1968, GENETICS, V60, P615; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Koshino T, 1999, Mol Cell Biol Res Commun, V2, P32, DOI 10.1006/mcbr.1999.0147; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LEWONTIN RC, 1964, GENETICS, V50, P757; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; NICOLAE D, 1999, ALLELE SHARING MODEL; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; POOLE JCF, 1958, J PATHOL BACTERIOL, V75, P245, DOI 10.1002/path.1700750202; ROTH DM, 1983, PROSTAGLANDINS, V26, P573, DOI 10.1016/0090-6980(83)90195-8; Sala A, 1996, J BIOL CHEM, V271, P17944, DOI 10.1074/jbc.271.30.17944; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Steeds R, 1998, THROMB HAEMOSTASIS, V79, P980; STRATFORD N, 1986, ATHEROSCLEROSIS, V59, P271, DOI 10.1016/0021-9150(86)90122-X; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; WARGOVICH T, 1985, J AM COLL CARDIOL, V6, P1047, DOI 10.1016/S0735-1097(85)80307-7; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445	50	745	821	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					233	239		10.1038/ng1311	http://dx.doi.org/10.1038/ng1311			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14770184	Bronze			2022-12-27	WOS:000189250400011
J	Jeffreys, AJ; May, CA				Jeffreys, AJ; May, CA			Intense and highly localized gene conversion activity in human meiotic crossover hot spots	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; HAPLOTYPE BLOCKS; HUMAN GENOME; SACCHAROMYCES-CEREVISIAE; INITIATION SITE; RECOMBINATION; LOCUS; MUTATION; CHROMOSOMES; DIVERSITY	Meiotic gene conversion has an important role in allele diversification and in the homogenization of gene and other repeat DNA sequence families(1-5), sometimes with pathological consequences(6,7). But little is known about the dynamics of gene conversion in humans and its relationship to meiotic crossover. We therefore developed screening and selection methods to characterize sperm conversions in two meiotic crossover hot spots in the major histocompatibility complex (MHC)(8) and one in the sex chromosomal pseudoautosomal pairing region PAR1 (ref. 9). All three hot spots are active in gene conversion and crossover. Conversion tracts are short and define a steep bidirectional gradient centered at the peak of crossover activity, consistent with crossovers and conversions being produced by the same recombination-initiating events. These initiations seem to be spread over a narrow zone, rather than occurring at a single site, and seem preferentially to yield conversions rather than crossovers. Crossover breakpoints are more broadly diffused than conversion breakpoints, suggesting either differences between conversion and crossover processing after initiation or the existence of a quality control checkpoint at which short interactions between homologous chromosomes are preferentially aborted as conversions.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@le.ac.uk		May, Celia/0000-0001-8541-2458				Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; BORTS RH, 1989, GENETICS, V123, P69; CLARKE SH, 1982, P NATL ACAD SCI-BIOL, V79, P3280, DOI 10.1073/pnas.79.10.3280; COLLIER S, 1993, NAT GENET, V3, P260, DOI 10.1038/ng0393-260; ERLICH HA, 1991, IMMUNOL TODAY, V12, P411, DOI 10.1016/0167-5699(91)90143-H; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Guillon H, 2002, NAT GENET, V32, P296, DOI 10.1038/ng990; HILLIKER AJ, 1994, GENETICS, V137, P1019; HUANG MM, 1995, HUM MUTAT, V6, P303, DOI 10.1002/humu.1380060404; Jaatinen T, 2002, J IMMUNOL, V168, P5652, DOI 10.4049/jimmunol.168.11.5652; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 2003, GENOME RES, V13, P2316, DOI 10.1101/gr.1214603; JINKSROBERTSON S, 1985, P NATL ACAD SCI USA, V82, P3350, DOI 10.1073/pnas.82.10.3350; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Koppens PFJ, 2002, HUM MOL GENET, V11, P2581, DOI 10.1093/hmg/11.21.2581; Losekoot M, 1997, J MED GENET, V34, P924, DOI 10.1136/jmg.34.11.924; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Ogasawara K, 2001, IMMUNOGENETICS, V53, P190, DOI 10.1007/s002510100315; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; POWERS PA, 1986, GENETICS, V112, P343; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; SCHULTES NP, 1990, GENETICS, V126, P813; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Watnick TJ, 1998, HUM MOL GENET, V7, P1239, DOI 10.1093/hmg/7.8.1239; ZANGENBERG G, 1995, NAT GENET, V10, P407, DOI 10.1038/ng0895-407	30	224	231	0	11	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2004	36	2					151	156		10.1038/ng1287	http://dx.doi.org/10.1038/ng1287			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14704667	Bronze			2022-12-27	WOS:000188542700016
J	Oshima, K; Kakizawa, S; Nishigawa, H; Jung, HY; Wei, W; Suzuki, S; Arashida, R; Nakata, D; Miyata, S; Ugaki, M; Namba, S				Oshima, K; Kakizawa, S; Nishigawa, H; Jung, HY; Wei, W; Suzuki, S; Arashida, R; Nakata, D; Miyata, S; Ugaki, M; Namba, S			Reductive evolution suggested from the complete genome sequence of a plant-pathogenic phytoplasma	NATURE GENETICS			English	Article							DIVERSITY	The minimal gene set essential for life has long been sought. We report the 860-kb genome of the obligate intracellular plant pathogen phytoplasma (Candidatus Phytoplasma asteris, OY strain). The phytoplasma genome encodes even fewer metabolic functions than do mycoplasma genomes. It lacks the pentose phosphate cycle and, more unexpectedly, ATP-synthase subunits, which are thought to be essential for life. This may be the result of reductive evolution as a consequence of life as an intracellular parasite in a nutrient-rich environment.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Namba, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, 202 Biosci Bldg,5-1-5 Kashiwanoha, Chiba 2778562, Japan.		kakizawa, shigeyuki/L-8901-2018; Suzuki, Shiho/Z-4458-2019	kakizawa, shigeyuki/0000-0003-3885-4434; Oshima, Kenro/0000-0001-7327-4481; Suzuki, Shiho/0000-0003-3168-1729; WEI, WEI/0000-0003-3561-913X				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; DOI Y., 1967, Annals of the Phytopathological Society of Japan, V33, P259; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; NAMBA S, 1993, INT J SYST BACTERIOL, V43, P461, DOI 10.1099/00207713-43-3-461; Nishigawa H, 2002, MICROBIOL-SGM, V148, P1389, DOI 10.1099/00221287-148-5-1389; Oshima K, 2001, PHYTOPATHOLOGY, V91, P1024, DOI 10.1094/PHYTO.2001.91.11.1024; Oshima Kenro, 2002, Journal of General Plant Pathology, V68, P225, DOI 10.1007/PL00013081; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931	15	321	486	0	34	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					27	29		10.1038/ng1277	http://dx.doi.org/10.1038/ng1277			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14661021	Bronze			2022-12-27	WOS:000187666800010
J	Sheen, VL; Ganesh, VS; Topcu, M; Sebire, G; Bodell, A; Hill, RS; Grant, PE; Shugart, YY; Imitola, J; Khoury, SJ; Guerrini, R; Walsh, CA				Sheen, VL; Ganesh, VS; Topcu, M; Sebire, G; Bodell, A; Hill, RS; Grant, PE; Shugart, YY; Imitola, J; Khoury, SJ; Guerrini, R; Walsh, CA			Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCHANGE PROTEINS; ADP-RIBOSYLATION FACTORS; TRANS-GOLGI NETWORK; BREFELDIN-A; PERIVENTRICULAR HETEROTOPIA; NEURONAL MIGRATION; CORTICAL SIZE; CELL-ADHESION; GROWTH; BIG2	Disruption of human neural precursor proliferation can give rise to a small brain ( microcephaly), and failure of neurons to migrate properly can lead to an abnormal arrest of cerebral cortical neurons in proliferative zones near the lateral ventricles (periventricular heterotopia). Here we show that an autosomal recessive condition characterized by microcephaly and periventricular heterotopia 1 maps to chromosome 20 and is caused by mutations in the gene ADP-ribosylation factor guanine nucleotide-exchange factor-2 (ARFGEF2). By northern-blot analysis, we found that mouse Arfgef2 mRNA levels are highest during embryonic periods of ongoing neuronal proliferation and migration, and by in situ hybridization, we found that the mRNA is widely distributed throughout the embryonic central nervous system (CNS). ARFGEF2 encodes the large (>200 kDa) brefeldin A (BFA)-inhibited GEF2 protein (BIG2), which is required for vesicle and membrane trafficking from the trans-Golgi network (TGN). Inhibition of BIG2 by BFA, or by a dominant negative ARFGEF2 cDNA, decreases cell proliferation in vitro, suggesting a cell-autonomous regulation of neural expansion. Inhibition of BIG2 also disturbed the intracellular localization of such molecules as E-cadherin and beta-catenin by preventing their transport from the Golgi apparatus to the cell surface. Our findings show that vesicle trafficking is an important regulator of proliferation and migration during human cerebral cortical development.	Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol,Beth Israel Diaconess Med Ctr, Boston, MA 02115 USA; Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat Neurol, TR-06100 Ankara, Turkey; Univ Sherbrooke, CHU Fleurimont, Dept Pediat Neurol, Sherbrooke, PQ J1H 5N4, Canada; Harvard Univ, Sch Med, Athinoula A Marinos Ctr Biomed Imaging, Massachusetts Gen Hosp,Dept Pediat Neuroradiol, Boston, MA 02114 USA; Johns Hopkins Med Sch, Dept Pediat Epidemiol, Baltimore, MD 21205 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; Univ Pisa, Div Child Neurol & Psychiat, Epilepsy Neurophysiol & Neurogenet Unit, I-56018 Pisa, Italy; IRCCS Fdn Stella Maris, I-56018 Pisa, Italy; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Hacettepe University; University of Sherbrooke; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pisa; IRCCS Fondazione Stella Maris; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA.		Grant, Peter/HIR-3733-2022	Walsh, Christopher/0000-0002-0156-2238; khoury, samia/0000-0003-3198-6063; Grant, Patricia/0000-0003-1005-4013; YAO, YIN/0000-0003-3053-8429; Guerrini, Renzo/0000-0002-7272-7079	NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH063886] Funding Source: NIH RePORTER; NIMH NIH HHS [K08 MH063886] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bonifacino JS, 2003, CELL, V112, P141, DOI 10.1016/S0092-8674(03)00038-2; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Jareb M, 1997, J NEUROSCI, V17, P8955; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Pacheco-Rodriguez G, 2002, METHOD ENZYMOL, V345, P397; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Ruthel G, 1999, J NEUROBIOL, V39, P97, DOI 10.1002/(SICI)1097-4695(199904)39:1<97::AID-NEU8>3.0.CO;2-Z; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SHEEN VL, 1994, EXP NEUROL, V130, P67, DOI 10.1006/exnr.1994.1186; Sheen VL, 2003, NEUROLOGY, V60, P1108, DOI 10.1212/01.WNL.0000055898.00349.02; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Sheen Volney L, 2003, Curr Neurol Neurosci Rep, V3, P433, DOI 10.1007/s11910-003-0027-8; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567	30	261	270	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					69	76		10.1038/ng1276	http://dx.doi.org/10.1038/ng1276			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14647276	Bronze			2022-12-27	WOS:000187666800016
J	Olbrich, H; Fliegauf, M; Hoefele, J; Kispert, A; Otto, E; Volz, A; Wolf, MT; Sasmaz, G; Trauer, U; Reinhardt, R; Sudbrak, R; Antignac, C; Gretz, N; Walz, G; Schermer, B; Benzing, T; Hildebrandt, F; Omran, H				Olbrich, H; Fliegauf, M; Hoefele, J; Kispert, A; Otto, E; Volz, A; Wolf, MT; Sasmaz, G; Trauer, U; Reinhardt, R; Sudbrak, R; Antignac, C; Gretz, N; Walz, G; Schermer, B; Benzing, T; Hildebrandt, F; Omran, H			Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; SENIOR-LOKEN-SYNDROME; FAMILIAL NEPHROPATHY; PROTEIN; PROGRESSION; INTERACTS; LOCUS; IDENTIFICATION; NEPHROCYSTIN; P130(CAS)	Nephronophthisis (NPHP), a group of autosomal recessive cystic kidney disorders, is the most common genetic cause of progressive renal failure in children and young adults(1). NPHP may be associated with Leber congenital amaurosis, tapetoretinal degeneration, cerebellar ataxia, cone-shaped epiphyses, congenital oculomotor apraxia and hepatic fibrosis(2-6). Loci associated with an infantile type of NPHP on 9q22-q31 (NPHP2), juvenile types of NPHP on chromosomes 2q12-q13 (NPHP1) and 1p36 (NPHP4) and an adolescent type of NPHP on 3q21-q22 (NPHP3) have been mapped(7-10). NPHP1 and NPHP4 have been identified(11-13), and interaction of the respective encoded proteins nephrocystin and nephrocystin-4 has been shown(13). Here we report the identification of NPHP3, encoding a novel 1,330-amino acid protein that interacts with nephrocystin. We describe mutations in NPHP3 in families with isolated NPHP and in families with NPHP with associated hepatic fibrosis or tapeto-retinal degeneration. We show that the mouse ortholog Nphp3 is expressed in the node, kidney tubules, retina, respiratory epithelium, liver, biliary tract and neural tissues. In addition, we show that a homozygous missense mutation in Nphp3 is probably responsible for the polycystic kidney disease (pcy) mouse phenotype(14). Interventional studies in the pcy mouse have shown beneficial effects by modification of protein intake and administration of methylprednisolone(15-17), suggesting therapeutic strategies for treating individuals with NPHP3.	Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Hannover Med Sch, Inst Mol Biol, Hannover, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Univ Paris 05, Necker Hosp, Dept Genet, Paris, France; Heidelberg Univ, Klinikum Mannheim, Med Res Ctr, D-68167 Mannheim, Germany; Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; Univ Hosp Freiburg, Clin Res Ctr, D-79106 Freiburg, Germany	University of Freiburg; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hannover Medical School; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg	Omran, H (corresponding author), Univ Hosp Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany.	omran@kikli.ukl.uni-freiburg.de	Volz, Andreas/AAA-6290-2019; Hoefele, Julia/AAB-6448-2020; Schermer, Bernhard/E-9972-2014; Sudbrak, Ralf/HHZ-8821-2022; Benzing, Thomas/X-5476-2019; ANTIGNAC, Corinne/H-8945-2017	Hoefele, Julia/0000-0002-7917-7129; Schermer, Bernhard/0000-0002-5194-9000; Otto, Edgar/0000-0002-2387-9973; Omran, Heymut/0000-0003-0282-6765; ANTIGNAC, Corinne/0000-0002-9934-4940; Reinhardt, Richard/0000-0001-9376-2132				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; AUKEMA HM, 1992, KIDNEY INT, V42, P837, DOI 10.1038/ki.1992.358; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; BOICHIS H, 1973, Q J MED, V42, P221; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Erck C, 2000, NEUROCHEM RES, V25, P5, DOI 10.1023/A:1007523028834; GATTONE VH, 1995, AM J KIDNEY DIS, V25, P302, DOI 10.1016/0272-6386(95)90013-6; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2001, PEDIATR NEPHROL, V16, P168, DOI 10.1007/s004670000518; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; MAINZER F, 1970, AM J MED, V49, P556, DOI 10.1016/S0002-9343(70)80051-1; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175; Omran H, 2000, AM J HUM GENET, V66, P118, DOI 10.1086/302705; Omran H, 2001, NEPHROL DIAL TRANSPL, V16, P755, DOI 10.1093/ndt/16.4.755; Omran H, 2001, J AM SOC NEPHROL, V12, P107, DOI 10.1681/ASN.V121107; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; TAKAHASHI H, 1986, J UROLOGY, V135, P1280, DOI 10.1016/S0022-5347(17)46074-5; Tomobe K, 1998, AM J KIDNEY DIS, V31, P55, DOI 10.1053/ajkd.1998.v31.pm9428452; Volz A, 2002, CYTOGENET GENOME RES, V97, P163, DOI 10.1159/000066617	29	257	271	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					455	459		10.1038/ng1216	http://dx.doi.org/10.1038/ng1216			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12872122				2022-12-27	WOS:000184470500026
J	Toyo-oka, K; Shionoya, A; Gambello, MJ; Cardoso, C; Leventer, R; Ward, HL; Ayala, R; Tsai, LH; Dobyns, W; Ledbetter, D; Hirotsune, S; Wynshaw-Boris, A				Toyo-oka, K; Shionoya, A; Gambello, MJ; Cardoso, C; Leventer, R; Ward, HL; Ayala, R; Tsai, LH; Dobyns, W; Ledbetter, D; Hirotsune, S; Wynshaw-Boris, A			14-3-3 epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome	NATURE GENETICS			English	Article							PROTEIN PHOSPHATASE 2A; CYTOPLASMIC DYNEIN; CORTICAL DEVELOPMENT; EMBRYONIC LETHALITY; LISSENCEPHALY GENE; LIS1 GENE; PHOSPHORYLATION; DROSOPHILA; CDK5; MALFORMATION	Heterozygous deletions of 17p13.3 result in the human neuronal migration disorders isolated lissencephaly sequence (ILS) and the more severe Miller Dieker syndrome (MDS). Mutations in PAFAH1B1 (the gene encoding LIS1) are responsible for ILS and contribute to MDS, but the genetic causes of the greater severity of MDS are unknown. Here, we show that the gene encoding 14-3-3epsilon (YWHAE), one of a family of ubiquitous phosphoserine/threonine binding proteins, is always deleted in individuals with MDS. Mice deficient in Ywhae have defects in brain development and neuronal migration, similar to defects observed in mice heterozygous with respect to Pafah1b1. Mice heterozygous with respect to both genes have more severe migration defects than single heterozygotes. 14-3-3epsilon binds to CDK5/p35-phosphorylated NUDEL and this binding maintains NUDEL phosphorylation. Similar to LIS1, deficiency of 14-3-3epsilon results in mislocalization of NUDEL and LIS1, consistent with reduction of cytoplasmic dynein function. These results establish a crucial role for 14-3-3epsilon in neuronal development by sustaining the effects of CDK5 phosphorylation and provide a molecular explanation for the differences in severity of human neuronal migration defects with 17p13.3 deletions.	Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Ctr Canc, La Jolla, CA 92093 USA; Japan Sci & Technol Corp, Ctr Genome Med Sci, Saitama Med Sch, PRESTO, Hidaka, Saitama 3501241, Japan; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02115 USA; Fac Med Timone, INSERM, U491, F-13385 Marseille 05, France; Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; Japan Science & Technology Agency (JST); Saitama Medical University; University of Chicago; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Wynshaw-Boris, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Canc, 9500 Gilman Dr,Mailstop 0627, La Jolla, CA 92093 USA.		Dobyns, William Brian/ABC-6525-2021; Toyooka, Kazuhito/AAQ-6928-2020; Cardoso, Carlos/M-2767-2019; Cardoso, Carlos/H-4520-2016; Dobyns, William/AAI-2768-2020; Toyooka, Kazuhito/AAH-7175-2019	Toyooka, Kazuhito/0000-0002-0173-0430; Cardoso, Carlos/0000-0003-1914-9553; Cardoso, Carlos/0000-0003-1914-9553; Dobyns, William/0000-0002-7681-2844; Toyooka, Kazuhito/0000-0002-0173-0430				Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fleck MW, 2000, J NEUROSCI, V20, P2439; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Huang DQ, 1999, P NATL ACAD SCI USA, V96, P14445, DOI 10.1073/pnas.96.25.14445; LEDBETTER SA, 1992, AM J HUM GENET, V50, P182; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Price NE, 1999, MOL BRAIN RES, V73, P68, DOI 10.1016/S0169-328X(99)00237-5; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tsuda M, 2002, CELL GROWTH DIFFER, V13, P131; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; VEERANNA, 1995, J NEUROCHEM, V64, P2681; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Weinstein DE, 1999, DEV BRAIN RES, V116, P29, DOI 10.1016/S0165-3806(99)00072-3; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003	50	309	327	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					274	285		10.1038/ng1169	http://dx.doi.org/10.1038/ng1169			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796778				2022-12-27	WOS:000183815300014
J	Reich, DE; Gabriel, SB; Altshuler, D				Reich, DE; Gabriel, SB; Altshuler, D			Quality and completeness of SNP databases	NATURE GENETICS			English	Article								To address the quality and completeness of single-nucleotide polymorphism (SNP) databases, we resequenced 173 kb (spanning 17 loci) in 150 chromosomes of west African and European ancestry. Over 88% of SNPs in the public (TSC and BAC overlap) and Celera databases were confirmed in independent resequencing. Approximately 45% of all human heterozygosity is attributable to SNPs already available from the two databases, and of SNPs with minor-allele frequencies >10%, more than half are represented.	MIT, Program Med & Populat Genet, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reich, DE (corresponding author), MIT, Program Med & Populat Genet, Whitehead Inst, Ctr Genome Res, 1 Kendall Sq, Cambridge, MA 02139 USA.		Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107					0	145	150	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					457	458		10.1038/ng1133	http://dx.doi.org/10.1038/ng1133			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12652301	Bronze			2022-12-27	WOS:000181928600012
J	Robertson, SP; Twigg, SRF; Sutherland-Smith, AJ; Biancalana, V; Gorlin, RJ; Horn, D; Kenwrick, SJ; Kim, CA; Morava, E; Newbury-Ecob, R; Orstavik, KH; Quarrell, OWJ; Schwartz, CE; Shears, DJ; Suri, M; Kendrick-Jones, J; Wilkie, AOM				Robertson, SP; Twigg, SRF; Sutherland-Smith, AJ; Biancalana, V; Gorlin, RJ; Horn, D; Kenwrick, SJ; Kim, CA; Morava, E; Newbury-Ecob, R; Orstavik, KH; Quarrell, OWJ; Schwartz, CE; Shears, DJ; Suri, M; Kendrick-Jones, J; Wilkie, AOM		OPD-Spectrum Disorders Clinical Co	Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans	NATURE GENETICS			English	Article							MELNICK-NEEDLES-SYNDROME; SYNDROME TYPE-II; PERIVENTRICULAR HETEROTOPIA; DIGITAL SYNDROME; INACTIVATION; MIGRATION; NEURONS; DOMAIN; LOCUS; MALES	Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. Filamin A, encoded by the gene FLNA, is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers(1,2). We identified localized mutations in FLNA that conserve the reading frame and lead to a broad range of congenital malformations, affecting craniofacial structures, skeleton, brain, viscera and urogenital tract, in four X-linked human disorders: otopalatodigital syndrome types 1 (OPD1; OMIM 311300) and 2 (OPD2; OMIM 304120), frontometaphyseal dysplasia (FMD; OMIM 305620) and Melnick-Needles syndrome (MNS; OMIM 309350). Several mutations are recurrent, and all are clustered into four regions of the gene: the actin-binding domain and rod domain repeats 3, 10 and 14/15. Our findings contrast with previous observations that loss of function of FLNA is embryonic lethal in males but manifests in females as a localized neuronal migration disorder, called periventricular nodular heterotopia (PVNH; refs. 3-6). The patterns of mutation, X-chromosome inactivation and phenotypic manifestations in the newly described mutations indicate that they have gain-of-function effects, implicating. filamin A in signaling pathways that mediate organogenesis in multiple systems during embryonic development.	City Hosp, Clin Genet Serv, Nottingham NG5 1PB, England; Inst Child Hlth, Clin & Mol Genet Unit, London, England; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Sheffield Childrens Hosp, N Trent Clin Genet Serv, Sheffield, S Yorkshire, England; Univ Oslo, Inst Grp Clin Med, Oslo, Norway; United Bristol Hosp Trust, Clin Genet Serv, Bristol, Avon, England; Univ Pecs, Dept Med Genet, Pecs, Hungary; Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; Humboldt Univ, Inst Humangenet, Berlin, Germany; Univ Minnesota, Dept Oral Pathol & Genet, Minneapolis, MN USA; CHRU, Strasbourg, France; Fac Med, Lab Diagnost Genet, Strasbourg, France; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Nottingham; University of London; University College London; Greenwood Genetic Center; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Oslo; University of Pecs; Universidade de Sao Paulo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Humboldt University of Berlin; University of Minnesota System; University of Minnesota Twin Cities; CHU Strasbourg; MRC Laboratory Molecular Biology; University of Oxford	Robertson, SP (corresponding author), Univ Otago, Dept Paediat & Child Hlth, Dunedin, New Zealand.		Sutherland-Smith, Andrew/F-1813-2011; Twigg, Stephen/AAU-1135-2021; Wilkie, Andrew/AAC-3820-2020; Suri, Mohnish/HIK-0223-2022; Biancalana, Valerie/O-2351-2016; VERLOES, Alain/E-7287-2014	Sutherland-Smith, Andrew/0000-0001-9485-1428; Twigg, Stephen/0000-0001-5024-049X; Wilkie, Andrew/0000-0002-2972-5481; Suri, Mohnish/0000-0001-9037-701X; VERLOES, Alain/0000-0003-4819-0264; Kim, Chong/0000-0002-1754-1300; Lacombe, Didier/0000-0002-8956-2207; Robertson, Stephen/0000-0002-5181-7809				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ANDRE M, 1981, J PEDIATR-US, V98, P747, DOI 10.1016/S0022-3476(81)80835-9; BIANCALANA V, 1991, HUM GENET, V88, P228, DOI 10.1007/BF00206078; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; DONNENFELD AE, 1987, AM J MED GENET, V27, P159, DOI 10.1002/ajmg.1320270117; DUDDING BA, 1967, AM J DIS CHILD, V113, P214, DOI 10.1001/archpedi.1967.02090170078006; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FITCH N, 1983, AM J MED GENET, V15, P655, DOI 10.1002/ajmg.1320150416; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN RJ, 1969, AM J DIS CHILD, V118, P487, DOI 10.1001/archpedi.1969.02100040489014; Hassoun H, 1997, BLOOD, V90, P398; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kosho T, 2002, J Med Genet, V39, pE7, DOI 10.1136/jmg.39.2.e7; Kristiansen M, 2002, AM J MED GENET, V108, P120, DOI 10.1002/ajmg.10245; LEMAREC B, 1988, ANN GENET-PARIS, V31, P155; McCoy AJ, 1999, NAT STRUCT BIOL, V6, P836; MELNICK JC, 1966, AMER J ROENTGENOL RA, V97, P39, DOI 10.2214/ajr.97.1.39; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Robertson S, 1997, AM J MED GENET, V71, P341, DOI 10.1002/(SICI)1096-8628(19970822)71:3<341::AID-AJMG16>3.0.CO;2-K; Robertson SP, 2001, AM J HUM GENET, V69, P223, DOI 10.1086/321280; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; STRATTON RF, 1991, AM J MED GENET, V41, P169, DOI 10.1002/ajmg.1320410206; TAYBI H, 1962, AMER J ROENTGENOL RA, V88, P450; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Verloes A, 2000, AM J MED GENET, V90, P407, DOI 10.1002/(SICI)1096-8628(20000228)90:5<407::AID-AJMG11>3.0.CO;2-D	29	304	325	0	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					487	491		10.1038/ng1119	http://dx.doi.org/10.1038/ng1119			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612583	Bronze			2022-12-27	WOS:000181928600019
J	Lappe-Siefke, C; Goebbels, S; Gravel, M; Nicksch, E; Lee, J; Braun, PE; Griffiths, IR; Nave, KA				Lappe-Siefke, C; Goebbels, S; Gravel, M; Nicksch, E; Lee, J; Braun, PE; Griffiths, IR; Nave, KA			Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination	NATURE GENETICS			English	Article							2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; CENTRAL-NERVOUS-SYSTEM; PROTEOLIPID PROTEIN; SPINAL-CORD; CNS MYELIN; SUBCELLULAR-DISTRIBUTION; MULTIPLE-SCLEROSIS; MESSENGER-RNA; MICE; 3-PHOSPHODIESTERASE	Myelination of axons by oligodendrocytes enables rapid impulse propagation in the central nervous system. But long-term interactions between axons and their myelin sheaths are poorly understood. Here we show that Cnp1, which encodes 2',3'-cyclic nucleotide phosphodiesterase in oligodendrocytes, is essential for axonal survival but not for myelin assembly. In the absence of glial cyclic nucleotide phosphodiesterase, mice developed axonal swellings and neurodegeneration throughout the brain, leading to hydrocephalus and premature death. But, in contrast to previously studied myelin mutants, the ultrastructure, periodicity and physical stability of myelin were not altered in these mice. Genetically, the chief function of glia in supporting axonal integrity can thus be completely uncoupled from its function in maintaining compact myelin. Oligodendrocyte dysfunction, such as that in multiple sclerosis lesions, may suffice to cause secondary axonal loss.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Univ Glasgow, Appl Neurobiol Grp, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland	Max Planck Society; McGill University; University of Glasgow	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany.	nave@em.mpg.de	Nave, Klaus-Armin/C-8883-2011; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				AGRAWAL HC, 1990, J BIOL CHEM, V265, P11849; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Ballestero RP, 1999, J NEUROCHEM, V72, P1362, DOI 10.1046/j.1471-4159.1999.721362.x; BENNETT SAL, 1995, ACTA NEUROPATHOL, V89, P126; Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; BOISON D, 1995, J NEUROSCI, V15, P5502; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BRAUN PE, 1988, J NEUROSCI, V8, P3057; BRAUN PE, 1991, J NEUROSCI RES, V30, P540, DOI 10.1002/jnr.490300311; Chandross KJ, 1999, J NEUROSCI, V19, P759, DOI 10.1523/jneurosci.19-02-00759.1999; DEANGELIS D, 1994, NATO ADV SCI INST SE, V258, P49; DEANGELIS DA, 1994, J NEUROSCI RES, V39, P386, DOI 10.1002/jnr.490390405; Gallyas F, 1979, Neurol Res, V1, P203; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GIULIAN D, 1980, J BIOL CHEM, V255, P5993; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Gravel M, 1996, MOL CELL NEUROSCI, V7, P453, DOI 10.1006/mcne.1996.0033; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; GRIFFITHS IR, 1981, J NEUROCYTOL, V10, P847, DOI 10.1007/BF01262657; Heaton PA, 1996, NUCLEIC ACIDS RES, V24, P850, DOI 10.1093/nar/24.5.850; HOTCHKISS RD, 1948, ARCH BIOCHEM, V16, P131; Joyner AL, 1993, GENE TARGETING PRACT; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; KURIHARA T, 1967, J NEUROCHEM, V14, P1167, DOI 10.1111/j.1471-4159.1967.tb06164.x; Laezza C, 1997, FEBS LETT, V413, P260, DOI 10.1016/S0014-5793(97)00924-1; Lee J, 2002, J NEUROCHEM, V81, P65; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; McFerran BW, 1997, J CELL SCI, V110, P2979; NAVE KA, 2002, GLIAL CELL DEV; NISHIZAWA Y, 1985, NEUROCHEM RES, V10, P1107, DOI 10.1007/BF00965885; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; ONeill RC, 1997, J NEUROSCI RES, V50, P248; Raine C., 1984, MYELIN, P1, DOI 10.1007/978-1-4757-1830-0_1; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Rosenbluth J, 1996, J COMP NEUROL, V371, P336, DOI 10.1002/(SICI)1096-9861(19960722)371:2<336::AID-CNE12>3.0.CO;2-Q; SCHERER SS, 1994, NEURON, V12, P1363, DOI 10.1016/0896-6273(94)90451-0; Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2; SOGIN DC, 1976, J NEUROCHEM, V27, P1333, DOI 10.1111/j.1471-4159.1976.tb02612.x; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; SPRINKLE TJ, 1985, NEUROCHEM RES, V10, P919, DOI 10.1007/BF00964629; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Tsukada Yasuzo, 1992, P449; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; Yin X, 1997, J NEUROSCI RES, V50, P238, DOI 10.1002/(SICI)1097-4547(19971015)50:2<238::AID-JNR12>3.0.CO;2-4; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2	48	724	734	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					366	374		10.1038/ng1095	http://dx.doi.org/10.1038/ng1095			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590258				2022-12-27	WOS:000181312700013
J	Schoenherr, CJ; Levorse, JM; Tilghman, SM				Schoenherr, CJ; Levorse, JM; Tilghman, SM			CTCF maintains differential methylation at the Igf2/H19 locus	NATURE GENETICS			English	Article							MOUSE H19 GENE; IMPRINTED EXPRESSION; H19/IGF2 LOCUS; CPG ISLAND; REGION; DNA; INSULATOR; UPSTREAM; DELETION	Genomic imprinting relies on establishing and maintaining the parental-specific methylation of DNA elements that control the differential expression of maternal and paternal alleles. Although the essential DNA methyltransferases have been discovered, proteins that regulate the sequence-specific establishment and maintenance of allelic methylation have not been identified. One candidate regulator of methylation, the zinc-finger protein CTCF, binds to the imprinting control region (ICR) of the genes Igf2 (encoding insulin-like growth factor 2) and H19 (fetal liver mRNA; refs. 1,2). The unmethylated maternal ICR is a chromatin boundary that prevents distant enhancers from activating Igf2 (refs. 3-6). In vitro experiments have suggested that CTCF mediates boundary activity of the maternal ICR, and that methylation of the paternal ICR abolishes this activity by preventing CTCF binding(3,4,6). Using mice with point mutations in all four CTCF sites in the ICR, we show that maternally transmitted mutant ICRs in neonatal mice acquire a substantial but heterogeneous degree of methylation. Mutant ICRs in oocytes and blastocysts are not methylated, however, indicating that binding of CTCF is not required to establish the unmethylated ICR during oogenesis. We also show that the mutant ICR lacks enhancer-blocking activity, as the expression of Igf2 is activated on mutant maternal chromosomes. Conversely, maternal H19 expression is reduced, suggesting a positive role for CTCF in the transcription of that gene. This study constitutes the first in vivo demonstration of the multiple functions of CTCF in an ICR.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Princeton University; Princeton University; University of Illinois System; University of Illinois Urbana-Champaign	Schoenherr, CJ (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.							Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hata K, 2002, DEVELOPMENT, V129, P1983; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Jirtle RL, 1999, EXP CELL RES, V248, P18, DOI 10.1006/excr.1999.4453; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Kaffer CR, 2000, GENE DEV, V14, P1908; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Srivastava M, 2000, GENE DEV, V14, P1186; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422	25	233	249	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					66	69		10.1038/ng1057	http://dx.doi.org/10.1038/ng1057			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12461525				2022-12-27	WOS:000180136100019
J	Prokunina, L; Castillejo-Lopez, C; Oberg, F; Gunnarsson, I; Berg, L; Magnusson, V; Brookes, AJ; Tentler, D; Kristjansdottir, H; Grondal, G; Bolstad, AI; Svenungsson, E; Lundberg, I; Sturfelt, G; Jonssen, A; Truedsson, L; Lima, G; Alcocer-Varela, J; Jonsson, R; Gyllensten, UB; Harley, JB; Alarcon-Segovia, D; Steinsson, K; Alarcon-Riquelme, ME				Prokunina, L; Castillejo-Lopez, C; Oberg, F; Gunnarsson, I; Berg, L; Magnusson, V; Brookes, AJ; Tentler, D; Kristjansdottir, H; Grondal, G; Bolstad, AI; Svenungsson, E; Lundberg, I; Sturfelt, G; Jonssen, A; Truedsson, L; Lima, G; Alcocer-Varela, J; Jonsson, R; Gyllensten, UB; Harley, JB; Alarcon-Segovia, D; Steinsson, K; Alarcon-Riquelme, ME			A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans	NATURE GENETICS			English	Article							ALLELE-SPECIFIC HYBRIDIZATION; SIB-PAIR FAMILIES; HUMAN PD-1 GENE; AUTOIMMUNE-DISEASES; CROHNS-DISEASE; T-LYMPHOCYTES; EXPRESSION; IMMUNORECEPTOR; TOLERANCE; PEDIGREES	Systemic lupus erythematosus (SLE, OMIM 152700) is a complex autoimmune disease that affects 0.05% of the Western population, predominantly women(1-4). A number of susceptibility loci for SLE have been suggested in different populations, but the nature of the susceptibility genes and mutations is yet to be identified(5-9). We previously reported a susceptibility locus (SLEB2) for Nordic multi-case families(9,10). Within this locus, the programmed cell death 1 gene (PDCD1, also called PD-1) was considered the strongest candidate for association with the disease(11-14). Here, we analyzed 2,510 individuals, including members of five independent sets of families as well as unrelated individuals affected with SLE, for single-nucleotide polymorphisms (SNPs) that we identified in PDCD1. We show that one intronic SNP in PDCD1 is associated with development of SLE in Europeans (found in 12% of affected individuals versus 5% of controls; P=0.00001, r.r. (relative risk)=2.6) and Mexicans (found in 7% of affected individuals versus 2% of controls; P=0.0009, r.r.=3.5). The associated allele of this SNP alters a binding site for the runt-related transcription factor 1 (RUNX1, also called AML1) located in an intronic enhancer, suggesting a mechanism through which it can contribute to the development of SLE in humans.	Univ Uppsala, Rudbeck Labs, Inst Genet & Pathol, Med Genet Sect, S-75185 Uppsala, Sweden; Everygene AB, Uppsala, Sweden; Univ Uppsala, Rudbeck Labs, Inst Genet & Pathol, Sect Pathol, S-75185 Uppsala, Sweden; Univ Uppsala, Evolut Biol Ctr, Dept Comparat Physiol, S-75185 Uppsala, Sweden; Karolinska Inst, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, Stockholm, Sweden; Labdpitalinn, Dept Rheumatol, Reykjavik, Iceland; Labdpitalinn, Ctr Rheumatol Res, Reykjavik, Iceland; Univ Bergen, Broegelmann Res Lab, Bergen, Norway; Haukeland Univ Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; Univ Lund Hosp, Dept Clin Immunol, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden; Inst Nacl Ciencias Med & Nutr Salvador Zubirdan, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; Univ Oklahoma, Dept Med, Arthrit & Immunol Program, Oklahoma Med Res Fdn, Oklahoma City, OK USA; US Dept Vet Affairs, Oklahoma City, OK USA	Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Bergen; University of Bergen; Haukeland University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs	Alarcon-Riquelme, ME (corresponding author), Univ Uppsala, Rudbeck Labs, Inst Genet & Pathol, Med Genet Sect, Dag Hammarsjolds Vag 20, S-75185 Uppsala, Sweden.		Tentler, Dmitri/AAE-4519-2019; Alarcón-Riquelme, Marta E./ABF-8163-2020; Höiom, Veronica/F-4153-2012; lima, giuseppina GPPL/C-5995-2012; Prokunina-Olsson, Ludmila/V-7960-2019; Prokunina-Olsson, Ludmila/A-8240-2019	Tentler, Dmitri/0000-0003-3976-1205; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; lima, giuseppina GPPL/0000-0002-1792-2605; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Berg, Louise/0000-0001-6538-2837; Svenungsson, Elisabet/0000-0003-3396-3244				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARNETT FC, 1992, RHEUM DIS CLIN N AM, V18, P865; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Finger LR, 1997, GENE, V197, P177, DOI 10.1016/S0378-1119(97)00260-6; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; GUDMUNDSSON S, 1990, J RHEUMATOL, V17, P1162; Howell WM, 1999, NAT BIOTECHNOL, V17, P87, DOI 10.1038/5270; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; LATHROP GM, 1983, TISSUE ANTIGENS, V22, P160, DOI 10.1111/j.1399-0039.1983.tb01183.x; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; Magnusson V, 2000, GENOMICS, V70, P307, DOI 10.1006/geno.2000.6374; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Prince JA, 2001, GENOME RES, V11, P152, DOI 10.1101/gr.150201; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Stahl-Hallengren C, 2000, J RHEUMATOL, V27, P685; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THOMSON G, 1995, AM J HUM GENET, V57, P487; Vibhakar R, 1997, EXP CELL RES, V232, P25, DOI 10.1006/excr.1997.3493; Wong HK, 1999, J IMMUNOL, V163, P1682	29	594	652	0	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					666	669		10.1038/ng1020	http://dx.doi.org/10.1038/ng1020			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12402038				2022-12-27	WOS:000179593000022
J	Kitami, T; Nadeau, JH				Kitami, T; Nadeau, JH			Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication	NATURE GENETICS			English	Article							SEQUENCE; ROBUSTNESS; MUTATIONS; GENOME	During evolution different genes evolve at unequal rates, reflecting the varying functional constraints on phenotype. An important contributor to this variation is genetic buffering, which reduces the potential detrimental effects of mutations. We studied whether gene duplication and redundant metabolic networks affect genetic buffering by comparing the evolutionary rate of 242 human and mouse orthologous genes involved in metabolic pathways. A gene with a redundant network is defined as one for which the structural layout of metabolic pathways provides an alternative metabolic route that can, in principle, compensate for the loss of a protein function encoded by the gene. We found that genes with redundant networks evolved more quickly than did genes without redundant networks, but no significant difference was detected between single-copy genes and gene families. This implies that redundancy in metabolic networks provides significantly more genetic buffering than do gene families. We also found that genes encoding proteins involved in glycolysis and gluconeogenesis showed as a group a distinct pattern of variation, in contrast to genes involved in other pathways. These results suggest that redundant networks provide genetic buffering and contribute to the functional diversification of metabolic pathways.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Computat Genom, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Nadeau, JH (corresponding author), Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA.	jhn4@po.cwru.edu	Kitami, Toshimori/N-7460-2019	Kitami, Toshimori/0000-0001-8418-5230				Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Force A, 1999, GENETICS, V151, P1531; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; MICHAEL G, 1999, BIOCH PATHWAYS ATLAS; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohno S., 1970, P1; PICKETT FB, 1995, PLANT CELL, V7, P1347, DOI 10.1105/tpc.7.9.1347; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; Remold SK, 2001, P NATL ACAD SCI USA, V98, P11388, DOI 10.1073/pnas.201140198; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; TAJIMA F, 1993, GENETICS, V135, P599; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wagner A, 2000, P NATL ACAD SCI USA, V97, P6579, DOI 10.1073/pnas.110147097; WALSH JB, 1995, GENETICS, V139, P421; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	30	65	66	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					191	194		10.1038/ng945	http://dx.doi.org/10.1038/ng945			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12161750				2022-12-27	WOS:000177714900021
J	Reich, DE; Schaffner, SF; Daly, MJ; McVean, G; Mullikin, JC; Higgins, JM; Richter, DJ; Lander, ES; Altshuler, D				Reich, DE; Schaffner, SF; Daly, MJ; McVean, G; Mullikin, JC; Higgins, JM; Richter, DJ; Lander, ES; Altshuler, D			Human genome sequence variation and the influence of gene history, mutation and recombination	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NEUTRAL ALLELE MODEL; LINKAGE DISEQUILIBRIUM; INTRAGENIC RECOMBINATION; POPULATION EXPANSION; FINITE POPULATION; CANDIDATE GENES; SNP MAP; DIVERSITY; REGIONS	Variation in the human genome sequence is key to understanding susceptibility to disease in modern populations and the history of ancestral populations. Unlocking this information requires knowledge of the patterns and underlying causes of human sequence diversity. By applying a new population-genetic framework to two genome-wide polymorphism surveys, we find that the human genome contains sizeable regions (stretching over tens of thousands of base pairs) that have intrinsically high and low rates of sequence variation. We show that the primary determinant of these patterns is shared genealogical history. Only a fraction of the variation (at most 25%) is due to the local mutation rate. By measuring the average distance over which genealogical histories are typically preserved, these data provide the first genome-wide estimate of the average extent of correlation among variants (linkage disequilibrium). The results are best explained by extreme variability in the recombination rate at a fine scale, and provide the first empirical evidence that such recombination 'hot spots' are a general feature of the human genome and have a principal role in shaping genetic variation in the human population.	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Wellcome Trust Sanger Inst, Cambridge, England; MIT, Dept Biol, Cambridge, MA USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Oxford; Wellcome Trust Sanger Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 1 Kendall Sq, Cambridge, MA 02139 USA.	altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Schaffner, Stephen F/D-1189-2011	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Richter, Daniel/0000-0002-9238-5571; Schaffner, Stephen/0000-0001-6699-3568				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Cambien F, 1999, AM J HUM GENET, V65, P183, DOI 10.1086/302448; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Griffiths R., 1991, IMS LECT NOTES MONOG, V18, P100; GRIFFITHS RC, 1981, THEOR POPUL BIOL, V19, P169, DOI 10.1016/0040-5809(81)90016-2; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KAPLAN N, 1985, THEOR POPUL BIOL, V28, P382, DOI 10.1016/0040-5809(85)90036-X; Kimmel M, 1998, GENETICS, V148, P1921; Kimura M., 1983, NEUTRAL THEORY MOL E; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W. H, 1997, MOL EVOLUTION; LI WH, 1991, GENETICS, V129, P513; Lui BH, 1998, STAT GENOMICS LINKAG; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Nachman MW, 2000, GENETICS, V156, P297; OHTA T, 1971, GENETICS, V68, P571; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; STROBECK C, 1978, GENETICS, V88, P829; SVED J A, 1971, Theoretical Population Biology, V2, P125; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Takahata N, 1997, P NATL ACAD SCI USA, V94, P4811, DOI 10.1073/pnas.94.9.4811; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wakeley J, 1999, GENETICS, V153, P1863; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	46	222	246	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					135	142		10.1038/ng947	http://dx.doi.org/10.1038/ng947			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12161752				2022-12-27	WOS:000177714900012
J	Kim, JC; Badano, JL; Sibold, S; Esmail, MA; Hill, J; Hoskins, BE; Leitch, CC; Venner, K; Ansley, SJ; Ross, AJ; Leroux, MR; Katsanis, N; Beales, PL				Kim, JC; Badano, JL; Sibold, S; Esmail, MA; Hill, J; Hoskins, BE; Leitch, CC; Venner, K; Ansley, SJ; Ross, AJ; Leroux, MR; Katsanis, N; Beales, PL			The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression	NATURE GENETICS			English	Article							GAMMA-TUBULIN; CENTROSOME; OBESITY; COMPLEX; GENE; IDENTIFICATION; MUTATIONS; DYNACTIN; BINDS	BBS4 is one of several proteins that cause Bardet-Biedl syndrome (BBS), a multisystemic disorder of genetic and clinical complexity. Here we show that BBS4 localizes to the centriolar satellites of centrosomes and basal bodies of primary cilia, where it functions as an adaptor of the p150(glued) subunit of the dynein transport machinery to recruit PCM1 (pericentriolar material 1 protein) and its associated cargo to the satellites. Silencing of BBS4 induces PCM1 mislocalization and concomitant deanchoring of centrosomal microtubules, arrest in cell division and apoptotic cell death. Expression of two truncated forms of BBS4 that are similar to those found in some individuals with BBS had a similar effect on PCM1 and microtubules. Our findings indicate that defective targeting or anchoring of pericentriolar proteins and microtubule disorganization contribute to the BBS phenotype and provide new insights into possible causes of familial obesity, diabetes and retinal degeneration.	Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Neurol, Dept Electron Microscopy, London WC1N 3BG, England; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA	Simon Fraser University; Johns Hopkins University; University of London; University College London; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine	Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca; katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652				Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Beales PL, 1999, J MED GENET, V36, P437; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Moudjou M, 1996, J CELL SCI, V109, P875; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Ou YY, 2003, CELL MOTIL CYTOSKEL, V55, P125, DOI 10.1002/cm.10115; Rattner J. B., 1992, P45; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	29	323	331	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					462	470		10.1038/ng1352	http://dx.doi.org/10.1038/ng1352			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107855	Bronze			2022-12-27	WOS:000221183000017
J	De Luca, M; Roshina, NV; Geiger-Thornsberry, GL; Lyman, RF; Pasyukova, EG; Mackay, TFC				De Luca, M; Roshina, NV; Geiger-Thornsberry, GL; Lyman, RF; Pasyukova, EG; Mackay, TFC			Dopa decarboxylase (Ddc) affects variation in Drosophila longevity	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAIT; BRISTLE NUMBER; GENE; MELANOGASTER; EVOLUTION; DISSECTION; VIABILITY; LOCUS	Mutational analyses in model organisms have shown that genes affecting metabolism and stress resistance regulate life span(1), but the genes responsible for variation in longevity in natural populations are largely unidentified. Previously, we mapped quantitative trait loci (QTLs) affecting variation in longevity between two Drosophila melanogaster strains(2). Here, we show that the longevity QTL in the 36E;38B cytogenetic interval on chromosome 2 contains multiple closely linked QTLs, including the Dopa decarboxylase (Ddc) locus. Complementation tests to mutations show that Ddc is a positional candidate gene for life span in these strains. Linkage disequilibrium (LD) mapping in a sample of 173 alleles from a single population shows that three common molecular polymorphisms in Ddc account for 15.5% of the genetic contribution to variance in life span from chromosome 2. The polymorphisms are in strong LD, and the effects of the haplotypes on longevity suggest that the polymorphisms are maintained by balancing selection. DDC catalyzes the final step in the synthesis of the neurotransmitters, dopamine and serotonin(3). Thus, these data implicate variation in the synthesis of bioamines as a factor contributing to natural variation in individual life span.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, CS, Italy; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	University of North Carolina; North Carolina State University; University of Calabria; Russian Academy of Sciences	Mackay, TFC (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	trudy_mackay@ncsu.edu	Roshina, Natalya/AAU-6435-2020; Pasyukova, Elena G/I-8377-2017	De Luca, Maria/0000-0001-6345-7508				AQUADRO CF, 1992, GENETICS, V132, P443; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; De Benedictis G, 1998, EUR J HUM GENET, V6, P534, DOI 10.1038/sj.ejhg.5200222; De Luca M, 2001, EXP GERONTOL, V36, P1663, DOI 10.1016/S0531-5565(01)00146-2; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fry JD, 1998, GENETICS, V148, P1171; FU YX, 1993, GENETICS, V133, P693; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Leips J, 2002, EXP AGING RES, V28, P361, DOI 10.1080/03610730290080399; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; LUNAN KD, 1969, ARCH BIOCHEM BIOPHYS, V132, P450, DOI 10.1016/0003-9861(69)90388-9; LUNDELL MJ, 1994, ADV D BIOCH, V3, P55; Lyman RF, 1999, GENET RES, V74, P303, DOI 10.1017/S001667239900419X; Lyman RF, 1996, GENETICS, V143, P277; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEI M, 1981, GENETICS, V97, P145; PASYUKOVA EG, 1993, MOL GEN GENET, V240, P302, DOI 10.1007/BF00277071; Pasyukova EG, 2000, GENETICS, V156, P1129; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; ROSE M, 1980, NATURE, V287, P141, DOI 10.1038/287141a0; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stam LF, 1996, GENETICS, V144, P1559; STATHAKIS DG, 1995, GENETICS, V141, P629; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TAJIMA F, 1989, GENETICS, V123, P585; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	30	156	163	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					429	433		10.1038/ng1218	http://dx.doi.org/10.1038/ng1218			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12881721				2022-12-27	WOS:000184470500021
J	Scheid, OM; Afsar, K; Paszkowski, J				Scheid, OM; Afsar, K; Paszkowski, J			Formation of stable epialleles and their paramutation-like interaction in tetraploid Arabidopsis thaliana	NATURE GENETICS			English	Article							POLYPLOIDS; EVOLUTION; PLANTS; GENES; METHYLATION; EXPRESSION	Polyploidization is found frequently in plants(1,2), and species previously considered to be diploid may show remnants of earlier polyploidization events on closer inspection of their genomes(3). The success of polyploids may lie in increased genetic redundancy supporting subsequent genetic diversification(4-6). Although doubling the genome does not generate diversity per se, recent studies show that rapid genomic rearrangements and changes in DNA modification and gene expression patterns are associated with polyploid formation(7-13). But recessive modifications will not become phenotypically apparent in early polyploid generations. Here we show that epialleles in tetraploid plants (but not in diploids) interact in trans and lead to heritable gene silencing persisting after segregation from the inactivating allele. This mechanism, resembling paramutation, leads to the establishment of functional epigenetic homozygosity and, thus, to conversion of new recessive alleles into traits expressed in early polyploid generations. Such interactions probably contribute to rapid adaptation and evolution of polyploid plant species.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Scheid, OM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	ortrun@fmi.ch		Mittelsten Scheid, Ortrun/0000-0002-7757-4809				Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; BRINK RA, 1968, SCIENCE, V159, P161, DOI 10.1126/science.159.3811.161; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Finnegan EJ, 2002, CURR OPIN PLANT BIOL, V5, P101, DOI 10.1016/S1369-5266(02)00233-9; Hagemann R, 1993, MOL BIOL TOMATO, P75; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kashkush K, 2002, GENETICS, V160, P1651; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Martinez-Perez E, 2000, J CELL BIOL, V148, P233, DOI 10.1083/jcb.148.2.233; MASSON J, 1992, PLANT J, V2, P829, DOI 10.1111/j.1365-313X.1992.tb00153.x; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Scheid OM, 1996, P NATL ACAD SCI USA, V93, P7114, DOI 10.1073/pnas.93.14.7114; SEUFERT R, 1963, Z VEREBUNGSL, V94, P112, DOI 10.1007/BF00895161; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; STEBBINS GL, 1966, SCIENCE, V152, P1463, DOI 10.1126/science.152.3728.1463; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; Weiss H, 2000, HEREDITAS, V133, P255, DOI 10.1111/j.1601-5223.2000.00255.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384	28	103	108	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					450	454		10.1038/ng1210	http://dx.doi.org/10.1038/ng1210			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12847525				2022-12-27	WOS:000184470500025
J	Jin, YH; Clark, AB; Slebos, RJC; Al-Refai, H; Taylor, JA; Kunkel, TA; Resnick, MA; Gordenin, DA				Jin, YH; Clark, AB; Slebos, RJC; Al-Refai, H; Taylor, JA; Kunkel, TA; Resnick, MA; Gordenin, DA			Cadmium is a mutagen that acts by inhibiting mismatch repair	NATURE GENETICS			English	Article							DNA-POLYMERASES DELTA; REPLICATION; EXONUCLEASES; EPSILON; ERRORS; PCNA; RUNS	Most errors that arise during DNA replication can be corrected by DNA polymerase proofreading or by post-replication mismatch repair (MMR). Inactivation of both mutation-avoidance systems results in extremely high mutability that can lead to error catastrophe(1,2). High mutability and the likelihood of cancer can be caused by mutations and epigenetic changes that reduce MMR3,4. Hypermutability can also be caused by external factors that directly inhibit MMR. Identifying such factors has important implications for understanding the role of the environment in genome stability. We found that chronic exposure of yeast to environmentally relevant concentrations of cadmium, a known human carcinogen(5), can result in extreme hypermutability. The mutation specificity along with responses in proofreading-deficient and MMR-deficient mutants indicate that cadmium reduces the capacity for MMR of small misalignments and base-base mismatches. In extracts of human cells, cadmium inhibited at least one step leading to mismatch removal. Together, our data show that a high level of genetic instability can result from environmental impediment of a mutation-avoidance system.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Gordenin, DA (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.	gordenin@niehs.nih.gov	Dmitry, Gordenin/C-3907-2018; taylor, jack a/C-7154-2019; resnick, Michael/F-1668-2019; Kunkel, Thomas A./D-5088-2019	Dmitry, Gordenin/0000-0002-8399-1836; taylor, jack a/0000-0001-5303-6398; resnick, Michael/0000-0002-8473-7506; Kunkel, Thomas A./0000-0002-9900-1788	Intramural NIH HHS [Z99 ES999999] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065073] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Coleman WB, 1999, ANTICANCER RES, V19, P4645; Drotschmann K, 1999, CURR BIOL, V9, P907, DOI 10.1016/S0960-9822(99)80396-0; Elinder C-G, 1985, CADMIUM HLTH TOXICOL, P81; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Gary R, 1999, MOL CELL BIOL, V19, P5373; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Harfe BD, 2000, GENETICS, V156, P571; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; IARC, 1993, BER CADM MERC EXP GL, V58, P119; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; KHROMOVBORISOV NN, 2002, TECH TIPS ONLINE, V1; Kroutil LC, 1996, BIOCHEMISTRY-US, V35, P1046, DOI 10.1021/bi952178h; Leach Fredrick S, 2002, Curr Opin Urol, V12, P407, DOI 10.1097/00042307-200209000-00007; MAO L, 1994, P NATL ACAD SCI USA, V91, P9871, DOI 10.1073/pnas.91.21.9871; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Waalkes M.P., 1996, TOXICOLOGY METALS, P231	29	374	400	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					326	329		10.1038/ng1172	http://dx.doi.org/10.1038/ng1172			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796780	Green Accepted			2022-12-27	WOS:000183815300022
J	Thilly, WG				Thilly, WG			Have environmental mutagens caused oncomutations in people?	NATURE GENETICS			English	Article							NITROSO-N-METHYLUREA; MUTATIONAL SPECTRA; UNITED-STATES; DNA-ADDUCTS; HPRT GENE; P53 GENE; MAMMARY CARCINOGENESIS; LAMINATION WORKERS; T-LYMPHOCYTES; COLON-CANCER	Age-specific cancer rates show large historical increases that indict environmental risk factors. But these environmental factors did not necessarily act by increasing oncomutation rates. Mathematical analyses suggest selective effects on preexisting oncomutants. The widely held hypothesis that environmental chemicals induce a substantial fraction of human point mutations has not been supported by observation. Direct measurement of the kinds and numbers of point mutations in human tissues have, in fact, found no clear relationship with exposure to environmental agents, save for sunlight in the skin. Alternative hypotheses that point mutations arise primarily as errors during turnover of undamaged DNA and that environmental conditions select rather than induce oncomutants seem to better explain the facts of environmental carcinogenesis in humans.	MIT, Biol Engn Div, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Thilly, WG (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Albertini RJ, 2001, CHEM-BIOL INTERACT, V135, P429, DOI 10.1016/S0009-2797(01)00181-8; ALBERTINI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6617, DOI 10.1073/pnas.79.21.6617; ALEXANDROV K, 1992, CANCER RES, V52, P6248; ARMITAGE P, 1957, BRIT J CANCER, V11, P161, DOI 10.1038/bjc.1957.22; BENZER S, 1958, P NATL ACAD SCI USA, V44, P112, DOI 10.1073/pnas.44.2.112; Branum ME, 2001, J BIOL CHEM, V276, P25421, DOI 10.1074/jbc.M101032200; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brash DE, 1998, CANCER SURV, V32, P69; BurkhartSchultz KJ, 1996, CARCINOGENESIS, V17, P1871, DOI 10.1093/carcin/17.9.1871; BURNS FJ, 1976, CANCER RES, V36, P1422; Cariello NF, 1998, NUCLEIC ACIDS RES, V26, P198, DOI 10.1093/nar/26.1.198; CARIELLO NF, 1990, MUTAT RES, V231, P165, DOI 10.1016/0027-5107(90)90023-W; CHA RS, 1994, P NATL ACAD SCI USA, V91, P3749, DOI 10.1073/pnas.91.9.3749; Coller HA, 1998, CANCER RES, V58, P1268; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; COLLER HA, 1994, ENVIRON SCI TECHNOL, V28, P478; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Curry J, 1999, GENETICS, V152, P1065; Dong CH, 2001, INT J CANCER, V92, P144; DUNN JE, 1975, CANCER RES, V35, P3240; ERB LT, 2002, MATH MODEL PANCREATI; GRIVELL AR, 1975, J MOL BIOL, V98, P219, DOI 10.1016/S0022-2836(75)80110-0; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Herrero-Jimenez P, 2000, MUTAT RES-FUND MOL M, V447, P73, DOI 10.1016/S0027-5107(99)00201-8; Herrero-Jimenez P, 1998, MUTAT RES-FUND MOL M, V400, P553, DOI 10.1016/S0027-5107(98)00067-0; HERREROJIMENEZ P, 2001, DETERMINATION HIST C; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V400, P59, DOI 10.1016/S0027-5107(98)00051-7; Holmquist GP, 1998, MUTAT RES-FUND MOL M, V405, P155, DOI 10.1016/S0027-5107(98)00132-8; Jin ZA, 1996, CANCER RES, V56, P4927; KENSLER TW, 1996, IARC SCI PUBL, V139, P237; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luebeck EG, 1999, RADIAT RES, V152, P339, DOI 10.2307/3580219; Morley AA, 1999, MUTAT RES-FUND MOL M, V428, P11, DOI 10.1016/S1383-5742(99)00026-5; Muniappan BP, 2002, CANCER RES, V62, P3271; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; OLLER AR, 1992, J MOL BIOL, V228, P813, DOI 10.1016/0022-2836(92)90866-I; PELC SR, 1972, INT REV CYTOL, V32, P327, DOI 10.1016/S0074-7696(08)60344-7; Podlutsky A, 1999, MUTAT RES-FUND MOL M, V431, P325, DOI 10.1016/S0027-5107(99)00176-1; Rodin SN, 2000, P NATL ACAD SCI USA, V97, P12244, DOI 10.1073/pnas.180320897; THILLY WG, 1981, TECHNOL REV, V83, P37; TOMITAMITCHELL A, IN PRESS CANC RES; *US BUR CENS, 1900, MORT STAT; *US DEP HHS, 1937, VIT STAT US; VODICKA P, 1995, CARCINOGENESIS, V16, P1473, DOI 10.1093/carcin/16.7.1473; Vodicka P, 1999, MUTAT RES-GEN TOX EN, V445, P205, DOI 10.1016/S1383-5718(99)00127-8; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; Yang K, 1998, MUTAT RES-FUND MOL M, V422, P285, DOI 10.1016/S0027-5107(98)00210-3; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198; ZIEGLER A, 1994, NATURE, V372, P730	55	79	85	1	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					255	259		10.1038/ng1205	http://dx.doi.org/10.1038/ng1205			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12833049				2022-12-27	WOS:000183815300009
J	Cai, ST; Han, HJ; Kohwi-Shigematsu, T				Cai, ST; Han, HJ; Kohwi-Shigematsu, T			Tissue-specific nuclear architecture and gene expession regulated by SATB1	NATURE GENETICS			English	Article							MATRIX-ATTACHMENT REGION; BINDING PROTEIN SATB1; BETA-GLOBIN LOCUS; CELL-SPECIFIC DEMETHYLATION; HISTONE H3 METHYLATION; C-MYC; CHAIN ENHANCER; IN-VIVO; CHROMATIN; DNA	Eukaryotic chromosomes are packaged in nuclei by many orders of folding. Little is known about how higher-order chromatin packaging might affect gene expression. SATB1 is a cell-type specific nuclear protein that recruits chromatin-remodeling factors and regulates numerous genes during thymocyte differentiation. Here we show that in thymocyte nuclei, SATB1 has a cage-like 'network' distribution circumscribing heterochromatin and selectively tethers specialized DNA sequences onto its network. This was shown by fluorescence in situ hybridization on wild-type and Satb1-null thymocytes using in vivo SATB1-bound sequences as probes. Many gene loci, including that of Myc and a brain-specific gene, are anchored by the SATB1 network at specific genomic sites, and this phenomenon is precisely correlated with proper regulation of distant genes. Histone-modification analyses across a gene-enriched genomic region of 70 kb showed that acetylation of histone H3 at Lys9 and Lys14 peaks at the SATB1-binding site and extends over a region of roughly 10 kb covering genes regulated by SATB1. By contrast, in Satb1-null thymocytes, this site is marked by methylation at H3 Lys9. We propose SATB1 as a new type of gene regulator with a novel nuclear architecture, providing sites for tissue-specific organization of DNA sequences and regulating region-specific histone modification.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd 84-171, Berkeley, CA 94720 USA.							Alvarez JD, 2000, GENE DEV, V14, P521; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Chan HM, 2001, J CELL SCI, V114, P2363; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Hawkins SM, 2001, J BIOL CHEM, V276, P44472, DOI 10.1074/jbc.M104193200; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KOHWI Y, 1993, GENE DEV, V7, P1766, DOI 10.1101/gad.7.9.1766; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; KOHWISHIGEMATSU T, 1992, METHOD ENZYMOL, V212, P155; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu JQ, 1997, MOL CELL BIOL, V17, P5275, DOI 10.1128/MCB.17.9.5275; Liu WM, 1999, CANCER RES, V59, P5695; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; RIEGEL JS, 1990, J IMMUNOL, V144, P3611; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SANDERS J, 1992, NUCLEIC ACIDS RES, V20, P5907, DOI 10.1093/nar/20.22.5907; Schubeler D, 2000, GENE DEV, V14, P940; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	336	364	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					42	51		10.1038/ng1146	http://dx.doi.org/10.1038/ng1146			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692553	Green Published			2022-12-27	WOS:000182667900015
J	Cavalli-Sforza, LL; Feldman, MW				Cavalli-Sforza, LL; Feldman, MW			The application of molecular genetic approaches to the study of human evolution	NATURE GENETICS			English	Review							MITOCHONDRIAL-DNA SEQUENCES; Y-CHROMOSOME HAPLOTYPES; LINKAGE DISEQUILIBRIUM; HIGH-RESOLUTION; HUMAN GENOME; POPULATION-STRUCTURE; BALANCING SELECTION; NATURAL-SELECTION; HUMAN MIGRATIONS; NEANDERTHAL DNA	The past decade of advances in molecular genetic technology has heralded a new era for all evolutionary studies, but especially the science of human evolution. Data on various kinds of DNA variation in human populations have rapidly accumulated. There is increasing recognition of the importance of this variation for medicine and developmental biology and for understanding the history of our species. Haploid markers from mitochondrial DNA and the Y chromosome have proven invaluable for generating a standard model for evolution of modern humans. Conclusions from earlier research on protein polymorphisms have been generally supported by more sophisticated DNA analysis. Co-evolution of genes with language and some slowly evolving cultural traits, together with the genetic evolution of commensals and parasites that have accompanied modern humans in their expansion from Africa to the other continents, supports and supplements the standard model of genetic evolution. The advances in our understanding of the evolutionary history of humans attests to the advantages of multidisciplinary research.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Stanford Med Sch, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Feldman, MW (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	marc@charles.stanford.edu						ABETI PC, 2002, NATURE, V419, P832; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; ANATI E, 1983, VALC S 79 CTR CAM ST; ARENSBURG B, 1990, AM J PHYS ANTHROPOL, V83, P137, DOI 10.1002/ajpa.1330830202; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL., 2000, GENES PEOPLES LANGUA; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CAVALLISFORZA LL, 1975, THEOR POPUL BIOL, V8, P127, DOI 10.1016/0040-5809(75)90029-5; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, 1973, AM J HUM GENET, V25, P82; CEPPELLINI R, 1967, HISTOCOMPATIBILITY T; CHEN YS, 1995, AM J HUM GENET, V57, P133; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; CONKEY MW, 1997, MEMOIRS CALIFORNIA A, V23; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DONNELLY P, 1996, CIBA FDN S, V197; Edwards A. W. F., 1964, PHENETIC PHYLOGENETI, P67; Edwards A.W.F., 1964, P 11 INT C GEN, V2, P923; Ellis N, 2002, GENOME RES, V12, P339; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; EWENS WJ, 1979, MATH POPULATION GENE, P98; Fagan Brian M, 1987, GREAT JOURNEY PEOPLI; FELDMAN MW, 1974, GENET RES, V24, P151, DOI 10.1017/S0016672300015184; Finnila S, 2000, AM J HUM GENET, V66, P1017, DOI 10.1086/302802; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Greenberg J. H, 1987, LANGUAGE AM; Greenberg JH, 1971, CURR TRENDS LINGUIST, V8, P809; GREENBERG JH, 1963, LANGUAGES AFRICA; Greenberg Joseph H., 2000, INDOEUROPEAN ITS CLO; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; Hewlett BS, 2002, CURR ANTHROPOL, V43, P313, DOI 10.1086/339379; Hirschfeld L, 1918, ANTHROPOLOGIE, V29, P505; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1990, OXF SURV EVOL BIOL, V7, P203; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; Kajander OA, 2001, EMBO REP, V2, P1007, DOI 10.1093/embo-reports/kve233; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; KIVISILD T, IN PRESS AM J HUM GE; Klein R.G., 1999, HUMAN CAREER; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LEWONTIN RC, 1966, GENETICS, V54, P595; LEWONTIN RC, 1973, GENETICS, V74, P175; Lieberman Philip, 1971, LINGUIST INQ, V2, P203; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; MOUNTAIN JL, 1992, PHILOS T ROY SOC B, V337, P159, DOI 10.1098/rstb.1992.0093; MOURANT A. E, 1954, DISTRIBUTION HUMAN B; Mourant A. E., 1978, BLOOD GROUPS DIS; Mourant AE., 1976, DISTRIBUTION HUMAN B; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; NEI M, 1974, AM J HUM GENET, V26, P421; Nei M., 1988, HUMAN POLYMORPHIC GE; OBERACHER H, NUCL ACIDS RES, V30, pE67; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paracchini S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e27; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PAYNE R, 1977, TISSUE ANTIGENS, V9, P135; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Race RR., 1975, BLOOD GROUPS MAN; Rana BK, 1999, GENETICS, V151, P1547; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; RENFREW C, 1987, ARCHAEOLOGY LANGUAGE; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; ROSENBERG NA, 2002, MODERN DEV THEORETIC, P130; Ruhlen Merritt, 1994, ORIGIN LANGUAGES STU; RYMAN N, 1983, HUM HERED, V33, P93, DOI 10.1159/000153357; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salem AH, 1996, AM J HUM GENET, V59, P741; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shen PD, 2002, HUM MUTAT, V20, P209, DOI 10.1002/humu.10117; SLATKIN M, 1991, GENETICS, V129, P555; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Sugimoto C, 1997, P NATL ACAD SCI USA, V94, P9191, DOI 10.1073/pnas.94.17.9191; TAJIMA F, 1989, GENETICS, V123, P585; Tang H, 2002, GENETICS, V161, P447; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; THANGARAJ K, IN PRESS CURR BIOL; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Toomajian C, 2002, GENETICS, V161, P1609; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2001, HUM MUTAT, V17, P271, DOI 10.1002/humu.23; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Weidenreich Franz, 1946, APES GIANTS MAN; Weir BS., 1996, GENETIC DATA ANAL; WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; XIAO W, HUM MUTAT, V17, P439; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Zerjal T, 1997, AM J HUM GENET, V60, P1174	146	387	411	3	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			266	275		10.1038/ng1113	http://dx.doi.org/10.1038/ng1113			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	652QY	12610536				2022-12-27	WOS:000181390900007
J	Kanehisa, M; Bork, P				Kanehisa, M; Bork, P			Bioinformatics in the post-sequence era	NATURE GENETICS			English	Review							GENE-EXPRESSION; RESEARCH TOOL; DATABASE; IDENTIFICATION; ALIGNMENT; BIOLOGY; CLASSIFICATION; PREDICTION; ALGORITHM; PROTEINS	In the past decade, bioinformatics has become an integral part of research and development in the biomedical sciences. Bioinformatics now has an essential role both in deciphering genomic, transcriptomic and proteomic data generated by high-throughput experimental technologies and in organizing information gathered from traditional biology. Sequence-based methods of analyzing individual genes or proteins have been elaborated and expanded, and methods have been developed for analyzing large numbers of genes or proteins simultaneously, such as in the identification of clusters of related genes and networks of interacting proteins. With the complete genome sequences for an increasing number of organisms at hand, bioinformatics is beginning to provide both conceptual bases and practical methods for detecting systemic functional behaviors of the cell and the organism.	Kyoto Univ, Bioinformat Ctr, Kyoto 6110011, Japan; European Mol Biol Lab, D-69012 Heidelberg, Germany	Kyoto University; European Molecular Biology Laboratory (EMBL)	Kanehisa, M (corresponding author), Kyoto Univ, Bioinformat Ctr, Kyoto 6110011, Japan.	kanehisa@kuicr.kyoto-u.ac.jp	Bork, Peer/F-1813-2013; Kanehisa, Minoru/R-3081-2018	Bork, Peer/0000-0002-2627-833X; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2002, NUCLEIC ACIDS RES, V30, P239, DOI 10.1093/nar/30.1.239; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baxevanis AD, 2002, NUCLEIC ACIDS RES, V30, P1, DOI 10.1093/nar/30.1.1; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Bork P, 1998, NAT GENET, V18, P313, DOI 10.1038/ng0498-313; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, POSTGENOME INFORMATI; Karp PD, 1996, NUCLEIC ACIDS RES, V24, P32, DOI 10.1093/nar/24.1.32; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Ogata H, 2000, NUCLEIC ACIDS RES, V28, P4021, DOI 10.1093/nar/28.20.4021; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	56	122	133	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			305	310		10.1038/ng1109	http://dx.doi.org/10.1038/ng1109			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610540				2022-12-27	WOS:000181390900011
J	Tonon, G; Modi, S; Wu, LZ; Kubo, A; Coxon, AB; Komiya, T; O'Neil, K; Stover, K; El-Naggar, A; Griffin, JD; Kirsch, IR; Kaye, FJ				Tonon, G; Modi, S; Wu, LZ; Kubo, A; Coxon, AB; Komiya, T; O'Neil, K; Stover, K; El-Naggar, A; Griffin, JD; Kirsch, IR; Kaye, FJ			t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway	NATURE GENETICS			English	Article							MINOR SALIVARY-GLAND; NEOPLASTIC TRANSFORMATION; CHROMOSOMAL TRANSLOCATIONS; HUMAN HOMOLOG; GENE; TUMOR; ACTIVATION; EXPRESSION; MASTERMIND; RECEPTORS	Truncation of Notch1 has been shown to cause a subtype of acute leukemia(1), and activation of Notch4 has been associated with mammary and salivary gland carcinomas of mice(2). Here we identify a new mechanism for disrupting Notch signaling in human tumorigenesis, characterized by altered function of a new ortholog of the Drosophila melanogaster Notch co-activator molecule Mastermind. We cloned the t(11;19) translocation that underlies the most common type of human malignant salivary gland tumor. This rearrangement fuses exon 1 from a novel gene of unknown function at 19p13, termed mucoepidermoid carcinoma translocated 1 (MECT1), with exons 2-5 of a novel member of the Mastermind-like gene family (MAML2) at 11q21 (ref. 3). Similar to D. melanogaster Mastermind and MAML1 (refs. 4,5), full-length MAML2 functioned as a CSL (CBF-1, suppressor of hairless and Lag-1)-dependent transcriptional co-activator for ligand-stimulated Notch. In contrast, MECT1-MAML2 activated transcription of the Notch target gene HES1 independently of both Notch ligand and CSL binding sites. MECT1-MAML2 induced foci formation in RK3E epithelial cells, confirming a biological effect for the fusion product. These data suggest a new mechanism to disrupt the function of a Notch co-activator in a common type of malignant salivary gland tumor.	Natl Canc Inst, Genet Branch, Ctr Canc Res, Bethesda, MD 20889 USA; Natl Naval Med Ctr, Bethesda, MD 20889 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Natl Naval Med Ctr, Dept Med, Div Pulm, Bethesda, MD 20889 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Walter Reed National Military Medical Center; University of Texas System; UTMD Anderson Cancer Center	Kaye, FJ (corresponding author), Natl Canc Inst, Genet Branch, Ctr Canc Res, Bethesda, MD 20889 USA.	fkaye@helix.nih.gov	Tonon, Giovanni/J-9804-2018; kaye, frederic/E-2437-2011	Tonon, Giovanni/0000-0003-2973-5038; 	NATIONAL CANCER INSTITUTE [Z01SC007256, ZIASC007256] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; DAHLENFORS R, 1995, CANCER GENET CYTOGEN, V79, P188, DOI 10.1016/0165-4608(94)00121-Q; DAHLENFORS R, 1994, HEREDITAS, V120, P287, DOI 10.1111/j.1601-5223.1994.00287.x; Dumont E, 2000, ONCOGENE, V19, P556, DOI 10.1038/sj.onc.1203352; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; ElNaggar AK, 1996, CANCER GENET CYTOGEN, V87, P29, DOI 10.1016/0165-4608(95)00266-9; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; HORSMAN DE, 1995, CANCER GENET CYTOGEN, V80, P165, DOI 10.1016/0165-4608(94)00187-G; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; JOHANSSON M, 1995, CANCER GENET CYTOGEN, V80, P85, DOI 10.1016/0165-4608(94)00160-D; Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Tang H, 1998, J BIOL CHEM, V273, P29156, DOI 10.1074/jbc.273.44.29156; Tonon G, 2000, GENE CHROMOSOME CANC, V27, P418, DOI 10.1002/(SICI)1098-2264(200004)27:4<418::AID-GCC12>3.0.CO;2-O; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; Wolfe MS, 2001, J MOL NEUROSCI, V17, P199, DOI 10.1385/JMN:17:2:199; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; XU T, 1990, GENE DEV, V4, P464, DOI 10.1101/gad.4.3.464	30	373	399	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					208	213		10.1038/ng1083	http://dx.doi.org/10.1038/ng1083			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539049	Green Published			2022-12-27	WOS:000180773700022
J	Cook, PR				Cook, PR			Predicting three-dimensional genome structure from transcriptional activity	NATURE GENETICS			English	Editorial Material							RNA-POLYMERASE; INTERPHASE CHROMOSOMES; BACILLUS-SUBTILIS; SELF-ORGANIZATION; NUCLEAR MATRIX; LIVING CELLS; MODEL; GENES; DNA; SITES	We would like to be able to predict how genomes are folded in the cell from the primary DNA sequence. A model for the three-dimensional structure of all genomes is presented; it is based on the structure of the bacterial nucleoid, where RNA polymerases cluster and loop the DNA. Loops appear and disappear as polymerases initiate and terminate, but the microscopic structure is 'self-organizing' and, to some extent, predictable. At the macroscopic level, transcriptional activity drives pairing between homologous sequences, inactivity allows genome compaction, and the segregation machinery orients whole chromosomes.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Cook, PR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	peter.cook@path.ox.ac.uk		Cook, Peter/0000-0002-6639-188X				Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Bremer H, 1996, ESCHERICHIA COLI SAL; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 1997, J CELL SCI, V110, P1033; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1995, J CELL SCI, V108, P2927; Cook PR, 2001, PRINCIPLES NUCL STRU; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Gustafsson MGL, 1999, CURR OPIN STRUC BIOL, V9, P627, DOI 10.1016/S0959-440X(99)00016-0; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; Ishihama A, 1981, Adv Biophys, V14, P1; Jackson DA, 1996, NUCLEIC ACIDS RES, V24, P1212, DOI 10.1093/nar/24.7.1212; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1984, J CELL SCI, P59; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MCKEE BD, 1992, GENETICS, V132, P529; MCMANUS J, 1994, J CELL SCI, V107, P469; Minsky A, 2002, NAT REV MOL CELL BIO, V3, P50, DOI 10.1038/nrm700; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nickerson JA, 2001, J CELL SCI, V114, P463; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; Pombo A, 1998, EMBO J, V17, P1768, DOI 10.1093/emboj/17.6.1768; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; SAITOH Y, 1978, COLD SPRING HARB SYM, V58, P755; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sudbrak R, 2001, HUM MOL GENET, V10, P77, DOI 10.1093/hmg/10.1.77; Sugaya K, 2000, J CELL SCI, V113, P2679	52	123	128	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					347	352		10.1038/ng1102-347	http://dx.doi.org/10.1038/ng1102-347			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410231				2022-12-27	WOS:000179034800007
J	Howard, HC; Mount, DB; Rochefort, D; Byun, N; Dupre, N; Lu, JM; Fan, XM; Song, LY; Riviere, JB; Prevost, C; Horst, J; Simonati, A; Lemcke, B; Welch, R; England, R; Zhan, FQ; Mercado, A; Siesser, WB; George, AL; McDonald, MP; Bouchard, JP; Mathieu, J; Delpire, E; Rouleau, GA				Howard, HC; Mount, DB; Rochefort, D; Byun, N; Dupre, N; Lu, JM; Fan, XM; Song, LY; Riviere, JB; Prevost, C; Horst, J; Simonati, A; Lemcke, B; Welch, R; England, R; Zhan, FQ; Mercado, A; Siesser, WB; George, AL; McDonald, MP; Bouchard, JP; Mathieu, J; Delpire, E; Rouleau, GA			The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum	NATURE GENETICS			English	Article							ANDERMANN-SYNDROME; SENSORIMOTOR NEUROPATHY; FRENCH-CANADA; DEFECTS; CLONING; FAMILY	Peripheral neuropathy associated with agenesis of the corpus callosum (ACCPN) is a severe sensorimotor neuropathy associated with mental retardation, dysmorphic features and complete or partial agenesis of the corpus callosum. ACCPN is transmitted in an autosomal recessive fashion and is found at a high frequency in the province of Quebec, Canada. ACCPN has been previously mapped to chromosome 15q. The gene SLC12A6 (solute carrier family 12, member 6), which encodes the K+-Cl- transporter KCC3 and maps within the ACCPN candidate region, was screened for mutations in individuals with ACCPN. Four distinct protein-truncating mutations were found: two in the French Canadian population and two in non-French Canadian families. The functional consequence of the predominant French Canadian mutation (2436delG, Thr813fsX813) was examined by heterologous expression of wildtype and mutant KCC3 in Xenopus laevis oocytes; the truncated mutant is appropriately glycosylated and expressed at the cellular membrane, where it is non-functional. Mice generated with a targeted deletion of Slc12a6 have a locomotor deficit, peripheral neuropathy and a sensorimotor gating deficit, similar to the human disease. Our findings identify mutations in SLC12A6 as the genetic lesion underlying ACCPN and suggest a critical role for SLC12A6 in the development and maintenance of the nervous system.	McGill Univ, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Vet Adm Med Ctr W Roxbury, Div Renal, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; Complexe Hosp Sagamie, Chicoutimi, PQ, Canada; Univ Munster, Inst Human Genet, D-4400 Munster, Germany; Univ Verona, Dept Neurol & Visual Sci, Neurol Sect, I-37100 Verona, Italy; Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, John F Kennedy Ctr Res Human Dev, Nashville, TN USA; Hop Enfants Jesus, Dept Neurol, Quebec City, PQ G1J 1Z4, Canada	McGill University; McGill University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Munster; University of Verona; Vanderbilt University; Vanderbilt University; Vanderbilt University; Laval University	Rouleau, GA (corresponding author), McGill Univ, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	eric.delpire@vanderbilt.edu; guy.rouleau@mcgill.ca	Dupre, Nicolas/Y-1828-2019; Mercado, Adriana/AAR-6143-2021	Mercado, Adriana/0000-0002-6881-0160; McDonald, Michael P./0000-0002-9642-964X				Andermann E., 1981, HDB CLIN NEUROLOGY, P100; ANDERMANN F, 1972, P242; BATTISTELLA PA, 1993, NEUROPEDIATRICS, V24, P239, DOI 10.1055/s-2008-1071550; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; CARPENTER S, 1994, ADV BEHAV BIOL, V42, P27; Casaubon LK, 1996, AM J HUM GENET, V58, P28; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Cheng CM, 1998, J NEUROSCI, V18, P5673; DEBRAEKELEER M, 1993, HUM GENET, V91, P223, DOI 10.1007/BF00218260; Deleu D, 1997, EUR NEUROL, V37, P104, DOI 10.1159/000117419; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; FILTEAU MJ, 1991, ARCH NEUROL-CHICAGO, V48, P1275, DOI 10.1001/archneur.1991.00530240079027; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gurtubay IG, 1997, REV NEUROLOGIA, V25, P1087; HAUSER E, 1993, NEUROPEDIATRICS, V24, P107, DOI 10.1055/s-2008-1071524; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Howard HC, 2002, EUR J HUM GENET, V10, P406, DOI 10.1038/sj.ejhg.5200815; Kelsell DP, 2001, TRENDS CELL BIOL, V11, P2, DOI 10.1016/S0962-8924(00)01866-3; Kunchaparty S, 1999, AM J PHYSIOL-RENAL, V277, pF643, DOI 10.1152/ajprenal.1999.277.4.F643; LARBRISSEAU A, 1984, CAN J NEUROL SCI, V11, P257, DOI 10.1017/S0317167100045509; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lesca G, 2001, REV NEUROL-FRANCE, V157, P1279; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Liu YJ, 1997, P NATL ACAD SCI USA, V94, P8138, DOI 10.1073/pnas.94.15.8138; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Martin MG, 1996, NAT GENET, V12, P216, DOI 10.1038/ng0296-216; MATHIEU J, 1990, CAN J NEUROL SCI, V17, P103, DOI 10.1017/S0317167100030298; Mercado A, 2001, AM J PHYSIOL-CELL PH, V281, pC670, DOI 10.1152/ajpcell.2001.281.2.C670; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Shen MR, 2001, P NATL ACAD SCI USA, V98, P14714, DOI 10.1073/pnas.251388798; Strange K, 2000, AM J PHYSIOL-CELL PH, V279, pC860, DOI 10.1152/ajpcell.2000.279.3.C860; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	40	210	218	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					384	392		10.1038/ng1002	http://dx.doi.org/10.1038/ng1002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12368912				2022-12-27	WOS:000179034800013
J	Parvari, R; Hershkovitz, E; Grossman, N; Gorodischer, R; Loeys, B; Zecic, A; Mortier, G; Gregory, S; Sharony, R; Kambouris, M; Sakati, N; Meyer, BF; Al Aqeel, AI; Al Humaidan, AK; Al Zanhrani, F; Al Swaid, A; Al Othman, J; Diaz, GA; Weiner, R; Khan, KTS; Gordon, R; Gelb, BD				Parvari, R; Hershkovitz, E; Grossman, N; Gorodischer, R; Loeys, B; Zecic, A; Mortier, G; Gregory, S; Sharony, R; Kambouris, M; Sakati, N; Meyer, BF; Al Aqeel, AI; Al Humaidan, AK; Al Zanhrani, F; Al Swaid, A; Al Othman, J; Diaz, GA; Weiner, R; Khan, KTS; Gordon, R; Gelb, BD		HRD Autosomal Recessive Kenny-Caffey	Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome	NATURE GENETICS			English	Article							MICROTUBULE-ORGANIZING CENTER; CONGENITAL HYPOPARATHYROIDISM; MENTAL-RETARDATION; GOLGI-APPARATUS; GENE; GROWTH; POLARIZATION; REPEATS; PROTEIN; TUBULIN	The syndrome of congenital hypoparathyroidism, mental retardation, facial dysmorphism and extreme growth failure (HRD or Sanjad-Sakati syndrome; OMIM 241410) is an autosomal recessive disorder reported almost exclusively in Middle Eastern populations(1-3). A similar syndrome with the additional features of osteosclerosis and recurrent bacterial infections has been classified as autosomal recessive Kenny-Caffey syndrome(4) (AR-KCS; OMIM 244460). Both traits have previously been mapped to chromosome 1q43-44 (refs 5,6) and, despite the observed clinical variability, share an ancestral haplotype, suggesting a common founder mutation 7. We describe refinement of the critical region to an interval of roughly 230 kb and identification of deletion and truncation mutations of TBCE in affected individuals. The gene TBCE encodes one of several chaperone proteins required for the proper folding of alpha-tubulin subunits and the formation of alpha-beta-tubulin heterodimers. Analysis of diseased fibroblasts and lymphoblastoid cells showed lower microtubule density at the microtubule-organizing center (MTOC) and perturbed microtubule polarity in diseased cells. Immunofluorescence and ultrastructural studies showed disturbances in subcellular organelles that require microtubules for membrane trafficking, such as the Golgi and late endosomal compartments. These findings demonstrate that HRD and AR-KCS are chaperone diseases caused by a genetic defect in the tubulin assembly pathway, and establish a potential connection between tubulin physiology and the development of the parathyroid.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Ben Gurion Univ Negev, Dept Dev Mol Genet, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Pediat, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Skin Bank, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Invest Dermatol Lab, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Microbiol & Immunol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Ghent Univ Hosp, Dept Med Genet, Ghent, Belgium; Ghent Univ Hosp, Dept Neonatol, Ghent, Belgium; Wellcome Trust Res Labs, Sanger Inst, Cambridge, England; Tel Aviv Univ, Sapir Med Ctr, Genet Inst, Meir Hosp,Sackler Sch Med, IL-69978 Tel Aviv, Israel; King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; Riyadh Armed Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Al Jahra Hosp, Dept Pediat, Safat, Kuwait; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Wellcome Trust Sanger Institute; Tel Aviv University; Sackler Faculty of Medicine; King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Jahra Hosptial; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Diaz, GA (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, 1 Gustave Levy Pl, New York, NY 10029 USA.		Loeys, Bart/B-3236-2017; Mortier, Geert/D-2542-2012; Gorodischer, Rafael/AAQ-8132-2020; Diaz, George/AAF-6199-2021; Herskowitz, eli/F-1922-2012	Loeys, Bart/0000-0003-3703-9518; Mortier, Geert/0000-0001-9871-4578; Herskowitz, eli/0000-0003-1624-1960; Gregory, Simon/0000-0002-7805-1743; Gorodischer, Rafael/0000-0002-7649-3353; Meyer, Brian/0000-0002-0388-9568				BARTOLINI F, 2002, J BIOL CHEM, V14, P14; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; des Portes V, 1998, CELL, V92, P51; Diaz GA, 1999, AM J MED GENET, V85, P48, DOI 10.1002/(SICI)1096-8628(19990702)85:1<48::AID-AJMG9>3.0.CO;2-Y; Diaz GA, 1998, GENOMICS, V54, P13, DOI 10.1006/geno.1998.5530; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; HERSHKOVITZ E, 1995, ISRAEL J MED SCI, V31, P293; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Khan KTS, 1997, AM J MED GENET, V69, P126; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Martin N, 2002, NAT GENET, V32, P443, DOI 10.1038/ng1016; MERESSE S, 1995, J CELL SCI, V108, P3349; Parvari R, 1998, AM J HUM GENET, V63, P163, DOI 10.1086/301915; PIERRE P, 1994, J CELL SCI, V107, P1909; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; RICHARDSON RJ, 1990, ARCH DIS CHILD, V65, P1113, DOI 10.1136/adc.65.10.1113; SANJAD SA, 1991, ARCH DIS CHILD, V66, P193, DOI 10.1136/adc.66.2.193; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	30	154	160	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					448	452		10.1038/ng1012	http://dx.doi.org/10.1038/ng1012			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12389028				2022-12-27	WOS:000179034800025
J	Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; Flanagan, AM; Alitalo, K; Boshoff, C				Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; Flanagan, AM; Alitalo, K; Boshoff, C			Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma	NATURE GENETICS			English	Article							GROWTH-FACTOR; CELLS; HUMAN-HERPESVIRUS-8; TRANSFORMATION; INFECTION; CULTURE; LESIONS; VEGF	The biology of Kaposi sarcoma is poorly understood because the dominant cell type in Kaposi sarcoma lesions is not known(1-4). We show by gene expression microarrays that neoplastic cells of Kaposi sarcoma are closely related to lymphatic endothelial cells (LECs) and that Kaposi sarcoma herpesvirus (KSHV)(5,6) infects both LECs and blood vascular endothelial cells (BECs) in vitro. The gene expression microarray profiles of infected LECs and BECs show that KSHV induces transcriptional reprogramming of both cell types. The lymphangiogenic molecules VEGF-D and angiopoietin-2 were elevated in the plasma of individuals with acquired immune deficiency syndrome and Kaposi sarcoma. These data show that the gene expression profile of Kaposi sarcoma resembles that of LECs, that KSHV induces a transcriptional drift in both LECs and BECs and that lymphangiogenic molecules are involved in the pathogenesis of Kaposi sarcoma.	UCL, Wolfson Inst Biomed Res, Viral Oncol Grp, Canc Res UK, London WC1E 6BT, England; Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Helsinki Univ Cent Hosp, FIN-00014 Helsinki, Finland; UCL, Inst Orthopaed, London WC1E 6BT, England	Cancer Research UK; University of London; University College London; University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of London; University College London	Boshoff, C (corresponding author), UCL, Wolfson Inst Biomed Res, Viral Oncol Grp, Canc Res UK, Cruciform Bldg,Gower St, London WC1E 6BT, England.	c.boshoff@ucl.ac.uk	Alitalo, Kari K/J-5013-2014; Makinen, Taija/CAI-2233-2022; Makinen, Taija/C-5765-2014	Alitalo, Kari K/0000-0002-7331-0902; Makinen, Taija/0000-0002-9338-1257; Makinen, Taija/0000-0002-9338-1257; Trotter, Matthew/0000-0003-3702-915X; Lagos, Dimitris/0000-0003-0637-281X; Flanagan, Adrienne/0000-0002-2832-1303; Henderson, Stephen/0000-0002-9032-3828				Ascherl G, 1999, BLOOD, V93, P4232; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Brockmeyer N H, 1999, Eur J Med Res, V4, P95; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Ciufo DM, 2001, J VIROL, V75, P5614, DOI 10.1128/JVI.75.12.5614-5626.2001; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gallo RC, 1998, SCIENCE, V282, P1837, DOI 10.1126/science.282.5395.1837; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; HONG YK, 2004, NAT GENET       0627, DOI DOI 10.1038/NG1383; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KAAYA EE, 1995, J ACQ IMMUN DEF SYND, V10, P295; Kahn HJ, 2002, MODERN PATHOL, V15, P434, DOI 10.1038/modpathol.3880543; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lebbe C, 1997, ARCH DERMATOL RES, V289, P421, DOI 10.1007/s004030050215; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; REGEZI JA, 1993, AM J PATHOL, V143, P240; Renwick N, 2002, AIDS RES HUM RETROV, V18, P695, DOI 10.1089/088922202760072302; Samaniego F, 1997, J IMMUNOL, V158, P1887; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; [No title captured]	30	308	320	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					687	693		10.1038/ng1384	http://dx.doi.org/10.1038/ng1384			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220918	Bronze			2022-12-27	WOS:000222354100017
J	Freedman, ML; Reich, D; Penney, KL; McDonald, GJ; Mignault, AA; Patterson, N; Gabriel, SB; Topol, EJ; Smoller, JW; Pato, CN; Pato, MT; Petryshen, TYL; Kolonel, LN; Lander, ES; Sklar, P; Henderson, B; Hirschhorn, JN; Altshuler, D				Freedman, ML; Reich, D; Penney, KL; McDonald, GJ; Mignault, AA; Patterson, N; Gabriel, SB; Topol, EJ; Smoller, JW; Pato, CN; Pato, MT; Petryshen, TYL; Kolonel, LN; Lander, ES; Sklar, P; Henderson, B; Hirschhorn, JN; Altshuler, D			Assessing the impact of population stratification on genetic association studies	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROSTATE-CANCER; SUSCEPTIBILITY; MAP	Population stratification refers to differences in allele frequencies between cases and controls due to systematic differences in ancestry rather than association of genes with disease. It has been proposed that false positive associations due to stratification can be controlled by genotyping a few dozen unlinked genetic markers. To assess stratification empirically, we analyzed data from 11 case-control and case-cohort association studies. We did not detect statistically significant evidence for stratification but did observe that assessments based on a few dozen markers lack power to rule out moderate levels of stratification that could cause false positive associations in studies designed to detect modest genetic risk factors. After increasing the number of markers and samples in a case-cohort study ( the design most immune to stratification), we found that stratification was in fact present. Our results suggest that modest amounts of stratification can exist even in well designed studies.	Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Med & Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Charlestown, MA USA; Vet Adm, Syracuse, NY USA; SUNY Upstate Med Ctr, Ctr Psychiat & Mol Genet, Syracuse, NY USA; Univ Hawaii, Canc Etiol Program, Canc Res Ctr Hawaii, Honolulu, HI 96822 USA; MIT, Dept Biol, Cambridge, MA USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cleveland Clinic Foundation; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cancer Research Center of Hawaii; University of Hawaii System; Massachusetts Institute of Technology (MIT); University of Southern California; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Reich, D (corresponding author), Broad Inst, Program Med & Populat Genet, 1 Kendall Sq,Bldg 300, Cambridge, MA 02139 USA.	reich@receptor.med.harvard.edu	Petryshen, Tracey/X-5850-2019; Altshuler, David M/A-4476-2009; Peng, Bo/A-6920-2009	Petryshen, Tracey/0000-0002-7972-4612; Altshuler, David M/0000-0002-7250-4107; Peng, Bo/0000-0001-8225-2284; Topol, Eric/0000-0002-1478-4729				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bunker CH, 2002, CANCER EPIDEM BIOMAR, V11, P726; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2002, GENET EPIDEMIOL, V22, P196, DOI 10.1002/gepi.0126; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, GENET EPIDEMIOL, V22, P198; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	29	586	597	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					388	393		10.1038/ng1333	http://dx.doi.org/10.1038/ng1333			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15052270	Bronze			2022-12-27	WOS:000220647200023
J	Mnatzakanian, GN; Lohi, H; Munteanu, I; Alfred, SE; Yamada, T; MacLeod, PJM; Jones, JR; Scherer, SW; Schanen, NC; Friez, MJ; Vincent, JB; Minassian, BA				Mnatzakanian, GN; Lohi, H; Munteanu, I; Alfred, SE; Yamada, T; MacLeod, PJM; Jones, JR; Scherer, SW; Schanen, NC; Friez, MJ; Vincent, JB; Minassian, BA			A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome	NATURE GENETICS			English	Article							CPG-BINDING PROTEIN-2; MUTATIONS	Rett syndrome is caused by mutations in the gene MECP2 in 80% of affected individuals. We describe a previously unknown MeCP2 isoform. Mutations unique to this isoform and the absence, until now, of identified mutations specific to the previously recognized protein indicate an important role for the newly discovered molecule in the pathogenesis of Rett syndrome.	Hosp Sick Children, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; Victoria Gen Hosp, Div Med Genet, Victoria, BC V8R 6R5, Canada; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Alfred I duPOnt Hosp Children, Nemours Res Program, Wilmington, DE 19803 USA; Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Victoria; Greenwood Genetic Center; Nemours Alfred I. duPont Hospital for Children; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Minassian, BA (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bminass@sickkids.ca	Lohi, Hannes/F-4596-2011; Scherer, Stephen W./B-3785-2013; Yamada, Takahiro/A-4001-2011	Lohi, Hannes/0000-0003-1087-5532; Scherer, Stephen W./0000-0002-8326-1999; Vincent, Kirby/0000-0001-9325-5747				Aber KM, 2003, NEUROSCIENCE, V116, P77, DOI 10.1016/S0306-4522(02)00586-9; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Hagberg B, 2002, MENT RETARD DEV D R, V8, P61, DOI 10.1002/mrdd.10020; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Miltenberger-Miltenyi G, 2003, HUM MUTAT, V22, P107, DOI 10.1002/humu.10243; Reichwald K, 2000, MAMM GENOME, V11, P182, DOI 10.1007/s003350010035; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Stancheva I, 2003, MOL CELL, V12, P425, DOI 10.1016/S1097-2765(03)00276-4; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8	13	243	257	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					339	341		10.1038/ng1327	http://dx.doi.org/10.1038/ng1327			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15034579				2022-12-27	WOS:000220647200016
J	McCarroll, SA; Murphy, CT; Zou, SG; Pletcher, SD; Chin, CS; Jan, YN; Kenyon, C; Bargmann, CI; Li, H				McCarroll, SA; Murphy, CT; Zou, SG; Pletcher, SD; Chin, CS; Jan, YN; Kenyon, C; Bargmann, CI; Li, H			Comparing genomic expression patterns across species identifies shared transcriptional profile in aging	NATURE GENETICS			English	Article							MESSENGER-RNA DECAY; GENE-EXPRESSION; C-ELEGANS; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; LIFE-SPAN; CALORIC RESTRICTION; OXIDATIVE STRESS; INSULIN-RECEPTOR; WIDE ANALYSIS	We developed a method for systematically comparing gene expression patterns across organisms using genome-wide comparative analysis of DNA microarray experiments. We identified analogous gene expression programs comprising shared patterns of regulation across orthologous genes. Biological features of these patterns could be identified as highly conserved subpatterns that correspond to Gene Ontology categories. Here, we demonstrate these methods by analyzing a specific biological process, aging, and show that similar analysis can be applied to a range of biological processes. We found that two highly diverged animals, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster, implement a shared adult-onset expression program of genes involved in mitochondrial metabolism, DNA repair, catabolism, peptidolysis and cellular transport. Most of these changes were implemented early in adulthood. Using this approach to search databases of gene expression data, we found conserved transcriptional signatures in larval development, embryogenesis, gametogenesis and mRNA degradation.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; UCL, Dept Biol, London, England; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol & Med Informat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	haoli@genome.ucsf.edu	McCarroll, Steven A/A-8433-2009	Kenyon, Cynthia/0000-0003-3446-2636; Bargmann, Cornelia/0000-0002-8484-0618; McCarroll, Steven/0000-0002-6954-8184; Murphy, Coleen/0000-0002-8257-984X; Jan, Yuh Nung/0000-0003-1367-6299				Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lewis JA, 1995, METHOD CELL BIOL, V48, P4; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; SOMANI SM, 1992, INT J CLIN PHARM TH, V30, P1; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teichmann SA, 2002, TRENDS BIOTECHNOL, V20, P407, DOI 10.1016/S0167-7799(02)02032-2; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	50	320	336	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					197	204		10.1038/ng1291	http://dx.doi.org/10.1038/ng1291			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14730301	Bronze			2022-12-27	WOS:000188542700024
J	Allen, M; Heinzmann, A; Noguchi, E; Abecasis, G; Broxholme, J; Ponting, CP; Bhattacharyya, S; Tinsley, J; Zhang, YM; Holt, R; Jones, EY; Lench, N; Carey, A; Jones, H; Dickens, NJ; Dimon, C; Nicholls, R; Baker, C; Xue, LZ; Townsend, E; Kabesch, M; Weiland, SK; Carr, D; von Mutius, E; Adcock, IM; Barnes, PJ; Lathrop, GM; Edwards, M; Moffatt, MF; Cookson, WOCM				Allen, M; Heinzmann, A; Noguchi, E; Abecasis, G; Broxholme, J; Ponting, CP; Bhattacharyya, S; Tinsley, J; Zhang, YM; Holt, R; Jones, EY; Lench, N; Carey, A; Jones, H; Dickens, NJ; Dimon, C; Nicholls, R; Baker, C; Xue, LZ; Townsend, E; Kabesch, M; Weiland, SK; Carr, D; von Mutius, E; Adcock, IM; Barnes, PJ; Lathrop, GM; Edwards, M; Moffatt, MF; Cookson, WOCM			Positional cloning of a novel gene influencing asthma from Chromosome 2q14	NATURE GENETICS			English	Article							GENOME-WIDE SEARCH; AIRWAY HYPERRESPONSIVENESS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM; ASSOCIATION; FAMILIES; LOCI; ATOPY; MICE; MAPS	Asthma is a common disease in children and young adults. Four separate reports have linked asthma and related phenotypes to an ill-defined interval between 2q14 and 2q32 (refs. 1 4), and two mouse genome screens have linked bronchial hyper-responsiveness to the region homologous to 2q14 ( refs. 5,6). We found and replicated association between asthma and the D2S308 microsatellite, 800 kb distal to the IL1 cluster on 2q14. We sequenced the surrounding region and constructed a comprehensive, high-density, single-nucleotide polymorphism (SNP) linkage disequilibrium (LD) map. SNP association was limited to the initial exons of a solitary gene of 3.6 kb (DPP10), which extends over 1 Mb of genomic DNA. DPP10 encodes a homolog of dipeptidyl peptidases (DPPs) that cleave terminal dipeptides from cytokines and chemokines, and it presents a potential new target for asthma therapy.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxagen, Milton Pk, Oxon, England; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 2JD, England; Univ Munich, Childrens Hosp, D-8000 Munich, Germany; Univ Ulm, Dept Epidemiol, Ulm, Germany; Natl Heart & Lung Inst, Dept Thorac Med, London, England; Ctr Natl Genotypage, Evry, France	University of Oxford; Wellcome Centre for Human Genetics; Oxagen Limited; University of Oxford; University of Munich; Ulm University; Imperial College London; CEA; UDICE-French Research Universities; Universite Paris Saclay	Cookson, WOCM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.		Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022; Lench, Nicholas/AAB-1791-2021; Jones, Yvonne/J-2293-2016; Kabesch, Michael/AAB-5701-2020; Ponting, Chris/AAV-2621-2021; Adcock, Ian/L-3217-2019; Kabesch, Michael/GZM-1583-2022; Jones, Yvonne/N-8111-2019; Dickens, Nicholas/G-1445-2013	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Abecasis, Goncalo/0000-0003-1509-1825; Ponting, Chris/0000-0003-0202-7816; Lench, Nicholas/0000-0002-6108-0759; Dickens, Nicholas/0000-0003-0492-5855; von Mutius, Erika/0000-0002-8893-4515; Zhang, Youming/0000-0001-5403-4044; Adcock, Ian/0000-0003-2101-8843; Barnes, Peter/0000-0002-5122-4018				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BAILLY S, 1993, EUR J IMMUNOL, V23, P1240, DOI 10.1002/eji.1830230607; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Di Giovine F. S., 1992, Human Molecular Genetics, V1, P450; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; DUKECOHAN JS, 1995, J BIOL CHEM, V270, P14107, DOI 10.1074/jbc.270.23.14107; EPPLEN C, 1994, HUM MOL GENET, V3, P1710, DOI 10.1093/hmg/3.9.1710; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; HILL MR, 1995, BRIT MED J, V311, P776, DOI 10.1136/bmj.311.7008.776; Hizawa N, 1998, J ALLERGY CLIN IMMUN, V102, P436, DOI 10.1016/S0091-6749(98)70132-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; OCONNOR GT, 1994, AM J RESP CRIT CARE, V149, pS21, DOI 10.1164/ajrccm/149.2_Pt_2.S21; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Rao NV, 1997, J BIOL CHEM, V272, P10260; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166; 1987, AM REV RESP DIS, V136, P225	30	242	257	1	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					258	263		10.1038/ng1256	http://dx.doi.org/10.1038/ng1256			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14566338				2022-12-27	WOS:000186273300022
J	Hagan, CR; Sheffield, RF; Rudin, CM				Hagan, CR; Sheffield, RF; Rudin, CM			Human Alu element retrotransposition induced by genotoxic stress	NATURE GENETICS			English	Article							TRANSCRIPTION; SEQUENCES; REPEATS; SINES	Alu elements are found exclusively in primate species and comprise over 10% of the human genome. To better define the mechanisms responsible for Alu replication, we introduced a human Alu element into mouse cells. We report that Alu retrotransposition can be induced in mouse cells by exposure to the topoisomerase II inhibitor etoposide and is mediated in trans by endogenous mouse long interspersed elements (LINEs).	Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Rudin, CM (corresponding author), Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA.		Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465				Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Felix CA, 1998, LEUKEMIA, V12, P976, DOI 10.1038/sj.leu.2401026; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Rudin CM, 2001, GENE CHROMOSOME CANC, V30, P64, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F; Schmid CW, 1998, NUCLEIC ACIDS RES, V26, P4541, DOI 10.1093/nar/26.20.4541; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1	14	95	97	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					219	220		10.1038/ng1259	http://dx.doi.org/10.1038/ng1259			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14578886				2022-12-27	WOS:000186273300016
J	Seitz, H; Youngson, N; Lin, SP; Dalbert, S; Paulsen, M; Bachellerie, JP; Ferguson-Smith, AC; Cavaille, J				Seitz, H; Youngson, N; Lin, SP; Dalbert, S; Paulsen, M; Bachellerie, JP; Ferguson-Smith, AC; Cavaille, J			Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene	NATURE GENETICS			English	Article							IDENTIFICATION; DOMAIN; RNA; METHYLATION; TARGETS; AIR	MicroRNAs (miRNAs) are an abundant class of RNAs that are similar to21-25 nucleotides (nt) long, interact with mRNAs and trigger either translation repression or RNA cleavage (RNA interference, RNAi) depending on the degree of complementarity with their targets. Here we show that the imprinted mouse distal chromosome 12 locus encodes two miRNA genes expressed from the maternally inherited chromosome and antisense to a retrotransposon-like gene (Rtl1) expressed only from the paternal allele.	Univ Toulouse 3, LBME, CNRS UMR 5099, IFR 109, F-31062 Toulouse, France; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Saarland, FR Genet, Postfach 151150, D-66041 Saarbrucken, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Cambridge; Saarland University	Cavaille, J (corresponding author), Univ Toulouse 3, LBME, CNRS UMR 5099, IFR 109, 118 Route Narbonne, F-31062 Toulouse, France.		Ferguson-Smith, Anne C/G-7534-2011; cavaille, jerome/AAM-8047-2020; Paulsen, Martina/G-2262-2010; Seitz, Hervé/AAE-6487-2019; Youngson, Neil/AAB-7389-2019	Seitz, Hervé/0000-0001-8172-5393; Youngson, Neil/0000-0003-0690-4580; CAVAILLE, Jerome/0000-0003-2833-6836; Lin, Shau-Ping/0000-0003-3423-991X; Ferguson-Smith, Anne/0000-0002-7608-5894				Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rougeulle C, 2002, TRENDS GENET, V18, P434, DOI 10.1016/S0168-9525(02)02749-X; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	13	284	313	1	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					261	262		10.1038/ng1171	http://dx.doi.org/10.1038/ng1171			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796779				2022-12-27	WOS:000183815300010
J	Bachtrog, D				Bachtrog, D			Adaptation shapes patterns of genome evolution on sexual and asexual chromosomes in Drosophila	NATURE GENETICS			English	Article							NEO-Y CHROMOSOME; DEGENERATION; HYPOTHESIS; MIRANDA	What advantage might sexual recombination confer? Population genetics theory predicts that asexual genomes are less efficient at eliminating deleterious mutations and incorporating beneficial alleles(1,2). Here, I compare patterns of genome evolution in a 40-kb gene-rich region on homologous neo-sex chromosomes of Drosophila miranda(3). Genes on the non-recombining neo-Y show various signs of degeneration, including transposable-element insertions, frameshift mutations and a higher rate of amino-acid substitution. In contrast, loci on the recombining neo-X show intact open reading frames and generally low rates of amino-acid substitution. One exceptional gene on the neo-X shows evidence for adaptive protein evolution, affecting patterns of variability at neighboring regions along the chromosome. These findings illustrate the limits to natural selection in an asexual genome. Deleterious mutations, including repetitive DNA, accumulate on a non-recombining chromosome, whereas rapid protein evolution due to positive selection is confined to the recombining homolog.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Bachtrog, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	Doris.Bachtrog@ed.ac.uk						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bachtrog D, 2000, CURR BIOL, V10, P1025, DOI 10.1016/S0960-9822(00)00656-4; Bachtrog D, 2003, MOL BIOL EVOL, V20, P173, DOI 10.1093/molbev/msg035; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; BACHTROG D, IN PRESS GENETICS; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE; Bull J.J., 1983, EVOLUTION SEX DETERM; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; FELSENSTEIN J, 1974, GENETICS, V78, P737; HUDSON RR, 1987, GENETICS, V116, P153; Kimura M., 1983, NEUTRAL THEORY MOL E; Li W. H, 1997, MOL EVOLUTION; Macknight RH, 1939, GENETICS, V24, P180; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Ohno S., 1970, EVOLUTION GENE DUPLI; Orr HA, 1998, GENETICS, V150, P1693; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Rice WR, 2002, NAT REV GENET, V3, P241, DOI 10.1038/nrg760; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; SMITH JM, 1978, EVOLUTION SEX; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; TAJIMA F, 1989, GENETICS, V123, P585	28	79	83	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					215	219		10.1038/ng1164	http://dx.doi.org/10.1038/ng1164			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12754509				2022-12-27	WOS:000183200500030
J	Slobodkin, LB				Slobodkin, LB			Just before Watson and Crick	NATURE GENETICS			English	Editorial Material									SUNY Stony Brook, Ecol & Evolut Program, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Slobodkin, LB (corresponding author), SUNY Stony Brook, Ecol & Evolut Program, Stony Brook, NY 11794 USA.								0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					451	452		10.1038/ng0403-451	http://dx.doi.org/10.1038/ng0403-451			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12665868	Bronze			2022-12-27	WOS:000181928600009
J	Blazquez, MA; Ahn, JH; Weigel, D				Blazquez, MA; Ahn, JH; Weigel, D			A thermosensory pathway controlling flowering time in Arabidopsis thaliana	NATURE GENETICS			English	Article							MADS DOMAIN PROTEIN; CIRCADIAN CLOCK; PHYTOCHROME-B; MUTANTS; GENE; VERNALIZATION; ENCODES; LIGHT; PHENOTYPE; REPRESSOR	Onset of flowering is controlled by environmental signals such as light and temperature. Molecular-genetic studies in Arabidopsis thaliana have focused on daily light duration, or photoperiod, and transient exposure to winter-like temperatures, or vernalizationl. Yet ambient growth temperature, which is strongly affected by current changes in global climate(2), has been largely ignored. Here, we show that genes of the autonomous pathway, previously thought only to act independently of the environment as regulators of the floral repressor FLC (ref. 1), are centrally involved in mediating the effects of ambient temperature. In contrast to wild-type plants and those mutant in other pathways, autonomous-pathway mutants flower at the same time regardless of ambient temperature. In contrast, the exaggerated temperature response of cryptochrome-2 mutants is caused by temperature-dependent redundancy with the phytochrome A photoreceptor. As with vernalization and photoperiod, ambient temperature ultimately affects expression of the floral pathway integrator FT.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Max Planck Inst Dev Biol, Dept Biol Mol, D-72076 Tubingen, Germany	Salk Institute; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Korea University; Max Planck Society	Weigel, D (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	weigel@weigelworld.org	Ahn, Ji Hoon/A-4141-2011; Weigel, Detlef/AAR-3312-2021; Blazquez, Miguel A/B-1495-2008; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Ahn, Ji Hoon/0000-0003-0347-3922; Blazquez, Miguel A/0000-0001-5743-0448; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Halevy H., 1985, CRC HDB FLOWERING; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; *INT PAN CLIM CHAN, 2002, CLIM CHANG 2001 SYNT; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Long S. P., 1988, PLANTS TEMPERATURE; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mockler TC, 1999, DEVELOPMENT, V126, P2073; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596	30	345	389	6	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					168	171		10.1038/ng1085	http://dx.doi.org/10.1038/ng1085			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12548286				2022-12-27	WOS:000180773700014
J	Dyrskjot, L; Thykjaer, T; Kruhoffer, M; Jensen, JL; Marcussen, N; Hamilton-Dutoit, S; Wolf, H; Orntoft, TF				Dyrskjot, L; Thykjaer, T; Kruhoffer, M; Jensen, JL; Marcussen, N; Hamilton-Dutoit, S; Wolf, H; Orntoft, TF			Identifying distinct classes of bladder carcinoma using microarrays	NATURE GENETICS			English	Article							GENE-EXPRESSION PATTERNS; GENOME-WIDE; PREDICTION; CANCER; TUMOR; IDENTIFICATION; CLASSIFICATION	Bladder cancer is a common malignant disease characterized by frequent recurrences(1,2). The stage of disease at diagnosis and the presence of surrounding carcinoma in situ are important in determining the disease course of an affected individual(3). Despite considerable effort, no accepted immunohistological or molecular markers have been identified to define clinically relevant subsets of bladder cancer. Here we report the identification of clinically relevant subclasses of bladder carcinoma using expression microarray analysis of 40 well characterized bladder tumors. Hierarchical cluster analysis identified three major stages, Ta, T1 and T2-4, with the Ta tumors further classified into subgroups. We built a 32-gene molecular classifier using a cross-validation approach that was able to classify benign and muscle-invasive tumors with close correlation to pathological staging in an independent test set of 68 tumors. The classifier provided new predictive information on disease progression in Ta tumors compared with conventional staging (P < 0.005). To delineate non-recurring Ta tumors from frequently recurring Ta tumors, we analyzed expression patterns in 31 tumors by applying a supervised learning classification methodology, which classified 75% of the samples correctly (P < 0.006). Furthermore, gene expression profiles characterizing each stage and subtype identified their biological properties, producing new potential targets for therapy.	Aarhus Univ Hosp, Dept Clin Biochem, Mol Diagnost Lab, DK-8200 Aarhus N, Denmark; Aros Appl Biotechnol, Aarhus, Denmark; Aarhus Univ Hosp, Dept Urol, DK-8000 Aarhus N, Denmark; Dept Theoret Stat, Aarhus, Denmark; Dept Math Sci, Aarhus, Denmark; Aarhus Univ Hosp, Univ Inst Pathol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Orntoft, TF (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Mol Diagnost Lab, DK-8200 Aarhus N, Denmark.	orntoft@kba.sks.au.dk	Jensen, Jens Ledet/B-7172-2008; Dyrskjot, Lars/H-4922-2012	Dyrskjot, Lars/0000-0001-7061-9851; Jensen, Jens Ledet/0000-0002-8776-5764; Hamilton-Dutoit, Stephen/0000-0003-2158-3885				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bergkvist A, 1965, Acta Chir Scand, V130, P371; Cheng L, 1999, CANCER-AM CANCER SOC, V85, P2469, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.3.CO;2-L; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox SB, 2001, LANCET ONCOL, V2, P278, DOI 10.1016/S1470-2045(00)00323-5; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Kerr JS, 2000, EXPERT OPIN INV DRUG, V9, P1271, DOI 10.1517/13543784.9.6.1271; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Luo J, 2001, CANCER RES, V61, P4683; Notterman DA, 2001, CANCER RES, V61, P3124; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Seymour L, 1999, CANCER TREAT REV, V25, P301, DOI 10.1053/ctrv.1999.0134; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thykjaer T, 2001, CANCER RES, V61, P2492; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wolf H, 1986, Prog Clin Biol Res, V221, P223	26	387	398	2	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2003	33	1					90	96		10.1038/ng1061	http://dx.doi.org/10.1038/ng1061			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12469123				2022-12-27	WOS:000180136100024
J	Ang, SO; Chen, H; Hirota, K; Gordeuk, VR; Jelinek, J; Guan, YL; Liu, EL; Sergueeva, AI; Miasnikova, GY; Mole, D; Maxwell, PH; Stockton, DW; Semenza, GL; Prchal, JT				Ang, SO; Chen, H; Hirota, K; Gordeuk, VR; Jelinek, J; Guan, YL; Liu, EL; Sergueeva, AI; Miasnikova, GY; Mole, D; Maxwell, PH; Stockton, DW; Semenza, GL; Prchal, JT			Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; HIPPEL-LINDAU-DISEASE; TRANSCRIPTIONAL ACTIVITY; PROLYL HYDROXYLATION/; HIF-ALPHA; VHL GENE; HYPOXIA; ERYTHROPOIESIS; ERYTHROCYTOSIS	Chuvash polycythemia is an autosomal recessive disorder that is endemic to the mid-Volga River region. We previously mapped the locus associated with Chuvash polycythemia to chromosome 3p25. The gene associated with von Hippel-Lindau syndrome, VHL, maps to this region, and homozygosity with respect to a C-->T missense mutation in VHL, causing an arginine-to-tryptophan change at amino-acid residue 200 (Arg200Trp), was identified in all individuals affected with Chuvash polycythemia. The protein VHL modulates the ubiquitination and subsequent destruction of hypoxia-inducible factor 1, subunit alpha(HIF1alpha). Our data indicate that the Arg200Trp substitution impairs the interaction of VHL with HIF1alpha reducing the rate of degradation of HIF1alpha and resulting in increased expression of downstream target genes including EPO (encoding erythropoietin), SLC2A1 (also known as GLUT1, encoding solute carrier family 2 (facilitated glucose transporter), member 1), TF (encoding transferrin), TFRC (encoding transferrin receptor (p90, CD71)) and VEGF (encoding vascular endothelial growth factor).	Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; Howard Univ, Dept Med, Washington, DC 20059 USA; Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA; Chuvash State Univ, Cheboksary, Chuvashia, Russia; Univ Oxford, Oxford, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Howard University; Howard University; University of Oxford; Baylor College of Medicine	Prchal, JT (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	jprchal@bcm.tmc.edu	Jelinek, Jaroslav/O-6876-2019; Maxwell, Patrick H/C-5557-2008; Gordeuk, Victor/AAG-6577-2019; Jelinek, Jaroslav/D-2282-2012; Jelinek, Jaroslav/A-8476-2008; Hirota, Kiichi/E-9181-2010	Maxwell, Patrick H/0000-0002-0338-2679; Jelinek, Jaroslav/0000-0002-2533-0220; Hirota, Kiichi/0000-0003-1110-0827; Mole, David/0000-0002-0984-300X				Ang SO, 2002, BLOOD CELL MOL DIS, V28, P57, DOI 10.1006/bcmd.2002.0488; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Beutler E., 1971, RED CELL METABOLISM; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gordeuk VR, 2001, BLOOD, V98, p224A; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; HAGESAWA K, 1990, BIOCHIM BIOPHYS ACTA, V1051, P221; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jacobson LO, 2000, J AM SOC NEPHROL, V11, P589; Jenkins MM, 1996, BLOOD, V87, P2993, DOI 10.1182/blood.V87.7.2993.bloodjournal8772993; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Karasawa Y, 2001, INTERNAL MED, V40, P38, DOI 10.2169/internalmedicine.40.38; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; Kralovics R, 2000, CURR OPIN PEDIATR, V12, P29, DOI 10.1097/00008480-200002000-00006; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; POLYAKOVA LA, 1977, FAMILIAL HEREDITARY; Prchal J F, 1999, Curr Opin Hematol, V6, P100, DOI 10.1097/00062752-199903000-00008; Prchal JT, 2001, SEMIN HEMATOL, V38, P10, DOI 10.1053/shem.2001.23040; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sergeyeva A, 1997, BLOOD, V89, P2148, DOI 10.1182/blood.V89.6.2148; Shih LY, 1999, J AM SOC NEPHROL, V10, P315; Stopka T, 1998, BLOOD, V91, P3766; Vasserman NN, 1999, HUM HERED, V49, P129, DOI 10.1159/000022859; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhong H, 1999, CANCER RES, V59, P5830	34	386	400	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					614	621		10.1038/ng1019	http://dx.doi.org/10.1038/ng1019			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12415268				2022-12-27	WOS:000179593000013
J	Ramoz, N; Rueda, LA; Bouadjar, B; Montoya, LS; Orth, G; Favre, M				Ramoz, N; Rueda, LA; Bouadjar, B; Montoya, LS; Orth, G; Favre, M			Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis	NATURE GENETICS			English	Article							PAPILLOMAVIRUSES; LESIONS; MODEL	Epidermodysplasia verruciformis (OMIM 226400) is a rare autosomal recessive genodermatosis associated with a high risk of skin carcinoma that results from an abnormal susceptibility to infection by specific human papillomaviruses (HPVs). We recently mapped a susceptibility locus for epidermodysplasia verruciformis (EV1) to chromosome 17q25. Here we report the identification of nonsense mutations in two adjacent novel genes, EVER1 and EVER2, that are associated with the disease. The gene products EVER1 and EVER2 have features of integral membrane proteins and are localized in the endoplasmic reticulum.	Inst Pasteur, Unite Papillomavirus, F-75724 Paris 15, France; Unidad Dermatol LA Rueda, Bogota, Colombia; Ctr Hosp Univ Bab el Oued, Algiers, Algeria; Univ Ind Santander, Bucaramanga, Colombia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidad Industrial de Santander	Orth, G (corresponding author), Inst Pasteur, Unite Papillomavirus, 25 Rue Dr Roux, F-75724 Paris 15, France.	gorth@pasteur.fr	ORTH, Gérard C/C-2518-2009; ramoz, nicolas/K-3316-2015	ramoz, nicolas/0000-0002-8070-9938				Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197; JABLONSKA S, 1972, CANCER RES, V32, P583; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majewski S, 1997, CLIN DERMATOL, V15, P321, DOI 10.1016/S0738-081X(96)00169-1; ORTH G, 1979, CANCER RES, V39, P1074; ORTH G, 1978, P NATL ACAD SCI USA, V75, P1537, DOI 10.1073/pnas.75.3.1537; ORTH G, 1987, PAPOVAVIRIDAE, V2, P199; Ramoz N, 2000, J INVEST DERMATOL, V114, P1148, DOI 10.1046/j.1523-1747.2000.00996.x; Ramoz N, 1999, J INVEST DERMATOL, V112, P259, DOI 10.1046/j.1523-1747.1999.00536.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	14	278	290	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					579	581		10.1038/ng1044	http://dx.doi.org/10.1038/ng1044			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426567				2022-12-27	WOS:000179593000008
J	Daar, AS; Thorsteinsdottir, H; Martin, DK; Smith, AC; Nast, S; Singer, PA				Daar, AS; Thorsteinsdottir, H; Martin, DK; Smith, AC; Nast, S; Singer, PA			Top ten biotechnologies for improving health in developing countries	NATURE GENETICS			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; DRIED BLOOD-SAMPLES; CYANOVIRIN-N; HEPATITIS-B; VACCINE; TYPE-1; DIAGNOSIS; SAFETY; GP120; DNA	Most research into genomics and other related biotechnologies is concerned with the priorities of industrialized nations, and yet a limited number of projects have shown that these technologies could help improve health in developing countries. To encourage the successful application of biotechnology to global health, we carried out a study in which we asked an international group of eminent scientists with expertise in global health issues to identify the top ten biotechnologies for improving health in developing countries. The results offer concrete guidance to those in a position to influence the direction of research and development, and challenge common assumptions about the relevance and affordability of biotechnology for developing countries.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Program Appl Eth & Biotechnol, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Surg, Toronto, ON M5G 1L4, Canada; Univ Toronto, Pan Amer Hlth Org, WHO, Collaborating Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Collaborat Program Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Med, Toronto, ON M5G 1L4, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Pan American Health Organization; University of Toronto; World Health Organization; University of Toronto; University of Toronto; University of Toronto	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, 88 Coll St, Toronto, ON M5G 1L4, Canada.	peter.singer@utoronto.ca		Smith, Alyna/0000-0002-3396-715X				Abraham P, 1999, VACCINE, V17, P1125, DOI 10.1016/S0264-410X(98)00331-4; Adler M., 1996, GAZING ORACLE DELPHI; Aidoo S, 2001, J CLIN MICROBIOL, V39, P2572, DOI 10.1128/JCM.39.7.2572-2575.2001; Beck IA, 2001, J CLIN MICROBIOL, V39, P29, DOI 10.1128/JCM.39.1.29-33.2001; Belshe RB, 2001, J INFECT DIS, V183, P1343, DOI 10.1086/319863; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Butler D, 2001, NATURE, V411, P513, DOI 10.1038/35079269; Global Forum for Health Research, 2000, 10 90 REP HLTH RES 2; Gold ER, 2002, TRENDS BIOTECHNOL, V20, P327, DOI 10.1016/S0167-7799(02)01993-5; Harris E., 1998, LOW COST APPROACH PC; Jodar L, 2001, VACCINE, V19, P1594, DOI 10.1016/S0264-410X(00)00358-3; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kane A, 1999, B WORLD HEALTH ORGAN, V77, P801; Kelley BS, 2002, J AM CHEM SOC, V124, P3210, DOI 10.1021/ja025537m; Langridge WHR, 2000, SCI AM, V283, P66; Lee EAM, 2002, INFECT IMMUN, V70, P1417, DOI 10.1128/IAI.70.3.1417-1421.2002; MARTIN BR, 1995, TECHNOL ANAL STRATEG, V7, P139, DOI 10.1080/09537329508524202; Normile D, 2000, SCIENCE, V289, P843, DOI 10.1126/science.289.5481.843; Palmer CJ, 1998, J CLIN MICROBIOL, V36, P203, DOI 10.1128/JCM.36.1.203-206.1998; Panteleeff DD, 1999, J CLIN MICROBIOL, V37, P350, DOI 10.1128/JCM.37.2.350-353.1999; *U TOR JOINT CTR B, IN PRESS TOP 10 BIOT; *UN DEV PROGR, 2001, HUM DEV REP 2001 MAK; United States Environmental Protection Agency, 2001, CIT GUID BIOR; WHO, 106 WHO; *WHO, 2001, 169 WHO; WHO, 2002, GEN WORLD HLTH; Wiesner J, 2002, BIOORG MED CHEM LETT, V12, P543, DOI 10.1016/S0960-894X(01)00798-3; World Health Organization, 2001, MACR HLTH INV HLTH E	30	224	244	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					229	232		10.1038/ng1002-229	http://dx.doi.org/10.1038/ng1002-229			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355081	Bronze			2022-12-27	WOS:000178311100007
J	Robitaille, J; MacDonald, MLE; Kaykas, A; Sheldahl, LC; Zeisler, J; Dube, MP; Zhang, LH; Singaraja, RR; Guernsey, DL; Zheng, BY; Siebert, LF; Hoskin-Mott, A; Trese, MT; Pimstone, SN; Shastry, BS; Moon, RT; Hayden, MR; Goldberg, YP; Samuels, ME				Robitaille, J; MacDonald, MLE; Kaykas, A; Sheldahl, LC; Zeisler, J; Dube, MP; Zhang, LH; Singaraja, RR; Guernsey, DL; Zheng, BY; Siebert, LF; Hoskin-Mott, A; Trese, MT; Pimstone, SN; Shastry, BS; Moon, RT; Hayden, MR; Goldberg, YP; Samuels, ME			Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy	NATURE GENETICS			English	Article							CANDIDATE GENE ANALYSIS; TARGETED DISRUPTION; LINKAGE ANALYSIS; WNT; RECEPTOR; WINGLESS; COMPLEX; PROTEIN; MUTATIONS; CARCINOMA	Familial exudative vitreoretinopathy (FEVR) is a hereditary ocular disorder characterized by a failure of peripheral retinal vascularization. Loci associated with FEVR map to 11q13-q23 (EVR1; OMIM 133780, ref. 1), Xp11.4 (EVR2; OMIM 305390, ref. 2) and 11p13-12 (EVR3; OMIM 605750, ref. 3). Here we have confirmed linkage to the 11q13-23 locus for autosomal dominant FEVR in one large multigenerational family and refined the disease locus to a genomic region spanning 1.55 Mb. Mutations in FZD4, encoding the putative Wnt receptor frizzled-4, segregated completely with affected individuals in the family and were detected in affected individuals from an additional unrelated family, but not in normal controls. FZD genes encode Wnt receptors, which are implicated in development and carcinogenesis. Injection of wildtype and mutated FZD4 into Xenopus laevis embryos revealed that wildtype, but not mutant, frizzled-4 activated calcium/calmodulin-dependent protein kinase II (CAMKII) and protein kinase C (PKC), components of the Wnt/Ca2+ signaling pathway. In one of the mutants, altered subcellular trafficking led to defective signaling. These findings support a function for frizzled-4 in retinal angiogenesis and establish the first association between a Wnt receptor and human disease.	Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada; Dalhousie Univ, Dept Ophthalmol, Izaak Walton Killam Hlth Ctr, Halifax, NS B3H 2Y9, Canada; Dalhousie Univ, Dept Pathol, Div Mol Pathol & Mol Genet, Halifax, NS B3H 4H7, Canada; Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Western Ontario, Dept Ophthalmol, London, ON, Canada; Dalhousie Univ, QEII Sci Ctr, Dept Ophthalmol, Halifax, NS, Canada; William Beaumont Hosp, Royal Oak, MI 48072 USA; Oakland Univ, Dept Biol Sci, Rochester, MI USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	Dalhousie University; Dalhousie University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Western University (University of Western Ontario); Dalhousie University; Beaumont Health; Oakland University; University of British Columbia	Hayden, MR (corresponding author), Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada.		Hayden, Michael R/D-8581-2011; Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Dubé, Marie-Pierre/B-9364-2008	Hayden, Michael R/0000-0001-5159-1419; Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Dubé, Marie-Pierre/0000-0001-8442-4393; Sheldahl, Laird/0000-0002-3298-5436; Singaraja, Roshni/0000-0002-3418-3867; MacDonald, Marcia/0000-0001-7946-0023				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; de Crecchio G, 1998, CLIN GENET, V54, P315, DOI 10.1034/j.1399-0004.1998.5440409.x; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Kondo H, 2001, HUM GENET, V108, P368, DOI 10.1007/s004390100503; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; LI Y, 1992, AM J OPHTHALMOL, V113, P712, DOI 10.1016/S0002-9394(14)74800-7; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; MULLER B, 1994, GENOMICS, V20, P317, DOI 10.1006/geno.1994.1176; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Shastry BS, 2000, CLIN GENET, V58, P329, DOI 10.1034/j.1399-0004.2000.580412.x; SHASTRY BS, 1995, GENOMICS, V27, P341, DOI 10.1006/geno.1995.1052; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	27	339	425	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					326	330		10.1038/ng957	http://dx.doi.org/10.1038/ng957			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12172548				2022-12-27	WOS:000178311100026
J	Janecke, AR; Thompson, DA; Utermann, G; Becker, C; Hubner, CA; Schmid, E; McHenry, CL; Nair, AR; Ruschendorf, F; Heckenlively, J; Wissinger, B; Nurnberg, P; Gal, A				Janecke, AR; Thompson, DA; Utermann, G; Becker, C; Hubner, CA; Schmid, E; McHenry, CL; Nair, AR; Ruschendorf, F; Heckenlively, J; Wissinger, B; Nurnberg, P; Gal, A			Mutations in RDH12 encoding a photoreceptor cell retinol dehydrogenase cause childhood-onset severe retinal dystrophy	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; LINKAGE ANALYSIS; VERTEBRATE RETINA; IDENTIFICATION; METABOLISM; DISEASES; GENES	members affected by autosomal recessive childhood-onset severe retinal dystrophy, a genetically heterogeneous group of disorders characterized by degeneration of the photoreceptor cells(1). A whole-genome scan by microarray analysis of single-nucleotide polymorphisms (ref. 2) identified a founder haplotype and defined a critical interval of 1.53 cM on chromosome 14q23.3-q24.1 that contains the gene associated with this form of retinal dystrophy. RDH12 maps in this region and encodes a retinol dehydrogenase proposed to function in the visual cycle(3). A homozygous 677A --> G transition (resulting in Y226C) in RDH12 was present in all affected family members studied, as well as in two Austrian individuals with sporadic retinal dystrophy. We identified additional mutations in RDH12 in 3 of 89 non-Austrian individuals with retinal dystrophy: a 5-nucleotide deletion (806delCCCTG) and the transition 565C --> T ( resulting in Q189X), each in the homozygous state, and 146C --> T (resulting in T49M) and 184C --> T (resulting in R62X) in compound heterozygosity. When expressed in COS-7 cells, Cys226 and Met49 variants had diminished and aberrant activity, respectively, in interconverting isomers of retinol and retinal. The severe visual impairment of individuals with mutations in RDH12 is in marked contrast to the mild visual deficiency in individuals with fundus albipunctatus caused by mutations in RDH5, encoding another retinal dehydrogenase(4). Our studies show that RDH12 is associated with retinal dystrophy and encodes an enzyme with a unique, nonredundant role in the photoreceptor cells.	Med Univ Innsbruck, Inst Med Biol & Humangenet, Innsbruck, Austria; Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-22529 Hamburg, Germany; Med Univ Innsbruck, Klin Augenheilkunde, Innsbruck, Austria; Univ Tubingen, Klin Augenheilkunde, Tubingen, Germany; Hsch Med Berlin, Charite, Inst Med Genet, Berlin, Germany	Medical University of Innsbruck; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Utermann, G (corresponding author), Med Univ Innsbruck, Inst Med Biol & Humangenet, Innsbruck, Austria.	Gerd.Utermann@uibk.ac.at	Hübner, Christian/A-2950-2017; Janecke, Andreas/AAA-5227-2019	Hübner, Christian/0000-0002-1030-4943; Janecke, Andreas/0000-0001-7155-0315; Thompson, Debra/0000-0003-3485-0794				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Stockton DW, 1998, HUM GENET, V103, P328, DOI 10.1007/s004390050825; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707	16	182	188	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					850	854		10.1038/ng1394	http://dx.doi.org/10.1038/ng1394			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15258582				2022-12-27	WOS:000222974000017
J	Kuroiwa, Y; Kasinathan, P; Matsushita, H; Sathiyaselan, J; Sullivan, EJ; Kakitani, M; Tomizuka, K; Ishida, I; Robl, JM				Kuroiwa, Y; Kasinathan, P; Matsushita, H; Sathiyaselan, J; Sullivan, EJ; Kakitani, M; Tomizuka, K; Ishida, I; Robl, JM			Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle	NATURE GENETICS			English	Article							NUCLEAR TRANSFER; STEM-CELLS; CALVES; RECOMBINATION; EXPRESSION; GENOME; FETAL; PIGS	Gene targeting is accomplished using embryonic stem cells in the mouse but has been successful, only using primary somatic cells followed by embryonic cloning, in other species. Gene targeting in somatic cells versus embryonic stem cells is a challenge; consequently, there are few reported successes and none include the targeting of transcriptionally silent genes or double targeting to produce homozygotes. Here, we report a sequential gene targeting system for primary fibroblast cells that we used to knock out both alleles of a silent gene, the bovine gene encoding immunoglobulin-mu (IGHM), and produce both heterozygous and homozygous knockout calves. We also carried out sequential knockout targeting of both alleles of a gene that is active in fibroblasts, encoding the bovine prion protein ( PRNP), in the same genetic line to produce doubly homozygous knockout fetuses. The sequential gene targeting system we used alleviates the need for germline transmission for complex genetic modifications and should be broadly applicable to gene functional analysis and to biomedical and agricultural applications.	Hematech, Sioux Falls, SD 57106 USA; Gemini Sci, San Diego, CA 92109 USA; Kirin Brewery Co Ltd, Div Pharmaceut, Shibuya Ku, Tokyo, Japan	Kirin Brewery Company Limited	Robl, JM (corresponding author), Hematech, 4401 S Technol Dr, Sioux Falls, SD 57106 USA.	i-ishida@kirin.co.jp; jrobl@hematech.com		Sullivan, Eddie/0000-0001-7468-2006				Abuin A, 1996, MOL CELL BIOL, V16, P1851; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Denning C, 2003, REPRODUCTION, V126, P1, DOI 10.1530/rep.0.1260001; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Piedrahita JA, 2000, THERIOGENOLOGY, V53, P105, DOI 10.1016/S0093-691X(99)00244-7; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Sharma A, 2003, TRANSPLANTATION, V75, P430, DOI 10.1097/01.TP.0000053615.98201.77; Sullivan EJ, 2004, BIOL REPROD, V70, P146, DOI 10.1095/biolreprod.103.021220; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; Thomson AJ, 2003, REPRODUCTION, P495; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang Bin, 2003, Reprod Biol Endocrinol, V1, P103, DOI 10.1186/1477-7827-1-103; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	26	123	196	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					775	780		10.1038/ng1373	http://dx.doi.org/10.1038/ng1373			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15184897	Bronze			2022-12-27	WOS:000222354100031
J	Dewannieux, M; Dupressoir, A; Harper, F; Pierron, G; Heidmann, T				Dewannieux, M; Dupressoir, A; Harper, F; Pierron, G; Heidmann, T			Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells	NATURE GENETICS			English	Article							TY1 RETROTRANSPOSITION; RNA INTERFERENCE; GENE; ACTIVATION; SEQUENCE; ELEMENTS; FAMILY	Mammalian genomes contain two main classes of retrotransposons, the well-characterized long and short interspersed nuclear elements, which account for similar to30% of the genome, and the long terminal repeat (LTR) retrotransposons, which resemble the proviral integrated form of retroviruses, except for the absence of an envelope gene in some cases. Genetic studies confirmed mobility of the latter class of elements in mice, with a high proportion of phenotypic mutations consequent to transposition of the intracisternal A particle (IAP) family of LTR retrotransposons(1). Using the mouse genome sequence and an efficient ex vivo retrotransposition assay, we identified functional, master IAP copies that encode all the enzymatic and structural proteins necessary for their autonomous transposition in heterologous cells. By introducing mutations, we found that the three genes gag, prt and pol are all required for retrotransposition and identified the IAP gene products by electron microscopy in the form of intracellular A-type particles in the transfected cells. These prototypic elements, devoid of an envelope gene, are the first LTR retrotransposons autonomous for transposition to be identified in mammals. Their high rates of retrotransposition indicate that they are potent insertional mutagens that could serve as safe ( noninfectious) genetic tools in a large panel of cells.	Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, F-94805 Villejuif, France; Inst Andre Lwoff, UPR 1983, Lab Replicat Adn & Ultrastruct Noyau, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Heidmann, T (corresponding author), Inst Gustave Roussy, CNRS, UMR 8122, Unite Retrovirus Endogenes & Elements Retroides E, Rue Camille Desmoulins, F-94805 Villejuif, France.	heidmann@igr.fr	Dupressoir, Anne/M-5280-2018	Dupressoir, Anne/0000-0002-3464-8513; Dewannieux, Marie/0000-0003-3918-2414				BALASUNDARAM D, 1994, P NATL ACAD SCI USA, V91, P172, DOI 10.1073/pnas.91.1.172; Bernstein E, 2001, RNA, V7, P1509; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e49; Fehrmann F, 1997, VIROLOGY, V235, P352, DOI 10.1006/viro.1997.8708; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; KAWAKAMI K, 1993, GENETICS, V135, P309; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; LUEDERS KK, 1993, MOL CELL BIOL, V13, P7439, DOI 10.1128/MCB.13.12.7439; MIETZ JA, 1992, MOL CELL BIOL, V12, P220, DOI 10.1128/MCB.12.1.220; MIETZ JA, 1987, J VIROL, V61, P3020, DOI 10.1128/JVI.61.10.3020-3029.1987; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Welker R, 1997, J VIROL, V71, P5209, DOI 10.1128/JVI.71.7.5209-5217.1997; XU H, 1990, Proceedings of the National Academy of Sciences of the United States of America, V87, P8360, DOI 10.1073/pnas.87.21.8360	23	107	108	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					534	539		10.1038/ng1353	http://dx.doi.org/10.1038/ng1353			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107856	Bronze			2022-12-27	WOS:000221183000030
J	Kim, HJ; Hyun, Y; Park, JY; Park, MJ; Park, MK; Kim, MD; Kim, HJ; Lee, MH; Moon, J; Lee, I; Kim, J				Kim, HJ; Hyun, Y; Park, JY; Park, MJ; Park, MK; Kim, MD; Kim, HJ; Lee, MH; Moon, J; Lee, I; Kim, J			A genetic link between cold responses and flowering time through FVE in Arabidopsis thaliana	NATURE GENETICS			English	Article							MADS DOMAIN PROTEIN; HISTONE DEACETYLASE; EXPRESSION; ELEMENT; DROUGHT; ENCODES; PATHWAY	Cold induces expression of a number of genes that encode proteins that enhance tolerance to freezing temperatures in plants(1,2). A cis-acting element responsive to cold and drought, the C-repeat/dehydration-responsive element (C/DRE), was identified in the Arabidopsis thaliana stress-inducible genes RD29A(3) and COR15a(4) and found in other cold-inducible genes in various plants(1,5). C/DRE-binding factor/DRE-binding protein (CBF/DREB) is an essential component of the cold-acclimation response(1,2), but the signaling pathways and networks are mostly unknown. Here we used targeted genetic approach to isolate A. thaliana mutants with altered cold-responsive gene expression (acg) and identify ACG1 as a negative regulator of the CBF/DREB pathway. acg1 flowered late and had elevated expression of FLOWERING LOCUS C (FLC)(6), a repressor of flowering encoding a MADS-box protein. We showed that acg1 is a null allele of the autonomous pathway gene FVE. FVE encodes a homolog of the mammalian retinoblastoma-associated protein, a component of a histone deacetylase (HDAC) complex involved in transcriptional repression(7,8). We also showed that plants sense intermittent cold stress through FVE and delay flowering with increasing expression of FLC. Dual roles of FVE in regulating the flowering time and the cold response may have an evolutionary advantage for plants by increasing their survival rates.	Kumho Life & Environm Sci Lab, Puk Gu 500712, Gwangju, South Korea; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Chonnam Natl Univ, Agr Plant Stress Res Ctr, Solid State Phys Lab, Kwangju 500757, South Korea; Kyung Hee Univ, Plant Metab Res Ctr, Suwon 449701, South Korea	Seoul National University (SNU); Chonnam National University; Kyung Hee University	Kim, J (corresponding author), Kumho Life & Environm Sci Lab, 1 Oryong Dong, Puk Gu 500712, Gwangju, South Korea.	jungmookkim@hanmail.net		Hyun, Youbong/0000-0002-9421-7061; Kim, Jungmook/0000-0003-1735-5564				Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; HE Y, 2003, SCIENCE         1030, DOI DOI 10.1126/SCIENCE.1091109; Ishitani M, 1998, PLANT CELL, V10, P1151, DOI 10.1105/tpc.10.7.1151; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jefferson R. A., 1991, PLANT MOL BIOL MAN B, V14, P1; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Rossi V, 2003, PLANT MOL BIOL, V51, P401, DOI 10.1023/A:1022090916446; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2000, CURR OPIN PLANT BIOL, V3, P418, DOI 10.1016/S1369-5266(00)00106-0; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Wu KQ, 2003, PLANT J, V34, P241, DOI 10.1046/j.1365-313X.2003.01714.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251	25	213	235	5	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					167	171		10.1038/ng1298	http://dx.doi.org/10.1038/ng1298			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14745450	Bronze			2022-12-27	WOS:000188542700019
J	Kahle, KT; Wilson, FH; Leng, Q; Lalioti, MD; O'Connell, AD; Dong, K; Rapson, AK; MacGregor, GG; Giebisch, G; Hebert, SC; Lifton, RP				Kahle, KT; Wilson, FH; Leng, Q; Lalioti, MD; O'Connell, AD; Dong, K; Rapson, AK; MacGregor, GG; Giebisch, G; Hebert, SC; Lifton, RP			WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion	NATURE GENETICS			English	Article							INHERITED HYPERTENSION; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; HYPERKALEMIA; MUTATIONS; COTRANSPORTER; ENDOCYTOSIS; CLATHRIN; PROTEIN; CL	A key question in systems biology is how diverse physiologic processes are integrated to produce global homeostasis(1). Genetic analysis can contribute by identifying genes that perturb this integration. One system orchestrates renal NaCl and K+ flux to achieve homeostasis of blood pressure and serum K+ concentration (refs. 2,3). Positional cloning implicated the serine-threonine kinase WNK4 in this process(4); clustered mutations in PRKWNK4, encoding WNK4, cause hypertension and hyperkalemia (pseudohypoaldosteronism type II, PHAII(5)) by altering renal NaCl and K+ handling. Wild-type WNK4 inhibits the renal Na-Cl cotransporter (NCCT); mutations that cause PHAII relieve this inhibition(6). This explains the hypertension of PHAII but does not account for the hyperkalemia. By expression in Xenopus laevis oocytes, we show that WNK4 also inhibits the renal K+ channel ROMK. This inhibition is independent of WNK4 kinase activity and is mediated by clathrin-dependent endocytosis of ROMK, mechanisms distinct from those that characterize WNK4 inhibition of NCCT. Most notably, the same mutations in PRKWNK4 that relieve NCCT inhibition markedly increase inhibition of ROMK. These findings establish WNK4 as a multifunctional regulator of diverse ion transporters; moreover, they explain the pathophysiology of PHAII. They also identify WNK4 as a molecular switch that can vary the balance between NaCl reabsorption and K+ secretion to maintain integrated homeostasis.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St,TAC S-341D, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Leng, John/A-9359-2011; Leng, John/GRO-2256-2022	Wilson, Frederick/0000-0002-5019-0186				BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Charette SJ, 2001, J BIOL CHEM, V276, P36071, DOI 10.1074/jbc.C100340200; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Giebisch G, 1998, AM J PHYSIOL-RENAL, V274, pF817, DOI 10.1152/ajprenal.1998.274.5.F817; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Leipziger J, 2000, AM J PHYSIOL-RENAL, V279, pF919, DOI 10.1152/ajprenal.2000.279.5.F919; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Ortega B, 2000, J PHYSIOL-LONDON, V528, P5, DOI 10.1111/j.1469-7793.2000.00005.x; REEVES WB, 2000, KIDNEY PHYSL PATHOPH, P1333; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Verrey F., 2000, KIDNEY PHYSL PATHOPH, P1441; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	21	296	311	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					372	376		10.1038/ng1271	http://dx.doi.org/10.1038/ng1271			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14608358				2022-12-27	WOS:000186791000020
J	Chan, EM; Young, EJ; Ianzano, L; Munteanu, I; Zhao, XC; Christopoulos, CC; Avanzini, G; Elia, M; Ackerley, CA; Jovic, NJ; Bohlega, S; Andermann, E; Rouleau, GA; Delgado-Escueta, AV; Minassian, BA; Scherer, SW				Chan, EM; Young, EJ; Ianzano, L; Munteanu, I; Zhao, XC; Christopoulos, CC; Avanzini, G; Elia, M; Ackerley, CA; Jovic, NJ; Bohlega, S; Andermann, E; Rouleau, GA; Delgado-Escueta, AV; Minassian, BA; Scherer, SW			Mutations in NHLRC1 cause progressive myoclonus epilepsy	NATURE GENETICS			English	Article							LAFORIN; BODIES; FAMILY	Lafora progressive myoclonus epilepsy is characterized by pathognomonic endoplasmic reticulum (ER)-associated polyglucosan accumulations. We previously discovered that mutations in EPM2A cause Lafora disease. Here, we identify a second gene associated with this disease, NHLRC1 ( also called EPM2B), which encodes malin, a putative E3 ubiquitin ligase with a RING finger domain and six NHL motifs. Laforin and malin colocalize to the ER, suggesting they operate in a related pathway protecting against polyglucosan accumulation and epilepsy.	Hosp Sick Children, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Inst Nazl Neurol, I-20133 Milan, Italy; Oasi Inst Res Mental Retardat & Brain Aging, Dept Neurol, I-94018 Troina, Italy; Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; Clin Neurol & Psychiat Children & Youth, YU-11000 Belgrade, Serbia Monteneg, Serbia; King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; McGill Univ, Montreal Neurol Inst, Neurogenet Unit, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; Univ Calif Los Angeles, Sch Med, W Los Angeles DVA Med Ctr, Dept Neurol,Comprehens Epilepsy Program, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Sch Med, W Los Angeles DVA Med Ctr, Brain Res Inst, Los Angeles, CA 90073 USA; Hosp Sick Children, Dept Pediat, Div Neurol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; IRCCS Istituto Neurologico Besta; IRCCS Oasi Maria SS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); King Faisal Specialist Hospital & Research Center; McGill University; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Minassian, BA (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bminass@sickkids.ca; steve@genet.sickkids.on.ca	Elia, Maurizio/K-3285-2016; Scherer, Stephen W./B-3785-2013	Elia, Maurizio/0000-0002-0414-1359; Scherer, Stephen W./0000-0002-8326-1999; Delgado-Escueta, Antonio V./0000-0002-1581-6999; Young, Ted (Edwin)/0000-0003-4882-6752	Telethon [GFP01003] Funding Source: Medline	Telethon(Fondazione Telethon)		Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; Chan EM, 2003, J MED GENET, V40, P671, DOI 10.1136/jmg.40.9.671; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2003, HUM MOL GENET, V12, P2359, DOI 10.1093/hmg/ddg253; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Ganesh S, 2002, BIOCHEM BIOPH RES CO, V291, P1134, DOI 10.1006/bbrc.2002.6590; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Ianzano L, 2003, GENOMICS, V81, P579, DOI 10.1016/S0888-7543(03)00094-6; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2002, ADV NEUROL, V89, P199; Minassian BA, 1999, ANN NEUROL, V45, P262, DOI 10.1002/1531-8249(199902)45:2<262::AID-ANA20>3.0.CO;2-9; Minassian BA, 2001, ANN NEUROL, V49, P271, DOI 10.1002/1531-8249(20010201)49:2<271::AID-ANA52>3.3.CO;2-4; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7	15	211	218	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					125	127		10.1038/ng1238	http://dx.doi.org/10.1038/ng1238			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12958597				2022-12-27	WOS:000185625300007
J	Levy-Nissenbaum, E; Betz, RC; Frydman, M; Simon, M; Lahat, H; Bakhan, T; Goldman, B; Bygum, A; Pierick, M; Hillmer, AM; Jonca, N; Toribio, J; Kruse, R; Dewald, G; Cichon, S; Kubisch, C; Guerrin, M; Serre, G; Nothen, MM; Pras, E				Levy-Nissenbaum, E; Betz, RC; Frydman, M; Simon, M; Lahat, H; Bakhan, T; Goldman, B; Bygum, A; Pierick, M; Hillmer, AM; Jonca, N; Toribio, J; Kruse, R; Dewald, G; Cichon, S; Kubisch, C; Guerrin, M; Serre, G; Nothen, MM; Pras, E			Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin	NATURE GENETICS			English	Article							TERMINAL DIFFERENTIATION; DESMOSOMES; GENE; IDENTIFICATION; EXPRESSION; PSORIASIS; EPIDERMIS; EPITHELIA; ANTIGENS	We have identified nonsense mutations in the gene CDSN (encoding corneodesmosin) in three families suffering from hypotrichosis simplex of the scalp (HSS; OMIM 146520). CDSN, a glycoprotein expressed in the epidermis and inner root sheath (IRS) of hair follicles, is a keratinocyte adhesion molecule. Truncated CDSN aggregates were detected in the superficial dermis and at the periphery of hair follicles. Our findings suggest that CDSN is important in normal scalp hair physiology.	Chaim Sheba Med Ctr, Danek Gartner Inst Human Genet, Tel Hashomer, Israel; Tel Aviv Univ, IL-69978 Tel Aviv, Israel; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; CNRS, Unit Epidermis Differentiat & Rheumatoid Autoimmu, FRE2623, Toulouse, France; Univ Toulouse 3, F-31062 Toulouse, France; Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Univ Santiago de Compostela, Dept Dermatol, Santiago De Compostela, Spain; Univ Dusseldorf, Dept Dermatol, D-4000 Dusseldorf, Germany	Chaim Sheba Medical Center; Tel Aviv University; University of Antwerp; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Southern Denmark; Odense University Hospital; University of Bonn; Universidade de Santiago de Compostela; Heinrich Heine University Dusseldorf	Pras, E (corresponding author), Chaim Sheba Med Ctr, Danek Gartner Inst Human Genet, Tel Hashomer, Israel.		Jonca, Nathalie/AAX-3870-2020; Cichon, Sven/B-9618-2014; Hillmer, Axel M/N-2927-2014; Cichon, Sven/H-8803-2013; Hillmer, Axel M/B-7485-2015; Betz, Regina C/E-8591-2011; Simon, Michel/B-7308-2011; Nöthen, Markus/B-2027-2009; Kubisch, Christian/F-1893-2011	Jonca, Nathalie/0000-0003-3602-0102; Cichon, Sven/0000-0002-9475-086X; Hillmer, Axel M/0000-0002-3381-7266; Cichon, Sven/0000-0002-9475-086X; Hillmer, Axel M/0000-0002-3381-7266; Betz, Regina C/0000-0001-5024-3623; Simon, Michel/0000-0003-3655-6329; Nöthen, Markus/0000-0002-8770-2464; Kubisch, Christian/0000-0003-4220-0978; Bygum, Anette/0000-0002-3004-0180				Betz RC, 2000, AM J HUM GENET, V66, P1979, DOI 10.1086/302934; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; DIAZ ER, 1995, DERMATOLOGY, V191, P139; Guerrin M, 1998, J BIOL CHEM, V273, P22640, DOI 10.1074/jbc.273.35.22640; IBSEN HHW, 1991, ACTA DERM-VENEREOL, V71, P349; Jonca N, 2002, J BIOL CHEM, V277, P5024, DOI 10.1074/jbc.M108438200; KOHN G, 1987, CLIN GENET, V32, P120; MILS V, 1992, J HISTOCHEM CYTOCHEM, V40, P1329, DOI 10.1177/40.9.1506670; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; TORIBIO J, 1974, BRIT J DERMATOL, V91, P687, DOI 10.1111/j.1365-2133.1974.tb12455.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	15	116	124	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					151	153		10.1038/ng1163	http://dx.doi.org/10.1038/ng1163			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12754508				2022-12-27	WOS:000183200500019
J	Meeks, JJ; Weiss, J; Jameson, JL				Meeks, JJ; Weiss, J; Jameson, JL			Dax1 is required for testis determination	NATURE GENETICS			English	Article							ADRENAL HYPOPLASIA CONGENITA; SEX REVERSAL; CHROMOSOME; GENE	The orphan nuclear receptor, Dax1, was originally proposed to act as an 'anti-testis' factor. We find, however, that Nr0b1 (also called Dax1 and Ahch, which encodes Dax1) is in fact required for testis differentiation.	Northwestern Univ, Dept Med, Div Endocrinol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Jameson, JL (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol, Feinberg Sch Med, Chicago, IL 60611 USA.			Jameson, James/0000-0001-9538-4059				BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Eicher EM, 1996, NAT GENET, V14, P206, DOI 10.1038/ng1096-206; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Meeks JJ, 2003, DEVELOPMENT, V130, P1029, DOI 10.1242/dev.00316; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; VALERIE VPI, 2001, NAT GENET, V28, P216; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822	11	131	140	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					32	33		10.1038/ng1141	http://dx.doi.org/10.1038/ng1141			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12679814				2022-12-27	WOS:000182667900013
J	Amiel, J; Laudier, B; Attie-Bitach, T; Trang, H; de Pontual, L; Gener, B; Trochet, D; Etchevers, H; Ray, P; Simonneau, M; Vekemans, M; Munnich, A; Gaultier, C; Lyonnet, S				Amiel, J; Laudier, B; Attie-Bitach, T; Trang, H; de Pontual, L; Gener, B; Trochet, D; Etchevers, H; Ray, P; Simonneau, M; Vekemans, M; Munnich, A; Gaultier, C; Lyonnet, S			Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome	NATURE GENETICS			English	Article								Congenital central hypoventilation syndrome (CCHS or Ondine's curse; OMIM 209880) is a life-threatening disorder involving an impaired ventilatory response to hypercarbia and hypoxemia. This core phenotype is associated with lower-penetrance anomalies of the autonomic nervous system (ANS) including Hirschsprung disease and tumors of neural-crest derivatives such as ganglioneuromas and neuroblastomas. In mice, the development of ANS reflex circuits is dependent on the paired-like homeobox gene Phox2b. Thus, we regarded its human ortholog, PHOX2B, as a candidate gene in CCHS. We found heterozygous de novo mutations in PHOX2B in 18 of 29 individuals with CCHS. Most mutations consisted of 5-9 alanine expansions within a 20-residue polyalanine tract probably resulting from non-homologous recombination. We show that PHOX2B is expressed in both the central and the peripheral ANS during human embryonic development. Our data support an essential role of PHOX2B in the normal patterning of the autonomous ventilation system and, more generally, of the ANS in humans.	Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, INSERM, U393, F-75743 Paris 15, France; Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; Hop Robert Debre, Serv Physiol, CIC INSERM 9202, F-75019 Paris, France; Hop Robert Debre, Equipe INSERM E9935, F-75019 Paris, France; Hosp Cruces, Clin Maternoinfantil, Baracaldo 48903, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Universitario Cruces	Amiel, J (corresponding author), Hop Necker Enfants Malad, Unite Rech Handicaps Genet Enfant, INSERM, U393, 149 Rue de Sevres, F-75743 Paris 15, France.		Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; Etchevers, Heather C./B-5813-2012; Gener, Blanca/E-4310-2012; ATTIE-BITACH, Tania/K-1453-2017; amiel, jeanne/H-3501-2017; Ray, Pierre/B-9326-2012; Ray, Pierre F/D-7315-2019	Lyonnet, Stanislas/0000-0001-5426-9417; Etchevers, Heather C./0000-0003-0201-3799; ATTIE-BITACH, Tania/0000-0002-1155-3626; amiel, jeanne/0000-0001-5973-4728; Ray, Pierre F/0000-0003-1544-7449; Trochet, Delphine/0000-0002-9216-6117; DE PONTUAL, LOIC/0000-0002-3123-0453				Amiel J, 1998, AM J HUM GENET, V62, P715, DOI 10.1086/301759; Bolk S, 1996, NAT GENET, V13, P395, DOI 10.1038/ng0896-395; BROWN SA, 2002, AM J HUM GENET S166, V71; Bruneau S, 2001, DEV BIOL, V237, P345, DOI 10.1006/dbio.2001.0382; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Goodman FR, 2001, CLIN GENET, V59, P1, DOI 10.1034/j.1399-0004.2001.590101.x; Gozal D, 1998, PEDIATR PULM, V26, P273; KHALIFA MM, 1988, J PEDIATR-US, V113, P853, DOI 10.1016/S0022-3476(88)80016-7; Nakano M, 2001, NAT GENET, V29, P315, DOI 10.1038/ng744; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Sritippayawan S, 2002, AM J RESP CRIT CARE, V166, P367, DOI 10.1164/rccm.2112087; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Weese-Mayer DE, 2002, AM J MED GENET, V107, P306, DOI 10.1002/ajmg.10133; WEESEMAYER DE, 1993, AM J MED GENET, V47, P360, DOI 10.1002/ajmg.1320470313	15	594	624	0	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					459	461		10.1038/ng1130	http://dx.doi.org/10.1038/ng1130			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12640453	Bronze			2022-12-27	WOS:000181928600013
J	Knight, JC; Keating, BJ; Rockett, KA; Kwiatkowski, DR				Knight, JC; Keating, BJ; Rockett, KA; Kwiatkowski, DR			In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading	NATURE GENETICS			English	Article							C-TERMINAL DOMAIN; NECROSIS-FACTOR-ALPHA; PRADER-WILLI-SYNDROME; LYMPHOTOXIN-ALPHA; FACTOR GENES; TNF-ALPHA; HISTONE ACETYLATION; MASS-SPECTROMETRY; CEREBRAL MALARIA; DNA METHYLATION	In vivo characterization of regulatory polymorphisms is a key requirement for next-generation human genetic analysis. Here we describe haploChIP, a method that uses chromatin immunoprecipitation (ChIP) and mass spectrometry to identify differential protein-DNA binding in vivo associated with allelic variants of a gene. We demonstrate this approach with the imprinted gene SNRPN. HaploChIP showed close correlation between the level of bound phosphorylated RNA polymerase II at the SNRPN locus and allele-specific expression. Application of the approach to the TNF/LTA locus identified functionally important haplotypes that correlate with allele-specific transcription of LTA. The haploChIP method may be useful in high-throughput screening for common DNA polymorphisms that affect gene regulation in vivo.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Oxford, John Radcliffe Hosp, Dept Pediat, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; Harvard University; University of Oxford	Knight, JC (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.		Knight, Julian Charles/W-2399-2019; Knight, Julian/C-7242-2009	Knight, Julian Charles/0000-0002-0377-5536; Knight, Julian/0000-0002-0377-5536				BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14226; Braun A, 1997, CLIN CHEM, V43, P1151; Brinkman BMN, 1996, J INFLAMM, V46, P32; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; CADENA DL, 1987, J BIOL CHEM, V262, P12468; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Feil R, 1999, TRENDS GENET, V15, P431, DOI 10.1016/S0168-9525(99)01822-3; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Griffin TJ, 2000, TRENDS BIOTECHNOL, V18, P77, DOI 10.1016/S0167-7799(99)01401-8; Hu JF, 1998, BIOCHEM BIOPH RES CO, V251, P403, DOI 10.1006/bbrc.1998.9401; Jurinke C, 2001, Methods Mol Biol, V170, P103; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Richardson A, 2001, GENES IMMUN, V2, P343, DOI 10.1038/sj.gene.6363789; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Shaw MA, 2001, GENES IMMUN, V2, P196, DOI 10.1038/sj.gene.6363754; Takahashi Y, 2000, GENE DEV, V14, P804; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Whichelow CE, 1996, EUR J IMMUNOGENET, V23, P425, DOI 10.1111/j.1744-313X.1996.tb00133.x; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yamamoto S, 2001, MOL CELL BIOL, V21, P1, DOI 10.1128/MCB.21.1.1-15.2001	41	200	208	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					469	475		10.1038/ng1124	http://dx.doi.org/10.1038/ng1124			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12627232	Bronze			2022-12-27	WOS:000181928600017
J	Olofsson, P; Holmberg, J; Tordsson, J; Lu, SM; Akerstrom, B; Holmdahl, R				Olofsson, P; Holmberg, J; Tordsson, J; Lu, SM; Akerstrom, B; Holmdahl, R			Positional identification of Ncf1 as a gene that regulates arthritis severity in rats	NATURE GENETICS			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; OLIGOMERIC MATRIX PROTEIN; PHAGOCYTE NADPH OXIDASE; OIL-INDUCED ARTHRITIS; GENOME-WIDE LINKAGE; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ENCEPHALOMYELITIS; SUSCEPTIBILITY LOCUS	The identification of genes underlying quantitative-trait loci (QTL) for complex diseases, such as rheumatoid arthritis, is a challenging and difficult task for the human genome project. Through positional cloning of the Pia4 QTL in rats, we found that a naturally occurring polymorphism of Ncf1 (encoding neutrophil cytosolic factor 1, a component of the NADPH oxidase complex) regulates arthritis severity. The disease-related allele of Ncf1 has reduced oxidative burst response and promotes activation of arthritogenic T cells. Pharmacological treatment with substances that activate the NADPH oxidase complex is shown to ameliorate arthritis. Hence, Ncf1 is associated with a new autoimmune mechanism leading to severe destructive arthritis, notably similar to rheumatoid arthritis in humans.	Lund Univ, Sect Med Inflammat Res, S-22184 Lund, Sweden; Lund Univ, Dept Cell & Mol Biol, Sect Mol Pathogenesis, S-22184 Lund, Sweden	Lund University; Lund University	Holmdahl, R (corresponding author), Lund Univ, Sect Med Inflammat Res, Solvegatan 19,I11 BMC, S-22184 Lund, Sweden.		Lu, Shemin/AAI-6479-2021; Lu, Shemin/M-3350-2018; Holmdahl, Rikard/AAI-7682-2020	Lu, Shemin/0000-0002-5535-8320; Lu, Shemin/0000-0001-8250-850X; Olofsson, Peter/0000-0003-4849-8541				AKERSTROM B, 1985, J BIOL CHEM, V260, P4839; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bergsteinsdottir K, 2000, J IMMUNOL, V164, P1564, DOI 10.4049/jimmunol.164.3.1564; CANNON GW, 1993, ARTHRITIS RHEUM, V36, P126, DOI 10.1002/art.1780360120; CASIMIR CM, 1991, P NATL ACAD SCI USA, V88, P2753, DOI 10.1073/pnas.88.7.2753; Cooper AM, 2000, INFECT IMMUN, V68, P1231, DOI 10.1128/IAI.68.3.1231-1234.2000; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlman I, 1999, J IMMUNOL, V162, P2581; DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802; Geiszt M, 2001, J LEUKOCYTE BIOL, V69, P191; Gosele C, 2000, GENOMICS, V69, P287, DOI 10.1006/geno.2000.6352; Griffiths MM, 2000, ARTHRITIS RHEUM, V43, P1278, DOI 10.1002/1529-0131(200006)43:6<1278::AID-ANR10>3.0.CO;2-S; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Holmdahl R, 2001, IMMUNOL REV, V184, P184, DOI 10.1034/j.1600-065x.2001.1840117.x; HOLMDAHL R, 1992, CLIN EXP IMMUNOL, V88, P96; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Lapouge K, 2002, J BIOL CHEM, V277, P10121, DOI 10.1074/jbc.M112065200; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Mizuki K, 1998, EUR J BIOCHEM, V251, P573, DOI 10.1046/j.1432-1327.1998.2510573.x; Morel L, 2000, Int Rev Immunol, V19, P423, DOI 10.3109/08830180009055506; Nordquist N, 2000, J AUTOIMMUN, V15, P425, DOI 10.1006/jaut.2000.0450; Olofsson P, 2002, ARTHRITIS RHEUM, V46, P259, DOI 10.1002/1529-0131(200201)46:1<259::AID-ART10035>3.0.CO;2-2; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Schneider SM, 2001, INFLAMMATION, V25, P17, DOI 10.1023/A:1007019510569; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sun SH, 1999, INT IMMUNOL, V11, P529, DOI 10.1093/intimm/11.4.529; Svelander L, 1997, IMMUNOLOGY, V91, P260, DOI 10.1046/j.1365-2567.1997.00251.x; TAUROG JD, 1983, CELL IMMUNOL, V80, P198, DOI 10.1016/0008-8749(83)90106-5; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; van der Veen RC, 2000, J IMMUNOL, V164, P5177, DOI 10.4049/jimmunol.164.10.5177; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Vingsbo-Lundberg C, 1998, ARTHRITIS RHEUM, V41, P544, DOI 10.1002/1529-0131(199803)41:3<544::AID-ART21>3.0.CO;2-#; Vingsbo-Lundberg C, 1998, NAT GENET, V20, P401, DOI 10.1038/3887; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; Wang YK, 1998, GENOMICS, V48, P163, DOI 10.1006/geno.1997.5182; Weis JJ, 1999, J IMMUNOL, V162, P948; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Woon PY, 1998, GENOMICS, V50, P306, DOI 10.1006/geno.1998.5319; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; Zhang L, 1999, IMMUNOLOGY, V98, P267; Zheng CL, 2002, CLIN IMMUNOL, V103, P204, DOI 10.1006/clim.2002.5205; Zu YL, 1996, BLOOD, V87, P5287, DOI 10.1182/blood.V87.12.5287.bloodjournal87125287	50	299	309	2	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					25	32		10.1038/ng1058	http://dx.doi.org/10.1038/ng1058			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12461526				2022-12-27	WOS:000180136100013
J	Gerhold, DL; Jensen, RV; Gullans, SR				Gerhold, DL; Jensen, RV; Gullans, SR			Better therapeutics through microarrays	NATURE GENETICS			English	Review							MOLECULAR PHARMACOLOGY; EXPRESSION PROFILES; MECHANISM; GENES; CANCER; METABOLISM; PREDICTION; DISCOVERY; TOXICITY; SETS	DNA microarrays are an integral part of the process for therapeutic discovery, optimization and clinical validation. At an early stage, investigators use arrays to prioritize a few genes as potential therapeutic targets on the basis of various criteria. Subsequently, gene expression analysis assists in drug discovery and toxicology by eliminating poor compounds and optimizing the selection of promising leads. Integral to this process is the use of sophisticated statistics, mathematics and bioinformatics to define statistically valid observations and to deduce complex patterns of phenotypes and biological pathways. In short, microarrays are redefining the drug discovery process by providing greater knowledge at each step and by illuminating the complex workings of biological systems.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Funct Genom, Cambridge, MA 02139 USA; Merck Res Labs, Dept Mol Profiling, W Point, PA 19486 USA; Wesleyan Univ, Dept Phys, Middletown, CT 06459 USA	Harvard University; Brigham & Women's Hospital; Merck & Company; Wesleyan University	Gullans, SR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Funct Genom, 65 Landsdowne St, Cambridge, MA 02139 USA.			Gerhold, David/0000-0001-5739-730X				Baker TK, 2001, CHEM RES TOXICOL, V14, P1218, DOI 10.1021/tx015518a; Burczynski ME, 2000, TOXICOL SCI, V58, P399, DOI 10.1093/toxsci/58.2.399; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cho YS, 2001, P NATL ACAD SCI USA, V98, P9819, DOI 10.1073/pnas.171314398; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fryer RM, 2002, EXP NEPHROL, V10, P64; Gerhold D, 1996, BIOESSAYS, V18, P973, DOI 10.1002/bies.950181207; Gerhold D, 2001, PHYSIOL GENOMICS, V5, P161, DOI 10.1152/physiolgenomics.2001.5.4.161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HANSTEN PD, 2002, TOP 100 DRUG INTERAC; HEIMARK LD, 1987, CLIN PHARMACOL THER, V42, P388, DOI 10.1038/clpt.1987.168; Hu WY, 2002, J HYPERTENS, V20, P1323, DOI 10.1097/00004872-200207000-00019; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Karpen SJ, 2002, J HEPATOL, V36, P832, DOI 10.1016/S0168-8278(02)00129-0; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Pennie WD, 2001, TOXICOL LETT, V120, P353, DOI 10.1016/S0378-4274(01)00322-8; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; SARANG SS, 2002, PHYSL GENOM     0917; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; WHITLOCK JP, 1995, INDUCTION CYTOCHROME; Xu H, 2001, Biotechnol Annu Rev, V7, P131, DOI 10.1016/S1387-2656(01)07035-1; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	40	91	99	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			547	552		10.1038/ng1042	http://dx.doi.org/10.1038/ng1042			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454652				2022-12-27	WOS:000179742900017
J	Mollet, G; Salomon, R; Gribouval, O; Silbermann, F; Bacq, D; Landthaler, G; Milford, D; Nayir, A; Rizzoni, G; Antignac, C; Saunier, S				Mollet, G; Salomon, R; Gribouval, O; Silbermann, F; Bacq, D; Landthaler, G; Milford, D; Nayir, A; Rizzoni, G; Antignac, C; Saunier, S			The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin	NATURE GENETICS			English	Article							P130(CAS); DELETIONS; ELEGANS; LINKAGE; DOMAIN; MAP	Nephronophthisis, the most common genetic cause of chronic renal failure in children, is a progressive tubulo-interstitial kidney disorder that is inherited as an autosomal recessive trait. The disease is characterized by polyuria, growth retardation and deterioration of renal function during childhood or adolescence. The most prominent histological features are modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts(1). Nephronophthisis can also be associated with conditions affecting extrarenal organs, such as retinitis pigmentosa (Senior-Loken syndrome) (2,3) and ocular motor apraxia (Cogan syndrome)(4). Three loci are associated with the juvenile, infantile and adolescent forms, on chromosomes 2q13 (NPHP1; refs 5,6), 9q22 (NPHP2; ref. 7) and 3q21 (NPHP3; ref. 8), respectively. NPHP1, the only gene identified so far, encodes nephrocystin(9,10), which contains a Src homology 3 (SH3) domain and interacts with intracytoplasmic proteins involved in cell adhesion (11-13). Recently, a second locus associated with the juvenile form of the disease, NPHP4, was mapped to chromosome 1p36 (ref. 14). We carried out haplotype analysis of families affected with nephronophthisis that were not linked to the NPHP1, NPHP2 or NPHP3 loci, using markers covering this region. This allowed us to reduce the NPHP4 interval to a one centimorgan interval between D1S2795 and D1S2870, which contains six genes. We identified five different mutations in one of these genes, designated NPHP4, in unrelated individuals with nephronophthisis. The NPHP4 gene encodes a 1,250-amino acid protein of unknown function that we named nephrocystin-4. We demonstrated the interaction of nephrocystin-4 with nephrocystin suggesting that these two proteins participate in a common signaling pathway.	Univ Paris 05, Hop Necker Enfants Malad, INSERM, U423, Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Serv Neprol Pediat, Paris, France; Hop Charles Nicolle, Serv Nephrol pediat, Rouen, France; Ctr Natl Genotypage, Evry, France; Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England; Istanbul Univ, Fac Med, Dept Pediat Nephrol, Istanbul, Turkey; Bambino Gesu Pediat Hosp, Div Nephrol & Dialysis, Rome, Italy; Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Istanbul University; IRCCS Bambino Gesu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Antignac, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U423, Tour Lavoisier, Paris, France.	antignac@necker.fr	Gribouval, Olivier/A-7689-2015; Saunier, Sophie/G-6044-2015; Mollet, Geraldine/E-8049-2017; ANTIGNAC, Corinne/H-8945-2017	Gribouval, Olivier/0000-0003-0238-8224; Saunier, Sophie/0000-0002-1069-0047; Mollet, Geraldine/0000-0003-4685-5736; ANTIGNAC, Corinne/0000-0002-9934-4940; legendre, flora/0000-0002-4149-1913				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; ANTIGNAC C, 1998, CLIN NEPHROL, P2417; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Caridi G, 1998, AM J KIDNEY DIS, V32, P1059, DOI 10.1016/S0272-6386(98)70083-6; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; COGAN D G, 1952, Trans Am Acad Ophthalmol Otolaryngol, V56, P853; Desrosiers RR, 2000, J BIOL CHEM, V275, P14949, DOI 10.1074/jbc.275.20.14949; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Haider NB, 1998, AM J HUM GENET, V63, P1404, DOI 10.1086/302108; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; HILDEBRANDT F, 1993, AM J HUM GENET, V53, P1256; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; Omran H, 2002, J AM SOC NEPHROL, V13, P75, DOI 10.1681/ASN.V13175; Omran H, 2001, NEPHROL DIAL TRANSPL, V16, P755, DOI 10.1093/ndt/16.4.755; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7	27	165	174	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					300	305		10.1038/ng996	http://dx.doi.org/10.1038/ng996			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244321				2022-12-27	WOS:000178311100021
J	Ruivenkamp, CAL; van Wezel, T; Zanon, C; Stassen, APM; Vlcek, C; Csikos, T; Klous, AM; Tripodis, N; Perrakis, A; Boerrigter, L; Groot, PC; Lindeman, J; Mooi, WJ; Meijjer, GA; Scholten, G; Dauwerse, H; Paces, V; van Zandwijk, N; van Ommen, GJB; Demant, P				Ruivenkamp, CAL; van Wezel, T; Zanon, C; Stassen, APM; Vlcek, C; Csikos, T; Klous, AM; Tripodis, N; Perrakis, A; Boerrigter, L; Groot, PC; Lindeman, J; Mooi, WJ; Meijjer, GA; Scholten, G; Dauwerse, H; Paces, V; van Zandwijk, N; van Ommen, GJB; Demant, P			Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers	NATURE GENETICS			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MOLECULAR-CLONING; HUMAN GENOME; GENE; EXPRESSION; P27(KIP1); DEP-1; MAP; ALIGNMENT; SEQUENCE	Only a small proportion of cancers result from familial cancer syndromes with Mendelian inheritance. Nonfamilial, 'sporadic' cancers, which represent most cancer cases, also have a significant hereditary component(1,2), but the genes involved have low penetrance and are extremely difficult to detect(2,3). Therefore, mapping and cloning of quantitative trait loci (QTLs) for cancer susceptibility in animals could help identify homologous genes in humans. Several cancer-susceptibility QTLs have been mapped in mice and rats(4,5), but none have been cloned so far. Here we report the positional cloning of the mouse gene Scc1 (Susceptibility to colon cancer 1)(6) and the identification of Ptprj, encoding a receptor-type protein tyrosine phosphatase, as the underlying gene. In human colon, lung and breast cancers, we show frequent deletion of PTPRJ, allelic imbalance in loss of heterozygosity (LOH) and missense mutations. Our data suggest that PTPRJ is relevant to the development of several different human cancers.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Pathol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Clin Oncol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Acad Sci Czech Republic, Inst Mol Genet, Ctr Genom, Prague, Czech Republic; Slotervaart Hosp, Dept Pathol, Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands; Free Univ Amsterdam, Dept Pathol, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Slotervaart Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Demant, P (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	p.demant@nki.nl	Vlcek, Cestmir/I-8820-2014; van Wezel, Tom/AAL-5626-2021; Paces, Vaclav/G-3831-2014; van Zandwijk, Nico/E-4177-2012; van Wezel, Tom/A-9599-2008; Perrakis, Anastassis/E-8704-2013; van Wezel, Tom/Z-3092-2019	van Zandwijk, Nico/0000-0002-8405-9688; van Wezel, Tom/0000-0001-5773-7730; Perrakis, Anastassis/0000-0002-1151-6227; van Wezel, Tom/0000-0001-5773-7730; Groot, Peter C./0000-0003-3339-1469; Zanon, Carlo/0000-0003-2539-7238				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; FLORIJN RJ, 1995, HUM MOL GENET, V4, P831, DOI 10.1093/hmg/4.5.831; HONDA H, 1994, BLOOD, V84, P4186, DOI 10.1182/blood.V84.12.4186.bloodjournal84124186; Inoue K, 2000, GENE DEV, V14, P1797; Keane MM, 1996, CANCER RES, V56, P4236; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Kuramochi S, 1996, FEBS LETT, V378, P7, DOI 10.1016/0014-5793(95)01415-2; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Moen CJA, 1996, P NATL ACAD SCI USA, V93, P1082, DOI 10.1073/pnas.93.3.1082; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; PIETENPOL JA, 1995, CANCER RES, V55, P1206; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Rhodes M, 1998, GENOME RES, V8, P531, DOI 10.1101/gr.8.5.531; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Rozen S, 2000, Methods Mol Biol, V132, P365; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; VANWEZEL T, 2001, GENOTYPE PHENOTYPE, P107; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wielenga VJM, 2000, ADV CANCER RES, V77, P169	30	205	212	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					295	300		10.1038/ng903	http://dx.doi.org/10.1038/ng903			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089527				2022-12-27	WOS:000176494100019
J	Stoll, M; Corneliussen, B; Costello, CM; Waetzig, GH; Mellgard, B; Koch, WA; Rosenstiel, P; Albrecht, M; Croucher, PJP; Seegert, D; Nikolaus, S; Hampe, J; Lengauer, T; Pierrou, S; Foelsch, UR; Mathew, CG; Lagerstrom-Fermer, M; Schreiber, S				Stoll, M; Corneliussen, B; Costello, CM; Waetzig, GH; Mellgard, B; Koch, WA; Rosenstiel, P; Albrecht, M; Croucher, PJP; Seegert, D; Nikolaus, S; Hampe, J; Lengauer, T; Pierrou, S; Foelsch, UR; Mathew, CG; Lagerstrom-Fermer, M; Schreiber, S			Genetic variation in DLG5 is associated with inflammatory bowel disease	NATURE GENETICS			English	Article							CROHNS-DISEASE; FAMILY PROTEIN; SUSCEPTIBILITY; MUTATION; CANCER; CELLS	Crohn disease and ulcerative colitis are two subphenotypes of inflammatory bowel disease (IBD), a complex disorder resulting from gene-environment interaction. We refined our previously defined linkage region for IBD on chromosome 10q23 and used positional cloning to identify genetic variants in DLG5 associated with IBD. DLG5 encodes a scaffolding protein involved in the maintenance of epithelial integrity. We identified two distinct haplotypes with a replicable distortion in transmission (P = 0.000023 and P = 0.004 for association with IBD, P = 0.00012 and P = 0.04 for association with Crohn disease). One of the risk-associated DLG5 haplotypes is distinguished from the common haplotype by a nonsynonymous single-nucleotide polymorphism 113G-->A, resulting in the amino acid substitution R30Q in the DUF622 domain of DLG5. This mutation probably impedes scaffolding of DLG5. We stratified the study sample according to the presence of risk-associated CARD15 variants to study potential gene-gene interaction. We found a significant difference in association of the 113A DLG5 variant with Crohn disease in affected individuals carrying the risk-associated CARD15 alleles versus those carrying non-risk-associated CARD15 alleles. This is suggestive of a complex pattern of gene-gene interaction between DLG5 and CARD15, reflecting the complex nature of polygenic diseases. Further functional studies will evaluate the biological significance of DLG5 variants.	Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany; R&D Molndal, Dept Mol Sci, Molndal, Sweden; AstraZeneca, Expt Med, Molndal, Sweden; Conaris Res Inst AG, Kiel, Germany; Max Planck Inst Informat, Saarbrucken, Germany; Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; Guys Kings & St Thomas Sch Med, London, England	University of Kiel; Schleswig Holstein University Hospital; AstraZeneca; Max Planck Society; University of Kiel; University of London; King's College London	Schreiber, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, Schittenhelmstr 12, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Seegert, Dirk/B-8826-2011; Waetzig, Georg/AAV-7486-2021; Mathew, Christopher G/G-3434-2015; Rosenstiel, Philip/A-5137-2009; Albrecht, Mario/B-6694-2008; Eckhardt, Erik/G-1567-2010; Hampe, Jochen/A-2555-2010	Mathew, Christopher G/0000-0003-4178-1838; Rosenstiel, Philip/0000-0002-9692-8828; Albrecht, Mario/0000-0002-3103-9624; Hampe, Jochen/0000-0002-2421-6127				Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fisher R. A, 1946, STAT METHODS RES WOR; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lu G, 1999, GASTROENTEROLOGY, V116, P884, DOI 10.1016/S0016-5085(99)70071-5; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Nakamura H, 1998, FEBS LETT, V433, P63, DOI 10.1016/S0014-5793(98)00882-5; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Purmonen S, 2002, INT J CANCER, V102, P1, DOI 10.1002/ijc.10665; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Shah G, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-14; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; Wakabayashi M, 2003, J BIOL CHEM, V278, P21709, DOI 10.1074/jbc.M211004200	17	359	372	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					476	480		10.1038/ng1345	http://dx.doi.org/10.1038/ng1345			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107852	Bronze			2022-12-27	WOS:000221183000019
J	Wang, W; Yu, HJ; Long, MY				Wang, W; Yu, HJ; Long, MY			Duplication-degeneration as a mechanism of gene fission and the origin of new genes in Drosophila species	NATURE GENETICS			English	Article							EVOLUTION; MELANOGASTER; FUSION; RETROPOSONS; SELECTION; MUTATIONS; PROTEINS; JINGWEI; EXONS; LOCUS	Gene fission and fusion, the processes by which a single gene is split into two separate genes and two adjacent genes are fused into a single gene, respectively, are among the primary processes that generate new genes(1-4). Despite their seeming reversibility(4,5), nothing is known about the mechanism of gene fission. Because the nucleotide sequences of fission genes record little about their origination process, conventional analysis of duplicate genes may not be powerful enough to unravel the underlying mechanism. In a survey for young genes in species of the Drosophila melanogaster subgroup using fluorescence in situ hybridization, we identified a young gene family, monkey king, whose genesis sheds light on the evolutionary process of gene fission. Its members originated 1-2 million years ago as retroposed duplicates and evolved into fission genes that separately encode protein domains from a multidomain ancestor. The mechanism underlying this process is gene duplication with subsequent partial degeneration.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Chinese Acad Sci, Kunming Inst Zool, CAS Max Planck Jr Sci Grp, Key Lab Cellular & Mol Evolut, Kunming 650223, Yunnan, Peoples R China; Yunnan Univ, Sch Life Sci, Kunming 650091, Yunnan, Peoples R China	University of Chicago; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	mlong@midway.uchicago.edu	Wang, Wen/AAP-9873-2020	Wang, Wen/0000-0002-7801-2066				ABRINK M, 1995, DNA CELL BIOL, V14, P125, DOI 10.1089/dna.1995.14.125; Altschmied J, 2002, GENETICS, V161, P259; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fay JC, 2000, GENETICS, V155, P1405; Finta C, 2000, GENE, V260, P13, DOI 10.1016/S0378-1119(00)00470-4; Force A, 1999, GENETICS, V151, P1531; FU YH, 1993, GENETICS, V133, P6934; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; KUMAR S, 2001, MEGA2 MOL EVOLUTIONA; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Li W. H, 1997, MOL EVOLUTION; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nekrutenko A, 2002, GENOME RES, V12, P198, DOI 10.1101/gr.200901; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Powell J. R., 1997, PROGR PROSPECTS EVOL; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Sokal R. R., 2000, BIOMETRY; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; TAJIMA F, 1989, GENETICS, V123, P585; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399	30	75	79	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					523	527		10.1038/ng1338	http://dx.doi.org/10.1038/ng1338			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15064762	Bronze			2022-12-27	WOS:000221183000028
J	Bulavin, DV; Phillips, C; Nannenga, B; Timofeev, O; Donehower, LA; Anderson, CW; Appella, E; Fornace, AJ				Bulavin, DV; Phillips, C; Nannenga, B; Timofeev, O; Donehower, LA; Anderson, CW; Appella, E; Fornace, AJ			Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway	NATURE GENETICS			English	Article							CYCLIN D1; TRANSGENIC MICE; GENE PROMOTER; AMPLIFICATION; EXPRESSION; PPM1D; PHOSPHORYLATION; METHYLATION; APOPTOSIS; P53	Modulation of tumor suppressor activities may provide new opportunities for cancer therapy. Here we show that disruption of the gene Ppm1d encoding Wip1 phosphatase activated the p53 and p16 ( also called Ink4a) p19 ( also called ARF) pathways through p38 MAPK signaling and suppressed in vitro transformation of mouse embryo fibroblasts ( MEFs) by oncogenes. Disruption of the gene Cdkn2a ( encoding p16 and p19), but not of Trp53 ( encoding p53), reconstituted cell transformation in Ppm1d - null MEFs. In vivo, deletion of Ppm1d in mice bearing mouse mammary tumor virus ( MMTV) promoter driven oncogenes Erbb2 ( also called c - neu) or Hras1 impaired mammary carcinogenesis, whereas reduced expression of p16 and p19 by methylation-induced silencing or inactivation of p38 MAPK correlated with tumor appearance. We conclude that inactivation or depletion of the Wip1 phosphatase with resultant p38 MAPK activation suppresses tumor appearance by modulating the Cdkn2a tumor-suppressor locus.	NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bulavin, DV (corresponding author), NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bulavin@nih.gov	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Timofeev, Oleg/0000-0002-3114-6403; Dudgeon, Crissy/0000-0001-9010-2569	DIVISION OF BASIC SCIENCES - NCI [Z01BC007184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC005599, Z01BC005599] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj/onc/1205025; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 1999, ONCOGENE, V18, P5611, DOI 10.1038/sj.onc.1202945; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; DICKINSON AJ, 1990, OPHTHALMIC PAED GEN, V11, P1, DOI 10.3109/13816819009012942; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; GILLETT C, 1994, CANCER RES, V54, P1812; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Koch-Paiz CA, 2000, BIOTECHNIQUES, V29, P706, DOI 10.2144/00294bm07; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nielsen NH, 2001, CANCER LETT, V163, P59, DOI 10.1016/S0304-3835(00)00674-1; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	38	344	361	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					343	350		10.1038/ng1317	http://dx.doi.org/10.1038/ng1317			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	14991053	Bronze			2022-12-27	WOS:000220647200017
J	Fluck, CE; Tajima, T; Pandey, AV; Arlt, W; Okuhara, K; Verge, CF; Jabs, EW; Mendonca, BB; Fujieda, K; Miller, WL				Fluck, CE; Tajima, T; Pandey, AV; Arlt, W; Okuhara, K; Verge, CF; Jabs, EW; Mendonca, BB; Fujieda, K; Miller, WL			Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome	NATURE GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; PATIENT; 17-ALPHA-HYDROXYLASE/17,20-LYASE; DEFICIENCY; MUTATIONS; PREGNANCY; DEFECTS	Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan; Sydney Childrens Hosp, Dept Endocrinol, Randwick, NSW, Australia; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ Sao Paulo, Hosp Clin, Dept Med, Sao Paulo, Brazil; Asahikawa Med Coll, Dept Pediat, Asahikawa, Hokkaido 078, Japan	University of California System; University of California San Francisco; Hokkaido University; Johns Hopkins University; Universidade de Sao Paulo; Asahikawa Medical College	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Pandey, Amit V/A-7223-2008; Mendonca, Berenice B/C-2827-2012; Toshihiro, Tajima/A-5720-2012; Mendonca, Berenice/AAS-3742-2021; Mendonca, Berenice B/J-6917-2015; Arlt, Wiebke/B-6310-2009; Miller, Walter L/J-3696-2012; Pandey, Amit V/AAO-6442-2020	Pandey, Amit V/0000-0001-8331-5902; Mendonca, Berenice/0000-0003-1762-1084; Mendonca, Berenice B/0000-0003-1762-1084; Arlt, Wiebke/0000-0001-5106-9719; Pandey, Amit V/0000-0001-8331-5902; Jabs, Ethylin/0000-0001-8983-5466; Flueck, Christa/0000-0002-4568-5504				Adachi M, 1999, ENDOCR J, V46, P285, DOI 10.1507/endocrj.46.285; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Chun K, 1998, AM J MED GENET, V77, P219, DOI 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Kelley RI, 2002, AM J MED GENET, V110, P95, DOI 10.1002/ajmg.10510; MILLER WL, 1986, NEW ENGL J MED, V314, P1321; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; PETERSON RE, 1985, NEW ENGL J MED, V313, P1182, DOI 10.1056/NEJM198511073131903; Reardon W, 2000, J MED GENET, V37, P26, DOI 10.1136/jmg.37.1.26; Roth C, 2000, EUR J PEDIATR, V159, P189, DOI 10.1007/s004310050048; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	15	336	355	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					228	230		10.1038/ng1300	http://dx.doi.org/10.1038/ng1300			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14758361	Bronze			2022-12-27	WOS:000189250400009
J	Dominguez, M; Ferres-Marco, D; Gutierrez-Avino, FJ; Speicher, SA; Beneyto, M				Dominguez, M; Ferres-Marco, D; Gutierrez-Avino, FJ; Speicher, SA; Beneyto, M			Growth and specification of the eye are controlled independently by Eyegone and Eyeless in Drosophila melanogaster	NATURE GENETICS			English	Article							PAIRED DOMAIN; PAX PROTEINS; GENE; EXPRESSION; UPSTREAM; PATTERN; HOMEODOMAIN; BOUNDARIES; ANIRIDIA; POLARITY	Control of growth determines the size and shape of organs. Localized signals known as organizers and members of the Pax family of proto-oncogenes are both elements in this control. Pax proteins have a conserved DNA-binding paired domain, which is presumed to be essential for their oncogenic activity. We present evidence that the organizing signal Notch does not promote growth in eyes of D. melanogaster through either Eyeless (Ey) or Twin of eyeless (Toy), the two Pax6 transcription factors. Instead, it acts through Eyegone (Eyg), which has a truncated paired domain, consisting of only the C-terminal subregion. In humans and mice, the sole PAX6 gene produces the isoform PAX6(5a) by alternative splicing; like Eyegone, this isoform binds DNA though the C terminus of the paired domain. Overexpression of human PAX6(5a) induces strong overgrowth in vivo, whereas the canonical PAX6 variant hardly effects growth. These results show that growth and eye specification are subject to independent control and explain hyperplasia in a new way.	CSIC, Inst Neurciencias, E-03550 Sant Joan dAlacant, Spain; Univ Miguel Hernandez, E-03550 Sant Joan dAlacant, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Dominguez, M (corresponding author), CSIC, Inst Neurciencias, Apartado 18, E-03550 Sant Joan dAlacant, Spain.	m.dominguez@umh.es	Dominguez, Maria/G-2171-2014; Ferres-Marco, Maria/G-8364-2015	Dominguez, Maria/0000-0002-3329-7862; Ferres-Marco, Maria/0000-0002-0596-4891; Gutierrez Avino, Francisco Jose/0000-0002-9428-0765				Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643; Azuma N, 1999, AM J HUM GENET, V65, P656, DOI 10.1086/302529; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N; Cavodeassi F, 1999, DEVELOPMENT, V126, P4933; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Day SJ, 2000, DEVELOPMENT, V127, P2977; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GNARRA JR, 1995, CANCER RES, V55, P4092; Go MJ, 1998, DEVELOPMENT, V125, P2031; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEBERLEIN U, 2000, FINI, P37; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(01)00265-3; Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martinez S, 2001, INT J DEV BIOL, V45, P367; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Newsome TP, 2000, DEVELOPMENT, V127, P851; OHUCHI H, 1999, CELL TISSUE RES, V199, P247; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Scholl FA, 2001, CANCER RES, V61, P823; Sepp KJ, 1999, GENETICS, V151, P1093; Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X; Steinbach JP, 2001, INT J CANCER, V93, P459, DOI 10.1002/ijc.1371; TON CT, 1991, CELL, V68, P491; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; Winyard PJD, 1996, J CLIN INVEST, V98, P451, DOI 10.1172/JCI118811; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 1999, DEVELOPMENT, V126, P5857	50	120	123	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					31	39		10.1038/ng1281	http://dx.doi.org/10.1038/ng1281			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702038	Bronze			2022-12-27	WOS:000187666800011
J	Balbin, M; Fueyo, A; Tester, AM; Pendas, AM; Pitiot, AS; Astudillo, A; Overall, CM; Shapiro, SD; Lopez-Otin, C				Balbin, M; Fueyo, A; Tester, AM; Pendas, AM; Pitiot, AS; Astudillo, A; Overall, CM; Shapiro, SD; Lopez-Otin, C			Loss of collagenase-2 confers increased skin tumor susceptibility to male mice	NATURE GENETICS			English	Article							EXPRESSION; MMP-8; INHIBITION; CHEMOKINES; INFLAMMATION; CANCER; CELLS; GAMMA	Matrix metalloproteinases (MMPs) have fundamental roles in tumor progression(1,2), but most clinical trials with MMP inhibitors have not shown improvements in individuals with cancer(3). This may be partly because broad-range inhibitors also reduce host-protective antitumor properties of individual MMPs. We generated mice deficient in collagenase-2 (Mmp8), an MMP mainly produced by neutrophils in inflammatory reactions and detected in some malignant tumors(1,4). Loss of Mmp8 did not cause abnormalities during embryonic development or in adult mice. Contrary to previous studies with MMP-deficient mice, however, the absence of Mmp8 strongly increased the incidence of skin tumors in male Mmp8 / mice. Female Mmp8 / mice whose ovaries were removed or were treated with tamoxifen were also more susceptible to tumors compared with wild-type mice. Bone marrow transplantation experiments confirmed that Mmp8 supplied by neutrophils was sufficient to restore the natural protection against tumor development mediated by this protease in male mice. Histopathological analysis showed that mutant mice had abnormalities in the inflammatory response induced by carcinogens. Our study identifies a paradoxical protective role for Mmp8 in cancer and provides a genetic model to evaluate the molecular basis of gender differences in cancer susceptibility.	Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Biol Func, E-33006 Oviedo, Spain; Univ British Columbia, CIHR Grp Matrix Dynam, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, CIHR Grp Matrix Dynam, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Hosp Cent Asturias, Serv Anat Patol, Oviedo, Spain; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pulm & Crit Care Med, Boston, MA 02115 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of British Columbia; University of British Columbia; Central University Hospital Asturias; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	CLO@correo.uniovi.es	López-Otín, Carlos/AAB-2106-2020; Pendas, Alberto M/L-1017-2014; Balbín, Milagros/I-4206-2015; Pitiot, Ana S/AAA-9161-2020; Fueyo, Antonio/ABH-3243-2020	López-Otín, Carlos/0000-0001-6964-1904; Balbín, Milagros/0000-0001-5325-0407; Pitiot, Ana S/0000-0002-5318-3168; Fueyo, Antonio/0000-0002-7121-9398; Pendas, Alberto M/0000-0001-9264-3721; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809				Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, METH MOL B, V151, P149, DOI 10.1385/1-59259-046-2:149; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DEVARAJAN P, 1991, BLOOD, V77, P2731; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Kiili M, 2002, J CLIN PERIODONTOL, V29, P224, DOI 10.1034/j.1600-051x.2002.290308.x; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Moilanen M, 2002, J PATHOL, V197, P72, DOI 10.1002/path.1078; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pirila E, 2003, DIGEST DIS SCI, V48, P93, DOI 10.1023/A:1021790532723; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Ridger VC, 2001, J IMMUNOL, V166, P3484, DOI 10.4049/jimmunol.166.5.3484; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Wuyts A, 1999, J IMMUNOL, V163, P6155; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x	25	366	386	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					252	257		10.1038/ng1249	http://dx.doi.org/10.1038/ng1249			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14517555				2022-12-27	WOS:000186273300021
J	Bomar, JM; Benke, PJ; Slattery, EL; Puttagunta, R; Taylor, LP; Seong, E; Nystuen, A; Chen, WD; Albin, RL; Patel, PD; Kittles, RA; Sheffield, VC; Burmeister, M				Bomar, JM; Benke, PJ; Slattery, EL; Puttagunta, R; Taylor, LP; Seong, E; Nystuen, A; Chen, WD; Albin, RL; Patel, PD; Kittles, RA; Sheffield, VC; Burmeister, M			Mutations in a novel gene encoding a CRAL-TRIO domain cause human Cayman ataxia and ataxia/dystonia in the jittery mouse	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; TRANSFER PROTEIN; EXPRESSION; 19P13.3; GENOME; MAP; DNA	Cayman ataxia is a recessive congenital ataxia restricted to one area of Grand Cayman Island(1,2). Comparative mapping suggested that the locus on 19p13.3 associated with Cayman ataxia might be homologous to the locus on mouse chromosome 10 associated with the recessive ataxic mouse mutant jittery. Screening genes in the region of overlap identified mutations in a novel predicted gene in three mouse jittery alleles, including the first mouse mutation caused by an Alu-related (B1 element) insertion. We found two mutations exclusively in all individuals with Cayman ataxia. The gene ATCAY or Atcay encodes a neuron-restricted protein called caytaxin. Caytaxin contains a CRAL- TRIO motif common to proteins that bind small lipophilic molecules. Mutations in another protein containing a CRAL-TRIO domain, alpha-tocopherol transfer protein ( TTPA), cause a vitamin E responsive ataxia. Three-dimensional protein structural modeling predicts that the caytaxin ligand is more polar than vitamin E. Identification of the caytaxin ligand may help develop a therapy for Cayman ataxia.	Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Univ Miami, Dept Pediat, Miami, FL 33152 USA; Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Human Genet, Iowa City, IA 52242 USA; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Michigan, Vet Assoc Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Miami; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Howard University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burmeister, M (corresponding author), Univ Michigan, Mental Hlth Res Inst, 205 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.		Burmeister, Margit/A-3157-2013; Seong, Eunju/ABH-2705-2020; Puttagunta, Radhika/B-8664-2015; Puttagunta, Radhika/AAC-3217-2020	Burmeister, Margit/0000-0002-1914-2434; Puttagunta, Radhika/0000-0001-7674-8064; Sheffield, Val/0000-0002-6282-0835; Patel, Paresh/0000-0002-9145-4475				BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; BROWN L M, 1984, Neurology, V34, P273; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; DIETRICH W, 1992, GENETICS, V131, P423; Drewett PL, 2000, PREHISTORIC SETTLEME, P5; HERMAN JP, 1990, ENDOCRINOLOGY, V127, P2408, DOI 10.1210/endo-127-5-2408; JOHNSON WG, 1978, NEUROLOGY, V28, P352; Kapfhamer D, 1996, GENOMICS, V35, P533, DOI 10.1006/geno.1996.0394; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Puttagunta R, 2000, GENOME RES, V10, P1369, DOI 10.1101/gr.145200; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Stocker A, 2002, STRUCTURE, V10, P1533, DOI 10.1016/S0969-2126(02)00884-5; Zhang HM, 2002, CIRC RES, V90, P1251, DOI 10.1161/01.RES.0000024690.69379.5C	20	102	108	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					264	269		10.1038/ng1255	http://dx.doi.org/10.1038/ng1255			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14556008				2022-12-27	WOS:000186273300023
J	Varon, R; Gooding, R; Steglich, C; Marns, L; Tang, H; Angelicheva, D; Yong, KK; Ambrugger, P; Reinhold, A; Morar, B; Baas, F; Kwa, M; Tournev, I; Guerguelcheva, V; Kremensky, I; Lochmuller, H; Mullner-Eidenbock, A; Merlini, L; Neumann, L; Burger, J; Walter, M; Swoboda, K; Thomas, PK; von Moers, A; Risch, N; Kalaydjieva, L				Varon, R; Gooding, R; Steglich, C; Marns, L; Tang, H; Angelicheva, D; Yong, KK; Ambrugger, P; Reinhold, A; Morar, B; Baas, F; Kwa, M; Tournev, I; Guerguelcheva, V; Kremensky, I; Lochmuller, H; Mullner-Eidenbock, A; Merlini, L; Neumann, L; Burger, J; Walter, M; Swoboda, K; Thomas, PK; von Moers, A; Risch, N; Kalaydjieva, L			Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome	NATURE GENETICS			English	Article							CCFDN SYNDROME; MUTATION; DEPHOSPHORYLATES; FCP1; ROMA; GYPSIES; DISEASE; SITE	Congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome ( OMIM 604168) is an autosomal recessive developmental disorder that occurs in an endogamous group of Vlax Roma (Gypsies; refs. 1-3). We previously localized the gene associated with CCFDN to 18qter, where a conserved haplotype suggested a single founder mutation(4). In this study, we used recombination mapping to refine the gene position to a 155-kb critical interval. During haplotype analysis, we found that the non-transmitted chromosomes of some unaffected parents carried the conserved haplotype associated with the disease. Assuming such parents to be completely homozygous across the critical interval except with respect to the disease-causing mutation, we developed a new not quite identical by descent (NQIBD) approach, which allowed us to identify the mutation causing the disease by sequencing DNA from a single unaffected homozygous parent. We show that CCFDN is caused by a single-nucleotide substitution in an antisense Alu element in intron 6 of CTDP1 ( encoding the protein phosphatase FCP1, an essential component of the eukaryotic transcription machinery(5,6)), resulting in a rare mechanism of aberrant splicing and an Alu insertion in the processed mRNA. CCFDN thus joins the group of transcription syndromes(7) and is the first purely transcriptional defect identified that affects polymerase II mediated gene expression.	Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Mol Genet Lab, Perth, WA 6009, Australia; Humboldt Univ, Charite, Inst Human Genet, Berlin, Germany; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Humboldt Univ, Charite, Dept Neuropediat, Berlin, Germany; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1012 WX Amsterdam, Netherlands; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Univ Munich, Friedrich Baur Inst, Munich, Germany; Univ Hosp Vienna, Dept Ophthalmol, Vienna, Austria; Ist Ortoped Rizzoli, Bologna, Italy; Munich Re, Ctr Competence Biosci, Munich, Germany; Univ Utah, Sch Med, Salt Lake City, UT USA; Inst Neurol, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA USA	University of Western Australia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fred Hutchinson Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Amsterdam; Academic Medical Center Amsterdam; Medical University Sofia; Medical University Sofia; University of Munich; University Hospital Vienna; IRCCS Istituto Ortopedico Rizzoli; Munich RE Group; Utah System of Higher Education; University of Utah; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Stanford University; Kaiser Permanente	Kalaydjieva, L (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Mol Genet Lab, Perth, WA 6009, Australia.	luba@cyllene.uwa.edu.au	Morar, Bharti/O-8697-2014; Baas, Frank/F-9574-2010; Merlini, Luciano/N-6478-2019	Morar, Bharti/0000-0003-3897-1403; Baas, Frank/0000-0003-3912-5428; Merlini, Luciano/0000-0002-1108-1198; Lochmuller, Hanns/0000-0003-2324-8001; Swoboda, Kathryn/0000-0002-4593-6342				Angelicheva D, 1999, EUR J HUM GENET, V7, P560, DOI 10.1038/sj.ejhg.5200319; Archambault J, 1997, P NATL ACAD SCI USA, V94, P14300, DOI 10.1073/pnas.94.26.14300; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; CHAMBERS RS, 1994, J BIOL CHEM, V269, P26243; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Hunter M, 2002, PEDIATR RES, V51, P602, DOI 10.1203/00006450-200205000-00010; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LAGIERTOURENNE C, IN PRESS EUR J HUM G; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Licciardo P, 2001, NUCLEIC ACIDS RES, V29, P3539, DOI 10.1093/nar/29.17.3539; Mandal SS, 2002, MOL CELL BIOL, V22, P7543, DOI 10.1128/MCB.22.21.7543-7552.2002; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Merlini L, 2002, NEUROLOGY, V58, P231, DOI 10.1212/WNL.58.2.231; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; Muller-Felber W, 1998, NEUROPEDIATRICS, V29, P97, DOI 10.1055/s-2007-973542; Nachman MW, 2000, GENETICS, V156, P297; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Rogozin IB, 2003, MUTAT RES-REV MUTAT, V544, P65, DOI 10.1016/S1383-5742(03)00032-2; Tournev I, 1999, ANN NEUROL, V45, P742; Tournev I, 1999, ACTA NEUROPATHOL, V98, P165, DOI 10.1007/s004010051065; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200	30	110	113	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2003	35	2					185	189		10.1038/ng1243	http://dx.doi.org/10.1038/ng1243			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	14517542				2022-12-27	WOS:000185625300017
J	Zuccato, C; Tartari, M; Crotti, A; Goffredo, D; Valenza, M; Conti, L; Cataudella, T; Leavitt, BR; Hayden, MR; Timmusk, T; Rigamonti, D; Cattaneo, E				Zuccato, C; Tartari, M; Crotti, A; Goffredo, D; Valenza, M; Conti, L; Cataudella, T; Leavitt, BR; Hayden, MR; Timmusk, T; Rigamonti, D; Cattaneo, E			Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes	NATURE GENETICS			English	Article							RESTRICTIVE SILENCER FACTOR; WILD-TYPE HUNTINGTIN; HISTONE DEACETYLASE; MULTIPLE PROMOTERS; MUTANT HUNTINGTIN; BDNF-GENE; DISEASE; EXPRESSION; BRAIN; MOUSE	Huntingtin protein is mutated in Huntington disease(1). We previously reported that wild-type but not mutant huntingtin stimulates transcription of the gene encoding brain-derived neurotrophic factor (BDNF; ref. 2). Here we show that the neuron restrictive silencer element (NRSE) is the target of wildtype huntingtin activity on BDNF promoter II. Wild-type huntingtin inhibits the silencing activity of NRSE, increasing transcription of BDNF. We show that this effect occurs through cytoplasmic sequestering of repressor element-1 transcription factor/neuron restrictive silencer factor (REST/NRSF), the transcription factor that binds to NRSE3,4. In contrast, aberrant accumulation of REST/NRSF in the nucleus is present in Huntington disease. We show that wild-type huntingtin coimmunoprecipitates with REST/NRSF and that less immunoprecipitated material is found in brain tissue with Huntington disease. We also report that wild-type huntingtin acts as a positive transcriptional regulator for other NRSE-containing genes involved in the maintenance of the neuronal phenotype(5). Consistently, loss of expression of NRSE-controlled neuronal genes is shown in cells, mice and human brain with Huntington disease. We conclude that wild-type huntingtin acts in the cytoplasm of neurons to regulate the availability of REST/NRSF to its nuclear NRSE-binding site and that this control is lost in the pathology of Huntington disease. These data identify a new mechanism by which mutation of huntingtin causes loss of transcription of neuronal genes.	Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; Univ British Columbia, Dept Med Genet, Ctr mol Med & Therapeut, Vancouver, BC, Canada; Univ Helsinki, Inst Biotechnol, Helsinki, Finland; Tallinn Univ Technol, Dept Gene Technol, EE-200108 Tallinn, Estonia; NICPB, Tallinn, Estonia	University of Milan; University of Milan; University of British Columbia; University of Helsinki; Tallinn University of Technology; National Institute of Chemical Physics & Biophysics (NICPB)	Cattaneo, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.cattaneo@unimi.it	Conti, Luciano/H-4184-2012; Leavitt, Blair R/G-1934-2012; Hayden, Michael R/D-8581-2011; Timmusk, Tonis/H-4889-2015; VALENZA, MARTA/B-7763-2017	Conti, Luciano/0000-0002-2050-9846; Hayden, Michael R/0000-0001-5159-1419; ZUCCATO, CHIARA/0000-0003-1771-3392; Timmusk, Tonis/0000-0002-1015-3348; VALENZA, MARTA/0000-0002-7048-9257; CATTANEO, ELENA/0000-0002-0755-4917	Telethon [E.0840] Funding Source: Medline	Telethon(Fondazione Telethon)		Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Koenigsberger C, 2000, P NATL ACAD SCI USA, V97, P2291, DOI 10.1073/pnas.050578797; Lee JH, 2000, MOL BRAIN RES, V80, P88, DOI 10.1016/S0169-328X(00)00129-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; Timmusk T, 1999, J BIOL CHEM, V274, P1078; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; ZHANG Y, IN PRESS J NEUROCHEM; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	30	675	698	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					76	83		10.1038/ng1219	http://dx.doi.org/10.1038/ng1219			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12881722				2022-12-27	WOS:000185018500014
J	Pollock, PM; Cohen-Solal, K; Sood, R; Namkoong, J; Martino, JJ; Koganti, A; Zhu, H; Robbins, C; Makalowska, I; Shin, SS; Marin, Y; Roberts, KG; Yudt, LM; Chen, A; Cheng, J; Incao, A; Pinkett, HW; Graham, CL; Dunn, K; Crespo-Carbone, SM; Mackason, KR; Ryan, KB; Sinsimer, D; Goydos, J; Reuhl, KR; Eckhaus, M; Meltzer, PS; Pavan, WJ; Trent, JM; Chen, S				Pollock, PM; Cohen-Solal, K; Sood, R; Namkoong, J; Martino, JJ; Koganti, A; Zhu, H; Robbins, C; Makalowska, I; Shin, SS; Marin, Y; Roberts, KG; Yudt, LM; Chen, A; Cheng, J; Incao, A; Pinkett, HW; Graham, CL; Dunn, K; Crespo-Carbone, SM; Mackason, KR; Ryan, KB; Sinsimer, D; Goydos, J; Reuhl, KR; Eckhaus, M; Meltzer, PS; Pavan, WJ; Trent, JM; Chen, S			Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia	NATURE GENETICS			English	Article							PROTEIN-COUPLED RECEPTORS; MGLUR1 MUTANT MICE; TRANSGENIC MICE; CELL-GROWTH; DEFICIT	To gain insight into melanoma pathogenesis, we characterized an insertional mouse mutant, TG3, that is predisposed to develop multiple melanomas(1,2). Physical mapping identified multiple tandem insertions of the transgene into intron 3 of Grm1 (encoding metabotropic glutamate receptor 1) with concomitant deletion of 70 kb of intronic sequence. To assess whether this insertional mutagenesis event results in alteration of transcriptional regulation, we analyzed Grm1 and two flanking genes for aberrant expression in melanomas from TG3 mice. We observed aberrant expression of only Grm1. Although we did not detect its expression in normal mouse melanocytes, Grm1 was ectopically expressed in the melanomas from TG3 mice. To confirm the involvement of Grm1 in melanocytic neoplasia, we created an additional transgenic line with Grm1 expression driven by the dopachrome tautomerase promoter. Similar to the original TG3, the Tg(Grm1)EPv line was susceptible to melanoma. In contrast to human melanoma, these transgenic mice had a generalized hyperproliferation of melanocytes with limited transformation to fully malignant metastasis. We detected expression of GRM1 in a number of human melanoma biopsies and cell lines but not in benign nevi and melanocytes. This study provides compelling evidence for the importance of metabotropic glutamate signaling in melanocytic neoplasia.	Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genom Technol Branch, NIH, Bethesda, MD 20892 USA; Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Piscataway, NJ 08854 USA; Canc Inst New Jersey, New Brunswick, NJ 08903 USA; NIH, Vet Resources Program, Off Res Serv, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; National Institutes of Health (NIH) - USA	Chen, S (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ 08854 USA.	suziec@rci.rutgers.edu	Makalowska, Izabela/AAF-4967-2021; Makalowska, Izabela/AAU-2682-2021; Pinkett, Heather Wendy/M-9235-2014; Goydos, James/AAR-8990-2020	Makalowska, Izabela/0000-0002-8144-5671; Goydos, James/0000-0001-9811-939X; Pollock, Pamela/0000-0001-8420-1026	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000070, Z01HG000070, ZIAHG000136, Z01HG000136, Z01HG000037] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; Chen S, 1996, J INVEST DERMATOL, V106, P1145, DOI 10.1111/1523-1747.ep12340194; COLONTEICHER L, 1993, NUCLEIC ACIDS RES, V21, P2223, DOI 10.1093/nar/21.9.2223; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Frati C, 2000, J CELL PHYSIOL, V183, P364, DOI 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.3.CO;2-O; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Reedy MV, 1998, PIGMENTARY SYSTEM PH; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; SOOD R, IN PRESS GENOMICS; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Zhu H, 1999, MOL BRAIN RES, V73, P93, DOI 10.1016/S0169-328X(99)00239-9; Zhu H, 1998, J INVEST DERMATOL, V110, P247, DOI 10.1046/j.1523-1747.1998.00133.x; Zhu H, 2000, PIGM CELL RES, V13, P158, DOI 10.1034/j.1600-0749.2000.130307.x	20	214	228	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					108	112		10.1038/ng1148	http://dx.doi.org/10.1038/ng1148			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12704387				2022-12-27	WOS:000182667900026
J	Baird, DM; Rowson, J; Wynford-Thomas, D; Kipling, D				Baird, DM; Rowson, J; Wynford-Thomas, D; Kipling, D			Extensive allelic variation and ultrashort telomeres in senescent human cells	NATURE GENETICS			English	Article							HUMAN FIBROBLASTS; LIFE-SPAN; STOCHASTIC MECHANISM; LENGTH; REPEAT; PROLIFERATION; MODEL	By imposing a limit on the proliferative lifespan of most somatic cells, telomere erosion represents an innate mechanism for tumor suppression(1) and may contribute to age-related disease(2). A detailed understanding of the pathways that link shortened telomeres to replicative senescence has been severely hindered by the inability of current methods to analyze telomere dynamics in detail. Here we describe single telomere length analysis (STELA), a PCR-based approach that accurately measures the full spectrum of telomere lengths from individual chromosomes. STELA analysis of human XpYp telomeres in fibroblasts identifies several features of telomere biology. We observe bimodal distributions of telomeres in normal fibroblasts; these distributions result from inter-allelic differences of up to 6.5 kb, indicating that unexpectedly large-scale differences in zygotic telomere length are maintained throughout development. Most telomeres shorten in a gradual fashion consistent with simple losses through end replication, and the rates of erosion are independent of allele size. Superimposed on this are occasional, more substantial changes in length, which may be the consequence of additional mutational mechanisms. Notably, some alleles show almost complete loss of TTAGGG repeats at senescence.	Univ Wales Coll Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Baird, DM (corresponding author), Univ Wales Coll Med, Dept Pathol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Baird, Duncan M/C-9671-2011	Baird, Duncan M/0000-0001-8408-5467				ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; Baird DM, 2000, AM J HUM GENET, V66, P235, DOI 10.1086/302721; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bond JA, 1999, MOL CELL BIOL, V19, P3103; Coleman J, 1999, HUM MOL GENET, V8, P1637, DOI 10.1093/hmg/8.9.1637; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jones CJ, 1998, EXP CELL RES, V240, P333, DOI 10.1006/excr.1998.3944; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kipling D, 2001, MATURITAS, V38, P25, DOI 10.1016/S0378-5122(00)00189-4; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Rubelj I, 1999, J THEOR BIOL, V197, P425, DOI 10.1006/jtbi.1998.0886; Sambrook J., 2002, MOL CLONING LAB MANU; SMITH JR, 1980, SCIENCE, V207, P82; Tan Z, 1999, EXP GERONTOL, V34, P831, DOI 10.1016/S0531-5565(99)00056-X; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Varley H, 2002, NAT GENET, V30, P301, DOI 10.1038/ng834; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	29	382	407	1	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					203	207		10.1038/ng1084	http://dx.doi.org/10.1038/ng1084			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539050				2022-12-27	WOS:000180773700021
J	Devonald, MAJ; Smith, AN; Poon, JR; Ihrke, G; Karet, FE				Devonald, MAJ; Smith, AN; Poon, JR; Ihrke, G; Karet, FE			Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis	NATURE GENETICS			English	Article							EPITHELIAL-CELLS; SORTING SIGNALS; EXCHANGER; MUTATIONS; BAND-3; GENE	Autosomal dominant distal renal tubular acidosis (ddRTA) is caused by mutations in SLC4A1, which encodes the polytopic chloride-bicarbonate exchanger AE1 that is normally expressed at the basolateral surface of alpha-intercalated cells in the distal nephron. Here we report that, in contrast with many disorders in which mutant membrane proteins are retained intracellularly and degraded, ddRTA can result from aberrant targeting of AE1 to the apical surface.	Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Addenbrookes Hosp, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Div Nephrol, Addenbrookes Hosp, Cambridge CB2 2XY, England; Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Addenbrookes Hosp, Cambridge CB2 2XY, England	Addenbrooke's Hospital; University of Cambridge; Addenbrooke's Hospital; University of Cambridge; Addenbrooke's Hospital; University of Cambridge	Karet, FE (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Addenbrookes Hosp, Box 139, Cambridge CB2 2XY, England.			Karet, Fiona/0000-0002-2457-2869; Ihrke, Gudrun/0000-0003-4604-735X				Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Ihrke G, 2001, EMBO J, V20, P6256, DOI 10.1093/emboj/20.22.6256; Jarolim P, 1998, J BIOL CHEM, V273, P6380, DOI 10.1074/jbc.273.11.6380; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Karet FE, 1998, P NATL ACAD SCI USA, V95, P6337, DOI 10.1073/pnas.95.11.6337; Koivisto UM, 2001, CELL, V105, P575, DOI 10.1016/S0092-8674(01)00371-3; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Obrador G, 1998, J AM SOC NEPHROL, V9, P746; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342	15	115	116	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					125	127		10.1038/ng1082	http://dx.doi.org/10.1038/ng1082			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539048				2022-12-27	WOS:000180773700008
J	Wu, XM; Viveiros, MM; Eppig, JJ; Bai, YC; Fitzpatrick, SL; Matzuk, MM				Wu, XM; Viveiros, MM; Eppig, JJ; Bai, YC; Fitzpatrick, SL; Matzuk, MM			Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition	NATURE GENETICS			English	Article							MOUSE; ACTIVATION; PHD; DEFICIENT; MUTATION; DEFECTS; MOTIF	The female gamete (the oocyte) serves the distinct purpose of transmitting the maternal genome and other maternal factors that are critical for post-ovulation events(1-4). Through the identification and characterization of oocyte-specific factors, we are beginning to appreciate the diverse functions of oocytes in ovarian folliculogenesis, fertilization and embryogenesis(5),(6). To understand these processes further, we identified genes called zygote arrest 1 (Zar1 and ZAR1 in mouse and human, respectively) as novel oocyte-specific genes. These encode proteins of 361 amino acids and 424 amino acids, respectively, which share 59% amino-acid identity and an atypical plant homeo-domain (PHD) motif(7). Although Zar1-null (Zar1(-/-)) mice are viable and grossly normal, Zar1(-/-) females are infertile. Ovarian development and oogenesis through the early stages of fertilization are evidently unimpaired, but most embryos from Zar1(-/-) females arrest at the one-cell stage. Distinct pronuclei form and DNA replication initiates, but the maternal and paternal genomes remain separate in arrested zygotes. Fewer than 20% of the embryos derived from Zar1(-/-) females progress to the two-cell stage and show marked reduction in the synthesis of the transcription-requiring complex(8), and no embryos develop to the four-cell stage. Thus, Zar1 is the first identified oocyte-specific maternal-effect gene that functions at the oocyte-to-embryo transition and, as such, offers new insights into the initiation of embryonic development and fertility control in mammals.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wyeth Ayerst Res, Collegeville, PA USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Jackson Laboratory; Pfizer; Baylor College of Medicine; Baylor College of Medicine	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nnnatzuk@bcm.tmc.edu	Viveiros, Maria/P-4120-2015					AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; BRADLEY A, 1987, PRODUCTION ANAL CHIM, P113; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Eppig JJ, 1999, ADV MOLEC BIOL, P3; Ferreira J, 1997, J CELL SCI, V110, P889; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kumar TR, 2000, ENDOCRINOLOGY, V141, P4270, DOI 10.1210/en.141.11.4270; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Matzuk MM, 2002, NAT MED, V8, P41, DOI 10.1038/nm-fertilityS41; MATZUK MM, 1992, BIOCHEM BIOPH RES CO, V185, P404, DOI 10.1016/S0006-291X(05)81000-9; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yan W, 2002, MOL ENDOCRINOL, V16, P1168, DOI 10.1210/me.16.6.1168	29	314	341	6	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					187	191		10.1038/ng1079	http://dx.doi.org/10.1038/ng1079			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539046				2022-12-27	WOS:000180773700018
J	Lee, SS; Lee, RYN; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G				Lee, SS; Lee, RYN; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G			A systematic RNAi screen identifies a critical role for mitochondria in C-elegans longevity	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE STRESS; TELOMERE LENGTH; FAMILY MEMBER; GENE; INSULIN; YEAST; DAF-2; RESISTANCE	We report a systematic RNA interference (RNAi) screen of 5,690 Caenorhabditis elegans genes for gene inactivations that increase lifespan. We found that genes important for mitochondrial function stand out as a principal group of genes affecting C. elegans lifespan. A classical genetic screen identified a mutation in the mitochondrial leucyl-tRNA synthetase gene (lrs-2) that impaired mitochondrial function and was associated with longer-lifespan. The long-lived worms with impaired mitochondria had lower ATP content and oxygen consumption, but differential responses to free-radical and other stresses. These data suggest that the longer lifespan of C. elegans with compromised mitochrondria cannot simply be assigned to lower free radical production and suggest a more complex coupling of metabolism and longevity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Dept Genet, Sch Med, Boston, MA 02114 USA; Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge	Ruvkun, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA.			Fraser, Andrew/0000-0001-9939-6014; Lee, Raymond/0000-0002-8151-7479; Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Benard C, 2001, DEVELOPMENT, V128, P4045; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finch CE, 1990, LONGEVITY SENESCENCE; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRIEDMAN DB, 1988, GENETICS, V118, P75; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Jazwinski SM, 2001, MECH AGEING DEV, V122, P865, DOI 10.1016/S0047-6374(01)00244-5; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KAMATH R, 2002, IN PRESS NATURE; Kelly WG, 1997, GENETICS, V146, P227; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kirchman PA, 1999, GENETICS, V152, P179; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lim CS, 2001, CURR BIOL, V11, P1706, DOI 10.1016/S0960-9822(01)00526-7; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; OKIMOTO R, 1992, GENETICS, V130, P471; Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pearl R., 1928, RATE LIVING; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rose MR, 1999, EXP GERONTOL, V34, P577, DOI 10.1016/S0531-5565(99)00042-X; Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; Tzagoloff A, 1990, Prog Nucleic Acid Res Mol Biol, V39, P129, DOI 10.1016/S0079-6603(08)60625-X; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	46	707	767	1	53	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					40	48		10.1038/ng1056	http://dx.doi.org/10.1038/ng1056			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12447374				2022-12-27	WOS:000180136100015
J	Akman, L; Yamashita, A; Watanabe, H; Oshima, K; Shiba, T; Hattori, M; Aksoy, S				Akman, L; Yamashita, A; Watanabe, H; Oshima, K; Shiba, T; Hattori, M; Aksoy, S			Genome sequence of the endocellular obligate symbiont of tsetse flies, Wigglesworthia glossinidia	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; ENDOSYMBIONT; EVOLUTION; IDENTIFICATION; EXPRESSION; MORSITANS; SECRETION; BUCHNERA; PATHWAY; MIDGUT	Many insects that rely on a single food source throughout their developmental cycle harbor beneficial microbes that provide nutrients absent from their restricted diet. Tsetse flies, the vectors of African trypanosomes, feed exclusively on blood and rely on one such intracellular microbe for nutritional provisioning and fecundity. As a result of co-evolution with hosts over millions of years, these mutualists have lost the ability to survive outside the sheltered environment of their host insect cells. We present the complete annotated genome of Wigglesworthia glossinidia brevipalpis, which is composed of one chromosome of 697,724 base pairs (bp) and one small plasmid, called pWig1, of 5,200 bp. Genes involved in the biosynthesis of vitamin metabolites, apparently essential for host nutrition and fecundity, have been retained. Unexpectedly, this obligate's genome bears hallmarks of both parasitic and free-living microbes, and the gene encoding the important regulatory protein DnaA is absent.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Vector Biol, New Haven, CT 06510 USA; Kitasato Univ, Sch Sci, Kanagawa 2288555, Japan; RIKEN, Human Genome Res Grp, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; Hitachi Instruments Serv Co Ltd, Tokyo, Japan	Yale University; Kitasato University; RIKEN; Hitachi Limited	Hattori, M (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Vector Biol, 60 Coll St,606 LEPH, New Haven, CT 06510 USA.	hattori@genome.ls.kitasato_u.ac.jp; serap.aksoy@yale.edu	Aksoy, Serap/K-2244-2019; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019	Aksoy, Serap/0000-0001-9941-143X; Hattori, Masahira/0000-0001-9467-0344; 				Akman L, 2001, P NATL ACAD SCI USA, V98, P7546, DOI 10.1073/pnas.131057498; Aksoy S., 1995, Insect Molecular Biology, V4, P23, DOI 10.1111/j.1365-2583.1995.tb00004.x; Aksoy S, 2000, PARASITOL TODAY, V16, P114, DOI 10.1016/S0169-4758(99)01606-3; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ASAI T, 1994, J BACTERIOL, V176, P7113, DOI 10.1128/JB.176.22.7113-7114.1994; Charles H, 1999, J MOL EVOL, V48, P142, DOI 10.1007/PL00006452; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Douglas A.E., 1990, P319; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; HILL P, 1973, T ROY SOC TROP MED H, V67, P727, DOI 10.1016/0035-9203(73)90051-5; KAWAGISHI I, 1992, J GEN MICROBIOL, V138, P1051, DOI 10.1099/00221287-138-6-1051; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; MA WC, 1974, NATURE, V247, P301, DOI 10.1038/247301a0; MOLOO SK, 1971, PARASITOLOGY, V63, P507, DOI 10.1017/S0031182000080021; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; NOGGE G, 1976, EXPERIENTIA, V32, P995, DOI 10.1007/BF01933932; NOGGE G, 1981, PARASITOLOGY, V82, P101; Ochman H, 1994, EXS, V69, P479; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; ONEILL SL, 1993, MED VET ENTOMOL, V7, P377, DOI 10.1111/j.1365-2915.1993.tb00709.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	30	446	763	1	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					402	407		10.1038/ng986	http://dx.doi.org/10.1038/ng986			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12219091				2022-12-27	WOS:000179034800016
J	Wechsler, J; Greene, M; McDevitt, MA; Anastasi, J; Karp, JE; Le Beau, MM; Crispino, JD				Wechsler, J; Greene, M; McDevitt, MA; Anastasi, J; Karp, JE; Le Beau, MM; Crispino, JD			Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GATA-1; CELL-LINE; MEGAKARYOCYTIC DIFFERENTIATION; AML1/PEBP2-ALPHA-B GENE; POINT MUTATIONS; DNA-BINDING; RUNT DOMAIN; ZINC-FINGER; IN-VIVO; THROMBOCYTOPENIA	Children with Down syndrome have a 10-20-fold elevated risk of developing leukemia, particularly acute megakaryoblastic leukemia (AMKL)(1). While a subset of pediatric AMKLs is associated with the 1;22 translocation and expression of a mutant fusion protein(2,3), the genetic alterations that promote Down syndrome-related AMKL (DS-AMKL) have remained elusive. Here we show that leukemic cells from every individual with DS-AMKL that we examined contain mutations in GATA1, encoding the essential hematopoietic transcription factor GATA1 (GATA binding protein 1 or globin transcription factor 1). Each mutation results in the introduction of a premature stop codon in the gene sequence that encodes the amino-terminal activation domain. These mutations prevent synthesis of full-length GATA1, but not synthesis of a shorter variant that is initiated downstream. We show that the shorter GATA1 protein, which lacks the N-terminal activation domain, binds DNA and interacts with its essential cofactor Friend of GATA1 (FOG1; encoded by ZFPM1)(4) to the same extent as does full-length GATA1, but has a reduced transactivation potential. Although some reports suggest that the activation domain is dispensable in cell-culture models of hematopoiesis(5,6), one study has shown that it is required for normal development in vivo(7). Together, these findings indicate that loss of wildtype GATA1 constitutes one step in the pathogenesis of AMKL in Down syndrome.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; Johns Hopkins University; University of Chicago; University System of Maryland; University of Maryland Baltimore; University of Chicago	Crispino, JD (corresponding author), Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA.	crispino@huggins.bsd.uchicago.edu		Crispino, John/0000-0002-8182-8306; Wechsler, Joshua/0000-0002-1275-3275				Busson-Le Coniat M, 2001, GENE CHROMOSOME CANC, V32, P244, DOI 10.1002/gcc.1188; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Dal Cin P, 2001, GENE CHROMOSOME CANC, V30, P407, DOI 10.1002/1098-2264(2001)9999:9999<::AID-GCC1107>3.0.CO;2-C; Dickstein JI, 2001, CANCER GENET CYTOGEN, V129, P150, DOI 10.1016/S0165-4608(01)00508-8; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Kelly L, 2002, CURR OPIN ONCOL, V14, P10, DOI 10.1097/00001622-200201000-00003; KOMATSU N, 1989, BLOOD, V74, P42; Lange B, 2000, BRIT J HAEMATOL, V110, P512, DOI 10.1046/j.1365-2141.2000.02027.x; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Mehaffey MG, 2001, BLOOD, V98, P2681, DOI 10.1182/blood.V98.9.2681; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Vyas P, 1999, BLOOD, V93, P2867; Wang P, 1997, GENE CHROMOSOME CANC, V20, P282, DOI 10.1002/(SICI)1098-2264(199711)20:3<282::AID-GCC9>3.0.CO;2-Z; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642	30	552	567	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					148	152		10.1038/ng955	http://dx.doi.org/10.1038/ng955			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12172547				2022-12-27	WOS:000177714900014
J	Rustici, G; Mata, J; Kivinen, K; Lio, P; Penkett, CJ; Burns, G; Hayles, J; Brazma, A; Nurse, P; Bahler, J				Rustici, G; Mata, J; Kivinen, K; Lio, P; Penkett, CJ; Burns, G; Hayles, J; Brazma, A; Nurse, P; Bahler, J			Periodic gene expression program of the fission yeast cell cycle	NATURE GENETICS			English	Article							TRANSCRIPTIONAL REGULATORY NETWORKS; DNA-SYNTHESIS GENES; CENP-A; MEIOSIS; PROTEIN; IDENTIFICATION; MICROARRAYS; TRANSITION; MCM1; SWI5	Cell-cycle control of transcription seems to be universal, but little is known about its global conservation and biological significance. We report on the genome-wide transcriptional program of the Schizosaccharomyces pombe cell cycle, identifying 407 periodically expressed genes of which 136 show high-amplitude changes. These genes cluster in four major waves of expression. The forkhead protein Sep1p regulates mitotic genes in the first cluster, including Ace2p, which activates transcription in the second cluster during the M-G1 transition and cytokinesis. Other genes in the second cluster, which are required for G1-S progression, are regulated by the MBF complex independently of Sep1p and Ace2p. The third cluster coincides with S phase and a fourth cluster contains genes weakly regulated during G2 phase. Despite conserved cell-cycle transcription factors, differences in regulatory circuits between fission and budding yeasts are evident, revealing evolutionary plasticity of transcriptional control. Periodic transcription of most genes is not conserved between the two yeasts, except for a core set of similar to40 genes that seem to be universally regulated during the eukaryotic cell cycle and may have key roles in cell-cycle progression.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; European Bioinformat Inst, EMBL Outstn Hinxton, Cambridge CB10 1SD, England; Canc Res UK London Res Inst, London WC2A 3PX, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Cancer Research UK	Bahler, J (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	jurg@sanger.ac.uk	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Rustici, Gabriella/0000-0003-3085-1271; Kivinen, Katja/0000-0002-1135-7625; Brazma, Alvis/0000-0001-5988-7409; Mata, Juan/0000-0002-5514-3653	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cooper Stephen, 2003, Cell Chromosome, V2, P1, DOI 10.1186/1475-9268-2-1; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LOWNDES NF, 1992, NATURE, V357, P505, DOI 10.1038/357505a0; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; LYDALL D, 1991, GENE DEV, V5, P2405, DOI 10.1101/gad.5.12b.2405; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; MACNEILL SA, 1997, MOL CELLULAR BIOL YE, P697; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MATSUMOTO S, 1985, EMBO J, V4, P3531, DOI 10.1002/j.1460-2075.1985.tb04113.x; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; McInerny CJ, 1995, NUCLEIC ACIDS RES, V23, P4761; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tasto JJ, 2003, J CELL BIOL, V160, P1093, DOI 10.1083/jcb.200211126; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VILO J, 2000, ISMB, V8, P384; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Woollard A, 1996, EMBO J, V15, P4603, DOI 10.1002/j.1460-2075.1996.tb00838.x; WYNNE J, 1992, NUCLEIC ACIDS RES, V20, P3297, DOI 10.1093/nar/20.13.3297; Wyrick JJ, 2002, CURR OPIN GENET DEV, V12, P130, DOI 10.1016/S0959-437X(02)00277-0; Yang IV, 2002, GENOME BIOL, V3; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zilahi E, 2000, FEBS LETT, V481, P105, DOI 10.1016/S0014-5793(00)01990-6	50	390	396	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					809	817		10.1038/ng1377	http://dx.doi.org/10.1038/ng1377			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15195092				2022-12-27	WOS:000222974000012
J	Costoya, JA; Hobbs, RM; Barna, M; Cattoretti, G; Manova, K; Sukhwani, M; Orwig, KE; Wolgemuth, DJ; Pandolfi, PP				Costoya, JA; Hobbs, RM; Barna, M; Cattoretti, G; Manova, K; Sukhwani, M; Orwig, KE; Wolgemuth, DJ; Pandolfi, PP			Essential role of Plzf in maintenance of spermatogonial stem cells	NATURE GENETICS			English	Article							LEUKEMIA ZINC-FINGER; PROMYELOCYTIC LEUKEMIA; MALE-INFERTILITY; PROTEIN PLZF; MOUSE; EXPRESSION; TESTIS; GERM; GENE; DIFFERENTIATION	Little is known of the molecular mechanisms whereby spermatogonia, mitotic germ cells of the testis, self-renew and differentiate into sperm(1,2). Here we show that Zfp145, encoding the transcriptional repressor Plzf, has a crucial role in spermatogenesis. Zfp145 expression was restricted to gonocytes and undifferentiated spermatogonia and was absent in tubules of W/W-v mutants that lack these cells. Mice lacking Zfp145 underwent a progressive loss of spermatogonia with age, associated with increases in apoptosis and subsequent loss of tubule structure but without overt differentiation defects or loss of the supporting Sertoli cells. Spermatogonial transplantation experiments revealed a depletion of spermatogonial stem cells in the adult. Microarray analysis of isolated spermatogonia from Zfp145-null mice before testis degeneration showed alterations in the expression profile of genes associated with spermatogenesis. These results identify Plzf as a spermatogonia-specific transcription factor in the testis that is required to regulate self-renewal and maintenance of the stem cell pool.	Mem Sloan Kettering Canc Ctr, Dept Pathol, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, Dev Biol Program, Mol Cytol Core Facil, New York, NY 10021 USA; Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Costoya, Jose A./B-2718-2009; Cattoretti, Giorgio/H-2340-2011; Hobbs, Robin/I-2577-2014	Costoya, Jose A./0000-0003-3691-6419; Orwig, Kyle/0000-0002-7952-8419; Cattoretti, Giorgio/0000-0003-3799-3221; Hobbs, Robin/0000-0002-3853-2614				Andersson S, 1995, J STEROID BIOCHEM, V55, P533, DOI 10.1016/0960-0760(95)00202-2; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Beumer TL, 1999, ENDOCRINOLOGY, V140, P1834, DOI 10.1210/en.140.4.1834; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; BUAAS FW, 2004, NAT GENET       0523; COOK M, 1995, P NATL ACAD SCI USA, V92, P2249, DOI 10.1073/pnas.92.6.2249; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Costoya JA, 2001, CURR OPIN HEMATOL, V8, P212, DOI 10.1097/00062752-200107000-00006; COULOMBRE JL, 1954, J EXP ZOOL, V126, P277, DOI 10.1002/jez.1401260207; Cunningham DB, 1998, DEV BIOL, V204, P345, DOI 10.1006/dbio.1998.9004; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Handel MA, 1999, J EXP ZOOL, V285, P243, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;243::AID-JEZ7&gt;3.0.CO;2-#; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; MANOVA K, 1990, DEVELOPMENT, V110, P1057; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Narula A, 2002, AM J PATHOL, V161, P1723, DOI 10.1016/S0002-9440(10)64449-5; Orwig KE, 2002, BIOL REPROD, V66, P944, DOI 10.1095/biolreprod66.4.944; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Venables JP, 1999, CURR OPIN GENET DEV, V9, P346, DOI 10.1016/S0959-437X(99)80052-5; Wrobel KH, 1996, CELL TISSUE RES, V283, P191, DOI 10.1007/s004410050529; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375	30	717	759	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					653	659		10.1038/ng1367	http://dx.doi.org/10.1038/ng1367			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15156143	Bronze			2022-12-27	WOS:000221763700026
J	Suter, CM; Martin, DIK; Ward, RL				Suter, CM; Martin, DIK; Ward, RL			Germline epimutation of MLH1 in individuals with multiple cancers	NATURE GENETICS			English	Article							MICROSATELLITE INSTABILITY; EPIGENETIC INHERITANCE; METHYLATION; GENETICS; CPG; HYPERMETHYLATION; ALLELE	Epigenetic silencing can mimic genetic mutation by abolishing expression of a gene. We hypothesized that an epimutation could occur in any gene as a germline event that predisposes to disease and looked for examples in tumor suppressor genes in individuals with cancer. Here we report two individuals with soma-wide, allele-specific and mosaic hypermethylation of the DNA mismatch repair gene MLH1. Both individuals lack evidence of genetic mutation in any mismatch repair gene but have had multiple primary tumors that show mismatch repair deficiency, and both meet clinical criteria for hereditary nonpolyposis colorectal cancer. The epimutation was also present in spermatozoa of one of the individuals, indicating a germline defect and the potential for transmission to offspring. Germline epimutation provides a mechanism for phenocopying of genetic disease. The mosaicism and nonmendelian inheritance that are characteristic of epigenetic states could produce patterns of disease risk that resemble those of polygenic or complex traits.	Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; St Vincents Hosp, Dept Med Oncol, Sydney, NSW 2010, Australia; Univ New S Wales, Sch Med, Sydney, NSW, Australia; Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Martin, DIK (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.	d.martin@victorchang.unsw.edu.au	Ward, Robyn L/I-2313-2013	Ward, Robyn L/0000-0002-6877-8906				Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DAS OP, 1994, GENETICS, V136, P1121; Deng GR, 1999, CANCER RES, V59, P2029; Gazzoli I, 2002, CANCER RES, V62, P3925; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jass JR, 2000, ANN NY ACAD SCI, V910, P62; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Lynch HT, 1998, DIGESTION, V59, P481, DOI 10.1159/000007525; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nakagawa H, 2001, CANCER RES, V61, P6991; Rashid A, 2000, GASTROENTEROLOGY, V119, P323, DOI 10.1053/gast.2000.9361; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Renkonen E, 2003, J CLIN ONCOL, V21, P3629, DOI 10.1200/JCO.2003.03.181; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Schoell WMJ, 1999, OBSTET GYNECOL, V94, P623, DOI 10.1016/S0029-7844(99)00373-7; Schofield PN, 2001, TOXICOL LETT, V120, P151, DOI 10.1016/S0378-4274(01)00294-6; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	30	348	367	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					497	501		10.1038/ng1342	http://dx.doi.org/10.1038/ng1342			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15064764	Bronze			2022-12-27	WOS:000221183000023
J	Zhang, H; Smolen, GA; Palmer, R; Christoforou, A; van den Heuvel, S; Haber, DA				Zhang, H; Smolen, GA; Palmer, R; Christoforou, A; van den Heuvel, S; Haber, DA			SUMO modification is required for in vivo Hox gene regulation by the Caenorhabditis elegans Polycomb group protein SOP-2	NATURE GENETICS			English	Article							SAM DOMAIN; HOMOLOG; TEL	Post-translational modification of proteins by the ubiquitin-like molecule SUMO (sumoylation) regulates their subcellular localization and affects their functional properties in vitro 1,2, but the physiological function of sumoylation in multicellular organisms is largely unknown. Here, we show that the C. elegans Polycomb group (PcG) protein SOP-2 interacts with the SUMO-conjugating enzyme UBC-9 through its evolutionarily conserved SAM domain. Sumoylation of SOP-2 is required for its localization to nuclear bodies in vivo and for its physiological repression of Hox genes. Global disruption of sumoylation phenocopies a sop-2 mutation by causing ectopic Hox gene expression and homeotic transformations. Chimeric constructs in which the SOP-2 SAM domain is replaced with that derived from fruit fly or mammalian PcG proteins, but not those in which the SOP-2 SAM domain is replaced with the SAM domains of non-PcG proteins, confer appropriate in vivo nuclear localization and Hox gene repression. These observations indicate that sumoylation of PcG proteins, modulated by their evolutionarily conserved SAM domain, is essential to their physiological repression of Hox genes.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu	van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463				Apionishev S, 2001, GENES CELLS, V6, P215, DOI 10.1046/j.1365-2443.2001.00413.x; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; BRENNER S, 1974, GENETICS, V77, P71; Chakrabarti SR, 2000, P NATL ACAD SCI USA, V97, P13281, DOI 10.1073/pnas.240315897; EMMONS SW, 1999, CELL LINEAGE FATE DE, P139; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; Ferreira HB, 1999, DEV BIOL, V207, P215, DOI 10.1006/dbio.1998.9124; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Jones D, 2002, GENOME BIOL, V3; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Netter S, 2001, DNA CELL BIOL, V20, P483, DOI 10.1089/104454901316976118; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Seeler JS, 2001, ONCOGENE, V20, P7243, DOI 10.1038/sj.onc.1204758; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Zhang H, 2003, DEV CELL, V4, P903, DOI 10.1016/S1534-5807(03)00136-9; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	20	68	81	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					507	511		10.1038/ng1336	http://dx.doi.org/10.1038/ng1336			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107848	Bronze			2022-12-27	WOS:000221183000025
J	Bienengraeber, M; Olson, TM; Selivanov, VA; Kathmann, EC; O'Cochlain, F; Gao, F; Karger, AB; Ballew, JD; Hodgson, DM; Zingman, LV; Pang, YP; Alekseev, AE; Terzic, A				Bienengraeber, M; Olson, TM; Selivanov, VA; Kathmann, EC; O'Cochlain, F; Gao, F; Karger, AB; Ballew, JD; Hodgson, DM; Zingman, LV; Pang, YP; Alekseev, AE; Terzic, A			ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic K-ATP channel gating	NATURE GENETICS			English	Article							SULFONYLUREA RECEPTOR; HEART-FAILURE; KIR6.2; TRAFFICKING; GENE; SUR1	Stress tolerance of the heart requires high-fidelity metabolic sensing by ATP-sensitive potassium (K-ATP) channels that adjust membrane potential dependent functions to match cellular energetic demand. Scanning of genomic DNA from individuals with heart failure and rhythm disturbances due to idiopathic dilated cardiomyopathy identified two mutations in ABCC9, which encodes the regulatory SUR2A subunit of the cardiac K-ATP channel. These missense and frameshift mutations mapped to evolutionarily conserved domains adjacent to the catalytic ATPase pocket within SUR2A. Mutant SUR2A proteins showed aberrant redistribution of conformations in the intrinsic ATP hydrolytic cycle, translating into abnormal K-ATP channel phenotypes with compromised metabolic signal decoding. Defective catalysis-mediated pore regulation is thus a mechanism for channel dysfunction and susceptibility to dilated cardiomyopathy.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Dept Med, Coll Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Pediat Cardiol, Dept Pediat & Adolescent Med, Coll Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Terzic, A (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Dept Med, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	terzic.andre@mayo.edu	Alekseev, Alexey/I-5346-2013; Zingman, Leonid V/GXG-0136-2022	Zingman, Leonid V/0000-0002-7566-4616; Pang, Yuan-Ping/0000-0003-0838-2560; Selivanov, Vitaly/0000-0002-7937-9249; Karger, Amy/0000-0002-2781-3824; Olson, Timothy/0000-0003-2716-9423	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071225] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL071225, R01 HL071225-01, R01 HL071225-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chien KR, 2003, NAT MED, V9, P508, DOI 10.1038/nm0503-508; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Hodgson DM, 2003, EMBO J, V22, P1732, DOI 10.1093/emboj/cdg192; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsushita K, 2002, CIRC RES, V90, P554, DOI 10.1161/01.RES.0000012666.42782.30; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	29	263	273	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					382	387		10.1038/ng1329	http://dx.doi.org/10.1038/ng1329			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15034580	Green Accepted, Bronze			2022-12-27	WOS:000220647200022
J	Gissen, P; Johnson, CA; Morgan, NV; Stapelbroek, JM; Forshew, T; Cooper, WN; McKiernan, PJ; Klomp, LWJ; Morris, AAM; Wraith, JE; McClean, P; Lynch, SA; Thompson, RJ; Lo, B; Quarrell, OW; Di Rocco, M; Trembath, RC; Mandel, H; Wali, S; Karet, FE; Knisely, AS; Houwen, RHJ; Kelly, DA; Maher, ER				Gissen, P; Johnson, CA; Morgan, NV; Stapelbroek, JM; Forshew, T; Cooper, WN; McKiernan, PJ; Klomp, LWJ; Morris, AAM; Wraith, JE; McClean, P; Lynch, SA; Thompson, RJ; Lo, B; Quarrell, OW; Di Rocco, M; Trembath, RC; Mandel, H; Wali, S; Karet, FE; Knisely, AS; Houwen, RHJ; Kelly, DA; Maher, ER			Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROTEINS; HOMOLOG	ARC syndrome ( OMIM 208085) is an autosomal recessive multisystem disorder characterized by neurogenic arthrogryposis multiplex congenita, renal tubular dysfunction and neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase (gGT) activity. Platelet dysfunction is common. Affected infants do not thrive and usually die in the first year of life(1-5). To elucidate the molecular basis of ARC, we mapped the disease to a 7-cM interval on 15q26.1 and then identified germline mutations in the gene VPS33B in 14 kindreds with ARC. VPS33B encodes a homolog of the class C yeast vacuolar protein sorting gene, Vps33, that contains a Sec1-like domain important in the regulation of vesicle-to-target SNARE complex formation and subsequent membrane fusion(6-9).	Univ Birmingham, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Birmingham Childrens Hosp, Liver Unit, Birmingham B4 6NH, W Midlands, England; Univ Med Ctr, Dept Pediat Gastroenterol, Utrecht, Netherlands; Univ Med Ctr, Dept Metab & Endocrine Dis, Utrecht, Netherlands; Royal Manchester Childrens Hosp, Willink Biochem Genet Unit, Manchester M27 4HA, Lancs, England; Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Sheffield Childrens Hosp, Dept Clin Genet, Sheffield S10 2TH, S Yorkshire, England; Gaslini Inst, Pediat Unit 2, I-16147 Genoa, Italy; Univ Leicester, Dept Genet & Cardiovasc Dis, Div Med Genet, Leicester LE1 7RH, Leics, England; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Pediat,Metab Dis Unit, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Pediat,Pediat Gastroenterol & Nutr Unit, IL-31096 Haifa, Israel; Riyadh Armed Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; Univ Cambridge, Addenbrookes Hosp, Dept Med Genet & Neprhol, Cambridge Inst Med Res, Cambridge CB2 2XY, England; St James Hosp, Dept Paediat, Leeds LS9 7TF, W Yorkshire, England; Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of Birmingham; University of Birmingham; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Royal Manchester Children's Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Leicester; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Prince Sultan Military Medical City; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Saint James's University Hospital; Newcastle University - UK	Maher, ER (corresponding author), Univ Birmingham, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.	E.R.Maher@bham.ac.uk	Gissen, Paul/A-4352-2010; MAHER, EAMONN R/A-9507-2008; Lo, Bruce/AAV-1510-2021; Thompson, Richard J/B-7954-2009; Morgan, Neil V/A-5475-2009	Gissen, Paul/0000-0002-9712-6122; MAHER, EAMONN R/0000-0002-6226-6918; Lo, Bruce/0000-0001-6210-9667; Thompson, Richard J/0000-0001-5652-0150; Morgan, Neil V/0000-0001-6433-5692; Johnson, Colin/0000-0002-2979-8234; Karet, Fiona/0000-0002-2457-2869; Trembath, Richard/0000-0003-0550-3400; Lynch, Sally Ann/0000-0003-3540-1333; Forshew, Tim/0000-0003-2093-7020				Abdullah MA, 2000, SAUDI MED J, V21, P297; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; Denecke J, 2000, KLIN PADIATR, V212, P77, DOI 10.1055/s-2000-9656; Devonald MAJ, 2003, NAT GENET, V33, P125, DOI 10.1038/ng1082; DIROCCO M, 1995, EUR J PEDIATR, V154, P835, DOI 10.1007/BF01959793; Eastham KM, 2001, ARCH DIS CHILD, V85, P415, DOI 10.1136/adc.85.5.415; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GISSEN P, 2003, EUR J HUM GENET, V11, P827; Halachmi N, 1996, J NEUROCHEM, V66, P889; Hanigan MH, 2003, LAB INVEST, V83, p301A; HORSLEN SP, 1994, J MED GENET, V31, P62, DOI 10.1136/jmg.31.1.62; Huizing M, 2001, GENE, V264, P241, DOI 10.1016/S0378-1119(01)00333-X; Iwasaki H, 2002, DNA RES, V9, P59, DOI 10.1093/dnares/9.2.59; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Johnson CA, 2001, J BIOL CHEM, V276, P4539, DOI 10.1074/jbc.C000824200; Kim BY, 2001, J BIOL CHEM, V276, P29393, DOI 10.1074/jbc.M101778200; Morgan NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0; MUELLER RF, 1993, J MED GENET, V30, P798, DOI 10.1136/jmg.30.9.798; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	30	231	241	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					400	404		10.1038/ng1325	http://dx.doi.org/10.1038/ng1325			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15052268	Bronze			2022-12-27	WOS:000220647200025
J	Zhang, JK; Gray, J; Wu, LZ; Leone, G; Rowan, S; Cepko, CL; Zhu, XM; Craft, CM; Dyer, MA				Zhang, JK; Gray, J; Wu, LZ; Leone, G; Rowan, S; Cepko, CL; Zhu, XM; Craft, CM; Dyer, MA			Rb regulates proliferation and rod photoreceptor development in the mouse retina	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; RAT RETINA; CELL-DIFFERENTIATION; HISTONE ACETYLATION; RETINOBLASTOMA GENE; CHIMERIC MICE; LOCALIZATION; NEUROGENESIS; EXPRESSION; DEFICIENT	The retinoblastoma protein (Rb) regulates proliferation, cell fate specification and differentiation in the developing central nervous system (CNS), but the role of Rb in the developing mouse retina has not been studied, because Rb-deficient embryos die before the retinas are fully formed. We combined several genetic approaches to explore the role of Rb in the mouse retina. During postnatal development, Rb is expressed in proliferating retinal progenitor cells and differentiating rod photoreceptors. In the absence of Rb, progenitor cells continue to divide, and rods do not mature. To determine whether Rb functions in these processes in a cell-autonomous manner, we used a replication-incompetent retrovirus encoding Cre recombinase to inactivate the Rb1(lox) allele in individual retinal progenitor cells in vivo. Combined with data from studies of conditional inactivation of Rb1 using a combination of Cre transgenic mouse lines, these results show that Rb is required in a cell-autonomous manner for appropriate exit from the cell cycle of retinal progenitor cells and for rod development.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	St Jude Children's Research Hospital; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Southern California	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Rowan, Sheldon/AAA-3271-2019; Dyer, Michael/N-8134-2018	Rowan, Sheldon/0000-0002-1123-6743; 				Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DiCiommo D, 2000, SEMIN CANCER BIOL, V10, P255, DOI 10.1006/scbi.2000.0326; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Dyer MA, 2001, J COMP NEUROL, V429, P601; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Ferguson KL, 2001, NEUROREPORT, V12, pA55, DOI 10.1097/00001756-200107030-00001; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Greenlee MHW, 2002, SEMIN CELL DEV BIOL, V13, P99, DOI 10.1016/S1084-9521(02)00015-0; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Koulen P, 1999, EUR J NEUROSCI, V11, P2007, DOI 10.1046/j.1460-9568.1999.00622.x; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LIOU GI, 1991, BIOCHEM BIOPH RES CO, V181, P159, DOI 10.1016/S0006-291X(05)81395-6; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Schubeler D, 2000, GENE DEV, V14, P940; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Vooijs M, 2002, ONCOGENE, V21, P4635, DOI 10.1038/sj.onc.1205575; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	41	148	153	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2004	36	4					351	360		10.1038/ng1318	http://dx.doi.org/10.1038/ng1318			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	14991054	Bronze			2022-12-27	WOS:000220647200018
J	Lahav, G; Rosenfeld, N; Sigal, A; Geva-Zatorsky, N; Levine, AJ; Elowitz, MB; Alon, U				Lahav, G; Rosenfeld, N; Sigal, A; Geva-Zatorsky, N; Levine, AJ; Elowitz, MB; Alon, U			Dynamics of the p53-Mdm2 feedback loop in individual cells	NATURE GENETICS			English	Article							P53; GENE; MDM2; PROTEIN; PHOSPHORYLATION; EXPRESSION; MODULE	The tumor suppressor p53, one of the most intensely investigated proteins(1-5), is usually studied by experiments that are averaged over cell populations, potentially masking the dynamic behavior in individual cells. We present a system for following, in individual living cells, the dynamics of p53 and its negative regulator Mdm2 (refs.1, 4-7) : this system uses functional p53-CFP and Mdm2-YFP fusion proteins and time-lapse fluorescence microscopy. We found that p53 was expressed in a series of discrete pulses after DNA damage. Genetically identical cells had different numbers of pulses: zero, one, two or more. The mean height and duration of each pulse were fixed and did not depend on the amount of DNA damage. The mean number of pulses, however, increased with DNA damage. This approach can be used to study other signaling systems and suggests that the p53-Mdm2 feedback loop generates a digital clock that releases well-timed quanta of p53 until damage is repaired or the cell dies.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Inst Adv Studies, Sch Nat Sci, Princeton, NJ 08540 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Weizmann Institute of Science; Weizmann Institute of Science; Institute for Advanced Study - USA; California Institute of Technology	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Sigal, Alex/GWC-7488-2022; Geva-Zatorsky, Naama/AAP-9176-2021	Sigal, Alex/0000-0001-8571-2004; Geva-Zatorsky, Naama/0000-0002-7303-854X				Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; ANDERSEN RD, 1987, MOL CELL BIOL, V7, P3574, DOI 10.1128/MCB.7.10.3574; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bonner WM, 2003, P NATL ACAD SCI USA, V100, P4973, DOI 10.1073/pnas.1031538100; Deguin-Chambon V, 2000, ONCOGENE, V19, P5831, DOI 10.1038/sj.onc.1203960; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; LARKIN ND, 1999, ONCOGENE, V18, P7644; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Mihalas GI, 2000, J BIOL SYST, V8, P21, DOI 10.1142/S0218339000000031; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Offer H, 2001, CANCER RES, V61, P88; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOJTESEK B, 1993, J CELL SCI, V105, P607; Zhang TT, 2001, J BIOL CHEM, V276, P29702, DOI 10.1074/jbc.M011326200	30	759	791	3	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					147	150		10.1038/ng1293	http://dx.doi.org/10.1038/ng1293			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14730303	Bronze			2022-12-27	WOS:000188542700015
J	Yamada, K; Andrews, C; Chan, WM; McKeown, CA; Magli, A; de Berardinis, T; Loewenstein, A; Lazar, M; O'Keefe, M; Letson, R; London, A; Ruttum, M; Matsumoto, N; Saito, N; Morris, L; Del Monte, M; Johnson, RH; Uyama, E; Houtman, WA; de Vries, B; Carlow, TJ; Hart, BL; Krawiecki, N; Shoffner, J; Vogel, MC; Katowitz, J; Goldstein, SM; Levin, AV; Sener, EC; Ozturk, BT; Akarsu, AN; Brodsky, MC; Hanisch, F; Cruse, RP; Zubcov, AA; Robb, RM; Roggenkaemper, P; Gottlob, I; Kowal, L; Battu, R; Traboulsi, EI; Franceschini, P; Newlin, A; Demer, JL; Engle, EC				Yamada, K; Andrews, C; Chan, WM; McKeown, CA; Magli, A; de Berardinis, T; Loewenstein, A; Lazar, M; O'Keefe, M; Letson, R; London, A; Ruttum, M; Matsumoto, N; Saito, N; Morris, L; Del Monte, M; Johnson, RH; Uyama, E; Houtman, WA; de Vries, B; Carlow, TJ; Hart, BL; Krawiecki, N; Shoffner, J; Vogel, MC; Katowitz, J; Goldstein, SM; Levin, AV; Sener, EC; Ozturk, BT; Akarsu, AN; Brodsky, MC; Hanisch, F; Cruse, RP; Zubcov, AA; Robb, RM; Roggenkaemper, P; Gottlob, I; Kowal, L; Battu, R; Traboulsi, EI; Franceschini, P; Newlin, A; Demer, JL; Engle, EC			Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1)	NATURE GENETICS			English	Article							EXTERNAL OPHTHALMOPLEGIA; CHROMOSOME-12; REFINEMENT; REGION; MAPS	Congenital fibrosis of the extraocular muscles type 1 (CFEOM1; OMIM #135700) is an autosomal dominant strabismus disorder associated with defects of the oculomotor nerve. We show that individuals with CFEOM1 harbor heterozygous missense mutations in a kinesin motor protein encoded by KIF21A. We identified six different mutations in 44 of 45 probands. The primary mutational hotspots are in the stalk domain, highlighting an important new role for KIF21A and its stalk in the formation of the oculomotor axis.	Childrens Hosp Boston, Dept Med Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; Univ Naples, Dipartimento Sci Oftalmol, Naples, Italy; Tel Aviv Univ, Sackler Fac Med, Dept Ophthalmol, IL-69978 Tel Aviv, Israel; Our Ladys Hosp Sick Children, Dept Ophthalmol, Dublin, Ireland; Univ Minnesota, Dept Ophthalmol, St Paul, MN 55108 USA; Aspen Med Grp, Dept Pediat, St Paul, MN USA; Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; Shin Koga Hosp, Dept Gynecol, Kurume, Fukuoka, Japan; Univ Michigan, Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; Univ Washington, Childrens Hosp, Dept Ophthalmol, Seattle, WA 98195 USA; Kumamoto Univ, Sch Med, Dept Neurol, Kumamoto 860, Japan; Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; Univ New Mexico, Dept Radiol & Ophthalmol, Albuquerque, NM 87131 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; Horizon Mol Med, Atlanta, GA USA; Hosp Ninos Dr Roberto Del Rio, Dept Ophthalmol, Santiago, Chile; Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA; Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; Hacettepe Univ, Fac Med, Dept Ophthalmol, TR-06100 Ankara, Turkey; Hacettepe Univ, Fac Med, Dept Pediat, TR-06100 Ankara, Turkey; Univ Arkansas, Dept Ophthalmol, Little Rock, AR 72204 USA; Univ Arkansas, Dept Pediat, Little Rock, AR 72204 USA; Univ Halle Wittenberg, Dept Neurol, Halle An Der Saale, Germany; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Eye Hosp, Frankfurt, Germany; Childrens Hosp Boston, Dept Ophthalmol, Boston, MA USA; Univ Eye Clin, Bonn, Germany; Univ Leicester, Dept Ophthalmol, Leicester, Leics, England; Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; St Johns Med Coll, Dept Ophthalmol, Bangalore, Karnataka, India; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Univ Turin, Ctr Univ Dismorfol Clin, Turin, Italy; Univ Illinois, Dept Ophthalmol, Chicago, IL 60680 USA; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; Childrens Hosp Boston, Dept Neurol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Bascom Palmer Eye Institute; University of Naples Federico II; Tel Aviv University; Sackler Faculty of Medicine; Our Ladys Children Hospital Crumlin; University of Minnesota System; University of Minnesota Twin Cities; Medical College of Wisconsin; Nagasaki University; University of Michigan System; University of Michigan; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Kumamoto University; University of Groningen; University of New Mexico; Emory University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hacettepe University; Hacettepe University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Martin Luther University Halle Wittenberg; Baylor College of Medicine; Harvard University; Boston Children's Hospital; University of Bonn; University of Leicester; University of Melbourne; St. John's National Academy of Health Sciences; St. John's Medical College; Cleveland Clinic Foundation; University of Turin; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Boston Children's Hospital	Engle, EC (corresponding author), Childrens Hosp Boston, Dept Med Genet, Enders 5,300 Longwood Ave, Boston, MA 02115 USA.	engle@enders.tch.harvard.edu	Akarsu, Nurten/E-9758-2013; Traboulsi, Elias/AAY-7443-2020; Magli, Adriano/AAU-7380-2020	Akarsu, Nurten/0000-0001-5432-0032; Magli, Adriano/0000-0002-6490-2068; DE BERARDINIS, Teresa/0000-0001-6872-0432; Del Monte, Monte/0000-0002-3153-959X	NATIONAL EYE INSTITUTE [R01EY008313] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY008313] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brodsky MC, 1998, OPHTHALMOLOGY, V105, P717, DOI 10.1016/S0161-6420(98)94029-5; Doherty EJ, 1999, INVEST OPHTH VIS SCI, V40, P1687; ENGLE EC, 1994, NAT GENET, V7, P69, DOI 10.1038/ng0594-69; ENGLE EC, 1995, AM J HUM GENET, V57, P1086; Engle EC, 1997, ANN NEUROL, V41, P314, DOI 10.1002/ana.410410306; Engle EC, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-3; HARLEY RD, 1978, J PEDIAT OPHTH STRAB, V15, P346; Mackey DA, 2002, HUM GENET, V110, P510, DOI 10.1007/s00439-002-0707-5; Magli Adriano, 2003, BMC Ophthalmol, V3, P6, DOI 10.1186/1471-2415-3-6; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Uyama E, 2003, NEUROMUSCULAR DISORD, V13, P472, DOI 10.1016/S0960-8966(03)00065-8; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	173	192	1	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					318	321		10.1038/ng1261	http://dx.doi.org/10.1038/ng1261			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14595441				2022-12-27	WOS:000186791000012
J	Zhou, ZH; Toh, SY; Chen, ZM; Guo, K; Ng, CP; Ponniah, S; Lin, SC; Hong, WJ; Li, P				Zhou, ZH; Toh, SY; Chen, ZM; Guo, K; Ng, CP; Ponniah, S; Lin, SC; Hong, WJ; Li, P			Cidea-deficient mice have lean phenotype and are resistant to obesity	NATURE GENETICS			English	Article							BROWN ADIPOSE-TISSUE; MITOCHONDRIAL UNCOUPLING PROTEIN; TRANSGENIC MICE; ENERGY-BALANCE; THERMOGENESIS; APOPTOSIS; LACKING; MUSCLE; DOMAIN	The thermogenic activity of brown adipose tissue (BAT), important for adaptive thermogenesis and energy expenditure, is mediated by the mitochondrial uncoupling protein1 (Ucp1) that uncouples ATP generation and dissipates the energy as heat. We show here that Cidea, a protein of unknown function sharing sequence similarity with the N-terminal region of DNA fragmentation factors Dffb and Dffa, is expressed at high levels in BAT. Cidea-null mice had higher metabolic rate, lipolysis in BAT and core body temperature when subjected to cold treatment. Notably, Cidea-null mice are lean and resistant to diet-induced obesity and diabetes. Furthermore, we provide evidence that the role of Cidea in regulating thermogenesis, lipolysis and obesity may be mediated in part through its direct suppression of Ucp1 activity. Our data thus indicate a role for Cidea in regulating energy balance and adiposity.	Inst Cell & Mol Biol, Lab Apoptosis Regulat, Singapore 117609, Singapore; Inst Cell & Mol Biol, Lab Regulatory Biol, Singapore 117609, Singapore; Inst Cell & Mol Biol, Lab Membrane Biol, Singapore 117609, Singapore; Inst Cell & Mol Biol, In Vivo Model Unit, Singapore 117609, Singapore; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Hong Kong University of Science & Technology	Li, P (corresponding author), Inst Cell & Mol Biol, Lab Apoptosis Regulat, 30 Med Dr, Singapore 117609, Singapore.	bolipeng@ust.hk	Zhou, Z Hong/HDN-0747-2022; Lin, SC/G-4666-2010; HONG, Wanjin/E-9927-2010	Toh, Shen Yon/0000-0002-6421-0862				Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BOUILLAUD F, 1994, EMBO J, V13, P1990, DOI 10.1002/j.1460-2075.1994.tb06468.x; Carson F. L., 1997, HISTOTECHNOLOGY SELF; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; KOZAK LP, 1991, GENE DEV, V5, P2256, DOI 10.1101/gad.5.12a.2256; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Griffiths Gareth, 1993, Trends in Cell Biology, V3, P214, DOI 10.1016/0962-8924(93)90114-G; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	26	359	384	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					49	56		10.1038/ng1225	http://dx.doi.org/10.1038/ng1225			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12910269				2022-12-27	WOS:000185018500010
J	Nicolas, G; Viatte, L; Lou, DQ; Bennoun, M; Beaumont, C; Kahn, A; Andrews, NC; Vaulont, S				Nicolas, G; Viatte, L; Lou, DQ; Bennoun, M; Beaumont, C; Kahn, A; Andrews, NC; Vaulont, S			Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis	NATURE GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE; TRANSGENIC MICE; CHRONIC DISEASE; GENE; HFE; ANEMIA; METABOLISM; LIVER; DEFICIENCY	Hereditary hemochromatosis is a prevalent genetic disorder of iron hyperabsorption leading to hyperferremia, tissue iron deposition and complications including cirrhosis, hepatocarcinoma, cardiomyopathy and diabetes. Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref. 1; OMIM 235200). Mice lacking Hfe(2-4) or producing a C282Y mutant Hfe protein(3) develop hyperferremia and have high hepatic iron levels. in both humans and mice, hereditary hemochromatosis is associated with a paucity of iron in reticuloendothelial cells. It has been suggested that HFE modulates uptake of transferrin-bound iron by undifferentiated intestinal crypt cells, thereby programming the absorptive capacity of enterocytes derived from these cells(5,6); however, this model is unproven and controversial(7,8). Hepcidin, a peptide hormone (HAMP; OMIM 606464), seems to act in the same regulatory pathway as HFE. Although expression of mouse Hamp is normally greater during iron overload, Hfe(-/-) mice have inappropriately low expression of Hamp. We crossed Hfe(-/-) mice with transgenic mice overexpressing Hamp and found that Hamp inhibited the iron accumulation normally observed in the Hfe(-/-) mice. This argues against the crypt programming model and suggests that failure of Hamp induction contributes to the pathogenesis of hemochromatosis, providing a rationale for the use of HAMP in the treatment of this disease.	CNRS, INSERM, Inst Cochin, Dept Genet Dev & Pathol Mol, F-75014 Paris, France; Univ Paris 05, Fac Med Cochin Port Royal, F-75014 Paris, France; Univ Paris 07, INSERM, U409, F-75018 Paris, France; Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Vaulont, S (corresponding author), CNRS, INSERM, Inst Cochin, Dept Genet Dev & Pathol Mol, 24 Rue Fg St Jacques, F-75014 Paris, France.		NICOLAS, Gaël/D-7611-2013; Vaulont, Sophie/O-6732-2017; NICOLAS, Gaël/X-9555-2019	NICOLAS, Gaël/0000-0002-1671-8274; NICOLAS, Gaël/0000-0002-1671-8274; Andrews, Nancy/0000-0003-0243-4462				Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Drakesmith H, 2002, P NATL ACAD SCI USA, V99, P15602, DOI 10.1073/pnas.242614699; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FINCH C, 1994, BLOOD, V84, P1697; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Roy CN, 2000, BLOOD, V96, P4020, DOI 10.1182/blood.V96.13.4020.h8004020_4020_4027; Townsend A, 2002, LANCET, V359, P786, DOI 10.1016/S0140-6736(02)07885-6; Trinder D, 2002, P NATL ACAD SCI USA, V99, P5622, DOI 10.1073/pnas.082112299; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	24	250	272	0	14	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					97	101		10.1038/ng1150	http://dx.doi.org/10.1038/ng1150			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12704388				2022-12-27	WOS:000182667900024
J	Chuaqui, RF; Bonner, RF; Best, CJM; Gillespie, JW; Flaig, MJ; Hewitt, SM; Phillips, JL; Krizman, DB; Tangrea, MA; Ahram, M; Linehan, WM; Knezevic, V; Emmert-Buck, MR				Chuaqui, RF; Bonner, RF; Best, CJM; Gillespie, JW; Flaig, MJ; Hewitt, SM; Phillips, JL; Krizman, DB; Tangrea, MA; Ahram, M; Linehan, WM; Knezevic, V; Emmert-Buck, MR			Post-analysis follow-up and validation of microarray experiments	NATURE GENETICS			English	Review							LASER CAPTURE MICRODISSECTION; DIFFERENTIALLY EXPRESSED GENES; HUMAN PROSTATE-CANCER; CDNA MICROARRAY; BREAST-CANCER; PROTEOMIC ANALYSIS; CELL-LINES; RNA; DNA; PROFILES	Measurement of gene-expression profiles using microarray technology is becoming increasingly popular among the biomedical research community. Although there has been great progress in this field, investigators are still confronted with a difficult question after completing their experiments: how to validate the large data sets that are generated? This review summarizes current approaches to verifying global expression results, discusses the caveats that must be considered, and describes some methods that are being developed to address outstanding problems.	NCI, Pathogenet Unit, Pathol Lab, Bethesda, MD 20892 USA; NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Emmert-Buck, MR (corresponding author), NCI, Pathogenet Unit, Pathol Lab, Bethesda, MD 20892 USA.	mbuck@helix.nih.gov	Bonner, Robert F/C-6783-2015; Bonner, Robert/GQO-9087-2022; Ahram, Mamoun/D-8497-2015; Best, Carolyn J.M./J-4009-2015	Ahram, Mamoun/0000-0003-4457-3604; Best, Carolyn J.M./0000-0002-3868-6816; Hewitt, Stephen/0000-0001-8283-1788				Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Alevizos I, 2001, ONCOGENE, V20, P6196, DOI 10.1038/sj.onc.1204685; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Bangur CS, 2002, ONCOGENE, V21, P3814, DOI 10.1038/sj.onc.1205480; BATTIFORA H, 1986, LAB INVEST, V55, P244; Bonaventure P, 2002, BRAIN RES, V943, P38, DOI 10.1016/S0006-8993(02)02504-0; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Burton GR, 2002, GENE, V293, P21, DOI 10.1016/S0378-1119(02)00726-6; Canada AT, 1996, BIOCHEM PHARMACOL, V51, P87, DOI 10.1016/0006-2952(95)02157-4; Carlisle AJ, 2000, MOL CARCINOGEN, V28, P12, DOI 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clark J, 2002, GENE CHROMOSOME CANC, V34, P104, DOI 10.1002/gcc.10039; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ellis M, 2002, CLIN CANCER RES, V8, P1155; Emmert-Buck MR, 2000, MOL CARCINOGEN, V27, P158, DOI 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2; Emmert-Buck MR, 2000, AM J PATHOL, V156, P1109, DOI 10.1016/S0002-9440(10)64979-6; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Englert CR, 2000, CANCER RES, V60, P1526; Fejzo MS, 2001, AM J PATHOL, V159, P1645, DOI 10.1016/S0002-9440(10)63011-8; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; Hess KR, 2001, TRENDS BIOTECHNOL, V19, P463, DOI 10.1016/S0167-7799(01)01792-9; Hodge DL, 2002, J IMMUNOL, V168, P6090, DOI 10.4049/jimmunol.168.12.6090; Holloway AJ, 2002, NAT GENET, V32, P481, DOI 10.1038/ng1030; Hoos A, 2001, LAB INVEST, V81, P1331, DOI 10.1038/labinvest.3780347; Jiang YQ, 2002, ONCOGENE, V21, P2270, DOI 10.1038/sj.onc.1205278; JONES MB, IN PRESS CLIN CANC R; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Kang JS, 2002, CLIN CANCER RES, V8, P117; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LaTulippe E, 2002, CANCER RES, V62, P4499; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Luo J, 2001, CANCER RES, V61, P4683; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Luzzi V, 2001, AM J PATHOL, V158, P2005, DOI 10.1016/S0002-9440(10)64672-X; Magee JA, 2001, CANCER RES, V61, P5692; Mills JC, 2001, NAT CELL BIOL, V3, pE175, DOI 10.1038/35087108; Mousses S, 2002, CANCER RES, V62, P1256; Mutch DM, 2001, GENOME BIOL, V2; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Paweletz CP, 2000, CANCER RES, V60, P6293; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Qi ZY, 2002, J NEURO-ONCOL, V56, P197, DOI 10.1023/A:1015079705841; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Rhodes DR, 2002, CANCER RES, V62, P4427; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saban MR, 2001, PHYSIOL GENOMICS, V5, P147, DOI 10.1152/physiolgenomics.2001.5.3.147; Scheidl SJ, 2002, AM J PATHOL, V160, P801, DOI 10.1016/S0002-9440(10)64903-6; Sgroi DC, 1999, CANCER RES, V59, P5656; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Taniguchi M, 2001, GENOMICS, V71, P34, DOI 10.1006/geno.2000.6427; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vu H L, 2000, Nucleic Acids Res, V28, pE18, DOI 10.1093/nar/28.7.e18; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Welsh JB, 2001, CANCER RES, V61, P5974	70	324	350	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			509	514		10.1038/ng1034	http://dx.doi.org/10.1038/ng1034			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454646				2022-12-27	WOS:000179742900011
J	Pollack, JR; Iyer, VR				Pollack, JR; Iyer, VR			Characterizing the physical genome	NATURE GENETICS			English	Review							DNA COPY-NUMBER; YEAST SACCHAROMYCES-CEREVISIAE; BREAST-CANCER; CDNA MICROARRAYS; CELL-CYCLE; TUMOR-CELLS; HYBRIDIZATION; METHYLATION; GENES; CARCINOMAS	The genome of an organism is a dynamic physical entity, comprising genomic DNA bound to many different proteins and organized into chromosomes. A thorough characterization of the physical genome is relevant to our understanding of processes such as the regulation of gene expression, DNA replication and repair, recombination, chromosome segregation, epigenetic inheritance and genomic instability. Methods based on microarrays are beginning to provide a detailed picture of this physical genome, and they complement the genome-wide studies of mRNA expression profiling that have previously been so successful.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	Stanford University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Pollack, JR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, CCSR Bldg,Room 3245A,269 Campus Dr, Stanford, CA 94305 USA.							Adorjan P, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e21; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Clark J, 2002, GENE CHROMOSOME CANC, V34, P104, DOI 10.1002/gcc.10039; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fritz B, 2002, CANCER RES, V62, P2993; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Geschwind DH, 1998, DEV GENET, V23, P215, DOI 10.1002/(SICI)1520-6408(1998)23:3<215::AID-DVG7>3.0.CO;2-X; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Heiskanen MA, 2000, CANCER RES, V60, P799; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Hui ABY, 2002, INT J ONCOL, V20, P467; Hui ABY, 2001, LAB INVEST, V81, P717, DOI 10.1038/labinvest.3780280; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401; Kauraniemi P, 2001, CANCER RES, V61, P8235; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Liang G, 2002, CANCER RES, V62, P961; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN JY, 2002, GENOME BIOL, V3; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lucito R, 2000, GENOME RES, V10, P1726, DOI 10.1101/gr.138300; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Massion PP, 2002, CANCER RES, V62, P3636; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Schubert EL, 2002, AM J PATHOL, V160, P73, DOI 10.1016/S0002-9440(10)64351-9; Shi HD, 2002, CANCER RES, V62, P3214; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Takeo S, 2001, CANCER GENET CYTOGEN, V130, P127, DOI 10.1016/S0165-4608(01)00479-4; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Varis A, 2002, CANCER RES, V62, P2625; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wilhelm M, 2002, CANCER RES, V62, P957; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Yan PS, 2001, CANCER RES, V61, P8375; Yan PS, 2000, CLIN CANCER RES, V6, P1432; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao JM, 2002, GENE CHROMOSOME CANC, V34, P48, DOI 10.1002/gcc.10035	68	48	51	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			515	521		10.1038/ng1035	http://dx.doi.org/10.1038/ng1035			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454647				2022-12-27	WOS:000179742900012
J	Quackenbush, J				Quackenbush, J			Microarray data normalization and transformation	NATURE GENETICS			English	Review							EXPRESSION; PATTERNS	Underlying every microarray experiment is an experimental question that one would like to address. Finding a useful and satisfactory answer relies on careful experimental design and the use of a variety of data-mining tools to explore the relationships between genes or reveal patterns of expression. While other sections of this issue deal with these lofty issues, this review focuses on the much more mundane but indispensable tasks of 'normalizing' data from individual hybridizations to make meaningful comparisons of expression levels, and of 'transforming' them to select genes for further analysis and data mining.	Inst Genom Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Quackenbush, J (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.			Quackenbush, John/0000-0002-2702-5879				Bevington P. R., 1991, DATA REDUCTION ERROR, V2nd; Chatterjee S., 1991, BIOMETRICAL J, DOI DOI 10.1002/BIMJ.4710340613; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; YANG IV, 2002, GENOME BIOL, V3; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	16	1296	1430	3	140	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			496	501		10.1038/ng1032	http://dx.doi.org/10.1038/ng1032			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454644				2022-12-27	WOS:000179742900009
J	Kapfhamer, D; Valladares, O; Sun, Y; Nolan, PM; Rux, JJ; Arnold, SE; Veasey, SC; Bucan, M				Kapfhamer, D; Valladares, O; Sun, Y; Nolan, PM; Rux, JJ; Arnold, SE; Veasey, SC; Bucan, M			Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse	NATURE GENETICS			English	Article							STRUCTURAL BASIS; CLOCK; TRANSCRIPTION; MUTAGENESIS; PACEMAKER; COMPONENT; RHYTHMS	Rab3a is the most abundant Rab (ras-associated binding) protein in the brain and has a regulatory role in synaptic vesicle trafficking(1). Mice with a targeted loss-of-function mutation in Rab3a have defects in Ca2+-dependent synaptic transmission: the number of vesicles released in response to an action potential is greater than in wildtype mice, resulting in greater synaptic depression(2,3) and the abolishment of CA3 mossy-fiber long term potentiation(4). The effect of these changes on behavior is unknown. In a screen for mouse mutants with abnormal rest-activity and sleep patterns, we identified a semidominant mutation, called earlybird, that shortens the circadian period of locomotor activity. Sequence analysis of Rab3a identified a point mutation in the conserved amino acid (Asp77Gly) within the GTP-binding domain of this protein in earlybird mutants, resulting in significantly reduced levels of Rab3a protein. Phenotypic assessment of earlybird mice and a null allele of Rab3a revealed anomalies in circadian period and sleep homeostasis, providing evidence that Rab3a-mediated synaptic transmission is involved in these behaviors.	Univ Penn, Ctr Neurobiol Behav, Dept Psychiat, Philadelphia, PA 19104 USA; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Bucan, M (corresponding author), Univ Penn, Ctr Neurobiol Behav, Dept Psychiat, Philadelphia, PA 19104 USA.	bucan@pobox.upenn.edu	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; Valladares, Otto/0000-0001-8055-2187				BENINGTON JH, 1994, SLEEP, V17, P28, DOI 10.1093/sleep/17.1.28; Borbely A A, 1982, Hum Neurobiol, V1, P195; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; JOHN J, 1993, J BIOL CHEM, V268, P923; JUNG V, 1994, MOL CELL BIOL, V14, P3707, DOI 10.1128/MCB.14.6.3707; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Naylor E, 2000, J NEUROSCI, V20, P8138; Nolan Patrick M., 1998, P143; Nolan PM, 1997, METHODS, V13, P379, DOI 10.1006/meth.1997.0545; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Veasey SC, 2000, SLEEP, V23, P1025; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	28	66	70	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					290	295		10.1038/ng991	http://dx.doi.org/10.1038/ng991			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244319				2022-12-27	WOS:000178311100019
J	Nakai, J; Biggs, WH; Kitamura, T; Cavenee, WK; Wright, CVE; Arden, KC; Accili, D				Nakai, J; Biggs, WH; Kitamura, T; Cavenee, WK; Wright, CVE; Arden, KC; Accili, D			Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1	NATURE GENETICS			English	Article							FACTOR FKHR; CHOROID-PLEXUS; RESISTANCE; RECEPTOR; DAF-16; LIVER; MICE; PHOSPHORYLATION; LIFE; TRANSTHYRETIN	Type 2 diabetes results from impaired action and secretion of insulin. It is not known whether the two defects share a common pathogenesis. We show that haploinsufficiency of the Foxo1 gene, encoding a forkhead transcription factor (forkhead box transcription factor O1), restores insulin sensitivity and rescues the diabetic phenotype in insulin-resistant mice by reducing hepatic expression of glucogenetic genes and increasing adipocyte expression of insulin-sensitizing genes. Conversely, a gain-of-function Foxo1 mutation targeted to liver and pancreatic beta-cells results in diabetes arising from a combination of increased hepatic glucose production and impaired beta-cell compensation due to decreased Pdx1 expression. These data indicate that Foxo1 is a negative regulator of insulin sensitivity in liver, adipocytes and pancreatic beta-cells. Impaired insulin signaling to Foxo1 provides a unifying mechanism for the common metabolic abnormalities of type 2 diabetes.	Columbia Univ, Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37212 USA	Columbia University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Vanderbilt University	Accili, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, Berrie Res Pavil,1150 St Nicholas Ave, New York, NY 10032 USA.	da230@columbia.edu	Nakae, Jun/Q-6141-2019					Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; JACOBSSON B, 1989, J HISTOCHEM CYTOCHEM, V37, P31, DOI 10.1177/37.1.2642294; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kaestner KH, 2000, GENE DEV, V14, P142; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kitamura T, 2001, DIABETES, V50, pA345; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nakae J, 2001, DIABETES, V50, pA22; Nakae J, 2001, ANN MED, V33, P22, DOI 10.3109/07853890109002056; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; *NAT DIAB DAT GROU, 1995, DIAB AM; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x	40	494	529	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					245	253		10.1038/ng890	http://dx.doi.org/10.1038/ng890			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12219087				2022-12-27	WOS:000178311100012
J	Batourina, E; Choi, C; Paragas, N; Bello, N; Hensle, T; Costantini, FD; Schuchardt, A; Bacallao, RL; Mendelsohn, CL				Batourina, E; Choi, C; Paragas, N; Bello, N; Hensle, T; Costantini, FD; Schuchardt, A; Bacallao, RL; Mendelsohn, CL			Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret	NATURE GENETICS			English	Article							RETINOIC ACID RECEPTORS; NEUROTROPHIC FACTOR; URINARY-TRACT; TYROSINE KINASE; CONGENITAL-ANOMALIES; BUD DEVELOPMENT; RENAL AGENESIS; MICE LACKING; GDNF; KIDNEY	Almost 1% of human infants are born with urogenital abnormalities, many of which are linked to irregular connections between the distal ureters and the bladder. During development, ureters migrate by an unknown mechanism from their initial integration site in the Wolffian ducts up to the base of the bladder in a process that we call ureter maturation. Rara(-/-) Rarb2(-/-) mice display impaired vitamin A signaling and develop syndromic urogenital malformations similar to those that occur in humans, including renal hypoplasia, hydronephrosis and mega-ureter, abnormalities also seen in mice with mutations in the proto-oncogene Ret. Here we show that ureter maturation depends on formation of the 'trigonal wedge', a newly identified epithelial outgrowth from the base of the Wolffian ducts, and that the distal ureter abnormalities seen in Rara(-/-) Rarb2(-/-) and Ret(-/-) mutant mice are probably caused by a failure of this process. Our studies indicate that formation of the trigonal wedge may be essential for correct insertion of the distal ureters into the bladder, and that these events are mediated by the vitamin A and Ret signaling pathways.	Columbia Univ, Dept Urol, New York, NY 10032 USA	Columbia University	Mendelsohn, CL (corresponding author), Columbia Univ, Dept Urol, 630 W 168th St, New York, NY 10032 USA.		Mendelsohn, Cathy/H-4280-2016; Bello, Natalie/J-1001-2019	Mendelsohn, Cathy/0000-0002-4026-4073; Bello, Natalie/0000-0003-3257-3623; Paragas, Neal/0000-0001-6084-8220; Bacallao, Robert/0000-0002-5703-5701	NIDDK NIH HHS [R01 DK061459-09, R56 DK082963-01, R01 DK061459-06, R56 DK082963, R01 DK061459, R01 DK061459-07S1, R01 DK061459-07, R01 DK061459-08] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061459, R56DK082963] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Clendenon JL, 2002, AM J PHYSIOL-CELL PH, V282, pC213, DOI 10.1152/ajpcell.2002.282.1.C213; DOLLE P, 1990, DEVELOPMENT, V110, P1133; Frazer JE, 1935, J ANAT, V69, P455; Giguere V, 1996, ANN NY ACAD SCI, V785, P12, DOI 10.1111/j.1749-6632.1996.tb56238.x; HUTCH JA, 1972, ANATOMY PHYSL BLADDE; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kume T, 2000, DEVELOPMENT, V127, P1387; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MAIZELS M, 1997, CAMPBELLS UROLOGY, V2, P1545; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MEYER R, 1946, ANAT REC, V68, P355; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Pope JC, 1999, J AM SOC NEPHROL, V10, P2018; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SCHLUSSEL RN, 1997, CAMPBELLS UROLOGY, V2, P1814; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; SCHUCHARDT A, 1994, THESIS COLUMBIA U; SCOTT JES, 1987, BRIT J UROL, V59, P291, DOI 10.1111/j.1464-410X.1987.tb04634.x; SCOTT JES, 1988, BRIT J UROL, V62, P295, DOI 10.1111/j.1464-410X.1988.tb04351.x; Srinivas S, 1999, DEV GENET, V24, P241; Srinivas S, 1999, DEVELOPMENT, V126, P1375; TANAGHO EA, 1981, DEV URETER; Tang MJ, 1998, J CELL BIOL, V142, P1337, DOI 10.1083/jcb.142.5.1337; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Vega QC, 1996, P NATL ACAD SCI USA, V93, P10657, DOI 10.1073/pnas.93.20.10657; Vilar J, 1996, KIDNEY INT, V49, P1478, DOI 10.1038/ki.1996.208; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705	40	111	113	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					109	115		10.1038/ng952	http://dx.doi.org/10.1038/ng952			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12195422				2022-12-27	WOS:000177714900009
J	Rosenberg, MJ; Agarwala, R; Bouffard, G; Davis, J; Fiermonte, G; Hilliard, MS; Koch, T; Kalikin, LM; Makalowska, I; Morton, DH; Petty, EM; Weber, JL; Palmieri, F; Kelley, RI; Schaffer, AA; Biesecker, LG				Rosenberg, MJ; Agarwala, R; Bouffard, G; Davis, J; Fiermonte, G; Hilliard, MS; Koch, T; Kalikin, LM; Makalowska, I; Morton, DH; Petty, EM; Weber, JL; Palmieri, F; Kelley, RI; Schaffer, AA; Biesecker, LG			Mutant deoxynucleotide carrier is associated with congenital microcephaly	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; GENE; RECONSTITUTION; TRANSPORT; PROTEINS; MARKERS; AMISH; MAP	The disorder Amish microcephaly (MCPHA) is characterized by severe congenital microcephaly, elevated levels of alpha-ketoglutarate in the urine and premature death(1). The disorder is inherited in an autosomal recessive pattern and has been observed only in Old Order Amish families whose ancestors lived in Lancaster County, Pennsylvania. Here we show, by using a genealogy database and automated pedigree software, that 23 nuclear families affected with MCPHA are connected to a single ancestral couple. Through a whole-genome scan, fine mapping and haplotype analysis, we localized the gene affected in MCPHA to a region of 3 cM, or 2 Mb, on chromosome 17q25. We constructed a map of contiguous genomic clones spanning this region. One of the genes in this region, SLC25A19, which encodes a nuclear mitochondrial deoxynucleotide carrier (DNC)(2), contains a substitution that segregates with the disease in affected individuals and alters an amino acid that is highly conserved in similar proteins. Functional analysis shows that the mutant DNC protein lacks the normal transport activity, implying that failed deoxynucleotide transport across the inner mitochondrial membrane causes MCPHA. Our data indicate that mitochondrial deoxynucleotide transport may be essential for prenatal brain growth.	NHGRI, NIH, Bethesda, MD 20892 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; NIH, Intramural Sequencing Ctr, Gaithersburg, MD USA; Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, Bari, Italy; Logicon ROW Sci Corp, Rockville, MD USA; Konrad Zuse Zentrum Informat Tech, Berlin, Germany; Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; Clin Special Children, Strasburg, PA USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA; Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Universita degli Studi di Bari Aldo Moro; Zuse Institute Berlin; University of Michigan System; University of Michigan; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Rosenberg, MJ (corresponding author), NHGRI, NIH, 49 Convent Dr, Bethesda, MD 20892 USA.	marjr@nhgri.nih.gov	Makalowska, Izabela/AAU-2682-2021; Fiermonte, Giuseppe/D-3680-2018; Lindhurst, Marjorie/AHD-3412-2022; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019; Biesecker, Leslie/AAG-2526-2021; Makalowska, Izabela/AAF-4967-2021	Fiermonte, Giuseppe/0000-0002-6764-9395; Makalowska, Izabela/0000-0002-8144-5671; Koch, Thorsten/0000-0002-1967-0077	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000182] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097, Z01LM000097] Funding Source: NIH RePORTER; Telethon [E.0958] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Telethon(Fondazione Telethon)		Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Agarwala R, 2001, HUM BIOL, V73, P533, DOI 10.1353/hub.2001.0045; Becker A, 1998, HUM HERED, V48, P49, DOI 10.1159/000022781; BIESECKER LG, 1995, AM J MED GENET, V58, P389, DOI 10.1002/ajmg.1320580426; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CAREY JC, 1996, RUDOLPHS PEDIAT, P427; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dolce V, 2001, P NATL ACAD SCI USA, V98, P2284, DOI 10.1073/pnas.031430998; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Kalikin LM, 1999, GENOMICS, V57, P36, DOI 10.1006/geno.1998.5740; KELLEY RI, 2002, AM J MED GENET, DOI DOI 10.1002/AJMG10529; Koch T, 1998, NETWORKS, V32, P207, DOI 10.1002/(SICI)1097-0037(199810)32:3<207::AID-NET5>3.0.CO;2-O; Kuhlenbaumer G, 1999, GENOMICS, V62, P242, DOI 10.1006/geno.1999.5991; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Makalowska I, 2001, BIOINFORMATICS, V17, P843, DOI 10.1093/bioinformatics/17.9.843; MARCHANT CD, 1983, PEDIATR CLIN N AM, V30, P281; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Risk JM, 1999, DIS ESOPHAGUS, V12, P173, DOI 10.1046/j.1442-2050.1999.00042.x; Rosenberg MJ, 2001, HUM GENET, V109, P311, DOI 10.1007/s004390100559; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Vollrath D, 1999, GENOME ANAL, V4, P187; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5	26	110	113	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					175	179		10.1038/ng948	http://dx.doi.org/10.1038/ng948			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12185364				2022-12-27	WOS:000177714900018
J	Miller, DG; Petek, LM; Russell, DW				Miller, DG; Petek, LM; Russell, DW			Adeno-associated virus vectors integrate at chromosome breakage sites	NATURE GENETICS			English	Article							DOUBLE-STRAND BREAKS; CELLS; RECOMBINATION; REPAIR; PURIFICATION; TRANSDUCTION; SEQUENCES; JUNCTIONS; TITER	Adeno-associated virus (AAV) vectors transduce cells by multiple pathways, including integration at nonhomologous chromosomal locations by an unknown mechanism(1-5). We reasoned that spontaneous chromosome breaks may facilitate vector integration and investigated this in cells containing a specific chromosomal double-strand break created by the endonuclease I-Scel or multiple breaks created by treatment with etoposide or gamma-irradiation. Vector proviruses were found at I-Scel cleavage sites, and sequencing of vector-chromosome junctions detected microhomologies, deletions and insertions that were similar when integration occurred spontaneously at random locations or at induced double-strand breaks. Infection with AAV vectors did not increase mutation rates in normal human cells. Our results establish a mechanism for integration and suggest that AAV vectors can integrate at existing chromosome breaks rather than causing breaks themselves, which has implications for their clinical use.	Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Div Hematol, 1705 NE Pacific St, Seattle, WA 98195 USA.	drussell@u.washington.edu		Miller, Daniel/0000-0002-5700-3048	NIDDK NIH HHS [K08 DK062100] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062100] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Inoue N, 1999, J VIROL, V73, P7376, DOI 10.1128/JVI.73.9.7376-7380.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lin YF, 2001, GENETICS, V158, P1665; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Miller DG, 2003, MOL CELL BIOL, V23, P3550, DOI 10.1128/MCB.23.10.3550-3557.2003; Miller DG, 2002, NAT GENET, V30, P147, DOI 10.1038/ng824; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nakai H, 2003, MOL THER, V7, P101, DOI 10.1016/S1525-0016(02)00023-0; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; RUSSELL DW, 1994, P NATL ACAD SCI USA, V91, P8915, DOI 10.1073/pnas.91.19.8915; Russell DW, 2003, NAT GENET, V34, P241, DOI 10.1038/ng0703-241; RUSSELL DW, 1995, P NATL ACAD SCI USA, V92, P5719, DOI 10.1073/pnas.92.12.5719; Rutledge EA, 1997, J VIROL, V71, P8429, DOI 10.1128/JVI.71.11.8429-8436.1997; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Trobridge G, 2004, J VIROL, V78, P2327, DOI 10.1128/JVI.78.5.2327-2335.2004; Trobridge G, 2002, MOL THER, V6, P321, DOI 10.1006/mthe.2002.0672; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	30	170	178	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					767	773		10.1038/ng1380	http://dx.doi.org/10.1038/ng1380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208627	Bronze			2022-12-27	WOS:000222354100030
J	Khil, PP; Smirnova, NA; Romanienko, PJ; Camerini-Otero, RD				Khil, PP; Smirnova, NA; Romanienko, PJ; Camerini-Otero, RD			The mouse X chromosome is enriched for sex-biased genes not subject to selection by meiotic sex chromosome inactivation	NATURE GENETICS			English	Article							SPERMATOGENIC CELLS; C-ELEGANS; EXPRESSION; EVOLUTION; TRANSCRIPTOME; MICROARRAYS; GERMLINE; SYNAPSIS; SPO11	Sex chromosomes are subject to sex-specific selective evolutionary forcest(1,2). One model predicts that genes with sex-biased expression should be enriched on the X chromosome(2-5). In agreement with Rice's hypothesis(3), spermatogonial genes are over-represented on the X chromosome of mice(6) and sex- and reproduction-related genes are over-represented on the human X chromosome(7,8). Male-biased genes are under-represented on the X chromosome in worms and flies(9-11), however. Here we show that mouse spermatogenesis genes are relatively underrepresented on the X chromosome and female-biased genes are enriched on it. We used Spo11(-/-) mice blocked in spermatogenesis early in meiosis(12) to evaluate the temporal pattern of gene expression in sperm development. Genes expressed before the Spo11 block are enriched on the X chromosome, whereas those expressed later in spermatogenesis are depleted. Inactivation of the X chromosome in male meiosis may be a universal driving force for X-chromosome demasculinization.	NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Camerini-Otero, RD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, 5 Mem Dr, Bethesda, MD 20892 USA.	camerini@ncifcrf.gov		Khil, Pavel/0000-0002-4903-8777	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052008] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bono H, 2003, GENOME RES, V13, P1318, DOI 10.1101/gr.1075103; Charlesworth B, 2002, NOVART FDN SYMP, V244, P207; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; Fraser LR, 1999, BIOESSAYS, V21, P304, DOI 10.1002/(SICI)1521-1878(199904)21:4<304::AID-BIES6>3.0.CO;2-H; GOLDSTEIN P, 1982, CHROMOSOMA, V86, P577, DOI 10.1007/BF00330128; Huminiecki L, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-31; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lercher MJ, 2003, MOL BIOL EVOL, V20, P1113, DOI 10.1093/molbev/msg131; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallender EJ, 2004, BIOESSAYS, V26, P159, DOI 10.1002/bies.10393; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927	30	244	252	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					642	646		10.1038/ng1368	http://dx.doi.org/10.1038/ng1368			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15156144	Bronze			2022-12-27	WOS:000221763700024
J	O'Brien, SJ; Nelson, GW				O'Brien, SJ; Nelson, GW			Human genes that limit AIDS	NATURE GENETICS			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 2ND RECEPTORS; CHEMOKINE RECEPTORS; PROMOTER VARIANT; INFECTION; PROGRESSION; CCR5; HLA; POLYMORPHISM; ASSOCIATION	Discernable genetic variation among people and populations has an important role in infectious disease epidemics, including that of acquired immune deficiency syndrome (AIDS). Genetic association analysis of several large AIDS cohorts implicate 14 AIDS restriction genes, polymorphic variants in loci that regulate HIV-1 cell entry, acquired and innate immunity, and cytokine defenses to HIV-1. The influence and translational impact of these genes on individual and population sensitivity to AIDS is considerable.	NCI, Lab Genom Divers, Frederick, MD 21701 USA; SAIC Frederick, Basic Res Program, Lab Genom Divers, NIC, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	O'Brien, SJ (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21701 USA.	obrien@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				Allison PD, 1995, SURVIVAL ANAL USING, P155; An P, 2003, J INFECT DIS, V188, P228, DOI 10.1086/376455; An P, 2002, P NATL ACAD SCI USA, V99, P10002, DOI 10.1073/pnas.142313799; ANNAN K, 2002, AIDS AFRICA; [Anonymous], 1999, NAT GENET, V22, P1; Anzala AO, 1998, LANCET, V351, P1632, DOI 10.1016/S0140-6736(05)77688-1; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BENICHOU J, 1998, ENCY STAT; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bream J H, 1999, Science, V284, P223; Bream JH, 2002, GENES IMMUN, V3, P165, DOI 10.1038/sj.gene.6363870; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Cairns JS, 1998, NAT MED, V4, P563, DOI 10.1038/nm0598-563; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Carrington M, 2001, IMMUNOL LETT, V79, P131, DOI 10.1016/S0165-2478(01)00275-9; Cohen Jon, 2001, SHOTS DARK WAYWARD S; Cox D. R., 1984, ANAL SURVIVAL DATA; DARBY SC, 1990, STAT MED, V9, P681, DOI 10.1002/sim.4780090615; Dean M, 1999, CANCER RES, V59, P3561; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DETELS R, 1994, J ACQ IMMUN DEF SYND, V7, P1263; DSouza MP, 1996, NAT MED, V2, P1293, DOI 10.1038/nm1296-1293; Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950; Falush D, 2003, GENETICS, V164, P1567; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gallo RC, 1999, J CLIN IMMUNOL, V19, P293, DOI 10.1023/A:1020539524373; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; GOEDERT JJ, 1985, AM J EPIDEMIOL, V121, P629, DOI 10.1093/aje/121.5.629; Goldsmith MA, 2002, NAT IMMUNOL, V3, P709, DOI 10.1038/ni819; Gulick RM, 2003, CLIN MICROBIOL INFEC, V9, P186, DOI 10.1046/j.1469-0691.2003.00570.x; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jin X, 2002, J VIROL, V76, P12603, DOI 10.1128/JVI.76.24.12603-12610.2002; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KULLBACK S, 1968, INFORMATION THEORY S; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LEDERMAN MM, 1995, J INFECT DIS, V172, P228, DOI 10.1093/infdis/172.1.228; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mariani R, 1999, J VIROL, V73, P2450, DOI 10.1128/JVI.73.3.2450-2459.1999; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; McNicholl JM, 1997, EMERG INFECT DIS, V3, P261, DOI 10.3201/eid0303.970302; Mellado M, 1999, NATURE, V400, P723, DOI 10.1038/23382; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Modi WS, 2003, AIDS, V17, P2357, DOI 10.1097/00002030-200311070-00011; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nilsson S, 2001, J EPIDEMIOL COMMUN H, V55, P825, DOI 10.1136/jech.55.11.825; O'Brien SJ, 1998, HOSP PRACT, V33, P53, DOI 10.3810/hp.1998.07.96; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; O'Brien SJ, 2000, ANNU REV GENET, V34, P563, DOI 10.1146/annurev.genet.34.1.563; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; OBrien SJ, 1997, SCI AM, V277, P44, DOI 10.1038/scientificamerican0997-44; OBRIEN SJ, 1998, HIV NEWSLINE, V4, P3; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Schemper M, 2003, STAT MED, V22, P2299, DOI 10.1002/sim.1486; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sozzani S, 1998, J IMMUNOL, V161, P1083; Steinle A, 1996, IMMUNOGENETICS, V43, P105; STEVENSON HW, 2000, J PSYCHOL CHINESE SO, V1, P1; Tang JM, 1999, AIDS RES HUM RETROV, V15, P317, DOI 10.1089/088922299311277; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; *US CDC, 1987, MORB MORTAL WKLY S1, V36; VLAHOV D, 1990, AM J EPIDEMIOL, V132, P847, DOI 10.1093/oxfordjournals.aje.a115727; Weiss RA, 2003, NAT MED, V9, P887, DOI 10.1038/nm0703-887; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; WINKLER CA, 2002, AIDS AFRICA; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Zagury D, 1998, P NATL ACAD SCI USA, V95, P3857, DOI 10.1073/pnas.95.7.3857	95	233	245	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					565	574		10.1038/ng1369	http://dx.doi.org/10.1038/ng1369			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15167933	Bronze			2022-12-27	WOS:000221763700010
J	Zaslaver, A; Mayo, AE; Rosenberg, R; Bashkin, P; Sberro, H; Tsalyuk, M; Surette, MG; Alon, U				Zaslaver, A; Mayo, AE; Rosenberg, R; Bashkin, P; Sberro, H; Tsalyuk, M; Surette, MG; Alon, U			Just-in-time transcription program in metabolic pathways	NATURE GENETICS			English	Article							RESPONSIVE REGULATORY PROTEIN; BACTERIAL-CELL-CYCLE; ESCHERICHIA-COLI; GENE-EXPRESSION; REGULATION NETWORK; OPTIMIZATION; KINETICS; SYSTEMS; ENZYMES	A primary goal of systems biology is to understand the design principles of the transcription networks that govern the timing of gene expression(1-5). Here we measured promoter activity for similar to100 genes in parallel from living cells at a resolution of minutes and accuracy of 10%, based on GFP and Lux reporter libraries(3). Focusing on the amino-acid biosynthesis systems of Escherichia coli 4, we identified a previously unknown temporal expression program and expression hierarchy that matches the enzyme order in unbranched pathways. We identified two design principles: the closer the enzyme is to the beginning of the pathway, the shorter the response time of the activation of its promoter and the higher its maximal promoter activity. Mathematical analysis suggests that this 'just-in-time' (ref. 5) transcription program is optimal under constraints of rapidly reaching a production goal with minimal total enzyme production(6,7). Our findings suggest that metabolic regulation networks are designed to generate precision promoter timing and activity programs that can be understood using the engineering principles of production pipelines.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	Weizmann Institute of Science; Weizmann Institute of Science; University of Calgary	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Surette, Michael G/AAE-8825-2020; mayo, avi/N-3756-2019; MAYO, AVI E/K-1736-2012	mayo, avi/0000-0002-4479-3423; 				Aizawa S, 1998, GENES CELLS, V3, P625, DOI 10.1046/j.1365-2443.1998.00219.x; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CHARLIER D, 1992, J MOL BIOL, V226, P367, DOI 10.1016/0022-2836(92)90953-H; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; GILMAN A, 1995, BIOPHYS J, V69, P1321, DOI 10.1016/S0006-3495(95)79999-4; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HEINRICH R, 1991, EUR J BIOCHEM, V201, P1, DOI 10.1111/j.1432-1033.1991.tb16251.x; Heinrich R, 1996, J THEOR BIOL, V182, P243, DOI 10.1006/jtbi.1996.0161; Heinrich R., 1996, REGULATION CELLULAR; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hung SP, 2002, J BIOL CHEM, V277, P40309, DOI 10.1074/jbc.M204044200; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Klipp E, 2002, EUR J BIOCHEM, V269, P5406, DOI 10.1046/j.1432-1033.2002.03223.x; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; LEGRAIN C, 1972, EUR J BIOCHEM, V27, P93, DOI 10.1111/j.1432-1033.1972.tb01814.x; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Oh MK, 2000, BIOTECHNOL PROGR, V16, P278, DOI 10.1021/bp000002n; PETTERSSON G, 1993, BIOCHIM BIOPHYS ACTA, V1164, P1, DOI 10.1016/0167-4838(93)90104-Y; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881	30	354	358	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					486	491		10.1038/ng1348	http://dx.doi.org/10.1038/ng1348			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107854	Bronze			2022-12-27	WOS:000221183000021
J	Niwa, N; Hiromi, Y; Okabe, M				Niwa, N; Hiromi, Y; Okabe, M			A conserved developmental program for sensory organ formation in Drosophila melanogaster	NATURE GENETICS			English	Article							RETINAL GANGLION-CELL; EYE DEVELOPMENT; ECTOPIC EYES; EYELESS GENE; EXPRESSION; MORPHOGENESIS; MUTATION; HOMOLOG; ABSENT; PAX-6	Different sensory organs, such the eye and ear, are widely thought to have separate origins, guided by distinct organ-specific factors that direct all aspects of their development. Previous studies of the D. melanogaster gene eyeless (ey) and its vertebrate homolog Pax6 suggested that this gene acts in such a manner and specifically drives eye development(1,2). But diverse sensory organs might instead arise by segment-specific modification of a developmental program that is involved more generally in sensory organ formation. In D. melanogaster, a common proneural gene called atonal (ato) functions in the initial process of development of a number of segment-specific organs, including the compound eye, the auditory organ and the stretch receptor(3,4), suggesting that these organs share an evolutionary origin. Here we show that D. melanogaster segment-specific sensory organs form through the integration of decapentaplegic (dpp), wingless (wg) and ecdysone signals into a single cis-regulatory element of ato. The induction of ectopic eyes by ey also depends on these signals for ato expression, and the ey mutant eye imaginal disc allows ato expression if cell death is blocked. These results imply that ey does not induce the entire eye morphogenetic program but rather modifies ato dependent neuronal development. Our findings strongly suggest that various sensory organs evolved from an ato dependent protosensory organ through segment specification by ey and Hox genes.	SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, CREST, Tokyo, Japan; Natl Inst Genet, Div Dev Genet, Shizuoka 4118540, Japan	Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Hiromi, Y (corresponding author), Univ London Kings Coll, MRC, Ctr Dev Neurobiol, New Hunts House,4th Floor,Guys Hosp Campus, London SE1 1UL, England.	yhiromi@lab.nig.ac.jp; maokabe@lab.nig.ac.jp						Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Brown NL, 2001, DEVELOPMENT, V128, P2497; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Chen R, 1999, DEVELOPMENT, V126, P935; Chow RL, 1999, DEVELOPMENT, V126, P4213; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hallberg E, 1999, MICROSC RES TECHNIQ, V47, P428, DOI 10.1002/(SICI)1097-0029(19991215)47:6<428::AID-JEMT6>3.0.CO;2-P; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HENRICH VC, 1987, DEV BIOL, V120, P50, DOI 10.1016/0012-1606(87)90102-3; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rogers BT, 1997, INT REV CYTOL, V174, P1, DOI 10.1016/S0074-7696(08)62115-4; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sun Y, 1998, DEVELOPMENT, V125, P3731; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153	30	65	67	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					293	297		10.1038/ng1308	http://dx.doi.org/10.1038/ng1308			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981517	Bronze			2022-12-27	WOS:000189250400020
J	Paw, BH; Davidson, AJ; Zhou, Y; Li, R; Pratt, SJ; Lee, C; Trede, NS; Brownlie, A; Donovan, A; Liao, EC; Ziai, JM; Drejer, AH; Guo, W; Kim, CH; Gwynn, B; Peters, LL; Chernova, MN; Alper, SL; Zapata, A; Wickramasinghe, SN; Lee, MJ; Lux, SE; Fritz, A; Postlethwait, JH; Zon, LI				Paw, BH; Davidson, AJ; Zhou, Y; Li, R; Pratt, SJ; Lee, C; Trede, NS; Brownlie, A; Donovan, A; Liao, EC; Ziai, JM; Drejer, AH; Guo, W; Kim, CH; Gwynn, B; Peters, LL; Chernova, MN; Alper, SL; Zapata, A; Wickramasinghe, SN; Lee, MJ; Lux, SE; Fritz, A; Postlethwait, JH; Zon, LI			Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency	NATURE GENETICS			English	Article							ANEMIA TYPE-II; POLYMERASE CHAIN-REACTION; STRUCTURAL PROTEIN-4.1; MEMBRANE SKELETON; IDENTIFICATION; LOCALIZATION; BINDING; LINKAGE; GENE; AE1	Most eukaryotic cell types use a common program to regulate the process of cell division. During mitosis, successful partitioning of the genetic material depends on spatially coordinated chromosome movement and cell cleavage(1). Here we characterize a zebrafish mutant, retsina (ret), that exhibits an erythroid-specific defect in cell division with marked dyserythropoiesis similar to human congenital dyserythropoietic anemia. Erythroblasts from ret fish show binuclearity and undergo apoptosis due to a failure in the completion of chromosome segregation and cytokinesis. Through positional cloning, we show that the ret mutation is in a gene (slc4a1) encoding the anion exchanger 1 (also called band 3 and AE1), an erythroid-specific cytoskeletal protein. We further show an association between deficiency in Slc4a1 and mitotic defects in the mouse. Rescue experiments in ret zebrafish embryos expressing transgenic slc4a1 with a variety of mutations show that the requirement for band 3 in normal erythroid mitosis is mediated through its protein 4.1R-binding domains. Our report establishes an evolutionarily conserved role for band 3 in erythroid-specific cell division and illustrates the concept of cell-specific adaptation for mitosis.	Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Mol Med Unit, Boston, MA USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Renal Unit, Boston, MA USA; Univ Complutense, Dept Cell Biol, E-28040 Madrid, Spain; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; Univ London Imperial Coll Sci Technol & Med, Dept Hematol, London, England; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Maine System; University of Maine Orono; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Complutense University of Madrid; University of Oxford; Imperial College London; Emory University; University of Oregon	Zon, LI (corresponding author), Childrens Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA.			Paw, Barry/0000-0002-0492-1419; Kim, Carol/0000-0002-0465-4496; Cutts, Alison/0000-0002-4986-573X; Liao, Eric/0000-0001-6385-7448; Zapata, Agustin G/0000-0003-0576-2672; Peters, Luanne/0000-0002-0784-0534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064885] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064885] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alloisio N, 1996, BLOOD, V87, P4433, DOI 10.1182/blood.V87.10.4433.bloodjournal87104433; An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; De Franceschi L, 1998, EXP HEMATOL, V26, P869; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Fritz A, 1996, GENETICS, V144, P1735; FUKUDA MN, 1993, BAILLIERE CLIN HAEM, V6, P493, DOI 10.1016/S0950-3536(05)80156-8; Gasparini P, 1997, AM J HUM GENET, V61, P1112, DOI 10.1086/301609; Iolascon A, 1998, BLOOD, V92, P2593, DOI 10.1182/blood.V92.7.2593; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Krauss SW, 1997, P NATL ACAD SCI USA, V94, P7297, DOI 10.1073/pnas.94.14.7297; Krauss SW, 2002, J BIOL CHEM, V277, P44339, DOI 10.1074/jbc.M204135200; Liao EC, 2000, DEVELOPMENT, V127, P5123; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Perez-Ferreiro CM, 2001, J BIOL CHEM, V276, P44785, DOI 10.1074/jbc.M107369200; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; PETERS LL, 1998, BLOOD S, V92, P301; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rosse W., 1995, BLOOD PRINCIPLES PRA, P367; SEKLER I, 1995, J BIOL CHEM, V270, P28751, DOI 10.1074/jbc.270.48.28751; Shafizadeh E, 2002, DEVELOPMENT, V129, P4359; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wickramasinghe SN, 1998, BLOOD REV, V12, P178, DOI 10.1016/S0268-960X(98)90016-9	29	100	101	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					59	64		10.1038/ng1137	http://dx.doi.org/10.1038/ng1137			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12669066				2022-12-27	WOS:000182667900017
J	Rubinson, DA; Dillon, CP; Kwiatkowski, AV; Sievers, C; Yang, LL; Kopinja, J; Zhang, MD; McManus, MT; Gertler, FB; Scott, ML; Van Parijs, L				Rubinson, DA; Dillon, CP; Kwiatkowski, AV; Sievers, C; Yang, LL; Kopinja, J; Zhang, MD; McManus, MT; Gertler, FB; Scott, ML; Van Parijs, L			A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference	NATURE GENETICS			English	Article							NONDIVIDING CELLS; HAIRPIN RNAS; EXPRESSION; DELIVERY; VECTORS	RNA interference (RNAi) has recently emerged as a specific and efficient method to silence gene expression in mammalian cells either by transfection of short interfering RNAs (siRNAs; ref. 1) or, more recently, by transcription of short hairpin RNAs (shRNAs) from expression vectors and retroviruses(2-10). But the resistance of important cell types to transduction by these approaches, both in vitro and in vivo(11), has limited the use of RNAi. Here we describe a lentiviral system for delivery of shRNAs into cycling and non-cycling mammalian cells, stem cells, zygotes and their differentiated progeny. We show that lentivirus-delivered shRNAs are capable of specific, highly stable and functional silencing of gene expression in a variety of cell types and also in transgenic mice. Our lentiviral vectors should permit rapid and efficient analysis of gene function in primary human and animal cells and tissues and generation of animals that show reduced expression of specific genes. They may also provide new approaches for gene therapy.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Free Univ Berlin, Inst Biochem, D-1000 Berlin, Germany; CALTECH, Pasadena, CA 91125 USA; Biogen Inc, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Free University of Berlin; California Institute of Technology; Biogen	Van Parijs, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Dillon, Christopher/P-4457-2014; mcmanus, michael/AAB-1239-2020; Rubinson, Douglas/G-3502-2019	Dillon, Christopher/0000-0002-9458-0266; mcmanus, michael/0000-0003-3013-6569; Rubinson, Douglas/0000-0002-5337-5231				Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lois C, 2001, CURR OPIN IMMUNOL, V13, P496, DOI 10.1016/S0952-7915(00)00247-8; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; McManus MT, 2002, J IMMUNOL, V169, P5754, DOI 10.4049/jimmunol.169.10.5754; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Scherr Michaela, 2002, Current Gene Therapy, V2, P45, DOI 10.2174/1566523023348237; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Strasser A, 2000, ANN NY ACAD SCI, V917, P541; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tuschl T, 2002, NAT BIOTECHNOL, V20, P446, DOI 10.1038/nbt0502-446; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	28	1049	1329	2	102	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					401	406		10.1038/ng1117	http://dx.doi.org/10.1038/ng1117			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590264				2022-12-27	WOS:000181312700019
J	Bluteau, O; Jeannot, E; Bioulac-Sage, P; Marques, JM; Blanc, JF; Bui, H; Beaudoin, JC; Franco, D; Balabaud, C; Laurent-Puig, P; Zucman-Rossi, J				Bluteau, O; Jeannot, E; Bioulac-Sage, P; Marques, JM; Blanc, JF; Bui, H; Beaudoin, JC; Franco, D; Balabaud, C; Laurent-Puig, P; Zucman-Rossi, J			Bi-allelic inactivation of TCF1 in hepatic adenomas	NATURE GENETICS			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; LIVER-CELL ADENOMAS; I ALPHA-GENE; TRANSCRIPTION FACTOR; DNA-BINDING; HEPATOCELLULAR-CARCINOMA; DIABETES-MELLITUS; MUTATIONS; HOMEODOMAIN; DOMAIN	Liver adenomas are benign tumors at risk of malignant transformation. In a genome-wide search for loss of heterozygosity (LOH) associated with liver adenomas, we found a deletion in chromosome 12q in five of ten adenomas. In most cases, LOH at 12q was the only recurrent genetic alteration observed, suggesting the presence of a tumor-suppressor gene in that region. A minimal common region of deletion was defined in 12q24 that included the gene TCF1 (transcription factor 1), encoding hepatocyte nuclear factor 1 (HNF1; refs 1,2). Heterozygous germline mutations of TCF1 have been identified in individuals affected with maturity-onset diabetes of the young type 3 (MODY3; ref. 3). Bi-allelic inactivation of TCF1 was found in 10 of 16 screened adenomas, and heterozygous germline mutation were present in three affected individuals. Furthermore, 2 well-differentiated hepatocellular carcinomas (HCCs) occurring in normal liver contained somatic bi-allelic mutations of 30 screened HCCs. These results indicate that inactivation of TCF1, whether sporadic or associated with MODY3, is an important genetic event in the occurrence of human liver adenoma, and may be an early step in the development of some HCCs.	Fdn Jean Dausset, INSERM, U434, F-75010 Paris, France; Foie Univ Bordeaux 2, Grp Rech Etud, Bordeaux, France; Hop Pellegrin, Serv Anatomopathol, F-33076 Bordeaux, France; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; Hop Antoine Beclere, Assistance Publ Hop Paris, Serv Chirurg Digest, Clamart, France	Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Zucman-Rossi, J (corresponding author), Fdn Jean Dausset, INSERM, U434, 27 Rue Juliette Dodu, F-75010 Paris, France.	zucman@cephb.fr	bluteau, olivier/A-8844-2008; Laurent-Puig, Pierre/K-3641-2019; Bluteau, Olivier/T-9907-2017; j, zucman-rossi/AAV-3594-2021; zucman-rossi, Jessica/B-5098-2009; laurent-puig, pierre/B-2226-2013	Laurent-Puig, Pierre/0000-0001-8475-5459; Bluteau, Olivier/0000-0002-6943-8858; j, zucman-rossi/0000-0002-5687-0334; zucman-rossi, Jessica/0000-0002-5687-0334; laurent-puig, pierre/0000-0001-8475-5459				BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; Boland CR, 1998, CANCER RES, V58, P5248; CEREGHINI S, 1990, EMBO J, V9, P2257, DOI 10.1002/j.1460-2075.1990.tb07396.x; Chiche L, 2000, ANN SURG, V231, P74, DOI 10.1097/00000658-200001000-00011; CHOUARD T, 1990, NUCLEIC ACIDS RES, V18, P5853, DOI 10.1093/nar/18.19.5853; Collet C, 2002, DIABETES METAB, V28, P39; COMINGS DE, 1973, P NATL ACAD SCI USA, V70, P3324, DOI 10.1073/pnas.70.12.3324; EDMONDSON HA, 1976, NEW ENGL J MED, V294, P470, DOI 10.1056/NEJM197602262940904; Ellard S, 2000, HUM MUTAT, V16, P377, DOI 10.1002/1098-1004(200011)16:5<377::AID-HUMU1>3.0.CO;2-2; FERRELL LD, 1993, AM J SURG PATHOL, V17, P525, DOI 10.1097/00000478-199305000-00013; FLEJOU JF, 1985, GASTROENTEROLOGY, V89, P1132, DOI 10.1016/0016-5085(85)90220-3; FOSTER JH, 1978, NEW ENGL J MED, V299, P239, DOI 10.1056/NEJM197808032990508; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; GOLDFARB S, 1976, CANCER RES, V36, P2584; HOWELL RR, 1976, JAMA-J AM MED ASSOC, V236, P1481, DOI 10.1001/jama.236.13.1481; Kaisaki PJ, 1997, DIABETES, V46, P528, DOI 10.2337/diabetes.46.3.528; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; SALE GE, 1977, ARCH PATHOL LAB MED, V101, P600; Schott O, 1997, J MOL BIOL, V267, P673, DOI 10.1006/jmbi.1997.0905; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Vaxillaire M, 1999, J BIOL CHEM, V274, P35639, DOI 10.1074/jbc.274.50.35639; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	29	241	250	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2002	32	2					312	315		10.1038/ng1001	http://dx.doi.org/10.1038/ng1001			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355088				2022-12-27	WOS:000178311100023
J	Takashima, H; Boerkoel, CF; John, J; Saifi, GM; Salih, MAM; Armstrong, D; Mao, YX; Quiocho, FA; Roa, BB; Nakagawa, M; Stockton, DW; Lupski, JR				Takashima, H; Boerkoel, CF; John, J; Saifi, GM; Salih, MAM; Armstrong, D; Mao, YX; Quiocho, FA; Roa, BB; Nakagawa, M; Stockton, DW; Lupski, JR			Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy	NATURE GENETICS			English	Article							PHOSPHOLIPASE-D SUPERFAMILY; COVALENT COMPLEXES; LINKAGE ANALYSIS; GENE; MEMBER; FAMILY; PHOSPHODIESTERASE; APOPTOSIS; MOTOR	Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs covalently bound topoisomerase I-DNA complexes(1-3) and is essential for preventing the formation of double-strand breaks that result when stalled topoisomerase I complexes interfere with DNA replication in yeast(4). Here we show that a deficiency of this DNA repair pathway in humans does not predispose to neoplasia or dysfunctions in rapidly replicating tissues, but instead causes spinocerebellar ataxia with axonal neuropathy (SCAN1) by affecting large, terminally differentiated, nondividing neuronal cells. Using genome-wide linkage mapping and a positional candidate approach in a Saudi Arabian family affected with autosomal recessive SCAN1, we identified a homozygous mutation in TDP1 (A1478G) that results in the substitution of histidine 493 with an arginine residue. The His493 residue is conserved in TDP1 across species and is located in the active site of the enzyme(3,5). Protein modeling predicts that mutation of this amino acid to arginine will disrupt the symmetric structure of the active site. We propose that loss-of-function mutations in TDP1 may cause SCAN1 either by interfering with DNA transcription or by inducing apoptosis in postmitotic neurons.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Kleberg Genotyping Ctr, Houston, TX 77030 USA; King Saud Univ, Coll Med, Dept Pediat, Div Pediat Neurol, Riyadh 11461, Saudi Arabia; Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Baylor DNA Diagnost Lab, Houston, TX 77030 USA; Kagoshima Univ, Sch Med, Dept Internal Med 3, Kagoshima 890, Japan; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; King Saud University; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Kagoshima University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.		Boerkoel, Cornelius Franciscus/AFW-4948-2022; Salih, Mustafa/C-1222-2014	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Mao, Yuxin/0000-0002-5064-1397; Salih, Mustafa/0000-0002-4379-2111				BENDIXEN C, 1990, BIOCHEMISTRY-US, V29, P5613, DOI 10.1021/bi00475a028; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Di Donato S, 2001, NEUROL SCI, V22, P219, DOI 10.1007/s100720100017; Gobbel GT, 1998, J NEUROSCI, V18, P147; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HARDING A, 1993, BRAINS DIS NERVOUS S, P432; Inamura N, 2000, J NEUROSCI RES, V60, P450, DOI 10.1002/(SICI)1097-4547(20000515)60:4<450::AID-JNR3>3.3.CO;2-G; Interthal H, 2001, P NATL ACAD SCI USA, V98, P12009, DOI 10.1073/pnas.211429198; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; KROEGER PE, 1989, NUCLEIC ACIDS RES, V17, P8495, DOI 10.1093/nar/17.21.8495; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Mao YX, 2001, CELL, V104, P433, DOI 10.1016/S0092-8674(01)00230-6; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; Ponting CP, 1996, PROTEIN SCI, V5, P914; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534	30	379	384	1	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					267	272		10.1038/ng987	http://dx.doi.org/10.1038/ng987			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244316				2022-12-27	WOS:000178311100015
J	Park, C; Falls, W; Finger, JH; Longo-Guess, CM; Ackerman, SL				Park, C; Falls, W; Finger, JH; Longo-Guess, CM; Ackerman, SL			Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation	NATURE GENETICS			English	Article							DEFICIENT FOLIA CDF; PREPULSE INHIBITION; ADHESION COMPLEX; CADHERIN; EXPRESSION; MUTATION; REGIONS; NUCLEUS; SYSTEM; MODEL	Mice homozygous for the cerebellar deficient folia (cdf) mutation are ataxic and have cerebellar hypoplasia and abnormal lobulation of the cerebellum. In the cerebella of cdf/cdf homozygous mice, approximately 40% of Purkinje cells are located ectopically in the white matter and inner granule-cell layer. Many hippocampal pyramidal cells are scattered in the plexiform layers, and those that are correctly positioned are less densely packed than are cells in wild-type mice. We show that fear conditioning and prepulse inhibition of the startle response are also disrupted in cdf/cdf mice. We identify a deletion on chromosome 6 that removes approximately 150 kb in the cdf critical region. The deletion includes part of Catna2, encoding alphaN-catenin, a protein that links the classical cadherins to the neuronal cytoskeleton. Expression of a Catna2 transgene in cdf/cdf mice restored normal cerebellar and hippocampal morphology, prepulse inhibition and fear conditioning. The findings suggest that catenin-cadherin cell-adhesion complexes are important in cerebellar and hippocampal lamination and in the control of startle modulation.	Jackson Lab, Bar Harbor, ME 04609 USA; Univ Vermont, Burlington, VT 05405 USA	Jackson Laboratory; University of Vermont	Ackerman, SL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Falls, William/D-1208-2013	Falls, William/0000-0002-9246-1474				Beierbach E, 2001, J COMP NEUROL, V436, P42; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; Cook SA, 1997, MAMM GENOME, V8, P108, DOI 10.1007/s003359900368; Davis M, 1998, J CLIN NEUROPHYSIOL, V15, P378, DOI 10.1097/00004691-199809000-00002; DAVIS M, 1978, J EXP PSYCHOL ANIM B, V4, P95, DOI 10.1037//0097-7403.4.2.95; FALLS WA, IN PRESS CURRENT PRO; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Lynn RB, 1997, J AUTONOM NERV SYST, V62, P174, DOI 10.1016/S0165-1838(96)00125-7; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NAGAFUCHI A, 1994, J CELL BIOL, V127, P235, DOI 10.1083/jcb.127.1.235; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Ozol K, 1999, J COMP NEUROL, V412, P95; Park C, 2000, GENOMICS, V69, P135, DOI 10.1006/geno.2000.6322; Park C, 2002, GENESIS, V32, P32, DOI 10.1002/gene.10024; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Serafini T, 1997, TRENDS NEUROSCI, V20, P322; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; SWERDLOW NR, 1993, BEHAV NEUROSCI, V107, P104, DOI 10.1037/0735-7044.107.1.104; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864	30	91	93	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					279	284		10.1038/ng908	http://dx.doi.org/10.1038/ng908			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089526				2022-12-27	WOS:000176494100016
J	Williamson, CM; Ball, ST; Nottingham, WT; Skinner, JA; Plagge, A; Turner, MD; Powles, N; Hough, T; Papworth, D; Fraser, WD; Maconochie, M; Peters, J				Williamson, CM; Ball, ST; Nottingham, WT; Skinner, JA; Plagge, A; Turner, MD; Powles, N; Hough, T; Papworth, D; Fraser, WD; Maconochie, M; Peters, J			A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas	NATURE GENETICS			English	Article							GENE; ANTISENSE; CLUSTER; IDENTIFICATION; TRANSCRIPTS; METHYLATION; MUTATIONS; DELETION; MICE; NESP	Genomic imprinting brings about allele-specific silencing according to parental origin(1). Silencing is controlled by cis-acting regulatory regions that are differentially marked during gametogenesis and can act over hundreds of kilobases to silence many genes(2-6). Two candidate imprinting control regions (ICRs) have been identified at the compact imprinted Gnas cluster on distal mouse chromosome 2, one at exon 1A upstream of Gnas itself(7) and one covering the promoters for Gnasxl and the antisense Nespas (ref. 8). This imprinted cluster is complex, containing biallelic, maternally and paternally expressed transcripts that share exons(9). Gnas itself is mainly biallelically expressed but is weakly paternally repressed in specific tissues(10). Here we show that a paternally derived targeted deletion of the germline differentially methylated region at exon 1A abolishes tissue-specific imprinting of Gnas. This rescues the abnormal phenotype of mice with a maternally derived Gnas mutation(11,12). Imprinting of alternative transcripts, Nesp, Gnasxl and Nespas (ref. 13), in the cluster is unaffected. The results establish that the differentially methylated region at exon 1A contains an imprinting control element that specifically regulates Gnas and comprises a characterized ICR for a gene that is only weakly imprinted in a minority of tissues. There must be a second ICR regulating the alternative transcripts.	MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Babraham Inst, Dev Genet Programme, Cambridge CB2 4AT, England; Univ Liverpool, Dept Clin Chem, Liverpool L69 3GA, Merseyside, England	MRC Harwell; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Liverpool	Peters, J (corresponding author), MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England.	j.peters@har.mrc.ac.uk	Williamson, Christine/GSE-3696-2022; Plagge, Antonius/AAH-3877-2019; Turner, Martin/N-9976-2014	Plagge, Antonius/0000-0001-6592-1343; Turner, Martin/0000-0002-3801-9896				Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHANDRASEKARAN B, 1994, IEEE EXPERT, V9, P2, DOI 10.1109/64.363254; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Ischia R, 1997, J BIOL CHEM, V272, P11657; KEHLENBACH RH, 1994, NATURE, V372, P804; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li T, 2000, GENOMICS, V69, P295, DOI 10.1006/geno.2000.6337; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	29	129	131	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					894	899		10.1038/ng1398	http://dx.doi.org/10.1038/ng1398			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273687				2022-12-27	WOS:000222974000025
J	Ishkanian, AS; Malloff, CA; Watson, SK; deLeeuw, RJ; Chi, B; Coe, BP; Snijders, A; Albertson, DG; Pinkel, D; Marra, MA; Ling, V; MacAulay, C; Lam, WL				Ishkanian, AS; Malloff, CA; Watson, SK; deLeeuw, RJ; Chi, B; Coe, BP; Snijders, A; Albertson, DG; Pinkel, D; Marra, MA; Ling, V; MacAulay, C; Lam, WL			A tiling resolution DNA microarray with complete coverage of the human genome	NATURE GENETICS			English	Article							COPY NUMBER; HYBRIDIZATION; CGH; CANCER; PATHWAY; REGIONS; AMPLIFICATION; IMBALANCES; CARCINOMA; LYMPHOMA	We constructed a tiling resolution array consisting of 32,433 overlapping BAC clones covering the entire human genome. This increases our ability to identify genetic alterations and their boundaries throughout the genome in a single comparative genomic hybridization (CGH) experiment. At this tiling resolution, we identified minute DNA alterations not previously reported. These alterations include microamplifications and deletions containing oncogenes, tumor-suppressor genes and new genes that may be associated with multiple tumor types. Our findings show the need to move beyond conventional marker-based genome comparison approaches, that rely on inference of continuity between interval markers. Our submegabase resolution tiling set for array CGH (SMRT array) allows comprehensive assessment of genomic integrity and thereby the identification of new genes associated with disease.	British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; UCSF Comprehens Canc Ctr, San Francisco, CA 94115 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada	British Columbia Cancer Agency; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; British Columbia Cancer Agency	Lam, WL (corresponding author), British Columbia Canc Res Ctr, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	wanlam@bccrc.ca	Watson, Spencer/GWR-2457-2022; Coe, Bradley/A-2878-2009; MacAulay, Calum/K-1795-2016; Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Coe, Bradley/0000-0001-8471-4016; MacAulay, Calum/0000-0003-4440-2792				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Denyssevych T, 2002, LEUKEMIA, V16, P276, DOI 10.1038/sj.leu.2402372; Dreyling MH, 1997, CANCER RES, V57, P4608; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Forozan F, 1997, TRENDS GENET, V13, P405, DOI 10.1016/S0168-9525(97)01244-4; Garnis C, 2003, CANCER RES, V63, P8582; Garnis C, 2004, GENE CHROMOSOME CANC, V39, P93, DOI 10.1002/gcc.10294; GARNIS C, IN PRESS ORAL ONCOL; Girard L, 2000, CANCER RES, V60, P4894; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; Kraus J, 2003, GENE CHROMOSOME CANC, V36, P159, DOI 10.1002/gcc.10160; LEVIN NA, 1994, CANCER RES, V54, P5086; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; QUINN LA, 1979, CANCER RES, V39, P4914; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Veltman JA, 2003, CANCER RES, V63, P2872; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Watson SK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-6; Weiss MM, 2003, ONCOGENE, V22, P1872, DOI 10.1038/sj.onc.1206350; Wells D, 2003, BIOESSAYS, V25, P289, DOI 10.1002/bies.10232; Wessendorf S, 2002, LAB INVEST, V82, P47, DOI 10.1038/labinvest.3780394; Wilhelm M, 2002, CANCER RES, V62, P957; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003	28	478	512	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					299	303		10.1038/ng1307	http://dx.doi.org/10.1038/ng1307			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981516	Bronze			2022-12-27	WOS:000189250400021
J	Bean, CJ; Schaner, CE; Kelly, WG				Bean, CJ; Schaner, CE; Kelly, WG			Meiotic pairing and imprinted X chromatin assembly in Caenorhabditis elegans	NATURE GENETICS			English	Article							HISTONE H3 LYSINE-9; C-ELEGANS; SEX DETERMINATION; METHYLATION; CHROMOSOME; GERMLINE; INACTIVATION; PATTERNS; GENES; DNA	The genetic imprinting of individual loci or whole chromosomes, as in imprinted X-chromosome inactivation in mammals(1,2), is established and reset during gametogenesis; defects in this process in the parent can result in disease in the offspring(3). We describe a sperm-specific chromatin-based imprinting of the X chromosome in the nematode Caenorhabditis elegans that is restricted to histone H3 modifications. The epigenetic imprint is established during spermatogenesis and its stability in the offspring is affected by the presence of a pairing partner during meiosis in the parental germ line. We observed that DNA lacking a pairing partner during meiosis, the normal situation for the X chromosome in males, is targeted for methylation of histone H3 at Lys9 (H3-Lys9) and can be silenced. Targeting unpaired DNA for silencing during meiosis, a potential hallmark of genome defense, could therefore have a conserved role in imprinted X-chromosome inactivation and, ultimately, in sex chromosome evolution.	Emory Univ, Rollins Res Ctr, Dept Biol, Atlanta, GA 30322 USA; Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Kelly, WG (corresponding author), Emory Univ, Rollins Res Ctr, Dept Biol, 1510 Clifton Rd, Atlanta, GA 30322 USA.			Bean, Christopher/0000-0001-7433-9769	NIGMS NIH HHS [T32 GM008490, R01 GM077600] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077600, T32GM008490] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adenot PG, 1997, DEVELOPMENT, V124, P4615; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; BRENNER S, 1974, GENETICS, V77, P71; BROVERMAN SA, 1994, GENETICS, V136, P119; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; HANDEL MA, 1992, BIOESSAYS, V14, P817, DOI 10.1002/bies.950141205; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Higashimoto K, 2003, AM J HUM GENET, V73, P948, DOI 10.1086/378595; HODGKIN J, 1979, GENETICS, V91, P67; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; Hynes MJ, 2003, BIOESSAYS, V25, P99, DOI 10.1002/bies.10241; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuwabara PE, 2001, BIOESSAYS, V23, P596, DOI 10.1002/bies.1085; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Prahlad V, 2003, SCIENCE, V302, P1046, DOI 10.1126/science.1087946; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reuben M, 2002, DEV BIOL, V245, P71, DOI 10.1006/dbio.2002.0634; SCHEDL T, 1997, C ELEGANS, V2, P241; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Wu CI, 2003, TRENDS GENET, V19, P243, DOI 10.1016/S0168-9525(03)00058-1; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469	30	149	158	0	9	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					100	105		10.1038/ng1283	http://dx.doi.org/10.1038/ng1283			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702046	Green Accepted, Bronze			2022-12-27	WOS:000187666800021
J	van Overveld, PGM; Lemmers, RJFL; Sandkuijl, LA; Enthoven, L; Winokur, ST; Bakels, F; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM				van Overveld, PGM; Lemmers, RJFL; Sandkuijl, LA; Enthoven, L; Winokur, ST; Bakels, F; Padberg, GW; van Ommen, GJB; Frants, RR; van der Maarel, SM			Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy	NATURE GENETICS			English	Article							DNA REARRANGEMENTS; METHYLATION; MUTATIONS; FSHD	The autosomal dominant myopathy facioscapulohumeral muscular dystrophy (FSHD1, OMIM 158900) is caused by contraction of the D4Z4 repeat array on 4qter. We show that this contraction causes marked hypomethylation of the contracted D4Z4 allele in individuals with FSHD1. Individuals with phenotypic FSHD1, who are clinically identical to FSHD1 but have an unaltered D4Z4, also have hypomethylation of D4Z4. These results strongly suggest that hypomethylation of D4Z4 is a key event in the cascade of epigenetic events causing FSHD1.	Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, NL-2300 RA Leiden, Netherlands; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92717 USA; Radboud Univ Nijmegen Med Ctr, Dept Neurol, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Irvine; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, POB 9502, NL-2300 RA Leiden, Netherlands.	maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; Padberg, G.W.A.M./H-8079-2014	van der Maarel, Silvere/0000-0001-8103-711X; van Overveld, Petra GM/0000-0003-0216-5004				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; Padberg GW, 1982, FACIOSCAPULOHUMERAL; Rand E, 2003, J CELL BIOCHEM, V88, P400, DOI 10.1002/jcb.10352; Randolph-Anderson BL, 2002, AM J HUM GENET, V71, P530; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	15	275	288	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2003	35	4					315	317		10.1038/ng1262	http://dx.doi.org/10.1038/ng1262			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14634647				2022-12-27	WOS:000186791000011
J	Yvert, G; Brem, RB; Whittle, J; Akey, JM; Foss, E; Smith, EN; Mackelprang, R; Kruglyak, L				Yvert, G; Brem, RB; Whittle, J; Akey, JM; Foss, E; Smith, EN; Mackelprang, R; Kruglyak, L			Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors	NATURE GENETICS			English	Article							HUMAN GENE-EXPRESSION; CELL-CYCLE; ALLELIC VARIATION; BUDDING YEAST; GENOME; DISRUPTION; EVOLUTION; IDENTIFICATION; RECEPTORS; DELETION	Natural genetic variation can cause significant differences in gene expression, but little is known about the polymorphisms that affect gene regulation. We analyzed regulatory variation in a cross between laboratory and wild strains of Saccharomyces cerevisiae. Clustering and linkage analysis defined groups of coregulated genes and the loci involved in their regulation. Most expression differences mapped to trans-acting loci. Positional cloning and functional assays showed that polymorphisms in GPA1 and AMN1 affect expression of genes involved in pheromone response and daughter cell separation, respectively. We also asked whether particular classes of genes were more likely to contain trans-regulatory polymorphisms. Notably, transcription factors showed no enrichment, and trans-regulatory variation seems to be broadly dispersed across classes of genes with different molecular functions.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98103 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98103 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kruglyak, L (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Mailstop D4-100,1100 Fairview Ave N, Seattle, WA 98103 USA.		Smith, Erin/E-5933-2011; Mackelprang, Romel/GWV-4748-2022	Akey, Joshua/0000-0002-4411-1330; Yvert, Gael/0000-0003-1955-4786				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Brachmann CB, 1998, YEAST, V14, P115; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Foss EJ, 2001, GENETICS, V157, P567; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; HIRSCH JP, 1991, GENE DEV, V5, P467, DOI 10.1101/gad.5.3.467; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Spector MS, 1997, MOL CELL BIOL, V17, P545, DOI 10.1128/MCB.17.2.545; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wang YC, 2003, CELL, V112, P697, DOI 10.1016/S0092-8674(03)00121-1; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; [No title captured]	40	496	509	0	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					57	64		10.1038/ng1222	http://dx.doi.org/10.1038/ng1222			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12897782				2022-12-27	WOS:000185018500011
J	Huang, E; Ishida, S; Pittman, J; Dressman, H; Bild, A; Kloos, M; D'Amico, M; Pestell, RG; West, M; Nevins, JR				Huang, E; Ishida, S; Pittman, J; Dressman, H; Bild, A; Kloos, M; D'Amico, M; Pestell, RG; West, M; Nevins, JR			Gene expression phenotypic models that predict the activity of oncogenic pathways	NATURE GENETICS			English	Article							BREAST-CANCER; E2F; PROTEINS; GROWTH	High-density DNA microarrays measure expression of large numbers of genes in one assay. The ability to find underlying structure in complex gene expression data sets and rigorously test association of that structure with biological conditions is essential to developing multi-faceted views of the gene activity that defines cellular phenotype. We sought to connect features of gene expression data with biological hypotheses by integrating metagene patterns from DNA microarray experiments in the characterization and prediction of oncogenic phenotypes. We applied these techniques to the analysis of regulatory pathways controlled by the genes HRAS (Harvey rat sarcoma viral oncogene homolog), MYC (myelocytomatosis viral oncogene homolog) and E2F1, E2F2 and E2F3 (encoding E2F transcription factors 1, 2 and 3, respectively). The phenotypic models accurately predict the activity of these pathways in the context of normal cell proliferation. Moreover, the metagene models trained with gene expression patterns evoked by ectopic production of Myc or Ras proteins in primary tissue culture cells properly predict the activity of in vivo tumor models that result from deregulation of the MYC or HRAS pathways. We conclude that these gene expression phenotypes have the potential to characterize the complex genetic alterations that typify the neoplastic state, whether in vitro or in vivo, in a way that truly reflects the complexity of the regulatory pathways that are affected.	Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Duke Univ, Computat & Appl Genom Program, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; Duke Univ, Inst Stat & Decis Sci, Durham, NC 27710 USA; Duke Univ, Ctr Genome Technol, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA; Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Georgetown University; Duke University; Howard Hughes Medical Institute	Nevins, JR (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.		Huang, Erich/B-1894-2008	Huang, Erich/0000-0001-5547-9408; Clarke, Jennifer/0000-0002-2723-7249				Bearss DJ, 2002, CANCER RES, V62, P2077; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Nevins JR, 1997, METHOD ENZYMOL, V283, P205; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	14	195	206	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					226	230		10.1038/ng1167	http://dx.doi.org/10.1038/ng1167			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12754511				2022-12-27	WOS:000183200500032
J	Modrek, B; Lee, CJ				Modrek, B; Lee, CJ			Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss	NATURE GENETICS			English	Article							HUMAN GENES; WIDE DETECTION; SEQUENCE; INFORMATION; PREDICTION	One of the most interesting opportunities in comparative genomics is to compare not only genome sequences but additional phenomena, such as alternative splicing, using orthologous genes in different genomes to find similarities and differences between organisms(1,2). Recently, genomics studies have suggested that 40-60% of human genes are alternatively spliced(3-8) and have catalogued up to 30,000 alternative splice relationships in human genes(9). Here we report an analysis of 9,434 orthologous genes in human and mouse, which indicates that alternative splicing is associated with a large increase in frequency of recent exon creation and/or loss. Whereas most exons in the mouse and human genomes are strongly conserved in both genomes, exons that are only included in alternative splice forms (as opposed to the constitutive or major transcript form) are mostly not conserved and thus are the product of recent exon creation or loss events. A similar comparison of orthologous exons in rat and human validates this pattern. Although this says nothing about the complex question of adaptive benefit, it does indicate that alternative splicing in these genomes has been associated with increased evolutionary change.	Univ Calif Los Angeles, Ctr Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lee, CJ (corresponding author), Univ Calif Los Angeles, Ctr Genom & Proteom, Los Angeles, CA 90095 USA.	leec@mbi.ucla.edu						Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Cui Y, 2002, P NATL ACAD SCI USA, V99, P809, DOI 10.1073/pnas.022240299; GREEN P, 1993, SCIENCE, V259, P1711, DOI 10.1126/science.8456298; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492	18	417	428	4	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					177	180		10.1038/ng1159	http://dx.doi.org/10.1038/ng1159			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12730695				2022-12-27	WOS:000183200500023
J	Jamain, S; Quach, H; Betancur, C; Rastam, M; Colineaux, C; Gillberg, IC; Soderstrom, H; Giros, B; Leboyer, M; Gillberg, C; Bourgeron, T; Gillberg, C; Rastam, M; Gillberg, C; Nyden, A; Soderstrom, H; Leboyer, M; Betancur, C; Philippe, A; Giros, B; Colineaux, C; Cohen, D; Chabane, N; Mouren-Simeoni, MC; Brice, A; Sponheim, E; Spurkland, I; Skjeldal, OH; Coleman, M; Pearl, PL; Cohen, IL; Tsiouris, J; Zappella, M; Menchetti, G; Pompella, A; Aschauer, H; Van Maldergem, L				Jamain, S; Quach, H; Betancur, C; Rastam, M; Colineaux, C; Gillberg, IC; Soderstrom, H; Giros, B; Leboyer, M; Gillberg, C; Bourgeron, T; Gillberg, C; Rastam, M; Gillberg, C; Nyden, A; Soderstrom, H; Leboyer, M; Betancur, C; Philippe, A; Giros, B; Colineaux, C; Cohen, D; Chabane, N; Mouren-Simeoni, MC; Brice, A; Sponheim, E; Spurkland, I; Skjeldal, OH; Coleman, M; Pearl, PL; Cohen, IL; Tsiouris, J; Zappella, M; Menchetti, G; Pompella, A; Aschauer, H; Van Maldergem, L		Paris Autism Res Int Sibpair Study	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism	NATURE GENETICS			English	Article							BINDING; EXPRESSION; DISORDERS	Many studies have supported a genetic etiology for autism. Here we report Mutations in two X-linked genes encoding neuroligins NLGN3 and NLGN4 in siblings with autism-spectrum disorders. These mutations affect cell-adhesion molecules localized at the synapse and suggest that a defect of synaptogenesis may predispose to autism.	Univ Paris 07, Lab Genet Humaine & Fonct Cognit, INSERM, E0021,Inst Pasteur, F-75015 Paris, France; Univ Paris 12, INSERM, U513, Fac Med, F-94000 Creteil, France; Univ Gothenburg, Dept Child & Adolescent Psychiat, S-41119 Gothenburg, Sweden; Hop Robert Debre, Dept Child & Adolescent Psychiat, F-75019 Paris, France; Hop Albert Chenevier & Henri Mondor, Dept Psychiat, F-94000 Creteil, France; Univ London St Georges Hosp, Sch Med, London 5W17 ORE, England; Gothenburg Univ, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; Hop Albert Chenevier & Henri Mondor, Dept Psychiat, Creteil, France; INSERM, U513, Fac Med, Creteil, France; Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, Paris, France; Hop La Pitie Salpetriere, INSERM, U289, Paris, France; Univ Oslo, Ctr Child & Adolescent Psychiat, Oslo, Norway; Univ Oslo, Rikshosp, Dept Pediat, Oslo, Norway; Georgetown Univ, Sch Med, Dept Pediat, Washington, DC 20007 USA; George Washington Univ, Childrens Natl Med Ctr, Sch Med, Washington, DC USA; New York State Inst Basic Res Dev Disabil, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA; Azienda Osped Senese, Div Neuropsichiatria Infantile, Siena, Italy; Univ Hosp, Dept Gen Psychiat, Vienna, Austria; Inst Pathol & Genet, Ctr Genet Humaine, Gerpinnes, Loverval, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; St Georges University London; University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Oslo; University of Oslo; National Hospital Norway; Georgetown University; Children's National Health System; George Washington University; Institute for Basic Research in Developmental Disabilities; University of Siena; University Hospital of Siena; University Hospital Vienna	Bourgeron, T (corresponding author), Univ Paris 07, Lab Genet Humaine & Fonct Cognit, INSERM, E0021,Inst Pasteur, F-75015 Paris, France.	thomasb@pasteur.fr	Betancur, Catalina/K-3791-2017; Van Maldergem, Lionel/G-9849-2017; Anckarsater, Henrik/C-2244-2009; GIROS, Bruno/ABD-5790-2021; Jamain, Stéphane/L-1822-2019; Leboyer, Marion/AAW-3648-2021; brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Aschauer, Harald/G-8850-2016; Jamain, Stéphane/P-3710-2017; Van Maldergem, Lionel/O-3242-2019	Betancur, Catalina/0000-0002-3327-4804; Van Maldergem, Lionel/0000-0001-8880-5214; GIROS, Bruno/0000-0001-5876-9822; Leboyer, Marion/0000-0001-5473-3697; brice, alexis/0000-0002-0941-3990; Aschauer, Harald/0000-0002-4449-372X; Jamain, Stéphane/0000-0002-4321-4100; Van Maldergem, Lionel/0000-0001-8880-5214; Bourgeron, Thomas/0000-0001-8164-9220; Quach, Helene/0000-0002-3493-0973				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Gillberg C, 1998, BRIT J PSYCHIAT, V172, P200, DOI 10.1192/bjp.172.3.200; Gillberg C, 1998, J AUTISM DEV DISORD, V28, P415, DOI 10.1023/A:1026004505764; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jamain S, 2002, MOL PSYCHIATR, V7, P302, DOI 10.1038/sj.mp.4000979; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Philibert RA, 2000, GENE, V246, P303, DOI 10.1016/S0378-1119(00)00049-4; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Thomas NS, 1999, HUM GENET, V104, P43, DOI 10.1007/s004390050908; Tsigelny I, 2000, PROTEIN SCI, V9, P180	15	1263	1326	3	193	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					27	29		10.1038/ng1136	http://dx.doi.org/10.1038/ng1136			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12669065	Green Submitted, Green Accepted			2022-12-27	WOS:000182667900011
J	Hemann, MT; Fridman, JS; Zilfou, JT; Hernando, E; Paddison, PJ; Cordon-Cardo, C; Hannon, GJ; Lowe, SW				Hemann, MT; Fridman, JS; Zilfou, JT; Hernando, E; Paddison, PJ; Cordon-Cardo, C; Hannon, GJ; Lowe, SW			An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo	NATURE GENETICS			English	Article							C-ELEGANS; INTERFERENCE; SUPPRESSION; CANCER; MOUSE; GENES; DICER	The application of RNA interference (RNAi) to mammalian systems has the potential to revolutionize genetics and produce novel therapies. Here we investigate whether RNAi applied to a well-characterized gene can stably suppress gene expression in hematopoietic stem cells and produce detectable phenotypes in mice. Deletion of the Trp53 tumor suppressor gene greatly accelerates Myc-induced lymphomagenesis, resulting in highly disseminated disease(1,2). To determine whether RNAi suppression of Trp53 could produce a similar phenotype, we introduced several Trp53 short hairpin RNAs (shRNAs) into hematopoietic stem cells derived from Emu-Myc transgenic mice, and monitored tumor onset and overall pathology in lethally irradiated recipients. Different Trp53 shRNAs produced distinct phenotypes in vivo, ranging from benign lymphoid hyperplasias to highly disseminated lymphomas that paralleled Trp53(-/-) lymphomagenesis in the Emu-Myc mouse. In all cases, the severity and type of disease correlated with the extent to which specific shRNAs inhibited p53 activity. Therefore, RNAi can stably suppress gene expression in stem cells and reconstituted organs derived from those cells. In addition, intrinsic differences between individual shRNA expression vectors targeting the same gene can be used to create an 'epi-allelic series' for dissecting gene function in vivo.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.		Hannon, Gregory/AAB-3568-2019	Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	14	286	339	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					396	400		10.1038/ng1091	http://dx.doi.org/10.1038/ng1091			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12567186				2022-12-27	WOS:000181312700018
J	Nagy, A; Perrimon, N; Sandmeyer, S; Plasterk, R				Nagy, A; Perrimon, N; Sandmeyer, S; Plasterk, R			Tailoring the genome: the power of genetic approaches	NATURE GENETICS			English	Review							EMBRYONIC STEM-CELLS; DOUBLE-STRANDED-RNA; PROTEIN-PROTEIN INTERACTIONS; LARGE-SCALE ANALYSIS; CAENORHABDITIS-ELEGANS; DEVELOPMENTAL GENES; MICROARRAY ANALYSIS; FUNCTIONAL-ANALYSIS; REVERSE GENETICS; FLP RECOMBINASE	In the last century, genetics has developed into one of the most powerful tools for addressing basic questions concerning inheritance, development, individual and social operations and death. Here we summarize the current approaches to these questions in four of the most advanced models organisms: Saccharomyces cerevisiae (yeast), Caenorhabditis elegans (worm), Drosophila melanogaster (fly) and Mus muscuius (mouse). The genomes of each of these four models have been sequenced, and all have well developed methods of efficient genetic manipulations.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Univ Calif Irvine, Coll Med, Dept Biol Chem, Irvine, CA 92697 USA; Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Irvine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Nagy, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@mshri.on.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Perrimon, Norbert/0000-0001-7542-472X				Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bachman N, 2002, METHOD ENZYMOL, V350, P230, DOI 10.1016/S0076-6879(02)50966-6; Bellaiche Y, 1999, GENETICS, V152, P1037; BELTEKI G, 2003, IN PRESS NAT BIOTECH; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENNER S, 1974, GENETICS, V77, P71; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; Chowdhury K, 1997, NUCLEIC ACIDS RES, V25, P1531, DOI 10.1093/nar/25.8.1531; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; CRAIG NL, 2002, MOBILE DNA, V2; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; DEMARINI DM, 1989, MUTAT RES, V220, P11, DOI 10.1016/0165-1110(89)90006-7; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Furlong EEM, 2001, NAT BIOTECHNOL, V19, P153, DOI 10.1038/84422; GARFINKEL DJ, 1988, GENETICS, V120, P95; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOSSEN M, 1993, TRENDS BIOCHEM SCI, V18, P471, DOI 10.1016/0968-0004(93)90009-C; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Guthrie C, 1991, GUIDE YEAST GENETICS; Harrington JJ, 2001, NAT BIOTECHNOL, V19, P440, DOI 10.1038/88107; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hoskins RA, 2001, GENOME RES, V11, P1100, DOI 10.1101/gr.GR-1780R; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin SG, 2001, GENOME BIOL, V2; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; Munroe RJ, 2000, NAT GENET, V24, P318, DOI 10.1038/73563; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Newsome TP, 2000, DEVELOPMENT, V127, P851; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Perrimon N, 1996, GENETICS, V144, P1681; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong YS, 2001, GENETICS, V157, P1307; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; SEIFERT HS, 1986, P NATL ACAD SCI USA, V83, P735, DOI 10.1073/pnas.83.3.735; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; Stowers RS, 1999, GENETICS, V152, P1631; Teeter K, 2000, J EXP ZOOL, V288, P63, DOI 10.1002/(SICI)1097-010X(20000415)288:1&lt;63::AID-JEZ7&gt;3.0.CO;2-1; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; XU TA, 1995, DEVELOPMENT, V121, P1053; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; You Y, 1997, NAT GENET, V15, P285, DOI 10.1038/ng0397-285; ZHANG P, 1993, GENETICS, V133, P361; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	115	48	51	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			276	284		10.1038/ng1115	http://dx.doi.org/10.1038/ng1115			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610537				2022-12-27	WOS:000181390900008
J	Arkhipova, IR; Pyatkov, KI; Meselson, M; Evgen'ev, MB				Arkhipova, IR; Pyatkov, KI; Meselson, M; Evgen'ev, MB			Retroelements containing introns in diverse invertebrate taxa	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; DROSOPHILA-VIRILIS; RETROTRANSPOSITION; PENELOPE; TELOMERASE; EVOLUTION	We report that two structurally similar transposable elements containing reverse transcriptase (RT), Penelope in Drosophila virilis and Athena in bdelloid rotifers, have proliferated as copies containing introns. The ability of Penelope-like elements (PLEs) to retain introns, their separate phylogenetic placement and their peculiar structural features make them a novel class of eukaryotic retroelements.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Inst Cell Biophys, Pushchino, Russia; Inst Mol Biol, Moscow, Russia	Harvard University; Russian Academy of Sciences; Institute of Cell Biophysics RAS	Meselson, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	msm@wjh.harvard.edu		Arkhipova, Irina/0000-0002-4805-1339				Arkhipova I, 2000, P NATL ACAD SCI USA, V97, P14473, DOI 10.1073/pnas.97.26.14473; ARKHIPOVA IR, 1995, GENETICS, V139, P1359; Belfort M, 2002, MOBILE DNA; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Eickbush TH, 1997, SCIENCE, V277, P911, DOI 10.1126/science.277.5328.911; Evgenev MB, 1997, P NATL ACAD SCI USA, V94, P196, DOI 10.1073/pnas.94.1.196; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Lyozin GT, 2001, J MOL EVOL, V52, P445, DOI 10.1007/s002390010174; Moore M. J., 1993, RNA WORLD; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Nogare DED, 2002, MOL BIOL EVOL, V19, P247, DOI 10.1093/oxfordjournals.molbev.a004078; Volff JN, 2001, MOL GENET GENOMICS, V265, P711, DOI 10.1007/s004380100468; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211	15	99	103	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					123	124		10.1038/ng1074	http://dx.doi.org/10.1038/ng1074			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524543				2022-12-27	WOS:000180773700007
J	Zhang, Q; Zhao, BH; Li, W; Oiso, N; Novak, EK; Rusiniak, ME; Gautam, R; Chintala, S; O'Brien, EP; Zhang, Y; Roe, BA; Elliott, RW; Eicher, EM; Liang, P; Kratz, C; Legius, E; Spritz, RA; O'Sullivan, TN; Copeland, NG; Jenkins, NA; Swank, RT				Zhang, Q; Zhao, BH; Li, W; Oiso, N; Novak, EK; Rusiniak, ME; Gautam, R; Chintala, S; O'Brien, EP; Zhang, Y; Roe, BA; Elliott, RW; Eicher, EM; Liang, P; Kratz, C; Legius, E; Spritz, RA; O'Sullivan, TN; Copeland, NG; Jenkins, NA; Swank, RT			Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6	NATURE GENETICS			English	Article							STORAGE POOL DEFICIENCY; PALE EAR EP; MUTATIONS; TRAFFICKING; MELANOSOMES; BIOGENESIS; DISORDERS; TRANSPORT; PROTEINS; ADAPTER	Hermansky-Pudlak syndrome (HPS) is a genetically heterogeneous disease involving abnormalities of melanosomes, platelet dense granules and lysosomes. Here we have used positional candidate and transgenic rescue approaches to identify the genes mutated in ruby-eye 2 and ruby-eye mice (ru2 and ru, respectively), two 'mimic' mouse models of HPS. We also show that these genes are orthologs of the genes mutated in individuals with HPS types 5 and 6, respectively, and that their protein products directly interact. Both genes are previously unknown and are found only in higher eukaryotes, and together represent a new class of genes that have evolved in higher organisms to govern the synthesis of highly specialized lysosome-related organelles.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Univ Dusseldorf, Klin Padiat Hamatol & Onkol, D-4000 Dusseldorf, Germany; Univ Ziekenhuizen Leuven, Ctr Human Genet, Louvain, Belgium; Natl Canc Inst, Mouse Canc Genet Program, Frederick, MD USA	Roswell Park Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oklahoma System; University of Oklahoma - Norman; Jackson Laboratory; Roswell Park Cancer Institute; Heinrich Heine University Dusseldorf; KU Leuven; University Hospital Leuven; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Swank, RT (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.		Oiso, Naoki/H-6540-2019; Legius, Eric/H-1735-2011; Liang, Ping/D-2709-2009; Liang, Ping/S-3790-2018; Kratz, Christian/AAC-9726-2021	Oiso, Naoki/0000-0001-5593-6496; Liang, Ping/0000-0003-4423-0636; Liang, Ping/0000-0003-4423-0636; 				Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; CHISSOE SL, 1991, METHODS COMPANION ME, V3; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; DUNN LC, 1945, P NATL ACAD SCI USA, V31, P343, DOI 10.1073/pnas.31.11.343; EICHER EM, 1969, GENETICS, V64, P495; EICHER EM, 1977, MOUSE NEWS LETT, V56, P42; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Feng LJ, 2002, BLOOD, V99, P1651, DOI 10.1182/blood.V99.5.1651.h8001651_1651_1658; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huizing M, 2001, THROMB HAEMOSTASIS, V86, P233, DOI 10.1055/s-0037-1616221; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lee ST, 1995, MOL CELLS, V5, P668; MEISLER MH, 1984, J HERED, V75, P103, DOI 10.1093/oxfordjournals.jhered.a109881; MOORE KJ, 1990, GENETICS, V125, P421; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; NOVAK EK, 1984, BLOOD, V63, P536; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; NOVAK EK, 1980, BIOCHEM GENET, V18, P549, DOI 10.1007/BF00484401; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; OBRIEN EP, 1994, MAMM GENOME, V5, P356, DOI 10.1007/BF00356554; Oh J, 2000, HUM MOL GENET, V9, P375, DOI 10.1093/hmg/9.3.375; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; RUSSELL LB, 1995, GENETICS, V141, P1547; SILVERS WK, 1979, COAT COLORS MICE MOD, P103; Spritz RA, 1999, CLIN GENET, V55, P309, DOI 10.1034/j.1399-0004.1999.550503.x; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SUZUKI T, IN PRESS P NATL ACAD; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Swank RT, 2000, PIGM CELL RES, V13, P59, DOI 10.1034/j.1600-0749.13.s8.12.x; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wixler V, 1999, FEBS LETT, V445, P351, DOI 10.1016/S0014-5793(99)00151-9; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; [No title captured]	42	137	146	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					145	153		10.1038/ng1087	http://dx.doi.org/10.1038/ng1087			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12548288				2022-12-27	WOS:000180773700011
J	Chung, CH; Bernard, PS; Perou, CM				Chung, CH; Bernard, PS; Perou, CM			Molecular portraits and the family tree of cancer	NATURE GENETICS			English	Review							GENE-EXPRESSION PATTERNS; BREAST-CANCER; PROSTATE-CANCER; CARCINOMAS; PROFILES; CLASSIFICATION; ADENOCARCINOMA; SUBCLASSES; MICROARRAY; TARGETS	The twenty-first century heralds a new era for the biological sciences and medicine. The tools of our time are allowing us to analyze complex genomes more comprehensively than ever before. A principal technology contributing to this explosion of information is the DNA microarray, which enables us to study genome-wide expression patterns in complex biological systems. Although the potential of microarrays is yet to be fully realized, these tools have shown great promise in deciphering complex diseases such as cancer. The early results are painting a detailed portrait of cancer that illustrates the individuality of each tumor and allows familial relationships to be recognized through the identification of cell types sharing common expression patterns.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27599 USA; Univ Utah, Huntsman Canc Inst, Dept Pathol, Salt Lake City, UT 84112 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Perou, CM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, CB 7295, Chapel Hill, NC 27599 USA.		Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124122; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gruvberger S, 2001, CANCER RES, V61, P5979; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hippo Y, 2002, CANCER RES, V62, P233; Hofmann WK, 2002, LANCET, V359, P481, DOI 10.1016/S0140-6736(02)07678-X; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Jazaeri AA, 2002, JNCI-J NATL CANCER I, V94, P990, DOI 10.1093/jnci/94.13.990; LaTulippe E, 2002, CANCER RES, V62, P4499; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rickman DS, 2001, CANCER RES, V61, P6885; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su AI, 2001, CANCER RES, V61, P7388; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang K, 1999, GENE, V229, P101, DOI 10.1016/S0378-1119(99)00035-9; Welsh JB, 2001, CANCER RES, V61, P5974; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wigle DA, 2002, CANCER RES, V62, P3005; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zou TT, 2002, ONCOGENE, V21, P4855, DOI 10.1038/sj.onc.1205613	50	211	223	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			533	540		10.1038/ng1038	http://dx.doi.org/10.1038/ng1038			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454650				2022-12-27	WOS:000179742900015
J	Ostertag, EM; DeBerardinis, RJ; Goodier, JL; Zhang, Y; Yang, N; Gerton, GL; Kazazian, HH				Ostertag, EM; DeBerardinis, RJ; Goodier, JL; Zhang, Y; Yang, N; Gerton, GL; Kazazian, HH			A mouse model of human L1 retrotransposition	NATURE GENETICS			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; SPERMATOGENIC CELLS; CULTURED-CELLS; LINE-1; GENE; EXPRESSION; ELEMENTS; SPECIFICITY; SEQUENCE; PROTEIN	The L1 retrotransposon has had an immense impact on the size and structure of the human genome through a variety of mechanisms, including insertional mutagenesis(1,2). To study retrotransposition in a living organism, we created a mouse model of human L1 retrotransposition. Here we show that L1 elements can retrotranspose in male germ cells, and that expression of a human L1 element under the control of its endogenous promoter is restricted to testis and ovary. In the mouse line with the highest level of L1 expression, we found two de novo L1 insertions in 135 offspring. Both insertions were structurally indistinguishable from natural endogenous insertions. This suggests that an individual L1 element can have substantial mutagenic potential. In addition to providing a valuable in vivo model of retrotransposition in mammals, these mice are an important step in the development of a new random mutagenesis system.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Kazazian, HH (corresponding author), Univ Penn, Sch Med, Dept Genet, 475 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	kazazian@mail.med.upenn.edu	Gerton, George L/A-1039-2007	Gerton, George L/0000-0001-9894-5640				Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; FANNING T, 1987, NUCLEIC ACIDS RES, V15, P2251, DOI 10.1093/nar/15.5.2251; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; PADGETT RW, 1988, NUCLEIC ACIDS RES, V16, P739, DOI 10.1093/nar/16.2.739; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869	30	153	156	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					655	660		10.1038/ng1022	http://dx.doi.org/10.1038/ng1022			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12415270				2022-12-27	WOS:000179593000020
J	Harroch, S; Furtado, GC; Brueck, W; Rosenbluth, J; Lafaille, J; Chao, M; Buxbaum, JD; Schlessinger, J				Harroch, S; Furtado, GC; Brueck, W; Rosenbluth, J; Lafaille, J; Chao, M; Buxbaum, JD; Schlessinger, J			A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions	NATURE GENETICS			English	Article							MICE LACKING; RAT-BRAIN; RPTP-BETA; OLIGODENDROCYTE; DIFFERENTIATION; MYELINATION; SIGMA; GENE	Several lines of evidence suggest that tyrosine phosphorylation is a key element in myelin formation, differentiation of oligodendrocytes and Schwann cells, and recovery from demyelinating lesions(1-7). Multiple sclerosis is a demyelinating disease of the human central nervous system, and studies of experimental demyelination indicate that remyelination in vivo requires the local generation(8), migration or maturation 9 of new oligodendrocytes, or some combination of these. Failure of remyelination in multiple sclerosis could result from the failure of any of these processes or from the death of oligodendrocytes. Ptprz encodes protein tyrosine phosphatase receptor type Z (Ptpz, also designated Rptpbeta), which is expressed primarily in the nervous system but also in oligodendrocytes(10,11), astrocytes and neurons(12). Here we examine the susceptibility of mice deficient in Ptprz to experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. We observe that mice deficient in Ptprz show impaired recovery from EAE induced by myelin oligodendrocyte glycoprotein (MOG) peptide. This sustained paralysis is associated with increased apoptosis of mature oligodendrocytes in the spinal cords of mutant mice at the peak of inflammation. We further demonstrate that expression of PTPRZ1, the human homolog of Ptprz, is induced in multiple sclerosis lesions and that the gene is specifically expressed in remyelinating oligodendrocytes in these lesions. These results support a role for Ptprz in oligodendrocyte survival and in recovery from demyelinating disease.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; NYU, Med Ctr, Skirball Inst, New York, NY 10016 USA; Dept Neuropathol, Charite, Berlin, Germany; NYU, Med Ctr, Dept Physiol & Neurosci, New York, NY 10016 USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; Mt Sinai Sch Med, Dept Neurobiol, New York, NY USA	Yale University; New York University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Harroch, S (corresponding author), Inst Pasteur, Unite Neurovirol & Regenerscence Syst Nerveux, 25 Rue Dr Roux, F-75724 Paris 15, France.		Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313; Chao, Moses/0000-0002-6969-3744				BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Fernandez PA, 2000, NEURON, V28, P81, DOI 10.1016/S0896-6273(00)00087-8; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Liu X, 1998, GLIA, V24, P390, DOI 10.1002/(SICI)1098-1136(199812)24:4<390::AID-GLIA4>3.0.CO;2-1; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Raine CS, 1997, J NEUROIMMUNOL, V77, P135, DOI 10.1016/S0165-5728(97)00073-8; Ranjan M, 1996, MOL CELL NEUROSCI, V7, P404, DOI 10.1006/mcne.1996.0029; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Umemori H, 1999, J NEUROSCI, V19, P1393; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866	17	114	119	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					411	414		10.1038/ng1004	http://dx.doi.org/10.1038/ng1004			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12355066				2022-12-27	WOS:000179034800018
J	Martin, N; Jaubert, J; Gounon, P; Salido, E; Haase, G; Szatanik, M; Guenet, JL				Martin, N; Jaubert, J; Gounon, P; Salido, E; Haase, G; Szatanik, M; Guenet, JL			A missense mutation in Tbce causes progressive motor neuronopathy in mice	NATURE GENETICS			English	Article							FISSION YEAST; TUBULIN; PROTEINS; DYNAMICS	Mice that are homozygous with respect to the progressive motor neuronopathy (pmn) mutation (chromosome 13) develop a progressive caudio-cranial degeneration of their motor axons from the age of two weeks and die four to six weeks after birth(1). The mutation is fully penetrant, and expressivity does not depend on the genetic background. Based on its pathological features, the pmn mutation has been considered an excellent model for the autosomal recessive proximal childhood form of spinal muscular atrophy (SMA). Previously, we demonstrated that the genes responsible for these disorders were not orthologous(2,3). Here, we identify the pmn mutation as resulting in a Trp524Gly substitution at the last residue of the tubulin-specific chaperone e (Tbce) protein that leads to decreased protein stability. Electron microscopy of the sciatic and phrenic nerves of affected mice showed a reduced number of microtubules, probably due to defective stabilization. Transgenic complementation with a wildtype Tbce cDNA restored a normal phenotype in mutant mice. Our observations indicate that Tbce is critical for the maintenance of microtubules in mouse motor axons, and suggest that altered function of tubulin cofactors might be implicated in human motor neuron diseases.	Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; Inst Pasteur, Stn Cent Microscopie Elect, Paris, France; Hosp Univ Canarias, Unidad Invest, Tenerife, Spain; Univ Mediterranee, INSERM, CNRS, Inst Biol Dev Marseille, Marseille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidad de la Laguna; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Guenet, JL (corresponding author), Inst Pasteur, Unite Genet Mammiferes, 25 Rue Dr Roux, F-75724 Paris, France.		Salido, Eduardo C/I-2232-2015	Salido, Eduardo C/0000-0001-9599-9854				BRUNIALTI ALB, 1995, GENOMICS, V29, P131, DOI 10.1006/geno.1995.1223; Fleming JA, 2000, GENETICS, V156, P69; Grishchuk EL, 1999, J CELL SCI, V112, P1979; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hoyt MA, 1997, GENETICS, V146, P849; Hunter AW, 2000, J CELL SCI, V113, P4379; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Martin N, 2001, GENOMICS, V75, P9, DOI 10.1006/geno.2001.6595; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; Parvari R, 2002, NAT GENET, V32, P448, DOI 10.1038/ng1012; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Viollet L, 1997, GENOMICS, V40, P185, DOI 10.1006/geno.1996.4551	15	130	133	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					443	447		10.1038/ng1016	http://dx.doi.org/10.1038/ng1016			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12389029				2022-12-27	WOS:000179034800024
J	Guillon, H; de Massy, B				Guillon, H; de Massy, B			An initiation site for meiotic crossing-over and gene conversion in the mouse	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SACCHAROMYCES-CEREVISIAE; RECOMBINATION HOTSPOT; CHROMOSOMES; SEQUENCE; MEIOSIS; REPAIR; LOCUS; MLH1	During meiosis, the reductional segregation of homologous chromosomes at the first meiotic division requires reciprocal exchange (crossing over) between homologs(1). The number of crossovers is tightly regulated (one to two per homolog in mice 2), and their distribution in the genome is not random-recombination 'hot' and 'cold' regions can be identified(3,4). We developed a molecular assay to study these events directly in mouse germ cells. This analysis was developed with reference to the proteosome subunit beta type 9 (Psmb9, previously called Lmp2) hot-spot region identified through genetic analysis(5,6). Here we show that this hot spot is an initiation site of meiotic recombination on the basis of two observations: (i) crossover density is maximal in an interval of 210 bp and decreases on both sides of this region; (ii) a high frequency of gene conversion is found in the region of highest crossover density. We then used this strategy to carry out the first temporal analysis of meiotic recombination in mouse spermatogenesis and demonstrate that crossover events occur during the pachytene stage of meiotic prophase.	Inst Genet Humaine, CNRS, UPR 1142, F-34396 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	de Massy, B (corresponding author), Inst Genet Humaine, CNRS, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 05, France.							Anderson LK, 1999, GENETICS, V151, P1569; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BORTS RH, 1989, GENETICS, V123, P69; Cobb J, 1999, DEV BIOL, V205, P49, DOI 10.1006/dbio.1998.9101; DETLOFF P, 1992, GENETICS, V132, P113; GOETZ P, 1984, J CELL SCI, V65, P249; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; LAWRIE NM, 1995, CHROMOSOMA, V104, P308, DOI 10.1007/BF00352262; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Mizuno K, 1996, MAMM GENOME, V7, P490, DOI 10.1007/s003359900149; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SCHULTES NP, 1990, GENETICS, V126, P813; SHIROISHI T, 1990, IMMUNOGENETICS, V31, P79, DOI 10.1007/BF00661217; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; SHIROISHI T, 1995, ADV BIOPHYS, V31, P119, DOI 10.1016/0065-227X(95)99387-5; SYMINGTON LS, 1991, GENETICS, V128, P717; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8	21	75	76	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					296	299		10.1038/ng990	http://dx.doi.org/10.1038/ng990			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12244318				2022-12-27	WOS:000178311100020
J	Lee, JT				Lee, JT			Homozygous Tsix mutant mice reveal a sex-ratio distortion and revert to random X-inactivation	NATURE GENETICS			English	Article							ENHANCER-BLOCKING ACTIVITY; XIST GENE; CHROMOSOME INACTIVATION; MOUSE; CTCF; METHYLATION; EXPRESSION; TRANSCRIPTION; ANTISENSE; MUTATION	Tsix(1) controls X-chromosome inactivation (XCI) by blocking the accumulation of Xist(2-4) RNA on the future active X chromosome(5-7). Deleting Tsix on one X chromosome ((XX)-X-Delta) skews XCI toward the mutated X chromosome in the female soma. Here 1 have generated homozygous Tsix-null mice ((XXDelta)-X-Delta) to test how deleting the second allele affects the choice of XCI. Homozygosity leads to extremely low fertility and reveals two previously unknown non-mendelian patterns of inheritance. First, the sex ratio is skewed against female births so that one daughter is born for every two to three sons: Second, the pattern of XCI unexpectedly returns to random in surviving (XXDelta)-X-Delta mice. Thus, with respect to choice, mutation of Tsix yields a phenotypic abnormality in heterozygotes but not homozygotes. To reconcile the paradox of female loss with apparent reversion to random choice, I propose that deleting both Tsix alleles results In chaotic choice and that randomness in (XXDelta)-X-Delta survivors reflects a fortuitous selection of distinct X chromosomes as active and inactive.	Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@frodo.mgh.harvard.edu						Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; deVillena FPM, 1997, MAMM GENOME, V8, P642, DOI 10.1007/s003359900529; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Percec I, 2002, SCIENCE, V296, P1136, DOI 10.1126/science.1070087; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Sado T, 2001, DEVELOPMENT, V128, P1275; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0	30	65	75	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					195	200		10.1038/ng939	http://dx.doi.org/10.1038/ng939			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12145659				2022-12-27	WOS:000177714900022
J	Yokoi, N; Komeda, K; Wang, HY; Yano, H; Kitada, K; Saitoh, Y; Seino, Y; Yasuda, K; Serikawa, T; Seino, S				Yokoi, N; Komeda, K; Wang, HY; Yano, H; Kitada, K; Saitoh, Y; Seino, Y; Yasuda, K; Serikawa, T; Seino, S			Cblb is a major susceptibility gene for rat type 1 diabetes mellitus	NATURE GENETICS			English	Article							AUTOIMMUNE THYROID-DISEASE; NEGATIVE REGULATOR; C-CBL; PROTEIN; KINASE; IDDM; ACTIVATION; CLONING; PRONE; MOUSE	The autoimmune disease type 1 diabetes mellitus (insulin-dependent diabetes mellitus, IDDM) has a multifactorial etiology. So far, the major histocompatibility complex (MHC) is the only major susceptibility locus that has been identified for this disease 1 and its animal models(2,3). The Komeda diabetes-prone (KDP) rat is a spontaneous animal model of human type 1 diabetes 4 in which the major susceptibility locus Iddm/kdp1 accounts, in combination with MHC, for most of the genetic predisposition to diabetes(5). Here we report the positional cloning of Iddm/kdp1 and identify a nonsense mutation in Cblb, a member of the Cbl/Sli family of ubiquitin-protein ligases(6,7). Lymphocytes of the KDP rat infiltrate into pancreatic islets and several tissues including thyroid gland and kidney, indicating autoimmunity. Similar findings in Cblb-deficient mice are caused by enhanced T-cell activation(8,9). Transgenic complementation with wildtype Cblb significantly suppresses development of the KDP phenotype. Thus, Cblb functions as a negative regulator of autoimmunity and Cblb is a major susceptibility gene for type 1 diabetes in the rat. Impairment of the Cblb signaling pathway may contribute to human autoimmune diseases, including type 1 diabetes.	Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; Chiba Univ, Sch Med, Dept Med Genet, Novo Nordisk Pharma,Chuo Ku, Chiba 2608670, Japan; Tokyo Med Unig, Div Lab Anim Sci, Ctr Anim Res, Shinjuku Ku, Tokyo, Japan; Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 606, Japan; Tokyo Med Univ, Dept Internal Med 3, Shinjuku Ku, Tokyo, Japan; Kyoto Univ, Grad Sch Med, Dept Metab & Clin Nutr, Sakyo Ku, Kyoto, Japan; Int Med Ctr Japan, Dept Metab Disorder, Inst Res, Shinjuku Ku, Tokyo, Japan	Chiba University; Chiba University; Novo Nordisk; Kyoto University; Tokyo Medical University; Kyoto University; National Center for Global Health & Medicine - Japan	Seino, S (corresponding author), Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.							Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; BOWEN MA, 1995, J EXP MED, V181, P2213, DOI 10.1084/jem.181.6.2213; Bustelo XR, 1997, ONCOGENE, V15, P2511, DOI 10.1038/sj.onc.1201430; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; CHIKUBA N, 1992, INTERNAL MED, V31, P1076, DOI 10.2169/internalmedicine.31.1076; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Ellerman KE, 2000, DIABETOLOGIA, V43, P890, DOI 10.1007/s001250051466; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; KAWANO K, 1991, DIABETES, V40, P1375, DOI 10.2337/diabetes.40.11.1375; KEANE MM, 1995, ONCOGENE, V10, P2367; Komeda K, 1998, ENDOCR J, V45, P737, DOI 10.1507/endocrj.45.737; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Lorini R, 1996, J PEDIATR ENDOCR MET, V9, P89; Nepom GT, 1998, DIABETES, V47, P1177, DOI 10.2337/diabetes.47.8.1177; NISHI M, 1988, NATURE, V331, P267, DOI 10.1038/331267a0; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Yokoi N, 1997, J CLIN INVEST, V100, P2015, DOI 10.1172/JCI119733	21	149	158	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					391	394		10.1038/ng927	http://dx.doi.org/10.1038/ng927			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12118252				2022-12-27	WOS:000177147100014
J	Suzuki, H; Watkins, DN; Jair, KW; Schuebel, KE; Markowitz, SD; Chen, WD; Pretlow, TP; Bin Yang,; Akiyama, Y; van Engeland, M; Toyota, M; Tokino, T; Hinoda, Y; Imai, K; Herman, JG; Baylin, SB				Suzuki, H; Watkins, DN; Jair, KW; Schuebel, KE; Markowitz, SD; Chen, WD; Pretlow, TP; Bin Yang,; Akiyama, Y; van Engeland, M; Toyota, M; Tokino, T; Hinoda, Y; Imai, K; Herman, JG; Baylin, SB			Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer	NATURE GENETICS			English	Article							FRIZZLED-RELATED PROTEIN; BETA-CATENIN; COLON-CARCINOMA; APC; EXPRESSION; IDENTIFICATION; INHIBITION; ANTAGONIST; ACTIVATION; MUTATIONS	Aberrant WNT pathway signaling is an early progression event in 90% of colorectal cancers(1). It occurs through mutations mainly of APC and less often of CTNNB1 (encoding beta-catenin)(1-3) or AXIN2 (encoding axin-2, also known as conductin)(4). These mutations allow ligand-independent WNT signaling that culminates in abnormal accumulation of free beta-catenin in the nucleus(1-3). We previously identified frequent promoter hypermethylation and gene silencing of the genes encoding secreted frizzled-related proteins (SFRPs) in colorectal cancer(5). SFRPs possess a domain similar to one in the WNT-receptor frizzled proteins and can inhibit WNT receptor binding to downregulate pathway signaling during development(6-10). Here we show that restoration of SFRP function in colorectal cancer cells attenuates WNT signaling even in the presence of downstream mutations. We also show that the epigenetic loss of SFRP function occurs early in colorectal cancer progression and may thus provide constitutive WNT signaling that is required to complement downstream mutations in the evolution of colorectal cancer.	Johns Hopkins Med Inst, Div Tumor Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido, Japan; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; Univ Maastricht, Dept Pathol, NL-6200 MC Maastricht, Netherlands; Sapporo Med Univ, Dept Mol Biol, Inst Canc Res, Sapporo, Hokkaido, Japan; JST, PRESTO, Kawaguchi, Japan; Yamaguchi Univ, Dept Clin Lab Sci, Sch Med, Yamaguchi, Japan; Howard Hughes Med Inst, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins Medicine; Sapporo Medical University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Maastricht University; Sapporo Medical University; Japan Science & Technology Agency (JST); Yamaguchi University; Howard Hughes Medical Institute	Baylin, SB (corresponding author), Johns Hopkins Med Inst, Div Tumor Biol, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu	van Engeland, Manon/A-7479-2009; CHEN, WEI-DONG/F-4521-2014; Watkins, David N/I-6113-2013; Tokino, Takashi/AAI-9887-2021	van Engeland, Manon/0000-0002-7952-6843; CHEN, WEI-DONG/0000-0003-2264-5515; 				Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Chang JHT, 1999, HUM MOL GENET, V8, P575, DOI 10.1093/hmg/8.4.575; Cong F, 2003, MOL CELL BIOL, V23, P8462, DOI 10.1128/MCB.23.23.8462-8470.2003; Dennis S, 1999, J CELL SCI, V112, P3815; Dimitriadis A, 2001, CANCER LETT, V166, P185, DOI 10.1016/S0304-3835(01)00428-1; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; JEN J, 1994, CANCER RES, V54, P5523; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rhee CS, 2002, ONCOGENE, V21, P6598, DOI 10.1038/sj.onc.1205920; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Siu IM, 1999, CANCER RES, V59, P63; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Xu QH, 1998, DEVELOPMENT, V125, P4767	30	862	919	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					417	422		10.1038/ng1330	http://dx.doi.org/10.1038/ng1330			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15034581	Bronze			2022-12-27	WOS:000220647200028
J	Watts, GDJ; Wymer, J; Kovach, MJ; Mehta, SG; Mumm, S; Darvish, D; Pestronk, A; Whyte, MP; Kimonis, VE				Watts, GDJ; Wymer, J; Kovach, MJ; Mehta, SG; Mumm, S; Darvish, D; Pestronk, A; Whyte, MP; Kimonis, VE			Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein	NATURE GENETICS			English	Article							AAA-ATPASE P97; ENDOPLASMIC-RETICULUM; UBIQUITIN; GENE; CHAPERONE; DISORDERS; MUTATIONS; PATHWAYS; FAMILY; DOMAIN	Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD) is a dominant progressive disorder that maps to chromosome 9p21.1-p12. We investigated 13 families with IBMPFD linked to chromosome 9 using a candidate-gene approach. We found six missense mutations in the gene encoding valosin-containing protein (VCP, a member of the AAA-ATPase superfamily) exclusively in all 61 affected individuals. Haplotype analysis indicated that descent from two founders in two separate North American kindreds accounted for IBMPFD in similar to 50% of affected families. VCP is associated with a variety of cellular activities, including cell cycle control, membrane fusion and the ubiquitin-proteasome degradation pathway. Identification of VCP as causing IBMPFD has important implications for other inclusion-body diseases, including myopathies, dementias and Paget disease of bone (PDB), as it may define a new common pathological ubiquitin-based pathway.	Harvard Univ, Childrens Hosp Boston, Div Genet, Sch Med, Boston, MA 02115 USA; Univ Tennessee, Dept Biol & Environm Sci, Chattanooga, TN USA; Univ Washington, Barnes Jewish Hosp, Div Bone & Mineral Dis, Sch Med, St Louis, MO USA; Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA; HIBM, Res Grp, Encino, CA USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Tennessee System; University of Tennessee at Chattanooga; Barnes-Jewish Hospital; Washington University (WUSTL); Washington University (WUSTL)	Kimonis, VE (corresponding author), Harvard Univ, Childrens Hosp Boston, Div Genet, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	virginia.kimonis@childrens.harvard.edu						Beyer A, 1997, PROTEIN SCI, V6, P2043; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; WANG Q, 2003, J STRUCT BIOL   1219; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Wood JD, 2003, NEUROPATH APPL NEURO, V29, P529, DOI 10.1046/j.0305-1846.2003.00518.x; YABE H, 1986, 8 ANN M AM SOC BON M, pA221; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	29	992	1025	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					377	381		10.1038/ng1332	http://dx.doi.org/10.1038/ng1332			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15034582	Green Published, Bronze			2022-12-27	WOS:000220647200021
J	van den Brink, GR; Bleuming, SA; Hardwick, JCH; Schepman, BL; Offerhaus, GJ; Keller, JJ; Nielsen, C; Gaffield, W; van Deventer, SJH; Roberts, DJ; Peppelenbosch, MP				van den Brink, GR; Bleuming, SA; Hardwick, JCH; Schepman, BL; Offerhaus, GJ; Keller, JJ; Nielsen, C; Gaffield, W; van Deventer, SJH; Roberts, DJ; Peppelenbosch, MP			Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation	NATURE GENETICS			English	Article							INTESTINAL TREFOIL FACTOR; COLORECTAL-CANCER; EXPRESSION; INHIBITION; CARCINOMA; BUTYRATE; COMPLEX; CULTURE; GROWTH; VILLIN	Wnt signaling defines the colonic epithelial progenitor cell phenotype(1), and mutations in the gene adenomatous polyposis coli (APC) that activate the Wnt pathway cause the familial adenomatous polyposis coli (FAP) syndrome and most sporadic colon cancers(2). The mechanisms that regulate the transition of epithelial precursor cells into their differentiated derivatives are poorly characterized. We report that Indian hedgehog (Ihh) is expressed by mature colonocytes and regulates their differentiation in vitro and in vivo. Hedgehog (Hh) signaling restricts the expression of Wnt targets to the base of the colonic crypt in vivo, and transfection of Ihh into colon cancer cells leads to a downregulation of both components of the nuclear TCF4-beta-catenin complex and abrogates endogenous Wnt signaling in vitro. In turn, expression of Ihh is downregulated in polyps of individuals with FAP and expression of doxycycline-inducible dominant negative TCF4 (dnTCF4) restores Ihh expression in APC mutant DLD-1 colon cancer cells. These data identify a new Wnt-Hh axis in colonic epithelial renewal.	Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; ARS, Western Reg Res Ctr, USDA, Albany, CA USA; Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Massachusetts General Hospital; United States Department of Agriculture (USDA); University of Amsterdam; Academic Medical Center Amsterdam	van den Brink, GR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.r.vandenbrink@amc.uva.nl	Roberts, Drucilla/AAB-6379-2022; Hardwick, James/J-4862-2013	Peppelenbosch, Maikel/0000-0001-9112-6028; Hardwick, James/0000-0002-9575-5099				Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; AUGERON C, 1984, CANCER RES, V44, P3961; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boon EMJ, 2002, CANCER RES, V62, P5126; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Hao XP, 2001, CANCER RES, V61, P8085; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; PRINGAULT E, 1986, EMBO J, V5, P3119, DOI 10.1002/j.1460-2075.1986.tb04618.x; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Taupin D, 1996, LAB INVEST, V75, P25; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; van den Brink GR, 2002, GUT, V51, P628, DOI 10.1136/gut.51.5.628; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0	21	295	302	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2004	36	3					277	282		10.1038/ng1304	http://dx.doi.org/10.1038/ng1304			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14770182	Bronze			2022-12-27	WOS:000189250400017
J	Yu, H; Ito, T; Wellmer, F; Meyerowitz, EM				Yu, H; Ito, T; Wellmer, F; Meyerowitz, EM			Repression of AGAMOUS-LIKE 24 is a crucial step in promoting flower development	NATURE GENETICS			English	Article							FLORAL MERISTEM IDENTITY; HOMEOTIC GENES; INFLORESCENCE DEVELOPMENT; ARABIDOPSIS-THALIANA; LEAFY; APETALA1; ARCHITECTURE; ACTIVATION; REGULATOR	Flower development begins as floral meristems arise in succession on the flank of the inflorescence meristem. Floral meristem identity genes LEAFY (LFY) and APETALA1 (AP1) promote establishment and maintenance of floral identity in newly formed floral primordia(1-9). Without their activity, the floral primordia develop with inflorescence characteristics. The underlying molecular-genetic mechanism is unknown. Here we show that these phenotypes are due in large part to the ectopic expression of AGAMOUS-LIKE 24 (AGL24), a central regulator of floral meristem identity. We present evidence that AGL24 is an early target of transcriptional repression by LFY and AP1. Without such repression, continued AGL24 expression in floral meristems is sufficient to cause floral reversion regardless of the activation of floral organ identity genes. This indicates that LFY and AP1 promote floral development not only by positively regulating genes activated in flower development, but also by repressing AGL24, a promoter of inflorescence fate.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore	California Institute of Technology; National University of Singapore	Meyerowitz, EM (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	meyerow@its.caltech.edu	Yu, Hao/A-3867-2010; Meyerowitz, Elliot M/A-7118-2009	Yu, Hao/0000-0002-9778-8855; Wellmer, Frank/0000-0002-2095-0981; Ito, Toshiro/0000-0002-8206-2787				Blazquez MA, 1997, DEVELOPMENT, V124, P3835; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; CLARK SE, 1993, DEVELOPMENT, V119, P397; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Long JA, 1998, DEVELOPMENT, V125, P3027; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Mizukami Y, 1997, PLANT CELL, V9, P393, DOI 10.1105/tpc.9.3.393; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; OKAMURO JK, 1993, PLANT CELL, V5, P1183, DOI 10.1105/tpc.5.10.1183; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Parcy F, 2002, DEVELOPMENT, V129, P2519; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; SHANNON S, 1993, PLANT CELL, V5, P639, DOI 10.1105/tpc.5.6.639; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Yu Hao, 2002, Proceedings of the National Academy of Sciences of the United States of America, V99, P16336, DOI 10.1073/pnas.212624599	30	196	217	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					157	161		10.1038/ng1286	http://dx.doi.org/10.1038/ng1286			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14716314	Bronze			2022-12-27	WOS:000188542700017
J	Li, W; Zhang, Q; Oiso, N; Novak, EK; Gautam, R; O'Brien, EP; Tinsley, CL; Blake, DJ; Spritz, RA; Copeland, NG; Jenkins, NA; Amato, D; Roe, BA; Starcevic, M; Dell'Angelica, EC; Elliott, RW; Mishra, V; Kingsmore, SF; Paylor, RE; Swank, RT				Li, W; Zhang, Q; Oiso, N; Novak, EK; Gautam, R; O'Brien, EP; Tinsley, CL; Blake, DJ; Spritz, RA; Copeland, NG; Jenkins, NA; Amato, D; Roe, BA; Starcevic, M; Dell'Angelica, EC; Elliott, RW; Mishra, V; Kingsmore, SF; Paylor, RE; Swank, RT			Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)	NATURE GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; STORAGE POOL DEFICIENCY; PLATELET-DENSE GRANULES; GENETIC-VARIATION; MOUSE MODEL; 6P22.3 GENE; MUTATION; PROTEIN; HOMOLOG; TRAFFICKING	Hermansky-Pudlak syndrome (HPS; MIM 203300) is a genetically heterogeneous disorder characterized by oculocutaneous albinism, prolonged bleeding and pulmonary fibrosis due to abnormal vesicle trafficking to lysosomes and related organelles, such as melanosomes and platelet dense granules(1-3). In mice, at least 16 loci are associated with HPS4-6, including sandy (sdy; ref. 7). Here we show that the sdy mutant mouse expresses no dysbindin protein owing to a deletion in the gene Dtnbp1 (encoding dysbindin) and that mutation of the human ortholog DTNBP1 causes a novel form of HPS called HPS-7. Dysbindin is a ubiquitously expressed protein that binds to alpha- and beta-dystrobrevins, components of the dystrophin-associated protein complex (DPC) in both muscle and nonmuscle cells(8). We also show that dysbindin is a component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1; refs. 9-11), which regulates trafficking to lysosome-related organelles and includes the proteins pallidin, muted and cappuccino, which are associated with HPS in mice. These findings show that BLOC-1 is important in producing the HPS phenotype in humans, indicate that dysbindin has a role in the biogenesis of lysosome-related organelles and identify unexpected interactions between components of DPC and BLOC-1.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Toronto, Dept Med, Div Hematol & Med Oncol, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA; Mol Staging, New Haven, CT 06511 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Roswell Park Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Florida; Baylor College of Medicine	Swank, RT (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.		Oiso, Naoki/H-6540-2019	Oiso, Naoki/0000-0001-5593-6496; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631	NHLBI NIH HHS [R01 HL068117] Funding Source: Medline; NIAID NIH HHS [P01 AI039824-050002, P01 AI039824] Funding Source: Medline; NICHD NIH HHS [U19 HD077693] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039824] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huizing M, 2001, THROMB HAEMOSTASIS, V86, P233, DOI 10.1055/s-0037-1616221; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Lee ST, 1995, MOL CELLS, V5, P668; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; REDDINGTON M, 1987, BLOOD, V69, P1300; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Spritz RA, 1999, TRENDS GENET, V15, P337, DOI 10.1016/S0168-9525(99)01785-0; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; [No title captured]	30	337	351	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					84	89		10.1038/ng1229	http://dx.doi.org/10.1038/ng1229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12923531	Green Accepted			2022-12-27	WOS:000185018500015
J	Haga, SB; Khoury, MJ; Burke, W				Haga, SB; Khoury, MJ; Burke, W			Genomic profiling to promote a healthy lifestyle: not ready for prime time	NATURE GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; RISK-FACTOR; COMMON MUTATION; VASCULAR-DISEASE; PHARMACOGENETICS; HOMOCYSTEINE; THERAPY; EPIDEMIOLOGY; GENOTYPE	Genomic profiling has the potential to usher in a revolution of personalized healthcare and disease prevention. But evidence to support genomic profiling is inconsistent, and data on the health outcome benefits based on such testing are lacking. For genomic profiling to become valid and useful, well designed epidemiologic studies and thorough clinical evaluations of recommended interventions based on genotype are required.	Ctr Advancement Genom, Rockville, MD 20850 USA; Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA 30333 USA; Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA	J. Craig Venter Institute; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle	Haga, SB (corresponding author), Ctr Advancement Genom, 1901 Res Blvd,6th Floor, Rockville, MD 20850 USA.	shaga@tcag.org						Ames BN, 1999, P NATL ACAD SCI USA, V96, P12216, DOI 10.1073/pnas.96.22.12216; Beutler E, 2001, BLOOD, V98, P2597, DOI 10.1182/blood.V98.9.2597; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Deloughery TG, 1996, CIRCULATION, V94, P3074, DOI 10.1161/01.CIR.94.12.3074; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Holtzman NA, 1997, PROMOTING SAFE EFFEC; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; KANG SS, 1991, AM J HUM GENET, V48, P536; Khoury MJ, 2002, AM J EPIDEMIOL, V156, P297, DOI 10.1093/aje/kwf053; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Krynetski EY, 1998, AM J HUM GENET, V63, P11, DOI 10.1086/301941; Krynetski EY, 1999, PHARM RES-DORDR, V16, P342, DOI 10.1023/A:1011909315614; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Marteau TM, 2001, BMJ-BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056; Mayor S, 2003, BRIT MED J, V327, P359, DOI 10.1136/bmj.327.7411.359; PINSKY L, IN PRESS HUMAN GENOM; Potter JD, 2001, NAT REV GENET, V2, P142, DOI 10.1038/35052575; RAMACHANDRAN S, 2003, JAMA-J AM MED ASSOC, V289, P1251; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; *SECR ADV COM GEN, 2000, ENH OV GEN TESTS REC; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; vanBockxmeer FM, 1997, CIRCULATION, V95, P21, DOI 10.1161/01.CIR.95.1.21; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003	35	115	116	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2003	34	4					347	350		10.1038/ng0803-347	http://dx.doi.org/10.1038/ng0803-347			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	706TE	12923535				2022-12-27	WOS:000184470500002
J	McGregor, L; Makela, V; Darling, SM; Vrontou, S; Chalepakis, G; Roberts, C; Smart, N; Rutland, P; Prescott, N; Hopkins, J; Bentley, E; Shaw, A; Roberts, E; Mueller, R; Jadeja, S; Philip, N; Nelson, J; Francannet, C; Perez-Aytes, A; Megarbane, A; Kerr, B; Wainwright, B; Woolf, AS; Winter, RM; Scambler, PJ				McGregor, L; Makela, V; Darling, SM; Vrontou, S; Chalepakis, G; Roberts, C; Smart, N; Rutland, P; Prescott, N; Hopkins, J; Bentley, E; Shaw, A; Roberts, E; Mueller, R; Jadeja, S; Philip, N; Nelson, J; Francannet, C; Perez-Aytes, A; Megarbane, A; Kerr, B; Wainwright, B; Woolf, AS; Winter, RM; Scambler, PJ			Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein	NATURE GENETICS			English	Article							RENAL DEVELOPMENT; DOMAINS; CRYPTOPHTHALMOS; MESENCHYME; BINDING; MODEL	Fraser syndrome (OMIM 219000) is a multisystem malformation usually comprising cryptophthalmos, syndactyly and renal defects(1). Here we report autozygosity mapping and show that the locus FS1 at chromosome 4q21 is associated with Fraser syndrome, although the condition is genetically heterogeneous. Mutation analysis identified five frameshift mutations in FRAS1, which encodes one member of a family of novel proteins related to an extracellular matrix (ECM) blastocoelar protein found in sea urchin. The FRAS1 protein contains a series of N-terminal cysteine-rich repeat motifs previously implicated in BMP metabolism, suggesting that it has a role in both structure and signal propagation in the ECM. It has been speculated that Fraser syndrome is a human equivalent of the blebbed phenotype in the mouse(2), which has been associated with mutations in at least five loci including bl(3). As mapping data were consistent with homology of FRAS1 and bl, we screened DNA from bl/bl mice and identified a premature termination of mouse Fras1. Thus, the bl mouse is a model for Fraser syndrome in humans, a disorder caused by disrupted epithelial integrity in utero.	Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Crete, Inst Mol Biol & Biotechnol, FORTH, Iraklion, Greece; Univ Crete, Dept Biol, Iraklion, Greece; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Hosp Enfants Timone, Marseille, France; King Edward Mem Hosp Women, Perth, WA, Australia; Ctr Hosp Univ, Clermont Ferrand, France; Hosp Infantil La Fe, Valencia, Spain; Univ St Joseph, Beirut, Lebanon; St Marys Hosp, Manchester M13 0JH, Lancs, England; Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London; University of London; University College London; University of Crete; University of Crete; Saint James's University Hospital; University of Leeds; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; King Edward Memorial Hospital; University of Western Australia; CHU Clermont Ferrand; Saint Joseph University Beirut; University of Manchester; University of Queensland; University of London; University College London	Scambler, PJ (corresponding author), Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.	pscamble@hgmp.mrc.ac.uk	Smart, Nicola/AAD-3874-2020; Scambler, Peter/AAZ-6026-2020; Megarbane, Andre/ABD-5574-2021; Philip, Nicole/I-2881-2016; Scambler, Peter J/C-4998-2008; Prescott, Natalie J/F-6490-2011; Smart, Nicola/AAN-4011-2020; Woolf, Adrian S./AAZ-1075-2020	Smart, Nicola/0000-0002-3501-7254; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Prescott, Natalie J/0000-0002-5901-7371; Woolf, Adrian S./0000-0001-5541-1358; Wainwright, Brandon/0000-0003-0406-2092; Perez-Aytes, Antonio/0000-0003-3401-6943				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arin MJ, 2001, TRENDS MOL MED, V7, P422, DOI 10.1016/S1471-4914(01)02095-0; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Carter T. C., 1959, Journal of Genetics, V56, P401, DOI 10.1007/BF02984794; Center EM, 1997, HISTOL HISTOPATHOL, V12, P901; Conley CA, 2000, DEVELOPMENT, V127, P3947; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Darling S, 1994, Clin Dysmorphol, V3, P91; Davies JA, 2002, EXP NEPHROL, V10, P102; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Dupe V, 1999, DEV BIOL, V208, P30, DOI 10.1006/dbio.1998.9176; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; Matsui M, 2000, P NATL ACAD SCI USA, V97, P5291, DOI 10.1073/pnas.090020497; Mellerio JE, 1999, CLIN EXP DERMATOL, V24, P25; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Nodder S, 1997, ANAT EMBRYOL, V195, P215, DOI 10.1007/s004290050041; ROBERTS C, 1991, DEVELOPMENT, V112, P959; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; SORENSON CM, 1995, AM J PHYSIOL-RENAL, V268, pF73, DOI 10.1152/ajprenal.1995.268.1.F73; THOMAS IT, 1986, AM J MED GENET, V25, P85, DOI 10.1002/ajmg.1320250111; TIDMAN MJ, 1984, J INVEST DERMATOL, V83, P448, DOI 10.1111/1523-1747.ep12273562; Warkany J, 1944, P SOC EXP BIOL MED, V57, P49, DOI 10.3181/00379727-57-14695P; WINTER RM, 1990, CLIN GENET, V37, P494; Winyard PJD, 1996, KIDNEY INT, V49, P135, DOI 10.1038/ki.1996.18	27	172	178	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					203	208		10.1038/ng1142	http://dx.doi.org/10.1038/ng1142			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12766769				2022-12-27	WOS:000183200500028
J	Nauli, SM; Alenghat, FJ; Luo, Y; Williams, E; Vassilev, P; Lil, XG; Elia, AEH; Lu, WN; Brown, EM; Quinn, SJ; Ingber, DE; Zhou, J				Nauli, SM; Alenghat, FJ; Luo, Y; Williams, E; Vassilev, P; Lil, XG; Elia, AEH; Lu, WN; Brown, EM; Quinn, SJ; Ingber, DE; Zhou, J			Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells	NATURE GENETICS			English	Article							SEQUENCE-ANALYSIS; CATION CHANNEL; MOUSE HOMOLOG; CYSTIC TISSUE; DISEASE GENE; PKD1 GENE; EXPRESSION; DEFECTS; PROTEIN; MICE	Several proteins implicated in the pathogenesis of polycystic kidney disease (PKD) localize to cilia. Furthermore, cilia are malformed in mice with PKD with mutations in TgN737Rpw (encoding polaris). It is not known, however, whether ciliary dysfunction occurs or is relevant to cyst formation in PKD. Here, we show that polycystin-1 (PC1) and polycystin-2 (PC2), proteins respectively encoded by Pkd1 and Pkd2, mouse orthologs of genes mutated in human autosomal dominant PKD, co-distribute in the primary cilia of kidney epithelium. Cells isolated from transgenic mice that lack functional PC1 formed cilia but did not increase Ca2+ influx in response to physiological fluid flow. Blocking antibodies directed against PC2 similarly abolished the flow response in wildtype cells as did inhibitors of the ryanodine receptor, whereas inhibitors of G-proteins, phospholipase C and InsP(3) receptors had no effect. These data suggest that PC1 and PC2 contribute to fluid-flow sensation by the primary cilium in renal epithelium and that they both function in the same mechanotransduction pathway. Loss or dysfunction of PC1 or PC2 may therefore lead to PKD owing to the inability of cells to sense mechanical cues that normally regulate tissue morphogenesis.	Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Vasc Biol Program, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Vasc Biol Program, Dept Surg, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Endocrine Hypertens, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Zhou, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, 4 Blackfan Circle, Boston, MA 02115 USA.		Alenghat, Francis/T-3059-2019; Ingber, Donald E/AAC-5894-2019	Alenghat, Francis/0000-0003-4151-9258; Lu, Weining/0000-0002-6570-3044				Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brueckner M, 2001, AM J MED GENET, V101, P339, DOI 10.1002/1096-8628(20010715)101:4<339::AID-AJMG1442>3.0.CO;2-P; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; CHOU CL, 1987, AM J PHYSIOL, V253, pF366, DOI 10.1152/ajprenal.1987.253.2.F366; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; DeMaria MA, 1997, CYTOMETRY, V29, P178; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lohning C, 1997, MAMM GENOME, V8, P307, DOI 10.1007/s003359900429; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Muto S, 2002, HUM MOL GENET, V11, P1731, DOI 10.1093/hmg/11.15.1731; Nauli SM, 2001, AM J PHYSIOL-CELL PH, V281, pC1785, DOI 10.1152/ajpcell.2001.281.6.C1785; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 1998, MAMM GENOME, V9, P749, DOI 10.1007/s003359900857; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Rossetti S, 2002, J AM SOC NEPHROL, V13, P1230, DOI 10.1097/01.ASN.0000013300.11876.37; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Stayner C, 2001, TRENDS PHARMACOL SCI, V22, P543, DOI 10.1016/S0165-6147(00)01832-0; TORRES VE, 1999, AM J KIDNEY DIS, V34; Tulis DA, 1998, AM J PHYSIOL-HEART C, V274, pH874, DOI 10.1152/ajpheart.1998.274.3.H874; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WATANABE M, 1981, J HISTOCHEM CYTOCHEM, V29, P779, DOI 10.1177/29.7.7053086; Weston BS, 1997, HISTOCHEM J, V29, P847, DOI 10.1023/A:1026489723733; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Wu GQ, 1997, GENOMICS, V45, P220, DOI 10.1006/geno.1997.4920; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	46	1490	1539	5	125	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					129	137		10.1038/ng1076	http://dx.doi.org/10.1038/ng1076			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12514735				2022-12-27	WOS:000180773700009
J	Fitzpatrick, GV; Soloway, PD; Higgins, MJ				Fitzpatrick, GV; Soloway, PD; Higgins, MJ			Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; GENE-CLUSTER; CONTROL ELEMENT; MOUSE MODEL; EXPRESSION; P57(KIP2); DISRUPTION; DOMAIN; IGF2; H19	Genomic imprinting is an epigenetic modification that results in expression from only one of the two parental copies of a gene. Differences in methylation between the two parental chromosomes are often observed at or near imprinted genes. Beckwith-Wiedemann syndrome (BWS), which predisposes to cancer and excessive growth, results from a disruption of imprinted gene expression in chromosome band 11p15.5. One third of individuals with BWS lose maternal-specific methylation at KvDMR1, a putative imprinting control region within intron 10 of the KCNQ1 gene(1-3), and it has been proposed that this epimutation results in aberrant imprinting and, consequently, BWS1,2. Here we show that paternal inheritance of a deletion of KvDMR1 results in the de-repression in cis of six genes, including Cdkn1c, which encodes cyclin-dependent kinase inhibitor 1C. Furthermore, fetuses and adult mice that inherited the deletion from their fathers were 20-25% smaller than their wildtype littermates. By contrast, maternal inheritance of this deletion had no effect on imprinted gene expression or growth. Thus, the unmethylated paternal KvDMR1 allele regulates imprinted expression by silencing genes on the paternal chromosome. These findings support the hypothesis that loss of methylation in BWS patients activates the repressive function of KvDMR1 on the maternal chromosome, resulting in abnormal silencing of CDKN1C and the development of BWS.	Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Higgins, MJ (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.		Soloway, Paul/T-8243-2019	Soloway, Paul/0000-0003-1967-0437				Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Cooper PR, 1998, GENOMICS, V49, P38, DOI 10.1006/geno.1998.5221; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Grandjean V, 2000, P NATL ACAD SCI USA, V97, P5279, DOI 10.1073/pnas.080409297; Hata K, 2002, DEVELOPMENT, V129, P1983; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Lee MP, 1999, HUM MOL GENET, V8, P683, DOI 10.1093/hmg/8.4.683; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Qian N, 1997, HUM MOL GENET, V6, P2021, DOI 10.1093/hmg/6.12.2021; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; SINGERSAM J, 1994, PCR METH APPL, V3, pS48; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Srivastava M, 2000, GENE DEV, V14, P1186; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	29	377	385	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					426	431		10.1038/ng988	http://dx.doi.org/10.1038/ng988			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12410230				2022-12-27	WOS:000179034800021
J	Oleksiak, MF; Churchill, GA; Crawford, DL				Oleksiak, MF; Churchill, GA; Crawford, DL			Variation in gene expression within and among natural populations	NATURE GENETICS			English	Article							FUNDULUS-HETEROCLITUS; CDNA MICROARRAY; PROMOTER; PATTERNS; VARIANCE; CANCER; SITE	Evolution may depend more strongly on variation in gene expression than on differences between variant forms of proteins(1). Regions of DNA that affect gene expression are highly variable, containing 0.6% polymorphic sites(2). These naturally occurring polymorphic nucleotides can alter in vivo transcription rates(3-7). Thus, one might expect substantial variation in gene expression between individuals. But the natural variation in mRNA expression for a large number of genes has not been measured. Here we report microarray studies addressing the variation in gene expression within and between natural populations of teleost fish of the genus Fundulus. We observed statistically significant differences in expression between individuals within the same population for approximately 18% of 907 genes. Expression typically differed by a factor of 1.5, and often more than 2.0. Differences between populations increased the variation. Much of the variation between populations was a positive function of the variation within populations and thus is most parsimoniously described as random. Some genes showed unexpected patterns of expression-changes unrelated to evolutionary distance. These data suggest that substantial natural variation exists in gene expression and that this quantitative variation is important in evolution.	Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University of Missouri System; University of Missouri Kansas City; Jackson Laboratory	Crawford, DL (corresponding author), Univ Missouri, Sch Biol Sci, 5007 Rockhill Rd, Kansas City, MO 64110 USA.		Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284; Crawford, Douglas/0000-0002-6239-4012				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; BEATY JS, 1995, MOL CELL BIOL, V15, P4771; BERNARDI G, 1995, COPEIA, P469; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BROWN BL, 1991, EVOLUTION, V45, P1147, DOI 10.1111/j.1558-5646.1991.tb04381.x; Cashner R.C., 1993, P421; Crawford DL, 1999, MOL BIOL EVOL, V16, P194, DOI 10.1093/oxfordjournals.molbev.a026102; CRAWFORD DL, 1989, P NATL ACAD SCI USA, V86, P9365, DOI 10.1073/pnas.86.23.9365; DeRisi J, 1996, NAT GENET, V14, P457; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kerr MK, 2001, GENET RES, V77, P123; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; Lau WY, 2000, ONCOL RES, V12, P59; Lewohl JM, 2001, J BIOMED SCI, V8, P28, DOI 10.1007/BF02255968; LOTRICH VA, 1975, ECOLOGY, V56, P191, DOI 10.2307/1935311; Nei M., 1987, MOL EVOLUTIONARY GEN; Oleksiak MF, 2001, MAR BIOTECHNOL, V3, pS203, DOI 10.1007/s10126-001-0043-0; Pierce VA, 1997, SCIENCE, V276, P256, DOI 10.1126/science.276.5310.256; Podrabsky JE, 2000, AM J PHYSIOL-REG I, V279, pR2344, DOI 10.1152/ajpregu.2000.279.6.R2344; Segal JA, 1999, J MOL EVOL, V49, P736, DOI 10.1007/PL00006596; Sokal R. R, 1981, BIOMETRY; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; WILEY EO, 1986, AM ZOOL, V26, P121	30	561	576	0	91	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					261	266		10.1038/ng983	http://dx.doi.org/10.1038/ng983			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12219088				2022-12-27	WOS:000178311100014
J	Ihmels, J; Friedlander, G; Bergmann, S; Sarig, O; Ziv, Y; Barkai, N				Ihmels, J; Friedlander, G; Bergmann, S; Sarig, O; Ziv, Y; Barkai, N			Revealing modular organization in the yeast transcriptional network	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CLUSTERING ANALYSIS; GENE-EXPRESSION; PROTEIN; PATTERNS; DATABASE	Standard clustering methods can classify genes successfully when applied to relatively small data sets, but have limited use in the analysis of large-scale expression data, mainly owing to their assignment of a gene to a single cluster. Here we propose an alternative method for the global analysis of genome-wide expression data. Our approach assigns genes to context-dependent and potentially overlapping 'transcription modules', thus overcoming the main limitations of traditional clustering methods. We use our method to elucidate regulatory properties of cellular pathways and to characterize cis-regulatory elements. By applying our algorithm systematically to all of the available expression data on Saccharomyces cerevisiae, we identify a comprehensive set of overlapping transcriptional modules. Our results provide functional predictions for numerous genes, identify relations between modules and present a global view on the transcriptional network.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il		Bergmann, Sven/0000-0002-6785-9034; Friedlander, Gerard/0000-0002-6854-4261				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bittner M, 1999, NAT GENET, V22, P213, DOI 10.1038/10265; Bojunga N, 1999, MOL GEN GENET, V262, P869, DOI 10.1007/s004380051152; Buscemi G, 2000, J CELL SCI, V113, P1199; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fikus MU, 2000, GENETICS, V154, P73; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Zimmerman ZA, 2001, MOL BIOL CELL, V12, P201, DOI 10.1091/mbc.12.1.201	16	539	555	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					370	377		10.1038/ng941	http://dx.doi.org/10.1038/ng941			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134151				2022-12-27	WOS:000177147100011
J	Jeffreys, AJ; Neumann, R				Jeffreys, AJ; Neumann, R			Reciprocal crossover asymmetry and meiotic drive in a human recombination hot spot	NATURE GENETICS			English	Article							DOUBLE-STRAND BREAKS; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II REGION; INITIATION SITE; SACCHAROMYCES-CEREVISIAE; GENE CONVERSION; YEAST; HOTSPOT; DNA; MEIOSIS	Human DNA diversity arises ultimately from germline mutation that creates new haplotypes that can be reshuffled by meiotic recombination. Reciprocal crossover generates recombinant haplotypes but should not influence the frequencies of alleles in a population. We demonstrate crossover asymmetry at a recombination hot spot in the major histocompatibility complex(1), whereby reciprocal exchanges in sperm map to different locations in the hot spot. We identify a single-nucleotide polymorphism at the center of the hot spot and show that, when heterozygous, it seems sufficient to cause this asymmetry, apparently by influencing the efficiency of highly localized crossover initiation. As a consequence, crossovers in heterozygotes are accompanied by biased gene conversion, most likely occurring by gap repair(2), that can also affect nearby polymorphisms through repair of an extended gap. The result is substantial over-transmission of the recombination-suppressing allele and neighboring markers to crossover products. Computer simulations show that this meiotic drive, although weak at the population level, is sufficient to favor eventual fixation of the recombination-suppressing variant. These findings provide an explanation for the relatively uniform widths of human crossover hot spots and suggest that hot spots may be generally prone to extinction by meiotic drive(3).	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.							ALANI E, 1994, GENETICS, V137, P19; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cullen M, 1997, AM J HUM GENET, V60, P397; DEMASSY B, 1995, EMBO J, V14, P4589, DOI 10.1002/j.1460-2075.1995.tb00138.x; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; LIU JH, 1995, EMBO J, V14, P4599, DOI 10.1002/j.1460-2075.1995.tb00139.x; Morton N. E., 1982, OUTLINE GENETIC EPID; Murray J, 1999, GENOME RES, V9, P130; Nasar F, 2000, MOL CELL BIOL, V20, P3449, DOI 10.1128/MCB.20.10.3449-3458.2000; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; NICOLAS A, 1994, EXPERIENTIA, V50, P242, DOI 10.1007/BF01924007; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; SCHULTES NP, 1990, GENETICS, V126, P813; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; ZIMMERING S, 1970, ANNU REV GENET, V4, P409, DOI 10.1146/annurev.ge.04.120170.002205	23	184	188	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					267	271		10.1038/ng910	http://dx.doi.org/10.1038/ng910			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12089523				2022-12-27	WOS:000176494100013
J	Nakamura, T; Yao, R; Ogawa, T; Suzuki, T; Ito, C; Tsunekawa, N; Inoue, K; Ajima, R; Miyasaka, T; Yoshida, Y; Ogura, A; Toshimori, K; Noce, T; Yamamoto, T; Noda, T				Nakamura, T; Yao, R; Ogawa, T; Suzuki, T; Ito, C; Tsunekawa, N; Inoue, K; Ajima, R; Miyasaka, T; Yoshida, Y; Ogura, A; Toshimori, K; Noce, T; Yamamoto, T; Noda, T			Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta	NATURE GENETICS			English	Article							ALPHA MUTANT MICE; CCR4-NOT COMPLEX; MESSENGER-RNA; STEM-CELLS; VITAMIN-A; RXR-ALPHA; COMPONENT; TRANSPLANTATION; SPERMATOGENESIS; YEAST	Spermatogenesis is a complex process that involves cooperation of germ cells and testicular somatic cells. Various genetic disorders lead to impaired spermatogenesis, defective sperm function and male infertility(1). Here we show that Cnot7(-/-) males are sterile owing to oligo-astheno-teratozoospermia, suggesting that Cnot7, a CCR4-associated transcriptional cofactor(2), is essential for spermatogenesis. Maturation of spermatids is unsynchronized and impaired in seminiferous tubules of Cnot7(-/-) mice. Transplantation of spermatogonial stem cells from male Cnot7(-/-) mice to seminiferous tubules of Kit mutant mice (Kit(W/W-v)) restores spermatogenesis, suggesting that the function of testicular somatic cells is damaged in the Cnot7(-/-) condition. The testicular phenotypes of Cnot7(-/-) mice are similar to those of mice deficient in retinoid X receptor beta (Rxrb)(3). We further show that Cnot7 binds the AF-1 domain of Rxrb and that Rxrb malfunctions in the absence of Cnot7. Therefore, Cnot7 seems to function as a coregulator of Rxrb in testicular somatic cells and is thus involved in spermatogenesis.	Univ Tokyo, Inst Med Sci, Inst Med Sci, Tokyo 1088639, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1708455, Japan; Yokohama City Univ, Sch Med, Dept Urol, Kanagawa 2360004, Japan; Chiba Univ, Grad Sch Med, Dept Anat & Dev Biol, Chiba 2608670, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; RIKEN, Bioresource Ctr, Tsukuba 3050074, Japan; Tohoku Univ, Sch Med, Ctr Translat & Adv Anim Res Human Dis, Sendai, Miyagi 9808575, Japan; RIKEN, Genom Sci Ctr, Mouse Funct Genom Res Grp, Kanagawa 2440804, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Yokohama City University; Chiba University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); RIKEN; Tohoku University; RIKEN	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Inst Med Sci, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp; tnoda@ims.u-tokyo.ac.jp	noce, toshiaki/L-1739-2013; Noda, Tetsuo/B-1667-2016; Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988; Ito, Chizuru/0000-0003-2697-0382				Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Creemers LB, 2002, BIOL REPROD, V66, P1579, DOI 10.1095/biolreprod66.6.1579; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Maleszewski M, 1996, MOL REPROD DEV, V44, P256, DOI 10.1002/(SICI)1098-2795(199606)44:2&lt;256::AID-MRD16&gt;3.0.CO;2-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 2003, BIOL REPROD, V68, P316, DOI 10.1095/biolreprod.102.004549; Ogonuki N, 2003, BIOL REPROD, V68, P1821, DOI 10.1095/biolreprod.102.011726; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tabuchi Y, 2002, J UROLOGY, V167, P1538, DOI 10.1016/S0022-5347(05)65359-1; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Yoshida Y, 2001, JPN J CANCER RES, V92, P592, DOI 10.1111/j.1349-7006.2001.tb01135.x	30	93	97	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					528	533		10.1038/ng1344	http://dx.doi.org/10.1038/ng1344			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107851	Bronze			2022-12-27	WOS:000221183000029
J	Wang, L; McDonnell, SK; Cunningham, JM; Hebbring, S; Jacobsen, SJ; Cerhan, JR; Slager, SL; Blute, ML; Schaid, DJ; Thibodeau, SN				Wang, L; McDonnell, SK; Cunningham, JM; Hebbring, S; Jacobsen, SJ; Cerhan, JR; Slager, SL; Blute, ML; Schaid, DJ; Thibodeau, SN			No association of germline alteration of MSR1 with prostate cancer risk	NATURE GENETICS			English	Article							SCAVENGER RECEPTOR-1 GENE; SEQUENCE VARIANTS	The macrophage scavenger receptor 1 gene (MSR1) was recently identified as a candidate susceptibility gene for hereditary prostate cancer and as a risk factor for sporadic prostate cancer. To confirm these findings, we screened MSR1 for germline mutations among individuals with familial prostate cancer and tested gene variants for associations in both sporadic and familial prostate cancer. Our results do not support MSR1 as a risk factor for prostate cancer.	Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Thibodeau, SN (corresponding author), Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Expt Pathol, 920 Hilton Bldg,200 1st St SW, Rochester, MN 55905 USA.		Slager, Susan L./B-6756-2009	Jacobsen, Steven/0000-0002-8174-8533; Cerhan, James/0000-0002-7482-178X; McDonnell, Shannon/0000-0001-6201-369X				Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; Xu JF, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802	6	44	48	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					128	129		10.1038/ng1239	http://dx.doi.org/10.1038/ng1239			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12958598				2022-12-27	WOS:000185625300008
J	Bridge, AJ; Pebernard, S; Ducraux, A; Nicoulaz, AL; Iggo, R				Bridge, AJ; Pebernard, S; Ducraux, A; Nicoulaz, AL; Iggo, R			Induction of an interferon response by RNAi vectors in mammalian cells	NATURE GENETICS			English	Article							EXPRESSION; VIRUS; GENE	DNA vectors that express short hairpin RNAs (shRNAs) from RNA polymerase III (Pol III) promoters are a promising new tool to reduce gene expression in mammalian cells. shRNAs are processed to small interfering RNAs (siRNAs) of 21 nucleotides (nt) that guide the cleavage of the cognate mRNA by the RNA-induced silencing complex. Although siRNAs are thought to be too short to induce interferon expression, we report here that a substantial number of shRNA vectors can trigger an interferon response.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Iggo, R (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.		Käser-Pébernard, Stéphanie GM/C-4219-2014; Iggo, Richard/G-3546-2014; Bridge, Alan/U-4209-2018	Käser-Pébernard, Stéphanie GM/0000-0002-6035-6979; Bridge, Alan/0000-0003-2148-9135				AKUSJARVI G, 1987, MOL CELL BIOL, V7, P549, DOI 10.1128/MCB.7.1.549; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002	6	790	882	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					263	264		10.1038/ng1173	http://dx.doi.org/10.1038/ng1173			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796781				2022-12-27	WOS:000183815300011
J	Jaenisch, R; Bird, A				Jaenisch, R; Bird, A			Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals	NATURE GENETICS			English	Review							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; CPG-BINDING-PROTEIN; HISTONE H3 METHYLTRANSFERASE; HYPERVARIABLE YELLOW A(HVY); ENHANCER-BLOCKING ACTIVITY; PRIMORDIAL GERM-CELLS; DNA METHYLATION; RETT-SYNDROME	Cells of a multicellular organism are genetically homogeneous but structurally and functionally heterogeneous owing to the differential expression of genes. Many of these differences in gene expression arise during development and are subsequently retained through mitosis. Stable alterations of this kind are said to be 'epigenetic', because they are heritable in the short term but do not involve mutations of the DNA itself. Research over the past few years has focused on two molecular mechanisms that mediate epigenetic phenomena: DNA methylation and histone modifications. Here, we review advances in the understanding of the mechanism and role of DNA methylation in biological processes. Epigenetic effects by means of DNA methylation have an important role in development but can also arise stochastically as animals age. Identification of proteins that mediate these effects has provided insight into this complex process and diseases that occur when it is perturbed. External influences on epigenetic processes are seen in the effects of diet on long-term diseases such as cancer. Thus, epigenetic mechanisms seem to allow an organism to respond to the environment through changes in gene expression. The extent to which environmental effects can provoke epigenetic responses represents an exciting area of future research.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Edinburgh	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			Bird, Adrian/0000-0002-8600-0372				Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Adorjan P, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e21; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Argeson AC, 1996, GENETICS, V142, P557; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Barbot W, 2002, NUCLEIC ACIDS RES, V30, P2365, DOI 10.1093/nar/30.11.2365; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Betts DH, 2001, P NATL ACAD SCI USA, V98, P1077, DOI 10.1073/pnas.031559298; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; BORTVIN A, IN PRESS DEVELOPMENT; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chan MF, 2001, MOL CELL BIOL, V21, P7587, DOI 10.1128/MCB.21.22.7587-7600.2001; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Cohen DE, 2002, CURR OPIN GENET DEV, V12, P219, DOI 10.1016/S0959-437X(02)00289-7; Cooney CA, 2002, J NUTR, V132, p2393S; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DIBERARDINO MA, 1980, DIFFERENTIATION, V17, P17, DOI 10.1111/j.1432-0436.1980.tb01078.x; DIZIK M, 1991, CARCINOGENESIS, V12, P1307, DOI 10.1093/carcin/12.7.1307; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Ehrlich M, 2001, J MED GENET, V38, P882, DOI 10.1136/jmg.38.12.882; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feng Q, 2001, GENE DEV, V15, P827; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Group M. V. S. R., 1991, LANCET, V338, P131, DOI DOI 10.1016/0140-6736(91)90133-A; Gurdon JB, 1999, SEMIN CELL DEV BIOL, V10, P239, DOI 10.1006/scdb.1998.0284; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hata K, 2002, DEVELOPMENT, V129, P1983; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Inoue Kimiko, 2002, Science (Washington D C), V295, P297, DOI 10.1126/science.295.5553.297; Issa JP, 2000, CURR TOP MICROBIOL, V249, P101; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jacob RA, 1999, ADV EXP MED BIOL, V472, P101; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; JAENISCH R, 1985, P NATL ACAD SCI USA, V82, P1451, DOI 10.1073/pnas.82.5.1451; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; KAWAI J, 1994, MOL CELL BIOL, V14, P7421, DOI 10.1128/MCB.14.11.7421; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Lee J, 2002, DEVELOPMENT, V129, P1807; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lei H, 1996, DEVELOPMENT, V122, P3195; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Macleod D, 1998, MOL CELL BIOL, V18, P4433, DOI 10.1128/MCB.18.8.4433; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; POIRIER LA, 1990, PROG CLIN BIOL RES, V340, P97; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rietveld LEG, 2002, EMBO J, V21, P1389, DOI 10.1093/emboj/21.6.1389; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Riggs AD, 1998, CIBA F SYMP, V214, P214; Santini V, 2001, ANN INTERN MED, V134, P573, DOI 10.7326/0003-4819-134-7-200104030-00011; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Sheldon CC, 2000, CURR OPIN PLANT BIOL, V3, P418, DOI 10.1016/S1369-5266(00)00106-0; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; SIRACUSA LD, 1995, J HERED, V86, P121, DOI 10.1093/oxfordjournals.jhered.a111541; Stancheva I, 2001, EMBO J, V20, P1963, DOI 10.1093/emboj/20.8.1963; Stancheva I, 2000, GENE DEV, V14, P313; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Urnov FD, 2001, J MAMMARY GLAND BIOL, V6, P153, DOI 10.1023/A:1011304606604; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; WAINFAN E, 1992, CANCER RES, V52, pS2071; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; WILSON VL, 1987, J BIOL CHEM, V262, P9948; WILSON VL, 1983, SCIENCE, V220, P1054; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	186	4269	4484	28	1218	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			245	254		10.1038/ng1089	http://dx.doi.org/10.1038/ng1089			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610534				2022-12-27	WOS:000181390900005
J	Wolfe, KH; Li, WH				Wolfe, KH; Li, WH			Molecular evolution meets the genomics revolution	NATURE GENETICS			English	Review							POSITIVE DARWINIAN SELECTION; MALE-DRIVEN EVOLUTION; PARASITE ENCEPHALITOZOON-CUNICULI; ASYMMETRIC SUBSTITUTION PATTERNS; DIRECTIONAL MUTATION PRESSURE; ANTARCTIC NOTOTHENIOID FISH; PROTEIN-INTERACTION NETWORK; LATERAL GENE-TRANSFER; AMINO-ACID SITES; RAPID EVOLUTION	Changes in technology in the past decade have had such an impact on the way that molecular evolution research is done that it is difficult now to imagine working in a world without genomics or the Internet. In 1992, GenBank was less than a hundredth of its current size and was updated every three months on a huge spool of tape. Homology searches took 30 minutes and rarely found a hit. Now it is difficult to find sequences with only a few homologs to use as examples for teaching bioinformatics. For molecular evolution researchers, the genomics revolution has showered us with raw data and the information revolution has given us the wherewithal to analyze it. In broad terms, the most significant outcome from these changes has been our newfound ability to examine the evolution of genomes as a whole, enabling us to infer genome-wide evolutionary patterns and to identify subsets of genes whose evolution has been in some way atypical.	Univ Dublin Trinity Coll, Dept Genet, Smurfit Inst, Dublin 2, Ireland; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Trinity College Dublin; University of Chicago	Wolfe, KH (corresponding author), Univ Dublin Trinity Coll, Dept Genet, Smurfit Inst, Dublin 2, Ireland.	khwolfe@tcd.ie	Wolfe, Kenneth H/B-4653-2009	Wolfe, Kenneth/0000-0003-4992-4979; Li, Wen-Hsiung/0000-0003-1086-1456				Abi-Rached L, 2002, NAT GENET, V31, P100, DOI 10.1038/ng855; Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Aguade M, 1999, GENETICS, V152, P543; AGUADE M, 1992, GENETICS, V132, P755; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bargelloni L, 1998, P NATL ACAD SCI USA, V95, P8670, DOI 10.1073/pnas.95.15.8670; Baric RS, 1997, J VIROL, V71, P1946, DOI 10.1128/JVI.71.3.1946-1955.1997; Baum J, 2002, MOL BIOL EVOL, V19, P223, DOI 10.1093/oxfordjournals.molbev.a004075; Beletskii A, 1998, BIOL CHEM, V379, P549; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Betran E, 2002, MOL BIOL EVOL, V19, P654, DOI 10.1093/oxfordjournals.molbev.a004124; Bielawski JP, 2000, GENETICS, V156, P1299; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Bishop JG, 2000, P NATL ACAD SCI USA, V97, P5322, DOI 10.1073/pnas.97.10.5322; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; Carmichael AN, 2000, J MOL EVOL, V50, P443, DOI 10.1007/s002390010046; Chang BHJ, 1996, ZOOL STUD, V35, P36; CHANG BHJ, 1994, P NATL ACAD SCI USA, V91, P827, DOI 10.1073/pnas.91.2.827; CHANG BHJ, 1995, J MOL EVOL, V40, P70, DOI 10.1007/BF00166597; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Clark MA, 2001, J BACTERIOL, V183, P1853, DOI 10.1128/JB.183.6.1853-1861.2001; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fay JC, 2001, GENETICS, V158, P1227; FERRIS SD, 1979, J MOL EVOL, V12, P267, DOI 10.1007/BF01732026; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; FILIPSKI J, 1988, J THEOR BIOL, V134, P159, DOI 10.1016/S0022-5193(88)80199-1; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; FITCH WM, 1980, J MOL EVOL, V16, P153, DOI 10.1007/BF01804976; Force A, 1999, GENETICS, V151, P1531; Ford MJ, 1999, MOL ECOL, V8, P1055, DOI 10.1046/j.1365-294x.1999.00651.x; Francino MP, 2001, MOL BIOL EVOL, V18, P1147, DOI 10.1093/oxfordjournals.molbev.a003888; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Francino MP, 2000, MOL BIOL EVOL, V17, P416; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gierlik A, 2000, J THEOR BIOL, V202, P305, DOI 10.1006/jtbi.1999.1062; Gilley J, 1999, HUM MOL GENET, V8, P1313, DOI 10.1093/hmg/8.7.1313; Gilson PR, 1996, P NATL ACAD SCI USA, V93, P7737, DOI 10.1073/pnas.93.15.7737; Gilson PR, 2002, GENETICA, V115, P13, DOI 10.1023/A:1016011812442; Goodwin RL, 1996, MOL BIOL EVOL, V13, P346, DOI 10.1093/oxfordjournals.molbev.a025594; GRAUR D, 1999, FUNDAMENTALS MOL EVO, P443; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Haydon DT, 2001, GENETICS, V157, P7; Hellberg ME, 1999, MOL BIOL EVOL, V16, P839, DOI 10.1093/oxfordjournals.molbev.a026168; Hellberg ME, 2000, MOL BIOL EVOL, V17, P458, DOI 10.1093/oxfordjournals.molbev.a026325; Herdman M., 1985, EVOLUTION GENOME SIZ, P37; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Huang W, 1997, J MOL EVOL, V44, P463, DOI 10.1007/PL00006166; Hughes AL, 1997, J MOL EVOL, V44, P675, DOI 10.1007/PL00006191; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1991, GENETICS, V127, P345; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; HUGHES AL, 1995, J MOL EVOL, V41, P539, DOI 10.1007/BF00175811; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Ishimizu T, 1998, FEBS LETT, V440, P337, DOI 10.1016/S0014-5793(98)01470-7; JERMIIN LS, 1995, MOL BIOL EVOL, V12, P558; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Kadowaki KI, 1996, EMBO J, V15, P6652, DOI 10.1002/j.1460-2075.1996.tb01055.x; Kahn NW, 1999, J MOL EVOL, V49, P750, DOI 10.1007/PL00006597; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Kashkush K, 2002, GENETICS, V160, P1651; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kitano T, 1998, BIOCHEM BIOPH RES CO, V249, P78, DOI 10.1006/bbrc.1998.9074; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Korneev S, 2002, MOL BIOL EVOL, V19, P1228, DOI 10.1093/oxfordjournals.molbev.a004183; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Kubo N, 1999, P NATL ACAD SCI USA, V96, P9207, DOI 10.1073/pnas.96.16.9207; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; LEE YH, 1995, MOL BIOL EVOL, V12, P231; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lercher MJ, 2001, MOL BIOL EVOL, V18, P2032, DOI 10.1093/oxfordjournals.molbev.a003744; Li W. H, 1997, MOL EVOLUTION; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; Liu JC, 2001, MOL BIOL EVOL, V18, P945, DOI 10.1093/oxfordjournals.molbev.a003895; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Malpertuy A, 2000, FEBS LETT, V487, P113, DOI 10.1016/S0014-5793(00)02290-0; Maniloff J, 1996, P NATL ACAD SCI USA, V93, P10004, DOI 10.1073/pnas.93.19.10004; Mannila H, 2002, BIOINFORMATICS, V18, P482, DOI 10.1093/bioinformatics/18.3.482; MARKERT CL, 1964, CONGENITAL MALFORMAT, P163; Maston GA, 2002, MOL BIOL EVOL, V19, P320, DOI 10.1093/oxfordjournals.molbev.a004085; Matassi G, 1999, CURR BIOL, V9, P786, DOI 10.1016/S0960-9822(99)80361-3; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McInerney JO, 1998, P NATL ACAD SCI USA, V95, P10698, DOI 10.1073/pnas.95.18.10698; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; NAKASHIMA KI, 1995, P NATL ACAD SCI USA, V92, P5605, DOI 10.1073/pnas.92.12.5605; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pamilo P, 1997, MOL BIOL EVOL, V14, P49, DOI 10.1093/oxfordjournals.molbev.a025701; PAPP B, IN PRESS NATURE; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pennisi E, 2002, SCIENCE, V296, P1589; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Perry J, 1999, CURR BIOL, V9, P987, DOI 10.1016/S0960-9822(99)80430-8; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Peyret P, 2001, GENOME RES, V11, P198, DOI 10.1101/gr.164301; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Qi CF, 1998, MAMM GENOME, V9, P1049, DOI 10.1007/s003359900923; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Riley M, 1997, J MOL BIOL, V268, P857, DOI 10.1006/jmbi.1997.1003; RILEY MA, 1993, MOL BIOL EVOL, V10, P1048; ROBERTS JD, 1994, J BIOL CHEM, V269, P1711; Rocha EPC, 2001, MOL BIOL EVOL, V18, P1789, DOI 10.1093/oxfordjournals.molbev.a003966; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Schmidt TR, 1999, MOL BIOL EVOL, V16, P619, DOI 10.1093/oxfordjournals.molbev.a026144; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Shields DC, 1996, J IMMUNOL, V156, P1062; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; Singhania NA, 1999, J MOL EVOL, V49, P721, DOI 10.1007/PL00006594; Slattery JP, 1998, GENETICS, V148, P1245; Smith NGC, 1999, GENETICS, V153, P1395; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; STRATHERN JN, 1995, GENETICS, V140, P965; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Swanson WJ, 2001, MOL BIOL EVOL, V18, P376, DOI 10.1093/oxfordjournals.molbev.a003813; Szczepanik D, 2001, J MOL EVOL, V52, P426, DOI 10.1007/s002390010172; Takano-Shimizu T, 2001, MOL BIOL EVOL, V18, P606, DOI 10.1093/oxfordjournals.molbev.a003841; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; Thomas JW, 2002, TRENDS GENET, V18, P104, DOI 10.1016/S0168-9525(02)02599-4; Tillier ERM, 2000, J MOL EVOL, V51, P459, DOI 10.1007/s002390010108; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Tsaur SC, 1997, MOL BIOL EVOL, V14, P544, DOI 10.1093/oxfordjournals.molbev.a025791; Tsaur SC, 1998, MOL BIOL EVOL, V15, P1040, DOI 10.1093/oxfordjournals.molbev.a026002; Vacquier VD, 1997, J MOL EVOL, V44, pS15, DOI 10.1007/PL00000049; von Mering C, 2002, NATURE, V417, P797, DOI 10.1038/417797a; Wagner A, 2000, P NATL ACAD SCI USA, V97, P6579, DOI 10.1073/pnas.110147097; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Wallis M, 1996, J MOL EVOL, V43, P93, DOI 10.1007/BF02337353; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399; Ward TJ, 1997, GENETICS, V147, P1863; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Wu JC, 1999, MOL BIOL EVOL, V16, P1622, DOI 10.1093/oxfordjournals.molbev.a026075; Wu W, 1997, J MOL EVOL, V44, P477, DOI 10.1007/PL00006172; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zanotto PMD, 1999, GENETICS, V153, P1077; Zhang JZ, 2000, MOL BIOL EVOL, V17, P1413, DOI 10.1093/oxfordjournals.molbev.a026425; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; ZIPKAS D, 1975, P NATL ACAD SCI USA, V72, P1354, DOI 10.1073/pnas.72.4.1354	214	105	106	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			255	265		10.1038/ng1088	http://dx.doi.org/10.1038/ng1088			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610535				2022-12-27	WOS:000181390900006
J	Puri, PL; Bhakta, K; Wood, LD; Costanzo, A; Zhu, JY; Wang, JYJ				Puri, PL; Bhakta, K; Wood, LD; Costanzo, A; Zhu, JY; Wang, JYJ			A myogenic differentiation checkpoint activated by genotoxic stress	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR MYOD; CELL-CYCLE ARREST; HELIX-LOOP-HELIX; DNA-DAMAGE; SKELETAL MYOGENESIS; TYROSINE KINASE; MADS-BOX; C-ABL; MUSCLE; PROTEIN	Cell-cycle checkpoints help to protect the genomes of proliferating cells under genotoxic stress. In multicellular organisms, cell proliferation is often directed toward differentiation during development and throughout adult homeostasis. To prevent the formation of differentiated cells with genetic instability, we hypothesized that genotoxic stress may trigger a differentiation checkpoint. Here we show that exposure to genotoxic agents causes a reversible inhibition of myogenic differentiation. Muscle-specific gene expression is suppressed by DNA-damaging agents if applied prior to differentiation induction but not after the differentiation program is established. The myogenic determination factor, MyoD (encoded by Myod1), is a target of the differentiation checkpoint in myoblasts. The inhibition of MyoD by DNA damage requires a functional c-Abl tyrosine kinase (encoded by Abl1), but occurs in cells deficient for p53 (transformation-related protein 53, encoded by Trp53) or c-Jun (encoded by the oncogene Jun). These results support the idea that genotoxic stress can regulate differentiation, and identify a new biological function for DNA damage-activated signaling network.	Univ Roma La Sapienza, Fdn Andrea Cesalpino, Gene Express Lab, Dulbecco Telethon Inst, I-00161 Rome, Italy; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Sapienza University Rome; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Puri, PL (corresponding author), Univ Roma La Sapienza, Fdn Andrea Cesalpino, Gene Express Lab, Dulbecco Telethon Inst, Piazzale Aldo Moro 5, I-00161 Rome, Italy.	plorenzo@salk.edu; jywang@ucsd.edu	Costanzo, Antonio/D-3896-2012; Costanzo, Antonio/GZG-2433-2022; Wood, Laura/ABF-1531-2020	Costanzo, Antonio/0000-0001-9697-2557; Puri, Pier Lorenzo/0000-0003-4964-0095	NCI NIH HHS [R01 CA043054, R37 CA043054] Funding Source: Medline; Telethon [TCP00081] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043054, R37CA043054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ALEMA S, 1994, SEMIN CANCER BIOL, V5, P147; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Buchdunger E, 1996, CANCER RES, V56, P100; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; KURABAYASHI M, 1994, J BIOL CHEM, V269, P6031; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, J CELL BIOCHEM, V66, P27, DOI 10.1002/(SICI)1097-4644(19970701)66:1<27::AID-JCB4>3.0.CO;2-#; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Smith L, 1998, NAT GENET, V19, P39, DOI 10.1038/ng0598-39; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang JYJ, 1998, CURR OPIN CELL BIOL, V10, P240, DOI 10.1016/S0955-0674(98)80146-4; WANG JYJ, 2000, INTEGRATIVE SIGNALIN; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	34	93	95	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32	4					585	593		10.1038/ng1023	http://dx.doi.org/10.1038/ng1023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12415271				2022-12-27	WOS:000179593000010
J	Bond, J; Roberts, E; Mochida, GH; Hampshire, DJ; Scott, S; Askham, JM; Springell, K; Mahadevan, M; Crow, YJ; Markham, AF; Walsh, CA; Woods, CG				Bond, J; Roberts, E; Mochida, GH; Hampshire, DJ; Scott, S; Askham, JM; Springell, K; Mahadevan, M; Crow, YJ; Markham, AF; Walsh, CA; Woods, CG			ASPM is a major determinant of cerebral cortical size	NATURE GENETICS			English	Article							RECESSIVE MICROCEPHALY MAPS; NEURONAL MIGRATION; MOLECULAR-GENETICS; ABNORMAL SPINDLE; DROSOPHILA; LOCUS; ADULT; NEUROGENESIS; CENTROSOMES; MUTATIONS	One of the most notable trends in mammalian evolution is the massive increase in size of the cerebral cortex, especially in primates. Humans with autosomal recessive primary microcephaly (MCPH) show a small but otherwise grossly normal cerebral cortex associated with mild to moderate mental retardation(1-4). Genes linked to this condition offer potential insights into the development and evolution of the cerebral cortex. Here we show that the most common cause of MCPH is homozygous mutation of ASPM, the human ortholog of the Drosophila melanogaster abnormal spindle gene (asp)(5), which is essential for normal mitotic spindle function in embryonic neuroblasts(6). The mouse gene Aspm is expressed specifically in the primary sites of prenatal cerebral cortical neurogenesis. Notably, the predicted ASPM proteins encode systematically larger numbers of repeated 'IQ' domains between flies, mice and humans, with the predominant difference between Aspm and ASPM being a single large insertion coding for IQ domains. Our results and evolutionary considerations suggest that brain size is controlled in part through modulation of mitotic spindle activity in neuronal progenitor cells.	Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, St Jamess Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol,Div Neurogenet,Harvard Inst Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Woods, CG (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Beckett St, Leeds LS9 7TF, W Yorkshire, England.		Hampshire, Daniel/Q-3540-2019; woods, christopher g/A-1361-2010; Crow, Yanick J/N-6120-2014	Crow, Yanick J/0000-0001-7211-7564; Mochida, Ganeshwaran/0000-0001-7912-4097; Walsh, Christopher/0000-0002-0156-2238				AICARDI J, 1998, DIS NERVOUS SYSTEM C, V2, P90; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; BUNDEY S, 1997, EMERY RIMOINS PRINCI, P730; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Craig R, 1998, J CELL SCI, V111, P3609; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; GONZALEZ C, 1990, J CELL SCI, V96, P605; Gould E, 2000, BIOL PSYCHIAT, V48, P715, DOI 10.1016/S0006-3223(00)01021-0; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909; Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pattison L, 2000, AM J HUM GENET, V67, P1578, DOI 10.1086/316910; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; ROBERTS E, 2002, IN PRESS J MED GENET; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131	30	414	437	1	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					316	320		10.1038/ng995	http://dx.doi.org/10.1038/ng995			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12355089				2022-12-27	WOS:000178311100024
J	Emamian, ES; Hall, D; Birnbaum, MJ; Karayiorgou, M; Gogos, JA				Emamian, ES; Hall, D; Birnbaum, MJ; Karayiorgou, M; Gogos, JA			Convergent evidence for impaired AKT1-GSK3 beta signaling in schizophrenia	NATURE GENETICS			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROPATHOLOGY-CONSORTIUM; BIPOLAR-DISORDER; AKT; DISEQUILIBRIUM; ASSOCIATION; INHIBITION; PATHWAY; LITHIUM	AKT-GSK3beta signaling is a target of lithium and as such has been implicated in the pathogenesis of mood disorders. Here, we provide evidence that this signaling pathway also has a role in schizophrenia. Specifically, we present convergent evidence for a decrease in AKT1 protein levels and levels of phosphorylation of GSK3beta at Ser9 in the peripheral lymphocytes and brains of individuals with schizophrenia; a significant association between schizophrenia and an AKT1 haplotype associated with lower AKT1 protein levels; and a greater sensitivity to the sensorimotor gating disruptive effect of amphetamine, conferred by AKT1 deficiency. Our findings support the proposal that alterations in AKT1-GSK3beta signaling contribute to schizophrenia pathogenesis and identify AKT1 as a potential schizophrenia susceptibility gene. Consistent with this proposal, we also show that haloperidol induces a stepwise increase in regulatory phosphorylation of AKT1 in the brains of treated mice that could compensate for an impaired function of this signaling pathway in schizophrenia.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Rockefeller Univ, Lab Human Neurogenet, New York, NY 10021 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Columbia University; Rockefeller University; Howard Hughes Medical Institute; University of Pennsylvania	Gogos, JA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, 630 W 168th St,P&S 11-519, New York, NY 10032 USA.	karayim@rockefeller.edu; jag90@columbia.edu		Birnbaum, Morris/0000-0001-9972-8680				Akama KT, 2003, J NEUROSCI, V23, P2333; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Knable MB, 2001, BRAIN RES BULL, V55, P651, DOI 10.1016/S0361-9230(01)00521-4; LEWONTIN RC, 1988, GENETICS, V120, P849; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Toyota T, 2003, NEUROSCI LETT, V339, P5, DOI 10.1016/S0304-3940(02)01428-3; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1	30	734	790	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					131	137		10.1038/ng1296	http://dx.doi.org/10.1038/ng1296			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14745448	Bronze			2022-12-27	WOS:000188542700013
J	Papanikolaou, G; Samuels, ME; Ludwig, EH; MacDonald, MLE; Franchini, PL; Dube, MP; Andres, L; MacFarlane, J; Sakellaropoulos, N; Politou, M; Nemeth, E; Thompson, J; Risler, JK; Zaborowska, C; Babakaiff, R; Radomski, CC; Pape, TD; Davidas, O; Christakis, J; Brissot, P; Lockitch, G; Ganz, T; Hayden, MR; Goldberg, YP				Papanikolaou, G; Samuels, ME; Ludwig, EH; MacDonald, MLE; Franchini, PL; Dube, MP; Andres, L; MacFarlane, J; Sakellaropoulos, N; Politou, M; Nemeth, E; Thompson, J; Risler, JK; Zaborowska, C; Babakaiff, R; Radomski, CC; Pape, TD; Davidas, O; Christakis, J; Brissot, P; Lockitch, G; Ganz, T; Hayden, MR; Goldberg, YP			Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis	NATURE GENETICS			English	Article							ANTIMICROBIAL PEPTIDE HEPCIDIN; CHRONIC DISEASE; HEREDITARY HEMOCHROMATOSIS; GENETIC-HETEROGENEITY; LIVER HEPCIDIN; LOCUS MAPS; ANEMIA; EXPRESSION; PROTEIN; MOUSE	Juvenile hemochromatosis is an early-onset autosomal recessive disorder of iron overload resulting in cardiomyopathy, diabetes and hypogonadism that presents in the teens and early 20s (refs. 1,2). Juvenile hemochromatosis has previously been linked to the centromeric region of chromosome 1q (refs. 3 6), a region that is incomplete in the human genome assembly. Here we report the positional cloning of the locus associated with juvenile hemochromatosis and the identification of a new gene crucial to iron metabolism. We finely mapped the recombinant interval in families of Greek descent and identified multiple deleterious mutations in a transcription unit of previously unknown function (LOC148738), now called HFE2, whose protein product we call hemojuvelin. Analysis of Greek, Canadian and French families indicated that one mutation, the amino acid substitution G320V, was observed in all three populations and accounted for two-thirds of the mutations found. HFE2 transcript expression was restricted to liver, heart and skeletal muscle, similar to that of hepcidin, a key protein implicated in iron metabolism(7-9). Urinary hepcidin levels were depressed in individuals with juvenile hemochromatosis, suggesting that hemojuvelin is probably not the hepcidin receptor. Rather, HFE2 seems to modulate hepcidin expression.	Xenon Genet, Burnaby, BC V5G 4W8, Canada; Univ Athens, Dept Internal Med 1, Sch Med, Laikon Gen Hosp, Athens 11527, Greece; Xenon Genet Res, Montreal, PQ H3A 1L2, Canada; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Theagenio Canc Ctr, Dept Hematol, Thessaloniki 54007, Greece; Univ Rennes, Serv Malad Foie, F-35033 Rennes, France; Univ Rennes, INSERM, U522, F-35033 Rennes, France; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; University of California System; University of California Los Angeles; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of British Columbia; University of British Columbia	Hayden, MR (corresponding author), Xenon Genet, Burnaby, BC V5G 4W8, Canada.	mrh@cmmt.ubc.ca	Girelli, Domenico/B-1183-2008; Ganz, Tomas/AAN-3308-2020; Hayden, Michael R/D-8581-2011; Dubé, Marie-Pierre/B-9364-2008; PAPANIKOLAOU, GEORGE/AAL-9017-2021; Ganz, Tomas/D-4567-2009	Girelli, Domenico/0000-0001-9684-1899; Hayden, Michael R/0000-0001-5159-1419; Dubé, Marie-Pierre/0000-0001-8442-4393; PAPANIKOLAOU, GEORGE/0000-0002-6755-3633; Nemeth, Elizabeta/0000-0002-3477-2397; MacDonald, Marcia/0000-0001-7946-0023; Ganz, Tomas/0000-0002-2830-5469				Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Camaschella C, 2002, SEMIN HEMATOL, V39, P242, DOI 10.1053/shem.2002.35635; De Gobbi M, 2002, BRIT J HAEMATOL, V117, P973, DOI 10.1046/j.1365-2141.2002.03509.x; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P8160, DOI 10.1073/pnas.161296298; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Means RT, 2000, BEST PRACT RES CL HA, V13, P151, DOI 10.1053/beha.1999.0065; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Papanikolaou G, 2000, BLOOD CELL MOL DIS, V26, P163, DOI 10.1006/bcmd.2000.0292; Papanikolaou G, 2002, BLOOD CELL MOL DIS, V29, P168, DOI 10.1006/bcmd.2002.0553; Papanikolaou G, 2001, BLOOD CELL MOL DIS, V27, P744, DOI 10.1006/bcmd.2001.0444; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rivard SR, 2003, EUR J HUM GENET, V11, P585, DOI 10.1038/sj.ejhg.5201009; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Roy CN, 2003, PEDIATR RES, V53, P507, DOI 10.1203/01.PDR.0000049513.67410.2D; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weiss G, 2002, BLOOD REV, V16, P87, DOI 10.1054/blre.2002.0193	29	732	777	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					77	82		10.1038/ng1274	http://dx.doi.org/10.1038/ng1274			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14647275	Bronze			2022-12-27	WOS:000187666800017
J	Kalscheuer, VM; Freude, K; Musante, L; Jensen, LR; Yntema, HG; Gecz, J; Sefiani, A; Hoffmann, K; Moser, B; Haas, S; Gurok, U; Haesler, S; Aranda, B; Nshedjan, A; Tzschach, A; Hartmann, N; Roloff, TC; Shoichet, S; Hagens, O; Tao, J; van Bokhoven, H; Turner, G; Chelly, J; Moraine, C; Fryns, JP; Nuber, U; Hoeltzenbein, M; Scharff, C; Scherthan, H; Lenzner, S; Hamel, BCJ; Schweiger, S; Ropers, HH				Kalscheuer, VM; Freude, K; Musante, L; Jensen, LR; Yntema, HG; Gecz, J; Sefiani, A; Hoffmann, K; Moser, B; Haas, S; Gurok, U; Haesler, S; Aranda, B; Nshedjan, A; Tzschach, A; Hartmann, N; Roloff, TC; Shoichet, S; Hagens, O; Tao, J; van Bokhoven, H; Turner, G; Chelly, J; Moraine, C; Fryns, JP; Nuber, U; Hoeltzenbein, M; Scharff, C; Scherthan, H; Lenzner, S; Hamel, BCJ; Schweiger, S; Ropers, HH			Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation	NATURE GENETICS			English	Article							BINDING PROTEIN; TRACT-BINDING; WW DOMAIN; TRANSCRIPTION; PQBP-1; NPW38	We found mutations in the gene PQBP1 in 5 of 29 families with nonsyndromic (MRX) and syndromic (MRXS) forms of X-linked mental retardation (XLMR). Clinical features in affected males include mental retardation, microcephaly, short stature, spastic paraplegia and midline defects. PQBP1 has previously been implicated in the pathogenesis of polyglutamine expansion diseases. Our findings link this gene to XLMR and shed more light on the pathogenesis of this common disorder.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia; Dept Genet & Biol Mol INH, Rabat, Morocco; Hunter Genet, Waratah, NSW 2298, Australia; Univ Newcastle, Waratah, NSW 2298, Australia; CHU Cochin Port Royal, INSERM, CNRS, Inst Cochin Genet Mol, F-75014 Paris, France; CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours, France; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium	Max Planck Society; Radboud University Nijmegen; Womens & Childrens Hospital Australia; University of Adelaide; University of Newcastle; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Catholique Louvain	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.		Haesler, Sebastian/A-8755-2012; Scharff, Constance/HHN-0673-2022; Musante, Luciana/AAA-5726-2021; Hoeltzenbein, Maria/AAP-4145-2020; Tzschach, Andreas/I-2648-2019; Gecz, Jozef/X-3469-2019; Bokhoven, J.H.L.M. van van/H-8015-2014; Chelly, Jamel/J-7528-2015; Yntema, H.G./L-4771-2015; van Bokhoven, Hans/D-8764-2012	Musante, Luciana/0000-0002-2742-1484; Hoeltzenbein, Maria/0000-0002-2451-4247; Tzschach, Andreas/0000-0002-6840-965X; Gecz, Jozef/0000-0002-7884-6861; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Chelly, Jamel/0000-0002-0939-8719; Freude, Kristine/0000-0001-9480-2386; Haas, Stefan/0000-0003-3418-3688; Haesler, Sebastian/0000-0003-4924-7381; Kalscheuer, Vera/0000-0001-6898-3259				Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Craggs G, 2001, J BIOL CHEM, V276, P30552, DOI 10.1074/jbc.M103142200; Deqaqi SC, 1998, ANN GENET-PARIS, V41, P11; HAMEL BCJ, 1994, AM J MED GENET, V51, P591, DOI 10.1002/ajmg.1320510459; Iwamoto K, 2000, GENE, V259, P69, DOI 10.1016/S0378-1119(00)00437-6; Komuro A, 1999, NUCLEIC ACIDS RES, V27, P1957, DOI 10.1093/nar/27.9.1957; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Okazawa H, 2001, BRAIN RES BULL, V56, P273, DOI 10.1016/S0361-9230(01)00579-2; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Reuter K, 1999, J MOL BIOL, V294, P515, DOI 10.1006/jmbi.1999.3258; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; SHOICHET S, IN PRESS AM J HUM GE; SUTHERLAND GR, 1988, AM J MED GENET, V30, P493, DOI 10.1002/ajmg.1320300152; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Waragai M, 2000, BIOCHEM BIOPH RES CO, V273, P592, DOI 10.1006/bbrc.2000.2992	15	122	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2003	35	4					313	315		10.1038/ng1264	http://dx.doi.org/10.1038/ng1264			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	747DY	14634649	Green Published			2022-12-27	WOS:000186791000010
J	Bok, D; Galbraith, G; Lopez, I; Woodruff, M; Nusinowitz, S; BeltrandelRio, H; Huang, WH; Zhao, SL; Geske, R; Montgomery, C; Van Sligtenhorst, I; Friddle, C; Platt, K; Sparks, MJ; Pushkin, A; Abuladze, N; Ishiyama, A; Dukkipati, R; Liu, WX; Kurtz, I				Bok, D; Galbraith, G; Lopez, I; Woodruff, M; Nusinowitz, S; BeltrandelRio, H; Huang, WH; Zhao, SL; Geske, R; Montgomery, C; Van Sligtenhorst, I; Friddle, C; Platt, K; Sparks, MJ; Pushkin, A; Abuladze, N; Ishiyama, A; Dukkipati, R; Liu, WX; Kurtz, I			Blindness and auditory impairment caused by loss of the sodium bicarbonate cotransporter NBC3	NATURE GENETICS			English	Article							EXPRESSION; FIBROCYTES; PROTONS; COLOCALIZATION; CHANNELS; ISOFORMS; SUBUNIT; USH2B; GENE	Normal sensory transduction requires the efficient disposal of acid (H+) generated by neuronal and sensory receptor activity(1,2). Multiple highly sensitive transport mechanisms have evolved in prokaryotic and eukaryotic organisms to maintain acidity within strict limits(3-5). It is currently assumed that the multiplicity of these processes provides a biological robustness(6). Here we report that the visual and auditory systems have a specific requirement for H+ disposal mediated by the sodium bicarbonate cotransporter NBC3 (refs. 7,8). Mice lacking NBC3 develop blindness and auditory impairment because of degeneration of sensory receptors in the eye and inner ear as in Usher syndrome(9). Our results indicate that in certain sensory organs, in which the requirement to transduce specific environmental signals with speed, sensitivity and reliability is paramount, the choice of the H+ disposal mechanism used is limited.	Univ Calif Los Angeles, Div Nephrol, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurobiol, Jules Stein Eye Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Head & Neck Surg, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol Sci, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Ophthalmol, Jules Stein Eye Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kurtz, I (corresponding author), Univ Calif Los Angeles, Div Nephrol, Dept Med, David Geffen Sch Med, Room 7-155 Factor Bldg,10833 Conte Ave, Los Angeles, CA 90095 USA.	Ikurtz@mednet.ucla.edu	lopez, ivan/GSM-8495-2022; Lopez, Ivan A/U-2177-2019	Lopez, Ivan A/0000-0001-5205-7293				BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Denison SH, 2000, FUNGAL GENET BIOL, V29, P61, DOI 10.1006/fgbi.2000.1188; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Gross E, 2002, AM J PHYSIOL-RENAL, V283, pF876, DOI 10.1152/ajprenal.00148.2002; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; Hmani-Aifa M, 2002, J MED GENET, V39, P281, DOI 10.1136/jmg.39.4.281; Kimberling WJ, 2000, ADV OTO-RHINO-LARYNG, V56, P11; Koulen P, 1998, J NEUROSCI, V18, P10136; Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; KRULWICH TA, 1995, MOL MICROBIOL, V15, P403, DOI 10.1111/j.1365-2958.1995.tb02253.x; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Pushkin A, 2000, J ANDROL, V21, P708; Pushkin A, 1999, GENOMICS, V57, P321, DOI 10.1006/geno.1999.5781; Pushkin A, 2003, AM J PHYSIOL-CELL PH, V284, pC667, DOI 10.1152/ajpcell.00225.2002; Pushkin A, 1999, AM J PHYSIOL-RENAL, V277, pF974, DOI 10.1152/ajprenal.1999.277.6.F974; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; SALT AN, 2001, PHYSL EAR, P333; SPICER SS, 1991, HEARING RES, V56, P53, DOI 10.1016/0378-5955(91)90153-Z; Spicer SS, 1997, HEARING RES, V111, P93, DOI 10.1016/S0378-5955(97)00097-X; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Trapp S, 1996, NEUROREPORT, V7, P2000, DOI 10.1097/00001756-199608120-00029; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293	30	96	99	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					313	319		10.1038/ng1176	http://dx.doi.org/10.1038/ng1176			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808454				2022-12-27	WOS:000183815300020
J	Planet, PJ; Kachlany, SC; Fine, DH; DeSalle, R; Figurski, DH				Planet, PJ; Kachlany, SC; Fine, DH; DeSalle, R; Figurski, DH			The widespread colonization island of Actinobacillus actinomycetemcomitans	NATURE GENETICS			English	Article							LENGTH DIFFERENCE TEST; NONSPECIFIC ADHERENCE; CAULOBACTER-CRESCENTUS; GENE; IDENTIFICATION; INCONGRUENCE; PHYLOGENY; REQUIRES; PROTEIN; TREE	Genomic islands, such as pathogenicity islands, contribute to the evolution and diversification of microbial life(1). Here we report on the Widespread Colonization Island, which encompasses the tad (tight adherence) locus for colonization of surfaces and biofilm formation by the human pathogen Actinobacillus actinomycetemcomitans. At least 12 of the 14 genes at the tad locus are required for tenacious biofilm formation and synthesis of bundled Flp pili (fibrils) that mediate adherence. The pilin subunit(2), Flp1, remains inside the cell in tad-locus mutants, indicating that these genes encode a secretion system for export and assembly of fibrils. We found tad-related regions in a wide variety of Bacterial and Archaeal species(3), and their sequence characteristics indicate possible horizontal transfer. To test the hypothesis of horizontal transfer, we compared the phylogeny of the tad locus to a robust organismal phylogeny using statistical tests of congruence and tree reconciliation techniques. Our analysis strongly supports a complex history of gene shuffling by recombination and multiple horizontal transfers, duplications and losses. We present evidence for a specific horizontal transfer event leading to the establishment of this region as a determinant of disease.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Univ Med & Dent New Jersey, Dept Oral Biol, Newark, NJ 07103 USA; Amer Museum Nat Hist, Mol Biol Lab, New York, NY 10024 USA	Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; American Museum of Natural History (AMNH)	Figurski, DH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERGEY DH, 1984, BERGEYS MANUAL SYSTE, V4; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Brochier C, 2002, TRENDS GENET, V18, P1, DOI 10.1016/S0168-9525(01)02522-7; Brown EW, 2002, MOL PHYLOGENET EVOL, V24, P102, DOI 10.1016/S1055-7903(02)00222-1; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Fine DH, 2001, ARCH ORAL BIOL, V46, P1065, DOI 10.1016/S0003-9969(01)00067-X; Fuller TE, 2000, MICROB PATHOGENESIS, V29, P25, DOI 10.1006/mpat.2000.0365; Haase EM, 1999, INFECT IMMUN, V67, P2901, DOI 10.1128/IAI.67.6.2901-2908.1999; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue T, 1998, MICROBIOL IMMUNOL, V42, P253, DOI 10.1111/j.1348-0421.1998.tb02280.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Nika JR, 2002, INFECT IMMUN, V70, P2965, DOI 10.1128/IAI.70.6.2965-2975.2002; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989; Thomas NA, 2002, MOL MICROBIOL, V46, P879, DOI 10.1046/j.1365-2958.2002.03220.x; Thomson VJ, 1999, J BACTERIOL, V181, P7298, DOI 10.1128/JB.181.23.7298-7307.1999; Thornton JW, 2000, SYST BIOL, V49, P183, DOI 10.1093/sysbio/49.2.183; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002	30	114	122	0	7	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					193	198		10.1038/ng1154	http://dx.doi.org/10.1038/ng1154			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12717435				2022-12-27	WOS:000183200500026
J	Segal, E; Shapira, M; Regev, A; Pe'er, D; Botstein, D; Koller, D; Friedman, N				Segal, E; Shapira, M; Regev, A; Pe'er, D; Botstein, D; Koller, D; Friedman, N			Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; GENOME; MOTIFS; TRANSCRIPTION; IDENTIFICATION; LOCALIZATION; ORGANIZATION; DISCOVERY; SEQUENCES	Much of a cell's activity is organized as a network of interacting modules: sets of genes coregulated to respond to different conditions. We present a probabilistic method for identifying regulatory modules from gene expression data. Our procedure identifies modules of coregulated genes, their regulators and the conditions under which regulation occurs, generating testable hypotheses in the form regulator X regulates module Y under conditions W'. We applied the method to a Saccharomyces cerevisiae expression data set, showing its ability to identify functionally coherent modules and their correct regulators. We present microarray experiments supporting three novel predictions, suggesting regulatory roles for previously uncharacterized proteins.	Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel	Stanford University; Stanford University; Tel Aviv University; Weizmann Institute of Science; Hebrew University of Jerusalem	Segal, E (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	eran@cs.stanford.edu; koller@cs.stanford.edu	Friedman, Nir/H-9692-2012; Segal, Eran/AAF-4855-2019	Friedman, Nir/0000-0002-9678-3550; Pe'er, Dana/0000-0002-9259-8817; Segal, Eran/0000-0002-6859-1164				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duda R. O., 1973, PATTERN CLASSIFICATI; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; FRIEDMAN N, 1998, P 14 C UNC ART INT, P129; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; HARTEMINK AJ, 2002, PAC S BIOC KAUAI; Heckerman D, 1998, NATO ADV SCI I D-BEH, V89, P301; Hlavacek WS, 1996, J MOL BIOL, V255, P121, DOI 10.1006/jmbi.1996.0011; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Inoue Y, 1998, J BIOL CHEM, V273, P2977, DOI 10.1074/jbc.273.5.2977; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lenssen E, 2002, MOL MICROBIOL, V43, P1023, DOI 10.1046/j.1365-2958.2002.02799.x; Mayordomo I, 2002, J BIOL CHEM, V277, P35650, DOI 10.1074/jbc.M204198200; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Norbeck J, 2000, YEAST, V16, P121, DOI 10.1002/(SICI)1097-0061(20000130)16:2<121::AID-YEA511>3.0.CO;2-A; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Segal E, 2001, Bioinformatics, V17 Suppl 1, pS243; SEGAL E, 2002, P 6 INT C RES COMP M, P263; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanay A, 2001, Bioinformatics, V17 Suppl 1, pS270; Tanay Amos, 2002, Bioinformatics, V18 Suppl 1, pS136; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Zahringer H, 2000, MOL MICROBIOL, V35, P397, DOI 10.1046/j.1365-2958.2000.01706.x	46	1154	1207	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					166	176		10.1038/ng1165	http://dx.doi.org/10.1038/ng1165			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12740579				2022-12-27	WOS:000183200500022
J	Tartaglia, M; Niemeyer, CM; Fragale, A; Song, XL; Buechner, J; Jung, A; Hahlen, K; Hasle, H; Licht, JD; Gelb, BD				Tartaglia, M; Niemeyer, CM; Fragale, A; Song, XL; Buechner, J; Jung, A; Hahlen, K; Hasle, H; Licht, JD; Gelb, BD			Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE SHP-2; NOONAN-SYNDROME	We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML. Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML). Functional analyses documented that the two most common mutations in PTPN11 associated with JMML caused a gain of function.	CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Ist Super Sanita, Lab Metab & Biochim Patol, I-00161 Rome, Italy; Univ Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; Ist Super Sanita, Lab Biol Cellulare, I-00161 Rome, Italy; Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; Sophia Childrens Univ Hosp, Rotterdam, Netherlands; Skejby Hosp, Dept Pediat, Aarhus, Denmark; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Istituto Superiore di Sanita (ISS); University of Freiburg; Istituto Superiore di Sanita (ISS); University of Erlangen Nuremberg; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Aarhus University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Gelb, BD (corresponding author), CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA.		Tartaglia, Marco/K-2955-2018; Licht, Jonathan/L-4239-2019; Fragale, Alessandra/K-1071-2016	Tartaglia, Marco/0000-0001-7736-9672; Fragale, Alessandra/0000-0002-0362-1983; Hasle, Henrik/0000-0003-3976-9231; Buechner, Jochen/0000-0001-5848-4501; Licht, Jonathan/0000-0002-3942-1369				BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; Emanuel PD, 1996, MOL MED TODAY, V2, P468, DOI 10.1016/1357-4310(96)10044-7; Fukuda M, 1997, J PEDIAT HEMATOL ONC, V19, P177, DOI 10.1097/00043426-199703000-00019; Hasle H, 1999, LEUKEMIA, V13, P376, DOI 10.1038/sj.leu.2401342; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847	10	754	789	1	39	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					148	150		10.1038/ng1156	http://dx.doi.org/10.1038/ng1156			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12717436				2022-12-27	WOS:000183200500018
J	Pollock, PM; Harper, UL; Hansen, KS; Yudt, LM; Stark, M; Robbins, CM; Moses, TY; Hostetter, G; Wagner, U; Kakareka, J; Salem, G; Pohida, T; Heenan, P; Duray, P; Kallioniemi, O; Hayward, NK; Trent, JM; Meltzer, PS				Pollock, PM; Harper, UL; Hansen, KS; Yudt, LM; Stark, M; Robbins, CM; Moses, TY; Hostetter, G; Wagner, U; Kakareka, J; Salem, G; Pohida, T; Heenan, P; Duray, P; Kallioniemi, O; Hayward, NK; Trent, JM; Meltzer, PS			High frequency of BRAF mutations in nevi	NATURE GENETICS			English	Article								To evaluate the timing of mutations in BRAF (v-raf murine sarcoma viral oncogene homolog B1) during melanocytic neoplasia, we carried out mutation analysis on microdissected melanoma and nevi samples. We observed mutations resulting in the V599E amino-acid substitution in 41 of 60 (68%) melanoma metastases, 4 of 5 (80%) primary melanomas and, unexpectedly, in 63 of 77 (82%) nevi. These data suggest that mutational activation of the RAS/RAF/MAPK pathway in nevi is a critical step in the initiation of melanocytic neoplasia but alone is insufficient for melanoma tumorigenesis.	NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Queensland Inst Med Res, Canc & Cell Biol Div, Herston, Qld 4006, Australia; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Pathol, Nedlands, WA 6009, Australia; NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); QIMR Berghofer Medical Research Institute; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Meltzer, PS (corresponding author), NHGRI, Canc Genet Branch, NIH, 50 South Dr, Bethesda, MD 20892 USA.		hayward, nick/AAV-8802-2020; Stark, Mitchell S/E-3542-2010; Stark, Mitchell/K-3874-2019; Kallioniemi, Olli P/H-5111-2011; Stark, Mitchell/K-6794-2019; hayward, nicholas k/C-1367-2015	Stark, Mitchell S/0000-0002-4510-2161; Kallioniemi, Olli P/0000-0002-3231-0332; Stark, Mitchell/0000-0002-4510-2161; hayward, nicholas k/0000-0003-4760-1033; Pollock, Pamela/0000-0001-8420-1026; Kakareka, John/0000-0003-0072-0035	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000261, ZIACT000261] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT))		ARMSTRONG BK, 1996, CANC EPIDEMIOLOGY PR; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; ELDER DE, 1991, ATLAS TUMOR PATHOL, P5; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844	6	1237	1267	0	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					19	20		10.1038/ng1054	http://dx.doi.org/10.1038/ng1054			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12447372				2022-12-27	WOS:000180136100010
J	Garcia-Cao, M; Gonzalo, S; Dean, D; Blasco, MA				Garcia-Cao, M; Gonzalo, S; Dean, D; Blasco, MA			A role for the Rb family of proteins in controlling telomere length	NATURE GENETICS			English	Article							HUMAN EPITHELIAL-CELLS; G-STRAND OVERHANG; CHROMOSOMAL INSTABILITY; MICE; FUSIONS; TRF1	The molecular mechanisms of cellular mortality have recently begun to be unraveled. In particular, it has been discovered that cells that lack telomerase are subject to telomere attrition with each round of replication, eventually leading to loss of telomere capping function at chromosome ends(1-5). Critically short telomeres and telomeres lacking telomere-binding proteins lose their functionality and are metabolized as DNA breaks, thus generating chromosomal fusions(1-8). Telomerase activity is sufficient to rescue short telomeres and confers an unlimited proliferative capacity(9-11). In addition, the tumor-suppressor pathway Cdkn2a/Rb1 has also been implicated as a barrier to immortalization(12-14). Here, we report a connection between the members of the retinoblastoma family of proteins, Rb1 (retinoblastoma 1), Rbl1 (retinoblastoma-like 1) and Rbl2 (retinoblastoma-like 2), and the mechanisms that regulate telomere length. In particular, mouse embryonic fibroblasts doubly deficient in Rbl1 and Rbl2 or triply deficient in Rbl1, Rbl2 and Rb1 have markedly elongated telomeres compared with those of wildtype or Rb1-deficient cells. This deregulation of telomere length is not associated with increased telomerase activity. Notably, the abnormally elongated telomeres in doubly or triply deficient cells retain their end-capping function, as shown by the normal frequency of chromosomal fusions. These findings demonstrate a connection between the Rb1 family and the control of telomere length in mammalian cells.	Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain; Washington Univ, Sch Med, Div Mol Oncol, St Louis, MO USA	Washington University (WUSTL)	Blasco, MA (corresponding author), Natl Biotechnol Ctr, Dept Immunol & Oncol, E-28049 Madrid, Spain.		Gonzalo, Susana/T-8275-2019; Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Gonzalo, Susana/0000-0001-9631-1206				Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Farwell DG, 2000, AM J PATHOL, V156, P1537, DOI 10.1016/S0002-9440(10)65025-0; Goytisolo FA, 2002, ONCOGENE, V21, P584, DOI 10.1038/sj.onc.1205085; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; McIlrath J, 2001, CANCER RES, V61, P912; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; STOPPLER H, 1997, J BIOL CHEM, V272, P1332; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	29	97	100	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					415	419		10.1038/ng1011	http://dx.doi.org/10.1038/ng1011			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379853				2022-12-27	WOS:000179034800019
J	Wilson, SM; Bhattacharyya, B; Rachel, RA; Coppola, V; Tessarollo, L; Householder, DB; Fletcher, CF; Miller, RJ; Copeland, NG; Jenkins, NA				Wilson, SM; Bhattacharyya, B; Rachel, RA; Coppola, V; Tessarollo, L; Householder, DB; Fletcher, CF; Miller, RJ; Copeland, NG; Jenkins, NA			Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease	NATURE GENETICS			English	Article							NEUROMUSCULAR-JUNCTION; RECEPTORS; SUSCEPTIBILITY; MONOUBIQUITIN; LOCUS	Mice that are homozygous with respect to a mutation (ax J) in the ataxia (ax) gene develop severe tremors by 2-3 weeks of age followed by hindlimb paralysis and death by 6-10 weeks of age(1). Here we show that ax encodes ubiquitin-specific protease 14 (Usp14). Ubiquitin proteases are a large family of cysteine proteases that specifically cleave ubiquitin conjugates. Although Usp14 can cleave a ubiquitin-tagged protein in vitro, it is unable to process polyubiquitin 2, which is believed to be associated with the protein aggregates seen in Parkinson disease 3, spinocerebellar ataxia type 1 (SCA1; ref. 4) and gracile axonal dystrophy (GAD)(5). The physiological substrate of Usp14 may therefore contain a mono-ubiquitin side chain, the removal of which would regulate processes such as protein localization 6 and protein activity(7,8). Expression of Usp14 is significantly altered in ax(J)/ax(J) mice as a result of the insertion of an intracisternal-A particle (IAP) into intron 5 of Usp14. In contrast to other neurodegenerative disorders such as Parkinson disease and SCA1 in humans and GAD in mice, neither ubiquitin-positive protein aggregates nor neuronal cell loss is detectable in the central nervous system (CNS) of ax(J) mice. Instead, ax(J) mice have defects in synaptic transmission in both the central and peripheral nervous systems. These results suggest that ubiquitin proteases are important in regulating synaptic activity in mammals.	NCI, Mouse Canc Genet Program, Ft Detrick, MD 21702 USA; Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; Novartis Fdn, Genom Inst, San Diego, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Novartis	Jenkins, NA (corresponding author), NCI, Mouse Canc Genet Program, Ft Detrick, MD 21702 USA.		Coppola, Vincenzo/D-5352-2014; Coppola, Vincenzo/E-2917-2011	Coppola, Vincenzo/0000-0001-6163-1779; Coppola, Vincenzo/0000-0001-6163-1779; Wilson, Scott/0000-0001-9376-9430				Bhattacharyya BJ, 1997, SYNAPSE, V27, P367, DOI 10.1002/(SICI)1098-2396(199712)27:4<367::AID-SYN10>3.0.CO;2-P; BURT AM, 1980, ANAT REC, V196, P61, DOI 10.1002/ar.1091960107; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; DAMATO CJ, 1965, ARCH PATHOL, V80, P604; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; DIONNE VE, 1975, J PHYSIOL-LONDON, V251, P245, DOI 10.1113/jphysiol.1975.sp011090; DUCHEN LW, 1968, Q J EXP PHYSIOL CMS, V53, P84, DOI 10.1113/expphysiol.1968.sp001948; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; KATZ B, 1957, J PHYSIOL-LONDON, V137, P267, DOI 10.1113/jphysiol.1957.sp005811; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; *MGD, 2001, MOUS GEN INF PROJ; Plomp JJ, 2000, BRAIN, V123, P463, DOI 10.1093/brain/123.3.463; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Royaux I, 1997, GENOMICS, V42, P479, DOI 10.1006/geno.1997.4772; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schwab SG, 1998, AM J HUM GENET, V63, P1139, DOI 10.1086/302046; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; WILSON DF, 1982, AM J PHYSIOL, V242, pC366, DOI 10.1152/ajpcell.1982.242.5.C366; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019	30	218	225	1	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					420	425		10.1038/ng1006	http://dx.doi.org/10.1038/ng1006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12368914				2022-12-27	WOS:000179034800020
J	Wheeler, JC; VanderZwan, C; Xu, XT; Swantek, D; Tracey, WD; Gergen, JP				Wheeler, JC; VanderZwan, C; Xu, XT; Swantek, D; Tracey, WD; Gergen, JP			Distinct in vivo requirements for establishment versus maintenance of transcriptional repression	NATURE GENETICS			English	Article							ZINC-FINGER PROTEINS; DROSOPHILA SEGMENTATION; HISTONE DEACETYLASE; GENE RUNT; TRAMTRACK; GROUCHO; DOMAIN; EMBRYO; EXPRESSION; ACTIVATION	Low-level ectopic expression of the Runt transcription factor blocks activation of the Drosophila melanogaster segmentation gene engrailed (en) in odd-numbered parasegments and is associated with a lethal phenotype. Here we show, by using a genetic screen for maternal factors that contribute in a dose-dependent fashion to Runt-mediated repression, that there are two distinct steps in the repression of en by Runt. The initial establishment of repression is sensitive to the dosage of the zinc-finger transcription factor Tramtrack. By contrast, the corepressor proteins Groucho and dCtBP, and the histone deacetylase Rpd3, do not affect establishment but instead maintain repression after the blastoderm stage. The distinction between establishment and maintenance is confirmed by experiments with Runt derivatives that are impaired specifically for either co-repressor interaction or DNA binding. Other transcription factors can also establish repression in Rpd3-deficient embryos, which indicates that the distinction between establishment and maintenance may be a general feature of eukaryotic transcriptional repression.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gergen, JP (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.			Tracey, W. Daniel/0000-0003-4666-8199				Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chou TB, 1996, GENETICS, V144, P1673; DeRubertis F, 1996, NATURE, V384, P589; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Giesen K, 1997, DEVELOPMENT, V124, P2307; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; KLINGLER M, 1993, MECH DEVELOP, V43, P3, DOI 10.1016/0925-4773(93)90019-T; Kramer SG, 1999, DEVELOPMENT, V126, P191; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; MANOUKIAN AS, 1992, GENE DEV, V6, P1740, DOI 10.1101/gad.6.9.1740; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Phippen TM, 2000, J BIOL CHEM, V275, P37628, DOI 10.1074/jbc.M004234200; READ D, 1992, MECH DEVELOP, V38, P183, DOI 10.1016/0925-4773(92)90052-L; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Reichmann Veit, 1997, Development (Cambridge), V124, P2915; Tracey WD, 2000, GENETICS, V154, P273; TSAI CC, 1994, DEVELOPMENT, V120, P1671; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	23	45	45	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					206	210		10.1038/ng942	http://dx.doi.org/10.1038/ng942			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12145660				2022-12-27	WOS:000177714900024
J	Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; Malli, R; Reed, JA; Dierick, I; Verpoorten, N; Warner, TT; Proukakis, C; Van den Bergh, P; Verellen, C; Van Maldergem, L; Merlini, L; De Jonghe, P; Timmerman, V; Crosby, AH; Wagner, K				Windpassinger, C; Auer-Grumbach, M; Irobi, J; Patel, H; Petek, E; Horl, G; Malli, R; Reed, JA; Dierick, I; Verpoorten, N; Warner, TT; Proukakis, C; Van den Bergh, P; Verellen, C; Van Maldergem, L; Merlini, L; De Jonghe, P; Timmerman, V; Crosby, AH; Wagner, K			Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; CHROMOSOME 11Q12-Q14; AGGRESOME FORMATION; SPASTIC PARAPLEGIA; HETEROGENEITY	Distal hereditary motor neuropathy (dHMN) or distal spinal muscular atrophy (OMIM #182960) is a heterogeneous group of disorders characterized by an almost exclusive degeneration of motor nerve fibers, predominantly in the distal part of the limbs(1). Silver syndrome (OMIM #270685) is a rare form of hereditary spastic paraparesis mapped to chromosome 11q12q14 (SPG17) in which spasticity of the legs is accompanied by amyotrophy of the hands and occasionally also the lower limbs(2,3). Silver syndrome and most forms of dHMN are autosomal dominantly inherited with incomplete penetrance and a broad variability in clinical expression. A genome-wide scan in an Austrian family with dHMN-V (ref. 4) showed linkage to the locus SPG17, which was confirmed in 16 additional families with a phenotype characteristic of dHMN or Silver syndrome. After refining the critical region to 1 Mb, we sequenced the gene Berardinelli-Seip congenital lipodystrophy (BSCL2) and identified two heterozygous missense mutations resulting in the amino acid substitutions N88S and S90L. Null mutations in BSCL2, which encodes the protein seipin, were previously shown to be associated with autosomal recessive Berardinelli-Seip congenital lipodystrophy 5 (OMIM #269700). We show that seipin is an integral membrane protein of the endoplasmic reticulum (ER). The amino acid substitutions N88S and S90L affect glycosylation of seipin and result in aggregate formation leading to neurodegeneration.	Med Univ Graz, Inst Med Biol & Human Genet, A-8010 Graz, Austria; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ London St Georges Hosp, Sch Med, Div Med Genet, London SW17 0RE, England; Med Univ Graz, Dept Med Biochem & Med Mol Biol, A-8010 Graz, Austria; UCL Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London NW3 2PF, England; Univ Louvain, St Luc Univ Hosp, Dept Neurol, Brussels, Belgium; Univ Louvain, St Luc Univ Hosp, Med Genet Unit, Brussels, Belgium; Ctr Human Genet, Inst Pathol & Genet, Loverval, Belgium; Ist Ortoped Rizzoli, Neuromuscular Lab, Bologna, Italy	Medical University of Graz; Flanders Institute for Biotechnology (VIB); University of Antwerp; St Georges University London; Medical University of Graz; University of London; University College London; UCL Medical School; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Istituto Ortopedico Rizzoli	Wagner, K (corresponding author), Med Univ Graz, Inst Med Biol & Human Genet, Harrachgasse 21-8, A-8010 Graz, Austria.	klaus.wagner@meduni-graz.at	Merlini, Luciano/N-6478-2019; Warner, Thomas T/A-1454-2013; Malli, Roland/B-7369-2008; Timmerman, Vincent/O-7283-2019; Van Maldergem, Lionel/G-9849-2017; Proukakis, Christos/G-4548-2013; Crosby, Andrew H/E-2218-2015; proukakis, christos/ABE-3447-2020; Van Maldergem, Lionel/O-3242-2019	Merlini, Luciano/0000-0002-1108-1198; Warner, Thomas T/0000-0001-6195-6995; Timmerman, Vincent/0000-0002-2162-0933; Van Maldergem, Lionel/0000-0001-8880-5214; Crosby, Andrew H/0000-0003-3667-9054; proukakis, christos/0000-0001-6423-6539; Van Maldergem, Lionel/0000-0001-8880-5214; Hoerl, Gerd/0000-0002-0884-0851; Malli, Roland/0000-0001-6327-8729				Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Auer-Grumbach M, 2000, BRAIN, V123, P1612, DOI 10.1093/brain/123.8.1612; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee MJ, 2003, HUM MOL GENET, V12, P1917, DOI 10.1093/hmg/ddg198; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Patel H, 2001, AM J HUM GENET, V69, P209, DOI 10.1086/321267; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saliba RS, 2002, J CELL SCI, V115, P2907; SILVER JR, 1966, J NEUROL NEUROSUR PS, V29, P135, DOI 10.1136/jnnp.29.2.135; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Windpassinger C, 2003, HUM GENET, V114, P99, DOI 10.1007/s00439-003-1021-6	17	273	296	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					271	276		10.1038/ng1313	http://dx.doi.org/10.1038/ng1313			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981520	Bronze			2022-12-27	WOS:000189250400016
J	Shirane, D; Sugao, K; Namiki, S; Tanabe, M; Iino, M; Hirose, K				Shirane, D; Sugao, K; Namiki, S; Tanabe, M; Iino, M; Hirose, K			Enzymatic production of RNAi libraries from cDNAs	NATURE GENETICS			English	Article							SHORT-INTERFERING RNAS; MAMMALIAN-CELLS; GENE-EXPRESSION; INOSITOL 1,4,5-TRISPHOSPHATE; CAENORHABDITIS-ELEGANS; STEM-CELLS; GENOME; MESSENGER; SEQUENCE; RECEPTOR	RNA interference (RNAi) induced by small interfering (siRNA) or short hairpin RNA (shRNA) is an important research approach in mammalian genetics. Here we describe a technology called enzymatic production of RNAi library (EPRIL) by which cDNAs are converted by a sequence of enzymatic treatments into an RNAi library consisting of a vast array of different shRNA expression constructs. We applied EPRIL to a single cDNA source and prepared an RNAi library consisting of shRNA constructs with various RNAi efficiencies. High-throughput screening allowed us to rapidly identify the best shRNA constructs from the library. We also describe a new selection scheme using the thymidine kinase gene for obtaining efficient shRNA constructs. Furthermore, we show that EPRIL can be applied to constructing an RNAi library from a cDNA library, providing a basis for future whole-genome phenotypic screening of genes.	Univ Tokyo, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirose, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pharmacol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kenzo@m.u-tokyo.ac.jp	Namiki, Shigeyuki/AAF-6157-2019	Namiki, Shigeyuki/0000-0003-1520-8261; Hirose, Kenzo/0000-0002-8944-6513				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; BOYD AC, 1986, NUCLEIC ACIDS RES, V14, P5255, DOI 10.1093/nar/14.13.5255; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; DESMEDT H, 1994, J BIOL CHEM, V269, P21691; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Paddison PJ, 2002, CANCER CELL, V2, P17, DOI 10.1016/S1535-6108(02)00092-2; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	28	127	153	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					190	196		10.1038/ng1290	http://dx.doi.org/10.1038/ng1290			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14704669	Bronze			2022-12-27	WOS:000188542700023
J	Meetei, AR; de Winter, JP; Medhurst, AL; Wallisch, M; Waisfisz, Q; van de Vrugt, HJ; Oostra, AB; Yan, ZJ; Ling, C; Bishop, CE; Hoatlin, ME; Joenje, H; Wang, WD				Meetei, AR; de Winter, JP; Medhurst, AL; Wallisch, M; Waisfisz, Q; van de Vrugt, HJ; Oostra, AB; Yan, ZJ; Ling, C; Bishop, CE; Hoatlin, ME; Joenje, H; Wang, WD			A novel ubiquitin ligase is deficient in Fanconi anemia	NATURE GENETICS			English	Article							TARGETED DISRUPTION; NUCLEAR-COMPLEX; REDUCED FERTILITY; GROUP-C; PROTEINS; GENE; FANCG/XRCC9; PATHWAY; MICE; HYPERSENSITIVITY	Fanconi anemia is a recessively inherited disease characterized by congenital defects, bone marrow failure and cancer susceptibility(1,2). Cells from individuals with Fanconi anemia are highly sensitive to DNA-crosslinking drugs, such as mitomycin C (MMC). Fanconi anemia proteins function in a DNA damage response pathway involving breast cancer susceptibility gene products, BRCA1 and BRCA2 (refs. 1,2). A key step in this pathway is monoubiquitination of FANCD2, resulting in the redistribution of FANCD2 to nuclear foci containing BRCA1 (ref. 3). The underlying mechanism is unclear because the five Fanconi anemia proteins known to be required for this ubiquitination have no recognizable ubiquitin ligase motifs. Here we report a new component of a Fanconi anemia protein complex, called PHF9, which possesses E3 ubiquitin ligase activity in vitro and is essential for FANCD2 monoubiquitination in vivo. Because PHF9 is defective in a cell line derived from an individual with Fanconi anemia, we conclude that PHF9 ( also called FANCL) represents a novel Fanconi anemia complementation group (FA-L). Our data suggest that PHF9 has a crucial role in the Fanconi anemia pathway as the likely catalytic subunit required for monoubiquitination of FANCD2.	NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Free Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Oregon Hlth & Sci Univ, Div Mol Med, Portland, OR 97239 USA; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vrije Universiteit Amsterdam; Oregon Health & Science University; Baylor College of Medicine	Wang, WD (corresponding author), NIA, Genet Lab, NIH, 333 Cassell Dr,TRIAD Ctr Room 3000, Baltimore, MD 21224 USA.		Wang, Weidong/AAV-2446-2021; 高, 雨莉/HGU-8187-2022	Wallisch, Michael/0000-0002-7133-795X; Wang, Weidong/0000-0002-0658-7928; Waisfisz, Quinten/0000-0002-7384-9182	NATIONAL INSTITUTE ON AGING [ZIAAG000688, Z01AG000688] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; BRUNN D, 2003, DNA REPAIR; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hoatlin ME, 1998, BLOOD, V91, P1418, DOI 10.1182/blood.V91.4.1418; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Taniguchi T, 2002, BLOOD, V100, P2457, DOI 10.1182/blood-2002-03-0860; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Whitney MA, 1996, BLOOD, V88, P49; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435	30	446	464	0	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2003	35	2					165	170		10.1038/ng1241	http://dx.doi.org/10.1038/ng1241			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726WV	12973351				2022-12-27	WOS:000185625300013
J	Fantes, J; Ragge, NK; Lynch, SA; McGill, NI; Collin, JRO; Howard-Peebles, PN; Hayward, C; Vivian, AJ; Williamson, K; van Heyningen, V; FitzPatrick, DR				Fantes, J; Ragge, NK; Lynch, SA; McGill, NI; Collin, JRO; Howard-Peebles, PN; Hayward, C; Vivian, AJ; Williamson, K; van Heyningen, V; FitzPatrick, DR			Mutations in SOX2 cause anophthalmia	NATURE GENETICS			English	Article							EXPRESSION; GENE; ARM	A submicroscopic deletion containing SOX2 was identified at the 3q breakpoint in a child with t(3;11)(q26.3;p11.2) associated with bilateral anophthalmia. Subsequent SOX2 mutation analysis identified de novo truncating mutations of SOX2 in 4 of 35 (11%) individuals with anophthalmia. Both eyes were affected in all cases with an identified mutation.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; St Thomas Hosp, Dept Ophthalmol, London, England; Moorfields Eye Hosp, Adnexal Serv, London, ON, Canada; Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Genet & IVF Inst, Fairfax, VA 22039 USA; W Suffolk Hosp, Dept Ophthalmol, Bury St Edmunds, Suffolk, England; Addenbrookes Hosp, Cambridge, England	University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Newcastle University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	FitzPatrick, DR (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk	FitzPatrick, David R/B-8311-2008; Hayward, Caroline/M-8818-2016; VAN HEYNINGEN, Veronica/GYE-0531-2022; FitzPatrick, David R/C-7301-2013; van Heyningen, Veronica/B-8039-2008	Hayward, Caroline/0000-0002-9405-9550; van Heyningen, Veronica/0000-0003-0359-0141; Lynch, Sally Ann/0000-0003-3540-1333; FitzPatrick, David R./0000-0003-4861-969X	MRC [MC_U127527199] Funding Source: UKRI; Medical Research Council [MC_U127527199] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Chitayat D, 1996, AM J MED GENET, V61, P45, DOI 10.1002/(SICI)1096-8628(19960102)61:1<45::AID-AJMG9>3.0.CO;2-W; Driggers RW, 1999, AM J MED GENET, V87, P201, DOI 10.1002/(SICI)1096-8628(19991126)87:3<201::AID-AJMG1>3.0.CO;2-H; Guan XY, 1996, NAT GENET, V12, P10, DOI 10.1038/ng0196-10; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kurbasic M, 2000, Ophthalmic Genet, V21, P239, DOI 10.1076/1381-6810(200012)21:4;1-H;FT239; Le Rouedec D, 2002, J ANAT, V200, P51, DOI 10.1046/j.0021-8782.2001.00007.x; Male A, 2002, EUR J HUM GENET, V10, P807, DOI 10.1038/sj.ejhg.5200890; STEVANOVIC M, 1994, MAMM GENOME, V5, P640, DOI 10.1007/BF00411460; Szymanski M, 2002, GENOME BIOL, V3; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Zappone MV, 2000, DEVELOPMENT, V127, P2367	13	400	415	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2003	33	4					461	463		10.1038/ng1120	http://dx.doi.org/10.1038/ng1120			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612584	Bronze			2022-12-27	WOS:000181928600014
J	Botstein, D; Risch, N				Botstein, D; Risch, N			Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease	NATURE GENETICS			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; MARIE-TOOTH-DISEASE; CYSTIC-FIBROSIS GENE; LINKAGE-DISEQUILIBRIUM; FANCONI-ANEMIA; BREAST-CANCER; AXONAL FORM; HAPLOTYPE; SEQUENCE; MAP	The past two decades have witnessed an explosion in the identification, largely by positional cloning, of genes associated with mendelian diseases. The roughly 1,200 genes that have been characterized have clarified our understanding of the molecular basis of human genetic disease. The principles derived from these successes should be applied now to strategies aimed at finding the considerably more elusive genes that underlie complex disease phenotypes. The distribution of types of mutation in mendelian disease genes argues for serious consideration of the early application of a genomic-scale sequence-based approach to association studies and against complete reliance on a positional cloning approach based on a map of anonymous single nucleotide polymorphism haplotypes.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA 94612 USA	Stanford University; Kaiser Permanente	Botstein, D (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	Botstein@genome.Stanford.edu						Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bouhouche A, 1999, AM J HUM GENET, V65, P722, DOI 10.1086/302542; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEAN M, 1994, AM J HUM GENET, V55, P788; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GILLARD EF, 1989, AM J HUM GENET, V45, P507; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gschwend M, 1996, AM J HUM GENET, V59, P377; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Klein C, 1999, ANN HUM GENET, V63, P285, DOI 10.1046/j.1469-1809.1999.6340285.x; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LANDER ES, 1986, P NATL ACAD SCI USA, V83, P7353, DOI 10.1073/pnas.83.19.7353; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Leal A, 2001, AM J HUM GENET, V68, P269, DOI 10.1086/316934; LeGuern E, 1996, HUM MOL GENET, V5, P1685, DOI 10.1093/hmg/5.10.1685; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LITT M, 1989, AM J HUM GENET, V44, P397; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marth G, 2001, NAT GENET, V27, P371, DOI 10.1038/86864; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Morris AP, 2000, ANN HUM GENET, V64, P223, DOI 10.1017/S0003480000008058; MullerMyhsok B, 1997, SCIENCE, V275, P1328; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PALZKILL T, 1992, PROTEINS, V14, P29, DOI 10.1002/prot.340140106; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peltonen L, 2001, SCIENCE, V291, P1224, DOI 10.1126/science.291.5507.1224; RIORDAN JR, 1989, SCIENCE, V245, P1066; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 1997, NAT GENET, V17, P375, DOI 10.1038/ng1297-375; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rogers T, 2000, AM J HUM GENET, V67, P664, DOI 10.1086/303053; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; Saar K, 1998, EUR J HUM GENET, V6, P501, DOI 10.1038/sj.ejhg.5200241; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Sidow A, 2002, CELL, V111, P13, DOI 10.1016/S0092-8674(02)01003-6; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; WALLER NG, 1990, PSYCHOL SCI, V1, P138, DOI 10.1111/j.1467-9280.1990.tb00083.x; WEBER JL, 1989, AM J HUM GENET, V44, P388; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wright AF, 2001, GENOME BIOL, V2	78	1051	1119	1	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			228	237		10.1038/ng1090	http://dx.doi.org/10.1038/ng1090			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610532				2022-12-27	WOS:000181390900003
J	Phillips, MS; Lawrence, R; Sachidanandam, R; Morris, AP; Balding, DJ; Donaldson, MA; Studebaker, JF; Ankener, WM; Alfisi, SV; Kuo, FS; Camisa, AL; Pazorov, V; Scott, KE; Carey, BJ; Faith, J; Katari, G; Bhatti, HA; Cyr, JM; Derohannessian, V; Elosua, C; Forman, AM; Grecco, NM; Hock, CR; Kuebler, JM; Lathrop, JA; Mockler, MA; Nachtman, EP; Restine, SL; Varde, SA; Hozza, MJ; Gelfand, CA; Broxholme, J; Abecasis, GR; Boyce-Jacino, MT; Cardon, LR				Phillips, MS; Lawrence, R; Sachidanandam, R; Morris, AP; Balding, DJ; Donaldson, MA; Studebaker, JF; Ankener, WM; Alfisi, SV; Kuo, FS; Camisa, AL; Pazorov, V; Scott, KE; Carey, BJ; Faith, J; Katari, G; Bhatti, HA; Cyr, JM; Derohannessian, V; Elosua, C; Forman, AM; Grecco, NM; Hock, CR; Kuebler, JM; Lathrop, JA; Mockler, MA; Nachtman, EP; Restine, SL; Varde, SA; Hozza, MJ; Gelfand, CA; Broxholme, J; Abecasis, GR; Boyce-Jacino, MT; Cardon, LR			Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots	NATURE GENETICS			English	Article							GENOME SEQUENCE VARIATION; LINKAGE DISEQUILIBRIUM; MEIOTIC RECOMBINATION; DIVERSITY; MAP	Recent studies of human populations suggest that the genome consists of chromosome segments that are ancestrally conserved ('haplotype blocks'; refs. 1-3) and have discrete boundaries defined by recombination hot spots(4,5). Using publicly available genetic markers(6), we have constructed a first-generation haplotype map of chromosome 19. As expected for this marker density(7), approximately one-third of the chromosome is encompassed within haplotype blocks. Evolutionary modeling of the data indicates that recombination hot spots are not required to explain most of the observed blocks, providing that marker ascertainment and the observed marker spacing are considered. In contrast, several long blocks are inconsistent with our evolutionary models, and different mechanisms could explain their origins.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Orchid Biosci Inc, Princeton, NJ 08540 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, Fac Med, London W2 1PG, England; Univ Michigan, Ann Arbor, MI 48109 USA	University of Oxford; Wellcome Centre for Human Genetics; Cold Spring Harbor Laboratory; Imperial College London; University of Michigan System; University of Michigan	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk	Abecasis, Goncalo R/B-7840-2010; sachidanandam, ravi/Q-6916-2019; Bhatti, Huma Aslam/AAX-1837-2021; Balding, David/G-9898-2011	sachidanandam, ravi/0000-0001-9844-4459; Balding, David/0000-0002-1480-6115; Abecasis, Goncalo/0000-0003-1509-1825; Kuo, Fengshen/0000-0003-1797-2896				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bell PA, 2002, BIOTECHNIQUES, P70; Casci T, 2002, NAT REV GENET, V3, P573, DOI 10.1038/nrg867; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Eberle MA, 2000, GENET EPIDEMIOL, V19, pS29, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI5>3.0.CO;2-P; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Thompson EA, 1986, PEDIGREE ANAL HUMAN; WEIR BS, 1996, GENETIC DATA ANAL, V2, P113; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1	30	225	251	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					382	387		10.1038/ng1100	http://dx.doi.org/10.1038/ng1100			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590262				2022-12-27	WOS:000181312700015
J	Ranish, JA; Yi, EC; Leslie, DM; Purvine, SO; Goodlett, DR; Eng, J; Aebersold, R				Ranish, JA; Yi, EC; Leslie, DM; Purvine, SO; Goodlett, DR; Eng, J; Aebersold, R			The study of macromolecular complexes by quantitative proteomics	NATURE GENETICS			English	Article							YEAST; TRANSCRIPTION; IDENTIFICATION; BINDING; TAGS; DNA	We describe a generic strategy for determining the specific composition, changes in the composition, and changes in the abundance of protein complexes. It is based on the use of isotope-coded affinity tag (ICAT) reagents(1) and mass spectrometry to compare the relative abundances of tryptic peptides derived from suitable pairs of purified or partially purified protein complexes. In a first application, the genuine protein components of a large RNA polymerase II (Pol II) preinitiation complex (PIC) were distinguished from a background of co-purifying proteins by comparing the relative abundances of peptides derived from a control sample and the specific complex that was purified from nuclear extracts by a single-step promoter DNA affinity procedure(2). In a second application, peptides derived from immunopurified STE12 protein complexes isolated from yeast cells in different states were used to detect quantitative changes in the abundance of the complexes, and to detect dynamic changes in the composition of the samples. The use of quantitative mass spectrometry to guide identification of specific complex components in partially purified samples, and to detect quantitative changes in the abundance and composition of protein complexes, provides the researcher with powerful new tools for the comprehensive analysis of macromolecular complexes.	Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Aebersold, R (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	raebersold@systemsbiology.org	Purvine, Samuel O/O-3358-2017; Eng, Jimmy K/I-4202-2012	Purvine, Samuel O/0000-0002-2257-2400; Eng, Jimmy K/0000-0001-6352-6737; Leslie Pedrioli, Deena/0000-0003-2342-8010				AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Cagney G, 2002, NAT BIOTECHNOL, V20, P163, DOI 10.1038/nbt0202-163; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Griffin TJ, 2001, J AM SOC MASS SPECTR, V12, P1238, DOI 10.1016/S1044-0305(01)00316-6; Griffin TJ, 2001, ANAL CHEM, V73, P978, DOI 10.1021/ac001169y; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; OLSON MV, 1991, MOL CELLULAR BIOL YE, V1, P1; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; SPRAGUE GF, 1992, MOL CELLULAR BIOL YE, V2, P657; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yi EC, 2002, ELECTROPHORESIS, V23, P3205, DOI 10.1002/1522-2683(200209)23:18<3205::AID-ELPS3205>3.0.CO;2-Y; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhang XL, 2002, RAPID COMMUN MASS SP, V16, P2325, DOI 10.1002/rcm.864; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512	30	281	294	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33	3					349	355		10.1038/ng1101	http://dx.doi.org/10.1038/ng1101			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12590263				2022-12-27	WOS:000181312700011
J	Chen, WY; Zeng, XB; Carter, MG; Morrell, CN; Yen, RWC; Esteller, M; Watkins, DN; Herman, JG; Mankowski, JL; Baylin, SB				Chen, WY; Zeng, XB; Carter, MG; Morrell, CN; Yen, RWC; Esteller, M; Watkins, DN; Herman, JG; Mankowski, JL; Baylin, SB			Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors	NATURE GENETICS			English	Article							SUPPRESSOR GENE; DNA HYPERMETHYLATION; CANCER; TUMORIGENESIS; METHYLATION; P53; EXPRESSION; P16(INK4A); RETENTION	The gene hypermethylated in cancer-1 (HIC1) encodes a zinc-finger transcription factor(1) that belongs to a group of proteins known as the POZ family(2). HIC1 is hypermethylated and transcriptionally silent in several types of human cancer(1,3-5). Homozygous disruption of Hic1 impairs development and results in embryonic and perinatal lethality in mice(6). Here we show that mice disrupted in the germ line for only one allele of Hic1 develop many different spontaneous malignant tumors, including a predominance of epithelial cancers in males and lymphomas and sarcomas in females. The complete loss of Hic1 function in the heterozygous mice seems to involve dense methylation of the promoter of the remaining wild-type allele. We conclude that HIC1 is a candidate tumor-suppressor gene for which loss of function in both mouse and human cancers is associated only with epigenetic modifications.	Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Div Tumor Biol, Baltimore, MD 21231 USA; NIA, Genet Lab, Dev Genom & Aging Sect, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Comparat Med, Baltimore, MD 21205 USA; Ctr Nacl Invest Oncol, Mol Pathol Program, Canc Epigenet Lab, Madrid, Spain	Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University	Baylin, SB (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Div Tumor Biol, 1650 Orleans St, Baltimore, MD 21231 USA.		Chen, WenYong/D-6748-2012; Watkins, David N/I-6113-2013; Carter, Mark/B-5089-2010; Esteller, Manel/L-5956-2014	Esteller, Manel/0000-0003-4490-6093; Chen, WenYong/0000-0001-6913-5729				BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; Baylin SB, 2000, J NATL CANCER I, V92, P1460, DOI 10.1093/jnci/92.18.1460; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Baylin SB, 2001, J NATL CANCER I, V93, P664, DOI 10.1093/jnci/93.9.664; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fujii H, 1998, ONCOGENE, V16, P2159, DOI 10.1038/sj.onc.1201976; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Issa JPJ, 1997, CANCER RES, V57, P1678; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kanai Y, 1999, HEPATOLOGY, V29, P703, DOI 10.1002/hep.510290338; KAWADA K, 1978, ACTA PATHOL JAPON, V28, P25; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; LUONGO C, 1994, CANCER RES, V54, P5947; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570	23	171	189	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					197	202		10.1038/ng1077	http://dx.doi.org/10.1038/ng1077			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539045				2022-12-27	WOS:000180773700020
J	Duyk, GM				Duyk, GM			Sharper tools and simpler methods	NATURE GENETICS			English	Editorial Material								In this issue of The Chipping Forecast, we are witnesses to the adolescence of a class of technologies that are enabling us to monitor globally aspects of gene expression. Chip-based technologies are specific examples of a more general trend toward the implementation of systematic and comprehensive methods in biological research. We need to recognize, however, that these technologies, while seductive, can sometimes be corruptive. In other words, we must guard against committing the mortal sin of genomics by confusing throughput with output, which too often blurs the distinction between data and knowledge. Instead, we must maintain the necessary focus to achieve an ever-more operational understanding of all the molecular components and the interactions that define a cell or an organism.	Exelixis Inc, San Francisco, CA 94083 USA	Exelixis, Inc.	Duyk, GM (corresponding author), Exelixis Inc, San Francisco, CA 94083 USA.								0	19	20	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32			S			465	468		10.1038/ng1027	http://dx.doi.org/10.1038/ng1027			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454639				2022-12-27	WOS:000179742900004
J	Schubeler, D; Scalzo, D; Kooperberg, C; van Steensel, B; Delrow, J; Groudine, M				Schubeler, D; Scalzo, D; Kooperberg, C; van Steensel, B; Delrow, J; Groudine, M			Genome-wide DNA replication profile for Drosophila melanogaster: a link between transcription and replication timing	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; GENE-EXPRESSION; HETEROCHROMATIN; ORGANIZATION; ASSOCIATION; REGION; LOCUS	Replication of the genome before mitotic cell division is a highly regulated process that ensures the fidelity of DNA duplication. DNA replication initiates at specific locations, termed origins of replication, and progresses in a defined temporal order during the S phase of the cell cycle. The relationship between replication timing and gene expression has been the subject of some speculation(1). A recent genome-wide analysis in Saccharomyces cerevisiae showed no association between replication timing and gene expression(2). In higher eukaryotes, the limited number of genomic loci analyzed has not permitted a firm conclusion regarding this association. To explore the relationship between DNA replication and gene expression in higher eukaryotes, we developed a strategy to measure the timing of DNA replication for thousands of genes in a single DNA array hybridization experiment. Using this approach, we generated a genome-wide map of replication timing for Drosophila melanogaster. Moreover, by surveying over 40% of all D. melanogaster genes, we found a strong correlation between DNA replication early in S phase and transcriptional activity. As this correlation does not exist in S. cerevisiae, this interplay between DNA replication and transcription may be a unique characteristic of higher eukaryotes.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Netherlands Canc Inst, Amsterdam, Netherlands; Fred Hutchinson Canc Res Ctr, DNA Array Facil, Seattle, WA 98104 USA; Univ Washington, Dept Radiat Oncol, Seattle, WA USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Netherlands Cancer Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Schubeler, D (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.							Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; CAIZZI R, 1993, GENETICS, V133, P335; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; DOLFINI S, 1970, EXPERIENTIA, V26, P1020, DOI 10.1007/BF02114171; EBERL DF, 1993, GENETICS, V134, P277; Fan J., 1996, LOCAL POLYNOMIAL MOD; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; HANSEN RS, 1995, HUM MOL GENET, V4, P813; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; JAKUBCZAK JL, 1992, GENETICS, V131, P129; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kooperberg C, 2002, J COMPUT BIOL, V9, P55, DOI 10.1089/10665270252833190; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Sullivan B, 2001, J CELL BIOL, V154, P683, DOI 10.1083/jcb.200103001; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; WAKIMOTO BT, 1990, GENETICS, V125, P141; Yang YH, 2001, MICROARRAYS OPTICAL	25	263	272	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					438	442		10.1038/ng1005	http://dx.doi.org/10.1038/ng1005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12355067				2022-12-27	WOS:000179034800023
J	Feng, BJ; Huang, W; Shugart, YY; Lee, MK; Zhang, F; Xia, JC; Wang, HY; Huang, TB; Jian, SW; Huang, P; Feng, QS; Huang, LX; Yu, XJ; Li, D; Chen, LZ; Jia, WH; Fang, Y; Huang, HM; Zhu, JL; Liu, XM; Zhao, Y; Liu, WQ; Deng, MQ; Hu, WH; Wu, SX; Mo, HY; Hong, MF; King, MC; Chen, Z; Zeng, YX				Feng, BJ; Huang, W; Shugart, YY; Lee, MK; Zhang, F; Xia, JC; Wang, HY; Huang, TB; Jian, SW; Huang, P; Feng, QS; Huang, LX; Yu, XJ; Li, D; Chen, LZ; Jia, WH; Fang, Y; Huang, HM; Zhu, JL; Liu, XM; Zhao, Y; Liu, WQ; Deng, MQ; Hu, WH; Wu, SX; Mo, HY; Hong, MF; King, MC; Chen, Z; Zeng, YX			Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4	NATURE GENETICS			English	Article							RISK-FACTORS; MICROSATELLITES; SCORES; MODEL; MAPS	Nasopharyngeal carcinoma (NPC) occurs with high frequency in Asian populations, especially among people of Cantonese ancestry. In areas with high incidence, NPC clusters in families, which suggests that both geography and genetics may influence disease risk(1-6). Although the HLA-Bw46 locus is associated with increased risk of NPC7,8, no predisposing genes have been identified so far. Here we report the results of a genome-wide search carried out in families at high risk of NPC from Guangdong Province, China. Parametric analyses provide evidence of linkage to the D4S405 marker on chromosome 4 with a logarithm of odds for linkage (lod) score of 3.06 and a heterogeneity-adjusted lod (hlod) score of 3.21. Fine mapping with additional markers flanking D4S405 resulted in a lod score of 3.54 and hlod score of 3.67 for the region 4p15.1-q12. Multipoint nonparametric linkage analysis gives lod scores of 3.54 at D4S405 (P = 5.4 x 10(-5)) and 4.2 at D4S3002 (P = 1.1 x 10(-5)), which is positioned 4.5 cM away from D4S405. When Epstein-Barr virus antibody titer was included as a covariate, the lod scores reached 4.70 (P = 2.0 x 10(-5)) and 5.36 (P = 4.36 x 10(-6)) for D4S405 and D4S3002, respectively. Our findings provide evidence of a major susceptibility locus for NPC on chromosome 4 in a subset of families.	Sun Yat Sen Univ, Inst Canc, Guangzhou, Peoples R China; Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Guangzhou, Peoples R China; Sun Yat Sen Univ, Dept Radiotherapy, Ctr Canc, Guangzhou, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, Shanghai, Peoples R China; Shanghai Med Univ 2, Hlth Sci Ctr, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sc, Shanghai, Peoples R China; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Washington, Dept Med & Genet, Seattle, WA 98195 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle	Zeng, YX (corresponding author), Sun Yat Sen Univ, Inst Canc, Guangzhou, Peoples R China.	yxzeng@gzsums.edu.cn	Liu, Xiaoming/C-2743-2008; Feng, Bing-Jian/C-6974-2009	Liu, Xiaoming/0000-0001-8285-5528; YAO, YIN/0000-0003-3053-8429; King, Mary-Claire/0000-0001-9426-1743				Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHAN S H, 1990, Annals Academy of Medicine Singapore, V19, P201; Chen DL, 1997, CANCER LETT, V117, P17, DOI 10.1016/S0304-3835(97)00182-1; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FISCHER A, 1984, PATHOLOGY, V16, P23, DOI 10.3109/00313028409067906; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HENDERSON BE, 1976, NEW ENGL J MED, V295, P1101, DOI 10.1056/NEJM197611112952003; Huang TB, 1998, NASOPHARYNGEAL CARCI, P6; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; NEVO S, 1971, CANCER, V28, P807, DOI 10.1002/1097-0142(197109)28:3<807::AID-CNCR2820280342>3.0.CO;2-C; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; Ooi EE, 1997, INT J CANCER, V74, P229; OTT J, 1986, GENET EPIDEMIOL, P251; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Sobel E, 1996, AM J HUM GENET, V58, P1323; Vokes EE, 1997, LANCET, V350, P1087, DOI 10.1016/S0140-6736(97)07269-3	24	194	222	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					395	399		10.1038/ng932	http://dx.doi.org/10.1038/ng932			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12118254				2022-12-27	WOS:000177147100015
J	Hirata, H; Bessho, Y; Kokubu, H; Masamizu, Y; Yamada, S; Lewis, J; Kageyama, R				Hirata, H; Bessho, Y; Kokubu, H; Masamizu, Y; Yamada, S; Lewis, J; Kageyama, R			Instability of Hes7 protein is crucial for the somite segmentation clock	NATURE GENETICS			English	Article							LUNATIC-FRINGE EXPRESSION; OSCILLATORY EXPRESSION; PRESOMITIC MESODERM; DYNAMIC EXPRESSION; MECHANISM; GENES; SUGGESTS; PATHWAY; HER1; TIME	During somitogenesis, a pair of somites buds off from the presomitic mesoderm every 2 hours in mouse embryos, suggesting that somite segmentation is controlled by a biological clock with a 2-hour cycle(1-3). Expression of the basic helix-loop-helix factor Hes7, an effector of Notch signaling, follows a 2-hour oscillatory cycle controlled by negative feedback; this is proposed to be the molecular basis for the somite segmentation clock(4-6). If the proposal is correct, this clock should depend crucially on the short lifetime of Hes7. To address the biological importance of Hes7 instability, we generated mice expressing mutant Hes7 with a longer half-life (similar to30 min compared with similar to22 min for wild-type Hes7) but normal repressor activity. In these mice, somite segmentation and oscillatory expression became severely disorganized after a few normal cycles of segmentation. We simulated this effect mathematically using a direct autorepression model. Thus, instability of Hes7 is essential for sustained oscillation and for its function as a segmentation clock.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Canc Res UK London Res Inst, Vertebrate Dev Lab, London WC2A 3PX, England	Kyoto University; Cancer Research UK	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	rkageyam@virus.kyoto-u.ac.jp	Lewis, Julian H/E-8733-2010	Hirata, Hiromi/0000-0002-3769-7441; Masamizu, Yoshito/0000-0002-6929-4882				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Henry CA, 2002, DEVELOPMENT, V129, P3693; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jensen MH, 2003, FEBS LETT, V541, P176, DOI 10.1016/S0014-5793(03)00279-5; Jouve C, 2000, DEVELOPMENT, V127, P1421; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Oates AC, 2002, DEVELOPMENT, V129, P2929; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sawada A, 2000, DEVELOPMENT, V127, P1691; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460	25	182	190	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					750	754		10.1038/ng1372	http://dx.doi.org/10.1038/ng1372			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15170214	Bronze			2022-12-27	WOS:000222354100027
J	Thibault, ST; Singer, MA; Miyazaki, WY; Milash, B; Dompe, NA; Singh, CM; Buchholz, R; Demsky, M; Fawcett, R; Francis-Lang, HL; Ryner, L; Cheung, LM; Chong, A; Erickson, C; Fisher, WW; Greer, K; Hartouni, SR; Howie, E; Jakkula, L; Joo, D; Killpack, K; Laufer, A; Mazzotta, J; Smith, RD; Stevens, LM; Stuber, C; Tan, LR; Ventura, R; Woo, A; Zakrajsek, I; Zhao, L; Chen, F; Swimmer, C; Kopczynski, C; Duyk, G; Winberg, ML; Margolis, J				Thibault, ST; Singer, MA; Miyazaki, WY; Milash, B; Dompe, NA; Singh, CM; Buchholz, R; Demsky, M; Fawcett, R; Francis-Lang, HL; Ryner, L; Cheung, LM; Chong, A; Erickson, C; Fisher, WW; Greer, K; Hartouni, SR; Howie, E; Jakkula, L; Joo, D; Killpack, K; Laufer, A; Mazzotta, J; Smith, RD; Stevens, LM; Stuber, C; Tan, LR; Ventura, R; Woo, A; Zakrajsek, I; Zhao, L; Chen, F; Swimmer, C; Kopczynski, C; Duyk, G; Winberg, ML; Margolis, J			A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac	NATURE GENETICS			English	Article							INSERTIONAL MUTAGENESIS; FLP RECOMBINASE; GENOME PROJECT; ELEMENT; GENE; TRANSFORMATION; SEQUENCE; PROTEIN; RNA	With the availability of complete genome sequence for Drosophila melanogaster, one of the next strategic goals for fly researchers is a complete gene knockout collection. The P element transposon(1), the workhorse of D. melanogaster molecular genetics, has a pronounced nonrandom insertion spectrum(2). It has been estimated that 87% saturation of the 13,500-gene complement of D. melanogaster(3) might require generating and analyzing up to 150,000 insertions(2). We describe specific improvements to the lepidopteran transposon piggyBac(4) and the P element that enabled us to tag and disrupt genes in D. melanogaster more efficiently. We generated over 29,000 inserts resulting in 53% gene saturation and a more diverse collection of phenotypically stronger insertional alleles. We found that piggyBac has distinct global and local gene-tagging behavior from that of P elements. Notably, piggyBac excisions from the germ line are nearly always precise, piggyBac does not share chromosomal hotspots associated with P and piggyBac is more effective at gene disruption because it lacks the P bias for insertion in 5' regulatory sequences.	Exelixis, San Francisco, CA 94083 USA	Exelixis, Inc.	Thibault, ST (corresponding author), Exelixis, 170 Harbor Way, San Francisco, CA 94083 USA.	thibault@exelixis.com	Wilson, Matthew H/K-3193-2013					Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M., 1989, DROSOPHILA LAB HDB; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Goodwin SF, 2000, GENETICS, V154, P725; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P111, DOI 10.1016/S0965-1748(00)00159-4; Horn C, 2003, GENETICS, V163, P647; HOROWITZ H, 1995, GENETICS, V139, P327; KIM YJ, 1992, GENE DEV, V6, P2569, DOI 10.1101/gad.6.12b.2569; PARKS AL, 2004, NAT GENET       0222; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROSEMAN RR, 1995, GENETICS, V141, P1061; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; SERANO T, 1995, DEVELOPMENT, V121, P3809; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; THEURKAUF WE, 1986, P NATL ACAD SCI USA, V83, P8477, DOI 10.1073/pnas.83.22.8477; ZHANG P, 1993, GENETICS, V133, P361	26	630	643	0	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2004	36	3					283	287		10.1038/ng1314	http://dx.doi.org/10.1038/ng1314			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14981521	Bronze			2022-12-27	WOS:000189250400018
J	Ausin, I; Alonso-Blanco, C; Jarillo, JA; Ruiz-Garcia, L; Martinez-Zapater, JM				Ausin, I; Alonso-Blanco, C; Jarillo, JA; Ruiz-Garcia, L; Martinez-Zapater, JM			Regulation of flowering time by FVE, a retinoblastoma-associated protein	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; REPRODUCTIVE DEVELOPMENT; REPEAT PROTEINS; GENE; VERNALIZATION; MUTATIONS; ENCODES; MUTANTS; FRIGIDA; LUMINIDEPENDENS	The initiation of flowering in plants is controlled by environmental and endogenous signals(1,2). Molecular analysis of this process in Arabidopsis thaliana indicates that environmental control is exerted through the photoperiod and vernalization pathways, whereas endogenous signals regulate the autonomous and gibberellin pathways. The vernalization and autonomous pathways converge on the negative regulation of FLC3,4, a gene encoding a MADS-box protein that inhibits flowering(3,4). We cloned FVE, a component of the autonomous pathway that encodes AtMSI4, a putative retinoblastoma-associated protein. FVE interacted with retinoblastoma protein in immunoprecipitation assays, and FLC chromatin was enriched in acetylated histones in fve mutants. We conclude that FVE participates in a protein complex repressing FLC transcription through a histone deacetylation mechanism. Our data provide genetic evidence of a new developmental function of these conserved proteins and identify a new genetic mechanism in the regulation of flowering.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, E-28049 Madrid, Spain; Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid 28040, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Martinez-Zapater, JM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Campus Univ, E-28049 Madrid, Spain.	zapater@cnb.uam.es	Martinez Zapater, Jose/I-4892-2012; Alonso-Blanco, Carlos/F-8864-2016; Ausin, Israel/A-7065-2011	Martinez Zapater, Jose/0000-0001-7217-4454; Alonso-Blanco, Carlos/0000-0002-4738-5556; Ausin, Israel/0000-0002-3707-1780; Ruiz-Garcia, Leonor/0000-0002-3182-4438; Jarillo, Jose Antonio/0000-0002-2963-7641				Ach RA, 1997, PLANT CELL, V9, P1595, DOI 10.1105/tpc.9.9.1595; Boniotti MB, 2001, PLANT J, V28, P341, DOI 10.1046/j.1365-313X.2001.01160.x; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kenzior AL, 1998, FEBS LETT, V440, P425, DOI 10.1016/S0014-5793(98)01500-2; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; MACKNIGHT R, 1997, CELL, V89, P1; MARTINEZZAPATER JM, 1990, PLANT PHYSIOL, V92, P770, DOI 10.1104/pp.92.3.770; MARTINEZZAPATER JM, 1995, PLANT J, V7, P543, DOI 10.1046/j.1365-313X.1995.7040543.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Rossi V, 2003, PLANT MOL BIOL, V51, P401, DOI 10.1023/A:1022090916446; Rossi V, 2001, MOL GENET GENOMICS, V265, P576, DOI 10.1007/s004380100461; Sanda SL, 1996, MOL GEN GENET, V251, P69; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8	30	290	309	5	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					162	166		10.1038/ng1295	http://dx.doi.org/10.1038/ng1295			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14745447	Bronze			2022-12-27	WOS:000188542700018
J	Herbert, A				Herbert, A			The four Rs of RNA-directed evolution	NATURE GENETICS			English	Review							DROSOPHILA BITHORAX COMPLEX; DOUBLE-STRANDED-RNA; MESSENGER-RNA; GENE-EXPRESSION; NONCODING RNAS; ANTISENSE RNA; HUMAN GENOME; POSTTRANSCRIPTIONAL REGULATION; METHYLTRANSFERASE ACTIVITY; TRANSPOSABLE ELEMENTS	The way we quantify the human genome has changed markedly. The estimated percentage of the genome derived from retrotransposition has increased (now 45%; refs. 1,2), as have the estimates for alternative splicing (now 41-60% of multiexon genes)(3,4), antisense transcription (now 10-20% of genes)(5,6) and non protein coding RNA (now similar to7% of full-length cDNAs)(7). Concomitantly, the estimated number of protein-coding genes ( now 24,500) has decreased(8). These numbers support an RNA-centric view of evolution in which phenotypic diversity arises through extensive RNA processing and widespread RNA-directed rewriting of DNA enables dissemination of selfish RNAs associated with successful outcomes(9).. The numbers also indicate important roles for sense-antisense transcription units (SATs) and coregulatory RNAs (coRNAs) in directing the read-out of genetic information, in reconciling different regulatory inputs and in transmitting epigenetic information to progeny. Together, the actions of reading, 'riting, 'rithmetic and replication constitute the four Rs of RNA-directed evolution.	Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA	Boston University	Herbert, A (corresponding author), Boston Univ, Sch Med, Dept Genet & Genom, 715 Albany St, Boston, MA 02118 USA.	aherbert@bu.edu	Herbert, Alan/AAY-4286-2020	Herbert, Alan/0000-0002-0093-1572				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Argeson AC, 1996, GENETICS, V142, P557; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Borsu L, 2000, J BIOL CHEM, V275, P40576, DOI 10.1074/jbc.M006524200; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brosius J, 2003, GENETICA, V118, P99, DOI 10.1023/A:1024141306559; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cassidy SB, 2000, AM J MED GENET, V97, P136, DOI 10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Erdmann VA, 2001, NUCLEIC ACIDS RES, V29, P189, DOI 10.1093/nar/29.1.189; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Finnegan EJ, 2003, CURR BIOL, V13, P236, DOI 10.1016/S0960-9822(03)00010-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haddad F, 2003, J BIOL CHEM, V278, P37132, DOI 10.1074/jbc.M305911200; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Herbert A, 1996, TRENDS GENET, V12, P6, DOI 10.1016/0168-9525(96)81375-8; Herbert A, 1999, NAT GENET, V21, P265, DOI 10.1038/6780; Horton TL, 2002, CURR OPIN MICROBIOL, V5, P620, DOI 10.1016/S1369-5274(02)00379-X; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kardia SLR, 2003, AM J PREV MED, V24, P143, DOI 10.1016/S0749-3797(02)00587-1; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Migeon BR, 2002, AM J HUM GENET, V71, P286, DOI 10.1086/341605; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Negroni M, 2001, ANNU REV GENET, V35, P275, DOI 10.1146/annurev.genet.35.102401.090551; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nikaido L, 2003, GENOME RES, V13, P1402, DOI 10.1101/gr.1055303; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pennisi E, 2003, SCIENCE, V300, P1484, DOI 10.1126/science.300.5625.1484b; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; STEINBRECH RW, 1992, FRACT MECH, V9, P187; Vacek M, 2003, CELL MOL LIFE SCI, V60, P825, DOI 10.1007/s00018-003-3042-7; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	100	48	52	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2004	36	1					19	25		10.1038/ng1275	http://dx.doi.org/10.1038/ng1275			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702037	Bronze			2022-12-27	WOS:000187666800009
J	Person, RE; Li, FQ; Duan, ZJ; Benson, KF; Wechsler, J; Papadaki, HA; Eliopoulos, G; Kaufman, C; Bertolone, SJ; Nakamoto, B; Papayannopoulou, T; Grimes, HL; Horwitz, M				Person, RE; Li, FQ; Duan, ZJ; Benson, KF; Wechsler, J; Papadaki, HA; Eliopoulos, G; Kaufman, C; Bertolone, SJ; Nakamoto, B; Papayannopoulou, T; Grimes, HL; Horwitz, M			Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2	NATURE GENETICS			English	Article							SEVERE CONGENITAL NEUTROPENIA; HERMANSKY-PUDLAK-SYNDROME; ELASTASE; GENE; DIFFERENTIATION	Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic(1,2). We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.	Univ Washington, Div Med Genet, Dept Med, Sch Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; Univ Crete, Dept Hematol, Sch Med, Univ Hosp Heraklion, Iraklion, Greece; Univ Louisville, Inst Cellular Therapeut, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Dept Surg, Sch Med, Louisville, KY 40202 USA; Univ Louisville, Div Hematol Oncol, Sch Med, Dept Pediat, Louisville, KY 40202 USA; Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Hospital of Heraklion; University of Crete; University of Louisville; University of Louisville; University of Louisville; University of Washington; University of Washington Seattle	Horwitz, M (corresponding author), Univ Washington, Div Med Genet, Dept Med, Sch Med, Box 357720, Seattle, WA 98195 USA.			Grimes, H. Leighton/0000-0001-8162-6758; Horwitz, Marshall/0000-0002-1683-1680	NATIONAL CANCER INSTITUTE [R01CA105152] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105152-02, R01 CA105152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Duan ZJ, 2003, P NATL ACAD SCI USA, V100, P5932, DOI 10.1073/pnas.1031694100; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2003, CURR OPIN HEMATOL, V10, P49, DOI 10.1097/00062752-200301000-00008; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Papadaki HA, 2002, ANN HEMATOL, V81, P50, DOI 10.1007/s00277-001-0401-z; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; ZWEIDLERMCKAY PA, 1996, MOL CELL BIOL, V16, P40242	19	269	281	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					308	312		10.1038/ng1170	http://dx.doi.org/10.1038/ng1170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12778173	Green Accepted			2022-12-27	WOS:000183815300019
J	Zhang, YM; Leaves, NI; Anderson, GG; Ponting, CP; Broxholme, J; Holt, R; Edser, P; Bhattacharyya, S; Dunham, A; Adcock, IM; Pulleyn, L; Barnes, PJ; Harper, JI; Abecasis, G; Cardon, L; White, M; Burton, J; Matthews, L; Mott, R; Ross, M; Cox, R; Moffatt, MF; Cookson, WOCM				Zhang, YM; Leaves, NI; Anderson, GG; Ponting, CP; Broxholme, J; Holt, R; Edser, P; Bhattacharyya, S; Dunham, A; Adcock, IM; Pulleyn, L; Barnes, PJ; Harper, JI; Abecasis, G; Cardon, L; White, M; Burton, J; Matthews, L; Mott, R; Ross, M; Cox, R; Moffatt, MF; Cookson, WOCM			Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma	NATURE GENETICS			English	Article							IGE LEVELS; ASSOCIATION; LINKAGE; ATOPY; POLYMORPHISM; GENE; MAP	Atopic or immunoglobulin E (IgE)-mediated diseases include the common disorders of asthma, atopic dermatitis and allergic rhinitis(1). Chromosome 13q14 shows consistent linkage to atopy and the total serum IgE concentration(2-6). We previously identified association between total serum IgE levels and a novel 13q14 microsatellite (USAT24G1; ref. 7) and have now localized the underlying quantitative-trait locus (QTL) in a comprehensive single-nucleotide polymorphism (SNP) map. We found replicated association to IgE levels that was attributed to several alleles in a single gene, PHF11. We also found association with these variants to severe clinical asthma. The gene product (PHF11) contains two PHD zinc fingers and probably regulates transcription. Distinctive splice variants were expressed in immune tissues and cells.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 2JD, England; Wellcome Trust Sanger Inst, Cambridge, England; Natl Heart & Lung Inst, Dept Thorac Med, London, England; Great Ormond St Hosp Sick Children, London, England; Inst Child Hlth, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Trust Sanger Institute; Imperial College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Cookson, WOCM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	william.cookson@ndm.ox.ac.uk	Ponting, Chris/AAV-2621-2021; Adcock, Ian/L-3217-2019; Abecasis, Goncalo R/B-7840-2010; Cookson, William/HHC-1790-2022; White, Melanie/J-5565-2019	White, Melanie/0000-0002-7399-8348; Adcock, Ian/0000-0003-2101-8843; Ponting, Chris/0000-0003-0202-7816; Abecasis, Goncalo/0000-0003-1509-1825; Cox, Roger/0000-0001-7170-5014; Barnes, Peter/0000-0002-5122-4018; Mott, Richard/0000-0002-1022-9330; Zhang, Youming/0000-0001-5403-4044				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Anderson GG, 2002, EUR J HUM GENET, V10, P266, DOI 10.1038/sj.ejhg.5200801; Angioni A, 1998, CANCER GENET CYTOGEN, V107, P107, DOI 10.1016/S0165-4608(98)00105-8; Beyer K, 1998, J ALLERGY CLIN IMMUN, V101, pS152; Bhattacharyya S, 2000, GENOMICS, V70, P286, DOI 10.1006/geno.2000.6398; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; EIBERG H, 1985, CYTOGENET CELL GENET, V40, P622; Garlisi CG, 2001, AM J RESP CELL MOL, V24, P90, DOI 10.1165/ajrcmb.24.1.4224; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HILL MR, 1995, BRIT MED J, V311, P776, DOI 10.1136/bmj.311.7008.776; Hizawa N, 1998, J ALLERGY CLIN IMMUN, V102, P436, DOI 10.1016/S0091-6749(98)70132-0; Jarvis D, 1998, BRIT MED J, V316, P607, DOI 10.1136/bmj.316.7131.607; Kimura K, 1999, HUM MOL GENET, V8, P1487, DOI 10.1093/hmg/8.8.1487; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; OSCIER DG, 1994, BLOOD REV, V8, P88, DOI 10.1016/S0268-960X(05)80013-X; Palmer LJ, 2000, AM J RESP CRIT CARE, V161, P1836, DOI 10.1164/ajrccm.161.6.9805104; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Risch NJ, 1996, AM J HUM GENET, V58, P836; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Walker WH, 1996, J BIOL CHEM, V271, P20145, DOI 10.1074/jbc.271.33.19668	32	237	255	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2003	34	2					181	186		10.1038/ng1166	http://dx.doi.org/10.1038/ng1166			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12754510	Green Submitted			2022-12-27	WOS:000183200500024
J	Freimer, N; Sabatti, C				Freimer, N; Sabatti, C			The Human Phenome Project	NATURE GENETICS			English	Article							HUMAN GENOME; PHENOTYPES; DISCOVERY; GENETICS; CANCER	A principal goal of genetic research is to identify specific genotypes that are associated with human phenotypes. it will soon be possible to conduct genome-wide genotyping on a massive scale. Our current approaches for defining and assaying phenotypes may be inadequate for making optimal use of such genotypic data. We propose an international effort to create phenomic databases, that is, comprehensive assemblages of systematically collected phenotypic information, and to develop new approaches for analyzing such phenotypic data. We term this effort the Human Phenome Project and suggest a scientific and organizational scope for the project.	Ctr Neurobehav Genet, Inst Neuropsychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Freimer, N (corresponding author), Ctr Neurobehav Genet, Inst Neuropsychiat, Gonda Bldg Room 3506,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.							Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Barron A, 1998, IEEE T INFORM THEORY, V44, P2743, DOI 10.1109/18.720554; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Breiman, 1999, 567 U CAL DEP STAT, P29; Breiman L., 1984, CLASSIFICATION REGRE; Cardno AG, 2002, AM J PSYCHIAT, V159, P539, DOI 10.1176/appi.ajp.159.4.539; Couzin J, 2002, SCIENCE, V298, P941, DOI 10.1126/science.298.5595.941a; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Feijen M, 2000, BRIT MED BULL, V56, P894, DOI 10.1258/0007142001903580; Goldschmidt R, 2001, FOCUS BIOTECHNOL, V1, P15; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KELSEY JF, 2000, COMPREHENSIVE TXB PS, P2432; Mahner M, 1997, J THEOR BIOL, V186, P55, DOI 10.1006/jtbi.1996.0335; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Mitchell P, 2002, NAT BIOTECHNOL, V20, P529, DOI 10.1038/nbt0602-529; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; SILVERMAN BW, 1986, DENT ESTIMATION STAT; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Vapnik V., 2013, NATURE STAT LAERNING; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	30	279	298	1	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					15	21		10.1038/ng0503-15	http://dx.doi.org/10.1038/ng0503-15			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12721547				2022-12-27	WOS:000182667900006
J	Hernandez, PA; Gorlin, RJ; Lukens, JN; Taniuchi, S; Bohinjec, J; Francois, F; Klotman, ME; Diaz, GA				Hernandez, PA; Gorlin, RJ; Lukens, JN; Taniuchi, S; Bohinjec, J; Francois, F; Klotman, ME; Diaz, GA			Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease	NATURE GENETICS			English	Article							SEVERE CONGENITAL NEUTROPENIA; LINKAGE ANALYSIS; MYELOKATHEXIS; LYMPHOPOIESIS; MYELOPOIESIS; DISORDER; MICE; INTERNALIZATION; HEMATOPOIESIS; APOPTOSIS	WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection(1). Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis(2). The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Minnesota, Sch Dent, Dept Oral Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Dent, Dept Genet, Minneapolis, MN 55455 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Kansai Med Univ, Dept Pediat, Osaka, Japan; Univ Med Ctr, Dept Haematol, Ljubljana, Slovenia; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Vanderbilt University; Kansai Medical University; University Medical Centre Ljubljana; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Diaz, GA (corresponding author), Mt Sinai Sch Med, Dept Human Genet, 1 Gustave L Levy Pl, New York, NY 10029 USA.		klotman, mary e/A-1921-2016; Diaz, George/AAF-6199-2021					Aprikyan AAG, 2000, BLOOD, V95, P320, DOI 10.1182/blood.V95.1.320.001k23_320_327; Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; BOHINJEC J, 1981, BLUT, V42, P191, DOI 10.1007/BF01026389; Burger JA, 2000, BLOOD, V96, P2655; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Diaz GA, 1998, GENOMICS, V54, P13, DOI 10.1006/geno.1998.5530; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hord JD, 1997, J PEDIAT HEMATOL ONC, V19, P443, DOI 10.1097/00043426-199709000-00007; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MENTZER WC, 1977, BRIT J HAEMATOL, V36, P313, DOI 10.1111/j.1365-2141.1977.tb00654.x; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Onai N, 2000, BLOOD, V96, P2074; OREGAN S, 1977, AM J DIS CHILD, V131, P655, DOI 10.1001/archpedi.1977.02120190049011; Signoret N, 1998, J CELL SCI, V111, P2819; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Taniuchi S, 1999, AM J HEMATOL, V62, P106, DOI 10.1002/(SICI)1096-8652(199910)62:2<106::AID-AJH8>3.3.CO;2-4; WETZLER M, 1990, AM J MED, V89, P663, DOI 10.1016/0002-9343(90)90187-I; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269; ZUELZER WW, 1964, NEW ENGL J MED, V270, P699, DOI 10.1056/NEJM196404022701402	30	461	498	2	29	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					70	74		10.1038/ng1149	http://dx.doi.org/10.1038/ng1149			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692554				2022-12-27	WOS:000182667900019
J	Hieronymus, H; Silver, PA				Hieronymus, H; Silver, PA			Genome-wide analysis of RNA-protein interactions illustrates specificity of the mRNA export machinery	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING-FACTOR; YEAST; MEX67P; YRA1P; SUB2P	Nuclear export of mRNA is mediated by a complex machinery of RNA-binding proteins that recognizes and routes mRNAs through a messenger ribonucleoprotein (mRNP) network. The full spectrum of mRNA cargoes for any dedicated mRNA export factor is unknown. We identified the mRNAs that bind two conserved yeast mRNA export factors, Yra1 (refs. 1-5) and Mex67 (refs. 6,7), on a genome-wide scale and determined their level of binding. Yra1 and Mex67 bind approximately 1,000 and 1,150 mRNAs, respectively, corresponding to almost 20% of the yeast genome and roughly 36% of all transcriptional events each. The binding level of Yra1 targets is related to their transcriptional frequency, but that of Mex67 targets is not. Yra1-bound transcripts are enriched in mRNAs that are regulated by a number of transcription factors. Yra1- and Mex67-bound populations also show enrichment of mRNAs encoding distinct functional classes of proteins, some of which are regulated by these transcription factors. We determined that one such transcription factor, Abf1 (refs. 8-10), associates with Yra1. These results indicate a previously unidentified specificity of mRNA export factors, which coordinates the export of transcriptionally co-regulated, functional classes of transcripts, perhaps through interactions with the transcriptional machinery.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.							Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Cole CN, 2000, NAT CELL BIOL, V2, pE55, DOI 10.1038/35008681; constanzo M. C., 2001, NUCLEIC ACIDS RES, V29, P75; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; Duncan K, 2000, CURR BIOL, V10, P687, DOI 10.1016/S0960-9822(00)00527-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; LOO S, 1995, GENETICS, V141, P889; Lopez PJ, 1999, RNA, V5, P1135, DOI 10.1017/S135583829999091X; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MATUNIS EL, 1993, J CELL BIOL, V121, P219, DOI 10.1083/jcb.121.2.219; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; RHODE PR, 1989, GENE DEV, V3, P1926, DOI 10.1101/gad.3.12a.1926; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	30	170	176	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					155	161		10.1038/ng1080	http://dx.doi.org/10.1038/ng1080			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524544				2022-12-27	WOS:000180773700012
J	Lohmueller, KE; Pearce, CL; Pike, M; Lander, ES; Hirschhorn, JN				Lohmueller, KE; Pearce, CL; Pike, M; Lander, ES; Hirschhorn, JN			Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease	NATURE GENETICS			English	Article							GLUCOSE-TRANSPORTER; DIABETES-MELLITUS; INSULIN-RECEPTOR; ACTIVITY ALLELE; POLYMORPHISM; RISK; REPLICATION; FREQUENCY; REGION; BIAS	Association studies offer a potentially powerful approach to identify genetic variants that influence susceptibility to common disease(1-4), but are plagued by the impression that they are not consistently reproducible(5,6). In principle, the inconsistency may be due to false positive studies, false negative studies or true variability in association among different populations(4-8). The critical question is whether false positives overwhelmingly explain the inconsistency. We analyzed 301 published studies covering 25 different reported associations. There was a large excess of studies replicating the first positive reports, inconsistent with the hypothesis of no true positive associations (P < 10(-14)). This excess of replications could not be reasonably explained by publication bias and was concentrated among 11 of the 25 associations. For 8 of these 11 associations, pooled analysis of follow-up studies yielded statistically significant replication of the first report, with modest estimated genetic effects. Thus, a sizable fraction (but under half) of reported associations have strong evidence of replication; for these, false negative, underpowered studies probably contribute to inconsistent replication. We conclude that there are probably many common variants in the human genome with modest but real effects on common disease risk, and that studies using large samples will convincingly identify such variants.	MIT, Ctr Genome Res, Cambridge, MA 02139 USA; Georgetown Univ, Washington, DC 20057 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Georgetown University; University of Southern California; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Hirschhorn, JN (corresponding author), MIT, Ctr Genome Res, Cambridge, MA 02139 USA.	joel.hirschhorn@tch.harvard.edu						ALCOLADO JC, 1991, DIABETOLOGIA, V34, P734, DOI 10.1007/BF00401519; Altshuler D, 1998, NEW ENGL J MED, V338, P1626, DOI 10.1056/NEJM199805283382214; [Anonymous], 1999, NAT GENET, V22, P1; Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; BAZERMAN MH, 1983, J CONFLICT RESOLUT, V27, P618, DOI 10.1177/0022002783027004003; Bellivier F, 1998, ARCH GEN PSYCHIAT, V55, P33, DOI 10.1001/archpsyc.55.1.33; Breslow NE, 1980, ANAL CASE CONTROL ST; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; CROCQ MA, 1992, J MED GENET, V29, P858, DOI 10.1136/jmg.29.12.858; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; GALTON DJ, 1988, BIOMED BIOCHIM ACTA, V47, P323; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; GROOP LC, 1993, NEW ENGL J MED, V328, P10, DOI 10.1056/NEJM199301073280102; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Harrington CR, 1995, NEUROSCI LETT, V202, P101, DOI 10.1016/0304-3940(95)12218-4; Helzlsouer KJ, 1998, J NATL CANCER I, V90, P512, DOI 10.1093/jnci/90.7.512; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; Inayama Y, 1996, AM J MED GENET, V67, P103, DOI 10.1002/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO;2-S; Inoue H, 1996, DIABETES, V45, P825, DOI 10.2337/diabetes.45.6.825; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LI SR, 1988, LANCET, V2, P368; Li T, 1997, PHARMACOGENETICS, V7, P349, DOI 10.1097/00008571-199710000-00002; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Montoya SE, 1998, NAT GENET, V18, P211, DOI 10.1038/ng0398-211; NANKO S, 1994, ACTA PSYCHIAT SCAND, V89, P390, DOI 10.1111/j.1600-0447.1994.tb01534.x; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Reis IM, 1999, STAT MED, V18, P893, DOI 10.1002/(SICI)1097-0258(19990430)18:8<893::AID-SIM84>3.0.CO;2-5; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; Serrato M, 1995, J CLIN INVEST, V96, P3005, DOI 10.1172/JCI118373; Stram DO, 1996, BIOMETRICS, V52, P536, DOI 10.2307/2532893; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; tHart LM, 1996, AM J HUM GENET, V59, P1119; TRIZNA Z, 1995, AM J SURG, V170, P499, DOI 10.1016/S0002-9610(99)80339-0	42	1509	1554	0	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					177	182		10.1038/ng1071	http://dx.doi.org/10.1038/ng1071			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12524541				2022-12-27	WOS:000180773700016
J	Kondo, S; Schutte, BC; Richardson, RJ; Bjork, BC; Knight, AS; Watanabe, Y; Howard, E; de Lima, RLLF; Daack-Hirsch, S; Sander, A; McDonald-McGinn, DM; Zackai, EH; Lammer, EJ; Aylsworth, AS; Ardinger, HH; Lidral, AC; Pober, BR; Moreno, L; Arcos-Burgos, M; Valencia, C; Houdayer, C; Bahuau, M; Moretti-Ferreira, D; Richieri-Costa, A; Dixon, MJ; Murray, JC				Kondo, S; Schutte, BC; Richardson, RJ; Bjork, BC; Knight, AS; Watanabe, Y; Howard, E; de Lima, RLLF; Daack-Hirsch, S; Sander, A; McDonald-McGinn, DM; Zackai, EH; Lammer, EJ; Aylsworth, AS; Ardinger, HH; Lidral, AC; Pober, BR; Moreno, L; Arcos-Burgos, M; Valencia, C; Houdayer, C; Bahuau, M; Moretti-Ferreira, D; Richieri-Costa, A; Dixon, MJ; Murray, JC			Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes	NATURE GENETICS			English	Article							INTERFERON REGULATORY FACTORS; SEQUENCE; GENE; EXPRESSION; 1Q32-Q41; HOMOLOG; DEFECTS; LINKAGE; DOMAIN; PALATE	Interferon regulatory factor 6 (IRF6) belongs to a family of nine transcription factors that share a highly conserved helix-turn-helix DNA-binding domain and a less conserved protein-binding domain. Most IRFs regulate the expression of interferon-alpha and -beta after viral infection(1), but the function of IRF6 is unknown. The gene encoding IRF6 is located in the critical region for the Van der Woude syndrome (VWS; OMIM 119300) locus at chromosome 1q32-q41 (refs 2,3). The disorder is an autosomal dominant form of cleft lip and palate with lip pits(4), and is the most common syndromic form of cleft lip or palate. Popliteal pterygium syndrome (PPS; OMIM 119500) is a disorder with a similar orofacial phenotype that also includes skin and genital anomalies(5). Phenotypic overlap(6) and linkage data(7) suggest that these two disorders are allelic. We found a nonsense mutation in IRF6 in the affected twin of a pair of monozygotic twins who were discordant for VWS. Subsequently, we identified mutations in IRF6 in 45 additional unrelated families affected with VWS and distinct mutations in 13 families affected with PPS. Expression analyses showed high levels of Irf6 mRNA along the medial edge of the fusing palate, tooth buds, hair follicles, genitalia and skin. Our observations demonstrate that haploinsufficiency of IRF6 disrupts orofacial development and are consistent with dominant-negative mutations disturbing development of the skin and genitalia.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary PhD Program Genet, Iowa City, IA 52242 USA; Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; Univ Manchester, Dept Dent Med & Surg, Manchester, Lancs, England; Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; Univ Estadual Paulista, Serv Aconselhamento Genet, Botucatu, SP, Brazil; Univ Hamburg, Clin Oral Maxillofacial Surg, Hamburg, Germany; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Childrens Hosp, Oakland, CA 94609 USA; Univ N Carolina, Dept Pediat & Genet, Chapel Hill, NC USA; Univ Kansas, Childrens Med Ctr, Dept Pediat, Kansas City, KS USA; Univ Iowa, Dept Orthodont, Iowa City, IA USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Iowa, PhD Program Oral Sci, Iowa City, IA USA; Univ Antioquia, Medellin, Colombia; Hop Enfants Armand Trousseau, Serv Biochim & Biol Mol, Paris, France; Hop Enfants Armand Trousseau, Serv Chirurg Maxillofaciale & Plast Stomatol, Paris, France; Univ Sao Paulo, Serv Chirurg Maxillofaciale & Lesoes Labio Palati, Dept Clin Genet, Bauru, Brazil; Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Manchester; University of Manchester; Harvard University; Brigham & Women's Hospital; Universidade Estadual Paulista; University of Hamburg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Kansas; University of Iowa; Yale University; University of Iowa; Universidad de Antioquia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidade de Sao Paulo; University of Iowa	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.		Moretti-Ferreira, Danilo/P-3456-2019; Richieri-Costa, Antonio/B-2514-2013; Moretti-Ferreira, Danilo/F-9565-2012; McDonald-McGinn, Donna/L-8643-2019; Arcos-Burgos, Mauricio/H-1326-2017	Moretti-Ferreira, Danilo/0000-0002-9256-7623; Daack-Hirsch, Sandra/0000-0003-1192-7154; Richardson, Beck/0000-0002-4701-8713; Watanabe, Yoriko/0000-0003-4685-8021; Houdayer, Claude/0000-0002-5190-0389; McDonald-McGinn, Donna/0000-0003-4077-250X; Arcos-Burgos, Mauricio/0000-0002-8529-0574	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013076, R01DE014667] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE014667-03, R01 DE014667, P60 DE013076-030005, P60 DE013076-020005, P60 DE013076-040005, P60 DE013076-010005, P60 DE013076, R01 DE014667-01, P60 DE013076-050005, P60 DE013076-01S10005, R01 DE014667-02, P60 DE013076-03S10005, R01 DE014667-04] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; BIXLER D, 1973, CLIN GENET, V4, P220; BOCIAN M, 1987, AM J MED GENET, V26, P437, DOI 10.1002/ajmg.1320260223; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Dixon J, 1997, HUM MOL GENET, V6, P727, DOI 10.1093/hmg/6.5.727; Eroshkin A, 1999, J MOL MED, V77, P403, DOI 10.1007/s001090050369; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; FRASER F C, 1955, Acta Genet Stat Med, V5, P358; GORLIN RJ, 1968, PEDIATRICS, V41, P503; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Lees MM, 1999, J MED GENET, V36, P888; Lin RT, 1999, MOL CELL BIOL, V19, P959; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; MURRAY JC, 1990, AM J HUM GENET, V46, P486; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SANDER A, 1994, HUM MOL GENET, V3, P575, DOI 10.1093/hmg/3.4.575; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schutte BC, 1999, AM J MED GENET, V84, P145, DOI 10.1002/(SICI)1096-8628(19990521)84:2<145::AID-AJMG11>3.0.CO;2-L; Schutte BC, 2000, GENOME RES, V10, P81; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244	29	590	618	2	77	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					285	289		10.1038/ng985	http://dx.doi.org/10.1038/ng985			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12219090	Green Accepted, Green Published			2022-12-27	WOS:000178311100018
J	Castillo-Davis, CI; Mekhedov, SL; Hartl, DL; Koonin, EV; Kondrashov, FA				Castillo-Davis, CI; Mekhedov, SL; Hartl, DL; Koonin, EV; Kondrashov, FA			Selection for short introns in highly expressed genes	NATURE GENETICS			English	Article							GENOME EVOLUTION; CODON BIAS; C-ELEGANS; DROSOPHILA; LENGTH; TRANSCRIPTION; RATES; SIZE; DNA; CAENORHABDITIS	Transcription is a slow and expensive process: in eukaryotes, approximately 20 nucleotides can be transcribed per second(1,2) at the expense of at least two ATP molecules per nucleotide(3). Thus, at least for highly expressed genes, transcription of long introns, which are particularly common in mammals, is costly. Using data on the expression of genes that encode proteins in Caenorhabditis elegans and Homo sapiens, we show that introns in highly expressed genes are substantially shorter than those in genes that are expressed at low levels. This difference is greater in humans, such that introns are, on average, 14 times shorter in highly expressed genes than in genes with low expression, whereas in C. elegans the difference in intron length is only twofold. In contrast, the density of introns in a gene does not strongly depend on the level of gene expression. Thus, natural selection appears to favor short introns in highly expressed genes to minimize the cost of transcription and other molecular processes, such as splicing.	Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; Harvard University	Kondrashov, FA (corresponding author), Natl Ctr Biotechnol Informat, NIH, 8600 Rockville Pike, Bethesda, MD 20894 USA.	fkondras@ncbi.nlm.nih.gov	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694	NATIONAL LIBRARY OF MEDICINE [Z01LM000073, ZIALM000073] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bortoluzzi S, 1999, TRENDS GENET, V15, P118, DOI 10.1016/S0168-9525(98)01682-5; BOULIKAS T, 1992, J MOL EVOL, V35, P156, DOI 10.1007/BF00183227; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carels N, 2000, GENETICS, V154, P1819; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Coghlan A, 2000, YEAST, V16, P1131, DOI 10.1002/1097-0061(20000915)16:12<1131::AID-YEA609>3.0.CO;2-F; Comeron JM, 2000, GENETICS, V156, P1175; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; EyreWalker A, 1996, MOL BIOL EVOL, V13, P864, DOI 10.1093/oxfordjournals.molbev.a025646; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hurst LD, 1999, TRENDS GENET, V15, P437, DOI 10.1016/S0168-9525(99)01832-6; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; LEHNINGER AL, 1982, PRINCIPLES BIOCH, P615; Moriyama EN, 1998, MOL BIOL EVOL, V15, P770, DOI 10.1093/oxfordjournals.molbev.a025980; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Ogata H, 1996, FEBS LETT, V390, P99, DOI 10.1016/0014-5793(96)00636-9; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; SULLIVAN DT, 1995, CURR OPIN GENET DEV, V5, P786, DOI 10.1016/0959-437X(95)80012-T; UCKER DS, 1984, J BIOL CHEM, V259, P7416; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	30	386	404	3	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					415	418		10.1038/ng940	http://dx.doi.org/10.1038/ng940			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134150	Green Published			2022-12-27	WOS:000177147100019
J	Patel, H; Cross, H; Proukakis, C; Hershberger, R; Bork, P; Ciccarelli, FD; Patton, MA; McKusick, VA; Crosby, AH				Patel, H; Cross, H; Proukakis, C; Hershberger, R; Bork, P; Ciccarelli, FD; Patton, MA; McKusick, VA; Crosby, AH			SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia	NATURE GENETICS			English	Article							PROTEIN TRAFFICKING; MAMMALIAN-CELLS; MORPHOLOGY; VPS4P	Troyer syndrome (TRS) is an autosomal recessive complicated hereditary spastic paraplegia (HSP) that occurs with high frequency in the Old Order Amish. We report mapping of the TRS locus to chromosome 13q12.3 and identify a frameshift mutation in SPG20, encoding spartin. Comparative sequence analysis indicates that spartin shares similarity with molecules involved in endosomal trafficking and with spastin, a molecule implicated in microtubule interaction that is commonly mutated in HSP.	Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England	St Georges University London	Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Crosby, Andrew H/E-2218-2015; Cross, J. Helen/ACK-3032-2022; proukakis, christos/ABE-3447-2020; Proukakis, Christos/G-4548-2013; Bork, Peer/F-1813-2013; Ciccarelli, Francesca/D-5380-2014	Crosby, Andrew H/0000-0003-3667-9054; Cross, J. Helen/0000-0001-7345-4829; proukakis, christos/0000-0001-6423-6539; Bork, Peer/0000-0002-2627-833X; Ciccarelli, Francesca/0000-0002-9325-0900				Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barr VA, 2000, TRAFFIC, V1, P904, DOI 10.1034/j.1600-0854.2000.011109.x; Bloom GS, 1998, J CELL BIOL, V140, P1277, DOI 10.1083/jcb.140.6.1277; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Patel H, 2001, AM J HUM GENET, V69, P209, DOI 10.1086/321267; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Terada S, 2000, CURR OPIN NEUROBIOL, V10, P566, DOI 10.1016/S0959-4388(00)00129-X; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	14	184	192	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					347	348		10.1038/ng937	http://dx.doi.org/10.1038/ng937			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134148				2022-12-27	WOS:000177147100007
J	Steinmetz, LM; Scharfe, C; Deutschbauer, AM; Mokranjac, D; Herman, ZS; Jones, T; Chu, AM; Giaever, G; Prokisch, H; Oefner, PJ; Davis, RW				Steinmetz, LM; Scharfe, C; Deutschbauer, AM; Mokranjac, D; Herman, ZS; Jones, T; Chu, AM; Giaever, G; Prokisch, H; Oefner, PJ; Davis, RW			Systematic screen for human disease genes in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; LOCUS HETEROGENEITY; OPTIC ATROPHY; MITOCHONDRIAL; CHROMOSOME; EXPRESSION; SEQUENCES; DATABASE; DELETION; LINKAGE	High similarity between yeast and human mitochondria allows functional genomic study of Saccharomyces cerevisiae to be used to identify human genes involved in disease(1). So far, 102 heritable disorders have been attributed to defects in a quarter of the known nuclear-encoded mitochondrial proteins in humans(2). Many mitochondrial diseases remain unexplained, however, in part because only 40-60% of the presumed 700-1,000 proteins involved in mitochondrial function and biogenesis have been identified(3). Here we apply a systematic functional screen using the pre-existing whole-genome pool of yeast deletion mutants(4-6) to identify mitochondrial proteins. Three million measurements of strain fitness identified 466 genes whose deletions impaired mitochondrial respiration, of which 265 were new. Our approach gave higher selection than other systematic approaches, including fivefold greater selection than gene expression analysis. To apply these advantages to human disorders involving mitochondria, human orthologs were identified and linked to heritable diseases using genomic map positions.	Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Univ Munich, Inst Physiol Chem, D-8000 Munich, Germany	Stanford University; Stanford University; Stanford University; University of Munich	Steinmetz, LM (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	larsms@stanford.edu; curts@stanford.edu	Prokisch, Holger/N-8964-2013	Prokisch, Holger/0000-0003-2379-6286; Steinmetz, Lars/0000-0002-3962-2865; Mokranjac, Dejana/0000-0002-4005-6979				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Assink JJM, 1997, AM J HUM GENET, V61, P934, DOI 10.1086/514884; Birrell GW, 2001, P NATL ACAD SCI USA, V98, P12608, DOI 10.1073/pnas.231366398; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Christodoulou K, 2001, NEUROGENETICS, V3, P127, DOI 10.1007/s100480100112; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Grivell LA, 1999, FEBS LETT, V452, P57, DOI 10.1016/S0014-5793(99)00532-3; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; McMullan TFW, 2000, AM J HUM GENET, V66, P1455, DOI 10.1086/302860; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; PRIEST JM, 1995, GENOMICS, V29, P409, DOI 10.1006/geno.1995.9987; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627	29	425	434	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					400	404		10.1038/ng929	http://dx.doi.org/10.1038/ng929			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12134146				2022-12-27	WOS:000177147100016
J	Mizuguchi, T; Collod-Beroud, G; Akiyama, T; Abifadel, M; Harada, N; Morisaki, T; Allard, D; Varret, M; Claustres, M; Morisaki, H; Ihara, M; Kinoshita, A; Yoshiura, K; Junien, C; Kajii, T; Jondeau, G; Ohta, T; Kishino, T; Furukawa, Y; Nakamura, Y; Niikawa, N; Boileau, C; Matsumoto, N				Mizuguchi, T; Collod-Beroud, G; Akiyama, T; Abifadel, M; Harada, N; Morisaki, T; Allard, D; Varret, M; Claustres, M; Morisaki, H; Ihara, M; Kinoshita, A; Yoshiura, K; Junien, C; Kajii, T; Jondeau, G; Ohta, T; Kishino, T; Furukawa, Y; Nakamura, Y; Niikawa, N; Boileau, C; Matsumoto, N			Heterozygous TGFBR2 mutations in Marfan syndrome	NATURE GENETICS			English	Article							II RECEPTOR GENE; BETA ACTIVATION; MICROSATELLITE INSTABILITY; COLON-CANCER; INACTIVATION; LOCUS	Marfan syndrome is an extracellular matrix disorder with cardinal manifestations in the eye, skeleton and cardiovascular systems associated with defects in the gene encoding fibrillin (FBN1) at 15q21.1 (ref. 1). A second type of the disorder ( Marfan syndrome type 2; OMIM 154705) is associated with a second locus, MFS2, at 3p25-p24.2 in a large French family (family MS1)(2). Identification of a 3p24.1 chromosomal breakpoint disrupting the gene encoding TGF-beta receptor 2 (TGFBR2) in a Japanese individual with Marfan syndrome led us to consider TGFBR2 as the gene underlying association with Marfan syndrome at the MSF2 locus. The mutation 1524G --> A in TGFBR2 ( causing the synonymous amino acid substitution Q508Q) resulted in abnormal splicing and segregated with MFS2 in family MS1. We identified three other missense mutations in four unrelated probands, which led to loss of function of TGF-beta signaling activity on extracellular matrix formation. These results show that heterozygous mutations in TGFBR2, a putative tumor-suppressor gene implicated in several malignancies, are also associated with inherited connective-tissue disorders.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan; Inst Univ Rech Clin, Genet Mol Lab, Montpellier, France; Univ Paris 05, INSERM, U383, Hop Necker Enfants Malad, Paris, France; Natl Okayama Med Ctr, Div Pediat Surg, Okayama, Japan; Kyushu Med Sci Nagasaki Lab, Nagasaki, Japan; Natl Cardiovasc Ctr, Res Inst, Dept Biosci, Suita, Osaka 565, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Biophys, Nagasaki 852, Japan; Hop Ambroise Pare, Lab Biochim Hormonol & Genet Mol, Boulogne, France; Hop Ambroise Pare, Serv Cardiol, Boulogne, France; Nagasaki Univ, Ctr Frontier Life Sci, Div Funct Gen, Nagasaki 852, Japan; Hlth Sci Univ Hokkaido, Ishikari, Hokkaido 06102, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan	Nagasaki University; Japan Science & Technology Agency (JST); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Cerebral & Cardiovascular Center - Japan; Nagasaki University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Nagasaki University; Health Sciences University of Hokkaido; University of Tokyo; Yokohama City University	Boileau, C (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 852, Japan.	boileau@necker.fr; naomat@yokohama-cu.ac.jp	COLLOD-BEROUD, Gwenaëlle/A-8342-2008; VARRET, Mathilde/C-2279-2016; Abifadel, Marianne/ABH-5370-2020; boileau, catherine/M-4482-2017	COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; VARRET, Mathilde/0000-0001-9261-1551; boileau, catherine/0000-0002-0371-7539; ABIFADEL, Marianne/0000-0001-7645-8323; ALLARD, Delphine/0000-0001-7534-8982				Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; BOILEAU C, 1993, AM J HUM GENET, V53, P46; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; COLLOD G, 1994, NAT GENET, V8, P264, DOI 10.1038/ng1194-264; Collod-Beroud G, 2002, EUR J HUM GENET, V10, P673, DOI 10.1038/sj.ejhg.5200876; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; Grady WM, 1999, CANCER RES, V59, P320; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Kissin EY, 2002, ARTHRITIS RHEUM, V46, P3000, DOI 10.1002/art.10621; Lu SL, 1999, BIOCHEM BIOPH RES CO, V259, P385, DOI 10.1006/bbrc.1999.0788; Lu SL, 1998, NAT GENET, V19, P17, DOI 10.1038/ng0598-17; Lucke CD, 2001, CANCER RES, V61, P482; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Matsukawa R, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<71::AID-HUMU9>3.0.CO;2-0; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; PARSONS R, 1995, CANCER RES, V55, P5548; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Tanaka S, 2000, BRIT J CANCER, V82, P1557	22	456	483	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					855	860		10.1038/ng1392	http://dx.doi.org/10.1038/ng1392			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15235604	Green Accepted			2022-12-27	WOS:000222974000018
J	Simone, C; Forcales, SV; Hill, DA; Imbalzano, AN; Latella, L; Puri, PL				Simone, C; Forcales, SV; Hill, DA; Imbalzano, AN; Latella, L; Puri, PL			p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; MAP KINASE; MYOD; DIFFERENTIATION; BINDING; FAMILY; ACETYLATION; ROLES; MEF2C; PCAF	During skeletal myogenesis, genomic reprogramming toward terminal differentiation is achieved by recruiting chromatin-modifying enzymes to muscle-specific loci(1,2). The relative contribution of extracellular signaling cascades in targeting these enzymes to individual genes is unknown. Here we show that the differentiation-activated p38 pathway(3-5) targets the SWI-SNF chromatin-remodeling complex to myogenic loci. Upon differentiation, p38 kinases were recruited to the chromatin of muscle-regulatory elements. Blockade of p38alpha/beta repressed the transcription of muscle genes by preventing recruitment of the SWI-SNF complex at these elements without affecting chromatin binding of muscle-regulatory factors and acetyltransferases. The SWI-SNF subunit BAF60 could be phosphorylated by p38alpha-beta in vitro, and forced activation of p38alpha/beta in myoblasts by expression of a constitutively active MKK6 (refs. 5-7) promoted unscheduled SWI-SNF recruitment to the myogenin promoter. Conversely, inactivation of SWI-SNF enzymatic subunits abrogated MKK6-dependent induction of muscle gene expression. These results identify an unexpected function of differentiation-activated p38 in converting external cues into chromatin modifications at discrete loci, by selectively targeting SWI-SNF to muscle-regulatory elements.	Fdn A Cesalpino, Inst Cell Biol & Tissue Engn, Dulbecco Telethon Inst, Gene Express Lab, I-00128 Rome, Italy; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92093 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Salk Institute; University of Massachusetts System; University of Massachusetts Worcester	Puri, PL (corresponding author), Fdn A Cesalpino, Inst Cell Biol & Tissue Engn, Dulbecco Telethon Inst, Gene Express Lab, San Raffaele Biomed Sci Pk Rome, I-00128 Rome, Italy.	plpuri@dti.telethon.it	Latella, Lucia/K-7834-2016; Forcales, Sonia/AAU-8996-2020; Forcales, Sonia-V./B-2157-2013; Simone, Cristiano/K-3452-2018	Forcales, Sonia/0000-0002-7111-4959; Forcales, Sonia-V./0000-0002-7111-4959; Simone, Cristiano/0000-0002-2628-7658; Puri, Pier Lorenzo/0000-0003-4964-0095; LATELLA, LUCIA/0000-0003-1317-9233	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056244] Funding Source: Medline; Telethon [TCP00081, GFP01009] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon)		Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DEBRIL MB, 2003, J BIOL CHEM, V16, P16677; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 2000, GENE DEV, V14, P574; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 1999, MOL CELL BIOL, V19, P21	29	308	319	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					738	743		10.1038/ng1378	http://dx.doi.org/10.1038/ng1378			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208625	Bronze			2022-12-27	WOS:000222354100025
J	Pennaneach, V; Kolodner, RD				Pennaneach, V; Kolodner, RD			Recombination and the Tel1 and Mec1 checkpoints differentially effect genome rearrangements driven by telomere dysfunction in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL REARRANGEMENTS; DYSKERATOSIS-CONGENITA; BUDDING YEAST; DNA-DAMAGE; MAINTENANCE; FUSIONS; REPLICATION; INSTABILITY; PATHWAYS	In telomerase-deficient Saccharomyces cerevisiae, telomeres are maintained by recombination. Here we used a S. cerevisiae assay for characterizing gross chromosomal rearrangements (GCRs) to analyze genome instability in post-senescent telomerase-deficient cells. Telomerase-deficient tlc1 and est2 mutants did not have increased GCR rates, but their telomeres could be joined to other DNAs resulting in chromosome fusions. Inactivation of Tell or either the Rad51 or Rad59 recombination pathways in telomerase-deficient cells increased the GCR rate, even though telomeres were maintained. The GCRs were translocations and chromosome fusions formed by nonhomologous end joining. We observed chromosome fusions only in mutant strains expressing Rad51 and Rad55 or when Tel1 was inactivated. In contrast, inactivation of Mec1 resulted in more inversion translocations such as the isochromosomes seen in human tumors. These inversion translocations seemed to be formed by recombination after replication of broken chromosomes.	Univ Calif San Diego, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Ctr Canc, CMME 3058,9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu		Pennaneach, Vincent/0000-0002-2518-0517				Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bashkirov VI, 2000, MOL CELL BIOL, V20, P4393, DOI 10.1128/MCB.20.12.4393-4404.2000; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cervantes RB, 2002, CURR OPIN CELL BIOL, V14, P351, DOI 10.1016/S0955-0674(02)00325-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; DuBois ML, 2002, GENETICS, V161, P995; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Fouladi B, 2000, NEOPLASIA, V2, P540, DOI 10.1038/sj.neo.7900107; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Liti G, 2003, MOL CELL, V11, P1373, DOI 10.1016/S1097-2765(03)00177-1; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mieczkowski PA, 2003, P NATL ACAD SCI USA, V100, P10854, DOI 10.1073/pnas.1934561100; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zhang AJ, 2003, AM J HUM GENET, V72, P940, DOI 10.1086/374565	30	53	53	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					612	617		10.1038/ng1359	http://dx.doi.org/10.1038/ng1359			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15133512	Bronze			2022-12-27	WOS:000221763700019
J	Ravikumar, B; Vacher, C; Berger, Z; Davies, JE; Luo, SQ; Oroz, LG; Scaravilli, F; Easton, DF; Duden, R; O'Kane, CJ; Rubinsztein, DC				Ravikumar, B; Vacher, C; Berger, Z; Davies, JE; Luo, SQ; Oroz, LG; Scaravilli, F; Easton, DF; Duden, R; O'Kane, CJ; Rubinsztein, DC			Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease	NATURE GENETICS			English	Article							INTRANUCLEAR INCLUSIONS; SYNAPTIC PLASTICITY; CELLULAR GROWTH; TRANSGENIC MICE; DROSOPHILA; MUTATION; PROTEIN; TRANSLATION; NUCLEAR; DEATH	Huntington disease is one of nine inherited neurodegenerative disorders caused by a polyglutamine tract expansion. Expanded polyglutamine proteins accumulate abnormally in intracellular aggregates. Here we show that mammalian target of rapamycin (mTOR) is sequestered in polyglutamine aggregates in cell models, transgenic mice and human brains. Sequestration of mTOR impairs its kinase activity and induces autophagy, a key clearance pathway for mutant huntingtin fragments. This protects against polyglutamine toxicity, as the specific mTOR inhibitor rapamycin attenuates huntingtin accumulation and cell death in cell models of Huntington disease, and inhibition of autophagy has the converse effects. Furthermore, rapamycin protects against neurodegeneration in a fly model of Huntington disease, and the rapamycin analog CCI-779 improved performance on four different behavioral tasks and decreased aggregate formation in a mouse model of Huntington disease. Our data provide proof-of-principle for the potential of inducing autophagy to treat Huntington disease.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; UCL, Inst Neurol, Div Neuropathol, London, England; Univ Cambridge, Dept Publ Hlth, Genet Epidemiol Unit, Canc Res UK, Cambridge, England; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcr1000@cus.cam.ac.uk	Rubinsztein, David C/C-3472-2011; O'Kane, Cahir J/C-4413-2011; Duden, Rainer/C-8917-2011; O'Kane, Cahir/Q-6681-2019; Duden, Rainer/GXH-3206-2022	O'Kane, Cahir/0000-0002-3488-2078; Davies, Janet/0000-0002-8853-8328				*BRIT MED ASS ROYA, 2003, BRIT NATL FORUMULARY; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Elit Laurie, 2002, Curr Opin Investig Drugs, V3, P1249; Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gingras AC, 2001, PROG MOLEC, V27, P143; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Huang S, 2001, DRUG RESIST UPDATE, V4, P378, DOI 10.1054/drup.2002.0227; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; La Spada AR, 2003, NEURON, V38, P681, DOI 10.1016/S0896-6273(03)00328-3; Lione LA, 1999, J NEUROSCI, V19, P10428; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schwab MS, 1999, MOL CELL BIOL, V19, P2485; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; SUPKO JG, 1994, CANCER CHEMOTH PHARM, V33, P325; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Walpoth BH, 2001, EUR J CARDIO-THORAC, V19, P487, DOI 10.1016/S1010-7940(01)00582-6; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	48	1839	1941	9	227	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2004	36	6					585	595		10.1038/ng1362	http://dx.doi.org/10.1038/ng1362			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15146184	Bronze			2022-12-27	WOS:000221763700015
J	Schramke, V; Luciano, P; Brevet, V; Guillot, S; Corda, Y; Longhese, MP; Gilson, E; Geli, V				Schramke, V; Luciano, P; Brevet, V; Guillot, S; Corda, Y; Longhese, MP; Gilson, E; Geli, V			RPA regulates telomerase action by providing Est1p access to chromosome ends	NATURE GENETICS			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; IN-VIVO; DNA-REPLICATION; SIR PROTEINS; CELL-CYCLE; YEAST KU; S-PHASE; STRAND; REPAIR	Replication protein A (RPA) is a highly conserved single-stranded DNA binding protein involved in DNA replication, recombination and repair. We show here that RPA is present at the telomeres of the budding yeast Saccharomyces cerevisiae, with a maximal association in S phase. A truncation of the N-terminal region of Rfa2p ( associated with the rfa2Delta40 mutated allele) results in severe telomere shortening caused by a defect in the in vivo regulation of telomerase activity. Cells carrying rfa2Delta40 show impaired binding of the protein Est1p, which is required for telomerase action. In addition, normal telomere length can be restored by expressing a Cdc13-Est1p hybrid protein. These findings indicate that RPA activates telomerase by loading Est1p onto telomeres during S phase. We propose a model of in vivo telomerase action that involves synergistic action of RPA and Cdc13p at the G-rich 3' overhang of telomeric DNA.	CNRS, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; Ecole Normale Super Lyon, Lab Biol Mol Cellule, CNRS, Unite Mixte Rech 5161, F-69364 Lyon, France; Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; University of Milano-Bicocca	Geli, V (corresponding author), CNRS, Lab Ingn Syst Macromol, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.		Pia, Maria/AAK-2693-2020	Luciano, Pierre/0000-0002-1394-4129; Longhese, Maria Pia/0000-0003-1726-2034	Fondazione Telethon Funding Source: Custom; Telethon [E.1247] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; Brush GS, 2001, NUCLEIC ACIDS RES, V29, P4808, DOI 10.1093/nar/29.23.4808; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Brush GS, 2000, NUCLEIC ACIDS RES, V28, P3725, DOI 10.1093/nar/28.19.3725; Chan SWL, 2001, CURR BIOL, V11, P1240, DOI 10.1016/S0960-9822(01)00391-8; Craven RJ, 1999, GENETICS, V152, P1531; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LONGHESE MP, 1994, MOL CELL BIOL, V14, P7884, DOI 10.1128/MCB.14.12.7884; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; Mallory JC, 2003, DNA REPAIR, V2, P1041, DOI 10.1016/S1568-7864(03)00115-0; Maniar HS, 1997, GENETICS, V145, P891; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Price CM, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1216; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Ritchie KB, 2000, GENETICS, V155, P475; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Smith J, 2000, BIOCHIMIE, V82, P71, DOI 10.1016/S0300-9084(00)00183-8; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	37	120	125	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					46	54		10.1038/ng1284	http://dx.doi.org/10.1038/ng1284			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14702040	Bronze			2022-12-27	WOS:000187666800013
J	Wienholds, E; Koudijs, MJ; van Eeden, FJM; Cuppen, E; Plasterk, RHA				Wienholds, E; Koudijs, MJ; van Eeden, FJM; Cuppen, E; Plasterk, RHA			The microRNA-producing enzyme Dicer1 is essential for zebrafish development	NATURE GENETICS			English	Article							RNA-INTERFERENCE; GENES; ELEGANS	MicroRNAs (miRNAs) are produced by the Dicer1 enzyme; the role of Dicer1 in vertebrate development is unknown. Here we report target-selected inactivation of the dicer1 gene in zebrafish. We observed an initial build-up of miRNA levels, produced by maternal Dicer1, in homozygous dicer1 mutants, but miRNA accumulation stopped after a few days. This resulted in developmental arrest around day 10. These results indicate that miRNA-producing Dicer1 is essential for vertebrate development.	Netherlands Inst Dev Biol, Hubrecht Lab, Dept Funct Genom, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Dept Funct Genom, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Van Eeden, Freek/E-6198-2010; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762	10	340	371	0	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					217	218		10.1038/ng1251	http://dx.doi.org/10.1038/ng1251			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14528306				2022-12-27	WOS:000186273300015
J	Noben-Trauth, K; Zheng, QY; Johnson, KR				Noben-Trauth, K; Zheng, QY; Johnson, KR			Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss	NATURE GENETICS			English	Article							SYNDROME TYPE 1D; INBRED STRAINS; MICE; LOCUS; SUSCEPTIBILITY; STEREOCILIA; MUTATIONS; HARMONIN; MODEL; MOUSE	Age-related hearing loss (AHL) in common inbred mouse strains is a genetically complex quantitative trait. We found a synonymous single-nucleotide polymorphism in exon 7 of Cdh23 that shows significant association with AHL and the deafness modifier mdfw (modifer of deafwaddler). The hypomorphic Cdh23(753A) allele causes in-frame skipping of exon 7. Altered adhesion or reduced stability of CDH23 may confer susceptibility to AHL. Homozygosity at Cdh23(753A) or in combination with heterogeneous secondary factors is a primary determinant of AHL in mice.	Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, Rockville, MD 20850 USA; Jackson Lab, Bar Harbor, ME 04609 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Jackson Laboratory	Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, 5 Res Court, Rockville, MD 20850 USA.		Zheng, Qing/C-1731-2012		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC005846, R01DC009246, R01DC004301, R03DC004376, R01DC005827, Z01DC000036] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005827, R01 DC005827-03, R01 DC009246, R03 DC004376-01A1, R21 DC005846, R21 DC005846-01A1, R01 DC004301-05, R01 DC004301] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Davis RR, 2001, HEARING RES, V155, P82, DOI 10.1016/S0378-5955(01)00250-7; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; Johnson KR, 2002, GENOMICS, V80, P461, DOI 10.1016/S0888-7543(02)96858-8; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; von Brederlow B, 2002, HUM MUTAT, V19, P268, DOI 10.1002/humu.10049; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zheng QY, 2001, HEARING RES, V154, P45, DOI 10.1016/S0378-5955(01)00215-5	15	330	346	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					21	23		10.1038/ng1226	http://dx.doi.org/10.1038/ng1226			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12910270	Green Accepted			2022-12-27	WOS:000185018500006
J	Roix, JJ; McQueen, PG; Munson, PJ; Parada, LA; Misteli, T				Roix, JJ; McQueen, PG; Munson, PJ; Parada, LA; Misteli, T			Spatial proximity of translocation-prone gene loci in human lymphomas	NATURE GENETICS			English	Article							HUMAN LEUKEMIC-CELLS; C-MYC; CHROMOSOME-ABERRATIONS; NUCLEAR TOPOGRAPHY; CANCER; INTERPHASE; LOCATION; ABL; BCR; DIFFERENTIATION	Cancer cells frequently have disease-specific chromosome rearrangements(1-4). It is poorly understood why translocations between chromosomes recur at specific breakpoints in the genome. Here we provide evidence that higher-order spatial genome organization is a contributing factor in the formation of recurrent translocations. We show that MYC, BCL and immunoglobulin loci, which are recurrently translocated in various B-cell lymphomas, are preferentially positioned in close spatial proximity relative to each other in normal B cells. Loci in spatial proximity are non-randomly positioned towards the nuclear interior in normal B cells. This locus proximity is the consequence of higher-order genome structure rather than a property of individual genes. Our results suggest that the formation of specific translocations in human lymphomas, and perhaps other tissues, is determined in part by higher-order spatial organization of the genome.	NCI, NIH, Bethesda, MD 20892 USA; NIH, Math & Stat Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			CENTER FOR INFORMATION TECHNOLOGY [Z01CT000227, ZIACT000227] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010309, ZIABC010309] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartova E, 2000, LEUKEMIA RES, V24, P233, DOI 10.1016/S0145-2126(99)00174-5; Bartova E, 2000, GENE, V244, P1, DOI 10.1016/S0378-1119(99)00572-7; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Fienberg S. E, 1982, ENCY STAT SCI, V2, P161; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Harris N L, 2001, Hematology Am Soc Hematol Educ Program, P194, DOI 10.1182/asheducation-2001.1.194; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kozubek S, 2002, CHROMOSOMA, V111, P321, DOI 10.1007/s00412-002-0210-8; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Parreira L, 1997, HUM GENET, V100, P588, DOI 10.1007/s004390050558; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sachs RK, 1997, INT J RADIAT BIOL, V71, P1, DOI 10.1080/095530097144364; Siebert R, 2001, CURR OPIN ONCOL, V13, P316, DOI 10.1097/00001622-200109000-00002; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; STEVENS MA, 1982, ENCY STAT SCI, V4, P393; TEUOLSKKY WH, 1992, NUMERICAL RECIPES C, P609; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhou J, 2002, MOL CELL BIOL, V22, P4876, DOI 10.1128/MCB.22.13.4876-4889.2002	29	321	332	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					287	291		10.1038/ng1177	http://dx.doi.org/10.1038/ng1177			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808455				2022-12-27	WOS:000183815300015
J	Sellar, GC; Watt, KP; Rabiasz, GJ; Stronach, EA; Li, L; Miller, EP; Massie, CE; Miller, J; Contreras-Moreira, B; Scott, D; Brown, I; Williams, AR; Bates, PA; Smyth, JF; Gabra, H				Sellar, GC; Watt, KP; Rabiasz, GJ; Stronach, EA; Li, L; Miller, EP; Massie, CE; Miller, J; Contreras-Moreira, B; Scott, D; Brown, I; Williams, AR; Bates, PA; Smyth, JF; Gabra, H			OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer	NATURE GENETICS			English	Article							ADHESION MOLECULE OBCAM; CELL-ADHESION; HETEROPHILIC INTERACTIONS; NEURITE OUTGROWTH; RAT-BRAIN; EXPRESSION; HETEROZYGOSITY; PROTEIN; FAMILY; GENES	Epithelial ovarian cancer (EOC), the leading cause of death from gynecological malignancy, is a poorly understood disease. The typically advanced presentation of EOC with loco-regional dissemination in the peritoneal cavity and the rare incidence of visceral metastases are hallmarks of the disease. These features relate to the biology of the disease, which is a principal determinant of outcome(1,2). EOC arises as a result of genetic alterations sustained by the ovarian surface epithelium (OSE; ref. 3). The causes of these changes are unknown but are manifest by activation of oncogenes and inactivation of tumor-suppressor genes (TSGs). Our analysis of loss of heterozygosity at 11q25 identified OPCML (also called OBCAM), a member of the IgLON family of immunoglobulin (Ig) domain containing glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecules, as a candidate TSG in EOC. OPCML is frequently somatically inactivated in EOC by allele loss and by CpG island methylation. OPCML has functional characteristics consistent with TSG properties both in vitro and in vivo. A somatic missense mutation from an individual with EOC shows clear evidence of loss of function. These findings suggest that OPCML is an excellent candidate for the 11q25 ovarian cancer TSG. This is the first description to our knowledge of the involvement of the IgLON family in cancer.	Univ Edinburgh, Canc Res UK Edinburgh Oncol Unit, Ctr Canc Res, Edinburgh EH4 2XR, Midlothian, Scotland; Imperial Canc Res Fund, Biomol Modelling Lab, Canc Res UK London Res Inst, London WC2A 3PX, England; Univ Aberdeen, Dept Surg, Aberdeen AB25 2ZD, Scotland; Univ Edinburgh, Dept Pathol, Sch Med, Edinburgh EH16 4SA, Midlothian, Scotland	University of Edinburgh; Cancer Research UK; University of Aberdeen; University of Edinburgh	Gabra, H (corresponding author), Univ Edinburgh, Canc Res UK Edinburgh Oncol Unit, Ctr Canc Res, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	grant.sellar@cancer.org.uk; hani.gabra@cancer.org.uk	Contreras-Moreira, Bruno/G-4334-2011; Williams, Alistair/A-3531-2008; Bates, Paul/A-1651-2011; Bates, Paul A/AAF-8561-2020	Bates, Paul A/0000-0003-0621-0925; Contreras Moreira, Bruno/0000-0002-5462-907X; Massie, Charlie/0000-0003-2314-4843; Scott, Derek Anthony/0000-0002-2029-6174; Gabra, Hani/0000-0002-3322-4399				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Axton RA, 1997, MOL CELL PROBE, V11, P287, DOI 10.1006/mcpr.1997.0117; Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Bates PA, 2001, PROTEINS, P39; Chi DS, 2001, GYNECOL ONCOL, V82, P532, DOI 10.1006/gyno.2001.6328; Davis M, 1996, CANCER RES, V56, P741; FOULKES WD, 1993, BRIT J CANCER, V67, P268, DOI 10.1038/bjc.1993.51; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Gabra H, 1996, CANCER RES, V56, P950; GABRA H, 1995, BRIT J CANCER, V72, P367, DOI 10.1038/bjc.1995.340; Gil OD, 1998, J NEUROSCI, V18, P9312; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Hachisuka A, 2000, DEV BRAIN RES, V122, P183, DOI 10.1016/S0165-3806(00)00072-9; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hoskins WJ, 1995, J CELL BIOCHEM, P189; Ji L, 2002, CANCER RES, V62, P2715; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Launonen V, 1998, GYNECOL ONCOL, V71, P299, DOI 10.1006/gyno.1998.5186; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Miyata S, 2000, J COMP NEUROL, V424, P74, DOI 10.1002/1096-9861(20000814)424:1<74::AID-CNE6>3.0.CO;2-5; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Sellar GC, 2001, CANCER RES, V61, P6977; SHARK KB, 1995, GENE, V155, P213, DOI 10.1016/0378-1119(94)00830-L; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson DJA, 1996, J CELL SCI, V109, P3129	30	147	161	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					337	343		10.1038/ng1183	http://dx.doi.org/10.1038/ng1183			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12819783				2022-12-27	WOS:000183815300024
J	Tafti, M; Petit, B; Chollet, D; Neidhart, E; de Bilbao, F; Kiss, JZ; Wood, PA; Franken, P				Tafti, M; Petit, B; Chollet, D; Neidhart, E; de Bilbao, F; Kiss, JZ; Wood, PA; Franken, P			Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep	NATURE GENETICS			English	Article							DEHYDROGENASE-DEFICIENCY; RHYTHM; MICE	In rodents, the electroencephalogram (EEG) during paradoxical sleep and exploratory behavior is characterized by theta oscillations. Here we show that a deficiency in short-chain acylcoenzyme A dehydrogenase (encoded by Acads) in mice causes a marked slowing in theta frequency during paradoxical sleep only. We found Acads expression in brain regions involved in theta generation, notably the hippocampus. Microarray analysis of gene expression in mice with mutations in Acads indicates overexpression of Glo1 (encoding glyoxylase 1), a gene involved in the detoxification of metabolic by-products. Administration of acetyl-L-carnitine (ALCAR) to mutant mice significantly recovers slow theta and Glo1 overexpression. Thus, an underappreciated metabolic pathway involving fatty acid beta-oxidation also regulates theta oscillations during sleep.	Univ Geneva, Biochem & Genet Unit, Dept Psychiat, CH-1225 Chene Bourg, Switzerland; Univ Hosp Geneva, CH-1225 Chene Bourg, Switzerland; Univ Hosp Geneva, Div Neuropsychiat, Dept Psychiat, CH-1225 Chene Bourg, Switzerland; Ctr Med Univ Geneva, Dept Morphol, CH-1211 Geneva, Switzerland; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Alabama System; University of Alabama Birmingham; Stanford University	Tafti, M (corresponding author), Univ Geneva, Biochem & Genet Unit, Dept Psychiat, Chemin Petit Bel Air 2, CH-1225 Chene Bourg, Switzerland.	mehdi.tafti@medecine.unige.ch	Tafti, Mehdi/A-8887-2017; Franken, Paul/A-9633-2018	Tafti, Mehdi/0000-0002-6997-3914; Franken, Paul/0000-0002-2500-2921				AMENDT BA, 1992, PEDIATR RES, V31, P552, DOI 10.1203/00006450-199206000-00003; BHALA A, 1995, J PEDIATR-US, V126, P910, DOI 10.1016/S0022-3476(95)70207-5; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Datta S, 1997, SYNAPSE, V27, P69, DOI 10.1002/(SICI)1098-2396(199709)27:1<69::AID-SYN7>3.3.CO;2-6; Franken P, 1999, SLEEP, V22, P155; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Huang EP, 1997, CURR BIOL, V7, pR141, DOI 10.1016/S0960-9822(97)70073-3; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MIZUMORI SJY, 1990, BRAIN RES, V528, P12, DOI 10.1016/0006-8993(90)90188-H; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; OLDENDORF WH, 1973, AM J PHYSIOL, V224, P1450, DOI 10.1152/ajplegacy.1973.224.6.1450; Rao KVR, 1997, CAN J PHYSIOL PHARM, V75, P423, DOI 10.1139/cjpp-75-5-423; REICHMANN H, 1988, J NEUROCHEM, V51, P339, DOI 10.1111/j.1471-4159.1988.tb01044.x; Reue K, 1996, MAMM GENOME, V7, P694, DOI 10.1007/s003359900208; SCHIFFER SP, 1989, BIOCHEM GENET, V27, P47, DOI 10.1007/BF00563017; Spitzer J J, 1973, Physiologist, V16, P55; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vertes RP, 2000, BEHAV BRAIN SCI, V23, P867, DOI 10.1017/S0140525X00004003; Vertes RP, 1997, NEUROSCIENCE, V81, P893; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; WOOD PA, 1989, PEDIATR RES, V25, P38, DOI 10.1203/00006450-198901000-00010	28	108	112	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					320	325		10.1038/ng1174	http://dx.doi.org/10.1038/ng1174			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796782				2022-12-27	WOS:000183815300021
J	Herman, H; Lu, M; Anggraini, M; Sikora, A; Chang, YJ; Yoon, BJ; Soloway, PD				Herman, H; Lu, M; Anggraini, M; Sikora, A; Chang, YJ; Yoon, BJ; Soloway, PD			Trans allele methylation and paramutation-like effects in mice	NATURE GENETICS			English	Article							DNA METHYLATION; IMPRINTED GENE; MOUSE; LOCUS; MAIZE; RASGRF1	In mammals, imprinted genes have parent-of-origin specific patterns of DNA methylation that cause allele-specific expression. At Rasgrf1 (encoding RAS protein-specific guanine nucleotide-releasing factor 1), a repeated DNA element is needed to establish methylation and expression of the active paternal allele(1). At Igf2r (encoding insulin-like growth factor 2 receptor), a sequence called region 2 is needed for methylation of the active maternal allele(2,3). Here we show that replacing the Rasgrf1 repeats on the paternal allele with region 2 allows both methylation and expression of the paternal copy of Rasgrf1, indicating that sequences that control methylation can function ectopically. Paternal transmission of the mutated allele also induced methylation and expression in trans of the normally unmethylated and silent wild-type maternal allele. Once activated, the wild-type maternal Rasgrf1 allele maintained its activated state in the next generation independently of the paternal allele. These results recapitulate in mice several features in common with paramutation described in plants(4).	Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Padjadjaran State Univ, Dept Orthopaed Surg, Sch Med, Sadikin Gen Hosp, Bandung, Indonesia	Cornell University; Roswell Park Cancer Institute; Universitas Padjadjaran	Soloway, PD (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.		Yoon, Bong June/L-7126-2017; Soloway, Paul/T-8243-2019	Soloway, Paul/0000-0003-1967-0437	NCI NIH HHS [R01 CA098597-01, R01 CA098597] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bennett ST, 1997, NAT GENET, V17, P350, DOI 10.1038/ng1197-350; Birger Y, 1999, NATURE, V397, P84, DOI 10.1038/16291; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Forne T, 1997, P NATL ACAD SCI USA, V94, P10243, DOI 10.1073/pnas.94.19.10243; Hatada I, 1997, J BIOL CHEM, V272, P9120, DOI 10.1074/jbc.272.14.9120; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; KENNISON JA, 2002, ADV GENET, V46, P699; LaSalle JM, 1996, SCIENCE, V272, P725, DOI 10.1126/science.272.5262.725; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; PATTERSON GI, 1993, GENETICS, V135, P881; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Plass C, 1996, NAT GENET, V14, P106, DOI 10.1038/ng0996-106; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Walker EL, 1998, GENETICS, V148, P1973; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	22	87	94	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2003	34	2					199	202		10.1038/ng1162	http://dx.doi.org/10.1038/ng1162			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684HZ	12740578	Green Accepted			2022-12-27	WOS:000183200500027
J	Wang, J; Parsons, LM; Derbyshire, KM				Wang, J; Parsons, LM; Derbyshire, KM			Unconventional conjugal DNA transfer in mycobacteria	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; PLASMID; RECOMBINATION; BACTERIAL; TRANSFORMATION; STREPTOMYCES; SMEGMATIS	Bacterial conjugation is an active process that results in unidirectional transfer of DNA from a donor to a recipient cell. Most transfer systems are plasmid-encoded and require proteins to act at a unique cis-acting site to initiate and complete DNA transfer. By contrast, the Mycobacterium smegmatis DNA transfer system is chromosomally encoded. Here we show that multiple cis-acting sequences present on the chromosome can mediate transfer of a non-mobilizable test plasmid. Moreover, unlike conventional plasmid transfer, recipient recombination functions are required to allow this plasmid, and derivatives of it, to re-circularize through a process similar to gap repair. Extended DNA homology with the recipient chromosome is required to facilitate repair, resulting in acquisition of recipient chromosomal DNA by the plasmid. Together, these results show that DNA transfer in M. smegmatis occurs by a mechanism different from that of prototypical plasmid transfer systems.	New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Derbyshire, KM (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12201 USA.	keith.derbyshire@wadsworth.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042308] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI042308] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1996, ESCHERICHIA COLI SAL; Bhatt A, 2002, MOL MICROBIOL, V43, P135, DOI 10.1046/j.1365-2958.2002.02722.x; BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0; CANOSI U, 1981, MOL GEN GENET, V181, P434, DOI 10.1007/BF00428732; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Derbyshire KM, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P93; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Ducote MJ, 2000, J BACTERIOL, V182, P6834, DOI 10.1128/JB.182.23.6834-6841.2000; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Griffin TJ, 1999, NUCLEIC ACIDS RES, V27, P3859, DOI 10.1093/nar/27.19.3859; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Hopwood D.A., 1993, BACTERIAL CONJUGATIO, P293, DOI DOI 10.1007/978-1-4757-9357-4_11; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; LLOYD RG, 1996, ESCHERICHIA COLI SAL, V2, P2236; Maas RM, 1998, MICROBIOL-SGM, V144, P2809, DOI 10.1099/00221287-144-10-2809; MIZUGUCHI Y, 1971, JPN J MICROBIOL, V15, P359, DOI 10.1111/j.1348-0421.1971.tb00592.x; Papavinasasundaram KG, 1998, MOL MICROBIOL, V30, P525, DOI 10.1046/j.1365-2958.1998.01083.x; Parsons LM, 1998, MOL MICROBIOL, V28, P571, DOI 10.1046/j.1365-2958.1998.00818.x; PETTIS GS, 1994, MOL MICROBIOL, V13, P955, DOI 10.1111/j.1365-2958.1994.tb00487.x; SMITH GR, 1991, CELL, V64, P19, DOI 10.1016/0092-8674(91)90205-D; WARREN GJ, 1978, NATURE, V274, P259, DOI 10.1038/274259a0; Waters VL, 2001, NAT GENET, V29, P375, DOI 10.1038/ng779; WOLLMAN EL, 1956, COLD SPRING HARB SYM, V21, P141, DOI 10.1101/SQB.1956.021.01.012; WU LJ, 1995, GENE DEV, V9, P1316, DOI 10.1101/gad.9.11.1316; Zechner E. L., 2000, HORIZONTAL GENE POOL, P87	28	28	30	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					80	84		10.1038/ng1139	http://dx.doi.org/10.1038/ng1139			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12669068				2022-12-27	WOS:000182667900021
J	Pal, C; Hurst, LD				Pal, C; Hurst, LD			Evidence for co-evolution of gene order and recombination rate	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; MEIOTIC RECOMBINATION; LINKAGE INTENSITY; NATURAL-SELECTION; GENOME; EVOLUTION; YEAST; EXPRESSION; PROVIDES	There is increasing evidence in eukaryotic genomes that gene order is not random, even allowing for tandem duplication. Notably, in numerous genomes(1-6), genes of similar expression tend to be clustered. Are there other reasons for clustering of functionally similar genes? If genes are linked to enable genetic, rather than physical clustering, then we also expect that clusters of certain genes might be associated with blocks of reduced recombination rates. Here we show that, in yeast, essential genes are highly clustered and this clustering is independent of clustering of co-expressed genes and of tandem duplications. Adjacent pairs of essential genes are preferentially conserved through evolution. Notably, we also find that clusters of essential genes are in regions of low recombination and that larger clusters have lower recombination rates. These results suggest that selection acts to modify both the fine-scale intragenomic variation in the recombination rate and the distribution of genes and provide evidence for co-evolution of gene order and recombination rate.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Somerset, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary	University of Bath; Eotvos Lorand University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Somerset, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball CA, 2001, NUCLEIC ACIDS RES, V29, P80, DOI 10.1093/nar/29.1.80; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COOPER DN, 1999, HUMAN GENE EVOLUTION; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; COX EC, 1972, NATURE-NEW BIOL, V92, P133; Dickinson J. R., 1999, METABOLISM MOL PHYSL; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gessler DDG, 1999, GENET RES, V73, P119, DOI 10.1017/S001667239800367X; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; LERCHER MJ, IN PRESS GENOME RES; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; NEI M, 1968, NATURE, V218, P1160, DOI 10.1038/2181160a0; NEI M, 1967, GENETICS, V57, P625; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Strathern J. N., 1981, MOL BIOL YEAST SACCH; STRATHERN JN, 1995, GENETICS, V140, P965; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	28	122	124	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					392	395		10.1038/ng1111	http://dx.doi.org/10.1038/ng1111			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12577060				2022-12-27	WOS:000181312700017
J	Venter, JC; Levy, S; Stockwell, T; Remington, K; Halpern, A				Venter, JC; Levy, S; Stockwell, T; Remington, K; Halpern, A			Massive parallelism, randomness and genomic advances	NATURE GENETICS			English	Review							EXPRESSED SEQUENCE TAGS; ESCHERICHIA-COLI; DNA-SEQUENCE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; MOLECULAR-BASIS; GENE-TRANSFER; PHYSICAL MAP; PROTEIN; BIOLOGY	In reviewing the past decade, it is clear that genomics was, and still is, driven by innovative technologies, perhaps more so than any other scientific area in recent memory. From the outset, computing, mathematics and new automated laboratory techniques have been key components in allowing the field to move forward rapidly. We highlight some key innovations that have come together to nurture the explosive growth that makes a new era of genomics a reality. We also document how these new approaches have fueled further innovations and discoveries.	Ctr Advancement Genom, Rockville, MD 20850 USA	J. Craig Venter Institute	Venter, JC (corresponding author), Ctr Advancement Genom, 1901 Res Blvd, Rockville, MD 20850 USA.	jcventer@tcag.org		Stockwell, Timothy/0000-0002-3595-4539				ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bankier A T, 1991, DNA Seq, V2, P1, DOI 10.3109/10425179109008433; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DOGGETT NA, 1995, NATURE, V377, P335; Drake JW, 1998, GENETICS, V148, P1667; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kent WJ, 2001, GENOME RES, V11, P1541, DOI 10.1101/gr.183201; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Krokan HE, 1997, BIOCHEM J, V325, P1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kuska B, 1998, J NATL CANCER I, V90, P93, DOI 10.1093/jnci/90.2.93; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Meldrum D, 2000, GENOME RES, V10, P1288, DOI 10.1101/gr.157400; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; *NIH, 1990, 901590 NIH; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pennisi E, 1998, SCIENCE, V280, P814, DOI 10.1126/science.280.5365.814; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; PUTNEY SD, 1983, NATURE, V302, P718, DOI 10.1038/302718a0; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; ROBERTS L, 1991, SCIENCE, V252, P1618, DOI 10.1126/science.2047871; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Somerville C, 1999, SCIENCE, V285, P380, DOI 10.1126/science.285.5426.380; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wada A, 1988, Basic Life Sci, V46, P119; WADA A, 1994, ADV BIOPHYS, V30, P85, DOI 10.1016/0065-227X(94)90011-6; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yates JR, 1998, J MASS SPECTROM, V33, P1; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	139	38	39	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			219	227		10.1038/ng1114	http://dx.doi.org/10.1038/ng1114			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610531				2022-12-27	WOS:000181390900002
J	Battersby, BJ; Loredo-Osti, JC; Shoubridge, EA				Battersby, BJ; Loredo-Osti, JC; Shoubridge, EA			Nuclear genetic control of mitochondrial DNA segregation	NATURE GENETICS			English	Article							RAGGED-RED FIBERS; SKELETAL-MUSCLE; POINT MUTATION; HETEROPLASMIC MICE; MTDNA MUTATION; MUTANT; SELECTION; ENCEPHALOMYOPATHY; REPLICATION; ADVANTAGE	Mammalian mitochondrial DNA (mtDNA) is a high copy-number, maternally inherited genome that codes for a small number of essential proteins involved in oxidative phosphorylation. Mutations in mtDNA are responsible for a broad spectrum of clinical disorders'. The segregation pattern of pathogenic mtDNA mutants is an important determinant of the nature and severity of mitochondrial disease, but it varies with the specific mutation, cell type and nuclear background and generally does not correlate well with mitochondrial dysfunction(2-11). To identify nuclear genes that modify the segregation behavior of mtDNA, we used a heteroplasmic mouse model derived from two inbred strains (BALB/c and NZB; ref. 12), in which we had previously demonstrated tissue-specific and age-dependent directional selection for different mtDNA genotypes in the same mouse(13). Here we show that this phenotype segregates in F2 mice from a genetic cross (BALB/c x CAST/Ei) and that it maps to at least three quantitative-trait loci (QTLs). Genome-wide scans showed linkage of the trait to loci on Chromosomes 2, 5 and 6, accounting for 16-35% of the variance in the trait, depending on the tissue and age of the mouse. This is the first genetic evidence for nuclear control of mammalian mtDNA segregation.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.							Basten C.J., 1997, QTL CARTOGRAPHER REF; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BOULET L, 1992, AM J HUM GENET, V51, P1187; Chinnery PF, 1999, AM J MED GENET, V85, P498; CHURCHILL GA, 1994, GENETICS, V138, P963; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DESTORDEUR E, 1989, MOL GEN GENET, V220, P127, DOI 10.1007/BF00260866; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; KAWAKAMI Y, 1994, ANN NEUROL, V35, P370, DOI 10.1002/ana.410350322; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Weber K, 1997, AM J HUM GENET, V60, P373; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	30	104	109	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					183	186		10.1038/ng1073	http://dx.doi.org/10.1038/ng1073			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539044				2022-12-27	WOS:000180773700017
J	De Fusco, M; Marconi, R; Silvestri, L; Atorino, L; Rampoldi, L; Morgante, L; Ballabio, A; Aridon, P; Casari, G				De Fusco, M; Marconi, R; Silvestri, L; Atorino, L; Rampoldi, L; Morgante, L; Ballabio, A; Aridon, P; Casari, G			Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha 2 subunit associated with familial hemiplegic migraine type 2	NATURE GENETICS			English	Article							EXTRACELLULAR DOMAIN; NA,K-ATPASE; AURA; POPULATION; LOCUS	Headache attacks and autonomic dysfunctions characterize migraine, a very common, disabling disorder with a prevalence of 12% in the general population of Western countries(1,2). About 20% of individuals affected with migraine experience aura, a visual or sensory-motor neurological dysfunction that usually precedes or accompanies the headache(3). Although the mode of transmission is controversial(4), population-based and twin studies have implicated genetic factors, especially in migraine with aura(5,6). Familial hemiplegic migraine is a hereditary form of migraine characterized by aura and some hemiparesis. Here we show that mutations in the gene ATP1A2 that encodes the alpha2 subunit of the Na+/K+ pump are associated with familial hemiplegic migraine type 2 (FHM2) linked to chromosome 1q23 (OMIM 602481). Functional data indicate that the putative pathogenetic mechanism is triggered by a loss of function of a single allele of ATP1A2. This is the first report associating mutations of Na+K+ pump subunits to genetic diseases.	San Raffaele Sci Inst, Human Mol Genet Unit, I-20132 Milan, Italy; Misericordia Hosp, Dept Neurol, Grosseto, Italy; Univ Messina, Dept Neurosci, Messina, Italy; Univ Naples 2, Fac Med, Naples, Italy; Univ Naples 2, Telethon Inst Genet & Med, Naples, Italy; Univ Palermo, Inst Neuropsychiat, Palermo, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Messina; Universita della Campania Vanvitelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Palermo	Casari, G (corresponding author), San Raffaele Sci Inst, Human Mol Genet Unit, Via Olgettina 58, I-20132 Milan, Italy.		Casari, Giorgio/J-3070-2018; De Fusco, Maurizio/AAN-7358-2020; Rampoldi, Luca/L-3639-2018; Rampoldi, Luca/AAN-6228-2020; BALLABIO, Andrea/AAL-2672-2020; Silvestri, Laura/A-1417-2015	Casari, Giorgio/0000-0002-0115-8980; Rampoldi, Luca/0000-0002-0544-7042; Rampoldi, Luca/0000-0002-0544-7042; BALLABIO, Andrea/0000-0003-1381-4604; Silvestri, Laura/0000-0002-8726-9808; Aridon, Paolo/0000-0002-7424-9533	Telethon [F.1, TGM03S01, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; BLAU JN, 1955, LANCET, V2, P1115; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; FITZSIMONS RB, 1985, BRAIN, V108, pS55; Gardner K, 1997, NEUROLOGY, V49, P1231, DOI 10.1212/WNL.49.5.1231; Hu YK, 2000, J BIOL CHEM, V275, P19185, DOI 10.1074/jbc.M000641200; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEMAS MV, 1994, J BIOL CHEM, V269, P825; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; MARCONI R, IN PRESS ANN NEUROL; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; PRICE EM, 1990, J BIOL CHEM, V265, P6638; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; RUSSELL MB, 1993, CEPHALALGIA, V13, P245, DOI 10.1046/j.1468-2982.1993.1304245.x; Russell MB, 2002, HEADACHE, V42, P332, DOI 10.1046/j.1526-4610.2002.02102.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1	26	657	679	0	32	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2003	33	2					192	196		10.1038/ng1081	http://dx.doi.org/10.1038/ng1081			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539047				2022-12-27	WOS:000180773700019
J	Sollars, V; Lu, XY; Xiao, L; Wang, XY; Garfinkel, MD; Ruden, DM				Sollars, V; Lu, XY; Xiao, L; Wang, XY; Garfinkel, MD; Ruden, DM			Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; KRUPPEL ACTIVITY; MODIFIER SCREEN; EYE DEVELOPMENT; MUTATIONS; POLYCOMB; GENES	Morphological alterations have been shown to occur in Drosophila melanogaster when function of Hsp90 (heat shock 90-kDa protein 1alpha, encoded by Hsp83) is compromised during development(1). Genetic selection maintains the altered phenotypes in subsequent generations(1). Recent experiments have shown, however, that phenotypic variation still occurs in nearly isogenic recombinant inbred strains of Arabidopsis thaliana(2). Using a sensitized isogenic D. melanogaster strain, iso-Krlf-1, we confirm this finding and present evidence supporting an epigenetic mechanism for Hsp90's capacitor function, whereby reduced activity of Hsp90 induces a heritably altered chromatin state. The altered chromatin state is evidenced by ectopic expression of the morphogen wingless in eye imaginal discs and a corresponding abnormal eye phenotype, both of which are epigenetically heritable in subsequent generations, even when function of Hsp90 is restored. Mutations in nine different genes of the trithorax group that encode chromatin-remodeling proteins also induce the abnormal phenotype. These findings suggest that Hsp90 acts as a capacitor for morphological evolution through epigenetic and genetic mechanisms.	Univ Alabama, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	University of Alabama System; University of Alabama Birmingham; Jefferson University; Columbia University	Ruden, DM (corresponding author), Univ Alabama, Dept Environm Hlth Sci, RPHB 530, Birmingham, AL 35294 USA.		Sollars, Vincent/R-3769-2019; Ruden, Douglas/A-5008-2016; Ruden, Douglas/ABE-1418-2021	Ruden, Douglas/0000-0002-0070-437X; Sollars, Vincent/0000-0002-5602-3610	NCI NIH HHS [R01 CA105349] Funding Source: Medline; NIAAA NIH HHS [R01 AA012276] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abrell S, 2000, CHROMOSOMA, V109, P334, DOI 10.1007/s004120000092; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M., 1989, DROSOPHILA LAB HDB; Bender J, 2002, CURR BIOL, V12, pR412, DOI 10.1016/S0960-9822(02)00910-7; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Dickson BJ, 1996, GENETICS, V142, P163; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Goldstein LSB, 1994, DROSOPHILA MELANOGAS; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; JACKLE H, 1985, COLD SPRING HARB SYM, V50, P465, DOI 10.1101/SQB.1985.050.01.058; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kohler C, 2002, CURR BIOL, V12, pR129, DOI 10.1016/S0960-9822(02)00705-4; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Mollaaghababa R, 2001, P NATL ACAD SCI USA, V98, P3958, DOI 10.1073/pnas.061497798; Paro R, 1998, CIBA F SYMP, V214, P51; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747	22	305	321	0	56	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					70	74		10.1038/ng1067	http://dx.doi.org/10.1038/ng1067			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12483213				2022-12-27	WOS:000180136100020
J	Collins, N; Poot, RA; Kukimoto, I; Garcia-Jimenez, C; Dellaire, G; Varga-Weisz, PD				Collins, N; Poot, RA; Kukimoto, I; Garcia-Jimenez, C; Dellaire, G; Varga-Weisz, PD			An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin	NATURE GENETICS			English	Article							CELL-CYCLE; ISWI; INHIBITION; SUBUNITS; CONTAINS; PROTEINS; CLONING; HOMOLOG; SITES; CHRAC	The mechanism by which the eukaryotic DNA-replication machinery penetrates condensed chromatin structures to replicate the underlying DNA is poorly understood. Here we provide evidence that an ACF1-ISWI chromatin-remodeling complex is required for replication through heterochromatin in mammalian cells. ACF1(ATP-utilizing chromatin assembly and remodeling factor 1) and an ISWI isoform, SNF2H (sucrose nonfermenting-2 homolog), become specifically enriched in replicating pericentromeric heterochromatin. RNAi-mediated depletion of ACF1 specifically impairs the replication of pericentromeric heterochromatin. Accordingly, depletion of ACF1 causes a delay in cell-cycle progression through the late stages of S phase. In vivo depletion of SNF2H slows the progression of DNA replication throughout S phase, indicating a functional overlap with ACF1. Decondensing the heterochromatin with 5-aza-2-deoxycytidine reverses the effects of ACF1 and SNF2H depletion. Expression of an ACF1 mutant that cannot interact with SNF2H also interferes with replication of condensed chromatin. Our data suggest that an ACF1-SNF2H complex is part of a dedicated mechanism that enables DNA replication through highly condensed regions of chromatin.	Marie Curie Res Inst, Surrey RH8 0TL, England; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh	Varga-Weisz, PD (corresponding author), Marie Curie Res Inst, Chart, Surrey RH8 0TL, England.		García-Jiménez, Custodia/AAS-7744-2020; Kukimoto, I/I-3995-2019; Dellaire, Graham/L-9948-2014	García-Jiménez, Custodia/0000-0003-0146-4424; Kukimoto, I/0000-0001-9080-1642; Dellaire, Graham/0000-0002-3466-6316; Varga-Weisz, Patrick/0000-0001-7409-8686				Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; Bernard P, 2002, TRENDS CELL BIOL, V12, P419, DOI 10.1016/S0962-8924(02)02344-9; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; BRAVO R, 1985, EMBO J, V4, P655, DOI 10.1002/j.1460-2075.1985.tb03679.x; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; DIMITROV S, 1993, DEV BIOL, V160, P214, DOI 10.1006/dbio.1993.1299; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; FOX MH, 1991, J CELL SCI, V99, P247; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Haaf T, 2000, CYTOGENET CELL GENET, V91, P113, DOI 10.1159/000056830; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Langst G, 2001, J CELL SCI, V114, P2561; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; MacCallum DE, 2002, MOL BIOL CELL, V13, P25, DOI 10.1091/mbc.01-09-0441; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; SASAKI K, 1993, CYTOMETRY, V14, P876, DOI 10.1002/cyto.990140805; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tate P, 1998, J CELL SCI, V111, P2575; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676	30	236	242	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					627	632		10.1038/ng1046	http://dx.doi.org/10.1038/ng1046			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12434153				2022-12-27	WOS:000179593000015
J	Petricoin, EF; Hackett, JL; Lesko, LJ; Puri, RK; Gutman, SI; Chumakov, K; Woodcock, J; Feigal, DW; Zoon, KC; Sistare, FD				Petricoin, EF; Hackett, JL; Lesko, LJ; Puri, RK; Gutman, SI; Chumakov, K; Woodcock, J; Feigal, DW; Zoon, KC; Sistare, FD			Medical applications of microarray technologies: a regulatory science perspective	NATURE GENETICS			English	Editorial Material							GENE-EXPRESSION PATTERNS; HUMAN PROSTATE-CANCER; CDNA MICROARRAY; MOLECULAR CLASSIFICATION; PROTEIN MICROARRAYS; MUTATION DETECTION; COMPLEMENTARY-DNA; GENOME; PREDICTION; IDENTIFICATION	The potential medical applications of microarrays have generated much excitement, and some skepticism, within the biomedical community. Some researchers have suggested that within the decade microarrays will be routinely used in the selection, assessment, and quality control of the best drugs for pharmaceutical development, as well as for disease diagnosis and for monitoring desired and adverse outcomes of therapeutic interventions. Realizing this potential will be a challenge for the whole scientific community, as breakthroughs that show great promise at the bench often fail to meet the requirements of clinicians and regulatory scientists. The development of a cooperative framework among regulators, product sponsors, and technology experts will be essential for realizing the revolutionary promise that microarrays hold for drug development, regulatory science, medical practice and public health.	US FDA, Div Therapeut Prod, Off Therapeut Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Ctr Devices & Radiol Hlth, Div Clin Lab Devices, Off Device Evaluat, Rockville, MD 20850 USA; US FDA, Off Clin Pharmacol & Biopharmaceut, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; US FDA, Div Cell & Gene Therapy, Off Therapeut Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; US FDA, Off Director, Ctr Drug Evaluat & Res, Rockville, MD 20852 USA; US FDA, Off Director, Ctr Devices & Radiol Hlth, Rockville, MD 20850 USA; US FDA, Off Director, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; US FDA, Div Appl Pharmacol Res, Off Testing & Res, Ctr Drug Evaluat & Res, Laurel, MD 20708 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Petricoin, EF (corresponding author), US FDA, Div Therapeut Prod, Off Therapeut Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	petricoin@cber.ffa.gov; sistare@cder.fda.gov						Alevizos I, 2001, ONCOGENE, V20, P6196, DOI 10.1038/sj.onc.1204685; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altman RB, 2002, ANNU REV PHARMACOL, V42, P113, DOI 10.1146/annurev.pharmtox.42.082401.140850; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bakay M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-4; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Brown PO, 1998, NAT GENET, V18, P91, DOI 10.1038/ng0298-91; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Cantor CR, 1999, MOL DIAGN, V4, P287, DOI 10.1016/S1084-8592(99)80004-6; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Cronin MT, 1996, HUM MUTAT, V7, P244, DOI 10.1002/(SICI)1098-1004(1996)7:3<244::AID-HUMU9>3.0.CO;2-A; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; DeRisi J, 1996, NAT GENET, V14, P457; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Favis R, 2000, ANN NY ACAD SCI, V906, P39; Figeys D, 2001, ELECTROPHORESIS, V22, P208, DOI 10.1002/1522-2683(200101)22:2<208::AID-ELPS208>3.0.CO;2-O; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hacia JC, 1998, GENOME RES, V8, P1245, DOI 10.1101/gr.8.12.1245; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219; Hamadeh HK, 2002, BIOTECHNIQUES, V32, P322; He B, 2001, INT IMMUNOPHARMACOL, V1, P867, DOI 10.1016/S1567-5769(01)00023-6; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; King HC, 2001, JAMA-J AM MED ASSOC, V286, P2280, DOI 10.1001/jama.286.18.2280; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luo J, 2001, CANCER RES, V61, P4683; MacBeath G, 2001, NAT BIOTECHNOL, V19, P828, DOI 10.1038/nbt0901-828; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nuwaysir EF, 1999, MOL CARCINOGEN, V24, P153, DOI 10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P; Okabe H, 2001, CANCER RES, V61, P2129; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raitio M, 2001, GENOME RES, V11, P471, DOI 10.1101/gr.156301; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Roses AD, 2002, NAT REV DRUG DISCOV, V1, P541, DOI 10.1038/nrd840; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SEUNGCHAN K, 2000, GENOMICS, V67, P201; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Shirota Y, 2001, HEPATOLOGY, V33, P832, DOI 10.1053/jhep.2001.23003; Sreekumar A, 2001, CANCER RES, V61, P7585; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Tefferi A, 2002, MAYO CLIN PROC, V77, P927; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walter G, 2002, TRENDS MOL MED, V8, P250, DOI 10.1016/S1471-4914(02)02352-3; WARING JF, 2001, NAT GENET, V29, P365; Warrington JA, 2000, MICROARRAY BIOCHIP TECHNOLOGY, P119; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	65	168	174	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			474	479		10.1038/ng1029	http://dx.doi.org/10.1038/ng1029			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454641				2022-12-27	WOS:000179742900006
J	Kawaguchi, Y; Cooper, B; Gannon, M; Ray, M; MacDonald, RJ; Wright, CVE				Kawaguchi, Y; Cooper, B; Gannon, M; Ray, M; MacDonald, RJ; Wright, CVE			The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors	NATURE GENETICS			English	Article							CRE-MEDIATED RECOMBINATION; DIFFERENTIATION; GENE; CELLS; EXOCRINE; PROTEIN; PDX-1; P48; EXPRESSION; PHENOTYPE	Pancreas development begins with the formation of buds at specific sites in the embryonic foregut endoderm. We used recombination-based lineage tracing in vivo to show that Ptf1a (also known as PTF1-p48) is expressed at these early stages in the progenitors of pancreatic ducts, exocrine and endocrine cells, rather than being an exocrine-specific gene as previously described. Moreover, inactivation of Ptf1a switches the character of pancreatic progenitors such that their progeny proliferate in and adopt the normal fates of duodenal epithelium, including its stem-cell compartment. Consistent with the proposal that Ptf1a supports the specification of precursors of all three pancreatic cell types, transgene-based expression of Pdx1, a gene essential to pancreas formation, from Ptf1a cis-regulatory sequences restores pancreas tissue to Pdx1-null mice that otherwise lack mature exocrine and endocrine cells because of an early arrest in organogenesis. These experiments provide evidence that Ptf1a expression is specifically connected to the acquisition of pancreatic fate by undifferentiated foregut endoderm.	Vanderbilt Univ, Sch Med, Vanderbilt Dev Biol Program, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med & Mol Physiol & Biophys, Nashville, TN 37232 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wright, CVE (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Dev Biol Program, 1161 21st Ave S, Nashville, TN 37232 USA.		MacDonald, Ray/AAA-1290-2022; Gannon, Maureen A/F-9060-2012					Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; GU G, 2000, DEVELOPMENT, V129, P2447; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HOGAN B, 1994, MANIPUALTING MOUSE E; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Li H, 2001, DEV BIOL, V240, P247, DOI 10.1006/dbio.2001.0440; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; MACDONALD RJ, 1977, J BIOL CHEM, V252, P5522; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Offield MF, 1996, DEVELOPMENT, V122, P983; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Sasaki H, 1996, GENES CELLS, V1, P59, DOI 10.1046/j.1365-2443.1996.04004.x; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3	26	736	758	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					128	134		10.1038/ng959	http://dx.doi.org/10.1038/ng959			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12185368				2022-12-27	WOS:000177714900011
J	Ottenhoff, THM; Verreck, FAW; Lichtenauer-Kaligis, EGR; Hoeve, MA; Sanal, O; van Dissel, JT				Ottenhoff, THM; Verreck, FAW; Lichtenauer-Kaligis, EGR; Hoeve, MA; Sanal, O; van Dissel, JT			Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae	NATURE GENETICS			English	Article							INTERFERON-GAMMA-RECEPTOR; BACILLE CALMETTE-GUERIN; SMALL DELETION HOTSPOT; IFN-GAMMA; INTERLEUKIN-12 DEFICIENCY; IMMUNITY; SUSCEPTIBILITY; IL-12; TUBERCULOSIS; ACTIVATION	Host genetic factors are important in determining the outcome of infections caused by intracellular pathogens, including mycobacteria and salmonellae, but until now have been poorly characterized. Recently, some individuals with severe infections due to otherwise weakly pathogenic mycobacteria (non-tuberculous mycobacteria or Mycobacterium bovis bacille Calmette-Guerin) or Salmonella species have been shown to be unable to produce or respond to interferon-gamma. This inability results from mutations in any of five genes encoding essential proteins of the type 1 cytokine cascade: interleukin-12p40, interleukin-12Rbeta1, interferon-gammaR1, interferon-gammaR2 or STAT1. Ten syndromes have thus far been identified. Recent insights in genetically controlled host defense and susceptibility to mycobacterial disease are discussed.	Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands; Hacettepe Univ, Childrens Hosp, Div Immunol, Ankara, Turkey	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hacettepe University	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, POB 9600, NL-2300 RC Leiden, Netherlands.	T.H.M.Ottenhoff@lumc.nl						Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aksu G, 2001, PEDIATR INFECT DIS J, V20, P551, DOI 10.1097/00006454-200105000-00021; Allende LM, 2001, CLIN DIAGN LAB IMMUN, V8, P133, DOI 10.1128/CDLI.8.1.133-137.2001; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; Arend SM, 2001, NETH J MED, V59, P140, DOI 10.1016/S0300-2977(01)00152-8; Bonecini-Almeida MG, 1998, J IMMUNOL, V160, P4490; Brombacher F, 1999, INT IMMUNOL, V11, P325, DOI 10.1093/intimm/11.3.325; Burghes AHM, 2001, SCIENCE, V293, P2213, DOI 10.1126/science.1065930; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Colantonio L, 1999, BLOOD, V94, P2981, DOI 10.1182/blood.V94.9.2981.421k27_2981_2989; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cunningham JA, 2000, INT J TUBERC LUNG D, V4, P791; de Jong R, 1998, SCIENCE, V280, P1435; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; DENIS M, 1991, CLIN EXP IMMUNOL, V84, P200, DOI 10.1111/j.1365-2249.1991.tb08149.x; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Dorman SE, 1999, J PEDIATR-US, V135, P640, DOI 10.1016/S0022-3476(99)70064-8; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dupuis S, 2000, IMMUNOL REV, V178, P129, DOI 10.1034/j.1600-065X.2000.17810.x; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Edgar JDM, 2001, J PEDIATR-US, V139, P600, DOI 10.1067/mpd.2001.117068; Elloumi-Zghal H, 2002, J INFECT DIS, V185, P1468, DOI 10.1086/340510; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frucht DM, 1996, J IMMUNOL, V157, P411; Gollob JA, 2000, J IMMUNOL, V165, P4120, DOI 10.4049/jimmunol.165.7.4120; Greenwood CMT, 2000, AM J HUM GENET, V67, P405, DOI 10.1086/303012; Haraguchi S, 1998, P NATL ACAD SCI USA, V95, P13125, DOI 10.1073/pnas.95.22.13125; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Holland SM, 2001, CLIN REV ALLERG IMMU, V20, P121, DOI 10.1385/CRIAI:20:1:121; JANSSEN R, IN PRESS J IMMUNOL; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; LICHTENAUERKALI.EG, UNPUB SEVERE OUTCOME; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; NOORDZIJ JG, IN PRESS PEDIAT RES; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ortmann R, 2001, J IMMUNOL, V166, P5712, DOI 10.4049/jimmunol.166.9.5712; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Picard C, 2002, AM J HUM GENET, V70, P336, DOI 10.1086/338625; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Roesler J, 1999, EXP HEMATOL, V27, P1368, DOI 10.1016/S0301-472X(99)00077-6; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Rosenzweig S, 2002, CLIN IMMUNOL, V102, P25, DOI 10.1006/clim.2001.5135; Sakai T, 2001, BLOOD, V97, P2688, DOI 10.1182/blood.V97.9.2688; Sasaki Y, 2002, J INFECT DIS, V185, P706, DOI 10.1086/339011; Selvaraj P., 1999, Tubercle and Lung Disease, V79, P221, DOI 10.1054/tuld.1999.0204; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Stenger S, 1999, IMMUNOL TODAY, V20, P390, DOI 10.1016/S0167-5699(99)01449-8; Ting LM, 1999, J IMMUNOL, V163, P3898; Verhagen CE, 2000, J EXP MED, V192, P517, DOI 10.1084/jem.192.4.517; Verreck FAW, 2002, CLIN INFECT DIS, V35, P210, DOI 10.1086/341314; Villella A, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e47; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Zou WP, 2000, J IMMUNOL, V165, P4388, DOI 10.4049/jimmunol.165.8.4388	70	199	219	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					97	105		10.1038/ng0902-97	http://dx.doi.org/10.1038/ng0902-97			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12205477				2022-12-27	WOS:000177714900007
J	Mykytyn, K; Nishimura, DY; Searby, CC; Shastri, M; Yen, HJ; Beck, JS; Braun, T; Streb, LM; Cornier, AS; Cox, GF; Fulton, AB; Carmi, R; Luleci, G; Chandrasekharappa, SC; Collins, FS; Jacobson, SG; Heckenlively, JR; Weleber, RG; Stone, EM; Sheffield, VC				Mykytyn, K; Nishimura, DY; Searby, CC; Shastri, M; Yen, HJ; Beck, JS; Braun, T; Streb, LM; Cornier, AS; Cox, GF; Fulton, AB; Carmi, R; Luleci, G; Chandrasekharappa, SC; Collins, FS; Jacobson, SG; Heckenlively, JR; Weleber, RG; Stone, EM; Sheffield, VC			Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome	NATURE GENETICS			English	Article							CHROMOSOME 16Q; SYNDROME LOCUS; DNA; MUTATIONS; INTERVAL; LINKAGE	Bardet-Biedl syndrome (BBS, OMIM 209900) is a genetic disorder with the primary features of obesity, pigmentary retinopathy, polydactyly, renal malformations, mental retardation and hypogenitalism(1-4). Individuals with BBS are also at increased risk for diabetes mellitus, hypertension and congenital heart disease(4-6). What was once thought to be a homogeneous autosomal recessive disorder is now known to map to at least six loci: 11q13 (BBS1), 16q21 (BBS2), 3p13-p12 (BBS3), 15q22.3-q23 (BBS4), 2q31 (BBS5) and 20p12 (BBS6)(7-13). There has been considerable interest in identifying the genes that underlie BBS, because some components of the phenotype are common. Cases of BBS mapping ro BBS6 are caused by mutations in MKKS12,13; mutations in this gene also cause McKusick-Kaufman syndrome (hydrometrocolpos, post-axial polydactyly and congenital heart defects)(14,15). In addition, we recently used positional cloning to identify the genes underlying BBS2 (ref. 16) and BBS4 (ref. 17). The BBS6 protein has similarity to a Thermoplasma acidophilum chaperonin(15), whereas BBS2 and BBS4 have no significant similarity to chaperonins. It has recently been suggested that three mutated alleles (two at one locus, and a third at a second locus) may be required for manifestation of BBS (triallelic inheritance)(18). Here we report the identification of the gene BBS1 and show that a missense mutation of this gene is a frequent cause of BBS. In addition, we provide data showing that this common mutation is not involved in triallelic inheritance.	Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Dept Elect Engn, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Ponce Sch Med, Dept Biochem, Ponce, PR USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; Ben Gurion Univ Negev, Inst Genet, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Arkdeniz Univ, Dept Med Biol Genet, Antalya, Turkey; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; Harbor UCLA Med Ctr, Jules Stein Eye Inst, Torrance, CA 90509 USA; Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Ben Gurion University; Soroka Medical Center; Akdeniz University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Oregon Health & Science University	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Mykytyn, Kirk/E-3723-2011	Mykytyn, Kirk/0000-0002-0158-4592; Searby, Charles/0000-0002-8108-8782; Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414; Jacobson, Samuel/0000-0003-2122-169X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bardet G., 1920, THESIS U PARIS; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; ELBEDOUR K, 1994, AM J MED GENET, V52, P164, DOI 10.1002/ajmg.1320520208; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HARNETT JD, 1988, NEW ENGL J MED, V319, P615, DOI 10.1056/NEJM198809083191005; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEPPERT M, 1994, NAT GENET, V7, P108, DOI 10.1038/ng0594-108; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; ROBINOW M, 1979, J PEDIATR-US, V94, P776, DOI 10.1016/S0022-3476(79)80155-9; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; SOLISCOHEN S, 1924, T ASSOC AM PHYSICIAN, V39, P356; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301; Young TL, 1999, AM J HUM GENET, V65, P1680, DOI 10.1086/302686	22	248	258	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2002	31	4					435	438		10.1038/ng935	http://dx.doi.org/10.1038/ng935			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12118255				2022-12-27	WOS:000177147100023
J	Vetter, DE; Li, CE; Zhao, LY; Contarino, A; Liberman, MC; Smith, GW; Marchuk, Y; Koob, GF; Heinemann, SF; Vale, W; Lee, KF				Vetter, DE; Li, CE; Zhao, LY; Contarino, A; Liberman, MC; Smith, GW; Marchuk, Y; Koob, GF; Heinemann, SF; Vale, W; Lee, KF			Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior	NATURE GENETICS			English	Article							CORTICOTROPIN-RELEASING FACTOR; RAT OLIVOCOCHLEAR NEURONS; TYPE-2 CRF RECEPTORS; GENE-RELATED PEPTIDE; LATERAL-LINE ORGAN; GUINEA-PIG; HORMONE RECEPTOR-2; UROTENSIN-I; MAMMALIAN COCHLEA; BASILAR-MEMBRANE	Urocortin is a member of the corticotropin-releasing hormone peptide family and is found in many discrete brain regions. The distinct expression pattern of urocortin suggests that it influences such behaviors as feeding, anxiety and auditory processing. To better define the physiological roles of urocortin, we have generated mice carrying a null mutation of the urocortin gene. Urocortin-deficient mice have normal basal feeding behavior and stress responses, but show heightened anxiety-like behaviors in the elevated plus maze and open-field tests. In addition, hearing is impaired in the mutant mice at the level of the inner ear, suggesting that urocortin is involved in the normal development of cochlear sensory-cell function. These results provide the first example of a function for any peptidergic system in hearing.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA	Salk Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Contarino, Angelo/C-9429-2014; Vetter, Douglas E./O-8150-2019	Contarino, Angelo/0000-0002-7286-6941	NIDCD NIH HHS [P30 DC005209] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005209] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABOUMADI L, 1987, HEARING RES, V30, P135, DOI 10.1016/0378-5955(87)90131-6; ADAMS JC, 1987, BRAIN RES, V419, P347, DOI 10.1016/0006-8993(87)90606-8; ALTSCHULER RA, 1984, J HISTOCHEM CYTOCHEM, V32, P839, DOI 10.1177/32.8.6379037; ALTSCHULER RA, 1985, HEARING RES, V17, P249, DOI 10.1016/0378-5955(85)90069-3; Bailey GP, 2000, J NEUROSCI, V20, P5163; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bittencourt JC, 1999, J COMP NEUROL, V415, P285; CHADWICK D, 1993, CORTICOTROPIN RELEAS; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; HASHIMOTO S, 1990, ACTA OTO-LARYNGOL, V109, P228, DOI 10.3109/00016489009107438; HOFFMAN DW, 1985, HEARING RES, V17, P47, DOI 10.1016/0378-5955(85)90129-7; HOFFMAN DW, 1983, HEARING RES, V9, P71, DOI 10.1016/0378-5955(83)90135-1; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Kihara N, 2001, AM J PHYSIOL-GASTR L, V280, pG406, DOI 10.1152/ajpgi.2001.280.3.G406; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6; LEDERIS K, 1982, SCIENCE, V218, P162, DOI 10.1126/science.6981844; LEDERIS K, 1982, P W PHARMACOL SOC, V25, P223; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V18, P113; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; RUGGERO MA, 1992, PHILOS T ROY SOC B, V336, P307, DOI 10.1098/rstb.1992.0063; SEWELL WF, 1991, J NEUROPHYSIOL, V65, P1158, DOI 10.1152/jn.1991.65.5.1158; Skelton KH, 2000, J NEUROSCI, V20, P1240, DOI 10.1523/JNEUROSCI.20-03-01240.2000; Slawecki CJ, 1999, PEPTIDES, V20, P211, DOI 10.1016/S0196-9781(98)00160-0; Smagin GN, 1998, NEUROREPORT, V9, P1601, DOI 10.1097/00001756-199805110-00063; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; Spina MG, 2002, PSYCHOPHARMACOLOGY, V160, P113, DOI 10.1007/s00213-001-0940-y; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Turnbull AV, 1999, ENDOCRINOLOGY, V140, P71, DOI 10.1210/en.140.1.71; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; VETTER DE, 1992, ANAT EMBRYOL, V185, P1, DOI 10.1007/BF00213596; VETTER DE, 1991, SYNAPSE, V7, P21, DOI 10.1002/syn.890070104; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Warr W.B., 1992, Springer Handbook of Auditory Research, V1, P410	44	131	134	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2002	31	4					363	369		10.1038/ng914	http://dx.doi.org/10.1038/ng914			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	578XV	12091910				2022-12-27	WOS:000177147100010
J	Adams, DJ; Biggs, PJ; Cox, T; Davies, R; van der Weyden, L; Jonkers, J; Smith, J; Plumb, B; Taylor, R; Nishijima, I; Yu, YJ; Rogers, J; Bradley, A				Adams, DJ; Biggs, PJ; Cox, T; Davies, R; van der Weyden, L; Jonkers, J; Smith, J; Plumb, B; Taylor, R; Nishijima, I; Yu, YJ; Rogers, J; Bradley, A			Mutagenic insertion and chromosome engineering resource (MICER)	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; MOUSE GENOME; HOMOLOGOUS RECOMBINATION; REARRANGEMENTS; ALLELES; LINE	Embryonic stem cell technology revolutionized biology by providing a means to assess mammalian gene function in vivo. Although it is now routine to generate mice from embryonic stem cells, one of the principal methods used to create mutations, gene targeting, is a cumbersome process. Here we describe the indexing of 93,960 ready-made insertional targeting vectors from two libraries. 5,925 of these vectors can be used directly to inactivate genes with an average targeting efficiency of 28%. Combinations of vectors from the two libraries can be used to disrupt both alleles of a gene or engineer larger genomic changes such as deletions, duplications, translocations or inversions. These indexed vectors constitute a public resource ( Mutagenic Insertion and Chromosome Engineering Resource; MICER) for high-throughput, targeted manipulation of the mouse genome.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Wellcome Trust Sanger Institute; Netherlands Cancer Institute; Baylor College of Medicine	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	abradley@sanger.ac.uk	Biggs, Patrick Jon/H-3355-2014; Jonkers, Jos/AAG-3246-2019; van der Weyden, Louise/AAV-5711-2021	Biggs, Patrick Jon/0000-0002-0285-4101; Jonkers, Jos/0000-0002-9264-9792; van der Weyden, Louise/0000-0002-0645-1879; Smith, James/0000-0002-0445-8305; Adams, David/0000-0001-9490-0306; Davies, Robert/0000-0002-9983-1378; Bradley, Allan/0000-0002-2349-8839				Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Bult CJ, 2004, NUCLEIC ACIDS RES, V32, pD476, DOI 10.1093/nar/gkh125; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; HASTY P, 1994, MOL CELL BIOL, V14, P8385, DOI 10.1128/MCB.14.12.8385; Klysik J, 2004, GENOMICS, V83, P303, DOI 10.1016/j.ygeno.2003.08.011; Kucera GT, 1996, DEV BIOL, V173, P162, DOI 10.1006/dbio.1996.0014; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nishijima I, 2003, GENESIS, V36, P142, DOI 10.1002/gene.10207; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zheng BH, 2002, CANCER BIOL THER, V1, P433, DOI 10.4161/cbt.1.4.24; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	26	106	126	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					867	871		10.1038/ng1388	http://dx.doi.org/10.1038/ng1388			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15235602				2022-12-27	WOS:000222974000020
J	Plagge, A; Gordon, E; Dean, W; Boiani, R; Cinti, S; Peters, J; Kelsey, G				Plagge, A; Gordon, E; Dean, W; Boiani, R; Cinti, S; Peters, J; Kelsey, G			The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding	NATURE GENETICS			English	Article							ADIPOSE-TISSUE; GENE; GNAS; IDENTIFICATION; TRANSCRIPTS; G-ALPHA(S); RESISTANCE; EXPRESSION; MUTATIONS; LOCUS	Genomic imprinting, by which maternal and paternal alleles of some genes have different levels of activity, has profound effects on growth and development of the mammalian fetus. The action of imprinted genes after birth, in particular while the infant is dependent on maternal provision of nutrients, is far less well understood. We disrupted a paternally expressed transcript at the Gnas locus, Gnasxl, which encodes the unusual Gsalpha isoform XLalphas. Mice with mutations in Gnasxl have poor postnatal growth and survival and a spectrum of phenotypic effects that indicate that XLas controls a number of key postnatal physiological adaptations, including suckling, blood glucose and energy homeostasis. Increased cAMP levels in brown adipose tissue of Gnasxl mutants and phenotypic comparison with Gnas mutants suggest that XLas can antagonize Gsalpha-dependent signaling pathways. The opposing effects of maternally and paternally expressed products of the Gnas locus provide tangible molecular support for the parental-conflict hypothesis of imprinting.	Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England; Multitech Univ MArche, Fac Med, I-60020 Ancona, Italy; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC Harwell	Kelsey, G (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England.	gavin.kelsey@bbsrc.ac.uk	Plagge, Antonius/AAH-3877-2019	Plagge, Antonius/0000-0001-6592-1343; Dean, Wendy/0000-0001-9441-5044; CINTI, Saverio/0000-0003-0362-5017; Kelsey, Gavin/0000-0002-9762-5634				Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; CRAWFORD JA, 1993, J BIOL CHEM, V268, P9879; DAVIES SJ, 1993, J MED GENET, V30, P101, DOI 10.1136/jmg.30.2.101; de la Casa-Esperon E, 2003, ANNU REV GENET, V37, P349, DOI 10.1146/annurev.genet.37.110801.143741; Fay RA, 1997, BRAIN RES REV, V25, P276, DOI 10.1016/S0165-0173(97)00027-1; Freson K, 2003, HUM MOL GENET, V12, P1121, DOI 10.1093/hmg/ddg130; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; Hurst L. D., 1997, GENOMIC IMPRINTING, P211; Ischia R, 1997, J BIOL CHEM, V272, P11657; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; KEHLENBACH RH, 1994, NATURE, V372, P804; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Klemke M, 2000, J BIOL CHEM, V275, P33633, DOI 10.1074/jbc.M006594200; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Li T, 2000, GENOMICS, V69, P295, DOI 10.1006/geno.2000.6337; Lund JP, 1998, CURR OPIN NEUROBIOL, V8, P718, DOI 10.1016/S0959-4388(98)80113-X; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Sawczuk A, 2001, CRIT REV ORAL BIOL M, V12, P18, DOI 10.1177/10454411010120010101; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Storck T, 1996, NUCLEIC ACIDS RES, V24, P4594, DOI 10.1093/nar/24.22.4594; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; VOLLMER RR, 1997, AM J PHYSIOL-REG I, V273, pR1758; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Williamson CM, 1998, GENET RES, V72, P255, DOI 10.1017/S0016672398003528; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Yu SH, 2001, J BIOL CHEM, V276, P19994, DOI 10.1074/jbc.M010313200; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	50	198	205	5	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					818	826		10.1038/ng1397	http://dx.doi.org/10.1038/ng1397			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273686				2022-12-27	WOS:000222974000013
J	Irobi, J; Van Impe, K; Seeman, P; Jordanova, A; Dierick, I; Verpoorten, N; Michalik, A; De Vriendt, E; Jacobs, A; Van Gerwen, V; Vennekens, K; Mazanec, R; Tournev, I; Hilton-Jones, D; Talbot, K; Kremensky, N; Van Den Bosch, L; Robberecht, W; Vandekerckhove, J; Van Broeckhoven, C; Gettemans, J; De Jonghe, P; Timmerman, V				Irobi, J; Van Impe, K; Seeman, P; Jordanova, A; Dierick, I; Verpoorten, N; Michalik, A; De Vriendt, E; Jacobs, A; Van Gerwen, V; Vennekens, K; Mazanec, R; Tournev, I; Hilton-Jones, D; Talbot, K; Kremensky, N; Van Den Bosch, L; Robberecht, W; Vandekerckhove, J; Van Broeckhoven, C; Gettemans, J; De Jonghe, P; Timmerman, V			Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; ALPHA-A-CRYSTALLIN; HMN-II; MISSENSE MUTATION; CANDIDATE GENES; UP-REGULATION; PROTEIN; HSP27; MEMBER; SUPERFAMILY	Distal hereditary motor neuropathies are pure motor disorders of the peripheral nervous system resulting in severe atrophy and wasting of distal limb muscles'. In two pedigrees with distal hereditary motor neuropathy type II linked to chromosome 12q24.3, we identified the same mutation (K141N) in small heat-shock 22-kDa protein 8 (encoded by HSPB8; also called HSP22). We found a second mutation (K141E) in two smaller families. Both mutations target the same amino acid, which is essential to the structural and functional integrity of the small heat-shock protein alphaA-crystallin(2). This positively charged residue, when mutated in other small heat-shock proteins, results in various human disorders(.)(3,4) Coimmunoprecipitation experiments showed greater binding of both HSPB8 mutants to the interacting partner HSPB1. Expression of mutant HSPB8 in cultured cells promoted formation of intracellular aggregates. Our findings provide further evidence that mutations in heat-shock proteins have an important role in neurodegenerative disorders.	Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; State Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Charles Univ Prague, Sch Med 2, Dept Child Neurol, Prague, Czech Republic; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Charles Univ Prague, Sch Med 2, Dept Neurol, Prague, Czech Republic; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 2JD, England; Katholieke Univ Leuven, Dept Expt Neurol, Neurobiol Lab, Louvain, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Ghent University; Charles University Prague; Medical University Sofia; Charles University Prague; Medical University Sofia; Radcliffe Infirmary; University of Oxford; KU Leuven; University of Antwerp	Timmerman, V (corresponding author), Univ Instelling Antwerp VIB, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Van Den Bosch, Ludo/B-7258-2012; Van Broeckhoven, Christine/M-7853-2019; Jordanova, Albena/H-8323-2015; Timmerman, Vincent/O-7283-2019; Van Broeckhoven, Christine/G-8362-2017; Talbot, Kevin/F-7361-2011	Van Broeckhoven, Christine/0000-0003-0183-7665; Jordanova, Albena/0000-0002-3833-3754; Timmerman, Vincent/0000-0002-2162-0933; Van Broeckhoven, Christine/0000-0003-0183-7665; Talbot, Kevin/0000-0001-5490-1697; Van Den Bosch, Ludo/0000-0003-0104-4067				Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPER SW, 1990, NUCLEIC ACIDS RES, V18, P6457, DOI 10.1093/nar/18.21.6457; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; GETTEMANS J, 1995, J BIOL CHEM, V270, P2644, DOI 10.1074/jbc.270.6.2644; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; HARDING AE, 1980, J NEUROL SCI, V45, P337, DOI 10.1016/0022-510X(80)90177-X; Irobi J, 2000, GENOMICS, V65, P34, DOI 10.1006/geno.2000.6149; Irobi J, 2002, J PERIPHER NERV SYST, V7, P87, DOI 10.1046/j.1529-8027.2002.02014.x; Irobi J, 2001, ANN HUM GENET, V65, P517, DOI 10.1017/S0003480001008910; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; TIMMERMAN V, 1992, J NEUROL SCI, V109, P41, DOI 10.1016/0022-510X(92)90091-X; Timmerman V, 1996, HUM MOL GENET, V5, P1065, DOI 10.1093/hmg/5.7.1065; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	30	329	350	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					597	601		10.1038/ng1328	http://dx.doi.org/10.1038/ng1328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122253	Bronze			2022-12-27	WOS:000221763700016
J	Teichmann, SA; Babu, MM				Teichmann, SA; Babu, MM			Gene regulatory network growth by duplication	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; COMPLEX NETWORKS; EVOLUTION; PROTEINS; MODEL; ORGANIZATION; ASSIGNMENTS; SEQUENCES; HOMOLOGY	We are beginning to elucidate transcriptional regulatory networks on a large scale(1) and to understand some of the structural principles of these networks(2,3), but the evolutionary mechanisms that form these networks are still mostly unknown. Here we investigate the role of gene duplication in network evolution. Gene duplication is the driving force for creating new genes in genomes: at least 50% of prokaryotic genes(4,5) and over 90% of eukaryotic genes(6) are products of gene duplication. The transcriptional interactions in regulatory networks consist of multiple components, and duplication processes that generate new interactions would need to be more complex. We define possible duplication scenarios and show that they formed the regulatory networks of the prokaryote Escherichia coli and the eukaryote Saccharomyces cerevisiae. Gene duplication has had a key role in network evolution: more than one-third of known regulatory interactions were inherited from the ancestral transcription factor or target gene after duplication, and roughly one-half of the interactions were gained during divergence after duplication. In addition, we conclude that evolution has been incremental, rather than making entire regulatory circuits or motifs by duplication with inheritance of interactions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Teichmann, SA (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	sat@mrc-lmb.cam.ac.uk; madanm@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	Teichmann, Sarah/0000-0002-6294-6366				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; BRENNER SE, 1995, NATURE, V378, P140, DOI 10.1038/378140a0; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gough J, 2002, NUCLEIC ACIDS RES, V30, P268, DOI 10.1093/nar/30.1.268; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Madera M, 2002, NUCLEIC ACIDS RES, V30, P4321, DOI 10.1093/nar/gkf544; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Papp B, 2003, TRENDS GENET, V19, P417, DOI 10.1016/S0168-9525(03)00174-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Salgado H, 2001, NUCLEIC ACIDS RES, V29, P72, DOI 10.1093/nar/29.1.72; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smith E D, 2002, ADV COMPLEX SYST, V5, P43, DOI DOI 10.1142/S021952590200047X; Teichmann SA, 1998, P NATL ACAD SCI USA, V95, P14658, DOI 10.1073/pnas.95.25.14658; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; VAZQUEZ A, 2003, COMPLEXUS, V21, P38; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	30	381	395	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					492	496		10.1038/ng1340	http://dx.doi.org/10.1038/ng1340			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107850	Bronze			2022-12-27	WOS:000221183000022
J	Pajukanta, P; Lilja, HE; Sinsheimer, JS; Cantor, RM; Lusis, AJ; Gentile, M; Duan, XQJ; Soro-Paavonen, A; Naukkarinen, J; Saarela, J; Laakso, M; Ehnholm, C; Taskinen, MR; Peltonen, L				Pajukanta, P; Lilja, HE; Sinsheimer, JS; Cantor, RM; Lusis, AJ; Gentile, M; Duan, XQJ; Soro-Paavonen, A; Naukkarinen, J; Saarela, J; Laakso, M; Ehnholm, C; Taskinen, MR; Peltonen, L			Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)	NATURE GENETICS			English	Article							DIABETES-SUSCEPTIBILITY GENES; INDEPENDENT REPLICATION; STIMULATORY FACTOR; LINKAGE ANALYSIS; SERUM-LIPIDS; GENOME-WIDE; LOCUS; PEDIGREES; SEARCH; SCAN	Familial combined hyperlipidemia (FCHL), characterized by elevated levels of serum total cholesterol, triglycerides or both(1,2), is observed in about 20% of individuals with premature coronary heart disease(1). We previously identified a locus linked to FCHL on 1q21-q23 in Finnish families with the disease(3). This region has also been linked to FCHL in families from other populations(4-6) as well as to type 2 diabetes mellitus(7-12). These clinical entities have several overlapping phenotypic features, raising the possibility that the same gene may underlie the obtained linkage results. Here, we show that the human gene encoding thioredoxin interacting protein (TXNIP) on 1q, which underlies combined hyperlipidemia in mice(13), is not associated with FCHL. We show that FCHL is linked and associated with the gene encoding upstream transcription factor 1 (USF1) in 60 extended families with FCHL, including 721 genotyped individuals (P = 0.00002), especially in males with high triglycerides (P = 0.0000009). Expression profiles in fat biopsy samples from individuals with FCHL seemed to differ depending on their carrier status for the associated USF1 haplotype. USF1 encodes a transcription factor known to regulate several genes of glucose and lipid metabolism(14-17).	Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Biomedicum, FIN-00290 Helsinki, Finland; Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath & Biostat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, UCLA DOE, Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; Univ Kuopio, FIN-70211 Kuopio, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Finland National Institute for Health & Welfare; University of Helsinki; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland	Pajukanta, P (corresponding author), Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA.	ppajukanta@mednet.ucla.edu; leena.peltonen@ktl.fi	Saarela, Janna S/E-5369-2014; Taskinen, Marja-Riitta/AAN-5432-2020	Taskinen, Marja-Riitta/0000-0002-6229-3588; Saarela, Janna/0000-0002-0853-6219				Allayee H, 2002, CIRC RES, V90, P926, DOI 10.1161/01.RES.0000015885.27134.F0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Casado M, 1999, J BIOL CHEM, V274, P2009, DOI 10.1074/jbc.274.4.2009; Coon H, 2000, ARTERIOSCL THROM VAS, V20, P2275, DOI 10.1161/01.ATV.20.10.2275; Elbein SC, 1999, DIABETES, V48, P1175, DOI 10.2337/diabetes.48.5.1175; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HOSACK DA, 2003, GENOME BIOL, V4; Hsueh WC, 2003, DIABETES, V52, P550, DOI 10.2337/diabetes.52.2.550; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; NIKKILA EA, 1973, LANCET, V1, P954; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Pei WD, 2000, CLIN GENET, V57, P29, DOI 10.1034/j.1399-0004.2000.570105.x; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; Sinsheimer JS, 2000, AM J HUM GENET, V66, P1168, DOI 10.1086/302826; Soro A, 2003, J LIPID RES, V44, P1536, DOI 10.1194/jlr.M300069-JLR200; Terwilliger JD, 2000, HUM BIOL, V72, P63; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Vakkilainen J, 2002, J LIPID RES, V43, P598; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; Vionnet N, 2000, AM J HUM GENET, V67, P1470, DOI 10.1086/316887; Watanabe RM, 2000, AM J HUM GENET, V67, P1186; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249	30	252	262	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					371	376		10.1038/ng1320	http://dx.doi.org/10.1038/ng1320			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	14991056	Bronze			2022-12-27	WOS:000220647200020
J	Takamiya, K; Kostourou, V; Adams, S; Jadeja, S; Chalepakis, G; Scambler, PJ; Huganir, RL; Adams, RH				Takamiya, K; Kostourou, V; Adams, S; Jadeja, S; Chalepakis, G; Scambler, PJ; Huganir, RL; Adams, RH			A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1	NATURE GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA; BLEBBED PHENOTYPE; PROTEOGLYCAN NG2; MOUSE; MICE; DERIVATION; MEMBRANE; MODEL; CELLS	Cell adhesion to extracellular matrix (ECM) proteins is crucial for the structural integrity of tissues and epithelial-mesenchymal interactions mediating organ morphogenesis(1,2). Here we describe how the loss of a cytoplasmic multi-PDZ scaffolding protein, glutamate receptor interacting protein 1 (GRIP1), leads to the formation of subepidermal hemorrhagic blisters, renal agenesis, syndactyly or polydactyly and permanent fusion of eyelids (cryptophthalmos). Similar malformations are characteristic of individuals with Fraser syndrome and animal models of this human genetic disorder, such as mice carrying the blebbed mutation (bl) in the gene encoding the Fras1 ECM protein(3,4). GRIP1 can physically interact with Fras1 and is required for the localization of Fras1 to the basal side of cells. In one animal model of Fraser syndrome, the eye-blebs (eb) mouse, Grip1 is disrupted by a deletion of two coding exons. Our data indicate that GRIP1 is required for normal cell-matrix interactions during early embryonic development and that inactivation of Grip1 causes Fraser syndrome like defects in mice.	Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Crete, Dept Biol, Iraklion 71409, Crete, Greece	Cancer Research UK; Howard Hughes Medical Institute; Johns Hopkins University; University of London; University College London; University of Crete	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@cancer.org.uk	Adams, Ralf H/AAE-9274-2019; Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Takamiya, Kogo/0000-0001-7240-6307; Kostourou, Vassiliki/0000-0001-7053-6247				Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Darling S, 1994, Clin Dysmorphol, V3, P91; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Harris BZ, 2001, J CELL SCI, V114, P3219; Heinonen S, 1999, J CELL SCI, V112, P3641; HUMMEL KP, 1971, MOUSE NEWS LETT, V45, P29; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Swiergiel JJ, 2000, DEV DYNAM, V219, P21, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1030>3.0.CO;2-S; Tillet E, 1997, J BIOL CHEM, V272, P10769; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; WINTER RM, 1990, CLIN GENET, V37, P494	20	101	107	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					172	177		10.1038/ng1292	http://dx.doi.org/10.1038/ng1292			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14730302	Bronze			2022-12-27	WOS:000188542700020
J	Balmain, A; Gray, J; Ponder, B				Balmain, A; Gray, J; Ponder, B			The genetics and genomics of cancer	NATURE GENETICS			English	Review							FLUORESCENCE INSITU HYBRIDIZATION; FAMILIAL BREAST-CANCER; TUMOR MODIFIER LOCI; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CENTROSOME AMPLIFICATION; SV40-TRANSFORMED CELLS; HAPLO-INSUFFICIENT; SOMATIC MUTATIONS; P53 MUTATIONS	The past decade has seen great strides in our understanding of the genetic basis of human disease. Arguably, the most profound impact has been in the area of cancer genetics, where the explosion of genomic sequence and molecular profiling data has illustrated the complexity of human malignancies. In a tumor cell, dozens of different genes may be aberrant in structure or copy number, and hundreds or thousands of genes may be differentially expressed. A number of familial cancer genes with high-penetrance mutations have been identified, but the contribution of low-penetrance genetic variants or polymorphisms to the risk of sporadic cancer development remains unclear. Studies of the complex somatic genetic events that take place in the emerging cancer cell may aid the search for the more elusive germline variants that confer increased susceptibility. Insights into the molecular pathogenesis of cancer have provided new strategies for treatment, but a deeper understanding of this disease will require new statistical and computational approaches for analysis of the genetic and signaling networks that orchestrate individual cancer susceptibility and tumor behavior.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Canc Res UK, Dept Oncol, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Balmain, A (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu; jgray@cc.ucsf.edu; bajp@mole.bio.cam.ac.uk						Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; BAKER RC, 1989, ACTA ARITH, V53, P217, DOI 10.4064/aa-53-3-217-250; Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Bernard PS, 2002, CLIN CHEM, V48, P1178; Bernardi R, 2002, ONCOGENE, V21, P3445, DOI 10.1038/sj.onc.1205313; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; BUELL P, 1965, CANCER, V18, P656, DOI 10.1002/1097-0142(196505)18:5<656::AID-CNCR2820180515>3.0.CO;2-3; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Conrads TP, 2000, ANAL CHEM, V72, P3349, DOI 10.1021/ac0002386; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies RJ, 2002, LANCET, V359, P1917, DOI 10.1016/S0140-6736(02)08739-1; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; ENG C, 2002, GENETIC BASIS HUMAN, P527; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Frame S, 2000, CURR OPIN GENET DEV, V10, P106, DOI 10.1016/S0959-437X(99)00052-0; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ginzinger DG, 2000, CANCER RES, V60, P5405; Gong G, 2001, CLIN CANCER RES, V7, P2410; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYASHIZAKI Y, 1993, ELECTROPHORESIS, V14, P251, DOI 10.1002/elps.1150140145; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Ji L, 2002, CANCER RES, V62, P2715; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kinzler K.W., 2002, GENETIC BASIS HUMAN, V2, P583; Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Linardopoulos S, 2000, INT J CANCER, V88, P920, DOI 10.1002/1097-0215(20001215)88:6<920::AID-IJC13>3.0.CO;2-#; LINEHAN WM, 2002, GENETIC BASIS HUMAN, P449; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Lynch HT, 1999, J MED GENET, V36, P801; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Marx J, 2002, SCIENCE, V297, P544, DOI 10.1126/science.297.5581.544; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nagase H, 2001, CANCER RES, V61, P1305; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olumi AF, 1999, CANCER RES, V59, P5002; PARSONS R, 1995, CANCER RES, V55, P5548; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peto J, 2002, CANCER CELL, V1, P411, DOI 10.1016/S1535-6108(02)00079-X; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; PETO J, 1980, BANBURY REPORT, P203; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; REHMAN I, 1994, LANCET, V344, P788, DOI 10.1016/S0140-6736(94)92343-4; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Saran A, 2000, INT J CANCER, V88, P424, DOI 10.1002/1097-0215(20001101)88:3<424::AID-IJC15>3.0.CO;2-D; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHOR SL, 1985, J CELL SCI, V73, P235; Shaaban AM, 2002, AM J SURG PATHOL, V26, P421, DOI 10.1097/00000478-200204000-00003; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vogel CL, 2001, ONCOLOGY-BASEL, V61, P37, DOI 10.1159/000055400; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wright AF, 2001, GENOME BIOL, V2; YOU M, 1992, P NATL ACAD SCI USA, V89, P5804, DOI 10.1073/pnas.89.13.5804; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	108	399	423	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			238	244		10.1038/ng1107	http://dx.doi.org/10.1038/ng1107			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610533				2022-12-27	WOS:000181390900004
J	Neptune, ER; Frischmeyer, PA; Arking, DE; Myers, L; Bunton, TE; Gayraud, B; Ramirez, F; Sakai, LY; Dietz, HC				Neptune, ER; Frischmeyer, PA; Arking, DE; Myers, L; Bunton, TE; Gayraud, B; Ramirez, F; Sakai, LY; Dietz, HC			Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; MOUSE MODEL; IN-VIVO; LUNG; ALVEOGENESIS; MICROFIBRILS; GENE	Marfan syndrome is an autosomal dominant disorder of connective tissue caused by mutations in fibrillin-1 (encoded by FBN1 in humans and Fbn1 in mice), a matrix component of extracellular microfibrils. A distinct subgroup of individuals with Marfan syndrome have distal airspace enlargement, historically described as emphysema, which frequently results in spontaneous lung rupture (pneumothorax; refs.(1-3)). To investigate the pathogenesis of genetically imposed emphysema, we analyzed the lung phenotype of mice deficient in fibrillin-1, an accepted model of Marfan syndrome(4). Lung abnormalities are evident in the immediate postnatal period and manifest as a developmental impairment of distal alveolar septation. Aged mice deficient in fibrillin-1 develop destructive emphysema consistent with the view that early developmental perturbations can predispose to late-onset, seemingly acquired phenotypes. We show that mice deficient in fibrillin-1 have marked dysregulation of transforming growth factor-beta (TGF-beta) activation and signaling, resulting in apoptosis in the developing lung. Perinatal antagonism of TGF-beta attenuates apoptosis and rescues alveolar septation in vivo. These data indicate that matrix sequestration of cytokines is crucial to their regulated activation and signaling and that perturbation of this function can contribute to the pathogenesis of disease.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; Dupont Merck Pharmaceut Co, Dept Safety Assessment, Newark, DE 19714 USA; Hosp Special Surg, New York, NY 10021 USA; Shriners Hosp Children, Portland, OR 97201 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; DuPont; Howard Hughes Medical Institute; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA.			Gayraud-Morel, Barbara/0000-0002-1168-8504				BARCELLOSHOFF MH, 1995, AM J PATHOL, V147, P1228; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DWYER EM, 1965, ANN INTERN MED, V62, P1285, DOI 10.7326/0003-4819-62-6-1285; FLANDERS KC, 1989, J CELL BIOL, V108, P653, DOI 10.1083/jcb.108.2.653; HALL JR, 1984, ANN THORAC SURG, V37, P500, DOI 10.1016/S0003-4975(10)61142-3; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273; Unsold C, 2001, J CELL SCI, V114, P187; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780; Yamamoto T, 1999, CLIN IMMUNOL, V92, P6, DOI 10.1006/clim.1999.4720; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	24	1048	1087	4	94	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2003	33	3					407	411		10.1038/ng1116	http://dx.doi.org/10.1038/ng1116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651GT	12598898				2022-12-27	WOS:000181312700020
J	Pruitt, RE; Bowman, JL; Grossniklaus, U				Pruitt, RE; Bowman, JL; Grossniklaus, U			Plant genetics: a decade of integration	NATURE GENETICS			English	Review							FLORAL HOMEOTIC GENE; BLUE-LIGHT RECEPTORS; POLYCOMB-GROUP GENE; MADS-BOX GENES; SACCHAROMYCES-CEREVISIAE GENOME; OVERDOMINANT EPISTATIC LOCI; DISRUPTS CIRCADIAN-RHYTHMS; DISEASE RESISTANCE GENES; QUANTITATIVE TRAIT LOCUS; ARABIDOPSIS-THALIANA	The last decade provided the plant science community with the complete genome sequence of Arabidopsis thaliana and rice, tools to investigate the function of potentially every plant gene, methods to dissect virtually any aspect of the plant life cycle, and a wealth of information on gene expression and protein function. Focusing on Arabidopsis as a model system has led to an integration of the plant sciences that triggered the development of new technologies and concepts benefiting plant research in general. These enormous changes led to an unprecedented increase in our understanding of the genetic basis and molecular mechanisms of developmental, physiological and biochemical processes, some of which will be discussed in this article.	Cold Spring Harbor Lab, Arabidopsis Mol Genet Course, Cold Spring Harbor, NY 11724 USA; Purdue Univ, W Lafayette, IN 47907 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	Cold Spring Harbor Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Davis; University of Zurich; University of Zurich	Grossniklaus, U (corresponding author), Cold Spring Harbor Lab, Arabidopsis Mol Genet Course, POB 100, Cold Spring Harbor, NY 11724 USA.	grossnik@botinst.unizh.ch	Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Bowman, John/0000-0001-7347-3691; Pruitt, Robert E/0000-0003-4817-5806				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Ahmad M, 1998, NATURE, V392, P720, DOI 10.1038/33701; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Alonso-Blanco C, 1998, GENETICS, V149, P749; Alvarez J, 1999, DEVELOPMENT, V126, P2377; Amasino RM, 1996, CURR OPIN GENET DEV, V6, P480, DOI 10.1016/S0959-437X(96)80071-2; Ambrose BA, 2000, MOL CELL, V5, P569, DOI 10.1016/S1097-2765(00)80450-5; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; ANGENENT GC, 1994, PLANT J, V5, P33, DOI 10.1046/j.1365-313X.1994.5010033.x; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; Bagnall DJ, 2001, AUST J PLANT PHYSIOL, V28, P401, DOI 10.1071/PP99123; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Briggs WR, 2001, PLANT PHYSIOL, V125, P85, DOI 10.1104/pp.125.1.85; BRINK RA, 1958, COLD SPRING HARB SYM, V23, P379, DOI 10.1101/SQB.1958.023.01.036; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; CARPENTER R, 1990, GENE DEV, V4, P1483, DOI 10.1101/gad.4.9.1483; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; CENTURY KS, 1995, P NATL ACAD SCI USA, V92, P6597, DOI 10.1073/pnas.92.14.6597; Chatterjee A, 2000, J PLANT GROWTH REGUL, V19, P284, DOI 10.1007/s003440000032; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; CHORY J, 1989, CELL, V58, P991, DOI 10.1016/0092-8674(89)90950-1; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Correns C. J., 1900, BERICHTE DTSCH BOT G, V18, P158, DOI DOI 10.1111/J.1438-8677.1900.TB04893.X; Coupland G, 1997, PLANT CELL ENVIRON, V20, P785, DOI 10.1046/j.1365-3040.1997.d01-114.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Vries H, 1900, CR HEBD ACAD SCI, V130, P845; DEHESH K, 1993, PLANT CELL, V5, P1081, DOI 10.1105/tpc.5.9.1081; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Dudash MR, 1998, NATURE, V393, P682, DOI 10.1038/31468; DUNLAP JC, 2002, ADV GENET, V46; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; ESHED Y, 1995, GENETICS, V141, P1147; ESTELLE MA, 1986, TRENDS GENET, V2, P89, DOI 10.1016/0168-9525(86)90190-3; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Galton F, 1889, NATURAL INHERITANCE, P1; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goethe J., 1946, CHRON BOT, V10, P67; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Grossniklaus U, 2001, CURR OPIN PLANT BIOL, V4, P21, DOI 10.1016/S1369-5266(00)00130-8; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; HAGEMANN R, 1958, Z VEREBUNGSL, V89, P587, DOI 10.1007/BF00889089; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Harushima Y, 2002, GENETICS, V160, P313; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Jorgensen RA, 1998, SCIENCE, V279, P1486, DOI 10.1126/science.279.5356.1486; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KEMPIN SA, 1995, SCIENCE, V267, P522, DOI 10.1126/science.7824951; KERMICLE JL, 1970, GENETICS, V66, P69; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kohler C, 2002, CURR OPIN CELL BIOL, V14, P773, DOI 10.1016/S0955-0674(02)00394-0; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef Maarten, 1994, P601; Krizek BA, 1996, DEVELOPMENT, V122, P11; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kyozuka J, 2000, PLANT CELL PHYSIOL, V41, P710, DOI 10.1093/pcp/41.6.710; LAIBACH F., 1943, BOT ARCH [LEIPZIG], V44, P439; LAIBACH F, 1907, BOT CBL S, V22, P197; Lamb RS, 2002, DEVELOPMENT, V129, P2079; LANDER ES, 1989, GENETICS, V121, P185; LANGRIDGE J, 1955, NATURE, V176, P260, DOI 10.1038/176260b0; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li Y, 2001, Biotechnol Annu Rev, V7, P239, DOI 10.1016/S1387-2656(01)07039-9; Li ZK, 2001, GENETICS, V158, P1737; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; LISCUM E, 2002, ARABIDOPSIS BOOK, DOI DOI 10.1199/TAB.0042; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; Luo LJ, 2001, GENETICS, V158, P1755; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MANDEL MA, 1992, CELL, V71, P133, DOI 10.1016/0092-8674(92)90272-E; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Mather K., 1949, BIOMETRICAL GENETICS; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Matzke Marjori A, 2002, Adv Genet, V46, P235; MCCLINTOCK B, 1965, BROOKHAVEN SYM BIOL, P162; MCCLUNG CR, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0044; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; MEYEROWITZ EM, 1985, SCIENCE, V229, P1214, DOI 10.1126/science.229.4719.1214; MEYEROWITZ EM, 1987, ANNU REV GENET, V21, P93, DOI 10.1146/annurev.genet.21.1.93; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MOOREEDE CM, 1982, CLOCKS TIME US; Morel JB, 2000, PLANT MOL BIOL, V43, P275, DOI 10.1023/A:1006499832424; Mouradov A, 1999, DEV GENET, V25, P245, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;245::AID-DVG7&gt;3.0.CO;2-N; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Neff MM, 2000, GENE DEV, V14, P257; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pelaz S, 2001, CURR BIOL, V11, P182, DOI 10.1016/S0960-9822(01)00024-0; Pineiro M, 1998, PLANT PHYSIOL, V117, P1, DOI 10.1104/pp.117.1.1; PIRROTTA V, 1995, CURR OPIN GENET DEV, V5, P466, DOI 10.1016/0959-437X(95)90050-Q; PNUELI L, 1994, PLANT CELL, V6, P175, DOI 10.1105/tpc.6.2.175; Potrykus I, 2001, PLANT PHYSIOL, V125, P1157, DOI 10.1104/pp.125.3.1157; PRUITT RE, 1986, J MOL BIOL, V187, P169, DOI 10.1016/0022-2836(86)90226-3; Quail PH, 1998, PHILOS T R SOC B, V353, P1399, DOI 10.1098/rstb.1998.0294; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Raikhel NV, 2001, PLANT PHYSIOL, V127, P1325, DOI 10.1104/pp.127.4.1325; REDEI GP, 1962, GENETICS, V47, P443; REDEI GP, 1975, ANNU REV GENET, V9, P111, DOI 10.1146/annurev.ge.09.120175.000551; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Riddihough G, 2001, SCIENCE, V293, P1063, DOI 10.1126/science.293.5532.1063; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schaefer DG, 2001, CURR OPIN PLANT BIOL, V4, P143, DOI 10.1016/S1369-5266(00)00150-3; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Scheid OM, 2000, PLANT MOL BIOL, V43, P235, DOI 10.1023/A:1006487529698; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schneider DS, 2002, CELL, V109, P537, DOI 10.1016/S0092-8674(02)00764-X; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; SMITH CJS, 1990, MOL GEN GENET, V224, P477, DOI 10.1007/BF00262443; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sundstrom J, 1999, DEV GENET, V25, P253, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;253::AID-DVG8&gt;3.0.CO;2-P; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Tandre K, 1998, PLANT J, V15, P615, DOI 10.1046/j.1365-313x.1998.00236.x; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Tschermak-Seysenegg Ev, 1900, BERICHTE DTSCH BOTAN, V18, P232; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van Lohuizen M, 1999, CURR OPIN GENET DEV, V9, P355, DOI 10.1016/S0959-437X(99)80053-7; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Whitelam GC, 1998, PHILOS T ROY SOC B, V353, P1445, DOI 10.1098/rstb.1998.0300; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yano M, 2001, PLANT PHYSIOL, V127, P1425, DOI 10.1104/pp.010710; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	221	25	26	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2003	33			S			294	304		10.1038/ng1108	http://dx.doi.org/10.1038/ng1108			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	652QY	12610539				2022-12-27	WOS:000181390900010
J	Ozaki, K; Ohnishi, Y; Iida, A; Sekine, A; Yamada, R; Tsunoda, T; Sato, H; Sato, H; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, K; Ohnishi, Y; Iida, A; Sekine, A; Yamada, R; Tsunoda, T; Sato, H; Sato, H; Hori, M; Nakamura, Y; Tanaka, T			Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction	NATURE GENETICS			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; MAXIMUM-LIKELIHOOD-ESTIMATION; E-SELECTIN; HEART-DISEASE; MAST-CELLS; ATHEROSCLEROSIS; RUPTURE; PLAQUE; GENOME; VCAM-1	By means of a large-scale, case-control association study using 92,788 gene-based single-nucleotide polymorphism (SNP) markers, we identified a candidate locus on chromosome 6p21 associated with susceptibility to myocardial infarction. Subsequent linkage-disequilibrium (LD) mapping and analyses of haplotype structure showed significant associations between myocardial infarction and a single 50 kb halpotype comprised of five SNPs in LTA (encoding lymphotoxin-alpha), NFKBIL1 (encoding nuclear factor of kappa light polypeptide gene enhancer in B cells, inhibitor-like 1) and BAT1 (encoding HLA-B associated transcript 1). Homozygosity with respect to each of the two SNPs in LTA was significantly associated with increased risk for myocardial infarction (odds ratio=1.78, chi(2)=21.6, P=0.00000033; 1,133 affected individuals versus 1,006 controls). In vitro functional analyses indicated that one SNP in the coding region of LTA, which changed an amino-acid residue from threonine to asparagine (Thr26Asn), effected a twofold increase in induction of several cell-adhesion molecules, including VCAM1, in vascular smooth-muscle cells of human coronary artery. Moreover, the SNP, in intron 1 of LTA, enhanced the transcriptional level of LTA. These results indicate that variants in the LTA are risk factors for myocardial infraction and implicate LTA in the pathogenesis of the disorder.	RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Lab Genotyping, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Lab Rheumat Dis, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Lab Med Informat,SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Osaka University; University of Tokyo	Tanaka, T (corresponding author), RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Tsunoda, Tatsuhiko/K-2061-2014; Iida, Aritoshi/CAA-1373-2022; Tanaka, Toshihiro/J-9310-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Iida, Aritoshi/0000-0001-7538-1651; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570; Yamada, Ryo/0000-0002-1587-630X				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Belch JJF, 1997, CIRCULATION, V95, P2027, DOI 10.1161/01.CIR.95.8.2027; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Breslow JL, 1997, NAT MED, V3, P600, DOI 10.1038/nm0697-600; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAVIES MJ, 1985, BRIT HEART J, V53, P363; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; GALLIS ZS, 1994, CIRC RES, V75, P181; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hwang SJ, 1997, CIRCULATION, V96, P4219; Iida A, 2001, J HUM GENET, V46, P668, DOI 10.1007/s100380170019; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; Kaartinen M, 1996, CIRCULATION, V94, P2787, DOI 10.1161/01.CIR.94.11.2787; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Morisaki N, 1997, ATHEROSCLEROSIS, V131, P43, DOI 10.1016/S0021-9150(97)06083-8; OBrien KD, 1996, CIRCULATION, V93, P672, DOI 10.1161/01.CIR.93.4.672; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Squadrito F, 1996, INFLAMM RES, V45, P14, DOI 10.1007/BF02263499; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; VANHAESEBROECK B, 1991, CANCER RES, V51, P2469; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789	27	690	738	1	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					650	654		10.1038/ng1047	http://dx.doi.org/10.1038/ng1047			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12426569				2022-12-27	WOS:000179593000019
J	Slonim, DK				Slonim, DK			From patterns to pathways: gene expression data analysis comes of age	NATURE GENETICS			English	Review							MOLECULAR CLASSIFICATION; CLUSTER-ANALYSIS; CLASS PREDICTION; TIME-SERIES; CANCER; IDENTIFICATION; CARCINOMAS; DISCOVERY; DIAGNOSIS; CIRCUITRY	Many different biological questions are routinely studied using transcriptional profiling on microarrays. A wide range of approaches are available for gleaning insights from the data obtained from such experiments. The appropriate choice of data-analysis technique depends both on the data and on the goals of the experiment. This review summarizes some of the common themes in microarray data analysis, including detection of differential expression, clustering, and predicting sample characteristics. Several approaches to each problem, and their relative merits, are discussed and key areas for additional research highlighted.	Wyeth Res, Dept Genom, Cambridge, MA 02140 USA	Pfizer	Slonim, DK (corresponding author), Wyeth Res, Dept Genom, 35 Cambridge Pk Dr, Cambridge, MA 02140 USA.	dslonim@wyeth.com		Slonim, Donna/0000-0003-3357-437X				Aach J, 2001, BIOINFORMATICS, V17, P495, DOI 10.1093/bioinformatics/17.6.495; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; [Anonymous], 2002, MANUAL SETTING USING; [Anonymous], 576 U CAL BERK DEP S; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; BENDOR A, 2000, 200038 HEBR U I COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bo TH, 2002, GENOME BIOL, V3; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; CALIFANO A, 2000, ISMB, V8, P75; Chatfield C., 1996, ANAL TIME SERIES INT, P283; Chiang D Y, 2001, Bioinformatics, V17 Suppl 1, pS49; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DUDOIT S, 2000, 578 U CAL BERK DEP S; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Filkov V, 2002, J COMPUT BIOL, V9, P317, DOI 10.1089/10665270252935485; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon AD, 1999, CLASSIFICATION; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hastie T, 2001, GENOME BIOL, V2; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes I, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P202; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Ideker T E, 2000, Pac Symp Biocomput, P305; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jain AK., 1988, TECHNOMETRICS; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Khan J, 1998, CANCER RES, V58, P5009; Kohane IS, 2000, J AM MED INFORM ASSN, V7, P512, DOI 10.1136/jamia.2000.0070512; Kohonen T., 1997, SELF ORGANIZING MAPS; Landgrebe J, 2002, GENOME BIOL, V3; Liang S, 1998, Pac Symp Biocomput, P18; Masys DR, 2001, BIOINFORMATICS, V17, P319, DOI 10.1093/bioinformatics/17.4.319; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Mitchell T.M., 1997, MACH LEARN, P414; Model F, 2001, Bioinformatics, V17 Suppl 1, pS157; Park P J, 2001, Pac Symp Biocomput, P52; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Potter JD, 2001, NAT REV GENET, V2, P142, DOI 10.1038/35052575; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Schapire RE, 1998, ANN STAT, V26, P1651; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Segal E, 2001, Bioinformatics, V17 Suppl 1, pS243; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Shatkay H, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P317; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHUMWAY RH, 2000, TIME SERIES ANAL ITS, P560; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Su AI, 2001, CANCER RES, V61, P7388; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Westfall P.H., 1993, RESAMPLING BASED MUL, P340; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; YONA G, 1999, THESIS HEBREW U JERU; Yoo C, 2002, Pac Symp Biocomput, P498; Zar J.H., 1996, BIOSTAT ANAL; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745	98	371	440	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			502	508		10.1038/ng1033	http://dx.doi.org/10.1038/ng1033			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454645				2022-12-27	WOS:000179742900010
J	Lewis, DL; Hagstrom, JE; Loomis, AG; Wolff, JA; Herweijer, H				Lewis, DL; Hagstrom, JE; Loomis, AG; Wolff, JA; Herweijer, H			Efficient delivery of siRNA for inhibition of gene expression in postnatal mice	NATURE GENETICS			English	Article							DOUBLE-STRANDED-RNA; DROSOPHILA CELLS; PLASMID DNA; INTERFERENCE	It has recently been shown that RNA interference can be induced in cultured mammalian cells by delivery of short interfering RNAs (siRNAs). Here we describe a method for efficient in vivo delivery of siRNAs to organs of postnatal mice and demonstrate effective and specific inhibition of transgene expression in a variety of organs.	Mirus Corp, Madison, WI 53719 USA; Univ Wisconsin, Waisman Ctr, Dept Pediat & Med Genet, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Lewis, DL (corresponding author), Mirus Corp, 505 S Rosa Rd, Madison, WI 53719 USA.							Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	15	461	594	1	55	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2002	32	1					107	108		10.1038/ng944	http://dx.doi.org/10.1038/ng944			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12145662				2022-12-27	WOS:000177714900008
